Gene	gene_allele	U2OS_cc_t_stat	U2OS_cc_t_pval	U2OS_prot_abun_t_stat	U2OS_prot_abun_t_pval	Metadata_Bio_Batch	Altered_95th_perc_both_batches_GFP	Altered_95th_perc_both_batches_DNA	Altered_95th_perc_both_batches_Mito	Altered_95th_perc_both_batches_AGP	Altered_95th_perc_both_batches_Morph	Altered_99th_perc_both_batches_GFP	Altered_99th_perc_both_batches_DNA	Altered_99th_perc_both_batches_Mito	Altered_99th_perc_both_batches_AGP	Altered_99th_perc_both_batches_Morph	AUROC_Mean_GFP	AUROC_Mean_DNA	AUROC_Mean_Mito	AUROC_Mean_AGP	AUROC_Mean_Morph	AUROC_BioRep1_Morph	AUROC_BioRep1_AGP	AUROC_BioRep1_Mito	AUROC_BioRep1_DNA	AUROC_BioRep1_GFP	AUROC_BioRep2_Morph	AUROC_BioRep2_AGP	AUROC_BioRep2_Mito	AUROC_BioRep2_DNA	AUROC_BioRep2_GFP	Gene_right	U2OS_cc_t_stat_right	U2OS_cc_t_pval_right	U2OS_prot_abun_t_stat_right	U2OS_prot_abun_t_pval_right	Metadata_Bio_Batch_right	Altered_95th_perc_both_batches_GFP_right	Altered_95th_perc_both_batches_DNA_right	Altered_95th_perc_both_batches_Mito_right	Altered_95th_perc_both_batches_AGP_right	Altered_95th_perc_both_batches_Morph_right	Altered_99th_perc_both_batches_GFP_right	Altered_99th_perc_both_batches_DNA_right	Altered_99th_perc_both_batches_Mito_right	Altered_99th_perc_both_batches_AGP_right	Altered_99th_perc_both_batches_Morph_right	AUROC_Mean_GFP_right	AUROC_Mean_DNA_right	AUROC_Mean_Mito_right	AUROC_Mean_AGP_right	AUROC_Mean_Morph_right	AUROC_BioRep1_Morph_right	AUROC_BioRep1_AGP_right	AUROC_BioRep1_Mito_right	AUROC_BioRep1_DNA_right	AUROC_BioRep1_GFP_right	AUROC_BioRep2_Morph_right	AUROC_BioRep2_AGP_right	AUROC_BioRep2_Mito_right	AUROC_BioRep2_DNA_right	AUROC_BioRep2_GFP_right	symbol	ensembl_gene_id	orf_id	mut_id	ccsb_mutation_id	ccsb_allele_id	spdi	nt_change	aa_change	collection	entry_plate_orig	entry_well_orig	entry_plate_conso	entry_well_conso	entry_seq_pool	db_plate	db_well	n2h_plate	n2h_well	dualip_plate	dualip_well	mislocalization_plate	mislocalization_well	entry_sequenced	entry_sequence_confirmation_class	db_sequenced	db_sequence_confirmation_class	n2h_sequenced	n2h_sequence_confirmation_class	n2h_ref_sequence_confirmation_class	dualip_sequenced	dualip_sequence_confirmation_class	dualip_ref_sequence_confirmation_class	mislocalization_sequenced	mislocalization_sequence_confirmation_class	mislocalization_ref_sequence_confirmation_class	chr_num	nuc_loc	ref_allele	alt_allele	Chrom	entry_seq_final	db_seq_final	n2h_seq_final	dualip_seq_final	mislocalization_seq_final	varid	#AlleleID	Type	Name	GeneID	GeneSymbol	HGNC_ID	ClinicalSignificance	ClinSigSimple	LastEvaluated	RS# (dbSNP)	nsv/esv (dbVar)	RCVaccession	PhenotypeIDS	PhenotypeList	Origin	OriginSimple	Assembly	ChromosomeAccession	Chromosome	Start	Stop	Cytogenetic	ReviewStatus	NumberSubmitters	Guidelines	TestedInGTR	OtherIDs	SubmitterCategories	VariationID	PositionVCF	ReferenceAlleleVCF	AlternateAlleleVCF	SomaticClinicalImpact	SomaticClinicalImpactLastEvaluated	ReviewStatusClinicalImpact	Oncogenicity	OncogenicityLastEvaluated	ReviewStatusOncogenicity	SCVsForAggregateGermlineClassification	SCVsForAggregateSomaticClinicalImpact	SCVsForAggregateOncogenicityClassification	clinvar_nt_change	clinvar_aa_change	RefSeq_mRNA	StarStatus	clinvar_clnsig_clean	gnomad_af	clinvar_id	#chr	pos(1-based)	ref	alt	aaref	aaalt	rs_dbSNP	hg19_chr	hg19_pos(1-based)	hg18_chr	hg18_pos(1-based)	aapos	genename	Ensembl_geneid	Ensembl_transcriptid	Ensembl_proteinid	Uniprot_acc	Uniprot_entry	HGVSc_snpEff	HGVSp_snpEff	HGVSc_VEP	HGVSp_VEP	APPRIS	GENCODE_basic	TSL	VEP_canonical	MANE	cds_strand	refcodon	codonpos	codon_degeneracy	Ancestral_allele	AltaiNeandertal	Denisova	VindijiaNeandertal	ChagyrskayaNeandertal	SIFT_score	SIFT_converted_rankscore	SIFT_pred	SIFT4G_score	SIFT4G_converted_rankscore	SIFT4G_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationTaster_model	MutationTaster_trees_benign	MutationTaster_trees_deleterious	MutationAssessor_score	MutationAssessor_rankscore	MutationAssessor_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST4_score	VEST4_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	Reliability_index	MetaRNN_score	MetaRNN_rankscore	MetaRNN_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	REVEL_score	REVEL_rankscore	MutPred_score	MutPred_rankscore	MutPred_protID	MutPred_AAchange	MutPred_Top5features	MVP_score	MVP_rankscore	gMVP_score	gMVP_rankscore	MPC_score	MPC_rankscore	PrimateAI_score	PrimateAI_rankscore	PrimateAI_pred	DEOGEN2_score	DEOGEN2_rankscore	DEOGEN2_pred	BayesDel_addAF_score	BayesDel_addAF_rankscore	BayesDel_addAF_pred	BayesDel_noAF_score	BayesDel_noAF_rankscore	BayesDel_noAF_pred	ClinPred_score	ClinPred_rankscore	ClinPred_pred	LIST-S2_score	LIST-S2_rankscore	LIST-S2_pred	VARITY_R_score	VARITY_R_rankscore	VARITY_ER_score	VARITY_ER_rankscore	VARITY_R_LOO_score	VARITY_R_LOO_rankscore	VARITY_ER_LOO_score	VARITY_ER_LOO_rankscore	ESM1b_score	ESM1b_rankscore	ESM1b_pred	AlphaMissense_score	AlphaMissense_rankscore	AlphaMissense_pred	PHACTboost_score	PHACTboost_rankscore	MutFormer_score	MutFormer_rankscore	MutScore_score	MutScore_rankscore	Aloft_Fraction_transcripts_affected	Aloft_prob_Tolerant	Aloft_prob_Recessive	Aloft_prob_Dominant	Aloft_pred	Aloft_Confidence	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-XF_coding_score	fathmm-XF_coding_rankscore	fathmm-XF_coding_pred	Eigen-raw_coding	Eigen-raw_coding_rankscore	Eigen-phred_coding	Eigen-PC-raw_coding	Eigen-PC-raw_coding_rankscore	Eigen-PC-phred_coding	GERP++_NR	GERP++_RS	GERP++_RS_rankscore	GERP_91_mammals	GERP_91_mammals_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP470way_mammalian	phyloP470way_mammalian_rankscore	phyloP17way_primate	phyloP17way_primate_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons470way_mammalian	phastCons470way_mammalian_rankscore	phastCons17way_primate	phastCons17way_primate_rankscore	bStatistic	bStatistic_converted_rankscore	1000Gp3_AC	1000Gp3_AF	1000Gp3_AFR_AC	1000Gp3_AFR_AF	1000Gp3_EUR_AC	1000Gp3_EUR_AF	1000Gp3_AMR_AC	1000Gp3_AMR_AF	1000Gp3_EAS_AC	1000Gp3_EAS_AF	1000Gp3_SAS_AC	1000Gp3_SAS_AF	TOPMed_frz8_AC	TOPMed_frz8_AN	TOPMed_frz8_AF	gnomAD2.1.1_exomes_flag	gnomAD2.1.1_exomes_controls_AC	gnomAD2.1.1_exomes_controls_AN	gnomAD2.1.1_exomes_controls_AF	gnomAD2.1.1_exomes_controls_nhomalt	gnomAD2.1.1_exomes_non_neuro_AC	gnomAD2.1.1_exomes_non_neuro_AN	gnomAD2.1.1_exomes_non_neuro_AF	gnomAD2.1.1_exomes_non_neuro_nhomalt	gnomAD2.1.1_exomes_non_cancer_AC	gnomAD2.1.1_exomes_non_cancer_AN	gnomAD2.1.1_exomes_non_cancer_AF	gnomAD2.1.1_exomes_non_cancer_nhomalt	gnomAD2.1.1_exomes_controls_AFR_AC	gnomAD2.1.1_exomes_controls_AFR_AN	gnomAD2.1.1_exomes_controls_AFR_AF	gnomAD2.1.1_exomes_controls_AFR_nhomalt	gnomAD2.1.1_exomes_controls_AMR_AC	gnomAD2.1.1_exomes_controls_AMR_AN	gnomAD2.1.1_exomes_controls_AMR_AF	gnomAD2.1.1_exomes_controls_AMR_nhomalt	gnomAD2.1.1_exomes_controls_ASJ_AC	gnomAD2.1.1_exomes_controls_ASJ_AN	gnomAD2.1.1_exomes_controls_ASJ_AF	gnomAD2.1.1_exomes_controls_ASJ_nhomalt	gnomAD2.1.1_exomes_controls_EAS_AC	gnomAD2.1.1_exomes_controls_EAS_AN	gnomAD2.1.1_exomes_controls_EAS_AF	gnomAD2.1.1_exomes_controls_EAS_nhomalt	gnomAD2.1.1_exomes_controls_FIN_AC	gnomAD2.1.1_exomes_controls_FIN_AN	gnomAD2.1.1_exomes_controls_FIN_AF	gnomAD2.1.1_exomes_controls_FIN_nhomalt	gnomAD2.1.1_exomes_controls_NFE_AC	gnomAD2.1.1_exomes_controls_NFE_AN	gnomAD2.1.1_exomes_controls_NFE_AF	gnomAD2.1.1_exomes_controls_NFE_nhomalt	gnomAD2.1.1_exomes_controls_SAS_AC	gnomAD2.1.1_exomes_controls_SAS_AN	gnomAD2.1.1_exomes_controls_SAS_AF	gnomAD2.1.1_exomes_controls_SAS_nhomalt	gnomAD2.1.1_exomes_controls_POPMAX_AC	gnomAD2.1.1_exomes_controls_POPMAX_AN	gnomAD2.1.1_exomes_controls_POPMAX_AF	gnomAD2.1.1_exomes_controls_POPMAX_nhomalt	gnomAD2.1.1_exomes_non_neuro_AFR_AC	gnomAD2.1.1_exomes_non_neuro_AFR_AN	gnomAD2.1.1_exomes_non_neuro_AFR_AF	gnomAD2.1.1_exomes_non_neuro_AFR_nhomalt	gnomAD2.1.1_exomes_non_neuro_AMR_AC	gnomAD2.1.1_exomes_non_neuro_AMR_AN	gnomAD2.1.1_exomes_non_neuro_AMR_AF	gnomAD2.1.1_exomes_non_neuro_AMR_nhomalt	gnomAD2.1.1_exomes_non_neuro_ASJ_AC	gnomAD2.1.1_exomes_non_neuro_ASJ_AN	gnomAD2.1.1_exomes_non_neuro_ASJ_AF	gnomAD2.1.1_exomes_non_neuro_ASJ_nhomalt	gnomAD2.1.1_exomes_non_neuro_EAS_AC	gnomAD2.1.1_exomes_non_neuro_EAS_AN	gnomAD2.1.1_exomes_non_neuro_EAS_AF	gnomAD2.1.1_exomes_non_neuro_EAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_FIN_AC	gnomAD2.1.1_exomes_non_neuro_FIN_AN	gnomAD2.1.1_exomes_non_neuro_FIN_AF	gnomAD2.1.1_exomes_non_neuro_FIN_nhomalt	gnomAD2.1.1_exomes_non_neuro_NFE_AC	gnomAD2.1.1_exomes_non_neuro_NFE_AN	gnomAD2.1.1_exomes_non_neuro_NFE_AF	gnomAD2.1.1_exomes_non_neuro_NFE_nhomalt	gnomAD2.1.1_exomes_non_neuro_SAS_AC	gnomAD2.1.1_exomes_non_neuro_SAS_AN	gnomAD2.1.1_exomes_non_neuro_SAS_AF	gnomAD2.1.1_exomes_non_neuro_SAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_POPMAX_AC	gnomAD2.1.1_exomes_non_neuro_POPMAX_AN	gnomAD2.1.1_exomes_non_neuro_POPMAX_AF	gnomAD2.1.1_exomes_non_neuro_POPMAX_nhomalt	gnomAD2.1.1_exomes_non_cancer_AFR_AC	gnomAD2.1.1_exomes_non_cancer_AFR_AN	gnomAD2.1.1_exomes_non_cancer_AFR_AF	gnomAD2.1.1_exomes_non_cancer_AFR_nhomalt	gnomAD2.1.1_exomes_non_cancer_AMR_AC	gnomAD2.1.1_exomes_non_cancer_AMR_AN	gnomAD2.1.1_exomes_non_cancer_AMR_AF	gnomAD2.1.1_exomes_non_cancer_AMR_nhomalt	gnomAD2.1.1_exomes_non_cancer_ASJ_AC	gnomAD2.1.1_exomes_non_cancer_ASJ_AN	gnomAD2.1.1_exomes_non_cancer_ASJ_AF	gnomAD2.1.1_exomes_non_cancer_ASJ_nhomalt	gnomAD2.1.1_exomes_non_cancer_EAS_AC	gnomAD2.1.1_exomes_non_cancer_EAS_AN	gnomAD2.1.1_exomes_non_cancer_EAS_AF	gnomAD2.1.1_exomes_non_cancer_EAS_nhomalt	gnomAD2.1.1_exomes_non_cancer_FIN_AC	gnomAD2.1.1_exomes_non_cancer_FIN_AN	gnomAD2.1.1_exomes_non_cancer_FIN_AF	gnomAD2.1.1_exomes_non_cancer_FIN_nhomalt	gnomAD2.1.1_exomes_non_cancer_NFE_AC	gnomAD2.1.1_exomes_non_cancer_NFE_AN	gnomAD2.1.1_exomes_non_cancer_NFE_AF	gnomAD2.1.1_exomes_non_cancer_NFE_nhomalt	gnomAD2.1.1_exomes_non_cancer_SAS_AC	gnomAD2.1.1_exomes_non_cancer_SAS_AN	gnomAD2.1.1_exomes_non_cancer_SAS_AF	gnomAD2.1.1_exomes_non_cancer_SAS_nhomalt	gnomAD2.1.1_exomes_non_cancer_POPMAX_AC	gnomAD2.1.1_exomes_non_cancer_POPMAX_AN	gnomAD2.1.1_exomes_non_cancer_POPMAX_AF	gnomAD2.1.1_exomes_non_cancer_POPMAX_nhomalt	gnomAD4.1_joint_flag	gnomAD4.1_joint_AC	gnomAD4.1_joint_AN	gnomAD4.1_joint_AF	gnomAD4.1_joint_nhomalt	gnomAD4.1_joint_POPMAX_AC	gnomAD4.1_joint_POPMAX_AN	gnomAD4.1_joint_POPMAX_AF	gnomAD4.1_joint_POPMAX_nhomalt	gnomAD4.1_joint_AFR_AC	gnomAD4.1_joint_AFR_AN	gnomAD4.1_joint_AFR_AF	gnomAD4.1_joint_AFR_nhomalt	gnomAD4.1_joint_AMI_AC	gnomAD4.1_joint_AMI_AN	gnomAD4.1_joint_AMI_AF	gnomAD4.1_joint_AMI_nhomalt	gnomAD4.1_joint_AMR_AC	gnomAD4.1_joint_AMR_AN	gnomAD4.1_joint_AMR_AF	gnomAD4.1_joint_AMR_nhomalt	gnomAD4.1_joint_ASJ_AC	gnomAD4.1_joint_ASJ_AN	gnomAD4.1_joint_ASJ_AF	gnomAD4.1_joint_ASJ_nhomalt	gnomAD4.1_joint_EAS_AC	gnomAD4.1_joint_EAS_AN	gnomAD4.1_joint_EAS_AF	gnomAD4.1_joint_EAS_nhomalt	gnomAD4.1_joint_FIN_AC	gnomAD4.1_joint_FIN_AN	gnomAD4.1_joint_FIN_AF	gnomAD4.1_joint_FIN_nhomalt	gnomAD4.1_joint_MID_AC	gnomAD4.1_joint_MID_AN	gnomAD4.1_joint_MID_AF	gnomAD4.1_joint_MID_nhomalt	gnomAD4.1_joint_NFE_AC	gnomAD4.1_joint_NFE_AN	gnomAD4.1_joint_NFE_AF	gnomAD4.1_joint_NFE_nhomalt	gnomAD4.1_joint_SAS_AC	gnomAD4.1_joint_SAS_AN	gnomAD4.1_joint_SAS_AF	gnomAD4.1_joint_SAS_nhomalt	ALFA_European_AC	ALFA_European_AN	ALFA_European_AF	ALFA_African_Others_AC	ALFA_African_Others_AN	ALFA_African_Others_AF	ALFA_East_Asian_AC	ALFA_East_Asian_AN	ALFA_East_Asian_AF	ALFA_African_American_AC	ALFA_African_American_AN	ALFA_African_American_AF	ALFA_Latin_American_1_AC	ALFA_Latin_American_1_AN	ALFA_Latin_American_1_AF	ALFA_Latin_American_2_AC	ALFA_Latin_American_2_AN	ALFA_Latin_American_2_AF	ALFA_Other_Asian_AC	ALFA_Other_Asian_AN	ALFA_Other_Asian_AF	ALFA_South_Asian_AC	ALFA_South_Asian_AN	ALFA_South_Asian_AF	ALFA_Other_AC	ALFA_Other_AN	ALFA_Other_AF	ALFA_African_AC	ALFA_African_AN	ALFA_African_AF	ALFA_Asian_AC	ALFA_Asian_AN	ALFA_Asian_AF	ALFA_Total_AC	ALFA_Total_AN	ALFA_Total_AF	clinvar_clnsig	clinvar_trait	clinvar_review	clinvar_hgvs	clinvar_var_source	clinvar_MedGen_id	clinvar_OMIM_id	clinvar_Orphanet_id	Interpro_domain	aaref_3	aaalt_3	#AlleleID_dbnsfp	Type_dbnsfp	Name_dbnsfp	GeneID_dbnsfp	GeneSymbol_dbnsfp	HGNC_ID_dbnsfp	ClinicalSignificance_dbnsfp	ClinSigSimple_dbnsfp	LastEvaluated_dbnsfp	RS# (dbSNP)_dbnsfp	nsv/esv (dbVar)_dbnsfp	RCVaccession_dbnsfp	PhenotypeIDS_dbnsfp	PhenotypeList_dbnsfp	Origin_dbnsfp	OriginSimple_dbnsfp	Assembly_dbnsfp	ChromosomeAccession_dbnsfp	Chromosome_dbnsfp	Start_dbnsfp	Stop_dbnsfp	Cytogenetic_dbnsfp	ReviewStatus_dbnsfp	NumberSubmitters_dbnsfp	Guidelines_dbnsfp	TestedInGTR_dbnsfp	OtherIDs_dbnsfp	SubmitterCategories_dbnsfp	VariationID_dbnsfp	PositionVCF_dbnsfp	ReferenceAlleleVCF_dbnsfp	AlternateAlleleVCF_dbnsfp	SomaticClinicalImpact_dbnsfp	SomaticClinicalImpactLastEvaluated_dbnsfp	ReviewStatusClinicalImpact_dbnsfp	Oncogenicity_dbnsfp	OncogenicityLastEvaluated_dbnsfp	ReviewStatusOncogenicity_dbnsfp	SCVsForAggregateGermlineClassification_dbnsfp	SCVsForAggregateSomaticClinicalImpact_dbnsfp	SCVsForAggregateOncogenicityClassification_dbnsfp	clinvar_nt_change_dbnsfp	clinvar_aa_change_dbnsfp	RefSeq_mRNA_dbnsfp	StarStatus_dbnsfp	clinvar_clnsig_clean_dbnsfp	plddt	rsa	OMIM_IDs	inheritance_pattern	disease_modules	disease_module_count	OMIM_disease_names	plddt_f32	rsa_f32	RSA_Category	pLDDT_Category	dualipa_abun_score	dualipa_abun_change	dualipa_abun_chg_dir	ppi_score_final_euclidean	ppi_hit	protein_AA	protein_Accessible surface area (Å²)*	protein_Acetylation	protein_Active site (UniProt)	protein_AlphaFold confidence (pLDDT)	protein_Amino acid properties	protein_Amino acid residues	protein_Binding site (UniProt)	protein_Chain (UniProt)	protein_Coiled coil (UniProt)	protein_Compositional bias (UniProt)	protein_Cross-link (UniProt)	protein_DNA binding (UniProt)	protein_Disease-associated PTMs	protein_Disulfide bond (UniProt)	protein_Domain (UniProt)	protein_Druggability score (fpocket)*	protein_Glycosylation (UniProt)	protein_Hydropathy	protein_Initiator methionine (UniProt)	protein_Inter-chain Disulfide bond (PDB)	protein_Inter-chain Hydrogen bond (PDB)	protein_Inter-chain Non-bonded interaction (PDB)	protein_Inter-chain Salt bridge (PDB)	protein_Intra-chain Disulfide bond (AlphaFold2)	protein_Intra-chain Disulfide bond (PDB)	protein_Intra-chain Hydrogen bond (AlphaFold2)	protein_Intra-chain Hydrogen bond (PDB)	protein_Intra-chain Non-bonded interaction (AlphaFold2)	protein_Intra-chain Non-bonded interaction (PDB)	protein_Intra-chain Salt bridge (AlphaFold2)	protein_Intra-chain Salt bridge (PDB)	protein_Intramembrane (UniProt)	protein_Lipidation (UniProt)	protein_Methylation	protein_Modified residue (UniProt)	protein_Molar mass (g/mol)	protein_Motif (UniProt)	protein_Mutagenesis (UniProt)	protein_Non-adjacent residues (UniProt)	protein_Non-standard residue (UniProt)	protein_Non-terminal residue (UniProt)	protein_O-GalNAc	protein_O-GlcNAc	protein_Peptide (UniProt)	protein_Phi angle (degrees)*	protein_Phosphorylation	protein_Pocket number (fpocket)*	protein_Propeptide (UniProt)	protein_Psi angle (degrees)*	protein_Region (UniProt)	protein_Regulatory sites	protein_Repeat (UniProt)	protein_SNP-associated PTMs	protein_SUMOylation	protein_Secondary structure (DSSP 3-state)*	protein_Secondary structure (DSSP 9-state)*	protein_Secondary structure (PDBe/SIFTS)	protein_Sequence conflict (UniProt)	protein_Sequence uncertainty (UniProt)	protein_Signal (UniProt)	protein_Site (UniProt)	protein_Substrate genes	protein_Topological domain (UniProt)	protein_Transit peptide (UniProt)	protein_Transmembrane (UniProt)	protein_Ubiquitination	protein_Zinc finger (UniProt)	protein_00000096-a-1 avg	protein_00000096-a-1 outliers⁺⁺	protein_00000096-b-1 avg	protein_00000096-b-1 outliers⁺⁺	protein_00000899-a-1 avg	protein_00000899-a-1 outliers⁺⁺	protein_00000050-a-1 avg	protein_00000050-a-1 outliers⁺⁺	protein_00000926-a-1 avg	protein_00000926-a-1 outliers⁺⁺	protein_00000927-a-1 avg	protein_00000927-a-1 outliers⁺⁺	protein_00000928-a-1 avg	protein_00000928-a-1 outliers⁺⁺	protein_00000091-a-1 avg	protein_00000091-a-1 outliers⁺⁺	protein_00000708-a-1 avg	protein_00000708-a-1 outliers⁺⁺	protein_00001200-a-1 avg	protein_00001200-a-1 outliers⁺⁺	protein_00001200-b-1 avg	protein_00001200-b-1 outliers⁺⁺	protein_00001200-c-1 avg	protein_00001200-c-1 outliers⁺⁺	protein_00001200-d-1 avg	protein_00001200-d-1 outliers⁺⁺	protein_00001200-e-1 avg	protein_00001200-e-1 outliers⁺⁺	protein_00000061-a-1 avg	protein_00000061-a-1 outliers⁺⁺	protein_00000061-b-1 avg	protein_00000061-b-1 outliers⁺⁺	protein_00000061-c-1 avg	protein_00000061-c-1 outliers⁺⁺	protein_00000061-d-1 avg	protein_00000061-d-1 outliers⁺⁺	protein_00000061-e-1 avg	protein_00000061-e-1 outliers⁺⁺	protein_00000061-f-1 avg	protein_00000061-f-1 outliers⁺⁺	protein_00000061-g-1 avg	protein_00000061-g-1 outliers⁺⁺	protein_00000061-h-1 avg	protein_00000061-h-1 outliers⁺⁺	protein_00000061-i-1 avg	protein_00000061-i-1 outliers⁺⁺	protein_00001002-a-1 avg	protein_00001002-a-1 outliers⁺⁺	protein_00000001-d-2 avg	protein_00000001-d-2 outliers⁺⁺	protein_00001050-a-1 avg	protein_00001050-a-1 outliers⁺⁺	protein_00000703-a-1 avg	protein_00000703-a-1 outliers⁺⁺	protein_00001087-a-1 avg	protein_00001087-a-1 outliers⁺⁺	image_assayed	gene_variant	protein_00000005-a-1 avg	protein_00000005-a-1 outliers⁺⁺	protein_00000005-a-2 avg	protein_00000005-a-2 outliers⁺⁺	protein_00000005-a-3 avg	protein_00000005-a-3 outliers⁺⁺	protein_00000005-a-4 avg	protein_00000005-a-4 outliers⁺⁺	protein_00000911-a-1 avg	protein_00000911-a-1 outliers⁺⁺	protein_00000875-a-1 avg	protein_00000875-a-1 outliers⁺⁺	protein_00000107-a-1 avg	protein_00000107-a-1 outliers⁺⁺	protein_00000107-b-1 avg	protein_00000107-b-1 outliers⁺⁺	protein_00000114-a-1 avg	protein_00000114-a-1 outliers⁺⁺	protein_00001007-a-1 avg	protein_00001007-a-1 outliers⁺⁺	protein_00000674-a-1 avg	protein_00000674-a-1 outliers⁺⁺	protein_00000674-a-2 avg	protein_00000674-a-2 outliers⁺⁺	protein_00000674-a-3 avg	protein_00000674-a-3 outliers⁺⁺	protein_00000674-a-4 avg	protein_00000674-a-4 outliers⁺⁺	protein_00000998-a-1 avg	protein_00000998-a-1 outliers⁺⁺	protein_00000108-a-1 avg	protein_00000108-a-1 outliers⁺⁺	protein_00000108-a-2 avg	protein_00000108-a-2 outliers⁺⁺	protein_00000108-a-3 avg	protein_00000108-a-3 outliers⁺⁺	protein_00000066-a-1 avg	protein_00000066-a-1 outliers⁺⁺	protein_00000736-a-1 avg	protein_00000736-a-1 outliers⁺⁺	protein_00000990-a-1 avg	protein_00000990-a-1 outliers⁺⁺	protein_00000059-a-1 avg	protein_00000059-a-1 outliers⁺⁺	protein_00000068-a-1 avg	protein_00000068-a-1 outliers⁺⁺	protein_00000068-b-1 avg	protein_00000068-b-1 outliers⁺⁺	protein_00000068-c-1 avg	protein_00000068-c-1 outliers⁺⁺	protein_00001211-0-2 avg	protein_00001211-0-2 outliers⁺⁺	protein_00001211-a-10 avg	protein_00001211-a-10 outliers⁺⁺	protein_00001211-a-11 avg	protein_00001211-a-11 outliers⁺⁺	protein_00001211-a-12 avg	protein_00001211-a-12 outliers⁺⁺	protein_00001211-a-13 avg	protein_00001211-a-13 outliers⁺⁺	protein_00001211-a-14 avg	protein_00001211-a-14 outliers⁺⁺	protein_00001211-a-15 avg	protein_00001211-a-15 outliers⁺⁺	protein_00001211-a-16 avg	protein_00001211-a-16 outliers⁺⁺	protein_00001211-a-9 avg	protein_00001211-a-9 outliers⁺⁺	protein_00000803-a-1 avg	protein_00000803-a-1 outliers⁺⁺	protein_00001205-a-1 avg	protein_00001205-a-1 outliers⁺⁺	protein_00000925-a-1 avg	protein_00000925-a-1 outliers⁺⁺	protein_00000057-a-1 avg	protein_00000057-a-1 outliers⁺⁺	protein_00000057-b-1 avg	protein_00000057-b-1 outliers⁺⁺	protein_00000057-c-1 avg	protein_00000057-c-1 outliers⁺⁺	protein_00000057-d-1 avg	protein_00000057-d-1 outliers⁺⁺	protein_00000067-a-1 avg	protein_00000067-a-1 outliers⁺⁺	protein_00000706-a-1 avg	protein_00000706-a-1 outliers⁺⁺	protein_00000787-a-1 avg	protein_00000787-a-1 outliers⁺⁺	protein_00000013-b-1 avg	protein_00000013-b-1 outliers⁺⁺	protein_00000051-c-1 avg	protein_00000051-c-1 outliers⁺⁺	protein_00001102-a-1 avg	protein_00001102-a-1 outliers⁺⁺	protein_00000060-a-1 avg	protein_00000060-a-1 outliers⁺⁺	protein_00000060-a-2 avg	protein_00000060-a-2 outliers⁺⁺	protein_00001090-a-1 avg	protein_00001090-a-1 outliers⁺⁺	protein_00000045-a-1 avg	protein_00000045-a-1 outliers⁺⁺	protein_00000045-b-1 avg	protein_00000045-b-1 outliers⁺⁺	protein_00000045-c-1 avg	protein_00000045-c-1 outliers⁺⁺	protein_00000045-d-1 avg	protein_00000045-d-1 outliers⁺⁺	protein_00000045-e-1 avg	protein_00000045-e-1 outliers⁺⁺	protein_00000045-f-1 avg	protein_00000045-f-1 outliers⁺⁺	protein_00000045-g-1 avg	protein_00000045-g-1 outliers⁺⁺	protein_00000045-h-1 avg	protein_00000045-h-1 outliers⁺⁺	protein_00000045-i-1 avg	protein_00000045-i-1 outliers⁺⁺	protein_00000045-j-1 avg	protein_00000045-j-1 outliers⁺⁺	protein_00000045-k-1 avg	protein_00000045-k-1 outliers⁺⁺	protein_00000045-l-1 avg	protein_00000045-l-1 outliers⁺⁺	protein_00000895-a-1 avg	protein_00000895-a-1 outliers⁺⁺	protein_00000809-a-1 avg	protein_00000809-a-1 outliers⁺⁺	protein_00000810-a-1 avg	protein_00000810-a-1 outliers⁺⁺	protein_00000939-a-1 avg	protein_00000939-a-1 outliers⁺⁺	protein_00000858-a-1 avg	protein_00000858-a-1 outliers⁺⁺	protein_00000112-a-1 avg	protein_00000112-a-1 outliers⁺⁺	protein_00000747-a-1 avg	protein_00000747-a-1 outliers⁺⁺	protein_00000847-a-1 avg	protein_00000847-a-1 outliers⁺⁺	protein_00001062-a-1 avg	protein_00001062-a-1 outliers⁺⁺	protein_00000657-a-1 avg	protein_00000657-a-1 outliers⁺⁺	protein_00000657-a-2 avg	protein_00000657-a-2 outliers⁺⁺	protein_00000738-a-1 avg	protein_00000738-a-1 outliers⁺⁺	protein_00000978-a-1 avg	protein_00000978-a-1 outliers⁺⁺	protein_00000710-a-1 avg	protein_00000710-a-1 outliers⁺⁺	protein_00000659-a-1 avg	protein_00000659-a-1 outliers⁺⁺	protein_00000748-a-1 avg	protein_00000748-a-1 outliers⁺⁺	protein_00000685-a-1 avg	protein_00000685-a-1 outliers⁺⁺	protein_00001204-a-2 avg	protein_00001204-a-2 outliers⁺⁺	protein_00001204-a-3 avg	protein_00001204-a-3 outliers⁺⁺	protein_00001204-a-4 avg	protein_00001204-a-4 outliers⁺⁺	protein_00001204-a-6 avg	protein_00001204-a-6 outliers⁺⁺	protein_00001206-a-1 avg	protein_00001206-a-1 outliers⁺⁺	protein_00001206-a-2 avg	protein_00001206-a-2 outliers⁺⁺	protein_00001082-a-1 avg	protein_00001082-a-1 outliers⁺⁺	protein_00000780-a-1 avg	protein_00000780-a-1 outliers⁺⁺	protein_00000095-a-1 avg	protein_00000095-a-1 outliers⁺⁺	protein_00000095-b-1 avg	protein_00000095-b-1 outliers⁺⁺	protein_00001051-a-1 avg	protein_00001051-a-1 outliers⁺⁺	protein_00001003-a-1 avg	protein_00001003-a-1 outliers⁺⁺	protein_00000664-a-1 avg	protein_00000664-a-1 outliers⁺⁺	protein_00000664-a-2 avg	protein_00000664-a-2 outliers⁺⁺	protein_00000664-a-3 avg	protein_00000664-a-3 outliers⁺⁺	protein_00000664-a-4 avg	protein_00000664-a-4 outliers⁺⁺	protein_00000664-a-6 avg	protein_00000664-a-6 outliers⁺⁺	protein_00000963-a-1 avg	protein_00000963-a-1 outliers⁺⁺	protein_00000739-a-1 avg	protein_00000739-a-1 outliers⁺⁺	protein_00001053-a-1 avg	protein_00001053-a-1 outliers⁺⁺	protein_00001032-a-1 avg	protein_00001032-a-1 outliers⁺⁺	protein_00001033-a-1 avg	protein_00001033-a-1 outliers⁺⁺	protein_00001034-a-1 avg	protein_00001034-a-1 outliers⁺⁺	protein_00000959-a-1 avg	protein_00000959-a-1 outliers⁺⁺	protein_00001177-a-1 avg	protein_00001177-a-1 outliers⁺⁺	protein_00000966-a-1 avg	protein_00000966-a-1 outliers⁺⁺	protein_00000013-a-1 avg	protein_00000013-a-1 outliers⁺⁺	protein_00000101-a-1 avg	protein_00000101-a-1 outliers⁺⁺	protein_00000102-0-1 avg	protein_00000102-0-1 outliers⁺⁺	protein_00000745-a-1 avg	protein_00000745-a-1 outliers⁺⁺	protein_00000746-a-1 avg	protein_00000746-a-1 outliers⁺⁺	protein_00001065-a-1 avg	protein_00001065-a-1 outliers⁺⁺	protein_00000686-a-1 avg	protein_00000686-a-1 outliers⁺⁺	protein_00001112-a-1 avg	protein_00001112-a-1 outliers⁺⁺
BRCA1	BRCA1_Glu631Lys	1.0983392108185215	0.30839265196900983	1.9419342156297024	0.09326896956291153	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.8084114314219375	0.8812034248171805	0.8465549446007504	0.8911650164474605	0.9209795429049877	0.8653114532543542	0.8609513783183007	0.7122638775895174	0.8390927652271518	0.6786680870186188	0.9766476325556213	0.9213786545766204	0.9808460116119835	0.9233140844072092	0.9381547758252562	BRCA1	1.0983392108185215	0.30839265196900983	1.9419342156297024	0.09326896956291153	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.8084114314219375	0.8812034248171805	0.8465549446007504	0.8911650164474605	0.9209795429049877	0.8653114532543542	0.8609513783183007	0.7122638775895174	0.8390927652271518	0.6786680870186188	0.9766476325556213	0.9213786545766204	0.9808460116119835	0.9233140844072092	0.9381547758252562	BRCA1	ENSG00000012048	14613	218448.0	CCSBVarC003307	ALE00003307	NC_000017.11:43057126:C:T	1891G>A	Glu631Lys	CEGS2	CegsMutGDEh1026	D09	GDEhDisVCh_40059	A09	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43057126.0	C	T	17	Y	N	N	N	N	17-43057126-C-T	70122.0	single nucleotide variant	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)	672.0	BRCA1	HGNC:1100	not provided	0.0	-	397509238.0	-	RCV000577367|RCV001072517	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057126.0	43057126.0	17q21.31	no classification provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	3.0	55455.0	43057126.0	C	T	-	-	-	-	-	-	SCV000679293|SCV001237915	-	-	5203G>A 	Glu1735Lys	NM_007294.4		5_Others		55455.0	17	43057126.0	C	T	E	K	rs397509238	17	41209143.0	17	38462669.0	1735.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5203G>A	p.Glu1735Lys	principal2	Y	1	.	.	-	GAA	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.904	0.90580	P	0.17	0.88579	B	.	.	.	.	.	.	3.64	0.94011	H	.	0.66115	.	.	0.97441	1.0854	0.99062	D	0.954	0.98504	D	10.0	.	0.91685	.	0.776902	0.98236	D	.	0.94374	.	.	.	.	.	.	0.94343	.	0.86555	.	0.10057	0.611799120903	0.54504	T	0.384042	0.81335	T	0.454957	0.92647	D	0.415738	0.92557	D	0.99232280254364	0.82639	D	.	0.97033	.	0.87069577	0.88763	0.49804372	0.70717	0.8283224	0.85601	0.4636008	0.68604	-14.271	0.93916	D	.	0.86411	.	0.997865992856704	0.93647	0.99988377	0.99849	0.931	0.96596	.	.	.	.	.	.	4.661471	0.74461	26.2	0.9990348176399078	0.97503	0.684509	0.64555	D	0.813291850711605	0.86860	9.046169	0.751252984158328	0.86175	8.829661	5.07	5.07	0.68064	3.31	0.60027	4.681	0.61438	7.412000	0.58717	0.593	0.32293	1.0	0.71675	1.0	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	no_classification_provided	NC_000017.11:g.43057126C>T	ClinGen:CA003353|UniProtKB:P38398#VAR_070505	C0346153|C2676676	114480|604370	227535|145	BRCT domain	Glu	Lys	70122.0	single nucleotide variant	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)	672.0	BRCA1	HGNC:1100	not provided	0.0	-	397509238.0	-	RCV000577367|RCV001072517	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057126.0	43057126.0	17q21.31	no classification provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	3.0	55455.0	43057126.0	C	T	-	-	-	-	-	-	SCV000679293|SCV001237915	-	-	5203G>A 	Glu1735Lys	NM_007294.4		5_Others	97.25	0.0618556701030927	['114480', '604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	97.25	0.06185567	<10	>90																																																																																																																																		true	BRCA1Glu631Lys																																																																																																																																																																																																																																		
RAF1	RAF1_Phe22Leu	0.9979103452561944	1.0	0.5106342537669916	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6594805189098774	0.6124843022453169	0.675111209225084	0.7088791061195389	0.6593495806741063	0.6611114622240368	0.6959964161221559	0.6634187249330441	0.6234668786162717	0.6718233999906628	0.6575876991241759	0.7217617961169218	0.686803693517124	0.6015017258743621	0.6471376378290921	RAF1	0.9979103452561944	1.0	0.5106342537669916	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6594805189098774	0.6124843022453169	0.675111209225084	0.7088791061195389	0.6593495806741063	0.6611114622240368	0.6959964161221559	0.6634187249330441	0.6234668786162717	0.6718233999906628	0.6575876991241759	0.7217617961169218	0.686803693517124	0.6015017258743621	0.6471376378290921	RAF1		732		CCSBVarC008857		NC_000003.12:12618656:A:C	66T>G	Phe22Leu																												3.0	12618656.0	A	C	3						3-12618656-A-C	49053.0	single nucleotide variant	NM_002880.4(RAF1):c.66T>G (p.Phe22Leu)	5894.0	RAF1	HGNC:9829	Likely benign	0.0	Apr 03, 2017	397516824.0	-	RCV004541061|RCV000037696|RCV000168020|RCV003362667	|MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	RAF1-related disorder|not specified|RASopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000003.12	3	12618656.0	12618656.0	3p25.2	reviewed by expert panel	5.0	-	N	ClinGen:CA134746	2.0	40583.0	12618656.0	A	C	-	-	-	-	-	-	SCV000616418	-	-	66T>G 	Phe22Leu	NM_002880.4	3.0	2_Benign		40583.0	3	12618656.0	A	C	F	L	rs397516824	3	12660155.0	3	12635155.0	22.0	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.66T>G	p.Phe22Leu	principal3	Y	.	.	.	-	TTT	3.0	2.0	A	A/A	A/A	A/A	A/A	.	0.51407	.	.	0.25352	.	0.06	0.23134	B	0.018	0.18486	B	.	0.78586	.	.	.	.	1.83	0.47902	L	.	0.21370	.	.	0.61652	-0.908	0.46899	T	0.2084	0.56595	T	10.0	.	0.52770	.	0.038866	0.58315	D	.	0.31809	0.372	0.38195	P04049	F22L	Loss of sheet (P = 0.0181)| Gain of loop (P = 0.0312)| Loss of methylation at K18 (P = 0.0891)| Gain of relative solvent accessibility (P = 0.09)| Loss of ubiquitination at K18 (P = 0.1216)	.	0.74448	.	0.36376	.	0.85880	0.814390659332	0.84138	D	0.468965	0.80119	T	-0.176835	0.23871	T	-0.255119	0.4898	T	0.135316427567574	0.15665	T	.	0.44238	.	0.10763881	0.25223	0.120846346	0.29089	0.14490148	0.32960	0.14525777	0.34355	-2.426	0.05558	T	.	0.68345	.	0.900999158324285	0.76121	0.35689947	0.78477	0.566	0.75580	.	.	.	.	.	.	2.085276	0.2657	17.15	0.9982590510952941	0.90858	0.234715	0.35536	N	-0.344430833306449	0.27198	1.507842	-0.211098281217204	0.30821	1.759308	6.03	0.769	0.17595	0.598	0.25895	1.009	0.29585	1.026000	0.23526	0.756	0.943	1.0	0.71675	0.989	0.31253	0.999	0.91597	615	0.66487	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	5	109406	4.570130e-05	0	12	208126	5.765740e-05	0	14	236942	5.908620e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	5	42768	1.169100e-04	0	0	15690	0.000000e+00	0	5	42768	1.169100e-04	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	12	89554	1.339970e-04	0	0	30608	0.000000e+00	0	12	89554	1.339970e-04	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	14	102744	1.362610e-04	0	0	30526	0.000000e+00	0	14	102744	1.362610e-04	0	.	199	1614116	1.232870e-04	1	196	1180052	1.660940e-04	1	0	74934	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29608	0.000000e+00	0	0	44900	0.000000e+00	0	0	64042	0.000000e+00	0	0	6084	0.000000e+00	0	196	1180052	1.660940e-04	1	0	91094	0.000000e+00	0	3	37246	8.054556193953713E-5	0	122	0	0	112	0	0	3438	0	0	500	0	0	628	0	0	56	0	0	98	0	1	7060	1.4164305949008498E-4	0	3560	0	0	168	0	4	49260	8.120178643930166E-5	Likely_benign	RASopathy|Cardiovascular_phenotype|not_specified|RAF1-related_disorder	reviewed_by_expert_panel	NC_000003.12:g.12618656A>C	ClinGen:CA134746	C5555857|CN230736|CN169374	.	536391	.	Phe	Leu	49053.0	single nucleotide variant	NM_002880.4(RAF1):c.66T>G (p.Phe22Leu)	5894.0	RAF1	HGNC:9829	Likely benign	0.0	Apr 03, 2017	397516824.0	-	RCV004541061|RCV000037696|RCV000168020|RCV003362667	|MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	RAF1-related disorder|not specified|RASopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000003.12	3	12618656.0	12618656.0	3p25.2	reviewed by expert panel	5.0	-	N	ClinGen:CA134746	2.0	40583.0	12618656.0	A	C	-	-	-	-	-	-	SCV000616418	-	-	66T>G 	Phe22Leu	NM_002880.4	3.0	2_Benign	33.54	1.0		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		33.54	1.0	$\geqslant$90	<=50						F	201			33.54	Aromatic	Phenylalanine		RAF proto-oncogene serine/threonine-protein kinase										2.8																		165									-142.6				128.3						C (loop/coil)	C (loop/coil)																																																																				true	RAF1Phe22Leu																																																																																																																																																																																																																																		
BRAF	BRAF_Glu501Lys	0.6633972900818994	0.528310912774345	-0.6694140404872534	0.5246885914445109	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8065547177045822	0.49347292971493256	0.7651846522279169	0.7871991704120311	0.5704559258490947	0.5795877855320548	0.7519196371322805	0.7376978443703014	0.4759953809032452	0.7961102983764758	0.5613240661661344	0.8224787036917817	0.7926714600855322	0.5109504785266199	0.8169991370326886	BRAF	0.6633972900818994	0.528310912774345	-0.6694140404872534	0.5246885914445109	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8065547177045822	0.49347292971493256	0.7651846522279169	0.7871991704120311	0.5704559258490947	0.5795877855320548	0.7519196371322805	0.7376978443703014	0.4759953809032452	0.7961102983764758	0.5613240661661344	0.8224787036917817	0.7926714600855322	0.5109504785266199	0.8169991370326886	BRAF	ENSG00000157764	71969	220604.0	CCSBVarC003167	ALE00003167	NC_000007.14:140778007:C:T	1501G>A	Glu501Lys	CEGS2	CegsMutGDEh1019	E10	GDEhDisVCh_40058	A08	2.0									1.0	5.0	0.0		0.0			0.0			0.0			7.0	140778007.0	C	T	7	N	N	N	N	N	7-140778007-C-T	29016.0	single nucleotide variant	NM_004333.6(BRAF):c.1501G>A (p.Glu501Lys)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jan 29, 2025	180177038.0	-	RCV000015011|RCV000207513|RCV000033315|RCV000844616|RCV004018630	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	Cardiofaciocutaneous syndrome 1|not provided|RASopathy|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000007.14	7	140778007.0	140778007.0	7q34	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA273130,UniProtKB:P15056#VAR_026118,OMIM:164757.0017	3.0	13977.0	140778007.0	C	T	-	-	-	-	-	-	SCV000263065|SCV000338452|SCV000948576|SCV002767018|SCV003610904	-	-	1501G>A 	Glu501Lys	NM_004333.6	2.0	1_Pathogenic		13977.0	7	140778007.0	C	T	E	K	rs180177038	7	140477807.0	7	140124276.0	501.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1501G>A	p.Glu501Lys	c.1501G>A	p.Glu501Lys	principal4	Y	.	YES	Select	-	GAA	1.0	0.0	C	C/C	C/C	C/C	C/C	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.96253	.	.	.	.	2.92	0.84163	M	.	.	.	.	.	0.5272	0.90891	D	0.6189	0.86511	D	9.0	0.98748183	0.99108	D	0.412682	0.93618	D	.	0.99740	0.984	0.99843	P15056	E501K	Gain of MoRF binding (P = 0.0045)| Gain of methylation at E501 (P = 0.0827)| Loss of ubiquitination at K499 (P = 0.1356)| Loss of stability (P = 0.2896)| Gain of catalytic residue at K499 (P = 0.3037)	.	0.99090	.	0.99420	.	0.95797	0.938608407974	0.99402	D	0.958012	0.99434	D	0.554969	0.95963	D	0.559398	0.959	D	0.99942809343338	0.97327	D	0.959604	0.84795	D	0.9500797	0.96215	0.8697107	0.92749	0.96031433	0.97269	0.83118904	0.90135	-12.836	0.88701	D	0.9999	0.99795	P	0.999976740337915	0.99427	0.99923956	0.99238	0.995	0.99826	.	.	.	.	.	.	5.637157	0.92725	32.0	0.9990304156241794	0.97428	0.904129	0.85351	D	0.639137191857678	0.75537	6.346777	0.630565185681596	0.77043	6.628201	4.96	4.96	0.65108	6.58	0.99812	7.869	0.85551	7.641000	0.63257	0.545	0.25635	1.0	0.71675	1.0	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic/Likely_pathogenic	Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiovascular_phenotype|not_provided|Cardiofaciocutaneous_syndrome_1|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778007C>T	ClinGen:CA273130|OMIM:164757.0017|UniProtKB:P15056#VAR_026118	C0028326|C1275081|CN230736|C3661900|CN029449|C5555857	PS163950|PS115150|115150	648|1340|1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Glu	Lys	29016.0	single nucleotide variant	NM_004333.6(BRAF):c.1501G>A (p.Glu501Lys)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jan 29, 2025	180177038.0	-	RCV000015011|RCV000207513|RCV000033315|RCV000844616|RCV004018630	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	Cardiofaciocutaneous syndrome 1|not provided|RASopathy|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000007.14	7	140778007.0	140778007.0	7q34	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA273130,UniProtKB:P15056#VAR_026118,OMIM:164757.0017	3.0	13977.0	140778007.0	C	T	-	-	-	-	-	-	SCV000263065|SCV000338452|SCV000948576|SCV002767018|SCV003610904	-	-	1501G>A 	Glu501Lys	NM_004333.6	2.0	1_Pathogenic	70.99	0.0463917525773195	['115150']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	70.99	0.04639175	<10	70-90						E	9			70.99	Negatively-charged	Glutamic Acid		Serine/threonine-protein kinase B-raf							Protein kinase			-3.5								E501-T599, E501-L505, E501-A497; PAE: 7.0, 1.5, 1.0	70 interactions	E501-T599, E501-A497, E501-L597, E501-L505, E501-V600; PAE: 7.0, 1.0, 7.0, 1.5, 7.5	70 interactions		7 interactions					146									-74.9				-38.7						H (helix)	H (α-helix)	Helix																									2.038																																										true	BRAFGlu501Lys																																																																																																																																																																																																																																		
FARS2	FARS2_Ala166Thr	1.7169263893776356	1.0	-1.639197575049847	0.2876744818638417	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6483853385794556	0.4692842672242876	0.703256235691029	0.6425071719073784	0.5510739881368546	0.4713106607706262	0.6370303960480233	0.6699912261170724	0.41871075186739654	0.6270861144226683	0.630837315503083	0.6479839477667335	0.7365212452649857	0.5198577825811788	0.6696845627362428	FARS2	1.7169263893776356	1.0	-1.639197575049847	0.2876744818638417	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6483853385794556	0.4692842672242876	0.703256235691029	0.6425071719073784	0.5510739881368546	0.4713106607706262	0.6370303960480233	0.6699912261170724	0.41871075186739654	0.6270861144226683	0.630837315503083	0.6479839477667335	0.7365212452649857	0.5198577825811788	0.6696845627362428	FARS2		12653		CCSBVarC011877		NC_000006.12:5369066:G:A	496G>A	Ala166Thr																												6.0	5369066.0	G	A	6						6-5369066-G-A	211251.0	single nucleotide variant	NM_006567.5(FARS2):c.496G>A (p.Ala166Thr)	10667.0	FARS2	HGNC:21062	Conflicting classifications of pathogenicity	0.0	May 06, 2024	764932724.0	-	RCV000197977|RCV001853177	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not specified|Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5369066.0	5369066.0	6p25.1	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA322451	2.0	214328.0	5369066.0	G	A	-	-	-	-	-	-	SCV000251368|SCV002217538	-	-	496G>A 	Ala166Thr	NM_006567.5	1.0	3_Conflicting		214328.0	6	5369066.0	G	A	A	T	rs764932724	6	5369299.0	6	5314298.0	166.0	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.496G>A	p.Ala166Thr	c.496G>A	p.Ala166Thr	principal1	Y	1	.	.	+	GCG	1.0	0.0	G	G/G	G/G	G/G	G/G	0.349	0.12418	T	0.319	0.19439	T	0.789	0.44584	P	0.273	0.40008	B	0.1	0.28107	N	simple_aae	90.0	10.0	1.57	0.39465	L	-1.32	0.32965	N	0.253	0.28534	-1.0287	0.20841	T	0.0493	0.20874	T	10.0	0.12830508	0.24112	T	0.014536	0.34468	T	0.060	0.17153	0.351	0.34780	O95363	A166T	Loss of helix (P = 0.0196)| Gain of loop (P = 0.069)| Loss of stability (P = 0.0942)| Loss of sheet (P = 0.302)| Gain of disorder (P = 0.3125)	0.653491938199	0.64789	0.5003925295663422	0.49766	0.172407162635	0.19145	0.372067689896	0.21105	T	0.063676	0.31993	T	-0.340643	0.05166	T	-0.55124	0.16906	T	0.152796268463135	0.17108	T	.	0.43452	.	0.06440483	0.13537	0.10302442	0.24659	0.08581967	0.19742	0.10970226	0.26384	-6.934	0.53619	T	0.0898	0.12616	LB	0.20033392600971	0.49936	0.15600365	0.70784	0.037	0.08577	.	.	.	.	.	.	0.792367	0.11648	8.215	0.9941088374453436	0.63313	0.116843	0.22702	N	-0.396344597065005	0.25323	1.390813	-0.454383794869487	0.23109	1.27738	5.68	1.35	0.21027	-0.754	0.16971	0.428	0.2119	2.603000	0.33615	-0.675	0.04283	0.339	0.25753	0.998	0.34068	0.571	0.30719	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	2	109328	1.829360e-05	0	4	207998	1.923100e-05	0	5	236750	2.111930e-05	0	0	7164	0.000000e+00	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13314	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	2	17112	1.168770e-04	0	0	16210	0.000000e+00	0	2	30522	6.552650e-05	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16654	0.000000e+00	0	2	89522	2.234090e-05	0	0	30606	0.000000e+00	0	2	30522	6.552650e-05	0	0	14902	0.000000e+00	0	2	34260	5.837710e-05	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21552	0.000000e+00	0	3	102636	2.922950e-05	0	0	30526	0.000000e+00	0	2	34260	5.837710e-05	0	.	18	1614038	1.115220e-05	0	3	6062	4.948860e-04	0	0	75018	0.000000e+00	0	0	912	0.000000e+00	0	2	60022	3.332110e-05	0	0	29606	0.000000e+00	0	0	44876	0.000000e+00	0	0	63952	0.000000e+00	0	3	6062	4.948860e-04	0	11	1180016	9.321910e-06	0	1	91064	1.098130e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Combined_oxidative_phosphorylation_defect_type_14|not_specified	criteria_provided,_conflicting_classifications	NC_000006.12:g.5369066G>A	ClinGen:CA322451	C4755312|CN169374	614946	319519	Phenylalanyl-tRNA synthetase	Ala	Thr	211251.0	single nucleotide variant	NM_006567.5(FARS2):c.496G>A (p.Ala166Thr)	10667.0	FARS2	HGNC:21062	Conflicting classifications of pathogenicity	0.0	May 06, 2024	764932724.0	-	RCV000197977|RCV001853177	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not specified|Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5369066.0	5369066.0	6p25.1	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA322451	2.0	214328.0	5369066.0	G	A	-	-	-	-	-	-	SCV000251368|SCV002217538	-	-	496G>A 	Ala166Thr	NM_006567.5	1.0	3_Conflicting	98.13	0.6132075471698113	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	98.13	0.6132075	10-90	>90						A	65			98.13	Aliphatic	Alanine												1.8								A166-D162; PAE: 1.0	9 interactions	A166-D162; PAE: 1.0	9 interactions							89									-72.5				-1.5						C (loop/coil)	T (turn)																																																																				true	FARS2Ala166Thr																																																																																																																																																																																																																																		
F9	F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8130491484278191	0.653857801462616	0.8297697543020721	0.7305391051120406	0.7678626336389018	0.8052223116539097	0.770374504469749	0.8380555280058175	0.688838888445426	0.8029166430497803	0.730502955623894	0.6907037057543322	0.8214839805983268	0.618876714479806	0.823181653805858	F9	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8130491484278191	0.653857801462616	0.8297697543020721	0.7305391051120406	0.7678626336389018	0.8052223116539097	0.770374504469749	0.8380555280058175	0.688838888445426	0.8029166430497803	0.730502955623894	0.6907037057543322	0.8214839805983268	0.618876714479806	0.823181653805858	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C	401G>C	Cys134Ser																												23.0	139548372.0	G	C	X						X-139548372-G-C	962086.0	single nucleotide variant	NM_000133.4(F9):c.401G>C (p.Cys134Ser)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 01, 2019	1927764839.0	-	RCV001265104	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548372.0	139548372.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA414438797	2.0	973818.0	139548372.0	G	C	-	-	-	-	-	-	SCV001424902	-	-	401G>C 	Cys134Ser	NM_000133.4		1_Pathogenic		973818.0	X	139548372.0	G	C	C	S	rs1927764839	X	138630531.0	X	138458197.0	134.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.401G>C	p.Cys134Ser	c.401G>C	p.Cys134Ser	principal1	Y	1	YES	Select	+	TGT	2.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.72	0.99504	H	-6.94	0.94803	D	0.899	0.94679	0.9872	0.96968	D	0.9993	0.99975	D	10.0	0.9919677	0.99728	D	0.454898	0.94399	D	0.936	0.98562	0.983	0.99835	P00740	C134S	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.999909622329	0.99990	0.9998499921215912	0.99985	3.32765753199	0.99614	0.624931335449	0.56360	T	0.872264	0.97227	D	0.720984	0.99946	D	0.797867	0.99946	D	0.999232292175293	0.9661	D	0.773323	0.40263	T	0.988561	0.99681	0.9841814	0.99909	0.9918276	0.99850	0.98336446	0.99894	-7.378	0.65331	T	0.979	0.95276	P	0.99951099997631	0.96835	0.99999320	0.99996	0.995	0.99826	.	.	.	.	.	.	4.089855	0.60976	24.3	0.9839080958512493	0.41088	.	.	.	.	.	.	.	.	.	4.94	4.94	0.646	4.69	0.86632	7.472	0.80047	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.0	0.68239	0.685	0.33728	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548372G>C	.	C0008533	306900	98879	.	Cys	Ser	962086.0	single nucleotide variant	NM_000133.4(F9):c.401G>C (p.Cys134Ser)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 01, 2019	1927764839.0	-	RCV001265104	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548372.0	139548372.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA414438797	2.0	973818.0	139548372.0	G	C	-	-	-	-	-	-	SCV001424902	-	-	401G>C 	Cys134Ser	NM_000133.4		1_Pathogenic	85.56	0.1407407407407407	['306900']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B	85.56	0.14074074	10-90	70-90						C	19			85.56	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa light chain						Disulfide bond 134-145	EGF-like 2			2.5								C134-N147; PAE: 3.5	4 interactions	C134-N147, C134-N138, C134-G139, C134-K146; PAE: 3.5, 2.0, 2.0, 2.5	15 interactions							121									-59.0				-21.4						C (loop/coil)	T (turn)	Turn																													0.419		0.337		0.349		0.301		0.117																														true	F9Cys134Ser																																																																																																																																																																																																																																		
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6450313094057936	0.45326332796157076	0.6488721004813884	0.5488738400520587	0.4992928126955379	0.5373757644945938	0.5822627811327424	0.6578265106439414	0.4497192100803939	0.6515171411520758	0.46120986089648197	0.5154848989713752	0.6399176903188355	0.45680744584274763	0.6385454776595112	F9	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6450313094057936	0.45326332796157076	0.6488721004813884	0.5488738400520587	0.4992928126955379	0.5373757644945938	0.5822627811327424	0.6578265106439414	0.4497192100803939	0.6515171411520758	0.46120986089648197	0.5154848989713752	0.6399176903188355	0.45680744584274763	0.6385454776595112	F9	ENSG00000101981	52861	204384.0	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561836.0	G	C	X	Y	N	N	N	N	X-139561836-G-C	25699.0	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Aug 04, 2016	137852283.0	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836.0	139561836.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255463,OMIM:300746.0111	1.0	10660.0	139561836.0	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic		10660.0	X	139561836.0	G	C	R	P	rs137852283	X	138643995.0	X	138471661.0	384.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.638	0.87292	D	10.0	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.994349058786681	0.6452	.	.	.	.	.	.	.	.	.	5.66	2.91	0.3282	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.0	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699.0	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Aug 04, 2016	137852283.0	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836.0	139561836.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255463,OMIM:300746.0111	1.0	10660.0	139561836.0	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic	94.23	0.7620967741935484	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	94.23	0.76209676	10-90	>90						R	189			94.23	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-4.5			3 interactions	4 interactions				R384-A380; PAE: 1.0	3 interactions	R384-A380; PAE: 1.0	3 interactions							175									-78.1				-25.4				dbSNP: rs137852283; Variant type: LP/P; AA change: Arg384Leu; PTM type: Phosphorylation; PTM morphology: LVDRAtCLR*ST; Var class: II		H (helix)	H (α-helix)	Helix																													1.099		0.946		0.91	1 mutation(s) (Arg384Asn: 1.152)	0.889	1 mutation(s) (Arg384Asn: 1.142)	0.889																														true	F9Arg384Pro																																																																																																																																																																																																																																		
F9	F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6452101551143459	0.6308198463326588	0.7352707335404538	0.6151165953018622	0.6358669359623879	0.6170391164027158	0.6119787070567009	0.7288431632537727	0.6132634122586127	0.7108338645049038	0.6546947555220599	0.6182544835470235	0.741698303827135	0.6483762804067048	0.5795864457237878	F9	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6452101551143459	0.6308198463326588	0.7352707335404538	0.6151165953018622	0.6358669359623879	0.6170391164027158	0.6119787070567009	0.7288431632537727	0.6132634122586127	0.7108338645049038	0.6546947555220599	0.6182544835470235	0.741698303827135	0.6483762804067048	0.5795864457237878	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T	589C>T	Pro197Ser																												23.0	139551130.0	C	T	X						X-139551130-C-T	2009495.0	single nucleotide variant	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	2158.0	F9	HGNC:3551	Likely benign	0.0	Feb 03, 2024	-1.0	-	RCV002710164	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551130.0	139551130.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA336137425	2.0	1959260.0	139551130.0	C	T	-	-	-	-	-	-	SCV002992787	-	-	589C>T 	Pro197Ser	NM_000133.4	1.0	2_Benign		1959260.0	X	139551130.0	C	T	P	S	rs867548424	X	138633289.0	X	138460955.0	197.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.589C>T	p.Pro197Ser	c.589C>T	p.Pro197Ser	principal1	Y	1	YES	Select	+	CCT	1.0	0.0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	1.0	0.02435	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.26006	N	simple_aae	93.0	7.0	-1.845	0.00268	N	0.67	0.02246	N	0.041	0.01414	-0.3909	0.7219	T	0.3717	0.72963	T	10.0	0.036299646	0.01924	T	0.027201	0.49836	D	0.197	0.47720	0.434	0.48357	P00740	P197S	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.445173020498	0.43755	0.9073591802246402	0.90650	0.63775699092	0.57233	0.310453176498	0.11967	T	0.277936	0.64861	T	-0.359869	0.03974	T	-0.562367	0.15863	T	0.0218413153825192	0.00888	T	0.561944	0.19427	T	0.030987347	0.02834	0.06478413	0.13037	0.030987347	0.02833	0.06478413	0.13037	-3.242	0.16375	T	0.0598	0.01911	B	0.0725587346858254	0.40442	0.99871650	0.98926	0.078	0.22017	.	.	.	.	.	.	-0.950913	0.00845	0.029	0.14416938963530473	0.00314	.	.	.	.	.	.	.	.	.	4.94	-2.38	0.06232	-1.7	0.12702	-0.387	0.07437	-0.073000	0.12324	-1.556	0.00956	0.001	0.13799	0.002	0.18256	0.003	0.0525	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	80343	0.000000e+00	0	1	151864	6.584840e-06	0	1	172276	5.804640e-06	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30955	0.000000e+00	0	0	9952	0.000000e+00	0	.	.	.	.	1	13134	7.613830e-05	0	0	24389	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	0	64674	0.000000e+00	0	0	19073	0.000000e+00	0	1	13134	7.613830e-05	0	1	12064	8.289120e-05	0	0	27167	0.000000e+00	0	0	7084	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	0	73493	0.000000e+00	0	0	19008	0.000000e+00	0	1	12064	8.289120e-05	0	.	2	1210973	1.651560e-06	0	1	57790	1.730400e-05	0	1	57790	1.730400e-05	0	0	688	0.000000e+00	0	0	46015	0.000000e+00	0	0	22039	0.000000e+00	0	0	33835	0.000000e+00	0	0	46864	0.000000e+00	0	0	4352	0.000000e+00	0	1	894804	1.117560e-06	0	0	56962	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551130C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	2009495.0	single nucleotide variant	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	2158.0	F9	HGNC:3551	Likely benign	0.0	Feb 03, 2024	-1.0	-	RCV002710164	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551130.0	139551130.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA336137425	2.0	1959260.0	139551130.0	C	T	-	-	-	-	-	-	SCV002992787	-	-	589C>T 	Pro197Ser	NM_000133.4	1.0	2_Benign	34.65	0.7867647058823529	['300807', '306900']	unknown	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	34.65	0.7867647	10-90	<=50						P	107			34.65	Special, No backbone hydrogen	Proline		Coagulation factor IX										1.6																		115									-69.8			Activation peptide	124.3						C (loop/coil)	C (loop/coil)																														0.931		0.928		0.921		0.905		0.923																														true	F9Pro197Ser																																																																																																																																																																																																																																		
ABCD1	ABCD1_Arg518Gln	6.2907017796871	0.00040780087036125073	0.28092595257451597	0.7868893052001036	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7890010976879126	0.6855350932990265	0.791448636647407	0.7410238592834242	0.7503000051148931	0.7135505295908988	0.7087000096964757	0.739258531964679	0.6905931159218803	0.7749904408990131	0.7870494806388876	0.7733477088703725	0.8436387413301347	0.6804770706761727	0.8030117544768121	ABCD1	6.2907017796871	0.00040780087036125073	0.28092595257451597	0.7868893052001036	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7890010976879126	0.6855350932990265	0.791448636647407	0.7410238592834242	0.7503000051148931	0.7135505295908988	0.7087000096964757	0.739258531964679	0.6905931159218803	0.7749904408990131	0.7870494806388876	0.7733477088703725	0.8436387413301347	0.6804770706761727	0.8030117544768121	ABCD1	ENSG00000101986	100008637	209132.0	CCSBVarC007021	ALE00007019	NC_000023.11:153740156:G:A	1553G>A	Arg518Gln	CEGS2	CegsMutGDEh1023	H06	GDEhDisVCh_40030	H07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	153740156.0	G	A	X	Y	N	N	N	N	X-153740156-G-A	98228.0	single nucleotide variant	NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)	215.0	ABCD1	HGNC:61	Pathogenic	1.0	Sep 23, 2024	398123102.0	-	RCV000077955|RCV000723540|RCV004752737	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900|	Adrenoleukodystrophy|not provided|ABCD1-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	153740156.0	153740156.0	Xq28	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA278403,UniProtKB:P33897#VAR_000070	2.0	92317.0	153740156.0	G	A	-	-	-	-	-	-	SCV000109784|SCV000840437|SCV001207477|SCV001338473|SCV001447138|SCV001812929|SCV002022800|SCV002045832|SCV002822049|SCV004206299|SCV004231793|SCV005418721	-	-	1553G>A 	Arg518Gln	NM_000033.4	2.0	1_Pathogenic	9.11811e-7	92317.0	X	153740156.0	G	A	R	Q	rs398123102	X	153005610.0	X	152658804.0	518.0	ABCD1	ENSG00000101986	ENST00000218104	ENSP00000218104	P33897	ABCD1_HUMAN	c.1553G>A	p.Arg518Gln	c.1553G>A	p.Arg518Gln	principal1	Y	1	YES	Select	+	CGG	2.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	0.999	0.77914	D	0.984	0.76117	D	0.8	0.87470	A	simple_aae	20.0	80.0	2.185	0.61163	M	-3.6	0.69394	D	0.814	0.80898	0.9308	0.96101	D	0.9934	0.99846	D	10.0	0.9942995	0.99935	D	0.874464	0.99039	D	0.942	0.98779	0.971	0.99725	P33897	R518Q	Gain of methylation at K513 (P = 0.0396)| Loss of MoRF binding (P = 0.0759)| Gain of ubiquitination at K513 (P = 0.1295)| Loss of catalytic residue at R518 (P = 0.1494)| Loss of loop (P = 0.2237)	0.999847574799	0.99984	0.9166754227494129	0.91590	1.62602313597	0.89103	0.596089541912	0.52286	T	0.956453	0.99402	D	0.679029	0.99908	D	0.737601	0.99907	D	0.954029619693756	0.63942	D	0.994593	0.98244	D	0.8978354	0.91064	0.8459693	0.91118	0.8978354	0.91065	0.8459693	0.91119	-13.047	0.89579	D	0.9361	0.85514	P	0.999942948768151	0.99079	0.99904543	0.99115	0.977	0.99166	.	.	.	.	.	.	5.329675	0.89461	30.0	0.9995109539516234	0.99945	.	.	.	.	.	.	.	.	.	4.93	4.93	0.64349	.	.	9.996	0.99292	.	.	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.904	0.44015	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	79946	1.250840e-05	0	1	151049	6.620370e-06	0	1	171265	5.838900e-06	0	0	5702	0.000000e+00	0	0	13607	0.000000e+00	0	0	1752	0.000000e+00	0	0	6916	0.000000e+00	0	0	9842	0.000000e+00	0	1	30802	3.246540e-05	0	0	9880	0.000000e+00	0	1	30802	3.246540e-05	0	0	13127	0.000000e+00	0	0	24304	0.000000e+00	0	0	4606	0.000000e+00	0	0	10125	0.000000e+00	0	0	12095	0.000000e+00	0	1	64282	1.555650e-05	0	0	18901	0.000000e+00	0	1	64282	1.555650e-05	0	0	12059	0.000000e+00	0	0	27059	0.000000e+00	0	0	6992	0.000000e+00	0	0	13307	0.000000e+00	0	0	15893	0.000000e+00	0	1	72992	1.370010e-05	0	0	18836	0.000000e+00	0	1	72992	1.370010e-05	0	.	1	1210866	8.258550e-07	0	1	894577	1.117850e-06	0	0	57962	0.000000e+00	0	0	687	0.000000e+00	0	0	46080	0.000000e+00	0	0	22002	0.000000e+00	0	0	33820	0.000000e+00	0	0	46886	0.000000e+00	0	0	4348	0.000000e+00	0	1	894577	1.117850e-06	0	0	56926	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Pathogenic	Adrenoleukodystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.153740156G>A	ClinGen:CA278403|UniProtKB:P33897#VAR_000070	C0162309|C3661900	300100	43	ABC transporter-like, ATP-binding domain|ABC transporter-like, ATP-binding domain|AAA+ ATPase domain	Arg	Gln	98228.0	single nucleotide variant	NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)	215.0	ABCD1	HGNC:61	Pathogenic	1.0	Sep 23, 2024	398123102.0	-	RCV000077955|RCV000723540|RCV004752737	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900|	Adrenoleukodystrophy|not provided|ABCD1-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	153740156.0	153740156.0	Xq28	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA278403,UniProtKB:P33897#VAR_000070	2.0	92317.0	153740156.0	G	A	-	-	-	-	-	-	SCV000109784|SCV000840437|SCV001207477|SCV001338473|SCV001447138|SCV001812929|SCV002022800|SCV002045832|SCV002822049|SCV004206299|SCV004231793|SCV005418721	-	-	1553G>A 	Arg518Gln	NM_000033.4	2.0	1_Pathogenic	92.92	0.3306451612903225	['300100']	x-linked recessive	Rare genetic developmental defect during embryogenesis; Rare genetic hepatic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Genetic infertility	6	ADRENOLEUKODYSTROPHY	92.92	0.33064517	10-90	>90						R	82			92.92	Positively-charged	Arginine		ATP-binding cassette sub-family D member 1							ABC transporter			-4.5			6 interactions	1 interaction	5 interactions			R518-S514, R518-L523, R518-W524; PAE: 1.0, 1.0, 1.0	8 interactions	R518-S514, R518-L523, R518-W524, R518-G522; PAE: 1.0, 1.0, 1.0, 1.5	10 interactions							175									-63.7				-36.0						H (helix)	H (α-helix)	Helix																																																																			true	ABCD1Arg518Gln																																																																																																																																																																																																																																		
RAF1	RAF1_Thr491Ile	-3.8359287255680843	0.2755942932717806	2.583864682897168	0.271931931279114	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6820517483120447	0.7561495833152446	0.7255756369012532	0.6670933686587139	0.7756351489848339	0.8142078548463356	0.7158286617781157	0.7233804167785814	0.793730906544224	0.7556981684615444	0.7370624431233321	0.6183580755393122	0.727770857023925	0.7185682600862653	0.608405328162545	RAF1	-3.8359287255680843	0.2755942932717806	2.583864682897168	0.271931931279114	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6820517483120447	0.7561495833152446	0.7255756369012532	0.6670933686587139	0.7756351489848339	0.8142078548463356	0.7158286617781157	0.7233804167785814	0.793730906544224	0.7556981684615444	0.7370624431233321	0.6183580755393122	0.727770857023925	0.7185682600862653	0.608405328162545	RAF1		732		CCSBVarC003427		NC_000003.12:12585745:G:C	1472C>T	Thr491Ile																												3.0	12585745.0	G	C	3						3-12585745-G-C	28998.0	single nucleotide variant	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Sep 11, 2024	80338799.0	-	RCV000014988|RCV000680803|RCV001229313	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 5|not provided|RASopathy	germline	germline	GRCh38	NC_000003.12	3	12585745.0	12585745.0	3p25.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	3.0	13959.0	12585745.0	G	C	-	-	-	-	-	-	SCV000808247|SCV001401755	-	-	1472C>G 	Thr491Arg	NM_002880.4	2.0	1_Pathogenic		13959.0	3	12585745.0	G	C	T	R	rs80338799	3	12627244.0	3	12602244.0	491.0	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1472C>G	p.Thr491Arg	c.1472C>G	p.Thr491Arg	principal3	Y	1	YES	Select	-	ACA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.122	0.40143	T	1.0	0.90580	D	0.999	0.92348	D	0.98	0.99291	A	simple_aae	2.0	98.0	0.02	0.07909	N	-5.37	0.84911	D	0.961	0.99191	0.1373	0.84771	D	0.4388	0.77686	T	10.0	0.899554	0.89196	D	0.235705	0.88439	D	0.786	0.92884	0.752	0.88177	P04049	T491R	Gain of MoRF binding (P = 0.0086)| Loss of ubiquitination at K493 (P = 0.0532)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K493 (P = 0.0976)| Gain of solvent accessibility (P = 0.1456)	0.974052792841	0.97352	.	0.85535	2.53490677304	0.97794	0.845280706882	0.88882	D	0.900422	0.98022	D	0.39866	0.89767	D	0.334871	0.89639	D	0.996480882167816	0.89353	D	.	0.92373	.	0.9571182	0.96940	0.9388268	0.97656	0.9463269	0.95828	0.90921533	0.95572	-12.126	0.85499	D	0.9852	0.92260	P	0.999988562000968	0.99579	0.99762386	0.98444	0.978	0.99209	.	.	.	.	.	.	5.424006	0.90747	31.0	0.994371183537825	0.64619	0.916990	0.88355	D	0.626065396186754	0.74692	6.199454	0.704879681503555	0.82653	7.84486	5.26	5.26	0.73443	.	.	9.996	0.99292	11.849000	0.98025	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.994	0.71086	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	RASopathy|not_provided|Noonan_syndrome_5	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.12585745G>C	ClinGen:CA257064|OMIM:164760.0003|UniProtKB:P04049#VAR_037819	C5555857|C3661900|C1969057	611553	536391|648	Protein kinase domain|Protein kinase domain|Protein kinase domain	Thr	Arg	28998.0	single nucleotide variant	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Sep 11, 2024	80338799.0	-	RCV000014988|RCV000680803|RCV001229313	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 5|not provided|RASopathy	germline	germline	GRCh38	NC_000003.12	3	12585745.0	12585745.0	3p25.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	3.0	13959.0	12585745.0	G	C	-	-	-	-	-	-	SCV000808247|SCV001401755	-	-	1472C>G 	Thr491Arg	NM_002880.4	2.0	1_Pathogenic	53.92	0.2746478873239437	['611553']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	NOONAN SYNDROME 5	53.92	0.2746479	10-90	50-70						T	39			53.92	Polar/Neutral	Threonine		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			-0.7								T491-R495; PAE: 5.0	4 interactions	T491-R495; PAE: 5.0	4 interactions						Phosphothreonine	119		Mutation: T -> D. Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494.							-65.0	Morphology: IGDFGLAtVksRWsG; Domain: PK_Tyr_Ser-Thr			-32.9		Regulatory site: T491-p; Morphology: IGDFGLAtVKSRWSG; Domain: PK_Tyr_Ser-Thr; On-Function: enzymatic activity, induced		dbSNP: rs80338799; Variant type: LP/P; AA change: Thr491Ile; PTM type: Ubiquitylation; PTM morphology: GLAt*VksRWsG; Var class: II&rs80338799		H (helix)	H (α-helix)																																																																				true	RAF1Thr491Ile																																																																																																																																																																																																																																		
RAD51D	RAD51D_Arg55Trp	1.021432754244928	0.341046466783239	-0.6516104897040342	0.5354521334844586	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7175440731695554	0.5472426618717947	0.6626546996038981	0.7216882419748716	0.5585899967966248	0.5773047600598085	0.7310209948174875	0.6615307574655238	0.566970418461294	0.731383595365466	0.5398752335334412	0.7123554891322557	0.6637786417422724	0.5275149052822954	0.7037045509736447	RAD51D	1.021432754244928	0.341046466783239	-0.6516104897040342	0.5354521334844586	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7175440731695554	0.5472426618717947	0.6626546996038981	0.7216882419748716	0.5585899967966248	0.5773047600598085	0.7310209948174875	0.6615307574655238	0.566970418461294	0.731383595365466	0.5398752335334412	0.7123554891322557	0.6637786417422724	0.5275149052822954	0.7037045509736447	RAD51D		7201		CCSBVarC024799		NC_000017.11:35118601:G:A	163C>T	Arg55Trp																												17.0	35118601.0	G	A	17						17-35118601-G-A	235907.0	single nucleotide variant	NM_002878.4(RAD51D):c.163C>T (p.Arg55Trp)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jan 26, 2025	775268017.0	-	RCV000222465|RCV000555250|RCV001547298|RCV002229933	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	35118601.0	35118601.0	17q12	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA8499638	2.0	230594.0	35118601.0	G	A	-	-	-	-	-	-	SCV000274193|SCV000651718|SCV000912002|SCV001766967|SCV002511654|SCV003926632|SCV004033554|SCV004208078|SCV004236536	-	-	163C>T 	Arg55Trp	NM_002878.4	1.0	3_Conflicting		230594.0	17	35118601.0	G	A	R	W	rs775268017	17	33445620.0	17	30469733.0	55.0	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.163C>T	p.Arg55Trp	c.163C>T	p.Arg55Trp	principal1	Y	1	YES	Select	-	CGG	1.0	2.0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.001	0.83643	D	0.997	0.70687	D	0.915	0.65085	D	0.63	0.78586	D	simple_aae	37.0	63.0	2.6	0.75898	M	-5.15	0.83383	D	0.825	0.81999	-0.524	0.67624	T	0.2724	0.64261	T	10.0	0.8072227	0.79845	D	0.111863	0.78916	D	0.374	0.69109	0.598	0.72759	O75771	R55W	Gain of catalytic residue at L53 (P = 0.0031)| Gain of helix (P = 0.005)| Loss of loop (P = 0.0153)| Loss of MoRF binding (P = 0.0884)| Loss of solvent accessibility (P = 0.1202)	0.873687315659	0.87147	.	.	.	.	.	.	.	0.547731	0.84489	D	0.0541436	0.58585	T	-0.0631489	0.6587	T	0.94793289899826	0.62559	D	.	0.72299	.	0.47494522	0.65280	0.46390733	0.68623	0.47494522	0.65280	0.46390733	0.68623	-9.321	0.69817	D	0.4599	0.65611	A	0.00577304038068542	0.19858	0.99482584	0.97637	0.599	0.77554	.	.	.	.	.	.	5.317904	0.89281	29.9	0.9988754684003013	0.96206	0.817233	0.73781	D	0.415643171291693	0.62085	4.441516	0.323933020451451	0.56721	3.859249	4.79	1.09	0.19474	1.94	0.38959	3.953	0.56497	3.143000	0.36573	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.993	0.69292	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	109344	9.145450e-06	0	2	207876	9.621120e-06	0	2	236752	8.447660e-06	0	0	7164	0.000000e+00	0	0	17108	0.000000e+00	0	1	2320	4.310340e-04	0	0	9040	0.000000e+00	0	0	13344	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16164	0.000000e+00	0	0	30520	0.000000e+00	0	1	6206	1.611340e-04	0	0	13410	0.000000e+00	0	0	16684	0.000000e+00	0	0	89422	0.000000e+00	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14848	0.000000e+00	0	0	34256	0.000000e+00	0	1	9566	1.045370e-04	0	0	17686	0.000000e+00	0	0	21582	0.000000e+00	0	0	102668	0.000000e+00	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	36	1614066	2.230390e-05	0	31	6084	5.095330e-03	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	2	60004	3.333110e-05	0	0	29608	0.000000e+00	0	0	44900	0.000000e+00	0	0	64002	0.000000e+00	0	31	6084	5.095330e-03	0	0	1180034	0.000000e+00	0	1	91096	1.097740e-05	0	1	19700	5.076142131979695E-5	0	298	0	0	86	0	0	7436	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1928	0	0	7734	0	0	112	0	1	30328	3.297283038776049E-5	Conflicting_classifications_of_pathogenicity	not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118601G>A	ClinGen:CA8499638	CN169374|C3661900|C0027672|C3280345	614291	140162|145	RAD51D, N-terminal domain	Arg	Trp	235907.0	single nucleotide variant	NM_002878.4(RAD51D):c.163C>T (p.Arg55Trp)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jan 26, 2025	775268017.0	-	RCV000222465|RCV000555250|RCV001547298|RCV002229933	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	35118601.0	35118601.0	17q12	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA8499638	2.0	230594.0	35118601.0	G	A	-	-	-	-	-	-	SCV000274193|SCV000651718|SCV000912002|SCV001766967|SCV002511654|SCV003926632|SCV004033554|SCV004208078|SCV004236536	-	-	163C>T 	Arg55Trp	NM_002878.4	1.0	3_Conflicting	90.91	0.7540322580645161	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	90.91	0.75403225	10-90	>90						R	187			90.91	Positively-charged	Arginine		DNA repair protein RAD51 homolog 4										-4.5								R55-V51, R55-A59; PAE: 1.0, 1.0	5 interactions	R55-V51, R55-A59; PAE: 1.0, 1.0	5 interactions							175									-63.3				-44.7	preferentially binds ssDNA					H (helix)	H (α-helix)	Helix																																																																			true	RAD51DArg55Trp																																																																																																																																																																																																																																		
FARS2	FARS2_Ile329Thr	-2.2456562230357777	1.0	-2.124393793498326	0.10954203012231523	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.7359343111613076	0.8903411572874099	0.8165044483584497	0.7945383828469674	0.9012340513092847	0.9497609191467175	0.8479652830539113	0.8337499264828268	0.9429145177669562	0.7922037280296529	0.8527071834718518	0.7411114826400237	0.7992589702340727	0.8377677968078636	0.6796648942929623	FARS2	-2.2456562230357777	1.0	-2.124393793498326	0.10954203012231523	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.7359343111613076	0.8903411572874099	0.8165044483584497	0.7945383828469674	0.9012340513092847	0.9497609191467175	0.8479652830539113	0.8337499264828268	0.9429145177669562	0.7922037280296529	0.8527071834718518	0.7411114826400237	0.7992589702340727	0.8377677968078636	0.6796648942929623	FARS2		12653		CCSBVarC011924		NC_000006.12:5545261:T:C	986T>C	Ile329Thr																												6.0	5545261.0	T	C	6						6-5545261-T-C	48424.0	single nucleotide variant	NM_006567.5(FARS2):c.986T>C (p.Ile329Thr)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	397514611.0	-	RCV000033045	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5545261.0	5545261.0	6p25.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA130597,UniProtKB:O95363#VAR_069488,OMIM:611592.0002	3.0	39825.0	5545261.0	T	C	-	-	-	-	-	-	SCV000845715	-	-	986T>C 	Ile329Thr	NM_006567.5	1.0	1_Pathogenic		39825.0	6	5545261.0	T	C	I	T	rs397514611	6	5545494.0	6	5490493.0	329.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.986T>C	p.Ile329Thr	c.986T>C	p.Ile329Thr	principal1	Y	1	YES	Select	+	ATC	2.0	0.0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.21	0.97827	H	-4.83	0.80975	D	0.969	0.97975	0.7613	0.93913	D	0.7276	0.90648	D	10.0	0.9569025	0.95004	D	0.551967	0.95867	D	0.926	0.98190	0.769	0.89555	O95363	I329T	Loss of stability (P = 0.0021)| Gain of phosphorylation at I329 (P = 0.0509)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1945)| Gain of loop (P = 0.2754)	0.979357470534	0.97892	.	0.96169	.	0.63719	0.75597679615	0.75288	T	0.633828	0.88570	D	0.383	0.88822	D	0.376023	0.91225	D	0.998961210250854	0.9569	D	0.994531	0.98201	D	0.94993186	0.96200	0.90557504	0.95310	0.9474884	0.95948	0.88929117	0.94138	-13.546	0.91505	D	0.899	0.83150	P	0.999640102774092	0.97310	0.97331387	0.94918	0.992	0.99727	.	.	.	.	.	.	5.001397	0.83025	27.9	0.9986857030934074	0.94641	0.907023	0.86001	D	0.963131837071811	0.94462	12.80027	0.855816931618299	0.93315	11.98561	5.27	5.27	0.73761	3.3	0.59857	7.646	0.82647	7.746000	0.68123	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.99	0.65338	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	3	208122	1.441460e-05	0	3	236776	1.267020e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13410	0.000000e+00	0	0	16734	0.000000e+00	0	3	89552	3.350010e-05	0	0	30608	0.000000e+00	0	3	89552	3.350010e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17686	0.000000e+00	0	0	21632	0.000000e+00	0	3	102598	2.924030e-05	0	0	30526	0.000000e+00	0	3	102598	2.924030e-05	0	.	3	1614088	1.858630e-06	0	1	64042	1.561480e-05	0	0	75056	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29604	0.000000e+00	0	0	44882	0.000000e+00	0	1	64042	1.561480e-05	0	0	6062	0.000000e+00	0	0	1179922	0.000000e+00	0	0	91082	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5545261T>C	ClinGen:CA130597|OMIM:611592.0002|UniProtKB:O95363#VAR_069488	C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Ile	Thr	48424.0	single nucleotide variant	NM_006567.5(FARS2):c.986T>C (p.Ile329Thr)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	397514611.0	-	RCV000033045	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5545261.0	5545261.0	6p25.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA130597,UniProtKB:O95363#VAR_069488,OMIM:611592.0002	3.0	39825.0	5545261.0	T	C	-	-	-	-	-	-	SCV000845715	-	-	986T>C 	Ile329Thr	NM_006567.5	1.0	1_Pathogenic	97.54	0.029585798816568	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	97.54	0.0295858	<10	>90						I	5			97.54	Aliphatic	Isoleucine										0.839		4.5								I329-S185; PAE: 1.0	9 interactions	I329-S185; PAE: 1.0	15 interactions							131									-59.9		Pocket 1: Mean pLDDT: 88.57, Volume: 570.18 Å³, Druggability score: 0.84		-23.1						H (helix)	G (3₁₀-helix)	Helix																																																																			true	FARS2Ile329Thr																																																																																																																																																																																																																																		
BRCA1	BRCA1_Lys502Glu	0.8105603126478718	0.44429777323077857	4.989655621459294	0.0015836344442593463	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8525610238001519	0.7467937031357241	0.9201521617024754	0.8600163182824268	0.8816377567624725	0.8872472228434505	0.8853565853297606	0.940891248085023	0.7309200947844363	0.883380119926835	0.8760282906814943	0.834676051235093	0.8994130753199278	0.762667311487012	0.8217419276734688	BRCA1	0.8105603126478718	0.44429777323077857	4.989655621459294	0.0015836344442593463	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8525610238001519	0.7467937031357241	0.9201521617024754	0.8600163182824268	0.8816377567624725	0.8872472228434505	0.8853565853297606	0.940891248085023	0.7309200947844363	0.883380119926835	0.8760282906814943	0.834676051235093	0.8994130753199278	0.762667311487012	0.8217419276734688	BRCA1	ENSG00000012048	14613	218418.0	CCSBVarC003301	ALE00003301	NC_000017.11:43071098:T:C	1504A>G	Lys502Glu	CEGS2	CegsMutGDEh1026	D01	GDEhDisVCh_40059	H08	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43071098.0	T	C	17	Y	N	N	N	N	17-43071098-T-C	46168.0	single nucleotide variant	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	80356943.0	-	RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43071098.0	43071098.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	2.0	37612.0	43071098.0	T	C	-	-	-	-	-	-	SCV001161595	-	-	4816A>G 	Lys1606Glu	NM_007294.4	3.0	2_Benign	0.0000321515	37612.0	17	43071098.0	T	C	K	E	rs80356943	17	41223115.0	17	38476641.0	1606.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.4816A>G	p.Lys1606Glu	principal2	Y	1	.	.	-	AAA	1.0	0.0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.49207	.	0.0	0.02950	B	0.0	0.01384	B	.	0.99291	.	.	.	.	0	0.06502	N	.	0.10767	.	.	0.28302	-0.5432	0.66897	T	0.4017	0.75178	T	10.0	.	0.37017	.	0.227152	0.88048	D	.	0.75894	.	.	.	.	.	.	0.58443	.	0.16602	.	0.12617	0.260015904903	0.04893	T	0.098826	0.40015	T	0.0938011	0.63355	D	0.0772584	0.75211	D	0.106747360008648	0.12918	T	0.852615	0.53662	D	0.096304744	0.22477	0.09333296	0.22003	0.09800102	0.22901	0.07730816	0.17192	-3.059	0.10842	T	.	0.04993	.	0.00105470856972761	0.09785	0.99718000	0.98290	0.042	0.10339	.	.	.	.	.	.	1.918289	0.24404	16.37	0.9181781247871236	0.21378	0.169829	0.29455	N	-0.929974890242364	0.10024	0.4834715	-0.879878298600479	0.12355	0.6474283	4.92	2.88	0.32534	3.03	0.55386	2.465	0.44835	6.225000	0.55234	-0.114	0.14662	0.492	0.26984	1.0	0.68239	0.007	0.07843	543	0.72771	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	3	109406	2.742080e-05	0	5	208130	2.402340e-05	0	7	236868	2.955230e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	5	89554	5.583220e-05	0	0	30608	0.000000e+00	0	5	89554	5.583220e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	7	102672	6.817830e-05	0	0	30526	0.000000e+00	0	7	102672	6.817830e-05	0	.	50	1613986	3.097920e-05	0	45	1180018	3.813500e-05	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29606	0.000000e+00	0	0	44898	0.000000e+00	0	0	64032	0.000000e+00	0	0	6084	0.000000e+00	0	45	1180018	3.813500e-05	0	0	91082	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	1	7864	1.271617497456765E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	1	8162	1.2251899044351874E-4	0	112	0	2	30890	6.474587245063128E-5	Benign	BRCA1-related_disorder|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43071098T>C	ClinGen:CA003037|UniProtKB:P38398#VAR_007790	CN169374|C0677776|CN221562|C0027672|C3661900|C2676676	604370	145|140162|145	.	Lys	Glu	46168.0	single nucleotide variant	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	80356943.0	-	RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43071098.0	43071098.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	2.0	37612.0	43071098.0	T	C	-	-	-	-	-	-	SCV001161595	-	-	4816A>G 	Lys1606Glu	NM_007294.4	3.0	2_Benign	29.69	0.975609756097561	['604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	29.69	0.9756098	$\geqslant$90	<=50																																																																																																																																		true	BRCA1Lys502Glu																																																																																																																																																																																																																																		
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.607880947432186	0.6317596895196784	0.7011675493869377	0.650899157793233	0.7096997914586485	0.6756812609368683	0.586632030944468	0.6037616745328747	0.5965526914812336	0.510599459620558	0.7437183219804285	0.7151662846419982	0.7985734242410008	0.6669666875581233	0.7051624352438142	F9	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.607880947432186	0.6317596895196784	0.7011675493869377	0.650899157793233	0.7096997914586485	0.6756812609368683	0.586632030944468	0.6037616745328747	0.5965526914812336	0.510599459620558	0.7437183219804285	0.7151662846419982	0.7985734242410008	0.6669666875581233	0.7051624352438142	F9	ENSG00000101981	52861	204372.0	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561592.0	C	T	X	Y	N	N	N	N	X-139561592-C-T	25680.0	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158.0	F9	HGNC:3551	Benign/Likely benign	0.0	Jan 19, 2025	1801202.0	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592.0	139561592.0	Xq27.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA121135,OMIM:300746.0085	3.0	10641.0	139561592.0	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2.0	2_Benign	0.000794178	10641.0	X	139561592.0	C	T	H	Y	rs1801202	X	138643751.0	X	138471417.0	303.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1.0	0.0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.6722	T	0.5304	0.82502	D	10.0	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.3283089783242922	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.0	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680.0	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158.0	F9	HGNC:3551	Benign/Likely benign	0.0	Jan 19, 2025	1801202.0	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592.0	139561592.0	Xq27.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA121135,OMIM:300746.0085	3.0	10641.0	139561592.0	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2.0	2_Benign	95.71	0.7445652173913043	['300807', '306900', '301052', '300807', '306900', '306900']	x-linked	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; WARFARIN SENSITIVITY, X-LINKED; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; HEMOPHILIA B	95.71	0.7445652	10-90	>90						H	137			95.71	Positively-charged	Histidine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-3.2																		155									-60.0				-29.0						C (loop/coil)	T (turn)	Turn																													1.004		0.921		0.885		0.853		0.883																														true	F9His303Tyr																																																																																																																																																																																																																																		
RET	RET_Arg330Gln	-1.7958396916116608	0.11558602092288398	12.792825715139873	4.1342425315877565e-6	2025_01_Batch_13-14	true	false	false	true	false	false	false	false	false	false	0.9590041229944257	0.862641504060798	0.9111919835237869	0.9419675031643922	0.9023044924450163	0.9939309951224155	0.9707838684532181	0.9826078401369326	0.9759573065456218	0.9702720270096226	0.8106779897676171	0.9131511378755663	0.8397761269106413	0.7493257015759742	0.9477362189792289	RET	-1.7958396916116608	0.11558602092288398	12.792825715139873	4.1342425315877565e-6	2025_01_Batch_13-14	true	false	false	true	false	false	false	false	false	false	0.9590041229944257	0.862641504060798	0.9111919835237869	0.9419675031643922	0.9023044924450163	0.9939309951224155	0.9707838684532181	0.9826078401369326	0.9759573065456218	0.9702720270096226	0.8106779897676171	0.9131511378755663	0.8397761269106413	0.7493257015759742	0.9477362189792289	RET	ENSG00000165731	8858	202957.0	CCSBVarC006881	ALE00006879	NC_000010.11:43106497:G:A	989G>A	Arg330Gln	CEGS2	CegsMutGDEh1026	D12	GDEhDisVCh_40066	F05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43106497.0	G	A	10	Y	N	N	N	N	10-43106497-G-A	28965.0	single nucleotide variant	NM_020975.6(RET):c.989G>A (p.Arg330Gln)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	1.0	Jun 22, 2023	80236571.0	-	RCV000014951|RCV004696636|RCV001379274	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43106497.0	43106497.0	10q11.21	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009415,UniProtKB:P07949#VAR_006302,OMIM:164761.0022	3.0	13926.0	43106497.0	G	A	-	-	-	-	-	-	SCV001577045|SCV004817287|SCV005198055|SCV005849412	-	-	989G>A 	Arg330Gln	NM_020975.6	1.0	3_Conflicting	6.84263e-7	13926.0	10	43106497.0	G	A	R	Q	rs80236571	10	43601945.0	10	42921951.0	330.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.989G>A	p.Arg330Gln	c.989G>A	p.Arg330Gln	principal4	Y	5	YES	Select	+	CGG	2.0	0.0	G	G/G	G/G	G/G	G/G	0.241	0.17740	T	0.612	0.07765	T	0.997	0.73231	D	0.775	0.63015	P	0.58	0.75656	D	simple_aae	42.0	58.0	2.585	0.75368	M	-0.99	0.26154	N	0.607	0.62248	-0.0406	0.81321	T	0.5279	0.82381	D	10.0	0.85925674	0.84978	D	0.089999	0.75354	D	0.569	0.82371	0.757	0.88590	P07949	R330Q	Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.1985)| Gain of loop (P = 0.2045)| Loss of catalytic residue at R330 (P = 0.2566)| Loss of MoRF binding (P = 0.3113)	0.965051945311	0.96435	0.6768372825309222	0.67462	0.826949697597	0.67244	0.388616234064	0.23448	T	0.474583	0.80450	T	0.330437	0.85088	D	0.236874	0.84893	D	0.956602513790131	0.64578	D	0.819018	0.47499	T	0.24423973	0.47042	0.1090586	0.26223	0.21209615	0.43230	0.109657414	0.26374	-3.803	0.21738	T	0.1014	0.27073	B	0.758352146287697	0.69115	0.99982280	0.99765	0.47	0.69480	.	.	.	.	.	.	4.587702	0.72592	25.8	0.9994746789002578	0.99913	0.525698	0.54678	D	0.535811506893486	0.69059	5.326549	0.557793047773544	0.71788	5.732199	5.32	5.32	0.75341	4.38	0.82553	4.133	0.57831	8.604000	0.77773	0.672	0.70176	1.0	0.71675	1.0	0.68239	0.976	0.56441	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613734	6.196810e-07	0	1	1179844	8.475700e-07	0	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29592	0.000000e+00	0	0	44862	0.000000e+00	0	0	63922	0.000000e+00	0	0	6056	0.000000e+00	0	1	1179844	8.475700e-07	0	0	91026	0.000000e+00	0	1	23858	4.191466174867969E-5	0	84	0	0	84	0	0	2230	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4558	0	0	2314	0	0	108	0	1	32060	3.1191515907673116E-5	Conflicting_classifications_of_pathogenicity	Hirschsprung_disease,_susceptibility_to,_1|not_provided|Multiple_endocrine_neoplasia,_type_2	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106497G>A	ClinGen:CA009415|OMIM:164761.0022|UniProtKB:P07949#VAR_006302	C3888239|C3661900|C4048306	142623	388|653	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Arg	Gln	28965.0	single nucleotide variant	NM_020975.6(RET):c.989G>A (p.Arg330Gln)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	1.0	Jun 22, 2023	80236571.0	-	RCV000014951|RCV004696636|RCV001379274	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43106497.0	43106497.0	10q11.21	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009415,UniProtKB:P07949#VAR_006302,OMIM:164761.0022	3.0	13926.0	43106497.0	G	A	-	-	-	-	-	-	SCV001577045|SCV004817287|SCV005198055|SCV005849412	-	-	989G>A 	Arg330Gln	NM_020975.6	1.0	3_Conflicting	95.21	0.3588709677419355	['142623']	autosomal dominant	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	95.21	0.35887095	10-90	>90						R	89			95.21	Positively-charged	Arginine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-4.5								R330-N359, R330-D290, R330-V357; PAE: 2.0, 2.0, 1.0	6 interactions	R330-V357; PAE: 1.0	6 interactions	R330-D290; PAE: 2.0	1 interaction					175									-125.7				160.4	Cadherin-like region 3 (CLD3)					B (undefined)	E (parallel sheets)							Extracellular																																																													true	RETArg330Gln																																																																																																																																																																																																																																		
RAD51D	RAD51D_Val66Leu	3.332290913702663	0.01255158257903223	1.7405392471192878	0.12531028330572558	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7344897306565745	0.5781693250050742	0.7827076376749831	0.7229242225745285	0.6052057889185325	0.7368980398348187	0.8389360038622496	0.8769572018758964	0.6571225292527669	0.7995719693817023	0.4735135380022462	0.6069124412868073	0.6884580734740696	0.49921612075738153	0.6694074919314468	RAD51D	3.332290913702663	0.01255158257903223	1.7405392471192878	0.12531028330572558	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7344897306565745	0.5781693250050742	0.7827076376749831	0.7229242225745285	0.6052057889185325	0.7368980398348187	0.8389360038622496	0.8769572018758964	0.6571225292527669	0.7995719693817023	0.4735135380022462	0.6069124412868073	0.6884580734740696	0.49921612075738153	0.6694074919314468	RAD51D		7201		CCSBVarC024807		NC_000017.11:35118568:C:A	196G>T	Val66Leu																												17.0	35118568.0	C	A	17						17-35118568-C-A	409903.0	single nucleotide variant	NM_002878.4(RAD51D):c.196G>T (p.Val66Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Oct 24, 2024	56026142.0	-	RCV000484401|RCV001373871|RCV001524373	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35118568.0	35118568.0	17q12	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA16620388	2.0	419663.0	35118568.0	C	A	-	-	-	-	-	-	SCV000567624|SCV001570603|SCV001734195|SCV002721596|SCV005641837	-	-	196G>T 	Val66Leu	NM_002878.4	1.0	3_Conflicting		419663.0	17	35118568.0	C	A	V	L	rs56026142	17	33445587.0	17	30469700.0	66.0	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.196G>T	p.Val66Leu	c.196G>T	p.Val66Leu	principal1	Y	1	YES	Select	-	GTG	1.0	0.0	C	C/C	C/C	C/C	C/C	0.831	0.13644	T	0.486	0.11871	T	0.0	0.02950	B	0.004	0.10086	B	0.06	0.18971	N	simple_aae	94.0	6.0	-0.185	0.04240	N	0.04	0.06455	N	0.164	0.17177	-1.0483	0.14873	T	0.052	0.21919	T	10.0	0.057495058	0.06602	T	0.008992	0.23404	T	0.048	0.13183	0.513	0.61027	O75771	V66L	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Loss of catalytic residue at V66 (P = 0.2378)| Gain of disorder (P = 0.3398)| Gain of loop (P = 0.3485)	0.394990421082	0.38713	.	.	.	.	.	.	.	0.112411	0.42566	T	-0.25802	0.12873	T	-0.608404	0.11857	T	0.170912176370621	0.1841	T	.	0.24645	.	0.08530245	0.19601	0.0358917	0.02939	0.08530245	0.19601	0.0358917	0.02939	-4.193	0.26677	T	0.1367	0.29891	LB	1.88384050960672e-05	0.00991	0.78514117	0.87977	0.009	0.00522	.	.	.	.	.	.	0.314705	0.06924	3.434	0.817221065887129	0.14047	0.088102	0.17661	N	-1.34751807488594	0.03118	0.1402777	-1.22328831331821	0.05450	0.2641167	4.79	-0.163	0.12675	-5.85	0.03264	0.004	0.13047	0.681000	0.20762	-1.926	0.00504	0.001	0.13799	0.444	0.24998	0.443	0.27788	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614178	1.239020e-06	0	1	75058	1.332300e-05	0	1	75058	1.332300e-05	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180038	0.000000e+00	0	0	91078	0.000000e+00	0	0	153016	0	0	176	0	0	4498	0	0	4724	0	0	442	0	0	950	0	0	1848	0	0	280	0	0	11718	0	0	4900	0	0	6346	0	0	177652	0	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118568C>A	ClinGen:CA16620388	C3661900|C0027672|C3280345	614291	140162|145	.	Val	Leu	409903.0	single nucleotide variant	NM_002878.4(RAD51D):c.196G>T (p.Val66Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Oct 24, 2024	56026142.0	-	RCV000484401|RCV001373871|RCV001524373	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35118568.0	35118568.0	17q12	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA16620388	2.0	419663.0	35118568.0	C	A	-	-	-	-	-	-	SCV000567624|SCV001570603|SCV001734195|SCV002721596|SCV005641837	-	-	196G>T 	Val66Leu	NM_002878.4	1.0	3_Conflicting	87.61	0.647887323943662	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	87.61	0.64788735	10-90	70-90						V	92			87.61	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2			4 interactions	5 interactions														117									-109.1				144.7	preferentially binds ssDNA					C (loop/coil)	C (loop/coil)																																																																				true	RAD51DVal66Leu																																																																																																																																																																																																																																		
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6646032971705318	0.6775313798754301	0.6266859465409534	0.7194036467263272	0.7150858388110624	0.7973980911773066	0.728972055903696	0.6126236306187102	0.7479509351289371	0.6417363100862536	0.6327735864448181	0.7098352375489585	0.6407482624631967	0.6071118246219231	0.68747028425481	F9	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6646032971705318	0.6775313798754301	0.6266859465409534	0.7194036467263272	0.7150858388110624	0.7973980911773066	0.728972055903696	0.6126236306187102	0.7479509351289371	0.6417363100862536	0.6327735864448181	0.7098352375489585	0.6407482624631967	0.6071118246219231	0.68747028425481	F9	ENSG00000101981	52861	24496.0	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2.0	RC4_Mut_GDDh1022	G11							1.0	1.0	1.0	1.0	0.0			0.0			0.0			23.0	139537138.0	G	A	X	Y	Y	N	N	N	X-139537138-G-A																																														5_Others																																																																																																																																																																																																																																																																																																																																																																																																																																																	unknown	Rare genetic hematologic disease	1				10-90	>90						E	79			86.94	Negatively-charged	Glutamic Acid	Ca(2+); Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain							Gla			-3.5										E73-V77; PAE: 1.5							4-carboxyglutamate	146									-62.5				-41.0						H (helix)	H (α-helix)	Helix																													1.004		0.808		0.84		0.061	5 mutation(s) (Glu73Lys: -0.019, Glu73Trp: -0.013, Glu73Ala: -0.005, Glu73Tyr: -0.005, Glu73Cys: -0.004)	0.964	4 mutation(s) (Glu73Thr: 1.256, Glu73Asn: 1.284, Glu73Gly: 1.293, Glu73Ser: 1.308)																													true	F9Glu73Lys																																																																																																																																																																																																																																		
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	true	false	true	true	false	false	false	false	false	false	0.9820599011186065	0.685411285134558	0.9693274348968446	0.9483818748939087	0.6820371842857371	0.6277013178121026	0.9458264867789534	0.960788624807321	0.6407207648505859	0.9785436051053813	0.7363730507593718	0.9509372630088639	0.9778662449863682	0.7301018054185299	0.9855761971318318	F9	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	true	false	true	true	false	false	false	false	false	false	0.9820599011186065	0.685411285134558	0.9693274348968446	0.9483818748939087	0.6820371842857371	0.6277013178121026	0.9458264867789534	0.960788624807321	0.6407207648505859	0.9785436051053813	0.7363730507593718	0.9509372630088639	0.9778662449863682	0.7301018054185299	0.9855761971318318	F9	ENSG00000101981	52861	204347.0	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139530846.0	T	C	X	Y	N	N	N	N	X-139530846-T-C	25696.0	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 02, 2021	387906481.0	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846.0	139530846.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3.0	10657.0	139530846.0	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1.0	1_Pathogenic		10657.0	X	139530846.0	T	C	C	R	rs387906481	X	138613005.0	X	138440671.0	28.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1.0	0.0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10.0	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.906661565102744	0.2017	.	.	.	.	.	.	.	.	.	5.23	4.0	0.4561	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.0	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696.0	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 02, 2021	387906481.0	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846.0	139530846.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3.0	10657.0	139530846.0	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1.0	1_Pathogenic	60.23	0.8296296296296296	['306900', '300807', '306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	60.23	0.8296296	10-90	50-70						C	112			60.23	Special, a very reactive sulfhydryl group	Cysteine												2.5																		121									-67.7				84.2						C (loop/coil)	C (loop/coil)				Signal																										0.323	2 mutation(s) (Cys28Trp: -0.011, Cys28Leu: 0.006)	0.379		0.499		0.512		0.41																														true	F9Cys28Arg																																																																																																																																																																																																																																		
RET	RET_Leu56Met	2.070499399299519	0.07715984473902697	4.176807048731463	0.004153743658106803	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7626787684074487	0.7572979481055021	0.8232553604190842	0.8031154367202464	0.7994809812678401	0.9547018505169517	0.8922386929915563	0.9252820879349938	0.8460785661873986	0.8183809072225747	0.6442601120187283	0.7139921804489365	0.7212286329031747	0.6685173300236056	0.7069766295923227	RET	2.070499399299519	0.07715984473902697	4.176807048731463	0.004153743658106803	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7626787684074487	0.7572979481055021	0.8232553604190842	0.8031154367202464	0.7994809812678401	0.9547018505169517	0.8922386929915563	0.9252820879349938	0.8460785661873986	0.8183809072225747	0.6442601120187283	0.7139921804489365	0.7212286329031747	0.6685173300236056	0.7069766295923227	RET	ENSG00000165731	8858	202944.0	CCSBVarC006872	ALE00006870	NC_000010.11:43100551:C:A	166C>A	Leu56Met	CEGS2	CegsMutGDEh1027	G04	GDEhDisVCh_40066	G05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43100551.0	C	A	10	Y	N	N	N	N	10-43100551-C-A	45384.0	single nucleotide variant	NM_020975.6(RET):c.166C>A (p.Leu56Met)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	145633958.0	-	RCV000121985|RCV000202649|RCV000034766|RCV000030402|RCV000163266|RCV001108850|RCV000148768|RCV001082759|RCV001108849|RCV001108851	MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388	not specified|Multiple endocrine neoplasia|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Aganglionic megacolon|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1	germline;unknown	germline	GRCh38	NC_000010.11	10	43100551.0	43100551.0	10q11.21	criteria provided, conflicting classifications	26.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007702	2.0	36723.0	43100551.0	C	A	-	-	-	-	-	-	SCV000113984|SCV000213794|SCV000258169|SCV000261742|SCV000514406|SCV000711342|SCV000807009|SCV001138019|SCV001147859|SCV001158030|SCV001266132|SCV001266133|SCV001266134|SCV001266135|SCV002011461|SCV002067079|SCV002529940|SCV002550377|SCV002774043|SCV004357214|SCV004838625	-	-	166C>A 	Leu56Met	NM_020975.6	1.0	3_Conflicting	0.00499724	36723.0	10	43100551.0	C	A	L	M	rs145633958	10	43595999.0	10	42916005.0	56.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.166C>A	p.Leu56Met	c.166C>A	p.Leu56Met	principal4	Y	5	YES	Select	+	CTG	1.0	2.0	C	C/C	C/C	C/C	C/C	0.393	0.11116	T	0.37	0.92967	T	0.558	0.44790	P	0.207	0.43709	B	0.08	0.23785	N	simple_aae	92.0	8.0	1.74	0.44959	L	-0.71	0.20082	N	0.234	0.27835	-0.4197	0.71275	T	0.2838	0.65421	T	10.0	0.01373741	0.00287	T	0.038562	0.58137	D	0.506	0.78612	.	.	.	.	.	0.965681725857	0.96499	0.5310686656002561	0.52839	0.936903531846	0.71884	0.436104416847	0.30008	T	0.443185	0.78547	T	-0.161264	0.2622	T	-0.00332951	0.699	D	0.00669683503352234	0.00074	T	0.677732	0.28414	T	0.13296163	0.30675	0.057930265	0.10627	0.15338261	0.34482	0.070077136	0.14837	-5.112	0.38089	T	0.2222	0.51413	B	0.420929723777606	0.58343	0.99925655	0.99252	0.115	0.31465	.	.	.	.	.	.	0.98931	0.13688	10.21	0.9780850831947717	0.36268	0.071078	0.13951	N	-0.303488539195444	0.28736	1.605345	-0.361080103655587	0.25850	1.44365	5.51	3.41	0.38072	1.56	0.34791	0.376	0.2034	0.096000	0.14644	0.599	0.40292	0.307	0.25474	0.003	0.18726	0.004	0.06081	862	0.33096	6	0.0011980830670926517	1	7.564296520423601E-4	4	0.003976143141153081	1	0.001440922190201729	0	0.0	0	0.0	779	264690	0.0029430655	.	289	109366	2.642500e-03	1	564	207736	2.714980e-03	1	625	236592	2.641680e-03	1	4	7148	5.595970e-04	0	27	17110	1.578020e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	35	13384	2.615060e-03	0	217	42756	5.075310e-03	1	0	15688	0.000000e+00	0	217	42756	5.075310e-03	1	11	16174	6.801040e-04	0	40	30516	1.310790e-03	0	0	6206	0.000000e+00	0	1	13410	7.457120e-05	0	44	16724	2.630950e-03	0	454	89240	5.087400e-03	1	0	30606	0.000000e+00	0	454	89240	5.087400e-03	1	9	14876	6.050010e-04	0	53	34256	1.547170e-03	0	0	9564	0.000000e+00	0	1	17692	5.652270e-05	0	49	21620	2.266420e-03	0	498	102440	4.861380e-03	1	0	30524	0.000000e+00	0	498	102440	4.861380e-03	1	.	7763	1613938	4.809970e-03	25	7135	1180022	6.046500e-03	24	54	75056	7.194630e-04	0	0	912	0.000000e+00	0	109	60026	1.815880e-03	0	1	29608	3.377470e-05	0	1	44880	2.228160e-05	0	194	63782	3.041610e-03	1	0	6060	0.000000e+00	0	7135	1180022	6.046500e-03	24	2	91090	2.195630e-05	0	981	198634	0.0049387315363935685	1	360	0.002777777777777778	0	4532	0	5	9432	5.301102629346904E-4	5	796	0.00628140703517588	0	966	0	0	1842	0	0	280	0	54	17500	0.003085714285714286	6	9792	6.127450980392157E-4	0	6374	0	1046	234342	0.004463561802835173	Conflicting_classifications_of_pathogenicity	not_specified|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon	criteria_provided,_conflicting_classifications	NC_000010.11:g.43100551C>A	ClinGen:CA007702	CN169374|C1619700|C0027662|C3661900|C0031511|C0027672|C4048306|C0025268|C3888239|C0019569	191830|PS131100|171300|171400|142623|PS142623	411709|276161|29072|140162|653|247698|653|388|388	Ret, cadherin like domain 1	Leu	Met	45384.0	single nucleotide variant	NM_020975.6(RET):c.166C>A (p.Leu56Met)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	145633958.0	-	RCV000121985|RCV000202649|RCV000034766|RCV000030402|RCV000163266|RCV001108850|RCV000148768|RCV001082759|RCV001108849|RCV001108851	MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388	not specified|Multiple endocrine neoplasia|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Aganglionic megacolon|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1	germline;unknown	germline	GRCh38	NC_000010.11	10	43100551.0	43100551.0	10q11.21	criteria provided, conflicting classifications	26.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007702	2.0	36723.0	43100551.0	C	A	-	-	-	-	-	-	SCV000113984|SCV000213794|SCV000258169|SCV000261742|SCV000514406|SCV000711342|SCV000807009|SCV001138019|SCV001147859|SCV001158030|SCV001266132|SCV001266133|SCV001266134|SCV001266135|SCV002011461|SCV002067079|SCV002529940|SCV002550377|SCV002774043|SCV004357214|SCV004838625	-	-	166C>A 	Leu56Met	NM_020975.6	1.0	3_Conflicting	94.01	0.0426829268292682	['171400', '171300', '191830', '142623']	multiple	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; PHEOCHROMOCYTOMA; RENAL HYPODYSPLASIA/APLASIA 1; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	94.01	0.042682927	<10	>90						L	7			94.01	Aliphatic	Leucine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										3.8								L56-Y30; PAE: 1.0	6 interactions	L56-Y30, L56-G183; PAE: 1.0, 1.0	7 interactions							131									-89.5				163.9	Cadherin-like region 1 (CLD1)					B (undefined)	E (parallel sheets)							Extracellular																																																													true	RETLeu56Met																																																																																																																																																																																																																																		
KRAS	KRAS_Asp153Val	-0.3822084358919264	0.7136459741761332	1.9062732019056778	0.09829495263619474	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8084061826422138	0.6496377218026227	0.8253721997347703	0.789708420357595	0.7410168665891441	0.9451762796566503	0.9568943207477909	0.9461182286792507	0.8472461347940353	0.9115073512637107	0.5368574535216379	0.6225225199673992	0.70462617079029	0.45202930881121006	0.7053050140207169	KRAS	-0.3822084358919264	0.7136459741761332	1.9062732019056778	0.09829495263619474	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8084061826422138	0.6496377218026227	0.8253721997347703	0.789708420357595	0.7410168665891441	0.9451762796566503	0.9568943207477909	0.9461182286792507	0.8472461347940353	0.9115073512637107	0.5368574535216379	0.6225225199673992	0.70462617079029	0.45202930881121006	0.7053050140207169	KRAS	ENSG00000133703	3084	214494.0	CCSBVarC006101	ALE00006101	NC_000012.12:25209904:T:A	458A>T	Asp153Val	CEGS2	CegsMutGDEh1042	B12	GDEhDisVCh_40061	E10	1.0	CegsMutGDDh1042	B12							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25209904.0	T	A	12	Y	Y	N	N	N	12-25209904-T-A	27626.0	single nucleotide variant	NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Nov 15, 2018	104894360.0	-	RCV000013418|RCV000013417|RCV000157940|RCV000212501|RCV000507330|RCV000763307|RCV000523200|RCV000844634|RCV003450634|RCV004018621	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN169374|11 conditions|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MedGen:CN230736	Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|not specified|11 conditions|Noonan syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25209904.0	25209904.0	12p12.1	reviewed by expert panel	16.0	-	N	ClinGen:CA256478,OMIM:190070.0010,OMIM:190070.0015	3.0	12587.0	25209904.0	T	A	-	-	-	-	-	-	SCV000616371	-	-	458A>T 	Asp153Val	NM_004985.5	3.0	1_Pathogenic		12587.0	12	25209904.0	T	A	D	V	rs104894360	12	25362838.0	12	25254105.0	128.0	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.383A>T	p.Asp128Val	.	Y	.	.	.	-	GAT	2.0	0.0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.83643	.	.	0.50195	.	.	0.47676	.	.	0.94378	.	.	.	.	.	.	.	.	0.82015	.	.	0.93732	0.2042	0.8592	D	0.4729	0.79666	T	7.0	.	0.91672	.	0.435687	0.94056	D	.	0.93084	.	0.87760	.	.	.	.	0.92600	.	.	.	.	.	.	.	.	.	.	0.432327	0.91589	D	0.383231	0.91485	D	0.955039322376251	0.64186	D	.	0.90939	.	.	.	.	.	.	.	.	.	.	0.77191	.	.	0.91639	.	.	.	0.96898425	0.94579	0.991	0.99694	.	.	.	.	.	.	4.964316	0.82142	27.7	0.9923318523929131	0.56347	0.867497	0.78650	D	0.565827697853449	0.70896	5.592508	0.631385021559758	0.77104	6.639681	5.87	5.87	0.94257	.	.	7.628	0.82424	7.901000	0.73593	0.583	0.30331	1.0	0.71675	1.000000	0.68239	0.997	0.79771	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Acute_myeloid_leukemia|Autoimmune_lymphoproliferative_syndrome_type_4|Malignant_tumor_of_urinary_bladder|Lung_carcinoma|Cardiofaciocutaneous_syndrome_2|Carcinoma_of_pancreas|Hereditary_diffuse_gastric_adenocarcinoma|Linear_nevus_sebaceous_syndrome|Cerebral_arteriovenous_malformation|Noonan_syndrome_3|Familial_cancer_of_breast|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|not_provided|Cardiovascular_phenotype|RASopathy|Noonan_syndrome_1|not_specified	reviewed_by_expert_panel	NC_000012.12:g.25209904T>A	ClinGen:CA256478|OMIM:190070.0010|OMIM:190070.0015	C0023467|C2674723|C0005684|C0684249|C3809005|C0235974|C1708349|C4552097|C0917804|C1860991|C0346153|C1275081|C0028326|C3661900|CN230736|C5555857|C4551602|CN169374	601626|614470|109800|615278|137215|163200|108010|609942|114480|PS115150|PS163950|163950	519|268114|157980|1340|1333|217074|26106|2612|46724|648|227535|1340|648|536391|648	.	Asp	Val	27626.0	single nucleotide variant	NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Nov 15, 2018	104894360.0	-	RCV000013418|RCV000013417|RCV000157940|RCV000212501|RCV000507330|RCV000763307|RCV000523200|RCV000844634|RCV003450634|RCV004018621	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN169374|11 conditions|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MedGen:CN230736	Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|not specified|11 conditions|Noonan syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25209904.0	25209904.0	12p12.1	reviewed by expert panel	16.0	-	N	ClinGen:CA256478,OMIM:190070.0010,OMIM:190070.0015	3.0	12587.0	25209904.0	T	A	-	-	-	-	-	-	SCV000616371	-	-	458A>T 	Asp153Val	NM_004985.5	3.0	1_Pathogenic			['609942', '615278', '163950']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3; CARDIOFACIOCUTANEOUS SYNDROME 2; NOONAN SYNDROME 1			10-90	>90																																																																																																																																		true	KRASAsp153Val																																																																																																																																																																																																																																		
RET	RET_Arg313Gln	-2.285823693071175	0.05615212771343529	5.8231339538018	0.0006480669481361119	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.782304211865213	0.7737256927664918	0.8165193923670089	0.8217510818095444	0.8546752579166506	0.9161398862175612	0.8072101041676472	0.7379005221049658	0.9027683134943302	0.7295364397706064	0.7932106296157398	0.8362920594514416	0.8951382626290518	0.6446830720386535	0.8350719839598196	RET	-2.285823693071175	0.05615212771343529	5.8231339538018	0.0006480669481361119	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.782304211865213	0.7737256927664918	0.8165193923670089	0.8217510818095444	0.8546752579166506	0.9161398862175612	0.8072101041676472	0.7379005221049658	0.9027683134943302	0.7295364397706064	0.7932106296157398	0.8362920594514416	0.8951382626290518	0.6446830720386535	0.8350719839598196	RET	ENSG00000165731	8858	202958.0	CCSBVarC006882	ALE00006880	NC_000010.11:43106446:G:A	938G>A	Arg313Gln	CEGS2	CegsMutGDEh1024	A02	GDEhDisVCh_40066	A05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43106446.0	G	A	10	Y	N	N	N	N	10-43106446-G-A	28971.0	single nucleotide variant	NM_020975.6(RET):c.938G>A (p.Arg313Gln)	5979.0	RET	HGNC:9967	Uncertain significance	0.0	Jan 24, 2025	77702891.0	-	RCV000014957|RCV000662693|RCV000654592|RCV000566081|RCV002476968|RCV003114192	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653;MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361|MedGen:C3661900	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Multiple endocrine neoplasia type 2B;Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Familial medullary thyroid carcinoma|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106446.0	43106446.0	10q11.21	criteria provided, multiple submitters, no conflicts	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009384,UniProtKB:P07949#VAR_009465,OMIM:164761.0028	3.0	13932.0	43106446.0	G	A	-	-	-	-	-	-	SCV000674841|SCV000776486|SCV000785424|SCV000896054|SCV003798648|SCV004018491|SCV005623124	-	-	938G>A 	Arg313Gln	NM_020975.6	2.0	4_VUS	0.0000287445	13932.0	10	43106446.0	G	A	R	Q	rs77702891	10	43601894.0	10	42921900.0	313.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.938G>A	p.Arg313Gln	c.938G>A	p.Arg313Gln	principal4	Y	5	YES	Select	+	CGG	2.0	0.0	G	G/G	G/G	G/G	G/G	0.017	0.51407	D	0.116	0.36834	T	0.943	0.56216	P	0.173	0.45142	B	0.64	0.79151	D	simple_aae	36.0	64.0	2.44	0.70564	M	-0.65	0.18812	N	0.45	0.48537	-0.6073	0.6436	T	0.3274	0.69436	T	10.0	0.22862077	0.39382	T	0.13682	0.81879	D	0.552	0.81390	0.723	0.85693	P07949	R313Q	Gain of sheet (P = 0.0049)| Gain of loop (P = 0.0312)| Loss of stability (P = 0.1084)| Loss of phosphorylation at T315 (P = 0.1211)| Gain of glycosylation at S316 (P = 0.2382)	0.928844329528	0.92757	0.8295473270931635	0.82810	0.306023030952	0.32606	0.403721630573	0.25557	T	0.452479	0.79124	T	-0.102543	0.35646	T	-0.0018559	0.69996	D	0.158066955150649	0.17507	T	0.875612	0.58615	D	0.2721727	0.49956	0.13592933	0.32442	0.18244144	0.39154	0.08550162	0.19721	-4.117	0.26502	T	0.1404	0.33018	B	0.547894901457323	0.62233	0.99958426	0.99505	0.446	0.67864	.	.	.	.	.	.	3.504925	0.49142	22.7	0.9989321191735554	0.96668	0.080145	0.16005	N	0.0737859261210792	0.44985	2.784067	0.0662528309478524	0.42582	2.600265	5.32	2.2	0.26894	2.0	0.39643	2.392	0.44189	6.435000	0.55709	0.672	0.70176	0.959	0.33632	1.0	0.68239	0.71	0.34491	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	16	264690	6.044807E-5	.	13	108632	1.196700e-04	0	26	206054	1.261810e-04	0	30	234958	1.276820e-04	0	0	7066	0.000000e+00	0	13	17006	7.644360e-04	0	0	2304	0.000000e+00	0	0	8992	0.000000e+00	0	0	13308	0.000000e+00	0	0	42460	0.000000e+00	0	0	15588	0.000000e+00	0	13	17006	7.644360e-04	0	0	15982	0.000000e+00	0	24	30344	7.909310e-04	0	1	6162	1.622850e-04	0	0	13304	0.000000e+00	0	0	16628	0.000000e+00	0	1	88370	1.131610e-05	0	0	30438	0.000000e+00	0	24	30344	7.909310e-04	0	0	14734	0.000000e+00	0	26	34094	7.625980e-04	0	1	9550	1.047120e-04	0	0	17626	0.000000e+00	0	0	21064	0.000000e+00	0	2	101936	1.962020e-05	0	0	30362	0.000000e+00	0	26	34094	7.625980e-04	0	.	45	1613324	2.789270e-05	0	30	59952	5.004000e-04	0	1	74906	1.335010e-05	0	0	912	0.000000e+00	0	30	59952	5.004000e-04	0	1	29586	3.379980e-05	0	0	44874	0.000000e+00	0	0	63780	0.000000e+00	0	0	6052	0.000000e+00	0	9	1179830	7.628220e-06	0	2	90976	2.198380e-05	0	0	15826	0	0	122	0	0	146	0	1	3804	2.628811777076761E-4	0	146	0	0	610	0	0	56	0	0	104	0	0	2876	0	1	3926	2.5471217524197657E-4	0	202	0	1	23690	4.2211903756859436E-5	Uncertain_significance	Multiple_endocrine_neoplasia,_type_2|not_provided|Pheochromocytoma|Hirschsprung_disease,_susceptibility_to,_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43106446G>A	ClinGen:CA009384|OMIM:164761.0028|UniProtKB:P07949#VAR_009465	C4048306|C3661900|C0031511|C3888239|C1833921|C0025268|C0025269|C0027672	171300|142623|155240|171400|162300	653|29072|388|653|99361|247698|653|247709|653|140162	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Arg	Gln	28971.0	single nucleotide variant	NM_020975.6(RET):c.938G>A (p.Arg313Gln)	5979.0	RET	HGNC:9967	Uncertain significance	0.0	Jan 24, 2025	77702891.0	-	RCV000014957|RCV000662693|RCV000654592|RCV000566081|RCV002476968|RCV003114192	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653;MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361|MedGen:C3661900	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Multiple endocrine neoplasia type 2B;Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Familial medullary thyroid carcinoma|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106446.0	43106446.0	10q11.21	criteria provided, multiple submitters, no conflicts	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009384,UniProtKB:P07949#VAR_009465,OMIM:164761.0028	3.0	13932.0	43106446.0	G	A	-	-	-	-	-	-	SCV000674841|SCV000776486|SCV000785424|SCV000896054|SCV003798648|SCV004018491|SCV005623124	-	-	938G>A 	Arg313Gln	NM_020975.6	2.0	4_VUS	78.93	0.1370967741935483	['142623', '171400', '171300', '162300', '142623', '171400', '155240']	autosomal dominant	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; PHEOCHROMOCYTOMA; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; THYROID CARCINOMA, FAMILIAL MEDULLARY	78.93	0.13709678	10-90	70-90						R	34			78.93	Positively-charged	Arginine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-4.5								R313-D266, R313-E309; PAE: 5.5, 5.5	1 interaction	R313-E309, R313-S379; PAE: 5.5, 4.0	6 interactions	R313-D266, R313-D380, R313-E309; PAE: 5.5, 5.0, 5.5						175									-94.5				-64.1	Cadherin-like region 3 (CLD3)					H (helix)	H (α-helix)							Extracellular																																																													true	RETArg313Gln																																																																																																																																																																																																																																		
BRCA1	BRCA1_Glu143Lys	1.0715681647773336	0.3194625014850119	-1.3011218450965225	0.23440439309487046	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.914782662401556	0.8217070960184036	0.929185029340914	0.872357912783629	0.9239672548193365	0.9480245505139957	0.8955713661160429	0.936478711330349	0.8952628504353902	0.9507439270755751	0.8999099591246774	0.8491444594512151	0.9218913473514789	0.748151341601417	0.8788213977275371	BRCA1	1.0715681647773336	0.3194625014850119	-1.3011218450965225	0.23440439309487046	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.914782662401556	0.8217070960184036	0.929185029340914	0.872357912783629	0.9239672548193365	0.9480245505139957	0.8955713661160429	0.936478711330349	0.8952628504353902	0.9507439270755751	0.8999099591246774	0.8491444594512151	0.9218913473514789	0.748151341601417	0.8788213977275371	BRCA1		14613		CCSBVarC013134		NC_000017.11:43104136:C:T	427G>A	Glu143Lys																												17.0	43104136.0	C	T	17						17-43104136-C-T	46136.0	single nucleotide variant	NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80356991.0	-	RCV000031161|RCV000162967|RCV000588563|RCV000159939|RCV001719704|RCV001798032|RCV002250474|RCV002504841|RCV004758611	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided|Breast and/or ovarian cancer|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43104136.0	43104136.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00055,ClinGen:CA002745	2.0	37580.0	43104136.0	C	T	-	-	-	-	-	-	SCV000244359	-	-	427G>A 	Glu143Lys	NM_007294.4	3.0	2_Benign		37580.0	17	43104136.0	C	T	E	K	rs80356991	17	41256153.0	17	38509679.0	143.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.427G>A	p.Glu143Lys	principal2	Y	1	.	.	-	GAA	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.34767	.	.	0.57928	.	0.019	0.68795	B	0.006	0.55829	B	.	0.49097	.	.	.	.	1.5	0.37685	L	.	0.42578	.	.	0.38091	0.5017	0.90534	D	0.8767	0.95897	D	10.0	.	0.21644	.	0.247707	0.88953	D	.	0.79415	0.303	0.27037	E9PFC7	E143K	Gain of ubiquitination at E143 (P = 0.0025)| Gain of MoRF binding (P = 0.0124)| Gain of methylation at E143 (P = 0.1317)| Gain of relative solvent accessibility (P = 0.1684)| Loss of phosphorylation at S146 (P = 0.184)	.	0.86141	.	0.37990	.	0.10163	0.315168946981	0.12679	T	0.158884	0.49950	T	0.019488	0.54001	T	0.120218	0.7809	D	0.0473425365312362	0.04979	T	0.851115	0.53361	D	0.03369628	0.03605	0.04770675	0.06945	0.034599107	0.03876	0.05370916	0.09113	-4.389	0.42050	T	.	0.13983	.	0.681098547151026	0.66393	0.99696964	0.98220	0.018	0.02411	.	.	.	.	.	.	2.363521	0.30377	18.4	0.9908741703673932	0.52206	0.188915	0.31406	N	-0.366331149050496	0.26398	1.457724	-0.342651888589345	0.26417	1.478785	5.32	3.28	0.36615	2.24	0.42522	1.938	0.39936	1.666000	0.28012	-0.187	0.09644	0.861	0.30721	0.92	0.28384	0.293	0.24381	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	10	264690	3.7780046E-5	.	11	109208	1.007250e-04	0	16	207718	7.702750e-05	0	19	236486	8.034300e-05	0	0	7152	0.000000e+00	0	1	17062	5.860980e-05	0	0	2320	0.000000e+00	0	5	9040	5.530970e-04	0	0	13370	0.000000e+00	0	2	42726	4.680990e-05	0	3	15626	1.919880e-04	0	5	9040	5.530970e-04	0	0	16186	0.000000e+00	0	1	30464	3.282560e-05	0	0	6212	0.000000e+00	0	5	13390	3.734130e-04	0	0	16710	0.000000e+00	0	6	89418	6.710060e-05	0	4	30484	1.312160e-04	0	5	13390	3.734130e-04	0	0	14870	0.000000e+00	0	1	34186	2.925170e-05	0	0	9572	0.000000e+00	0	8	17664	4.528990e-04	0	1	21600	4.629630e-05	0	5	102588	4.873860e-05	0	4	30402	1.315700e-04	0	8	17664	4.528990e-04	0	.	108	1613230	6.694640e-05	0	11	44878	2.451090e-04	0	0	74812	0.000000e+00	0	0	912	0.000000e+00	0	1	59920	1.668890e-05	0	0	29600	0.000000e+00	0	11	44878	2.451090e-04	0	0	63846	0.000000e+00	0	0	6080	0.000000e+00	0	89	1179784	7.543750e-05	0	6	90930	6.598480e-05	0	3	32728	9.166462967489611E-5	0	122	0	0	146	0	0	3824	0	0	500	0	0	628	0	0	56	0	0	104	0	0	6972	0	0	3946	0	0	202	0	3	45080	6.654835847382431E-5	Benign	Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43104136C>T	BRCA1-HCI:BRCA1_00055|ClinGen:CA002745	C0346153|C3280442|C2676676|C4554406|CN221562|C0677776|CN169374|C0027672|C3661900	114480|614320|604370|617883	227535|1333|145|145|140162	.	Glu	Lys	46136.0	single nucleotide variant	NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80356991.0	-	RCV000031161|RCV000162967|RCV000588563|RCV000159939|RCV001719704|RCV001798032|RCV002250474|RCV002504841|RCV004758611	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided|Breast and/or ovarian cancer|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43104136.0	43104136.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00055,ClinGen:CA002745	2.0	37580.0	43104136.0	C	T	-	-	-	-	-	-	SCV000244359	-	-	427G>A 	Glu143Lys	NM_007294.4	3.0	2_Benign	34.79	0.9020618556701032	['604370', '114480', '604370', '617883', '614320', '114480']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST CANCER	34.79	0.9020619	$\geqslant$90	<=50																																																																																																																																		true	BRCA1Glu143Lys																																																																																																																																																																																																																																		
KRAS	KRAS_Pro34Leu	-1.422648105997645	0.1978359955775831	4.76286831428778	0.0020526213309444738	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.819462913941984	0.6080966467131127	0.7868060474344328	0.7424926976613215	0.7119513153360237	0.4738729661856484	0.6095449270752253	0.6115574408962654	0.4367117374839895	0.7513551264015575	0.950029664486399	0.8754404682474177	0.9620546539726003	0.7794815559422359	0.8875707014824106	KRAS	-1.422648105997645	0.1978359955775831	4.76286831428778	0.0020526213309444738	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.819462913941984	0.6080966467131127	0.7868060474344328	0.7424926976613215	0.7119513153360237	0.4738729661856484	0.6095449270752253	0.6115574408962654	0.4367117374839895	0.7513551264015575	0.950029664486399	0.8754404682474177	0.9620546539726003	0.7794815559422359	0.8875707014824106	KRAS	ENSG00000133703	3084	214481.0	CCSBVarC006093	ALE00006093	NC_000012.12:25245284:G:A	101C>T	Pro34Leu	CEGS2	CegsMutGDEh1035	F07	GDEhDisVCh_40061	H08	1.0	CegsMutGDDh1035	F07							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25245284.0	G	A	12	Y	Y	N	N	N	12-25245284-G-A	48924.0	single nucleotide variant	NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Sep 17, 2024	104894366.0	-	RCV000150892|RCV000232330|RCV003152670|RCV000157668|RCV003450654	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Noonan syndrome|RASopathy|Noonan syndrome 3|not provided|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25245284.0	25245284.0	12p12.1	reviewed by expert panel	7.0	-	N	ClinGen:CA235301,UniProtKB:P01116#VAR_064852	2.0	40454.0	25245284.0	G	A	-	-	-	-	-	-	SCV000616368	-	-	101C>T 	Pro34Leu	NM_004985.5	3.0	1_Pathogenic		40454.0	12	25245284.0	G	A	P	L	rs104894366	12	25398218.0	12	25289485.0	34.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.101C>T	p.Pro34Leu	c.101C>T	p.Pro34Leu	alternative1	Y	1	.	Plus_Clinical	-	CCA	2.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.155	0.88323	M	-8.45	0.98724	D	0.966	0.97658	0.8491	0.95002	D	0.811	0.93606	D	10.0	0.9343852	0.92690	D	0.2884	0.90456	D	0.867	0.95976	0.768	0.89476	P01116	P34L	Gain of catalytic residue at I36 (P = 0.0054)| Loss of disorder (P = 0.0163)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.1364)| Loss of relative solvent accessibility (P = 0.1807)	0.993019268771	0.99286	0.9624586865523342	0.96210	2.72839044085	0.98645	0.913879752159	0.97821	D	0.916481	0.98452	D	0.461598	0.9294	D	0.425277	0.92852	D	0.999580919742584	0.98005	D	0.906909	0.69125	D	0.9735194	0.98554	0.9422203	0.97882	0.96042603	0.97281	0.9655402	0.99246	-15.775	0.98455	D	0.9976	0.97942	P	0.999893295116841	0.98645	0.99935130	0.99318	0.997	0.99892	.	.	.	.	.	.	5.430283	0.90819	31.0	0.9986618968256616	0.94461	0.907536	0.86118	D	1.07681546054986	0.97667	16.56095	1.0082682822431	0.98773	19.35518	5.68	5.68	0.88004	.	.	9.985	0.99185	11.891000	0.99094	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Noonan_syndrome|RASopathy|Noonan_syndrome_1|not_provided|Noonan_syndrome_3	reviewed_by_expert_panel	NC_000012.12:g.25245284G>A	ClinGen:CA235301|UniProtKB:P01116#VAR_064852	C0028326|C5555857|C4551602|C3661900|C1860991	PS163950|163950|609942	648|536391|648|648	Small GTP-binding domain	Pro	Leu	48924.0	single nucleotide variant	NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Sep 17, 2024	104894366.0	-	RCV000150892|RCV000232330|RCV003152670|RCV000157668|RCV003450654	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Noonan syndrome|RASopathy|Noonan syndrome 3|not provided|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25245284.0	25245284.0	12p12.1	reviewed by expert panel	7.0	-	N	ClinGen:CA235301,UniProtKB:P01116#VAR_064852	2.0	40454.0	25245284.0	G	A	-	-	-	-	-	-	SCV000616368	-	-	101C>T 	Pro34Leu	NM_004985.5	3.0	1_Pathogenic	86.47	0.4558823529411764	['609942', '163950']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3; NOONAN SYNDROME 1	86.47	0.45588234	10-90	70-90																																																																																																																																		true	KRASPro34Leu																																																																																																																																																																																																																																		
BRCA1	BRCA1_Cys64Tyr	-0.2411116846042154	0.8163785956912686	-2.2694527201623846	0.057523894319769224	2025_01_Batch_13-14	false	false	false	true	false	false	false	false	false	false	0.9229770223735969	0.8050353064957557	0.873184774404913	0.961233294307906	0.9304714009069367	0.8767777326467614	0.9730828220329724	0.7593569849355692	0.6491123281602564	0.8770861220785622	0.984165069167112	0.9493837665828397	0.9870125638742568	0.960958284831255	0.9688679226686315	BRCA1	-0.2411116846042154	0.8163785956912686	-2.2694527201623846	0.057523894319769224	2025_01_Batch_13-14	false	false	false	true	false	false	false	false	false	false	0.9229770223735969	0.8050353064957557	0.873184774404913	0.961233294307906	0.9304714009069367	0.8767777326467614	0.9730828220329724	0.7593569849355692	0.6491123281602564	0.8770861220785622	0.984165069167112	0.9493837665828397	0.9870125638742568	0.960958284831255	0.9688679226686315	BRCA1		14613		CCSBVarC011839		NC_000017.11:43106477:C:T	191G>A	Cys64Tyr																												17.0	43106477.0	C	T	17						17-43106477-C-T	69067.0	single nucleotide variant	NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 11, 2024	55851803.0	-	RCV000047641|RCV000077501|RCV000131896|RCV000236464|RCV003334380|RCV004566890	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	germline;not applicable;paternal;unknown	germline	GRCh38	NC_000017.11	17	43106477.0	43106477.0	17q21.31	reviewed by expert panel	27.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	UniProtKB:P38398#VAR_007759,ClinGen:CA001262	2.0	54400.0	43106477.0	C	T	-	-	-	-	-	-	SCV004101417	-	-	191G>A 	Cys64Tyr	NM_007294.4	3.0	1_Pathogenic		54400.0	17	43106477.0	C	T	C	Y	rs55851803	17	41258494.0	17	38512020.0	64.0	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.191G>A	p.Cys64Tyr	c.191G>A	p.Cys64Tyr	principal2	Y	1	.	.	-	TGT	2.0	0.0	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.972	0.84488	D	.	0.99291	.	.	.	.	4.34	0.98393	H	-2.59	0.99046	D	.	0.97441	0.9543	0.96449	D	0.9922	0.99809	D	10.0	0.9909615	0.99609	D	0.946477	0.99626	D	0.954	0.99189	0.991	0.99904	E9PFC7	C64Y	Loss of stability (P = 0.0601)| Loss of disorder (P = 0.0647)| Loss of methylation at K65 (P = 0.0701)| Gain of phosphorylation at T69 (P = 0.1857)| Loss of catalytic residue at L63 (P = 0.238)	0.999548998322	0.99953	.	0.88610	.	0.52543	0.801703929901	0.82191	T	0.476203	0.92995	T	0.553373	0.95819	D	0.557106	0.95755	D	0.998311161994934	0.93754	D	.	0.87587	.	0.98057026	0.99138	0.92475754	0.96684	0.9736041	0.98562	0.9065188	0.95378	-12.677	0.94701	D	0.9941	0.96039	LP	0.999711406740052	0.97610	0.99977249	0.99701	0.97	0.98836	.	.	.	.	.	.	5.19196	0.87099	29.1	0.9917919759080812	0.54687	0.851286	0.76729	D	0.880338828138272	0.90713	10.55451	0.762986794469818	0.87052	9.115097	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.0	0.68239	0.997	0.79771	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1601934	1.248490e-06	0	1	1170064	8.546540e-07	0	0	74760	0.000000e+00	0	0	912	0.000000e+00	0	0	59914	0.000000e+00	0	0	29512	0.000000e+00	0	0	44730	0.000000e+00	0	0	63954	0.000000e+00	0	0	5808	0.000000e+00	0	1	1170064	8.546540e-07	0	0	90238	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition	reviewed_by_expert_panel	NC_000017.11:g.43106477C>T	ClinGen:CA001262|UniProtKB:P38398#VAR_007759	C3661900|C0677776|C3280442|C0027672|C2676676|CN377757	614320|604370	145|1333|140162|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Tyr	69067.0	single nucleotide variant	NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 11, 2024	55851803.0	-	RCV000047641|RCV000077501|RCV000131896|RCV000236464|RCV003334380|RCV004566890	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	germline;not applicable;paternal;unknown	germline	GRCh38	NC_000017.11	17	43106477.0	43106477.0	17q21.31	reviewed by expert panel	27.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	UniProtKB:P38398#VAR_007759,ClinGen:CA001262	2.0	54400.0	43106477.0	C	T	-	-	-	-	-	-	SCV004101417	-	-	191G>A 	Cys64Tyr	NM_007294.4	3.0	1_Pathogenic	88.77	0.3333333333333333	['604370', '614320']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	88.77	0.33333334	10-90	70-90																																																																																																																																		true	BRCA1Cys64Tyr																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Arg213Trp	-6.429607337566906	0.00035709788012483603	5.315249216584618	0.001104943707691982	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8598591499165854	0.6607316399826737	0.7999829695534002	0.7986793716583096	0.7472993120881146	0.7307104948785454	0.734236566256333	0.725454189582057	0.6164665656785188	0.7917511009968734	0.7638881292976837	0.8631221770602862	0.8745117495247433	0.7049967142868286	0.9279671988362974	ZC4H2	-6.429607337566906	0.00035709788012483603	5.315249216584618	0.001104943707691982	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8598591499165854	0.6607316399826737	0.7999829695534002	0.7986793716583096	0.7472993120881146	0.7307104948785454	0.734236566256333	0.725454189582057	0.6164665656785188	0.7917511009968734	0.7638881292976837	0.8631221770602862	0.8745117495247433	0.7049967142868286	0.9279671988362974	ZC4H2		4320		CCSBVarC009197		NC_000023.11:64917821:G:A	637C>T	Arg213Trp																												23.0	64917821.0	G	A	X						X-64917821-G-A	65654.0	single nucleotide variant	NM_018684.4(ZC4H2):c.637C>T (p.Arg213Trp)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Feb 14, 2022	879255236.0	-	RCV000043679|RCV002354226|RCV001384432	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Wieacker-Wolff syndrome|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000023.11	X	64917821.0	64917821.0	Xq11.2	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA10575581,UniProtKB:Q9NQZ6#VAR_069624,OMIM:300897.0004	3.0	50983.0	64917821.0	G	A	-	-	-	-	-	-	SCV001583928|SCV002074112|SCV002655406	-	-	637C>T 	Arg213Trp	NM_018684.4	2.0	1_Pathogenic		50983.0	X	64917821.0	G	A	R	W	rs879255236	X	64137701.0	X	64054426.0	213.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.637C>T	p.Arg213Trp	c.637C>T	p.Arg213Trp	principal1	Y	1	YES	Select	-	CGG	1.0	2.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.993	0.81117	D	0.92	0.93300	A	simple_aae	8.0	92.0	.	.	.	-6.81	0.92962	D	0.63	0.64382	-0.216	0.77155	T	0.4185	0.76351	T	8.0	0.838971	0.82873	D	0.886685	0.99137	D	0.374	0.69109	0.495	0.58232	Q9NQZ6	R213W	Loss of solvent accessibility (P = 0.0036)| Loss of methylation at K209 (P = 0.0666)| Loss of relative solvent accessibility (P = 0.0676)| Gain of glycosylation at S210 (P = 0.1548)| Loss of helix (P = 0.2662)	0.964658073467	0.96396	0.7886100765468459	0.78692	3.13339230401	0.99404	0.893401861191	0.95671	D	0.814106	0.95348	D	0.49627	0.94129	D	0.475081	0.94052	D	0.998362839221954	0.93893	D	0.984002	0.95472	D	0.8943117	0.90750	0.79658544	0.87905	0.8859753	0.90028	0.83650655	0.90487	-12.468	0.87537	D	0.9996	0.99217	P	0.999161681495248	0.95853	0.99830365	0.98720	0.973	0.98982	.	.	.	.	.	.	4.527004	0.71085	25.6	0.9991548037498756	0.9838	.	.	.	.	.	.	.	.	.	5.42	3.58	0.40064	2.53	0.46530	3.404	0.52465	4.548000	0.43870	0.676	0.76753	1.0	0.71675	1.0	0.68239	1.0	0.97202	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome|not_provided|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917821G>A	ClinGen:CA10575581|OMIM:300897.0004|UniProtKB:Q9NQZ6#VAR_069624	C0796200|C3661900|C0950123	314580	3454|85283	Zinc finger C4H2-type	Arg	Trp	65654.0	single nucleotide variant	NM_018684.4(ZC4H2):c.637C>T (p.Arg213Trp)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Feb 14, 2022	879255236.0	-	RCV000043679|RCV002354226|RCV001384432	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Wieacker-Wolff syndrome|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000023.11	X	64917821.0	64917821.0	Xq11.2	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA10575581,UniProtKB:Q9NQZ6#VAR_069624,OMIM:300897.0004	3.0	50983.0	64917821.0	G	A	-	-	-	-	-	-	SCV001583928|SCV002074112|SCV002655406	-	-	637C>T 	Arg213Trp	NM_018684.4	2.0	1_Pathogenic	70.32	0.8387096774193549	['314580']	unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	70.32	0.83870965	10-90	70-90						R	208			70.32	Positively-charged	Arginine		Zinc finger C4H2 domain-containing protein										-4.5																		175									-66.7				-27.0				dbSNP: rs879255236; Variant type: LP/P; AA change: Arg213Trp; PTM type: Phosphorylation; PTM morphology: LCKAKsRSR*NP; Var class: II		C (loop/coil)	S (bend)																																																																				true	ZC4H2Arg213Trp																																																																																																																																																																																																																																		
F9	F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7344163062571347	0.5373015712206879	0.7367339879754062	0.699926094737854	0.6021105502899596	0.7099087143455147	0.7250776902536834	0.7881197423438256	0.5947157080506009	0.7300050971101899	0.49431238623440454	0.6747744992220248	0.6853482336069867	0.47988743439077497	0.7388275154040795	F9	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7344163062571347	0.5373015712206879	0.7367339879754062	0.699926094737854	0.6021105502899596	0.7099087143455147	0.7250776902536834	0.7881197423438256	0.5947157080506009	0.7300050971101899	0.49431238623440454	0.6747744992220248	0.6853482336069867	0.47988743439077497	0.7388275154040795	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T	523C>T	Pro175Ser																												23.0	139551064.0	C	T	X						X-139551064-C-T	689353.0	single nucleotide variant	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	2158.0	F9	HGNC:3551	Benign	0.0	Dec 27, 2024	762986355.0	-	RCV000868038|RCV001825736	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551064.0	139551064.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA10529810	2.0	700019.0	139551064.0	C	T	-	-	-	-	-	-	SCV001009324	-	-	523C>T 	Pro175Ser	NM_000133.4	1.0	2_Benign		700019.0	X	139551064.0	C	T	P	S	rs762986355	X	138633223.0	X	138460889.0	175.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.523C>T	p.Pro175Ser	c.523C>T	p.Pro175Ser	principal1	Y	1	YES	Select	+	CCA	1.0	0.0	C	C/C	C/C	C/C	C/C	0.036	0.44852	D	0.161	0.33883	T	0.354	0.33728	B	0.086	0.29523	B	0.48	0.69764	N	simple_aae	52.0	48.0	2.175	0.60790	M	-2.89	0.60697	D	0.463	0.57301	0.869	0.9525	D	0.8615	0.95381	D	10.0	0.250471	0.41984	D	0.228259	0.88100	D	0.756	0.91637	0.388	0.40807	P00740	P175S	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.975270461492	0.97476	0.9703241368253629	0.97004	1.6529612223	0.89525	0.425827980042	0.28604	T	0.697249	0.91165	D	0.0546764	0.58654	T	0.239642	0.85025	D	0.345082526519166	0.26526	T	0.842116	0.51695	T	0.40378746	0.60670	0.38183606	0.62938	0.40378746	0.60670	0.38183606	0.62938	-5.249	0.39483	T	0.1096	0.35518	B	0.970189561557157	0.83311	0.99996960	0.99978	0.852	0.91893	.	.	.	.	.	.	3.416071	0.47496	22.5	0.9989460400121672	0.96821	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	.	.	4.715	0.61684	4.861000	0.45547	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	15	264690	5.6670066E-5	.	4	80161	4.989960e-05	0	8	151269	5.288590e-05	0	11	171600	6.410260e-05	0	0	5698	0.000000e+00	0	0	13630	0.000000e+00	0	0	1757	0.000000e+00	0	4	6911	5.787870e-04	0	0	9927	0.000000e+00	0	0	30931	0.000000e+00	0	0	9860	0.000000e+00	0	4	6911	5.787870e-04	0	0	13125	0.000000e+00	0	0	24325	0.000000e+00	0	0	4624	0.000000e+00	0	8	10120	7.905140e-04	0	0	12181	0.000000e+00	0	0	64445	0.000000e+00	0	0	18839	0.000000e+00	0	8	10120	7.905140e-04	0	0	12057	0.000000e+00	0	0	27098	0.000000e+00	0	0	7059	0.000000e+00	0	11	13308	8.265700e-04	0	0	15971	0.000000e+00	0	0	73207	0.000000e+00	0	0	18774	0.000000e+00	0	11	13308	8.265700e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551064C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	689353.0	single nucleotide variant	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	2158.0	F9	HGNC:3551	Benign	0.0	Dec 27, 2024	762986355.0	-	RCV000868038|RCV001825736	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551064.0	139551064.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA10529810	2.0	700019.0	139551064.0	C	T	-	-	-	-	-	-	SCV001009324	-	-	523C>T 	Pro175Ser	NM_000133.4	1.0	2_Benign	94.18	0.8014705882352942	['306900', '300807', '306900']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	94.18	0.8014706	10-90	>90						P	109			94.18	Special, No backbone hydrogen	Proline		Coagulation factor IX; Coagulation factor IXa light chain										1.6																		115									-60.0				-37.6						C (loop/coil)	S (bend)	Beta strand																													0.866		0.856		0.837		0.802		0.829																														true	F9Pro175Ser																																																																																																																																																																																																																																		
SDHD	SDHD_Ala90Glu	6.330677185442039	0.0003987614285506209	-0.8867327192676124	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7781731453311838	0.7818028479783987	0.8254014795691521	0.8140298087266209	0.8069567363558607	0.82567217328441	0.8309871723130089	0.823567738429494	0.8256987354575871	0.7602068186207378	0.7882412994273116	0.7970724451402329	0.8272352207088102	0.7379069604992105	0.7961394720416298	SDHD	6.330677185442039	0.0003987614285506209	-0.8867327192676124	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7781731453311838	0.7818028479783987	0.8254014795691521	0.8140298087266209	0.8069567363558607	0.82567217328441	0.8309871723130089	0.823567738429494	0.8256987354575871	0.7602068186207378	0.7882412994273116	0.7970724451402329	0.8272352207088102	0.7379069604992105	0.7961394720416298	SDHD		6363		CCSBVarC023305		NC_000011.10:112088966:C:A	269C>A	Ala90Glu																												11.0	112088966.0	C	A	11						11-112088966-C-A	398391.0	single nucleotide variant	NM_003002.4(SDHD):c.269C>A (p.Ala90Glu)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Oct 26, 2024	200255724.0	-	RCV001016345|RCV001252746|RCV002230664|RCV003235231	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0000252,Human Phenotype Ontology:HP:0001366,Human Phenotype Ontology:HP:0005485,Human Phenotype Ontology:HP:0005489,Human Phenotype Ontology:HP:0005497,MONDO:MONDO:0001149,MedGen:C4551563|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Microcephaly|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|not provided	germline	germline	GRCh38	NC_000011.10	11	112088966.0	112088966.0	11q23.1	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA070965	2.0	412512.0	112088966.0	C	A	-	-	-	-	-	-	SCV000554064|SCV001177292|SCV003933375	-	-	269C>A 	Ala90Glu	NM_003002.4	1.0	3_Conflicting		412512.0	11	112088966.0	C	A	A	E	rs200255724	11	111959690.0	11	111464900.0	90.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.269C>A	p.Ala90Glu	c.269C>A	p.Ala90Glu	principal1	Y	1	YES	Select	+	GCG	2.0	0.0	C	./.	./.	./.	./.	0.007	0.65576	D	0.103	0.52087	T	0.932	0.52003	P	0.57	0.49852	P	.	.	.	.	.	.	2.42	0.69809	M	-3.44	0.67509	D	0.838	0.88119	0.6538	0.92564	D	0.9083	0.96954	D	10.0	0.71854925	0.73260	D	0.221482	0.87778	D	0.717	0.89925	0.651	0.78770	O14521	A90E	Gain of solvent accessibility (P = 0.1185)| Gain of helix (P = 0.132)| Loss of glycosylation at S94 (P = 0.2235)| Loss of loop (P = 0.2237)| Gain of disorder (P = 0.2283)	0.994050821033	0.99390	0.9025812371913887	0.90169	0.56273454734	0.52443	0.434535443783	0.29793	T	0.882903	0.97538	D	0.147502	0.68809	D	0.344014	0.9001	D	0.429612930299171	0.29737	T	0.662834	0.27239	T	0.5395673	0.69073	0.7364212	0.84234	0.5395673	0.69074	0.7364212	0.84235	-10.123	0.80928	D	0.5246	0.71218	A	0.962673093571584	0.82104	0.99742990	0.98376	0.483	0.70339	.	.	.	.	.	.	2.63182	0.34286	19.57	0.9909371197094622	0.52353	0.646940	0.62094	D	-0.0306763802736097	0.40204	2.403878	-0.139133932962987	0.33519	1.939294	5.04	1.52	0.22101	.	.	0.348	0.19856	-0.210000	0.10908	0.549	0.27038	0.03	0.20497	0.0	0.08389	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	3	109406	2.742080e-05	0	12	208128	5.765680e-05	0	11	236928	4.642760e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	3	9044	3.317120e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	3	9044	3.317120e-04	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	12	13414	8.945880e-04	0	0	16734	0.000000e+00	0	0	89554	0.000000e+00	0	0	30608	0.000000e+00	0	12	13414	8.945880e-04	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	11	17690	6.218200e-04	0	0	21632	0.000000e+00	0	0	102728	0.000000e+00	0	0	30526	0.000000e+00	0	11	17690	6.218200e-04	0	.	21	1614014	1.301100e-05	0	21	44888	4.678310e-04	0	0	74936	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29606	0.000000e+00	0	21	44888	4.678310e-04	0	0	64032	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179998	0.000000e+00	0	0	91090	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Microcephaly	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088966C>A	ClinGen:CA070965	C3661900|C0027672|C1868633|C1847319|C0031511|CN166604|C4551563	606864|171300	140162|97286|29072|201	.	Ala	Glu	398391.0	single nucleotide variant	NM_003002.4(SDHD):c.269C>A (p.Ala90Glu)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Oct 26, 2024	200255724.0	-	RCV001016345|RCV001252746|RCV002230664|RCV003235231	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0000252,Human Phenotype Ontology:HP:0001366,Human Phenotype Ontology:HP:0005485,Human Phenotype Ontology:HP:0005489,Human Phenotype Ontology:HP:0005497,MONDO:MONDO:0001149,MedGen:C4551563|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Microcephaly|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|not provided	germline	germline	GRCh38	NC_000011.10	11	112088966.0	112088966.0	11q23.1	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA070965	2.0	412512.0	112088966.0	C	A	-	-	-	-	-	-	SCV000554064|SCV001177292|SCV003933375	-	-	269C>A 	Ala90Glu	NM_003002.4	1.0	3_Conflicting	98.3	0.6320754716981132	['171300', '606864']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	98.3	0.6320755	10-90	>90						A	67			98.3	Aliphatic	Alanine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										1.8								A90-S94; PAE: 1.0	1 interaction	A90-S94; PAE: 1.0	1 interaction							89									-61.7				-36.6						H (helix)	H (α-helix)	Helix						Mitochondrial intermembrane																																																													true	SDHDAla90Glu																																																																																																																																																																																																																																		
BAP1	BAP1_Arg718Gln	-0.9458164145836372	0.37573764594446835	-3.420989205735933	0.01112045469917	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6620800143823764	0.5634591146876166	0.5967321418904766	0.6047554196033222	0.5924664092015309	0.6172341215461941	0.6324678911973177	0.5700899595063859	0.5552474311534583	0.6666082700400914	0.5676986968568678	0.5770429480093268	0.6233743242745674	0.5716707982217748	0.6575517587246613	BAP1	-0.9458164145836372	0.37573764594446835	-3.420989205735933	0.01112045469917	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6620800143823764	0.5634591146876166	0.5967321418904766	0.6047554196033222	0.5924664092015309	0.6172341215461941	0.6324678911973177	0.5700899595063859	0.5552474311534583	0.6666082700400914	0.5676986968568678	0.5770429480093268	0.6233743242745674	0.5716707982217748	0.6575517587246613	BAP1		3760		CCSBVarC009488		NC_000003.12:52402325:C:T	2153G>A	Arg718Gln																												3.0	52402325.0	C	T	3						3-52402325-C-T	1162261.0	single nucleotide variant	NM_004656.4(BAP1):c.2153G>A (p.Arg718Gln)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Jul 16, 2024	1440748203.0	-	RCV001797190|RCV003365424|RCV002568140	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome	de novo;germline;unknown	germline	GRCh38	NC_000003.12	3	52402325.0	52402325.0	3p21.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA353094106	2.0	1173084.0	52402325.0	C	T	-	-	-	-	-	-	SCV003284341|SCV004053060|SCV004213163	-	-	2153G>A 	Arg718Gln	NM_004656.4	2.0	4_VUS		1173084.0	3	52402325.0	C	T	R	Q	rs1440748203	3	52436341.0	3	52411381.0	718.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.2153G>A	p.Arg718Gln	c.2153G>A	p.Arg718Gln	principal1	Y	1	YES	Select	-	CGG	2.0	0.0	C	C/C	C/C	C/C	C/C	0.029	0.47069	D	0.067	0.63436	T	0.105	0.26009	B	0.013	0.16457	B	0.45	0.67594	N	simple_aae	55.0	45.0	0.695	0.17891	N	-1.06	0.33774	N	0.486	0.51792	-1.0347	0.18929	T	0.0947	0.35615	T	10.0	0.27956486	0.45144	D	0.017745	0.39328	T	0.076	0.22039	0.284	0.24003	Q92560	R718Q	Gain of glycosylation at S721 (P = 0.0061)| Gain of relative solvent accessibility (P = 0.0999)| Loss of stability (P = 0.1254)| Gain of helix (P = 0.132)| Loss of ubiquitination at K714 (P = 0.1982)	0.666395784662	0.66096	0.9176963108472813	0.91693	1.18041734594	0.79892	0.887522280216	0.94942	D	0.031629	0.21892	T	-0.0791375	0.39503	T	-0.351452	0.38683	T	0.692419946193695	0.40057	D	0.89941	0.65736	D	0.23402792	0.45888	0.15140484	0.35558	0.23402792	0.45888	0.15140484	0.35557	-4.022	0.24154	T	0.9167	0.95515	P	0.894653573905079	0.75692	0.99749726	0.98401	0.514	0.72347	.	.	.	.	.	.	4.896201	0.80464	27.3	0.9984449671145118	0.92495	0.924435	0.90210	D	0.0651513950594368	0.44583	2.750997	0.22881620568532	0.51201	3.327653	5.52	4.64	0.57348	2.61	0.47779	7.848	0.85237	5.982000	0.52258	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.99	0.65338	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	91766	1.089730e-05	0	1	177226	5.642510e-06	0	1	204170	4.897880e-06	0	0	5246	0.000000e+00	0	1	14932	6.697030e-05	0	0	1838	0.000000e+00	0	0	7348	0.000000e+00	0	0	11372	0.000000e+00	0	0	35934	0.000000e+00	0	0	13430	0.000000e+00	0	1	14932	6.697030e-05	0	0	13106	0.000000e+00	0	1	26036	3.840840e-05	0	0	5376	0.000000e+00	0	0	12242	0.000000e+00	0	0	13878	0.000000e+00	0	0	75596	0.000000e+00	0	0	26784	0.000000e+00	0	1	26036	3.840840e-05	0	0	12254	0.000000e+00	0	1	29894	3.345150e-05	0	0	8858	0.000000e+00	0	0	15560	0.000000e+00	0	0	17108	0.000000e+00	0	0	88666	0.000000e+00	0	0	26736	0.000000e+00	0	1	29894	3.345150e-05	0	.	3	1594688	1.881250e-06	0	1	56488	1.770290e-05	0	0	74946	0.000000e+00	0	0	912	0.000000e+00	0	1	56488	1.770290e-05	0	0	29090	0.000000e+00	0	0	44170	0.000000e+00	0	0	61120	0.000000e+00	0	0	6016	0.000000e+00	0	2	1172136	1.706290e-06	0	0	87956	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Neurodevelopmental_disorder|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52402325C>T	.	C0027672|C1535926|C3280492	614327	140162|289539	.	Arg	Gln	1162261.0	single nucleotide variant	NM_004656.4(BAP1):c.2153G>A (p.Arg718Gln)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Jul 16, 2024	1440748203.0	-	RCV001797190|RCV003365424|RCV002568140	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome	de novo;germline;unknown	germline	GRCh38	NC_000003.12	3	52402325.0	52402325.0	3p21.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA353094106	2.0	1173084.0	52402325.0	C	T	-	-	-	-	-	-	SCV003284341|SCV004053060|SCV004213163	-	-	2153G>A 	Arg718Gln	NM_004656.4	2.0	4_VUS	50.61	0.9435483870967742	['614327']	unknown		0	TUMOR PREDISPOSITION SYNDROME 1	50.61	0.9435484	$\geqslant$90	50-70						R	234			50.61	Positively-charged	Arginine		Ubiquitin carboxyl-terminal hydrolase BAP1										-4.5																		175	Classical bipartite Nuclear localization signal (NLS); Non-classical PY-nuclear localization signal (PY-NLS)	Predominantly localizes to the cytosol.; Abolishes deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome, probably due to disruption of nucleosome interaction. Does not affect deubiquitination of H2AK119ub1 on free histones.; Disrupts nucleosome interaction and abolishes deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome. Does not affect deubiquitination of H2AK119ub1 on free histones.; Reduces deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome, probably due to disruption of nucleosome interaction. Does not affect deubiquitination of H2AK119ub1 on free histones.; Impairs deubiquitination activity of histone H2AK118ub1 substrates, probably due to disruption of nucleosome association.; Mutation: RRKRSR -> AAAAAA. Abolishes nuclear localization.; Disrupts nucleosome interaction and reduces deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome.							-93.1				40.1	Interaction with BRCA1; Disordered; Positively charged C-terminal extension (CTE)					C (loop/coil)	C (loop/coil)																																																																				true	BAP1Arg718Gln																																																																																																																																																																																																																																		
LMNA	LMNA_Arg386Thr	1.4645911073941391	0.18644784142247456	-8.018250483099878	0.00008983232334729825	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9645899193012895	0.8100348611526262	0.9224588624236902	0.9108974699681556	0.7752309410325393	0.7326336048613691	0.9260771229356421	0.8918935283204882	0.7592879376153259	0.9588176831317521	0.8178282772037097	0.895717817000669	0.9530241965268922	0.8607817846899265	0.9703621554708268	LMNA	1.4645911073941391	0.18644784142247456	-8.018250483099878	0.00008983232334729825	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9645899193012895	0.8100348611526262	0.9224588624236902	0.9108974699681556	0.7752309410325393	0.7326336048613691	0.9260771229356421	0.8918935283204882	0.7592879376153259	0.9588176831317521	0.8178282772037097	0.895717817000669	0.9530241965268922	0.8607817846899265	0.9703621554708268	LMNA		3903		CCSBVarC021208		NC_000001.11:156136121:G:C	1157G>C	Arg386Thr																												1.0	156136121.0	G	C	1						1-156136121-G-C	257932.0	single nucleotide variant	NM_170707.4(LMNA):c.1157G>C (p.Arg386Thr)	4000.0	LMNA	HGNC:6636	Pathogenic	1.0	Feb 16, 2016	267607545.0	-	RCV000248263	MedGen:CN230736	Cardiovascular phenotype	germline	germline	GRCh38	NC_000001.11	1	156136121.0	156136121.0	1q22	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587419	2.0	264271.0	156136121.0	G	C	-	-	-	-	-	-	SCV000320081	-	-	1157G>C 	Arg386Thr	NM_170707.4	1.0	1_Pathogenic		264271.0	1	156136121.0	G	C	R	T	rs267607545	1	156105912.0	1	154372536.0	386.0	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.1157G>C	p.Arg386Thr	c.1157G>C	p.Arg386Thr	principal1	Y	1	YES	Select	+	AGG	2.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.635	0.99325	H	-5.93	0.89056	D	0.857	0.87350	1.1004	0.99677	D	0.9609	0.98739	D	10.0	0.90525204	0.89777	D	0.91892	0.99400	D	0.936	0.98562	0.661	0.79808	P02545	R386T	Gain of helix (P = 0.0034)| Loss of loop (P = 0.0073)| Gain of phosphorylation at R386 (P = 0.033)| Loss of MoRF binding (P = 0.0798)| Loss of glycosylation at P391 (P = 0.2507)	0.980401155553	0.97999	0.9678116666716702	0.96751	2.52078213034	0.97725	0.751040816307	0.74556	T	0.984156	0.99893	D	0.577996	0.96936	D	0.592475	0.96885	D	0.999515652656555	0.97697	D	0.986101	0.95472	D	0.91762745	0.92915	0.8370971	0.90525	0.9266469	0.93811	0.8441071	0.90994	-14.125	0.93500	D	0.9991	0.98500	P	0.99996834705116	0.99297	0.99997771	0.99989	0.981	0.99334	.	.	.	.	.	.	6.38395	0.95128	34.0	0.9854011695409562	0.42829	0.944311	0.95106	D	1.02757772399496	0.96510	14.80981	0.954406358037594	0.97520	16.2953	5.3	5.3	0.74708	5.54	0.94607	9.957	0.99008	11.529000	0.93089	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.991	0.66489	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiovascular_phenotype	criteria_provided,_single_submitter	NC_000001.11:g.156136121G>C	ClinGen:CA10587419	CN230736	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Thr	257932.0	single nucleotide variant	NM_170707.4(LMNA):c.1157G>C (p.Arg386Thr)	4000.0	LMNA	HGNC:6636	Pathogenic	1.0	Feb 16, 2016	267607545.0	-	RCV000248263	MedGen:CN230736	Cardiovascular phenotype	germline	germline	GRCh38	NC_000001.11	1	156136121.0	156136121.0	1q22	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587419	2.0	264271.0	156136121.0	G	C	-	-	-	-	-	-	SCV000320081	-	-	1157G>C 	Arg386Thr	NM_170707.4	1.0	1_Pathogenic	79.51	0.7137096774193549		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		79.51	0.71370965	10-90	70-90						R	177			79.51	Positively-charged	Arginine		Prelamin-A/C; Lamin-A/C							IF rod			-4.5								R386-G382; PAE: 9.0		R386-G382; PAE: 9.0		R386-E383; PAE: 7.5				Morphology: LLEGEEErLRLsPsP; Domain: Filament		175		Mutation: R -> M. Loss of interaction with IFFO1.; Mutation: R -> V, L, P. Impaired lamin assembly.							-63.7				-39.3	Tail; Disordered			dbSNP: rs267607545; Variant type: LP/P; AA change: Arg386Lys; PTM type: Phosphorylation; PTM morphology: Er*LRLsPsPts; Var class: II		H (helix)	H (α-helix)																																																																				true	LMNAArg386Thr																																																																																																																																																																																																																																		
SOS2	SOS2_Pro1318Ser	1.0493118206423042	0.328906085228044	9.648726316236788	0.000027068206037967004	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9120362645424587	0.6271063494920905	0.8281481396301045	0.7493866802750224	0.6132752996154462	0.5543402139385749	0.6887243058977645	0.745988592406421	0.5811270840807448	0.870454493436902	0.6722103852923177	0.8100490546522804	0.910307686853788	0.6730856149034364	0.9536180356480155	SOS2	1.0493118206423042	0.328906085228044	9.648726316236788	0.000027068206037967004	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9120362645424587	0.6271063494920905	0.8281481396301045	0.7493866802750224	0.6132752996154462	0.5543402139385749	0.6887243058977645	0.745988592406421	0.5811270840807448	0.870454493436902	0.6722103852923177	0.8100490546522804	0.910307686853788	0.6730856149034364	0.9536180356480155	SOS2		55187		CCSBVarC013771		NC_000014.9:50118391:G:A	3952C>T	Pro1318Ser																												14.0	50118391.0	G	A	14						14-50118391-G-A	463782.0	single nucleotide variant	NM_006939.4(SOS2):c.3952C>T (p.Pro1318Ser)	6655.0	SOS2	HGNC:11188	Benign/Likely benign	0.0	Jan 22, 2025	140995728.0	-	RCV000555942|RCV001175493|RCV001644664|RCV002358610|RCV003962607	MONDO:MONDO:0014691,MedGen:C4225282,OMIM:616559,Orphanet:648|MedGen:CN169374|MedGen:C3661900|MedGen:CN230736|	Noonan syndrome 9|not specified|not provided|Cardiovascular phenotype|SOS2-related disorder	germline	germline	GRCh38	NC_000014.9	14	50118391.0	50118391.0	14q21.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA7176682	2.0	475758.0	50118391.0	G	A	-	-	-	-	-	-	SCV000656031|SCV001339086|SCV001856913|SCV002621043|SCV002762964|SCV004134072	-	-	3952C>T 	Pro1318Ser	NM_006939.4	2.0	2_Benign		475758.0	14	50118391.0	G	A	P	S	rs140995728	14	50585109.0	14	49654859.0	1318.0	SOS2	ENSG00000100485	ENST00000216373	ENSP00000216373	Q07890	SOS2_HUMAN	c.3952C>T	p.Pro1318Ser	c.3952C>T	p.Pro1318Ser	principal1	Y	1	YES	Select	-	CCA	1.0	0.0	G	./.	./.	./.	./.	0.771	0.03390	T	0.183	0.29561	T	0.993	0.65587	D	0.968	0.71743	D	0.38	0.62259	N	simple_aae	62.0	38.0	1.24	0.30804	L	-2.62	0.56328	D	0.107	0.20263	-0.3437	0.73619	T	0.4792	0.79993	T	10.0	0.014707029	0.00305	T	0.035738	0.56369	D	0.311	0.63079	.	.	.	.	.	0.564192878985	0.55755	0.24931831313751454	0.24653	0.333972655293	0.35131	0.423311650753	0.28258	T	0.459389	0.79546	T	-0.27488	0.10979	T	-0.174886	0.56696	T	0.0457728085513322	0.04699	T	0.754025	0.37784	T	0.1488474	0.33678	0.22177863	0.46827	0.16657373	0.36701	0.19488566	0.42985	-3.805	0.20897	T	0.0792	0.15718	B	0.211387639361191	0.50480	0.92654955	0.92242	0.247	0.51713	.	.	.	.	.	.	1.857218	0.23634	16.08	0.8818050712329598	0.18028	0.426669	0.48918	N	0.376038629970589	0.59920	4.198247	0.407449731798897	0.61823	4.411648	5.37	5.37	0.76916	3.71	0.68166	2.631	0.46269	4.061000	0.41666	0.676	0.76753	0.998	0.41403	1.0	0.68239	0.996	0.76032	443	0.79891	4	7.987220447284345E-4	0	0.0	3	0.002982107355864811	1	0.001440922190201729	0	0.0	0	0.0	134	264690	5.062526E-4	.	47	109384	4.296790e-04	0	104	208088	4.997890e-04	0	113	236904	4.769860e-04	0	2	7164	2.791740e-04	0	3	17108	1.753570e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	40	42752	9.356290e-04	0	0	15688	0.000000e+00	0	40	42752	9.356290e-04	0	4	16218	2.466400e-04	0	6	30518	1.966050e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	90	89522	1.005340e-03	0	1	30606	3.267330e-05	0	90	89522	1.005340e-03	0	4	14902	2.684200e-04	0	8	34254	2.335490e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	96	102720	9.345790e-04	0	1	30524	3.276110e-05	0	96	102720	9.345790e-04	0	.	1235	1614102	7.651310e-04	1	1160	1180004	9.830480e-04	1	18	75012	2.399620e-04	0	0	912	0.000000e+00	0	17	60006	2.833050e-04	0	1	29606	3.377690e-05	0	0	44886	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	1160	1180004	9.830480e-04	1	2	91086	2.195730e-05	0	146	184512	7.912764481442942E-4	0	360	0	0	2712	0	2	9426	2.121790791427965E-4	0	796	0	0	968	0	0	682	0	0	280	0	13	15606	8.330129437395873E-4	2	9786	2.0437359493153485E-4	0	3394	0	161	215342	7.476479274827948E-4	Benign/Likely_benign	not_specified|not_provided|Cardiovascular_phenotype|SOS2-related_disorder|Noonan_syndrome_9	criteria_provided,_multiple_submitters,_no_conflicts	NC_000014.9:g.50118391G>A	ClinGen:CA7176682	CN169374|C3661900|CN230736|C4225282	616559	648	.	Pro	Ser	463782.0	single nucleotide variant	NM_006939.4(SOS2):c.3952C>T (p.Pro1318Ser)	6655.0	SOS2	HGNC:11188	Benign/Likely benign	0.0	Jan 22, 2025	140995728.0	-	RCV000555942|RCV001175493|RCV001644664|RCV002358610|RCV003962607	MONDO:MONDO:0014691,MedGen:C4225282,OMIM:616559,Orphanet:648|MedGen:CN169374|MedGen:C3661900|MedGen:CN230736|	Noonan syndrome 9|not specified|not provided|Cardiovascular phenotype|SOS2-related disorder	germline	germline	GRCh38	NC_000014.9	14	50118391.0	50118391.0	14q21.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA7176682	2.0	475758.0	50118391.0	G	A	-	-	-	-	-	-	SCV000656031|SCV001339086|SCV001856913|SCV002621043|SCV002762964|SCV004134072	-	-	3952C>T 	Pro1318Ser	NM_006939.4	2.0	2_Benign	44.32	0.7867647058823529	['616559']	unknown		0	NOONAN SYNDROME 9	44.32	0.7867647	10-90	<=50						P	107			44.32	Special, No backbone hydrogen	Proline		Son of sevenless homolog 2										1.6																		115									-134.6				-158.6	Disordered					C (loop/coil)	C (loop/coil)																																																																				true	SOS2Pro1318Ser																																																																																																																																																																																																																																		
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5925157314793699	0.6893350480338805	0.7080550488478474	0.6348244465050894	0.7509741906115102	0.7668926021102467	0.624655314780562	0.7401965367721299	0.6377602432753857	0.5717637727016314	0.7350557791127735	0.6449935782296168	0.6759135609235649	0.7409098527923751	0.6132676902571083	F9	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5925157314793699	0.6893350480338805	0.7080550488478474	0.6348244465050894	0.7509741906115102	0.7668926021102467	0.624655314780562	0.7401965367721299	0.6377602432753857	0.5717637727016314	0.7350557791127735	0.6449935782296168	0.6759135609235649	0.7409098527923751	0.6132676902571083	F9	ENSG00000101981	52861	204351.0	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139537158.0	A	C	X	Y	N	N	N	N	X-139537158-A-C	25613.0	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852229.0	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158.0	139537158.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1.0	10574.0	139537158.0	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic		10574.0	X	139537158.0	A	C	E	D	rs137852229	X	138619317.0	X	138446983.0	79.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3.0	2.0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9.0	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.929586329869304	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.0	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613.0	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852229.0	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158.0	139537158.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1.0	10574.0	139537158.0	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic	86.43	0.9072164948453608	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	86.43	0.9072165	$\geqslant$90	70-90						E	176			86.43	Negatively-charged	Glutamic Acid		Coagulation factor IX; Coagulation factor IXa light chain							Gla			-3.5								E79-R75; PAE: 3.5		E79-R75; PAE: 3.5							4-carboxyglutamate	146									49.6				22.1						C (loop/coil)	C (loop/coil)	Beta strand																													1.049		1.01	2 mutation(s) (Glu79Gln: 1.209, Glu79Lys: 1.253)	0.965	1 mutation(s) (Glu79Thr: 1.137)	0.759	1 mutation(s) (Glu79Gln: 1.103)	0.99	2 mutation(s) (Glu79Asn: 1.294, Glu79Pro: 1.295)																													true	F9Glu79Asp																																																																																																																																																																																																																																		
F9	F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9641893801668194	0.8328394969236035	0.8759864021765055	0.8812408598327411	0.6984734282738592	0.7144251743292489	0.8819927674073826	0.8604436111266539	0.7973320287624389	0.9535374330992443	0.6825216822184693	0.8804889522580996	0.891529193226357	0.8683469650847679	0.9748413272343945	F9	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9641893801668194	0.8328394969236035	0.8759864021765055	0.8812408598327411	0.6984734282738592	0.7144251743292489	0.8819927674073826	0.8604436111266539	0.7973320287624389	0.9535374330992443	0.6825216822184693	0.8804889522580996	0.891529193226357	0.8683469650847679	0.9748413272343945	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A	1004G>A	Cys335Tyr																												23.0	139561689.0	G	A	X						X-139561689-G-A	2417857.0	single nucleotide variant	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Feb 23, 2023	-1.0	-	RCV003152922	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561689.0	139561689.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414445316	2.0	2444124.0	139561689.0	G	A	-	-	-	-	-	-	SCV003841472	-	-	1004G>A 	Cys335Tyr	NM_000133.4	1.0	1_Pathogenic		2444124.0	X	139561689.0	G	A	C	Y	.	X	138643848.0	X	138471514.0	335.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1004G>A	p.Cys335Tyr	c.1004G>A	p.Cys335Tyr	principal1	Y	1	YES	Select	+	TGC	2.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.995	0.96666	H	-10.94	0.99269	D	0.878	0.99419	1.0812	0.98918	D	0.9328	0.9778	D	10.0	0.9946557	0.99955	D	0.929597	0.99487	D	0.959	0.99346	0.961	0.99597	P00740	C335Y	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.997392873545	0.99732	0.9999824557020938	0.99998	2.12843697498	0.95120	0.725244283676	0.70762	T	0.971543	0.99693	D	0.699893	0.99928	D	0.767572	0.99928	D	0.999975562095642	0.99958	D	0.924008	0.72162	D	0.9958085	0.99978	0.9928213	0.99993	0.9953884	0.99970	0.9910561	0.99985	-10.266	0.75565	D	0.986	0.92459	P	0.999974611784801	0.99427	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.989535	0.82746	27.9	0.9978519851251483	0.87142	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.568	0.97322	11.887000	0.98990	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.993	0.69292	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561689G>A	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Tyr	2417857.0	single nucleotide variant	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Feb 23, 2023	-1.0	-	RCV003152922	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561689.0	139561689.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414445316	2.0	2444124.0	139561689.0	G	A	-	-	-	-	-	-	SCV003841472	-	-	1004G>A 	Cys335Tyr	NM_000133.4	1.0	1_Pathogenic	96.87	0.0074074074074074	['306900']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B	96.87	0.0074074073	<10	>90						C	1			96.87	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa heavy chain						Disulfide bond 178-335	Peptidase S1			2.5				4 interactions				C335-L425, C335-S423; PAE: 1.0, 1.0	3 interactions	C335-G179, C335-L425, C335-C178; PAE: 1.5, 1.0, 1.5	6 interactions							121									-73.1				140.5						B (undefined)	B (beta bridge)																														0.169	1 mutation(s) (Cys335Leu: -0.045)	0.101		0.083	1 mutation(s) (Cys335Ile: -0.004)	0.083	3 mutation(s) (Cys335Phe: -0.014, Cys335Leu: -0.009, Cys335Ala: -0.006)	0.096	1 mutation(s) (Cys335Trp: -0.002)																													true	F9Cys335Tyr																																																																																																																																																																																																																																		
BRCA1	BRCA1_Val275Ile	-0.4219542876087648	0.6857151825709713	2.664548117941024	0.03225365624269284	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8504531113104965	0.7716806718722978	0.8821667688526504	0.936475378786529	0.8953148061074725	0.7971938108459706	0.9154008456443704	0.7702698951602724	0.6222736911823423	0.7399972816189054	0.9934358013689744	0.9575499119286874	0.9940636425450285	0.9210876525622533	0.9609089410020877	BRCA1	-0.4219542876087648	0.6857151825709713	2.664548117941024	0.03225365624269284	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8504531113104965	0.7716806718722978	0.8821667688526504	0.936475378786529	0.8953148061074725	0.7971938108459706	0.9154008456443704	0.7702698951602724	0.6222736911823423	0.7399972816189054	0.9934358013689744	0.9575499119286874	0.9940636425450285	0.9210876525622533	0.9609089410020877	BRCA1		14613		CCSBVarC013078		NC_000017.11:43090997:C:T	823G>A	Val275Ile																												17.0	43090997.0	C	T	17						17-43090997-C-T	69778.0	single nucleotide variant	NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	28897690.0	-	RCV000048456|RCV000112269|RCV000130952|RCV000195345|RCV000735522|RCV000588834|RCV001353555|RCV004803994	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43090997.0	43090997.0	17q21.31	reviewed by expert panel	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002653,UniProtKB:P38398#VAR_070487	2.0	55111.0	43090997.0	C	T	-	-	-	-	-	-	SCV001161590	-	-	4132G>A 	Val1378Ile	NM_007294.4	3.0	2_Benign		55111.0	17	43090997.0	C	T	V	I	rs28897690	17	41243014.0	17	38496540.0	1378.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4132G>A	p.Val1378Ile	c.4132G>A	p.Val1378Ile	principal2	Y	1	YES	Select	-	GTC	1.0	0.0	C	C/C	C/C	C/C	C/C	0.214	0.26644	T	0.235	0.32573	T	0.001	0.32504	B	0.0	0.18137	B	0.01	0.13669	N	simple_aae	99.0	1.0	-0.69	0.01960	N	-0.03	0.09903	N	0.195	0.22590	-0.7244	0.59072	T	0.3134	0.6821	T	10.0	0.012888253	0.00272	T	0.079338	0.73121	D	0.497	0.78048	.	.	.	.	.	0.158396225186	0.15034	.	0.03344	.	0.07277	0.214491963387	0.01019	T	0.079098	0.35782	T	-0.262208	0.12388	T	-0.205768	0.53787	T	0.0166096592434054	0.0042	T	.	0.29041	.	0.019548856	0.00487	0.028340364	0.01070	0.016553821	0.00205	0.02649676	0.00748	-3.941	0.23134	T	0.0686	0.07209	B	0.000385430296663524	0.05956	0.96491360	0.94286	0.084	0.23719	.	.	.	.	.	.	-0.113362	0.03572	0.688	0.7699144685971571	0.11882	0.095446	0.19078	N	-1.3898584281667	0.02705	0.1210794	-1.32035774990261	0.04105	0.1960024	4.66	0.167	0.14242	-6.06	0.02993	-0.366	0.07635	0.284000	0.16868	-2.609	0.00233	0.0	0.06393	0.024	0.21036	0.529	0.2973	519	0.74474	.	.	.	.	.	.	.	.	.	.	.	.	129	264690	4.873626E-4	.	19	108190	1.756170e-04	0	27	206062	1.310290e-04	0	41	234636	1.747390e-04	1	0	6938	0.000000e+00	0	16	16980	9.422850e-04	0	0	2220	0.000000e+00	0	1	9016	1.109140e-04	0	0	13288	0.000000e+00	0	2	42360	4.721440e-05	0	0	15500	0.000000e+00	0	16	16980	9.422850e-04	0	0	15900	0.000000e+00	0	18	30256	5.949230e-04	0	0	6090	0.000000e+00	0	1	13376	7.476080e-05	0	0	16568	0.000000e+00	0	5	88838	5.628220e-05	0	2	30224	6.617260e-05	0	18	30256	5.949230e-04	0	0	14596	0.000000e+00	0	34	33994	1.000180e-03	1	0	9436	0.000000e+00	0	1	17648	5.666360e-05	0	0	21354	0.000000e+00	0	4	101906	3.925190e-05	0	2	30142	6.635260e-05	0	34	33994	1.000180e-03	1	.	164	1612732	1.016910e-04	1	89	59814	1.487950e-03	1	1	74898	1.335150e-05	0	0	912	0.000000e+00	0	89	59814	1.487950e-03	1	1	29506	3.389140e-05	0	1	44890	2.227670e-05	0	0	63834	0.000000e+00	0	4	6084	6.574620e-04	0	61	1179578	5.171340e-05	0	5	90788	5.507340e-05	0	2	26660	7.501875468867217E-5	0	114	0	0	120	0	0	3236	0	0	498	0	0	628	0	0	26	0	0	104	0	0	4696	0	0	3350	0	0	146	0	2	36082	5.542929992794191E-5	Benign	Malignant_tumor_of_breast|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43090997C>T	ClinGen:CA002653|UniProtKB:P38398#VAR_070487	C0006142|CN169374|C3661900|C0677776|CN221562|C2676676|C0027672	604370	145|145|140162	.	Val	Ile	69778.0	single nucleotide variant	NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	28897690.0	-	RCV000048456|RCV000112269|RCV000130952|RCV000195345|RCV000735522|RCV000588834|RCV001353555|RCV004803994	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43090997.0	43090997.0	17q21.31	reviewed by expert panel	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002653,UniProtKB:P38398#VAR_070487	2.0	55111.0	43090997.0	C	T	-	-	-	-	-	-	SCV001161590	-	-	4132G>A 	Val1378Ile	NM_007294.4	3.0	2_Benign	34.39	0.943661971830986	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	34.39	0.943662	$\geqslant$90	<=50																																																																																																																																		true	BRCA1Val275Ile																																																																																																																																																																																																																																		
RAD51D	RAD51D_Ala231Ser	0.24888080055203415	0.8105973795143	15.706224815942017	1.0267282885890885e-6	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9611743430048734	0.7632100325914521	0.8580335209169332	0.8479247554468121	0.7471406333569957	0.6124205899357343	0.7948659978902257	0.779002624690744	0.6826065995404491	0.9617142773847289	0.8818606767782569	0.9009835130033984	0.9370644171431224	0.8438134656424551	0.9606344086250178	RAD51D	0.24888080055203415	0.8105973795143	15.706224815942017	1.0267282885890885e-6	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9611743430048734	0.7632100325914521	0.8580335209169332	0.8479247554468121	0.7471406333569957	0.6124205899357343	0.7948659978902257	0.779002624690744	0.6826065995404491	0.9617142773847289	0.8818606767782569	0.9009835130033984	0.9370644171431224	0.8438134656424551	0.9606344086250178	RAD51D		7201		CCSBVarC024850		NC_000017.11:35103301:C:A	691G>T	Ala231Ser																												17.0	35103301.0	C	A	17						17-35103301-C-A	478474.0	single nucleotide variant	NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jan 14, 2025	772135704.0	-	RCV000575670|RCV001351481|RCV001764647	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35103301.0	35103301.0	17q12	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA8499378	2.0	480531.0	35103301.0	C	A	-	-	-	-	-	-	SCV000663829|SCV000686480|SCV001545958|SCV001990804|SCV004208079	-	-	691G>T 	Ala231Ser	NM_002878.4	1.0	3_Conflicting		480531.0	17	35103301.0	C	A	A	S	rs772135704	17	33430320.0	17	30454433.0	231.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.691G>T	p.Ala231Ser	c.691G>T	p.Ala231Ser	principal1	Y	5	.	.	-	GCC	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.39016	.	0.148	0.35663	T	0.68	0.53374	P	0.562	0.49607	P	0.18	0.50204	N	simple_aae	82.0	18.0	1.42	0.35528	L	.	0.43338	.	0.222	0.39513	-0.6345	0.63221	T	0.2791	0.64952	T	10.0	0.45145473	0.58389	D	0.066725	0.69852	D	0.162	0.41623	0.644	0.78027	O75771	A231S	Gain of phosphorylation at A231 (P = 0.0655)| Gain of disorder (P = 0.0844)| Gain of MoRF binding (P = 0.1284)| Loss of ubiquitination at K235 (P = 0.2243)| Loss of methylation at R232 (P = 0.3779)	0.942670400808	0.94162	.	0.52746	.	0.36618	.	.	.	0.169282	0.51414	T	-0.0747325	0.40218	T	-0.00673246	0.69677	D	0.217512117147641	0.21078	T	0.864413	0.57408	D	0.5926053	0.72005	0.42019272	0.65736	0.5926053	0.72007	0.42019272	0.65736	-7.695	0.62579	D	0.116	0.32008	B	0.000766225569270482	0.08395	0.93499870	0.92618	0.232	0.50061	.	.	.	.	.	.	3.594988	0.50833	23.0	0.9622630750141308	0.29313	0.620192	0.60393	D	0.387026469158641	0.60517	4.263942	0.432911172391861	0.63430	4.600281	4.92	4.92	0.64102	3.22	0.58372	4.112	0.57674	2.653000	0.33911	0.549	0.27038	1.0	0.71675	1.0	0.68239	0.998	0.85369	908	0.22602	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	8	106972	7.478590e-05	0	15	203574	7.368330e-05	0	15	232448	6.453060e-05	0	0	6872	0.000000e+00	0	0	16800	0.000000e+00	0	0	2230	0.000000e+00	0	0	8846	0.000000e+00	0	0	13256	0.000000e+00	0	0	41826	0.000000e+00	0	8	15260	5.242460e-04	0	8	15260	5.242460e-04	0	0	15702	0.000000e+00	0	0	29908	0.000000e+00	0	0	6046	0.000000e+00	0	0	13302	0.000000e+00	0	0	16488	0.000000e+00	0	0	87500	0.000000e+00	0	15	29876	5.020750e-04	0	15	29876	5.020750e-04	0	0	14484	0.000000e+00	0	0	33672	0.000000e+00	0	0	9430	0.000000e+00	0	0	17458	0.000000e+00	0	0	21108	0.000000e+00	0	0	100948	0.000000e+00	0	15	29796	5.034230e-04	0	15	29796	5.034230e-04	0	.	47	1611894	2.915820e-05	0	46	90536	5.080850e-04	0	0	74890	0.000000e+00	0	0	912	0.000000e+00	0	0	59658	0.000000e+00	0	0	29510	0.000000e+00	0	0	44848	0.000000e+00	0	0	63892	0.000000e+00	0	0	6052	0.000000e+00	0	0	1179196	0.000000e+00	0	46	90536	5.080850e-04	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35103301C>A	ClinGen:CA8499378	C0027672|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Ala	Ser	478474.0	single nucleotide variant	NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jan 14, 2025	772135704.0	-	RCV000575670|RCV001351481|RCV001764647	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35103301.0	35103301.0	17q12	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA8499378	2.0	480531.0	35103301.0	C	A	-	-	-	-	-	-	SCV000663829|SCV000686480|SCV001545958|SCV001990804|SCV004208079	-	-	691G>T 	Ala231Ser	NM_002878.4	1.0	3_Conflicting	97.85	0.0283018867924528	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	97.85	0.028301887	<10	>90						A	3			97.85	Aliphatic	Alanine		DNA repair protein RAD51 homolog 4								0.0477		1.8								A231-K235, A231-M227; PAE: 1.0, 1.0	5 interactions	A231-K235, A231-M227; PAE: 1.0, 1.0	6 interactions							89									-57.4		Pocket 3: Mean pLDDT: 97.77, Volume: 250.74 Å³, Druggability score: 0.05		-37.4						H (helix)	H (α-helix)	Helix	in Ref. 9; CAB55937																																																																		true	RAD51DAla231Ser																																																																																																																																																																																																																																		
BRCA1	BRCA1_Glu116Lys	-0.5233944689523996	0.6168548518585896	-8.233502008527775	0.00007581852114808116	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9572879524093623	0.5471525100537117	0.9119979388562758	0.8841465212799839	0.4915951765292159	0.5045541015624009	0.8997581228520514	0.9519226502253639	0.53067015370023	0.9684817915298322	0.4786362514960309	0.8685349197079164	0.8720732274871875	0.5636348664071934	0.9460941132888923	BRCA1	-0.5233944689523996	0.6168548518585896	-8.233502008527775	0.00007581852114808116	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9572879524093623	0.5471525100537117	0.9119979388562758	0.8841465212799839	0.4915951765292159	0.5045541015624009	0.8997581228520514	0.9519226502253639	0.53067015370023	0.9684817915298322	0.4786362514960309	0.8685349197079164	0.8720732274871875	0.5636348664071934	0.9460941132888923	BRCA1	ENSG00000012048	14613	218399.0	CCSBVarC003298	ALE00003298	NC_000017.11:43104217:C:T	346G>A	Glu116Lys	CEGS2	CegsMutGDEh1028	G06	GDEhDisVCh_40059	G09	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43104217.0	C	T	17	Y	N	N	N	N	17-43104217-C-T	69560.0	single nucleotide variant	NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	672.0	BRCA1	HGNC:1100	Uncertain significance	0.0	Jan 25, 2022	397509071.0	-	RCV000577079|RCV002453364	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	43104217.0	43104217.0	17q21.31	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002236	3.0	54893.0	43104217.0	C	T	-	-	-	-	-	-	SCV002612990	-	-	346G>A 	Glu116Lys	NM_007294.4	1.0	4_VUS		54893.0	17	43104217.0	C	T	E	K	rs397509071	17	41256234.0	17	38509760.0	116.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.346G>A	p.Glu116Lys	c.346G>A	p.Glu116Lys	principal2	Y	1	YES	Select	-	GAA	1.0	0.0	C	./.	./.	./.	./.	0.001	0.78662	D	0.015	0.61973	D	0.956	0.54679	P	0.275	0.40079	B	0.99	0.97926	D	simple_aae	1.0	99.0	2.455	0.71058	M	-0.56	0.54726	N	0.665	0.73073	1.0626	0.98399	D	0.9333	0.97797	D	10.0	0.75375986	0.75596	D	0.687104	0.97412	D	0.698	0.89052	.	.	.	.	.	0.936910906656	0.93576	.	0.48618	.	0.25914	0.455957233906	0.32716	T	0.167623	0.51184	T	0.458962	0.92824	D	0.42149	0.92735	D	0.960671126842499	0.65652	D	.	0.90678	.	0.30580968	0.53088	0.31052214	0.56841	0.29307255	0.51944	0.32331142	0.58036	-4.132	0.26444	T	0.103	0.24020	B	0.315487270864402	0.54793	0.99916387	0.99185	0.137	0.36038	.	.	.	.	.	.	3.863469	0.56124	23.7	0.9991702379207898	0.9845	0.588432	0.58423	D	0.519732155081613	0.68091	5.192408	0.544271718873321	0.70840	5.588604	5.32	5.32	0.75341	.	.	2.768	0.47428	3.839000	0.40112	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.994	0.71086	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	17708	0	0	292	0	0	84	0	2	7360	2.717391304347826E-4	0	146	0	0	610	0	0	24	0	0	94	0	0	1904	0	2	7652	2.6136957658128593E-4	0	108	0	2	28222	7.086669973779322E-5	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast	criteria_provided,_single_submitter	NC_000017.11:g.43104217C>T	ClinGen:CA002236	C0027672|C0346153	114480	140162|227535	.	Glu	Lys	69560.0	single nucleotide variant	NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	672.0	BRCA1	HGNC:1100	Uncertain significance	0.0	Jan 25, 2022	397509071.0	-	RCV000577079|RCV002453364	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	43104217.0	43104217.0	17q21.31	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002236	3.0	54893.0	43104217.0	C	T	-	-	-	-	-	-	SCV002612990	-	-	346G>A 	Glu116Lys	NM_007294.4	1.0	4_VUS	29.1	0.9432989690721648	['114480']	autosomal dominant	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST CANCER	29.1	0.943299	$\geqslant$90	<=50																																																																																																																																		true	BRCA1Glu116Lys																																																																																																																																																																																																																																		
BRAF	BRAF_Val487Gly	-6.116199946608242	0.00048331137760885195	3.8723574361118165	0.006113032285350252	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7333372363125736	0.5814138684770508	0.6951171735574371	0.7367219635187786	0.6592298815897384	0.5407661447805905	0.6765742692118035	0.6841347854488865	0.507385551881682	0.7522435543255914	0.7776936183988863	0.7968696578257537	0.7060995616659878	0.6554421850724196	0.7144309182995557	BRAF	-6.116199946608242	0.00048331137760885195	3.8723574361118165	0.006113032285350252	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7333372363125736	0.5814138684770508	0.6951171735574371	0.7367219635187786	0.6592298815897384	0.5407661447805905	0.6765742692118035	0.6841347854488865	0.507385551881682	0.7522435543255914	0.7776936183988863	0.7968696578257537	0.7060995616659878	0.6554421850724196	0.7144309182995557	BRAF	ENSG00000157764	71969	220606.0	CCSBVarC003164	ALE00003164	NC_000007.14:140778048:A:C	1460T>G	Val487Gly	CEGS2	CegsMutGDEh1011	H06	GDEhDisVCh_40058	E03	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140778048.0	A	C	7	Y	N	N	N	N	7-140778048-A-C	53973.0	single nucleotide variant	NM_004333.6(BRAF):c.1460T>G (p.Val487Gly)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 21, 2021	397516893.0	-	RCV000788814|RCV000037922|RCV000622585|RCV001852794	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Cardio-facio-cutaneous syndrome|Inborn genetic diseases|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140778048.0	140778048.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA280007	2.0	44806.0	140778048.0	A	C	-	-	-	-	-	-	SCV000061585|SCV000740925|SCV000928070|SCV002008924|SCV002196994	-	-	1460T>G 	Val487Gly	NM_004333.6	2.0	1_Pathogenic		44806.0	7	140778048.0	A	C	V	G	rs397516893	7	140477848.0	7	140124317.0	487.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1460T>G	p.Val487Gly	c.1460T>G	p.Val487Gly	principal4	Y	.	YES	Select	-	GTG	2.0	0.0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.478	0.36724	P	0.148	0.34068	B	.	0.99291	.	.	.	.	0.895	0.22286	L	.	.	.	.	.	-0.8552	0.51413	T	0.1922	0.54309	T	10.0	0.9420905	0.93461	D	0.174902	0.85076	D	.	0.96086	0.828	0.93817	P15056	V487G	Gain of disorder (P = 0.0281)| Loss of stability (P = 0.0406)| Gain of ubiquitination at K483 (P = 0.0985)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.2005)	.	0.98130	.	0.92090	.	0.93269	0.828899681568	0.86370	D	0.848438	0.96500	D	0.417248	0.90811	D	0.361572	0.90697	D	0.99738210439682	0.91358	D	0.946505	0.79494	D	0.9640127	0.97644	0.93370944	0.97310	0.948537	0.96056	0.9274714	0.96876	-13.971	0.92975	D	0.9903	0.95874	P	0.999977702097208	0.99427	0.99449290	0.97559	0.997	0.99892	.	.	.	.	.	.	5.288129	0.8881	29.7	0.9959138909613369	0.73662	0.903643	0.85245	D	0.341902369550804	0.58100	4.002832	0.436077121338009	0.63630	4.624474	4.96	4.96	0.65108	.	.	9.289	0.95099	11.177000	0.88188	0.686	0.82694	1.0	0.71675	1.0	0.68239	0.997	0.79771	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|not_provided|Inborn_genetic_diseases|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778048A>C	ClinGen:CA280007	C1275081|C3661900|C0950123|C5555857	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Val	Gly	53973.0	single nucleotide variant	NM_004333.6(BRAF):c.1460T>G (p.Val487Gly)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 21, 2021	397516893.0	-	RCV000788814|RCV000037922|RCV000622585|RCV001852794	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Cardio-facio-cutaneous syndrome|Inborn genetic diseases|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140778048.0	140778048.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA280007	2.0	44806.0	140778048.0	A	C	-	-	-	-	-	-	SCV000061585|SCV000740925|SCV000928070|SCV002008924|SCV002196994	-	-	1460T>G 	Val487Gly	NM_004333.6	2.0	1_Pathogenic	72.04	0.1690140845070422		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		72.04	0.16901408	10-90	70-90						V	24			72.04	Aliphatic	Valine		Serine/threonine-protein kinase B-raf							Protein kinase			4.2									3 interactions		12 interactions							117									-137.8				105.0						C (loop/coil)	C (loop/coil)	Beta strand																																																																			true	BRAFVal487Gly																																																																																																																																																																																																																																		
KRAS	KRAS_Tyr71His	-4.892479479558333	0.001768232186353	6.312032320641843	0.0003995147857415345	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9420249261358699	0.43523395060883235	0.8641048224066088	0.8707022147652246	0.5929192664186796	0.5929192664186796	0.8707022147652246	0.8641048224066088	0.43523395060883235	0.9420249261358699						KRAS	-4.892479479558333	0.001768232186353	6.312032320641843	0.0003995147857415345	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9420249261358699	0.43523395060883235	0.8641048224066088	0.8707022147652246	0.5929192664186796	0.5929192664186796	0.8707022147652246	0.8641048224066088	0.43523395060883235	0.9420249261358699						KRAS	ENSG00000133703	3084	214490.0	CCSBVarC006099	ALE00006099	NC_000012.12:25227313:A:G	211T>C	Tyr71His	CEGS2	CegsMutGDEh1036	F03	GDEhDisVCh_40061	B09	1.0	CegsMutGDDh1036	F03							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25227313.0	A	G	12	Y	Y	N	N	N	12-25227313-A-G	40605.0	single nucleotide variant	NM_033360.4(KRAS):c.211T>C (p.Tyr71His)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Jan 15, 2013	387907205.0	-	RCV000024617	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Cardiofaciocutaneous syndrome 2	germline	germline	GRCh38	NC_000012.12	12	25227313.0	25227313.0	12p12.1	no assertion criteria provided	1.0	-	N	ClinGen:CA279983,UniProtKB:P01116#VAR_069784,OMIM:190070.0021	1.0	31940.0	25227313.0	A	G	-	-	-	-	-	-	SCV000050483	-	-	211T>C 	Tyr71His	NM_033360.4		1_Pathogenic		31940.0	12	25227313.0	A	G	Y	H	rs387907205	12	25380247.0	12	25271514.0	71.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.211T>C	p.Tyr71His	c.211T>C	p.Tyr71His	alternative1	Y	1	.	Plus_Clinical	-	TAC	1.0	0.0	A	A/A	A/A	A/A	A/A	0.025	0.48345	D	0.061	0.45880	T	0.919	0.50939	P	0.913	0.64880	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.48	0.71880	M	-4.45	0.77749	D	0.968	0.97870	0.6011	0.91886	D	0.7268	0.90619	D	10.0	0.88397557	0.87583	D	0.096778	0.76586	D	0.895	0.97016	0.693	0.82954	P01116	Y71H	Gain of catalytic residue at T74 (P = 0.0026)| Gain of disorder (P = 0.029)| Loss of phosphorylation at Y71 (P = 0.0387)| Loss of stability (P = 0.1315)| Loss of helix (P = 0.1706)	0.967032760806	0.96637	0.9119234105740558	0.91111	3.04366087562	0.99279	0.940733075142	0.99483	D	0.901474	0.98050	D	0.41344	0.90604	D	0.356102	0.90487	D	0.988144636154175	0.78358	D	0.884911	0.60851	D	0.93090373	0.94241	0.9041667	0.95206	0.927135	0.93859	0.8970921	0.94698	-12.052	0.85144	D	0.9986	0.98903	P	0.999975559545648	0.99427	0.99871314	0.98921	0.987	0.99559	.	.	.	.	.	.	5.005977	0.83126	28.0	0.9986039673354614	0.93915	0.873516	0.79516	D	0.756487767865435	0.83238	7.988538	0.776357426611185	0.88040	9.459321	5.77	5.77	0.91065	3.95	0.75212	9.309	0.95324	11.259000	0.91022	0.731	0.85655	1.0	0.71675	1.000000	0.68239	0.998	0.85369	856	0.34333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Cardiofaciocutaneous_syndrome_2	no_assertion_criteria_provided	NC_000012.12:g.25227313A>G	ClinGen:CA279983|OMIM:190070.0021|UniProtKB:P01116#VAR_069784	C3809005	615278	1340	Small GTP-binding domain	Tyr	His	40605.0	single nucleotide variant	NM_033360.4(KRAS):c.211T>C (p.Tyr71His)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Jan 15, 2013	387907205.0	-	RCV000024617	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Cardiofaciocutaneous syndrome 2	germline	germline	GRCh38	NC_000012.12	12	25227313.0	25227313.0	12p12.1	no assertion criteria provided	1.0	-	N	ClinGen:CA279983,UniProtKB:P01116#VAR_069784,OMIM:190070.0021	1.0	31940.0	25227313.0	A	G	-	-	-	-	-	-	SCV000050483	-	-	211T>C 	Tyr71His	NM_033360.4		1_Pathogenic	91.78	0.0405405405405405	['615278']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2	91.78	0.04054054	<10	>90																																																																																																																																		true	KRASTyr71His																																																																																																																																																																																																																																		
BRCA1	BRCA1_Arg595Gln	-1.2480440075438437	0.25214139106590744	6.662337598181629	0.00028723146358685287	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8612003333873312	0.8323580080770457	0.9230769851270171	0.9088564180208125	0.913199223964837	0.8646854932415327	0.9159245401802051	0.8902121761198842	0.7604411608793911	0.8449567484206457	0.9617129546881413	0.9017882958614198	0.9559417941341498	0.9042748552747004	0.8774439183540166	BRCA1	-1.2480440075438437	0.25214139106590744	6.662337598181629	0.00028723146358685287	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8612003333873312	0.8323580080770457	0.9230769851270171	0.9088564180208125	0.913199223964837	0.8646854932415327	0.9159245401802051	0.8902121761198842	0.7604411608793911	0.8449567484206457	0.9617129546881413	0.9017882958614198	0.9559417941341498	0.9042748552747004	0.8774439183540166	BRCA1	ENSG00000012048	14613	218429.0	CCSBVarC003306	ALE00003306	NC_000017.11:43063930:C:T	1784G>A	Arg595Gln	CEGS2	CegsMutGDEh1012	D06	GDEhDisVCh_40059	B04	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43063930.0	C	T	17	Y	N	N	N	N	17-43063930-C-T	46192.0	single nucleotide variant	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	May 10, 2017	41293459.0	-	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV002250479|RCV002496477|RCV003162265|RCV004802991|RCV004554634	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Gastric cancer|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	43063930.0	43063930.0	17q21.31	reviewed by expert panel	49.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	3.0	37636.0	43063930.0	C	T	-	-	-	-	-	-	SCV001156534	-	-	5096G>A 	Arg1699Gln	NM_007294.4	3.0	1_Pathogenic	0.0000191545	37636.0	17	43063930.0	C	T	R	Q	rs41293459	17	41215947.0	17	38469473.0	1699.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5096G>A	p.Arg1699Gln	principal2	Y	1	.	.	-	CGG	2.0	0.0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.995	0.90580	D	0.454	0.97365	P	.	0.97926	.	.	.	.	3.23	0.89408	M	.	0.63232	.	.	0.96659	0.9361	0.96178	D	0.8732	0.95778	D	10.0	.	0.83114	.	0.74691	0.97975	D	.	0.92843	.	.	.	.	.	.	0.96647	.	0.87449	.	0.39535	0.661911010742	0.61621	T	0.392783	0.80349	T	0.34877	0.86324	D	0.419574	0.92678	D	0.950455367565155	0.63113	D	.	0.97283	.	0.96523166	0.97765	0.7972393	0.87946	0.9692461	0.98160	0.77520096	0.86571	-11.318	0.81678	D	.	0.82063	.	0.987067707466189	0.87311	0.99990070	0.99879	0.902	0.94843	.	.	.	.	.	.	5.19884	0.87233	29.2	0.9995787177937168	0.99986	0.805899	0.72937	D	0.871042515796463	0.90217	10.32869	0.832238134394619	0.91891	11.14783	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.0	0.68239	0.998	0.85369	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	2	109352	1.828960e-05	0	4	207994	1.923130e-05	0	6	236774	2.534060e-05	0	0	7152	0.000000e+00	0	0	17106	0.000000e+00	0	0	2310	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	2	42748	4.678580e-05	0	0	15686	0.000000e+00	0	2	42748	4.678580e-05	0	0	16198	0.000000e+00	0	0	30512	0.000000e+00	0	0	6206	0.000000e+00	0	0	13408	0.000000e+00	0	0	16734	0.000000e+00	0	4	89478	4.470370e-05	0	0	30598	0.000000e+00	0	4	89478	4.470370e-05	0	0	14886	0.000000e+00	0	0	34248	0.000000e+00	0	0	9556	0.000000e+00	0	0	17686	0.000000e+00	0	0	21630	0.000000e+00	0	6	102642	5.845560e-05	0	0	30516	0.000000e+00	0	6	102642	5.845560e-05	0	.	30	1613816	1.858950e-05	0	3	44856	6.688070e-05	0	0	74854	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29598	0.000000e+00	0	3	44856	6.688070e-05	0	0	64006	0.000000e+00	0	0	6084	0.000000e+00	0	25	1179960	2.118720e-05	0	1	91080	1.097940e-05	0	0	49660	0	0	364	0	0	398	0	0	9488	0	0	498	0	0	802	0	0	62	0	0	146	0	0	2420	0	0	9852	0	0	460	0	0	63838	0	Pathogenic	BRCA1-related_disorder|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Ovarian_neoplasm|Gastric_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43063930C>T	ClinGen:CA003235|OMIM:113705.0037|UniProtKB:P38398#VAR_070501	C0346153|C3280442|C2676676|C4554406|C0677776|CN221562|C0919267|C0024623|C0027672|C3661900	114480|614320|604370|617883|613659	227535|1333|145|145|140162	BRCT domain|BRCT domain|BRCT domain	Arg	Gln	46192.0	single nucleotide variant	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	May 10, 2017	41293459.0	-	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV002250479|RCV002496477|RCV003162265|RCV004802991|RCV004554634	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Gastric cancer|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	43063930.0	43063930.0	17q21.31	reviewed by expert panel	49.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	3.0	37636.0	43063930.0	C	T	-	-	-	-	-	-	SCV001156534	-	-	5096G>A 	Arg1699Gln	NM_007294.4	3.0	1_Pathogenic	96.0	0.2862903225806452	['604370', '114480', '604370', '617883', '614320', '114480', '613659']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST CANCER; GASTRIC CANCER	96.0	0.28629032	10-90	>90																																																																																																																																		true	BRCA1Arg595Gln																																																																																																																																																																																																																																		
BRAF	BRAF_Thr241Arg	-8.877044476380464	0.0000466454663945854	6.127715259649578	0.000477871903155989	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8035507867832169	0.7485082955646319	0.7584846614033833	0.7721124795906301	0.8299258911292273	0.8299258911292273	0.7721124795906301	0.7584846614033833	0.7485082955646319	0.8035507867832169						BRAF	-8.877044476380464	0.0000466454663945854	6.127715259649578	0.000477871903155989	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8035507867832169	0.7485082955646319	0.7584846614033833	0.7721124795906301	0.8299258911292273	0.8299258911292273	0.7721124795906301	0.7584846614033833	0.7485082955646319	0.8035507867832169						BRAF	ENSG00000157764	71969	220596.0	CCSBVarC003154	ALE00003154	NC_000007.14:140801550:G:C	722C>G	Thr241Arg	CEGS2	CegsMutGDEh1016	G06	GDEhDisVCh_40058	D05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140801550.0	G	C	7	Y	N	N	N	N	7-140801550-G-C	38761.0	single nucleotide variant	NM_004333.6(BRAF):c.722C>G (p.Thr241Arg)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Feb 01, 2023	387906660.0	-	RCV000022679|RCV000208548|RCV002513171|RCV000624512|RCV001703420	MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Noonan syndrome 7|Noonan syndrome 1|RASopathy|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000007.14	7	140801550.0	140801550.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	UniProtKB:P15056#VAR_058622,OMIM:164757.0023,ClinGen:CA259663	3.0	29806.0	140801550.0	G	C	-	-	-	-	-	-	SCV000057185|SCV000743069|SCV003440618	-	-	722C>G 	Thr241Arg	NM_004333.6	2.0	1_Pathogenic		29806.0	7	140801550.0	G	C	T	R	rs387906660	7	140501350.0	7	140147819.0	241.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.722C>G	p.Thr241Arg	c.722C>G	p.Thr241Arg	principal4	Y	.	YES	Select	-	ACG	2.0	0.0	G	./.	./.	./.	./.	.	0.91343	.	.	0.53421	.	1.0	0.90580	D	0.998	0.88579	D	.	0.86984	.	.	.	.	3.175	0.88626	M	.	0.77586	.	.	0.96886	0.9426	0.96274	D	0.8732	0.95778	D	10.0	0.9803134	0.97976	D	0.440713	0.94148	D	.	0.99124	0.93	0.98894	P15056	T241R	Gain of solvent accessibility (P = 0.008)| Gain of relative solvent accessibility (P = 0.0289)| Gain of MoRF binding (P = 0.033)| Gain of methylation at T241 (P = 0.0391)| Loss of ubiquitination at K240 (P = 0.0594)	.	0.98932	.	0.97131	.	0.95664	0.916709661484	0.98061	D	0.89813	0.97961	D	0.503099	0.94327	D	0.484891	0.94248	D	0.998121440410614	0.93238	D	0.983902	0.95725	D	0.94158983	0.95338	0.8970028	0.94691	0.92752135	0.93899	0.90271693	0.95103	-14.509	0.94604	D	0.9977	0.98500	P	0.999963000543786	0.99297	0.99600226	0.97933	0.973	0.98982	.	.	.	.	.	.	5.408322	0.90554	31.0	0.9965266156936476	0.77405	0.880398	0.80631	D	0.884148484170867	0.90911	10.64868	0.845660358607975	0.92720	11.61548	5.17	5.17	0.70808	.	.	9.943	0.9894	11.755000	0.95501	0.672	0.70176	1.0	0.71675	1.0	0.68239	0.94	0.48078	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Inborn_genetic_diseases|RASopathy|not_provided|Noonan_syndrome_7|Noonan_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140801550G>C	ClinGen:CA259663|OMIM:164757.0023|UniProtKB:P15056#VAR_058622	C0950123|C5555857|C3661900|C3150970|C4551602	613706|163950	536391|648|648	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Thr	Arg	38761.0	single nucleotide variant	NM_004333.6(BRAF):c.722C>G (p.Thr241Arg)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Feb 01, 2023	387906660.0	-	RCV000022679|RCV000208548|RCV002513171|RCV000624512|RCV001703420	MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Noonan syndrome 7|Noonan syndrome 1|RASopathy|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000007.14	7	140801550.0	140801550.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	UniProtKB:P15056#VAR_058622,OMIM:164757.0023,ClinGen:CA259663	3.0	29806.0	140801550.0	G	C	-	-	-	-	-	-	SCV000057185|SCV000743069|SCV003440618	-	-	722C>G 	Thr241Arg	NM_004333.6	2.0	1_Pathogenic	89.33	0.3380281690140845	['613706', '163950']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	NOONAN SYNDROME 7; NOONAN SYNDROME 1	89.33	0.33802816	10-90	70-90						T	48			89.33	Polar/Neutral	Threonine		Serine/threonine-protein kinase B-raf										-0.7			3 interactions	3 interactions					1 interaction		3 interactions							119									-92.2				132.5				dbSNP: rs387906660; Variant type: LP/P; AA change: Thr241Met; PTM type: Phosphorylation; PTM morphology: RKT*FFtLAFCD; Var class: II&rs387906661		B (undefined)	E (parallel sheets)											Phorbol-ester/DAG-type																																																									true	BRAFThr241Arg																																																																																																																																																																																																																																		
FARS2	FARS2_Asp142Tyr	-2.483576660753394	1.0	0.5392488168522184	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6651434012053881	0.5356959125385754	0.6849037642318263	0.6853023769943204	0.5792752331231843	0.5906016339396649	0.6769868661927881	0.6554205626714743	0.532339517574178	0.6703108451762275	0.5679488323067037	0.6936178877958527	0.7143869657921782	0.5390523075029727	0.6599759572345486	FARS2	-2.483576660753394	1.0	0.5392488168522184	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6651434012053881	0.5356959125385754	0.6849037642318263	0.6853023769943204	0.5792752331231843	0.5906016339396649	0.6769868661927881	0.6554205626714743	0.532339517574178	0.6703108451762275	0.5679488323067037	0.6936178877958527	0.7143869657921782	0.5390523075029727	0.6599759572345486	FARS2		12653		CCSBVarC011914		NC_000006.12:5368994:G:T	424G>T	Asp142Tyr																												6.0	5368994.0	G	T	6						6-5368994-G-T	247571.0	single nucleotide variant	NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Jun 13, 2018	145555213.0	-	RCV000239526	MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722	Hereditary spastic paraplegia 77	germline	germline	GRCh38	NC_000006.12	6	5368994.0	5368994.0	6p25.1	criteria provided, single submitter	3.0	-	N	ClinGen:CA10586223,UniProtKB:O95363#VAR_077044,OMIM:611592.0005	3.0	253159.0	5368994.0	G	T	-	-	-	-	-	-	SCV000845707	-	-	424G>T 	Asp142Tyr	NM_006567.5	1.0	1_Pathogenic		253159.0	6	5368994.0	G	T	D	Y	rs145555213	6	5369227.0	6	5314226.0	142.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.424G>T	p.Asp142Tyr	c.424G>T	p.Asp142Tyr	principal1	Y	1	YES	Select	+	GAC	1.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.425	0.98710	H	-8.05	0.96618	D	0.974	0.98479	0.6034	0.91916	D	0.6504	0.87777	D	10.0	0.93858135	0.93109	D	0.279745	0.90164	D	0.809	0.93796	0.791	0.91245	O95363	D142Y	Loss of solvent accessibility (P = 0.0152)| Loss of relative solvent accessibility (P = 0.0186)| Loss of ubiquitination at K139 (P = 0.0246)| Loss of disorder (P = 0.0373)| Loss of phosphorylation at Y144 (P = 0.0593)	0.952766475807	0.95187	.	0.93477	.	0.62839	0.784124493599	0.79514	T	0.511236	0.82575	D	0.286301	0.81716	D	0.342604	0.89952	D	0.999397754669189	0.97208	D	0.961304	0.85467	D	0.9639511	0.97638	0.8991653	0.94847	0.95198554	0.96412	0.9112432	0.95718	-13.759	0.92263	D	0.6133	0.69372	P	0.998275433556404	0.94209	0.97490570	0.95052	0.995	0.99826	.	.	.	.	.	.	5.212362	0.87485	29.2	0.9956443339236986	0.72048	0.890111	0.82419	D	0.948429081889747	0.93888	12.37248	0.847583306341376	0.92834	11.68468	5.38	4.49	0.54123	2.52	0.46380	9.553	0.97226	9.744000	0.81475	0.676	0.76753	1.0	0.71675	1.0	0.68239	1.0	0.97202	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109406	0.000000e+00	0	0	208056	0.000000e+00	0	1	236838	4.222300e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16212	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13406	0.000000e+00	0	0	16734	0.000000e+00	0	0	89506	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	1	17688	5.653550e-05	0	0	21632	0.000000e+00	0	0	102650	0.000000e+00	0	0	30526	0.000000e+00	0	1	17688	5.653550e-05	0	.	1	1614168	6.195140e-07	0	1	44882	2.228060e-05	0	0	75044	0.000000e+00	0	0	910	0.000000e+00	0	0	60024	0.000000e+00	0	0	29604	0.000000e+00	0	1	44882	2.228060e-05	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180018	0.000000e+00	0	0	91082	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_spastic_paraplegia_77	criteria_provided,_single_submitter	NC_000006.12:g.5368994G>T	ClinGen:CA10586223|OMIM:611592.0005|UniProtKB:O95363#VAR_077044	C5569007	617046	466722	Phenylalanyl-tRNA synthetase	Asp	Tyr	247571.0	single nucleotide variant	NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Jun 13, 2018	145555213.0	-	RCV000239526	MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722	Hereditary spastic paraplegia 77	germline	germline	GRCh38	NC_000006.12	6	5368994.0	5368994.0	6p25.1	criteria provided, single submitter	3.0	-	N	ClinGen:CA10586223,UniProtKB:O95363#VAR_077044,OMIM:611592.0005	3.0	253159.0	5368994.0	G	T	-	-	-	-	-	-	SCV000845707	-	-	424G>T 	Asp142Tyr	NM_006567.5	1.0	1_Pathogenic	96.08	0.3496932515337423	['617046']	unknown		0	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE	96.08	0.34969324	10-90	>90						D	57			96.08	Negatively-charged	Aspartic Acid												-3.5								D142-R180; PAE: 1.0	9 interactions	D142-R180; PAE: 1.0	11 interactions							132									-115.7				-12.1						C (loop/coil)	T (turn)	Turn																																																																			true	FARS2Asp142Tyr																																																																																																																																																																																																																																		
FARS2	FARS2_Asp325Tyr	-0.023869672948344745	1.0	-2.20007671920073	0.07158255080772741	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7302541555456651	0.6833195427510824	0.6932543527262851	0.7166591934444592	0.7165507605210353	0.7875315940839283	0.7224129475293346	0.6805454834471193	0.7622528725017358	0.7460618465562038	0.6455699269581424	0.7109054393595837	0.7059632220054508	0.604386213000429	0.7144464645351264	FARS2	-0.023869672948344745	1.0	-2.20007671920073	0.07158255080772741	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7302541555456651	0.6833195427510824	0.6932543527262851	0.7166591934444592	0.7165507605210353	0.7875315940839283	0.7224129475293346	0.6805454834471193	0.7622528725017358	0.7460618465562038	0.6455699269581424	0.7109054393595837	0.7059632220054508	0.604386213000429	0.7144464645351264	FARS2		12653		CCSBVarC011942		NC_000006.12:5545248:G:T	973G>T	Asp325Tyr																												6.0	5545248.0	G	T	6						6-5545248-G-T	247570.0	single nucleotide variant	NM_006567.5(FARS2):c.973G>T (p.Asp325Tyr)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	764427452.0	-	RCV000239485	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5545248.0	5545248.0	6p25.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA10586222,OMIM:611592.0004	3.0	253158.0	5545248.0	G	T	-	-	-	-	-	-	SCV000845714	-	-	973G>T 	Asp325Tyr	NM_006567.5	1.0	1_Pathogenic		253158.0	6	5545248.0	G	T	D	Y	rs764427452	6	5545481.0	6	5490480.0	325.0	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.973G>T	p.Asp325Tyr	c.973G>T	p.Asp325Tyr	principal1	Y	1	.	.	+	GAC	1.0	0.0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.019	0.59495	D	0.997	0.70687	D	0.856	0.60995	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.89	0.83536	M	-3.91	0.73078	D	0.892	0.89118	-0.4312	0.70898	T	0.2879	0.65824	T	10.0	0.8789767	0.87061	D	0.327437	0.91634	D	0.365	0.68327	0.549	0.66319	O95363	D325Y	Loss of sheet (P = 0.0457)| Gain of helix (P = 0.1736)| Loss of relative solvent accessibility (P = 0.1903)| Loss of solvent accessibility (P = 0.2668)| Gain of loop (P = 0.2754)	0.863127915216	0.86073	0.818542452780431	0.81703	0.666257477821	0.58909	0.481479197741	0.36213	T	0.386013	0.74554	T	0.0497619	0.58021	T	-0.166297	0.57486	T	0.969270646572113	0.68326	D	.	0.94767	.	0.7669591	0.81643	0.55408955	0.73958	0.7752676	0.82147	0.51400286	0.71661	-13.746	0.92217	D	0.2762	0.51168	LB	0.927914649263957	0.78214	0.86435160	0.90056	0.613	0.78377	.	.	.	.	.	.	4.293796	0.65565	24.8	0.9948646677905981	0.67222	0.403449	0.47535	N	0.582178761681802	0.71915	5.747102	0.542820554954507	0.70738	5.573649	5.27	4.28	0.50124	2.38	0.44324	2.399	0.4425	2.441000	0.32855	0.676	0.76753	1.0	0.71675	0.995	0.32549	0.978	0.57275	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5545248G>T	ClinGen:CA10586222|OMIM:611592.0004	C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Asp	Tyr	247570.0	single nucleotide variant	NM_006567.5(FARS2):c.973G>T (p.Asp325Tyr)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	764427452.0	-	RCV000239485	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5545248.0	5545248.0	6p25.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA10586222,OMIM:611592.0004	3.0	253158.0	5545248.0	G	T	-	-	-	-	-	-	SCV000845714	-	-	973G>T 	Asp325Tyr	NM_006567.5	1.0	1_Pathogenic	94.72	0.2822085889570552	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	94.72	0.2822086	10-90	>90						D	46			94.72	Negatively-charged	Aspartic Acid										0.1923		-3.5								D325-K353; PAE: 2.0	5 interactions	D325-M321, D325-K353; PAE: 1.0, 2.0	9 interactions	D325-K353; PAE: 2.0						132									62.0		Pocket 3: Mean pLDDT: 74.2, Volume: 1231.61 Å³, Druggability score: 0.19		38.0						C (loop/coil)	T (turn)																																																																				true	FARS2Asp325Tyr																																																																																																																																																																																																																																		
RAD51D	RAD51D_Val56Gly	1.9985217593357885	0.08580618781279473	6.150467942611997	0.00046732469968957475	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.805857807085385	0.5390757118054736	0.7297184582054765	0.6976247356240626	0.5613379721184998	0.68541614335651	0.7903470561584305	0.8287716597985677	0.6506081281818463	0.8642881205783758	0.43725980088048955	0.6049024150896948	0.6306652566123854	0.427543295429101	0.7474274935923941	RAD51D	1.9985217593357885	0.08580618781279473	6.150467942611997	0.00046732469968957475	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.805857807085385	0.5390757118054736	0.7297184582054765	0.6976247356240626	0.5613379721184998	0.68541614335651	0.7903470561584305	0.8287716597985677	0.6506081281818463	0.8642881205783758	0.43725980088048955	0.6049024150896948	0.6306652566123854	0.427543295429101	0.7474274935923941	RAD51D		7201		CCSBVarC024801		NC_000017.11:35118597:A:C	167T>G	Val56Gly																												17.0	35118597.0	A	C	17						17-35118597-A-C	1087626.0	single nucleotide variant	NM_002878.4(RAD51D):c.167T>G (p.Val56Gly)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	May 03, 2021	745307359.0	-	RCV001779181|RCV001799083	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN221562	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	35118597.0	35118597.0	17q12	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA8499636	2.0	1098881.0	35118597.0	A	C	-	-	-	-	-	-	SCV001623514|SCV002043212	-	-	167T>G 	Val56Gly	NM_002878.4	1.0	3_Conflicting		1098881.0	17	35118597.0	A	C	V	G	rs745307359	17	33445616.0	17	30469729.0	56.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.167T>G	p.Val56Gly	c.167T>G	p.Val56Gly	principal1	Y	5	.	.	-	GTG	2.0	0.0	A	A/A	A/A	A/A	A/A	.	0.31374	.	0.002	0.79703	D	0.722	0.42404	P	0.488	0.47286	P	.	.	.	.	.	.	1.795	0.47093	L	.	0.62039	.	0.721	0.72170	-0.8783	0.49699	T	0.1726	0.51308	T	10.0	0.03294766	0.01460	T	0.089068	0.75174	D	.	0.75010	0.613	0.74554	O75771	V56G	Loss of stability (P = 2e-04)| Gain of helix (P = 0.0425)| Loss of loop (P = 0.0804)| Gain of relative solvent accessibility (P = 0.1066)| Loss of MoRF binding (P = 0.1311)	0.776739155903	0.77291	.	.	.	.	.	.	.	0.488934	0.81292	T	0.239419	0.7744	D	0.106132	0.77147	D	0.0787749525895067	0.09708	T	0.559044	0.19237	T	0.33676666	0.55690	0.3519664	0.60545	0.33676666	0.55690	0.3519664	0.60544	-8.078	0.61675	D	0.5902	0.68420	P	0.0493707858960898	0.37072	0.99278045	0.97206	0.385	0.63571	.	.	.	.	.	.	5.133939	0.85944	28.7	0.9973236098192383	0.82849	0.946436	0.95573	D	0.430607372517603	0.62920	4.538864	0.465062733801357	0.65503	4.855777	4.79	4.79	0.6086	.	.	7.519	0.80763	11.047000	0.85271	0.756	0.943	1.0	0.71675	1.0	0.68239	0.989	0.64309	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	108972	6.423670e-05	0	8	207056	3.863690e-05	0	82	235244	3.485740e-04	0	0	7146	0.000000e+00	0	0	17078	0.000000e+00	0	0	2320	0.000000e+00	0	3	9000	3.333330e-04	0	1	13178	7.588400e-05	0	2	42660	4.688230e-05	0	1	15678	6.378360e-05	0	3	9000	3.333330e-04	0	1	16102	6.210410e-05	0	0	30476	0.000000e+00	0	0	6194	0.000000e+00	0	3	13346	2.247860e-04	0	1	16510	6.056940e-05	0	2	88982	2.247650e-05	0	1	30596	3.268400e-05	0	3	13346	2.247860e-04	0	1	14812	6.751280e-05	0	0	34214	0.000000e+00	0	0	9556	0.000000e+00	0	3	17638	1.700870e-04	0	39	20808	1.874280e-03	0	36	102102	3.525890e-04	0	1	30514	3.277180e-05	0	36	102102	3.525890e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118597A>C	.	CN221562|C3280345	614291	145	RAD51D, N-terminal domain	Val	Gly	1087626.0	single nucleotide variant	NM_002878.4(RAD51D):c.167T>G (p.Val56Gly)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	May 03, 2021	745307359.0	-	RCV001779181|RCV001799083	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN221562	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	35118597.0	35118597.0	17q12	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA8499636	2.0	1098881.0	35118597.0	A	C	-	-	-	-	-	-	SCV001623514|SCV002043212	-	-	167T>G 	Val56Gly	NM_002878.4	1.0	3_Conflicting	90.63	0.3380281690140845	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	90.63	0.33802816	10-90	>90						V	48			90.63	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2								V56-Q60, V56-A52; PAE: 1.0, 1.0	5 interactions	V56-Q60, V56-A52; PAE: 1.0, 1.0	5 interactions							117									-65.6				-42.9	preferentially binds ssDNA					H (helix)	H (α-helix)	Helix																																																																			true	RAD51DVal56Gly																																																																																																																																																																																																																																		
BRCA1	BRCA1_Glu455Lys	-0.7002018322598149	0.5063990015883388	-8.447337291706038	0.00006429500751423088	2025_01_Batch_13-14	true	true	false	false	false	false	true	false	false	false	0.9899237197298381	0.9405476911006652	0.9361906175742223	0.8905004414855902	0.7458102230328609	0.8265669894377499	0.9153739121502169	0.9392603930163101	0.9493802375316499	0.9888722334786625	0.665053456627972	0.8656269708209633	0.9331208421321344	0.9317151446696804	0.9909752059810135	BRCA1	-0.7002018322598149	0.5063990015883388	-8.447337291706038	0.00006429500751423088	2025_01_Batch_13-14	true	true	false	false	false	false	true	false	false	false	0.9899237197298381	0.9405476911006652	0.9361906175742223	0.8905004414855902	0.7458102230328609	0.8265669894377499	0.9153739121502169	0.9392603930163101	0.9493802375316499	0.9888722334786625	0.665053456627972	0.8656269708209633	0.9331208421321344	0.9317151446696804	0.9909752059810135	BRCA1		14613		CCSBVarC011868		NC_000017.11:43074331:C:T	1363G>A	Glu455Lys																												17.0	43074331.0	C	T	17						17-43074331-C-T	46160.0	single nucleotide variant	NM_007294.4(BRCA1):c.4675G>A (p.Glu1559Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80356988.0	-	RCV000031185|RCV000131823|RCV000496604|RCV000482921	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43074331.0	43074331.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002963	2.0	37604.0	43074331.0	C	T	-	-	-	-	-	-	SCV001161548	-	-	4675G>A 	Glu1559Lys	NM_007294.4	3.0	1_Pathogenic		37604.0	17	43074331.0	C	T	E	K	rs80356988	17	41226348.0	17	38479874.0	1559.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4675G>A	p.Glu1559Lys	principal2	Y	1	.	.	-	GAG	1.0	0.0	c	C/C	C/C	C/C	C/C	.	0.68399	.	.	0.74454	.	0.011	0.43580	B	0.006	0.35928	B	.	0.99291	.	.	.	.	1.75	0.45271	L	.	0.37944	.	.	0.78942	-0.0701	0.80692	T	0.5963	0.85548	D	9.0	.	0.70725	.	0.851739	0.98855	D	.	0.92017	.	.	.	.	.	.	0.80535	.	0.33367	.	0.11248	0.348278313875	0.17650	T	0.166952	0.51091	T	0.26768	0.80087	D	0.146727	0.79829	D	0.861642837524414	0.50935	D	.	0.48225	.	0.16502066	0.36448	0.16464907	0.38009	0.15768379	0.35225	0.16500245	0.38072	-3.995	0.26211	T	.	0.39417	.	0.95000846091201	0.80446	0.99910450	0.99146	0.831	0.90686	.	.	.	.	.	.	6.609515	0.95486	35.0	0.9984248885113004	0.92321	0.733049	0.67845	D	0.189406980124867	0.50447	3.256703	0.339873231586349	0.57676	3.957668	5.54	5.54	0.82883	3.53	0.64053	3.38	0.52274	5.613000	0.49136	0.591	0.32125	0.985	0.36067	1.0	0.68239	0.995	0.73271	534	0.73376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613716	1.239380e-06	0	1	64026	1.561870e-05	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59978	0.000000e+00	0	0	29604	0.000000e+00	0	0	44886	0.000000e+00	0	1	64026	1.561870e-05	0	0	6080	0.000000e+00	0	1	1179808	8.475960e-07	0	0	91074	0.000000e+00	0	2	20546	9.734254842791784E-5	0	0	0	0	44	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	288	0	0	426	0	0	44	0	2	21304	9.38790837401427E-5	Pathogenic	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43074331C>T	ClinGen:CA002963	C3661900|C0027672|C2676676|C0677776	604370	140162|145|145	.	Glu	Lys	46160.0	single nucleotide variant	NM_007294.4(BRCA1):c.4675G>A (p.Glu1559Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80356988.0	-	RCV000031185|RCV000131823|RCV000496604|RCV000482921	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43074331.0	43074331.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002963	2.0	37604.0	43074331.0	C	T	-	-	-	-	-	-	SCV001161548	-	-	4675G>A 	Glu1559Lys	NM_007294.4	3.0	1_Pathogenic	29.18	0.8092783505154639	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	29.18	0.80927837	10-90	<=50																																																																																																																																		true	BRCA1Glu455Lys																																																																																																																																																																																																																																		
FH	FH_Asn340Lys	10.63377390618422	0.00004075682484155514	-10.83270980690384	0.0000125974853100848	2025_01_Batch_13-14	true	false	true	false	false	false	false	false	false	false	0.9732167620651213	0.790202418655738	0.9632640191032386	0.9166164475515988	0.7936091313455258	0.7936091313455258	0.9166164475515988	0.9632640191032386	0.790202418655738	0.9732167620651213						FH	10.63377390618422	0.00004075682484155514	-10.83270980690384	0.0000125974853100848	2025_01_Batch_13-14	true	false	true	false	false	false	false	false	false	false	0.9732167620651213	0.790202418655738	0.9632640191032386	0.9166164475515988	0.7936091313455258	0.7936091313455258	0.9166164475515988	0.9632640191032386	0.790202418655738	0.9732167620651213						FH	ENSG00000091483	3408	214598.0	CCSBVarC004054	ALE00004054	NC_000001.11:241504130:A:T	1020T>A	Asn340Lys	CEGS2	CegsMutGDEh1041	D11	GDEhDisVCh_40065	A09	1.0	CegsMutGDDh1041	D11							1.0	1.0	1.0	6.0	0.0			0.0			0.0			1.0	241504130.0	A	T	1	Y	N	N	N	N	1-241504130-A-T	98356.0	single nucleotide variant	NM_000143.4(FH):c.1020T>A (p.Asn340Lys)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Jan 11, 2025	398123159.0	-	RCV000078140|RCV000220396|RCV000445596|RCV003460741|RCV004555535|RCV005007992	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24||MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|FH-related disorder|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241504130.0	241504130.0	1q43	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA285319	2.0	92447.0	241504130.0	A	T	-	-	-	-	-	-	SCV000109978|SCV000251426|SCV000275280|SCV000283659|SCV000537251|SCV004037791|SCV004117278|SCV004186922|SCV004197347|SCV004218857|SCV005642265	-	-	1020T>A 	Asn340Lys	NM_000143.4	2.0	1_Pathogenic	6.84079e-6	92447.0	1	241504130.0	A	T	N	K	rs398123159	1	241667430.0	1	239734053.0	340.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1020T>A	p.Asn340Lys	c.1020T>A	p.Asn340Lys	principal1	Y	1	YES	Select	-	AAT	3.0	2.0	A	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.43	0.98728	H	-5.97	0.89297	D	0.997	0.99974	1.0745	0.98713	D	0.9852	0.99552	D	10.0	0.98295367	0.98388	D	0.933702	0.99521	D	0.885	0.96643	0.826	0.93687	P07954	N340K	Gain of MoRF binding (P = 0.0281)| Loss of stability (P = 0.0682)| Gain of ubiquitination at N340 (P = 0.0797)| Loss of catalytic residue at D341 (P = 0.1005)| Gain of loop (P = 0.1069)	0.976600358983	0.97612	0.992874591347995	0.99282	1.05267121501	0.76067	0.819319963455	0.84898	D	0.976563	0.99778	D	0.195964	0.73318	D	0.107358	0.7723	D	0.996594965457916	0.89586	D	0.989601	0.96580	D	0.9459451	0.95788	0.9137381	0.95897	0.9459451	0.95788	0.9137381	0.95898	-10.892	0.79130	D	0.994	0.95051	P	0.99958943095219	0.97080	0.90775520	0.91492	0.975	0.99076	.	.	.	.	.	.	3.413967	0.47456	22.4	0.9984274411175003	0.92321	0.475086	0.51740	N	0.628093012181	0.74823	6.222027	0.508360094466945	0.68379	5.235775	5.73	3.43	0.38299	-0.0628	0.21136	0.55	0.23134	-0.065000	0.12424	0.751	0.87726	0.996	0.3946	0.009000	0.19951	0.994	0.71086	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	segdup	1	109394	9.141270e-06	0	3	208100	1.441610e-05	0	3	236778	1.267010e-05	0	0	7164	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	2	89552	2.233340e-05	0	0	30606	0.000000e+00	0	2	89552	2.233340e-05	0	0	14902	0.000000e+00	0	0	34236	0.000000e+00	0	0	9566	0.000000e+00	0	0	17688	0.000000e+00	0	0	21632	0.000000e+00	0	2	102612	1.949090e-05	0	0	30524	0.000000e+00	0	2	102612	1.949090e-05	0	.	10	1614142	6.195240e-06	0	10	1179978	8.474730e-06	0	0	75056	0.000000e+00	0	0	910	0.000000e+00	0	0	60018	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	64034	0.000000e+00	0	0	6062	0.000000e+00	0	10	1179978	8.474730e-06	0	0	91078	0.000000e+00	0	1	15752	6.348400203148806E-5	0	122	0	0	112	0	0	3370	0	0	146	0	0	610	0	0	56	0	0	98	0	1	2772	3.6075036075036075E-4	0	3492	0	0	168	0	2	23038	8.681309141418526E-5	Pathogenic/Likely_pathogenic	FH-related_disorder|Fumarase_deficiency|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241504130A>T	ClinGen:CA285319	C0342770|C3661900|C1708350|C0027672	606812|150800	24|523|140162	Fumarate lyase, N-terminal	Asn	Lys	98356.0	single nucleotide variant	NM_000143.4(FH):c.1020T>A (p.Asn340Lys)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Jan 11, 2025	398123159.0	-	RCV000078140|RCV000220396|RCV000445596|RCV003460741|RCV004555535|RCV005007992	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24||MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|FH-related disorder|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241504130.0	241504130.0	1q43	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA285319	2.0	92447.0	241504130.0	A	T	-	-	-	-	-	-	SCV000109978|SCV000251426|SCV000275280|SCV000283659|SCV000537251|SCV004037791|SCV004117278|SCV004186922|SCV004197347|SCV004218857|SCV005642265	-	-	1020T>A 	Asn340Lys	NM_000143.4	2.0	1_Pathogenic	98.84	0.3949044585987261	['150800', '606812', '606812', '150800']	multiple	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; FUMARASE DEFICIENCY; FUMARASE DEFICIENCY; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	98.84	0.39490446	10-90	>90						N	62			98.84	Polar/Neutral	Asparagine		Fumarate hydratase, mitochondrial								0.0745		-3.5								N340-F344, N340-M336; PAE: 1.0, 1.0	6 interactions	N340-F344, N340-M336; PAE: 1.0, 1.0	6 interactions							132									-71.2		Pocket 2: Mean pLDDT: 99.39, Volume: 605.37 Å³, Druggability score: 0.07		-39.8						H (helix)	H (α-helix)	Helix																																																																			true	FHAsn340Lys																																																																																																																																																																																																																																		
CTCF	CTCF_Pro643Ser	-1.7124595339057247	0.13054179486316442	1.7682708607040432	0.1203399615971314	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5663857117125153	0.5710500138956038	0.6222099455884309	0.6820439070156232	0.6064710200374568	0.5445619721105004	0.6598887700312495	0.6456517057217984	0.47991567103928157	0.600793935814599	0.6683800679644131	0.7041990439999969	0.5987681854550634	0.6621843567519261	0.5319774876104315	CTCF	-1.7124595339057247	0.13054179486316442	1.7682708607040432	0.1203399615971314	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5663857117125153	0.5710500138956038	0.6222099455884309	0.6820439070156232	0.6064710200374568	0.5445619721105004	0.6598887700312495	0.6456517057217984	0.47991567103928157	0.600793935814599	0.6683800679644131	0.7041990439999969	0.5987681854550634	0.6621843567519261	0.5319774876104315	CTCF		6173		CCSBVarC010816		NC_000016.10:67636779:C:T	1927C>T	Pro643Ser																												16.0	67636779.0	C	T	16						16-67636779-C-T	208297.0	single nucleotide variant	NM_006565.4(CTCF):c.1927C>T (p.Pro643Ser)	10664.0	CTCF	HGNC:13723	Benign/Likely benign	0.0	Nov 01, 2024	145727304.0	-	RCV000193895|RCV000427860|RCV000989613|RCV002314799|RCV004530110	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MeSH:D030342,MedGen:C0950123|	not specified|not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|Inborn genetic diseases|CTCF-related disorder	germline;unknown	germline	GRCh38	NC_000016.10	16	67636779.0	67636779.0	16q22.1	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA207677	2.0	210800.0	67636779.0	C	T	-	-	-	-	-	-	SCV000247133|SCV000511014|SCV000706245|SCV000847384|SCV001096543|SCV001140120|SCV001855650|SCV002497922|SCV005218571	-	-	1927C>T 	Pro643Ser	NM_006565.4	2.0	2_Benign		210800.0	16	67636779.0	C	T	P	S	rs145727304	16	67670682.0	16	66228183.0	643.0	CTCF	ENSG00000102974	ENST00000646076	ENSP00000494538	P49711	CTCF_HUMAN	c.1927C>T	p.Pro643Ser	c.1927C>T	p.Pro643Ser	principal4	Y	.	.	.	+	CCA	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.36067	.	.	0.43323	.	0.993	0.65587	D	0.968	0.71743	D	.	0.81345	.	.	.	.	1.75	0.45271	L	.	0.13539	.	.	0.50538	-1.1289	0.01844	T	0.0334	0.14266	T	10.0	0.008668512	0.00193	T	0.022134	0.44775	T	.	0.47884	.	.	.	.	.	.	0.36087	0.4567110836694177	0.45390	.	0.88493	0.604438900948	0.53464	T	0.358122	0.72301	T	-0.428226	0.01423	T	-0.387077	0.34534	T	0.0343362705906861	0.02675	T	.	0.58028	.	0.048771452	0.08473	0.12885952	0.30913	0.057762917	0.11430	0.12383783	0.29781	-5.595	0.42817	T	.	0.19907	.	0.950983739944161	0.80561	0.51967055	0.82312	0.169	0.41634	.	.	.	.	.	.	4.725224	0.76095	26.4	0.9990928839770757	0.9795	0.770006	0.70400	D	0.635361922304199	0.75292	6.303452	0.69695071304512	0.82049	7.695614	6.03	6.03	0.97795	.	.	6.114	0.71317	7.668000	0.64675	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.99	0.65338	50	0.97656	1	1.9968051118210862E-4	0	0.0	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	780	264690	0.0029468434	.	221	106748	2.070300e-03	2	481	202560	2.374610e-03	1	511	231178	2.210420e-03	2	4	7038	5.683430e-04	0	9	16122	5.582430e-04	0	0	2306	0.000000e+00	0	0	8772	0.000000e+00	0	0	13394	0.000000e+00	0	205	42284	4.848170e-03	2	0	15048	0.000000e+00	0	205	42284	4.848170e-03	2	14	15880	8.816120e-04	0	21	28602	7.342140e-04	0	0	6170	0.000000e+00	0	0	12828	0.000000e+00	0	3	16706	1.795760e-04	0	434	88384	4.910390e-03	1	0	29358	0.000000e+00	0	434	88384	4.910390e-03	1	11	14564	7.552870e-04	0	21	32292	6.503160e-04	0	0	9506	0.000000e+00	0	0	17100	0.000000e+00	0	7	21596	3.241340e-04	0	457	101466	4.503970e-03	2	0	29276	0.000000e+00	0	457	101466	4.503970e-03	2	.	7521	1605712	4.683900e-03	22	7107	1176036	6.043180e-03	20	71	74680	9.507230e-04	0	0	912	0.000000e+00	0	54	58944	9.161240e-04	0	2	29508	6.777820e-05	0	0	44268	0.000000e+00	0	26	63952	4.065550e-04	0	0	6046	0.000000e+00	0	7107	1176036	6.043180e-03	20	4	89172	4.485710e-05	0	992	194484	0.005100676662347545	0	360	0	0	4546	0	11	9432	0.001166242578456319	0	796	0	2	968	0.002066115702479339	0	1848	0	0	280	0	70	17414	0.004019754220741932	11	9792	0.0011233660130718953	0	6394	0	1075	230128	0.004671313356045331	Benign/Likely_benign	not_specified|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder|not_provided|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67636779C>T	ClinGen:CA207677	CN169374|C3809686|C3661900|C0950123	615502	363611	.	Pro	Ser	208297.0	single nucleotide variant	NM_006565.4(CTCF):c.1927C>T (p.Pro643Ser)	10664.0	CTCF	HGNC:13723	Benign/Likely benign	0.0	Nov 01, 2024	145727304.0	-	RCV000193895|RCV000427860|RCV000989613|RCV002314799|RCV004530110	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MeSH:D030342,MedGen:C0950123|	not specified|not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|Inborn genetic diseases|CTCF-related disorder	germline;unknown	germline	GRCh38	NC_000016.10	16	67636779.0	67636779.0	16q22.1	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA207677	2.0	210800.0	67636779.0	C	T	-	-	-	-	-	-	SCV000247133|SCV000511014|SCV000706245|SCV000847384|SCV001096543|SCV001140120|SCV001855650|SCV002497922|SCV005218571	-	-	1927C>T 	Pro643Ser	NM_006565.4	2.0	2_Benign	58.81	0.9191176470588236	['615502']	unknown		0	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	58.81	0.9191176	$\geqslant$90	50-70						P	125			58.81	Special, No backbone hydrogen	Proline		Transcriptional repressor CTCF		Pro residues								1.6																		115									-76.0				129.5	Disordered					H (helix)	P (polyproline helix)																																																																				true	CTCFPro643Ser																																																																																																																																																																																																																																		
SDHD	SDHD_Phe34Cys	7.204566186715207	0.00017742529934530618	-1.9188547732241474	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8716618637517459	0.8104173738011209	0.8974089917406092	0.8823092927833753	0.8735094714700957	0.8930240841096873	0.9110751086339479	0.9395293461461559	0.8243090951965234	0.8882816334753623	0.8539948588305042	0.8535434769328026	0.8552886373350626	0.7965256524057183	0.8550420940281295	SDHD	7.204566186715207	0.00017742529934530618	-1.9188547732241474	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8716618637517459	0.8104173738011209	0.8974089917406092	0.8823092927833753	0.8735094714700957	0.8930240841096873	0.9110751086339479	0.9395293461461559	0.8243090951965234	0.8882816334753623	0.8539948588305042	0.8535434769328026	0.8552886373350626	0.7965256524057183	0.8550420940281295	SDHD		6363		CCSBVarC023269		NC_000011.10:112087905:T:G	101T>G	Phe34Cys																												11.0	112087905.0	T	G	11						11-112087905-T-G	138935.0	single nucleotide variant	NM_003002.4(SDHD):c.101T>G (p.Phe34Cys)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Jan 23, 2025	141802836.0	-	RCV000122008|RCV000569765|RCV001545828|RCV003230259|RCV002228410|RCV003997358|RCV004748588	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|	not specified|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|SDHD-related disorder	germline	germline	GRCh38	NC_000011.10	11	112087905.0	112087905.0	11q23.1	criteria provided, conflicting classifications	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016754	2.0	135196.0	112087905.0	T	G	-	-	-	-	-	-	SCV000287810|SCV000675108|SCV001765234|SCV003928129|SCV004845023	-	-	101T>G 	Phe34Cys	NM_003002.4	1.0	3_Conflicting		135196.0	11	112087905.0	T	G	F	C	rs141802836	11	111958629.0	11	111463839.0	34.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.101T>G	p.Phe34Cys	c.101T>G	p.Phe34Cys	principal1	Y	1	YES	Select	+	TTT	2.0	0.0	T	./.	./.	./.	./.	0.081	0.78662	T	0.157	0.92967	T	0.953	0.54293	P	0.43	0.45391	B	0.13	0.52324	N	simple_aae	87.0	13.0	2.3	0.65510	M	-0.55	0.96333	N	0.622	0.70120	0.2199	0.86189	D	0.6593	0.88119	D	10.0	0.53285825	0.62974	D	0.151246	0.83237	D	0.691	0.88724	.	.	.	.	.	0.931227753352	0.92998	0.5560470912091142	0.55343	0.662533756427	0.58709	0.521012783051	0.41709	T	0.32663	0.69546	T	0.127906	0.6692	D	0.251929	0.85611	D	0.116020513204259	0.13859	T	0.860814	0.58949	D	0.08004188	0.18151	0.07223325	0.15552	0.08004188	0.18151	0.07223325	0.15552	-3.982	0.23555	T	0.1996	0.63627	B	0.144711279699783	0.46760	0.99037120	0.96789	0.241	0.51065	.	.	.	.	.	.	3.395206	0.47109	22.4	0.9926121085672017	0.57287	0.736750	0.68100	D	0.209532460011217	0.51422	3.345592	0.250926334821979	0.52455	3.443302	4.81	3.66	0.41042	.	.	2.022	0.40755	5.897000	0.50911	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.939	0.47934	635	0.64545	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	32	264690	1.2089614E-4	segdup	5	109398	4.570470e-05	0	8	208124	3.843860e-05	0	8	236946	3.376300e-05	0	3	7164	4.187600e-04	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	3	7164	4.187600e-04	0	6	16218	3.699590e-04	0	2	30524	6.552220e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16724	0.000000e+00	0	0	89558	0.000000e+00	0	0	30608	0.000000e+00	0	6	16218	3.699590e-04	0	6	14902	4.026310e-04	0	2	34260	5.837710e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21622	0.000000e+00	0	0	102754	0.000000e+00	0	0	30526	0.000000e+00	0	6	14902	4.026310e-04	0	.	44	1614066	2.726030e-05	0	38	75038	5.064100e-04	0	38	75038	5.064100e-04	0	0	912	0.000000e+00	0	3	60030	4.997500e-05	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64038	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179892	0.000000e+00	0	0	91088	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	2	2784	7.183908045977011E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	2	2898	6.901311249137336E-4	0	112	0	2	14050	1.4234875444839857E-4	Conflicting_classifications_of_pathogenicity	not_specified|Paragangliomas_1|not_provided|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|Hereditary_pheochromocytoma-paraganglioma|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112087905T>G	ClinGen:CA016754	CN169374|C3494181|C3661900|C0031511|C1847319|C1868633|CN166604|C1708353|C0027672	168000|171300|606864	29072|29072|97286|201|29072|140162	.	Phe	Cys	138935.0	single nucleotide variant	NM_003002.4(SDHD):c.101T>G (p.Phe34Cys)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Jan 23, 2025	141802836.0	-	RCV000122008|RCV000569765|RCV001545828|RCV003230259|RCV002228410|RCV003997358|RCV004748588	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|	not specified|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|SDHD-related disorder	germline	germline	GRCh38	NC_000011.10	11	112087905.0	112087905.0	11q23.1	criteria provided, conflicting classifications	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016754	2.0	135196.0	112087905.0	T	G	-	-	-	-	-	-	SCV000287810|SCV000675108|SCV001765234|SCV003928129|SCV004845023	-	-	101T>G 	Phe34Cys	NM_003002.4	1.0	3_Conflicting	48.34	0.9289340101522844	['168000', '606864', '171300']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	48.34	0.92893404	$\geqslant$90	<=50						F	183			48.34	Aromatic	Phenylalanine												2.8																		165									-75.8				68.0						C (loop/coil)	C (loop/coil)								Mitochondrion																																																												true	SDHDPhe34Cys																																																																																																																																																																																																																																		
BRCA1	BRCA1_Val632Ala	2.1490587662768768	0.06870905490576534	3.8182324743496685	0.006557305473716383	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8990786387709804	0.866001395945438	0.9400525489322233	0.9010284770890846	0.9306709618821616	0.8813107186301907	0.8772968783547237	0.905743118181431	0.7797971771542498	0.8683821066344395	0.9800312051341326	0.9247600758234454	0.9743619796830157	0.9522056147366262	0.9297751709075213	BRCA1	2.1490587662768768	0.06870905490576534	3.8182324743496685	0.006557305473716383	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8990786387709804	0.866001395945438	0.9400525489322233	0.9010284770890846	0.9306709618821616	0.8813107186301907	0.8772968783547237	0.905743118181431	0.7797971771542498	0.8683821066344395	0.9800312051341326	0.9247600758234454	0.9743619796830157	0.9522056147366262	0.9297751709075213	BRCA1		14613		CCSBVarC011853		NC_000017.11:43057122:A:G	1895T>C	Val632Ala																												17.0	43057122.0	A	G	17						17-43057122-A-G	46204.0	single nucleotide variant	NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 25, 2019	45553935.0	-	RCV000195366|RCV000031229|RCV000048857|RCV000131291|RCV000585878	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43057122.0	43057122.0	17q21.31	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038	3.0	37648.0	43057122.0	A	G	-	-	-	-	-	-	SCV001161713	-	-	5207T>C 	Val1736Ala	NM_007294.4	3.0	1_Pathogenic		37648.0	17	43057122.0	A	G	V	A	rs45553935	17	41209139.0	17	38462665.0	1736.0	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5207T>C	p.Val1736Ala	principal2	Y	.	.	.	-	GTC	2.0	0.0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	0.802	0.90580	P	0.38	0.92348	B	.	0.99291	.	.	.	.	3.265	0.89891	M	.	0.66695	.	.	0.89680	0.8523	0.95041	D	0.8418	0.94704	D	10.0	.	0.91075	.	0.753957	0.98037	D	.	0.94487	.	.	.	.	.	.	0.89179	.	0.79043	.	0.13518	0.580183625221	0.50045	T	0.137814	0.46804	T	0.456703	0.9272	D	0.418246	0.9263	D	0.982382714748383	0.74278	D	.	0.83839	.	0.64500636	0.74826	0.18117532	0.40826	0.56882757	0.70704	0.19759434	0.43395	-8.463	0.64259	D	.	0.87654	.	0.989452318288449	0.88181	0.99978083	0.99714	0.81	0.89500	.	.	.	.	.	.	4.681403	0.74972	26.2	0.9988011486748988	0.95656	0.684452	0.64551	D	0.735250864207851	0.81845	7.641852	0.688539164513861	0.81406	7.543151	5.07	5.07	0.68064	.	.	5.554	0.67074	10.840000	0.83929	0.748	0.86774	1.0	0.71675	1.0	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	1613984	8.054600e-06	0	12	1179920	1.017020e-05	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29600	0.000000e+00	0	0	44870	0.000000e+00	0	0	64010	0.000000e+00	0	0	6056	0.000000e+00	0	12	1179920	1.017020e-05	0	0	91084	0.000000e+00	0	1	24506	4.080633314290378E-5	0	84	0	0	84	0	0	2656	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4632	0	0	2740	0	0	108	0	1	33208	3.0113225728740063E-5	Pathogenic	not_provided|Fanconi_anemia,_complementation_group_S|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43057122A>G	ClinGen:CA003357|OMIM:113705.0038|UniProtKB:P38398#VAR_070506	C3661900|C4554406|C0027672|C2676676|C0677776	617883|604370	140162|145|145	BRCT domain	Val	Ala	46204.0	single nucleotide variant	NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 25, 2019	45553935.0	-	RCV000195366|RCV000031229|RCV000048857|RCV000131291|RCV000585878	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43057122.0	43057122.0	17q21.31	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038	3.0	37648.0	43057122.0	A	G	-	-	-	-	-	-	SCV001161713	-	-	5207T>C 	Val1736Ala	NM_007294.4	3.0	1_Pathogenic	97.64	0.0	['604370', '617883']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S	97.64	0.0	<10	>90																																																																																																																																		true	BRCA1Val632Ala																																																																																																																																																																																																																																		
RAD51D	RAD51D_Asn138His	1.6166526065546751	0.14998682499991292	10.652301864900743	0.000014084472813108453	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9759745305361325	0.8058202887767171	0.944996742454274	0.9219285698910344	0.8486980791422416	0.7661350354466943	0.8948077182600973	0.9276685729320928	0.7468842806042563	0.9743968861454785	0.9312611228377888	0.9490494215219716	0.9623249119764552	0.8647562969491779	0.9775521749267864	RAD51D	1.6166526065546751	0.14998682499991292	10.652301864900743	0.000014084472813108453	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9759745305361325	0.8058202887767171	0.944996742454274	0.9219285698910344	0.8486980791422416	0.7661350354466943	0.8948077182600973	0.9276685729320928	0.7468842806042563	0.9743968861454785	0.9312611228377888	0.9490494215219716	0.9623249119764552	0.8647562969491779	0.9775521749267864	RAD51D		7201		CCSBVarC024825		NC_000017.11:35107056:T:G	412A>C	Asn138His																												17.0	35107056.0	T	G	17						17-35107056-T-G	133345.0	single nucleotide variant	NM_002878.4(RAD51D):c.412A>C (p.Asn138His)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	141690729.0	-	RCV000572128|RCV003321505|RCV000649680|RCV000760062	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35107056.0	35107056.0	17q12	criteria provided, conflicting classifications	11.0	-	N	ClinGen:CA287974	2.0	127888.0	35107056.0	T	G	-	-	-	-	-	-	SCV000149723|SCV000674693|SCV000686451|SCV000771512|SCV000822178|SCV000889821|SCV001472084|SCV002563404|SCV002579319|SCV004026736|SCV004208088	-	-	412A>C 	Asn138His	NM_002878.4	1.0	3_Conflicting		127888.0	17	35107056.0	T	G	N	H	rs141690729	17	33434075.0	17	30458188.0	138.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.412A>C	p.Asn138His	c.412A>C	p.Asn138His	principal1	Y	5	.	.	-	AAT	1.0	0.0	T	T/T	T/T	T/T	T/T	.	0.28402	.	0.1	0.56982	T	0.395	0.34741	B	0.591	0.50477	P	0.06	0.18971	N	simple_aae	94.0	6.0	2.35	0.67323	M	.	0.48032	.	0.307	0.34427	-0.433	0.70838	T	0.3126	0.68139	T	10.0	0.45225775	0.58437	D	0.154917	0.83550	D	0.281	0.59659	0.625	0.75933	O75771	N138H	Gain of sheet (P = 0.1945)| Gain of disorder (P = 0.2095)| Loss of stability (P = 0.211)| Loss of helix (P = 0.2662)| Loss of solvent accessibility (P = 0.2953)	0.920393908519	0.91898	.	0.26696	.	0.40252	.	.	.	0.188245	0.53985	T	-0.0652968	0.41729	T	-0.127971	0.60868	T	0.542844533920288	0.33898	D	0.843016	0.51848	T	0.14909644	0.33722	0.17573822	0.39925	0.14909644	0.33722	0.17573822	0.39925	-6.785	0.53382	T	0.1649	0.36807	B	0.00403443879358769	0.17381	0.62988700	0.84616	0.079	0.22306	.	.	.	.	.	.	4.260774	0.64815	24.7	0.5141254677218604	0.04613	0.615052	0.60072	D	0.261244387338902	0.53967	3.585971	0.218849069588625	0.50637	3.276757	4.65	3.52	0.39345	2.95	0.53955	4.397	0.59537	6.109000	0.53713	0.609	0.47831	1.0	0.71675	1.0	0.68239	0.885	0.42478	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	2	109408	1.828020e-05	0	1	208132	4.804640e-06	0	11	236936	4.642600e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89554	1.116640e-05	0	0	30608	0.000000e+00	0	1	89554	1.116640e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	11	102732	1.070750e-04	0	0	30526	0.000000e+00	0	11	102732	1.070750e-04	0	.	22	1613968	1.363100e-05	0	21	1180018	1.779630e-05	0	0	74892	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	64026	0.000000e+00	0	0	6084	0.000000e+00	0	21	1180018	1.779630e-05	0	0	91090	0.000000e+00	0	1	32854	3.0437694040299505E-5	0	114	0	0	86	0	0	2852	0	0	500	0	0	628	0	0	26	0	0	98	0	0	5026	0	0	2966	0	0	112	0	1	42184	2.370567039635881E-5	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35107056T>G	ClinGen:CA287974	C0027672|CN169374|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Asn	His	133345.0	single nucleotide variant	NM_002878.4(RAD51D):c.412A>C (p.Asn138His)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	141690729.0	-	RCV000572128|RCV003321505|RCV000649680|RCV000760062	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35107056.0	35107056.0	17q12	criteria provided, conflicting classifications	11.0	-	N	ClinGen:CA287974	2.0	127888.0	35107056.0	T	G	-	-	-	-	-	-	SCV000149723|SCV000674693|SCV000686451|SCV000771512|SCV000822178|SCV000889821|SCV001472084|SCV002563404|SCV002579319|SCV004026736|SCV004208088	-	-	412A>C 	Asn138His	NM_002878.4	1.0	3_Conflicting	90.24	0.5414012738853503	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	90.24	0.54140127	10-90	>90						N	85			90.24	Polar/Neutral	Asparagine		DNA repair protein RAD51 homolog 4										-3.5			2 interactions	5 interactions				N138-S207; PAE: 3.5	2 interactions	N138-S207; PAE: 3.5	5 interactions							132									-114.7				-8.1						C (loop/coil)	S (bend)	Beta strand																																																																			true	RAD51DAsn138His																																																																																																																																																																																																																																		
SDHD	SDHD_Glu69Lys	7.232879738605847	0.00017436415792478971	-4.0779855505012845	0.2861293525491404	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8625665401432564	0.8320534092255032	0.8829891162488104	0.8787784965888328	0.8803156269035975	0.8821027870189919	0.8894584643146449	0.8899949431301525	0.8409505617727295	0.8695156845974097	0.8785284667882032	0.8680985288630207	0.8759832893674684	0.8231562566782767	0.8556173956891031	SDHD	7.232879738605847	0.00017436415792478971	-4.0779855505012845	0.2861293525491404	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8625665401432564	0.8320534092255032	0.8829891162488104	0.8787784965888328	0.8803156269035975	0.8821027870189919	0.8894584643146449	0.8899949431301525	0.8409505617727295	0.8695156845974097	0.8785284667882032	0.8680985288630207	0.8759832893674684	0.8231562566782767	0.8556173956891031	SDHD		6363		CCSBVarC023285		NC_000011.10:112088902:G:A	205G>A	Glu69Lys																												11.0	112088902.0	G	A	11						11-112088902-G-A	165952.0	single nucleotide variant	NM_003002.4(SDHD):c.205G>A (p.Glu69Lys)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Jan 15, 2025	202198133.0	-	RCV000144171|RCV000484125|RCV001290090|RCV002515941|RCV002415627|RCV004748597	MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MedGen:C3661900|MONDO:MONDO:0100294,MedGen:C5700310,OMIM:252011,Orphanet:3208|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	Mitochondrial complex 2 deficiency, nuclear type 3|not provided|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Hereditary cancer-predisposing syndrome|SDHD-related disorder	germline;inherited	germline	GRCh38	NC_000011.10	11	112088902.0	112088902.0	11q23.1	criteria provided, conflicting classifications	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016681,UniProtKB:O14521#VAR_074105,OMIM:602690.0029	3.0	156153.0	112088902.0	G	A	-	-	-	-	-	-	SCV000568557|SCV000825280|SCV002725594	-	-	205G>A 	Glu69Lys	NM_003002.4	1.0	3_Conflicting		156153.0	11	112088902.0	G	A	E	K	rs202198133	11	111959626.0	11	111464836.0	69.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.205G>A	p.Glu69Lys	c.205G>A	p.Glu69Lys	principal1	Y	1	YES	Select	+	GAG	1.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.004	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.83	0.95555	H	-4.0	0.74082	D	0.996	0.99956	1.0385	0.97876	D	0.9843	0.99522	D	10.0	0.9897574	0.99448	D	0.760838	0.98097	D	0.991	0.99981	0.955	0.99499	O14521	E69K	Gain of MoRF binding (P = 0.0031)| Gain of methylation at E69 (P = 0.0104)| Gain of ubiquitination at E69 (P = 0.0539)| Gain of relative solvent accessibility (P = 0.0999)| Gain of solvent accessibility (P = 0.1045)	0.972172681102	0.97161	0.9609739073875347	0.96060	0.784672596276	0.65221	0.732807695866	0.71868	T	0.979582	0.99826	D	0.572592	0.96621	D	0.600199	0.96985	D	0.999643564224243	0.98285	D	0.974503	0.92926	D	0.98499125	0.99456	0.95455986	0.98647	0.98053944	0.99136	0.9438836	0.97990	-11.599	0.91228	D	0.8013	0.78519	P	0.996962020332363	0.92637	0.99919051	0.99205	0.997	0.99892	.	.	.	.	.	.	5.407385	0.9054	31.0	0.9993559176303065	0.99579	0.950494	0.96405	D	0.966518903071094	0.94586	12.90049	0.888994358309617	0.95048	13.28898	5.04	5.04	0.6725	.	.	9.348	0.96472	11.792000	0.96405	0.618	0.50684	1.0	0.71675	1.0	0.68239	0.997	0.79771	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	1	109406	9.140270e-06	0	2	208106	9.610490e-06	0	2	236722	8.448730e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13410	0.000000e+00	0	0	16734	0.000000e+00	0	2	89538	2.233690e-05	0	0	30608	0.000000e+00	0	2	89538	2.233690e-05	0	0	14900	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17686	0.000000e+00	0	0	21632	0.000000e+00	0	2	102538	1.950500e-05	0	0	30526	0.000000e+00	0	2	102538	1.950500e-05	0	.	4	1612768	2.480210e-06	0	4	1179938	3.390010e-06	0	0	74996	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29606	0.000000e+00	0	0	44872	0.000000e+00	0	0	64040	0.000000e+00	0	0	5002	0.000000e+00	0	4	1179938	3.390010e-06	0	0	91010	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|not_provided|Mitochondrial_complex_II_deficiency,_nuclear_type_1	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088902G>A	ClinGen:CA016681|OMIM:602690.0029|UniProtKB:O14521#VAR_074105	C0027672|C0031511|C1868633|C1847319|CN166604|C5436934|C3661900|C5700310	171300|606864|619167|252011	140162|29072|97286|201|3208	.	Glu	Lys	165952.0	single nucleotide variant	NM_003002.4(SDHD):c.205G>A (p.Glu69Lys)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Jan 15, 2025	202198133.0	-	RCV000144171|RCV000484125|RCV001290090|RCV002515941|RCV002415627|RCV004748597	MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MedGen:C3661900|MONDO:MONDO:0100294,MedGen:C5700310,OMIM:252011,Orphanet:3208|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	Mitochondrial complex 2 deficiency, nuclear type 3|not provided|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Hereditary cancer-predisposing syndrome|SDHD-related disorder	germline;inherited	germline	GRCh38	NC_000011.10	11	112088902.0	112088902.0	11q23.1	criteria provided, conflicting classifications	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016681,UniProtKB:O14521#VAR_074105,OMIM:602690.0029	3.0	156153.0	112088902.0	G	A	-	-	-	-	-	-	SCV000568557|SCV000825280|SCV002725594	-	-	205G>A 	Glu69Lys	NM_003002.4	1.0	3_Conflicting	98.58	0.0670103092783505	['619167', '252011', '171300', '606864']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3; MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1; PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	98.58	0.067010306	<10	>90						E	13			98.58	Negatively-charged	Glutamic Acid		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-3.5								E69-Q109, E69-H65, E69-S73; PAE: 1.0, 1.0, 1.0	2 interactions	E69-H65, E69-S73; PAE: 1.0, 1.0	3 interactions							146									-58.1		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-42.7						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDGlu69Lys																																																																																																																																																																																																																																		
BRCA1	BRCA1_His41Arg	-0.7905479031010616	0.45515193572773704	2.6259888042545514	0.03411090005792835	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8185758614683465	0.7601492308065976	0.8095085175879666	0.9294087597443343	0.8736152481968635	0.7635952103109366	0.9180190411090324	0.6385853229034477	0.5758214868863146	0.6955686537564537	0.9836352860827905	0.9407984783796364	0.9804317122724854	0.9444769747268804	0.9415830691802393	BRCA1	-0.7905479031010616	0.45515193572773704	2.6259888042545514	0.03411090005792835	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8185758614683465	0.7601492308065976	0.8095085175879666	0.9294087597443343	0.8736152481968635	0.7635952103109366	0.9180190411090324	0.6385853229034477	0.5758214868863146	0.6955686537564537	0.9836352860827905	0.9407984783796364	0.9804317122724854	0.9444769747268804	0.9415830691802393	BRCA1		14613		CCSBVarC011865		NC_000017.11:43115738:T:C	122A>G	His41Arg																												17.0	43115738.0	T	C	17						17-43115738-T-C	68833.0	single nucleotide variant	NM_007294.4(BRCA1):c.122A>G (p.His41Arg)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357276.0	-	RCV000047383|RCV000111820|RCV000484980|RCV000569789	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115738.0	43115738.0	17q21.31	reviewed by expert panel	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00130,ClinGen:CA000805	2.0	54166.0	43115738.0	T	C	-	-	-	-	-	-	SCV000244297	-	-	122A>G 	His41Arg	NM_007294.4	3.0	1_Pathogenic		54166.0	17	43115738.0	T	C	H	R	rs80357276	17	41267755.0	17	38521281.0	41.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.122A>G	p.His41Arg	principal2	Y	1	.	.	-	CAC	2.0	0.0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	0.959	0.90580	D	0.542	0.92348	P	.	0.99291	.	.	.	.	3.995	0.96666	H	.	0.95148	.	.	0.88119	0.9682	0.96663	D	0.9917	0.99792	D	10.0	.	0.99449	.	0.885446	0.99127	D	.	0.99491	0.966	0.99665	E9PFC7	H41R	Gain of MoRF binding (P = 0.0172)| Loss of catalytic residue at D40 (P = 0.0761)| Gain of disorder (P = 0.0885)| Gain of helix (P = 0.132)| Gain of phosphorylation at T37 (P = 0.2265)	.	0.99628	.	0.94303	.	0.46401	0.697537183762	0.66732	T	0.460215	0.93020	T	0.562828	0.96258	D	0.570687	0.96198	D	0.998141407966614	0.93292	D	0.955504	0.83052	D	0.9505324	0.96261	0.6308536	0.78232	0.9015565	0.91402	0.6761325	0.80766	-13.38	0.93979	D	.	0.95417	.	0.999422575166627	0.96550	0.99957854	0.99505	0.964	0.98523	.	.	.	.	.	.	4.490848	0.70206	25.5	0.9965055371952992	0.7728	0.750685	0.69060	D	0.939969350591933	0.93540	12.13134	0.850731219321243	0.93019	11.79838	5.97	5.97	0.96929	.	.	3.518	0.533	7.815000	0.69605	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.999	0.91597	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43115738T>C	BRCA1-HCI:BRCA1_00130|ClinGen:CA000805	C0677776|C0027672|C3661900|C2676676	604370	145|140162|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	His	Arg	68833.0	single nucleotide variant	NM_007294.4(BRCA1):c.122A>G (p.His41Arg)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357276.0	-	RCV000047383|RCV000111820|RCV000484980|RCV000569789	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115738.0	43115738.0	17q21.31	reviewed by expert panel	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00130,ClinGen:CA000805	2.0	54166.0	43115738.0	T	C	-	-	-	-	-	-	SCV000244297	-	-	122A>G 	His41Arg	NM_007294.4	3.0	1_Pathogenic	90.04	0.3369565217391304	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	90.04	0.33695653	10-90	>90																																																																																																																																		true	BRCA1His41Arg																																																																																																																																																																																																																																		
RET	RET_Val262Ala	-0.24949633256160386	0.8101398810197044	4.814403588905587	0.0019338869466561507	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8943625260042535	0.6760124434125196	0.8082057052149687	0.7572839306282749	0.7086812751029969	0.8362120849218996	0.7781827768721448	0.8840339082178769	0.7887272756339547	0.9195076526268073	0.5811504652840943	0.7363850843844051	0.7323775022120607	0.5632976111910845	0.8692173993816996	RET	-0.24949633256160386	0.8101398810197044	4.814403588905587	0.0019338869466561507	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8943625260042535	0.6760124434125196	0.8082057052149687	0.7572839306282749	0.7086812751029969	0.8362120849218996	0.7781827768721448	0.8840339082178769	0.7887272756339547	0.9195076526268073	0.5811504652840943	0.7363850843844051	0.7323775022120607	0.5632976111910845	0.8692173993816996	RET	ENSG00000165731	8858	202951.0	CCSBVarC006876	ALE00006874	NC_000010.11:43105111:T:C	785T>C	Val262Ala	CEGS2	CegsMutGDEh1029	C02	GDEhDisVCh_40066	C06	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43105111.0	T	C	10	Y	N	N	N	N	10-43105111-T-C	50284.0	single nucleotide variant	NM_020975.6(RET):c.785T>C (p.Val262Ala)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Feb 04, 2025	139790943.0	-	RCV000034777|RCV000148775|RCV000223157|RCV000123327|RCV000663296|RCV001103896|RCV001103897|RCV001103898|RCV000573525|RCV001269367|RCV001104177|RCV004528165	MedGen:C3661900|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MedGen:CN169374|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|	not provided|Aganglionic megacolon|not specified|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Multiple endocrine neoplasia|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43105111.0	43105111.0	10q11.21	criteria provided, conflicting classifications	17.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009350	2.0	41845.0	43105111.0	T	C	-	-	-	-	-	-	SCV000166634|SCV000279597|SCV000540171|SCV000664464|SCV000786544|SCV000822200|SCV000838371|SCV000891636|SCV001260709|SCV001260710|SCV001260711|SCV001261020|SCV002062909|SCV002068400|SCV002527924	-	-	785T>C 	Val262Ala	NM_020975.6	1.0	3_Conflicting	0.000210916	41845.0	10	43105111.0	T	C	V	A	rs139790943	10	43600559.0	10	42920565.0	262.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.785T>C	p.Val262Ala	c.785T>C	p.Val262Ala	principal4	Y	5	YES	Select	+	GTG	2.0	0.0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.011	0.65108	D	0.676	0.41333	P	0.568	0.49805	P	0.6	0.76851	D	simple_aae	40.0	60.0	2.325	0.66439	M	-2.44	0.53442	N	0.4	0.94561	0.2692	0.87004	D	0.6452	0.87575	D	10.0	0.23900184	0.40642	T	0.269317	0.89793	D	0.748	0.91294	.	.	.	.	.	0.986075961623	0.98577	0.9449520661963712	0.94443	1.39902537186	0.85084	0.654298603535	0.60534	T	0.747582	0.92993	D	0.147568	0.68816	D	0.296161	0.87936	D	0.110290273663753	0.13282	T	0.812119	0.46196	T	0.6398909	0.74551	0.46798772	0.68880	0.7156541	0.78674	0.51304674	0.71604	-11.708	0.84188	D	0.7004	0.80456	P	0.998087980433202	0.93939	0.99988472	0.99849	0.487	0.70601	.	.	.	.	.	.	5.265842	0.88433	29.6	0.9908014614277819	0.52036	0.704574	0.65902	D	0.206366859142037	0.51267	3.331407	0.220349645155146	0.50723	3.284379	4.79	3.64	0.40795	3.23	0.58548	5.516	0.66847	7.817000	0.69666	0.663	0.56753	1.0	0.71675	1.0	0.68239	0.946	0.49004	862	0.33096	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	67	264690	2.531263E-4	.	21	108014	1.944190e-04	0	57	203892	2.795600e-04	0	56	233278	2.400570e-04	0	0	6988	0.000000e+00	0	1	17006	5.880280e-05	0	0	2296	0.000000e+00	0	0	8944	0.000000e+00	0	2	12800	1.562500e-04	0	10	42450	2.355710e-04	0	7	15644	4.474560e-04	0	7	15644	4.474560e-04	0	1	15892	6.292470e-05	0	2	30354	6.588920e-05	0	1	6138	1.629200e-04	0	0	13250	0.000000e+00	0	2	16134	1.239620e-04	0	33	86794	3.802110e-04	0	13	30536	4.257270e-04	0	13	30536	4.257270e-04	0	1	14656	6.823140e-05	0	3	34114	8.794040e-05	0	1	9526	1.049760e-04	0	0	17590	0.000000e+00	0	2	20676	9.673050e-05	0	32	100690	3.178070e-04	0	13	30462	4.267610e-04	0	13	30462	4.267610e-04	0	.	347	1612474	2.151970e-04	2	38	6044	6.287230e-03	2	7	74994	9.334080e-05	0	1	912	1.096490e-03	0	11	59988	1.833700e-04	0	2	29562	6.765440e-05	0	0	44818	0.000000e+00	0	3	62808	4.776460e-05	0	38	6044	6.287230e-03	2	229	1179820	1.940970e-04	0	34	91062	3.733720e-04	0	19	38968	4.87579552453295E-4	0	122	0	0	112	0	1	3452	2.8968713789107763E-4	0	498	0	0	628	0	0	56	0	0	98	0	6	7306	8.212428141253764E-4	1	3574	2.797985450475658E-4	0	168	0	26	51240	5.07416081186573E-4	Conflicting_classifications_of_pathogenicity	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon|RET-related_disorder|not_provided|not_specified|Pheochromocytoma	criteria_provided,_conflicting_classifications	NC_000010.11:g.43105111T>C	ClinGen:CA009350	C1619700|C0027662|C4048306|C0027672|C0006142|C0025268|C3888239|C0019569|C3661900|CN169374|C0031511	191830|PS131100|171400|142623|PS142623|171300	411709|276161|653|140162|247698|653|388|388|29072	Cadherin-like	Val	Ala	50284.0	single nucleotide variant	NM_020975.6(RET):c.785T>C (p.Val262Ala)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Feb 04, 2025	139790943.0	-	RCV000034777|RCV000148775|RCV000223157|RCV000123327|RCV000663296|RCV001103896|RCV001103897|RCV001103898|RCV000573525|RCV001269367|RCV001104177|RCV004528165	MedGen:C3661900|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MedGen:CN169374|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|	not provided|Aganglionic megacolon|not specified|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Multiple endocrine neoplasia|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43105111.0	43105111.0	10q11.21	criteria provided, conflicting classifications	17.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009350	2.0	41845.0	43105111.0	T	C	-	-	-	-	-	-	SCV000166634|SCV000279597|SCV000540171|SCV000664464|SCV000786544|SCV000822200|SCV000838371|SCV000891636|SCV001260709|SCV001260710|SCV001260711|SCV001261020|SCV002062909|SCV002068400|SCV002527924	-	-	785T>C 	Val262Ala	NM_020975.6	1.0	3_Conflicting	94.03	0.0070422535211267	['171400', '142623', '171300', '191830']	multiple	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; PHEOCHROMOCYTOMA; RENAL HYPODYSPLASIA/APLASIA 1	94.03	0.0070422534	<10	>90						V	1			94.03	Aliphatic	Valine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment							Cadherin			4.2								V262-E235; PAE: 1.0	4 interactions	V262-E235; PAE: 1.0	5 interactions							117									-82.8				134.2						B (undefined)	E (parallel sheets)	Beta strand						Extracellular																																																													true	RETVal262Ala																																																																																																																																																																																																																																		
LMNA	LMNA_Arg377Leu	0.8303741991373911	0.4337309726645242	-1.7547994394249709	0.12273046621541059	2025_01_Batch_13-14	true	true	true	true	false	true	true	true	true	false	0.998535633897841	0.985630676709351	0.9912346028698616	0.981724053118151	0.706516823227123	0.732651144476482	0.9809019974562119	0.9899325537451653	0.9821100560733841	0.9985181048778051	0.6803825019777638	0.9825461087800901	0.992536651994558	0.989151297345318	0.9985531629178768	LMNA	0.8303741991373911	0.4337309726645242	-1.7547994394249709	0.12273046621541059	2025_01_Batch_13-14	true	true	true	true	false	true	true	true	true	false	0.998535633897841	0.985630676709351	0.9912346028698616	0.981724053118151	0.706516823227123	0.732651144476482	0.9809019974562119	0.9899325537451653	0.9821100560733841	0.9985181048778051	0.6803825019777638	0.9825461087800901	0.992536651994558	0.989151297345318	0.9985531629178768	LMNA	ENSG00000160789	3903	7292.0	CCSBVarC000580	ALE00000580	NC_000001.11:156136094:G:T	1130G>T	Arg377Leu	RC4	RC4_Mut_GDEh1027	B01	GDEhDisVCh_40057	F12	1.0	RC4_Mut_GDDh1027	B01							1.0	1.0	1.0	99.0	0.0			0.0			0.0			1.0	156136094.0	G	T	1	Y	Y	N	N	N	1-156136094-G-T	77675.0	single nucleotide variant	NM_170707.4(LMNA):c.1130G>T (p.Arg377Leu)	4000.0	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1.0	Nov 11, 2024	61672878.0	-	RCV000057236|RCV001237945|RCV002321554|RCV003448256|RCV003996497	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736|MONDO:MONDO:0013178,MedGen:C2750785,OMIM:613205,Orphanet:157973|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation|Primary dilated cardiomyopathy	germline	germline	GRCh38	NC_000001.11	1	156136094.0	156136094.0	1q22	criteria provided, multiple submitters, no conflicts	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016657,UniProtKB:P02545#VAR_039777	2.0	66778.0	156136094.0	G	T	-	-	-	-	-	-	SCV000271921|SCV001410737|SCV002610638|SCV004176574|SCV004825165	-	-	1130G>T 	Arg377Leu	NM_170707.4	2.0	1_Pathogenic	1.36824e-6	66778.0	1	156136094.0	G	T	R	L	rs61672878	1	156105885.0	1	154372509.0	377.0	LMNA	ENSG00000160789	ENST00000361308	ENSP00000355292	P02545	LMNA_HUMAN	c.1130G>T	p.Arg377Leu	c.1130G>T	p.Arg377Leu	principal1	Y	5	.	.	+	CGC	2.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.715	0.94651	H	-6.93	0.93423	D	0.951	0.99270	1.0722	0.98647	D	0.9311	0.97722	D	10.0	0.9717735	0.96765	D	0.774445	0.98215	D	0.971	0.99671	0.839	0.94511	P02545	R377L	Gain of helix (P = 0.2059)| Loss of MoRF binding (P = 0.211)| Gain of ubiquitination at K378 (P = 0.2392)| Gain of phosphorylation at Y376 (P = 0.2452)| Loss of methylation at K378 (P = 0.3112)	0.987595316139	0.98732	.	0.98530	.	0.96642	0.850583195686	0.89686	D	0.98346	0.99884	D	0.551552	0.95787	D	0.55449	0.95724	D	0.998611927032471	0.94603	D	.	0.68071	.	0.95186484	0.96399	0.92578965	0.96757	0.9515742	0.96369	0.8996569	0.94882	-9.847	0.73069	D	0.9926	0.94839	LP	0.999965529954525	0.99297	0.99997818	0.99989	0.996	0.99859	.	.	.	.	.	.	5.27379	0.8857	29.6	0.9987177117556731	0.94906	0.977482	0.99724	D	0.966889726849636	0.94600	12.91139	0.89589923552897	0.95367	13.57775	5.3	5.3	0.74708	5.54	0.94607	8.119	0.8947	11.663000	0.94018	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614014	1.239150e-06	0	1	59978	1.667280e-05	0	0	75048	0.000000e+00	0	0	912	0.000000e+00	0	1	59978	1.667280e-05	0	0	29604	0.000000e+00	0	0	44888	0.000000e+00	0	0	63898	0.000000e+00	0	0	6054	0.000000e+00	0	1	1180036	8.474320e-07	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|Primary_dilated_cardiomyopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156136094G>T	ClinGen:CA016657|UniProtKB:P02545#VAR_039777	C3661900|C2750785|C0270914|CN230736|C0007193	613205	157973|64746|217604	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Leu	77675.0	single nucleotide variant	NM_170707.4(LMNA):c.1130G>T (p.Arg377Leu)	4000.0	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1.0	Nov 11, 2024	61672878.0	-	RCV000057236|RCV001237945|RCV002321554|RCV003448256|RCV003996497	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736|MONDO:MONDO:0013178,MedGen:C2750785,OMIM:613205,Orphanet:157973|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation|Primary dilated cardiomyopathy	germline	germline	GRCh38	NC_000001.11	1	156136094.0	156136094.0	1q22	criteria provided, multiple submitters, no conflicts	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016657,UniProtKB:P02545#VAR_039777	2.0	66778.0	156136094.0	G	T	-	-	-	-	-	-	SCV000271921|SCV001410737|SCV002610638|SCV004176574|SCV004825165	-	-	1130G>T 	Arg377Leu	NM_170707.4	2.0	1_Pathogenic	84.59	0.5806451612903226	['613205']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	84.59	0.58064514	10-90	70-90						R	144			84.59	Positively-charged	Arginine		Prelamin-A/C; Lamin-A/C							IF rod			-4.5								R377-I373, R377-E381; PAE: 7.0, 9.5	4 interactions	R377-I373, R377-E381; PAE: 7.0, 9.5	5 interactions							175		Mutation: R -> H, P. Impaired lamin assembly.							-59.8				-49.4	Coil 2			dbSNP: rs61672878; Variant type: LP/P; AA change: Arg377His; PTM type: Phosphorylation; PTM morphology: MEIHAyR*kLLE; Var class: II&rs61672878		H (helix)	H (α-helix)																																																																				true	LMNAArg377Leu																																																																																																																																																																																																																																		
SHOC2	SHOC2_Ser57Phe	-1.2094902213471577	0.26573292360703604	3.471311167785418	0.010387464454151103	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6806918730038594	0.5866833610186557	0.7547936922023686	0.7525232076316	0.7172559161242507	0.529813433537089	0.6792801073072422	0.5861049791074834	0.49563981606248964	0.6143298928196269	0.9046983987114122	0.8257663079559578	0.9234824052972537	0.6777269059748217	0.7470538531880919	SHOC2	-1.2094902213471577	0.26573292360703604	3.471311167785418	0.010387464454151103	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6806918730038594	0.5866833610186557	0.7547936922023686	0.7525232076316	0.7172559161242507	0.529813433537089	0.6792801073072422	0.5861049791074834	0.49563981606248964	0.6143298928196269	0.9046983987114122	0.8257663079559578	0.9234824052972537	0.6777269059748217	0.7470538531880919	SHOC2		11602		CCSBVarC028011		NC_000010.11:110964528:C:T	170C>T	Ser57Phe																												10.0	110964528.0	C	T	10						10-110964528-C-T	174882.0	single nucleotide variant	NM_007373.4(SHOC2):c.170C>T (p.Ser57Phe)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0.0	Nov 25, 2024	536611911.0	-	RCV000156558|RCV000680347|RCV000471315|RCV001803094|RCV002399558	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MedGen:CN230736	not specified|not provided|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	110964528.0	110964528.0	10q25.2	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA185080	2.0	179760.0	110964528.0	C	T	-	-	-	-	-	-	SCV000206277|SCV000547943|SCV000576695|SCV002048966|SCV002712264|SCV003933893|SCV004127491	-	-	170C>T 	Ser57Phe	NM_007373.4	1.0	3_Conflicting		179760.0	10	110964528.0	C	T	S	F	rs536611911	10	112724286.0	10	112714276.0	57.0	SHOC2	ENSG00000108061	ENST00000688928	ENSP00000509273	Q9UQ13	SHOC2_HUMAN	.	.	c.170C>T	p.Ser57Phe	principal1	Y	.	.	.	+	TCC	2.0	0.0	C	C/C	C/C	C/C	C/C	.	0.48802	.	.	0.59495	.	0.214	0.33016	B	0.191	0.42849	B	.	0.63842	.	.	.	.	1.7	0.43657	L	.	0.42386	.	.	0.41012	0.3313	0.87999	D	0.7029	0.89743	D	10.0	.	0.24349	.	0.049509	0.63705	D	.	0.73303	0.197	0.10912	Q9UQ13	S57F	Loss of phosphorylation at S57 (P = 0.0075)| Loss of relative solvent accessibility (P = 0.0676)| Loss of loop (P = 0.0804)| Gain of helix (P = 0.0854)| Gain of methylation at K55 (P = 0.0918)	.	0.33999	.	0.11358	.	0.58683	0.648043274879	0.59645	T	0.393088	0.75087	T	-0.0567598	0.43068	T	-0.0642621	0.65789	T	0.111457248625392	0.13402	T	.	0.73431	.	0.24477392	0.47101	0.22556585	0.47330	0.24477392	0.47101	0.22556585	0.47329	-6.9	0.53367	T	.	0.31154	.	0.980925639856185	0.85540	0.01493649	0.46015	0.355	0.61325	.	.	.	.	.	.	3.839	0.55624	23.6	0.9958498458079164	0.7325	0.764929	0.70048	D	0.262239601804826	0.54016	3.590762	0.442202180045834	0.64024	4.67194	5.99	5.99	0.97294	3.68	0.67565	6.109	0.71273	7.666000	0.64570	0.596	0.33565	1.0	0.71675	1.0	0.68239	0.993	0.69292	915	0.20912	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	0	0.0	1	0.0010224948875255625	10	264690	3.7780046E-5	.	7	109336	6.402280e-05	0	21	207858	1.010310e-04	0	23	236064	9.743120e-05	0	0	7148	0.000000e+00	0	2	17094	1.170000e-04	0	0	2320	0.000000e+00	0	0	9036	0.000000e+00	0	0	13392	0.000000e+00	0	4	42762	9.354100e-05	0	1	15672	6.380810e-05	0	2	17094	1.170000e-04	0	0	16156	0.000000e+00	0	4	30470	1.312770e-04	0	0	6204	0.000000e+00	0	0	13392	0.000000e+00	0	0	16728	0.000000e+00	0	14	89460	1.564950e-04	0	3	30590	9.807130e-05	0	14	89460	1.564950e-04	0	0	14884	0.000000e+00	0	5	34202	1.461900e-04	0	0	9540	0.000000e+00	0	0	17678	0.000000e+00	0	0	21616	0.000000e+00	0	15	102040	1.470010e-04	0	3	30508	9.833490e-05	0	15	102040	1.470010e-04	0	.	87	1614030	5.390230e-05	1	1	6062	1.649620e-04	0	0	75008	0.000000e+00	0	0	912	0.000000e+00	0	9	59982	1.500450e-04	0	0	29606	0.000000e+00	0	0	44872	0.000000e+00	0	0	64008	0.000000e+00	0	1	6062	1.649620e-04	0	67	1179988	5.678020e-05	1	6	91084	6.587330e-05	0	4	42688	9.37031484257871E-5	0	306	0	0	112	0	0	8020	0	0	500	0	0	628	0	0	56	0	0	98	0	1	8288	1.2065637065637066E-4	0	8326	0	0	168	0	5	60696	8.237775141689732E-5	Conflicting_classifications_of_pathogenicity	Cardiovascular_phenotype|not_provided|RASopathy|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.110964528C>T	ClinGen:CA185080	CN230736|C3661900|C5555857|C4478716|CN169374	607721	536391|2701	.	Ser	Phe	174882.0	single nucleotide variant	NM_007373.4(SHOC2):c.170C>T (p.Ser57Phe)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0.0	Nov 25, 2024	536611911.0	-	RCV000156558|RCV000680347|RCV000471315|RCV001803094|RCV002399558	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MedGen:CN230736	not specified|not provided|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	110964528.0	110964528.0	10q25.2	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA185080	2.0	179760.0	110964528.0	C	T	-	-	-	-	-	-	SCV000206277|SCV000547943|SCV000576695|SCV002048966|SCV002712264|SCV003933893|SCV004127491	-	-	170C>T 	Ser57Phe	NM_007373.4	1.0	3_Conflicting	29.3	0.8076923076923077	['607721']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	29.3	0.8076923	10-90	<=50						S	105			29.3	Polar/Neutral	Serine		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-0.8																		105									-105.4				139.2	Disordered					C (loop/coil)	C (loop/coil)																																																																				true	SHOC2Ser57Phe																																																																																																																																																																																																																																		
SHOC2	SHOC2_Gly53Arg	-1.3521828512316285	0.21837236832015264	4.502630598472021	0.002789525522662503	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7143926155935283	0.6812143382260533	0.7925289325568711	0.8653763149819385	0.7863022232329444	0.8216650233696959	0.8816101159079917	0.7687754072288939	0.6632181990751883	0.7569201111391481	0.750939423096193	0.8491425140558854	0.8162824578848482	0.6992104773769182	0.6718651200479084	SHOC2	-1.3521828512316285	0.21837236832015264	4.502630598472021	0.002789525522662503	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7143926155935283	0.6812143382260533	0.7925289325568711	0.8653763149819385	0.7863022232329444	0.8216650233696959	0.8816101159079917	0.7687754072288939	0.6632181990751883	0.7569201111391481	0.750939423096193	0.8491425140558854	0.8162824578848482	0.6992104773769182	0.6718651200479084	SHOC2		11602		CCSBVarC028008		NC_000010.11:110964515:G:A	157G>A	Gly53Arg																												10.0	110964515.0	G	A	10						10-110964515-G-A	1330365.0	single nucleotide variant	NM_007373.4(SHOC2):c.157G>A (p.Gly53Arg)	8036.0	SHOC2	HGNC:15454	Likely pathogenic	1.0	Jan 05, 2022	2134121169.0	-	RCV002272501	MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	Noonan syndrome-like disorder with loose anagen hair 1	de novo	germline	GRCh38	NC_000010.11	10	110964515.0	110964515.0	10q25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA378381906	2.0	1339314.0	110964515.0	G	A	-	-	-	-	-	-	SCV002073494	-	-	157G>A 	Gly53Arg	NM_007373.4	1.0	1_Pathogenic		1339314.0	10	110964515.0	G	A	G	R	rs2134121169	10	112724273.0	10	112714263.0	53.0	SHOC2	ENSG00000108061	ENST00000691369	ENSP00000509754	Q9UQ13	SHOC2_HUMAN	.	.	c.157G>A	p.Gly53Arg	principal1	Y	.	.	.	+	GGA	1.0	0.0	G	G/G	G/G	G/G	G/G	.	0.41793	.	.	0.24765	.	0.982	0.62839	D	0.785	0.63333	P	.	0.88440	.	.	.	.	1.445	0.36203	L	.	0.20730	.	.	0.69502	0.5925	0.9177	D	0.8012	0.93256	D	10.0	.	0.60049	.	0.084434	0.74238	D	.	0.79415	0.2	0.11319	Q9UQ13	G53R	Gain of MoRF binding (P = 0.0334)| Loss of ubiquitination at K55 (P = 0.0365)| Gain of methylation at K54 (P = 0.0787)| Gain of loop (P = 0.1069)| Loss of glycosylation at K54 (P = 0.1528)	.	0.65811	.	0.19691	.	0.67780	0.874739408493	0.93229	D	0.259483	0.62867	T	0.335781	0.85447	D	0.24455	0.85257	D	0.902562320232391	0.55306	D	.	0.60013	.	0.30022958	0.52593	0.27641422	0.53380	0.30022958	0.52593	0.27641422	0.53379	-5.121	0.38173	T	.	0.64318	.	0.970648187277183	0.83393	0.15046370	0.70447	0.389	0.63863	.	.	.	.	.	.	4.506791	0.70599	25.5	0.9977242916624294	0.86015	0.909199	0.86504	D	0.713091895322115	0.80383	7.305809	0.767502526075403	0.87388	9.229115	5.99	5.99	0.97294	.	.	8.002	0.8806	9.913000	0.82471	0.672	0.70176	1.0	0.71675	1.0	0.68239	0.998	0.85369	915	0.20912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Noonan_syndrome-like_disorder_with_loose_anagen_hair_1	criteria_provided,_single_submitter	NC_000010.11:g.110964515G>A	.	C4478716	607721	2701	.	Gly	Arg	1330365.0	single nucleotide variant	NM_007373.4(SHOC2):c.157G>A (p.Gly53Arg)	8036.0	SHOC2	HGNC:15454	Likely pathogenic	1.0	Jan 05, 2022	2134121169.0	-	RCV002272501	MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	Noonan syndrome-like disorder with loose anagen hair 1	de novo	germline	GRCh38	NC_000010.11	10	110964515.0	110964515.0	10q25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA378381906	2.0	1339314.0	110964515.0	G	A	-	-	-	-	-	-	SCV002073494	-	-	157G>A 	Gly53Arg	NM_007373.4	1.0	1_Pathogenic	29.72	0.8333333333333334	['607721']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	29.72	0.8333333	10-90	<=50						G	70			29.72	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-0.4																		75									-87.4				170.3	Disordered					C (loop/coil)	C (loop/coil)																																																																				true	SHOC2Gly53Arg																																																																																																																																																																																																																																		
RPS19	RPS19_Arg62Trp	2.4791241841752996	0.042264292882514945	-2.5644722198235086	0.03730742779147683	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7600550019338441	0.74341438863389	0.5555206693929152	0.5877760909668668	0.7290373796001558	0.7290373796001558	0.5877760909668668	0.5555206693929152	0.74341438863389	0.7600550019338441						RPS19	2.4791241841752996	0.042264292882514945	-2.5644722198235086	0.03730742779147683	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7600550019338441	0.74341438863389	0.5555206693929152	0.5877760909668668	0.7290373796001558	0.7290373796001558	0.5877760909668668	0.5555206693929152	0.74341438863389	0.7600550019338441						RPS19	ENSG00000105372	3441	6069.0	CCSBVarC000467	ALE00000467	NC_000019.10:41869042:C:T	184C>T	Arg62Trp	RC4	RC4_Mut_GDEh1010	F11	GDEhDisVCh_40042	C02	2.0	RC4_Mut_GDDh1010	F11							1.0	1.0	1.0	1.0	0.0			0.0			0.0			19.0	41869042.0	C	T	19	Y	Y	N	N	N	19-41869042-C-T	21353.0	single nucleotide variant	NM_001022.4(RPS19):c.184C>T (p.Arg62Trp)	6223.0	RPS19	HGNC:10402	Pathogenic	1.0	Mar 09, 2023	104894711.0	-	RCV000033183|RCV000497714|RCV001065746|RCV003415668	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MedGen:C3661900|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|	Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder	germline	germline	GRCh38	NC_000019.10	19	41869042.0	41869042.0	19q13.2	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA130763,UniProtKB:P39019#VAR_006924,OMIM:603474.0002	3.0	6314.0	41869042.0	C	T	-	-	-	-	-	-	SCV000589354|SCV001230721|SCV002717112|SCV004047404|SCV004112877	-	-	184C>T 	Arg62Trp	NM_001022.4	2.0	1_Pathogenic		6314.0	19	41869042.0	C	T	R	W	rs104894711	19	42373112.0	19	47064952.0	62.0	RPS19	ENSG00000105372	ENST00000598742	ENSP00000470972	P39019	RS19_HUMAN	c.184C>T	p.Arg62Trp	c.184C>T	p.Arg62Trp	principal1	Y	1	YES	Select	+	CGG	1.0	2.0	C	./.	./.	./.	./.	.	.	.	0.019	0.60067	D	0.987	0.61929	D	0.679	0.53438	P	0.97	0.96253	A	simple_aae	3.0	97.0	3.89	0.95985	H	.	.	.	0.96	0.96999	0.2823	0.8722	D	0.495	0.80784	T	9.0	0.98888874	0.99322	D	0.794641	0.98386	D	.	.	0.982	0.99827	P39019	R62W	Gain of catalytic residue at A61 (P = 0.0262)| Loss of methylation at R67 (P = 0.0445)| Loss of disorder (P = 0.0768)| Loss of phosphorylation at T60 (P = 0.1237)| Loss of MoRF binding (P = 0.1355)	0.969246388482	0.96863	0.9363405839023272	0.93574	1.09019113237	0.77275	0.841621756554	0.88322	D	0.99269	0.99976	D	0.423948	0.91161	D	0.371195	0.91051	D	0.997496426105499	0.91622	D	.	0.75590	.	0.96338874	0.97581	0.87987745	0.93466	0.93570024	0.94732	0.88595665	0.93899	-12.316	0.86392	D	0.9544	0.90441	LP	0.999645938344676	0.97310	0.99993860	0.99939	0.169	0.41634	.	.	.	.	.	.	5.900132	0.94003	33.0	0.99907463222354	0.97802	0.886495	0.81725	D	0.68503384224157	0.78536	6.914856	0.596564645006298	0.74551	6.180586	4.3	4.3	0.50482	.	.	3.204	0.5088	2.200000	0.31363	0.596	0.33565	0.995	0.38864	0.976000	0.30138	0.996	0.76032	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	RPS19-related_disorder|Diamond-Blackfan_anemia|not_provided|Diamond-Blackfan_anemia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.41869042C>T	ClinGen:CA130763|OMIM:603474.0002|UniProtKB:P39019#VAR_006924	C1260899|C3661900|C2676137	PS105650|105650	124|124	.	Arg	Trp	21353.0	single nucleotide variant	NM_001022.4(RPS19):c.184C>T (p.Arg62Trp)	6223.0	RPS19	HGNC:10402	Pathogenic	1.0	Mar 09, 2023	104894711.0	-	RCV000033183|RCV000497714|RCV001065746|RCV003415668	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MedGen:C3661900|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|	Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder	germline	germline	GRCh38	NC_000019.10	19	41869042.0	41869042.0	19q13.2	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA130763,UniProtKB:P39019#VAR_006924,OMIM:603474.0002	3.0	6314.0	41869042.0	C	T	-	-	-	-	-	-	SCV000589354|SCV001230721|SCV002717112|SCV004047404|SCV004112877	-	-	184C>T 	Arg62Trp	NM_001022.4	2.0	1_Pathogenic	95.33	0.1814516129032258	['105650']	autosomal dominant	Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare inborn errors of metabolism; Inherited cancer-predisposing syndrome	4	DIAMOND-BLACKFAN ANEMIA 1	95.33	0.18145162	10-90	>90						R	45			95.33	Positively-charged	Arginine		Small ribosomal subunit protein eS19								0.032		-4.5								R62-A58, R62-L66; PAE: 1.0, 1.0	36 interactions	R62-A58, R62-L66; PAE: 1.0, 1.0	38 interactions							175									-60.1		Pocket 4: Mean pLDDT: 95.63, Volume: 462.36 Å³, Druggability score: 0.03		-41.6				dbSNP: rs104894711; Variant type: LP/P; AA change: Arg62Trp; PTM type: Phosphorylation; PTM morphology: ytrAAsTAR*HL; Var class: II&rs1555841301		H (helix)	H (α-helix)	Helix																																																																			true	RPS19Arg62Trp																																																																																																																																																																																																																																		
SDHD	SDHD_His102Leu	10.438326676694441	0.000021211171344780724	4.685700930445011	0.010670406461331302	2025_01_Batch_13-14	true	true	false	true	false	false	false	false	false	false	0.9639158107326624	0.8456947756609874	0.9454246518728007	0.9369958895688283	0.891830390864169	0.8313680258033279	0.947252744964598	0.9381400157371114	0.8279097867431578	0.9658088804128862	0.9522927559250102	0.9267390341730586	0.9527092880084899	0.863479764578817	0.9620227410524386	SDHD	10.438326676694441	0.000021211171344780724	4.685700930445011	0.010670406461331302	2025_01_Batch_13-14	true	true	false	true	false	false	false	false	false	false	0.9639158107326624	0.8456947756609874	0.9454246518728007	0.9369958895688283	0.891830390864169	0.8313680258033279	0.947252744964598	0.9381400157371114	0.8279097867431578	0.9658088804128862	0.9522927559250102	0.9267390341730586	0.9527092880084899	0.863479764578817	0.9620227410524386	SDHD	ENSG00000204370	5678	201957.0	CCSBVarC006160	ALE00006160	NC_000011.10:112089002:A:T	305A>T	His102Leu	CEGS2	CegsMutGDEh1014	D09	GDEhDisVCh_40066	F02	2.0									1.0	1.0	0.0		0.0			0.0			0.0			11.0	112089002.0	A	T	11	Y	N	N	N	N	11-112089002-A-T	21937.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>T (p.His102Leu)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	Apr 08, 2024	104894302.0	-	RCV000007307|RCV000566289|RCV002228003	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016665,UniProtKB:O14521#VAR_010040,OMIM:602690.0005	3.0	6898.0	112089002.0	A	T	-	-	-	-	-	-	SCV000664577|SCV000762668	-	-	305A>T 	His102Leu	NM_003002.4	2.0	1_Pathogenic		6898.0	11	112089002.0	A	T	H	L	rs104894302	11	111959726.0	11	111464936.0	102.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>T	p.His102Leu	c.305A>T	p.His102Leu	principal1	Y	1	YES	Select	+	CAT	2.0	0.0	A	./.	./.	./.	./.	0.001	0.91343	D	0.002	0.92967	D	0.999	0.77914	D	0.928	0.66273	D	0.99	0.99291	A	simple_aae	1.0	99.0	3.925	0.96220	H	-10.94	0.99269	D	0.946	0.98282	0.8082	0.94493	D	0.9985	0.99959	D	9.0	0.99472225	0.99961	D	0.795712	0.98395	D	0.909	0.97545	0.988	0.99876	O14521	H102L	Loss of catalytic residue at G103 (P = 0.0541)| Gain of helix (P = 0.2294)| Loss of disorder (P = 0.6187)| Gain of stability (P = 0.6318)| Gain of loop (P = 0.6993)	0.994554434502	0.99442	0.9890505541009824	0.98896	0.822681584721	0.67039	0.580342292786	0.50068	T	0.976715	0.99780	D	0.566984	0.96335	D	0.576657	0.96276	D	0.999900341033936	0.99626	D	0.716128	0.45817	T	0.8378367	0.86274	0.7502163	0.85055	0.8351151	0.86080	0.7859342	0.87236	-9.818	0.80483	D	0.8306	0.78714	P	0.996540517566282	0.92238	0.99904233	0.99109	0.983	0.99413	.	.	.	.	.	.	4.855792	0.79446	27.1	0.9666367747883696	0.30834	0.948642	0.96033	D	0.654068949213661	0.76505	6.522557	0.496041743816457	0.67552	5.122925	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.0	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112089002A>T	ClinGen:CA016665|OMIM:602690.0005|UniProtKB:O14521#VAR_010040	C0027672|CN166604|C1868633|C0031511|C1847319|C3494181	171300|606864|168000	140162|201|29072|97286|29072	.	His	Leu	21937.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>T (p.His102Leu)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	Apr 08, 2024	104894302.0	-	RCV000007307|RCV000566289|RCV002228003	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016665,UniProtKB:O14521#VAR_010040,OMIM:602690.0005	3.0	6898.0	112089002.0	A	T	-	-	-	-	-	-	SCV000664577|SCV000762668	-	-	305A>T 	His102Leu	NM_003002.4	2.0	1_Pathogenic	98.8	0.3858695652173913	['168000', '171300', '606864']	autosomal dominant	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	98.8	0.38586956	10-90	>90						H	71			98.8	Positively-charged	Histidine	heme b	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-3.2								H102-G106, H102-A98; PAE: 1.0, 1.0	2 interactions	H102-S73, H102-G106, H102-A98; PAE: 1.0, 1.0, 1.0	4 interactions							155									-59.3		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-46.5						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDHis102Leu																																																																																																																																																																																																																																		
SDHD	SDHD_Arg70Thr	6.934747073445434	0.00024459787473878774	-2.6398149628228182	0.48151603696647605	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8260919082474187	0.7633558169634097	0.8478866433442616	0.8392088832308814	0.8395821167643795	0.876907970433545	0.8712931700523606	0.890962358682571	0.8490884350443753	0.837882280490174	0.8022562630952141	0.8071245964094022	0.804810928005952	0.6776231988824442	0.8143015360046635	SDHD	6.934747073445434	0.00024459787473878774	-2.6398149628228182	0.48151603696647605	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8260919082474187	0.7633558169634097	0.8478866433442616	0.8392088832308814	0.8395821167643795	0.876907970433545	0.8712931700523606	0.890962358682571	0.8490884350443753	0.837882280490174	0.8022562630952141	0.8071245964094022	0.804810928005952	0.6776231988824442	0.8143015360046635	SDHD		6363		CCSBVarC023288		NC_000011.10:112088906:G:C	209G>C	Arg70Thr																												11.0	112088906.0	G	C	11						11-112088906-G-C	810762.0	single nucleotide variant	NM_003002.4(SDHD):c.209G>C (p.Arg70Thr)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Feb 25, 2023	755047928.0	-	RCV001014432|RCV001597242|RCV003769463	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome	germline	germline	GRCh38	NC_000011.10	11	112088906.0	112088906.0	11q23.1	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617234	2.0	820714.0	112088906.0	G	C	-	-	-	-	-	-	SCV001175136|SCV001831914|SCV004570824	-	-	209G>C 	Arg70Thr	NM_003002.4	1.0	3_Conflicting		820714.0	11	112088906.0	G	C	R	T	rs755047928	11	111959630.0	11	111464840.0	70.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.209G>C	p.Arg70Thr	c.209G>C	p.Arg70Thr	principal1	Y	1	YES	Select	+	AGG	2.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.004	0.74454	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.88	0.95915	H	-5.8	0.88177	D	0.956	0.96546	1.0507	0.98128	D	0.9847	0.99536	D	10.0	0.9923693	0.99772	D	0.720854	0.97738	D	0.962	0.99434	0.984	0.99843	O14521	R70T	Gain of catalytic residue at S73 (P = 0.146)| Loss of helix (P = 0.1706)| Loss of stability (P = 0.1869)| Loss of MoRF binding (P = 0.2156)| Gain of disorder (P = 0.2602)	0.983230327024	0.98287	0.9568632122871339	0.95645	0.91655607726	0.71085	0.688868284225	0.65485	T	0.981408	0.99854	D	0.576146	0.969	D	0.589817	0.96849	D	0.999165654182434	0.96363	D	0.946705	0.81107	D	0.9203629	0.93183	0.85851985	0.91973	0.9137901	0.92543	0.8970499	0.94695	-11.753	0.91834	D	0.8906	0.82186	P	0.996839713185994	0.92509	0.99914825	0.99178	0.966	0.98629	.	.	.	.	.	.	4.65578	0.74309	26.1	0.9850157872899288	0.42352	0.955196	0.97277	D	0.796092789603072	0.85785	8.704333	0.69577891730792	0.81957	7.673905	5.04	4.1	0.47135	.	.	7.535	0.80966	7.554000	0.60397	0.618	0.50684	1.0	0.71675	1.0	0.68239	0.998	0.85369	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088906G>C	.	C1868633|C0031511|CN166604|C1847319|C0027672|C3661900	171300|606864	29072|201|97286|140162	.	Arg	Thr	810762.0	single nucleotide variant	NM_003002.4(SDHD):c.209G>C (p.Arg70Thr)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Feb 25, 2023	755047928.0	-	RCV001014432|RCV001597242|RCV003769463	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome	germline	germline	GRCh38	NC_000011.10	11	112088906.0	112088906.0	11q23.1	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617234	2.0	820714.0	112088906.0	G	C	-	-	-	-	-	-	SCV001175136|SCV001831914|SCV004570824	-	-	209G>C 	Arg70Thr	NM_003002.4	1.0	3_Conflicting	98.66	0.4838709677419355	['171300', '606864']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	98.66	0.48387095	10-90	>90						R	120			98.66	Positively-charged	Arginine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-4.5								R70-W66, R70-V74; PAE: 1.0, 1.0	2 interactions	R70-W66, R70-V74; PAE: 1.0, 1.0	2 interactions							175									-66.9		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-40.8						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDArg70Thr																																																																																																																																																																																																																																		
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.90126101898287	0.5644177237136929	0.81461536040293	0.772992960699876	0.44395431203846614	0.4626556784325541	0.711744430069609	0.7750108713714473	0.539562470786803	0.8568053473569524	0.4252529456443782	0.834241491330143	0.8542198494344126	0.5892729766405828	0.9457166906087877	F9	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.90126101898287	0.5644177237136929	0.81461536040293	0.772992960699876	0.44395431203846614	0.4626556784325541	0.711744430069609	0.7750108713714473	0.539562470786803	0.8568053473569524	0.4252529456443782	0.834241491330143	0.8542198494344126	0.5892729766405828	0.9457166906087877	F9	ENSG00000101981	52861	204397.0	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561872.0	G	C	X	Y	N	N	N	N	X-139561872-G-C	25681.0	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jan 01, 1991	137852273.0	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872.0	139561872.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1.0	10642.0	139561872.0	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic		10642.0	X	139561872.0	G	C	C	S	rs137852273	X	138644031.0	X	138471697.0	396.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10.0	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.9952017959047548	0.692	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681.0	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jan 01, 1991	137852273.0	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872.0	139561872.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1.0	10642.0	139561872.0	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic	93.62	0.0074074074074074	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	93.62	0.0074074073	<10	>90						C	1			93.62	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa heavy chain						Disulfide bond 382-396	Peptidase S1			2.5						C396-C382; PAE: 1.5		C396-V377; PAE: 1.0	3 interactions	C396-C382; PAE: 1.5	4 interactions							121									-103.5				143.8						B (undefined)	E (parallel sheets)	Beta strand																													0.294		0.137		0.104		0.101		0.079	1 mutation(s) (Cys396Gln: -0.016)																													true	F9Cys396Ser																																																																																																																																																																																																																																		
RAF1	RAF1_Asn71Ser	0.6062636477246899	1.0	0.44825035148598597	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6264207508723234	0.5759088875107508	0.6665580623698677	0.6635722869316661	0.6339954618326464	0.5478643627268203	0.6137224913396894	0.6191672504260337	0.5349339648391073	0.6101961753365123	0.7201265609384726	0.7134220825236429	0.7139488743137018	0.6168838101823942	0.6426453264081347	RAF1	0.6062636477246899	1.0	0.44825035148598597	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6264207508723234	0.5759088875107508	0.6665580623698677	0.6635722869316661	0.6339954618326464	0.5478643627268203	0.6137224913396894	0.6191672504260337	0.5349339648391073	0.6101961753365123	0.7201265609384726	0.7134220825236429	0.7139488743137018	0.6168838101823942	0.6426453264081347	RAF1		732		CCSBVarC008840		NC_000003.12:12612058:T:C	212A>G	Asn71Ser																												3.0	12612058.0	T	C	3						3-12612058-T-C	49058.0	single nucleotide variant	NM_002880.4(RAF1):c.212A>G (p.Asn71Ser)	5894.0	RAF1	HGNC:9829	Benign	0.0	Apr 03, 2017	184022679.0	-	RCV000037686|RCV004532499|RCV000461248|RCV000586687|RCV000620637	MedGen:CN169374||MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN230736	not specified|RAF1-related disorder|RASopathy|not provided|Cardiovascular phenotype	germline	germline	GRCh38	NC_000003.12	3	12612058.0	12612058.0	3p25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA134721	2.0	40588.0	12612058.0	T	C	-	-	-	-	-	-	SCV000616420	-	-	212A>G 	Asn71Ser	NM_002880.4	3.0	2_Benign		40588.0	3	12612058.0	T	C	N	S	rs184022679	3	12653557.0	3	12628557.0	71.0	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.212A>G	p.Asn71Ser	c.212A>G	p.Asn71Ser	principal3	Y	1	YES	Select	-	AAT	2.0	0.0	T	T/T	T/T	T/T	T/T	0.466	0.08637	T	0.461	0.12752	T	0.107	0.26097	B	0.199	0.36806	B	0.51	0.71892	D	simple_aae	49.0	51.0	2.075	0.56867	M	-0.85	0.23101	N	0.396	0.46496	-0.7029	0.6013	T	0.2684	0.6384	T	10.0	0.023561597	0.00618	T	0.047179	0.62660	D	0.194	0.47225	.	.	.	.	.	0.700826663726	0.69587	.	0.38507	0.399458701232	0.40688	0.769439399242	0.77301	T	0.544649	0.84330	D	-0.441197	0.01189	T	-0.441903	0.28238	T	0.0241761773584133	0.01162	T	.	0.55502	.	0.367634	0.58081	0.13760614	0.32795	0.39323702	0.59936	0.16458307	0.37996	-5.34	0.40718	T	0.1357	0.33297	B	0.847923193550861	0.73002	0.26023328	0.75518	0.216	0.48172	.	.	.	.	.	.	2.411032	0.31048	18.61	0.9668943635677161	0.30927	0.643219	0.61854	D	-0.0733448836148503	0.38295	2.260626	0.0541083710929102	0.41984	2.553849	5.81	4.65	0.57575	3.15	0.57234	4.539	0.60453	1.237000	0.25166	-0.188	0.09552	1.0	0.71675	0.965	0.29555	0.34	0.25482	637	0.64339	3	5.990415335463259E-4	0	0.0	0	0.0	3	0.004322766570605188	0	0.0	0	0.0	48	264690	1.813442E-4	.	31	109408	2.833430e-04	0	57	208132	2.738650e-04	0	60	236954	2.532140e-04	0	0	7164	0.000000e+00	0	27	17112	1.577840e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	3	42768	7.014590e-05	0	1	15690	6.373490e-05	0	27	17112	1.577840e-03	0	1	16218	6.165990e-05	0	48	30524	1.572530e-03	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	6	89556	6.699720e-05	0	2	30608	6.534240e-05	0	48	30524	1.572530e-03	0	1	14902	6.710510e-05	0	49	34260	1.430240e-03	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	0	21632	0.000000e+00	0	7	102752	6.812520e-05	0	2	30526	6.551790e-05	0	49	34260	1.430240e-03	0	.	152	1613932	9.417990e-05	0	63	60008	1.049860e-03	0	8	75034	1.066180e-04	0	0	912	0.000000e+00	0	63	60008	1.049860e-03	0	0	29602	0.000000e+00	0	4	44860	8.916630e-05	0	0	64018	0.000000e+00	0	0	6056	0.000000e+00	0	63	1179858	5.339630e-05	0	11	91088	1.207620e-04	0	28	178468	1.5689087119259476E-4	0	352	0	0	4476	0	0	8846	0	0	796	0	0	968	0	0	1818	0	0	280	0	1	15160	6.596306068601583E-5	0	9198	0	0	6294	0	29	211164	1.3733401526775396E-4	Benign	not_specified|Cardiovascular_phenotype|RASopathy|not_provided|RAF1-related_disorder	reviewed_by_expert_panel	NC_000003.12:g.12612058T>C	ClinGen:CA134721	CN169374|CN230736|C5555857|C3661900	.	536391	Raf-like Ras-binding|Raf-like Ras-binding|Raf-like Ras-binding	Asn	Ser	49058.0	single nucleotide variant	NM_002880.4(RAF1):c.212A>G (p.Asn71Ser)	5894.0	RAF1	HGNC:9829	Benign	0.0	Apr 03, 2017	184022679.0	-	RCV000037686|RCV004532499|RCV000461248|RCV000586687|RCV000620637	MedGen:CN169374||MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN230736	not specified|RAF1-related disorder|RASopathy|not provided|Cardiovascular phenotype	germline	germline	GRCh38	NC_000003.12	3	12612058.0	12612058.0	3p25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA134721	2.0	40588.0	12612058.0	T	C	-	-	-	-	-	-	SCV000616420	-	-	212A>G 	Asn71Ser	NM_002880.4	3.0	2_Benign	89.2	0.7707006369426752		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		89.2	0.77070063	10-90	70-90						N	121			89.2	Polar/Neutral	Asparagine		RAF proto-oncogene serine/threonine-protein kinase							RBD			-3.5			1 interaction	3 interactions					1 interaction		10 interactions							132									-81.6				134.0						B (undefined)	E (parallel sheets)	Beta strand																																							-0.015		-0.037		-0.063		-0.055		-0.057		-0.072		-0.075	1 mutation(s) (Asn71Lys: 0.411)	-0.131	1 mutation(s) (Asn71Lys: 0.748)	-0.213	1 mutation(s) (Asn71Lys: 1.232)	-0.174										true	RAF1Asn71Ser																																																																																																																																																																																																																																		
RAD51D	RAD51D_His23Arg	0.46032392122955723	0.6592416574464562	5.8691667067277065	0.0006184625812000529	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9602886012957268	0.8041819022114969	0.9291546472785729	0.9035297099370408	0.8412231137986681	0.7620934902533477	0.8807734751440904	0.9040232974436648	0.7157911571535472	0.9570207008826094	0.9203527373439884	0.9262859447299913	0.9542859971134809	0.8925726472694465	0.9635565017088441	RAD51D	0.46032392122955723	0.6592416574464562	5.8691667067277065	0.0006184625812000529	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9602886012957268	0.8041819022114969	0.9291546472785729	0.9035297099370408	0.8412231137986681	0.7620934902533477	0.8807734751440904	0.9040232974436648	0.7157911571535472	0.9570207008826094	0.9203527373439884	0.9262859447299913	0.9542859971134809	0.8925726472694465	0.9635565017088441	RAD51D		7201		CCSBVarC024711		NC_000017.11:35119546:T:C	68A>G	His23Arg																												17.0	35119546.0	T	C	17						17-35119546-T-C	409908.0	single nucleotide variant	NM_002878.4(RAD51D):c.68A>G (p.His23Arg)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 03, 2024	990062370.0	-	RCV000485429|RCV000547804|RCV000566071	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35119546.0	35119546.0	17q12	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA16620393	2.0	418673.0	35119546.0	T	C	-	-	-	-	-	-	SCV000565901|SCV000651772|SCV000663810	-	-	68A>G 	His23Arg	NM_002878.4	1.0	3_Conflicting		418673.0	17	35119546.0	T	C	H	R	rs990062370	17	33446565.0	17	30470678.0	23.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.68A>G	p.His23Arg	c.68A>G	p.His23Arg	principal1	Y	5	.	.	-	CAC	2.0	0.0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	0.792	0.05378	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	-2.015	0.00188	N	-0.59	0.18393	N	0.064	0.10018	-0.9955	0.31058	T	0.0244	0.10333	T	10.0	0.032363117	0.01387	T	0.010514	0.26860	T	0.018	0.03036	0.425	0.46877	O75771	H23R	Loss of sheet (P = 0.003)| Gain of helix (P = 0.0034)| Gain of MoRF binding (P = 0.0286)| Gain of phosphorylation at S22 (P = 0.091)| Loss of ubiquitination at K26 (P = 0.1022)	0.319686207203	0.31162	.	0.34452	.	0.11066	.	.	.	0.115945	0.43190	T	-0.364518	0.03721	T	-0.761382	0.02907	T	0.0475806100992363	0.05021	T	0.0435956	0.00994	T	0.040238965	0.05652	0.052508783	0.08678	0.040238965	0.05652	0.052508783	0.08677	-1.909	0.10376	T	0.0613	0.02261	B	7.77047030966497e-07	0.00398	0.22299655	0.74091	0.028	0.05473	.	.	.	.	.	.	0.56021	0.09313	6.069	0.6915457572947424	0.09022	0.046472	0.07594	N	-1.35012510449794	0.03091	0.1390257	-1.25403651457861	0.04992	0.2407925	4.5	-1.34	0.08645	-3.41	0.07546	-1.008	0.03777	-1.240000	0.05963	-0.173	0.11029	0.0	0.06393	0.0	0.08389	0.771	0.36593	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	0	107948	0.000000e+00	0	1	204124	4.898980e-06	0	1	233180	4.288530e-06	0	0	7098	0.000000e+00	0	0	17080	0.000000e+00	0	0	2320	0.000000e+00	0	0	8998	0.000000e+00	0	0	12186	0.000000e+00	0	0	42690	0.000000e+00	0	0	15678	0.000000e+00	0	.	.	.	.	0	16112	0.000000e+00	0	0	30490	0.000000e+00	0	0	6182	0.000000e+00	0	0	13344	0.000000e+00	0	0	15526	0.000000e+00	0	1	87036	1.148950e-05	0	0	30596	0.000000e+00	0	1	87036	1.148950e-05	0	0	14834	0.000000e+00	0	0	34228	0.000000e+00	0	0	9560	0.000000e+00	0	0	17644	0.000000e+00	0	0	20424	0.000000e+00	0	1	100384	9.961750e-06	0	0	30514	0.000000e+00	0	1	100384	9.961750e-06	0	.	1	1612358	6.202100e-07	0	1	1179926	8.475110e-07	0	0	74908	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29596	0.000000e+00	0	0	44882	0.000000e+00	0	0	62504	0.000000e+00	0	0	6084	0.000000e+00	0	1	1179926	8.475110e-07	0	0	91090	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Conflicting_classifications_of_pathogenicity	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119546T>C	ClinGen:CA16620393	C3280345|C3661900|C0027672	614291	145|140162	RAD51D, N-terminal domain	His	Arg	409908.0	single nucleotide variant	NM_002878.4(RAD51D):c.68A>G (p.His23Arg)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 03, 2024	990062370.0	-	RCV000485429|RCV000547804|RCV000566071	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35119546.0	35119546.0	17q12	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA16620393	2.0	418673.0	35119546.0	T	C	-	-	-	-	-	-	SCV000565901|SCV000651772|SCV000663810	-	-	68A>G 	His23Arg	NM_002878.4	1.0	3_Conflicting	90.21	0.4021739130434782	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	90.21	0.4021739	10-90	>90						H	74			90.21	Positively-charged	Histidine		DNA repair protein RAD51 homolog 4										-3.2								H23-L19, H23-C43; PAE: 1.0, 2.5	3 interactions	H23-L19, H23-C43; PAE: 1.0, 2.5	4 interactions							155									-95.2				21.4	preferentially binds ssDNA					C (loop/coil)	T (turn)																																																																				true	RAD51DHis23Arg																																																																																																																																																																																																																																		
F9	F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8918860878784864	0.7276981865207304	0.8666821060532699	0.7885499799247945	0.708192380469411	0.8294935729820571	0.8216646242841691	0.9071619363443628	0.7980510018430784	0.9049360006536924	0.5868911879567651	0.7554353355654199	0.8262022757621769	0.6573453711983824	0.8788361751032804	F9	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8918860878784864	0.7276981865207304	0.8666821060532699	0.7885499799247945	0.708192380469411	0.8294935729820571	0.8216646242841691	0.9071619363443628	0.7980510018430784	0.9049360006536924	0.5868911879567651	0.7554353355654199	0.8262022757621769	0.6573453711983824	0.8788361751032804	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T	571C>T	Arg191Cys																												23.0	139551112.0	C	T	X						X-139551112-C-T	25623.0	single nucleotide variant	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Mar 11, 2024	137852237.0	-	RCV004700216|RCV005042030|RCV000011330|RCV001390295	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;maternal	germline	GRCh38	NC_000023.11	X	139551112.0	139551112.0	Xq27.1	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	3.0	10584.0	139551112.0	C	T	-	-	-	-	-	-	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	-	-	571C>T 	Arg191Cys	NM_000133.4	2.0	1_Pathogenic		10584.0	X	139551112.0	C	T	R	C	rs137852237	X	138633271.0	X	138460937.0	191.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.571C>T	p.Arg191Cys	c.571C>T	p.Arg191Cys	principal1	Y	1	YES	Select	+	CGT	1.0	0.0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.012	0.67073	D	1.0	0.90580	D	0.889	0.63094	P	0.78	0.90354	A	simple_aae	22.0	78.0	2.175	0.60790	M	-3.45	0.68090	D	0.607	0.78558	0.834	0.94814	D	0.8689	0.95632	D	10.0	0.9160565	0.90865	D	0.425573	0.93868	D	0.808	0.93758	.	.	.	.	.	0.999785564942	0.99978	0.9946210614807007	0.99458	1.92440498635	0.92993	0.471319615841	0.34817	T	0.800814	0.94875	D	0.535847	0.95281	D	0.53193	0.95211	D	0.855446166052384	0.50373	D	0.90041	0.67589	D	0.42700288	0.62235	0.24540712	0.49838	0.4647663	0.64653	0.22915632	0.47799	-7.779	0.59626	D	0.46	0.67153	A	0.999002392944659	0.95492	0.99998224	0.99989	0.779	0.87767	.	.	.	.	.	.	3.352229	0.46322	22.3	0.998355401600484	0.91634	.	.	.	.	.	.	.	.	.	4.94	4.04	0.462	.	.	2.17	0.42174	4.855000	0.45490	0.599	0.40292	0.996	0.3946	1.0	0.68239	0.058	0.15862	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	80341	1.244690e-05	0	1	151843	6.585750e-06	0	1	172245	5.805680e-06	0	0	5701	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	1	30954	3.230600e-05	0	0	9951	0.000000e+00	0	1	30954	3.230600e-05	0	0	13133	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	1	64659	1.546580e-05	0	0	19069	0.000000e+00	0	1	64659	1.546580e-05	0	0	12063	0.000000e+00	0	0	27168	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15993	0.000000e+00	0	1	73470	1.361100e-05	0	0	19004	0.000000e+00	0	1	73470	1.361100e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	92836	0	0	168	0	0	2682	0	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	0	3308	0	0	103560	0	Pathogenic/Likely_pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551112C>T	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	C2749016|C0008533	300807|306900	98879	.	Arg	Cys	25623.0	single nucleotide variant	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Mar 11, 2024	137852237.0	-	RCV004700216|RCV005042030|RCV000011330|RCV001390295	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;maternal	germline	GRCh38	NC_000023.11	X	139551112.0	139551112.0	Xq27.1	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	3.0	10584.0	139551112.0	C	T	-	-	-	-	-	-	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	-	-	571C>T 	Arg191Cys	NM_000133.4	2.0	1_Pathogenic	42.03	1.0	['300807', '301052', '306900', '306900', '300807', '306900']	unknown	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; WARFARIN SENSITIVITY, X-LINKED; HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	42.03	1.0	$\geqslant$90	<=50						R	259			42.03	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa light chain										-4.5											1 interaction							175									-68.1				40.0						C (loop/coil)	S (bend)					Cleavage; by factor XIa																									1.012		1.008		1.004		0.988	1 mutation(s) (Arg191Pro: 1.100)	0.978																														true	F9Arg191Cys																																																																																																																																																																																																																																		
BRCA1	BRCA1_Pro510Ser	1.2763374668476026	0.24254813146313225	4.261917325727005	0.0037377388491010573	2025_01_Batch_13-14	false	true	false	false	true	false	true	false	false	true	0.9205815895447915	0.9422616424605242	0.9568889394343272	0.9198813083344892	0.9741272427430834	0.9640036687223583	0.9118111337128814	0.9339901222773391	0.9422400489874985	0.9045387301347584	0.9842508167638085	0.9279514829560971	0.9797877565913151	0.94228323593355	0.9366244489548248	BRCA1	1.2763374668476026	0.24254813146313225	4.261917325727005	0.0037377388491010573	2025_01_Batch_13-14	false	true	false	false	true	false	true	false	false	true	0.9205815895447915	0.9422616424605242	0.9568889394343272	0.9198813083344892	0.9741272427430834	0.9640036687223583	0.9118111337128814	0.9339901222773391	0.9422400489874985	0.9045387301347584	0.9842508167638085	0.9279514829560971	0.9797877565913151	0.94228323593355	0.9366244489548248	BRCA1		14613		CCSBVarC013098		NC_000017.11:43071074:G:A	1528C>T	Pro510Ser																												17.0	43071074.0	G	A	17						17-43071074-G-A	69968.0	single nucleotide variant	NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	70953660.0	-	RCV000048676|RCV000112411|RCV000162988|RCV000167771|RCV001811342|RCV003492390	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	43071074.0	43071074.0	17q21.31	reviewed by expert panel	13.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00089,ClinGen:CA003048	2.0	55301.0	43071074.0	G	A	-	-	-	-	-	-	SCV000244370	-	-	4840C>T 	Pro1614Ser	NM_007294.4	3.0	2_Benign		55301.0	17	43071074.0	G	A	P	S	rs70953660	17	41223091.0	17	38476617.0	1614.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4840C>T	p.Pro1614Ser	c.4840C>T	p.Pro1614Ser	principal2	Y	1	YES	Select	-	CCA	1.0	0.0	G	G/G	G/G	G/G	G/G	0.074	0.34767	T	0.331	0.42259	T	0.001	0.11208	B	0.001	0.11213	B	0.2	0.44282	N	simple_aae	80.0	20.0	1.245	0.31258	L	-1.13	0.49862	N	0.197	0.28185	-0.726	0.58992	T	0.3747	0.73191	T	10.0	0.013456136	0.00282	T	0.081866	0.73689	D	0.544	0.80920	.	.	.	.	.	0.445007932271	0.43742	.	0.22008	.	0.10213	0.220991373062	0.01370	T	0.118253	0.43590	T	-0.292457	0.09169	T	-0.197798	0.54546	T	0.00209908424908425	0.00022	T	.	0.52390	.	0.01818675	0.00340	0.03539876	0.02796	0.012395442	0.00033	0.035112027	0.02713	-2.617	0.09611	T	0.0853	0.14859	B	0.209477282755653	0.50387	0.99514270	0.97711	0.086	0.24271	.	.	.	.	.	.	0.15678	0.05499	1.947	0.41163095527126975	0.02973	0.128273	0.24383	N	-1.18046810113445	0.05234	0.241072	-1.24446342853677	0.05132	0.2478793	4.36	-1.9	0.07233	0.973	0.28966	-0.1	0.10995	0.294000	0.16973	-0.106	0.15547	0.0	0.06393	0.0	0.08389	0.008	0.08289	543	0.72771	2	3.9936102236421724E-4	1	7.564296520423601E-4	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	187	264690	7.064868E-4	.	25	109408	2.285020e-04	0	44	208130	2.114060e-04	0	43	236858	1.815430e-04	0	24	7164	3.350080e-03	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	24	7164	3.350080e-03	0	41	16218	2.528060e-03	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	41	16218	2.528060e-03	0	38	14902	2.549990e-03	0	4	34260	1.167540e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102658	9.741080e-06	0	0	30526	0.000000e+00	0	38	14902	2.549990e-03	0	.	178	1614124	1.102770e-04	0	156	75024	2.079330e-03	0	156	75024	2.079330e-03	0	0	910	0.000000e+00	0	7	60006	1.166550e-04	0	0	29602	0.000000e+00	0	0	44892	0.000000e+00	0	0	64026	0.000000e+00	0	0	6062	0.000000e+00	0	4	1180006	3.389810e-06	0	0	91088	0.000000e+00	0	0	163048	0	0	360	0	0	4502	0	13	9362	0.0013885921811578722	0	442	0	0	950	0	0	1848	0	0	280	0	1	13148	7.6057195010648E-5	13	9722	0.0013371734211067683	0	6350	0	14	193940	7.218727441476746E-5	Benign	not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_and/or_ovarian_cancer	reviewed_by_expert_panel	NC_000017.11:g.43071074G>A	BRCA1-HCI:BRCA1_00089|ClinGen:CA003048	C3661900|CN169374|C0677776|C0027672|C2676676|CN221562	604370	145|140162|145	.	Pro	Ser	69968.0	single nucleotide variant	NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	70953660.0	-	RCV000048676|RCV000112411|RCV000162988|RCV000167771|RCV001811342|RCV003492390	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	43071074.0	43071074.0	17q21.31	reviewed by expert panel	13.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00089,ClinGen:CA003048	2.0	55301.0	43071074.0	G	A	-	-	-	-	-	-	SCV000244370	-	-	4840C>T 	Pro1614Ser	NM_007294.4	3.0	2_Benign	39.92	0.8823529411764706	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	39.92	0.88235295	10-90	<=50																																																																																																																																		true	BRCA1Pro510Ser																																																																																																																																																																																																																																		
RAD51D	RAD51D_Met308Val	-1.5191507364824384	0.17252213344359443	14.967472002836823	1.4261030216509061e-6	2025_01_Batch_13-14	true	true	true	true	false	true	false	false	false	false	0.9890161279770073	0.8756480035639739	0.9813279141932112	0.9650960299407709	0.9172776463458479	0.8740166193615838	0.9519753630441335	0.9746801363316713	0.8196698329128753	0.9903938708502005	0.960538673330112	0.9782166968374082	0.987975692054751	0.9316261742150724	0.9876383851038141	RAD51D	-1.5191507364824384	0.17252213344359443	14.967472002836823	1.4261030216509061e-6	2025_01_Batch_13-14	true	true	true	true	false	true	false	false	false	false	0.9890161279770073	0.8756480035639739	0.9813279141932112	0.9650960299407709	0.9172776463458479	0.8740166193615838	0.9519753630441335	0.9746801363316713	0.8196698329128753	0.9903938708502005	0.960538673330112	0.9782166968374082	0.987975692054751	0.9316261742150724	0.9876383851038141	RAD51D		7201		CCSBVarC024892		NC_000017.11:35101018:T:C	922A>G	Met308Val																												17.0	35101018.0	T	C	17						17-35101018-T-C	184803.0	single nucleotide variant	NM_002878.4(RAD51D):c.922A>G (p.Met308Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Sep 23, 2024	786201961.0	-	RCV000164512|RCV004782268|RCV000649679	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	germline	germline	GRCh38	NC_000017.11	17	35101018.0	35101018.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA191144	2.0	185144.0	35101018.0	T	C	-	-	-	-	-	-	SCV000215164|SCV000771511|SCV000911462|SCV005394802	-	-	922A>G 	Met308Val	NM_002878.4	1.0	3_Conflicting		185144.0	17	35101018.0	T	C	M	V	rs786201961	17	33428037.0	17	30452150.0	308.0	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.922A>G	p.Met308Val	c.922A>G	p.Met308Val	principal1	Y	1	YES	Select	-	ATG	1.0	0.0	T	T/T	T/T	T/T	T/T	0.274	0.15912	T	0.326	0.19266	T	0.0	0.09864	B	0.0	0.06938	B	0.04	0.13669	N	simple_aae	96.0	4.0	0.72	0.18616	N	-0.61	0.17975	N	0.017	0.04065	-0.9351	0.43192	T	0.0836	0.32564	T	10.0	0.091109514	0.15785	T	0.00703	0.18349	T	0.046	0.12499	0.368	0.37543	O75771	M308V	Loss of disorder (P = 0.066)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T303 (P = 0.2109)| Loss of MoRF binding (P = 0.2269)| Gain of glycosylation at T313 (P = 0.247)	0.445711490874	0.43808	.	0.24814	.	0.09186	.	.	.	0.090794	0.38381	T	-0.22766	0.16671	T	-0.564795	0.1564	T	0.04466512799263	0.04499	T	.	0.22727	.	0.09098598	0.21114	0.08494699	0.19556	0.09098598	0.21113	0.08494699	0.19555	-2.125	0.04505	T	0.0668	0.03206	LB	0.000116984907820501	0.03146	0.33311860	0.77819	0.031	0.06489	.	.	.	.	.	.	0.745387	0.11172	7.79	0.8488338337976611	0.15792	0.063394	0.12075	N	-1.10219193532207	0.06526	0.304481	-1.00842900774596	0.09439	0.4784977	5.16	-1.59	0.07985	0.883	0.28197	-0.196	0.09562	-0.511000	0.08784	0.665	0.62996	0.007	0.17722	0.0	0.08389	0.941	0.48226	913	0.21155	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8	1613598	4.957860e-06	0	3	74880	4.006410e-05	0	3	74880	4.006410e-05	0	0	910	0.000000e+00	0	0	59998	0.000000e+00	0	0	29602	0.000000e+00	0	0	44890	0.000000e+00	0	0	64022	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179678	4.238440e-06	0	0	91062	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	1	35432	2.8223075186272295E-5	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101018T>C	ClinGen:CA191144	C0027672|C3280345	614291	140162|145	.	Met	Val	184803.0	single nucleotide variant	NM_002878.4(RAD51D):c.922A>G (p.Met308Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Sep 23, 2024	786201961.0	-	RCV000164512|RCV004782268|RCV000649679	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	germline	germline	GRCh38	NC_000017.11	17	35101018.0	35101018.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA191144	2.0	185144.0	35101018.0	T	C	-	-	-	-	-	-	SCV000215164|SCV000771511|SCV000911462|SCV005394802	-	-	922A>G 	Met308Val	NM_002878.4	1.0	3_Conflicting	91.85	0.4361702127659574	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	91.85	0.43617022	10-90	>90						M	82			91.85	Aliphatic	Methionine		DNA repair protein RAD51 homolog 4										1.9								M308-S88; PAE: 1.0	3 interactions		6 interactions							149									-82.5				127.8						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	RAD51DMet308Val																																																																																																																																																																																																																																		
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9439059523550711	0.7602702357018682	0.8679390161794215	0.8332887811493594	0.6763540911777854	0.8558893364869741	0.7972960987930156	0.85055398051898	0.7640671439537013	0.9246924919224093	0.49681884586859676	0.8692814635057032	0.885324051839863	0.7564733274500351	0.9631194127877329	F9	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9439059523550711	0.7602702357018682	0.8679390161794215	0.8332887811493594	0.6763540911777854	0.8558893364869741	0.7972960987930156	0.85055398051898	0.7640671439537013	0.9246924919224093	0.49681884586859676	0.8692814635057032	0.885324051839863	0.7564733274500351	0.9631194127877329	F9	ENSG00000101981	52861	204359.0	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139548467.0	A	T	X	Y	N	N	N	N	X-139548467-A-T	25621.0	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 01, 1989	137852236.0	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467.0	139548467.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255337,OMIM:300746.0025	1.0	10582.0	139548467.0	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic		10582.0	X	139548467.0	A	T	N	Y	rs137852236	X	138630626.0	X	138458292.0	166.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1.0	0.0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9.0	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.0	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621.0	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 01, 1989	137852236.0	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467.0	139548467.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255337,OMIM:300746.0025	1.0	10582.0	139548467.0	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic	90.75	0.535031847133758	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	90.75	0.53503186	10-90	>90						N	84			90.75	Polar/Neutral	Asparagine		Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 2			-3.5																		132									-68.3				-3.7						C (loop/coil)	T (turn)	Beta strand																													0.476		0.292		0.286		0.261		0.224																														true	F9Asn166Tyr																																																																																																																																																																																																																																		
RAF1	RAF1_Leu613Val	-5.80016652158815	0.04739521026534352	5.723555823832908	0.0022460511579955496	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.796199025654295	0.6848428071283864	0.7788606988716829	0.7364161258611203	0.7624597863846476	0.7624597863846476	0.7364161258611203	0.7788606988716829	0.6848428071283864	0.796199025654295						RAF1	-5.80016652158815	0.04739521026534352	5.723555823832908	0.0022460511579955496	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.796199025654295	0.6848428071283864	0.7788606988716829	0.7364161258611203	0.7624597863846476	0.7624597863846476	0.7364161258611203	0.7788606988716829	0.6848428071283864	0.796199025654295						RAF1		732		CCSBVarC008860		NC_000003.12:12584624:G:C	1837C>G	Leu613Val																												3.0	12584624.0	G	C	3						3-12584624-G-C	28999.0	single nucleotide variant	NM_002880.4(RAF1):c.1837C>G (p.Leu613Val)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Apr 03, 2017	80338797.0	-	RCV000014990|RCV000014989|RCV000020508|RCV000159089|RCV000254689|RCV000440827|RCV000824753|RCV001256891|RCV004532353	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600|	Noonan syndrome 5|LEOPARD syndrome 2|Noonan syndrome with multiple lentigines|RASopathy|not provided|Noonan syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Hypertrophic cardiomyopathy 1|RAF1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	12584624.0	12584624.0	3p25.2	reviewed by expert panel	11.0	-	N	ClinGen:CA257066,UniProtKB:P04049#VAR_037821,OMIM:164760.0004	3.0	13960.0	12584624.0	G	C	-	-	-	-	-	-	SCV000616381	-	-	1837C>G 	Leu613Val	NM_002880.4	3.0	1_Pathogenic		13960.0	3	12584624.0	G	C	L	V	rs80338797	3	12626123.0	3	12601123.0	613.0	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1837C>G	p.Leu613Val	c.1837C>G	p.Leu613Val	principal3	Y	1	YES	Select	-	CTA	1.0	2.0	G	G/G	G/G	G/G	G/G	0.019	0.60085	D	0.022	0.57928	D	0.135	0.27320	B	0.252	0.39069	B	0.79	0.86984	A	simple_aae	21.0	79.0	2.485	0.72164	M	-2.57	0.56009	D	0.568	0.59354	-0.0874	0.80297	T	0.4146	0.76085	T	9.0	0.8424604	0.83230	D	0.082094	0.73737	D	0.579	0.82939	0.809	0.92541	P04049	L613V	Loss of catalytic residue at L613 (P = 0.0273)| Loss of glycosylation at K615 (P = 0.0453)| Gain of methylation at K615 (P = 0.0691)| Gain of ubiquitination at K615 (P = 0.1132)| Loss of stability (P = 0.1352)	0.91975856692	0.91833	.	0.69748	0.394351984474	0.40309	0.81423997879	0.84115	D	0.760318	0.93442	D	0.221088	0.75698	D	0.0798012	0.75382	D	0.969073593616486	0.68255	D	.	0.83110	.	0.5087415	0.67300	0.225398	0.47307	0.5052323	0.67095	0.22544135	0.47312	-9.343	0.70025	D	0.5072	0.64853	A	0.993864972354477	0.90295	0.98658720	0.96257	0.839	0.91143	.	.	.	.	.	.	4.008235	0.59191	24.1	0.9962761323624472	0.75865	0.504613	0.53448	D	0.1905950925256	0.50505	3.261897	0.307022034721395	0.55718	3.75805	5.41	4.46	0.53511	4.17	0.79380	3.761	0.55045	5.815000	0.50112	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.995	0.73271	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hypertrophic_cardiomyopathy_1|Noonan_syndrome|RAF1-related_disorder|Noonan_syndrome_with_multiple_lentigines|RASopathy|Noonan_syndrome_5|LEOPARD_syndrome_2	reviewed_by_expert_panel	NC_000003.12:g.12584624G>C	ClinGen:CA257066|OMIM:164760.0004|UniProtKB:P04049#VAR_037821	C3661900|C3495498|C0028326|C0175704|C5555857|C1969057|C1969056	192600|PS163950|PS151100|611553|611554	648|500|536391|648|500	.	Leu	Val	28999.0	single nucleotide variant	NM_002880.4(RAF1):c.1837C>G (p.Leu613Val)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Apr 03, 2017	80338797.0	-	RCV000014990|RCV000014989|RCV000020508|RCV000159089|RCV000254689|RCV000440827|RCV000824753|RCV001256891|RCV004532353	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600|	Noonan syndrome 5|LEOPARD syndrome 2|Noonan syndrome with multiple lentigines|RASopathy|not provided|Noonan syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Hypertrophic cardiomyopathy 1|RAF1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	12584624.0	12584624.0	3p25.2	reviewed by expert panel	11.0	-	N	ClinGen:CA257066,UniProtKB:P04049#VAR_037821,OMIM:164760.0004	3.0	13960.0	12584624.0	G	C	-	-	-	-	-	-	SCV000616381	-	-	1837C>G 	Leu613Val	NM_002880.4	3.0	1_Pathogenic	71.21	0.2378048780487804	['611553', '611554', '192600']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	NOONAN SYNDROME 5; LEOPARD SYNDROME 2; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	71.21	0.23780487	10-90	70-90						L	39			71.21	Aliphatic	Leucine		RAF proto-oncogene serine/threonine-protein kinase								0.0748		3.8				2 interactions				L613-L609; PAE: 2.5		L613-L609; PAE: 2.5	5 interactions							131									-68.2		Pocket 4: Mean pLDDT: 63.95, Volume: 1859.51 Å³, Druggability score: 0.07		142.2				dbSNP: rs80338797; Variant type: LP/P; AA change: Leu613Val; PTM type: Phosphorylation; PTM morphology: ELLQHsL*PKIN; Var class: II		C (loop/coil)	S (bend)	Turn																																																																			true	RAF1Leu613Val																																																																																																																																																																																																																																		
BRIP1	BRIP1_Arg848His	2.578571129238601	0.0754963461161795	-3.086811053904651	0.18383040953677723	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7563184624266117	0.730377139851222	0.7683645686373286	0.798971010103508	0.7732466334727437	0.7587827823803478	0.7491731842366169	0.7446874149976265	0.7116923345130145	0.7311718734894977	0.7877104845651395	0.8487688359703991	0.7920417222770307	0.7490619451894294	0.7814650513637258	BRIP1	2.578571129238601	0.0754963461161795	-3.086811053904651	0.18383040953677723	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7563184624266117	0.730377139851222	0.7683645686373286	0.798971010103508	0.7732466334727437	0.7587827823803478	0.7491731842366169	0.7446874149976265	0.7116923345130145	0.7311718734894977	0.7877104845651395	0.8487688359703991	0.7920417222770307	0.7490619451894294	0.7814650513637258	BRIP1		55128		CCSBVarC031388		NC_000017.11:61693462:C:T	2543G>A	Arg848His																												17.0	61693462.0	C	T	17						17-61693462-C-T	151213.0	single nucleotide variant	NM_032043.3(BRIP1):c.2543G>A (p.Arg848His)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	1.0	Dec 22, 2024	374334794.0	-	RCV000130056|RCV000699539|RCV001194712|RCV000663220|RCV001255230|RCV004760390|RCV002273958|RCV003460909	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MedGen:C3661900|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia complementation group J|not provided|Ovarian neoplasm;Fanconi anemia complementation group J|Fanconi anemia complementation group J|Hereditary breast ovarian cancer syndrome|Neurodevelopmental delay|Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61693462.0	61693462.0	17q23.2	criteria provided, conflicting classifications	13.0	-	N	ClinGen:CA165626	2.0	141499.0	61693462.0	C	T	-	-	-	-	-	-	SCV000184883|SCV000786407|SCV000828254|SCV000896650|SCV000909762|SCV001777038|SCV002558935|SCV004217033|SCV005205363|SCV005373762|SCV005416787	-	-	2543G>A 	Arg848His	NM_032043.3	1.0	3_Conflicting		141499.0	17	61693462.0	C	T	R	H	rs374334794	17	59770823.0	17	57125605.0	848.0	BRIP1	ENSG00000136492	ENST00000259008	ENSP00000259008	Q9BX63	FANCJ_HUMAN	c.2543G>A	p.Arg848His	c.2543G>A	p.Arg848His	principal2	Y	1	YES	Select	-	CGC	2.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.78	0.86494	D	simple_aae	22.0	78.0	4.15	0.97531	H	-4.6	0.79008	D	0.857	0.99270	1.0848	0.9904	D	0.9696	0.99037	D	9.0	0.94317496	0.93570	D	0.469494	0.94645	D	0.932	0.98414	.	.	.	.	.	0.999184905289	0.99916	0.8741008375185114	0.87298	0.750843833719	0.63531	0.644317030907	0.59114	T	0.839083	0.96201	D	0.542959	0.95468	D	0.542146	0.95401	D	0.999659895896912	0.98331	D	.	0.93863	.	0.9493171	0.96137	0.8188024	0.89326	0.9493171	0.96137	0.8188024	0.89327	-11.608	0.82941	D	0.8672	0.83733	P	0.999253341147957	0.96077	0.99724770	0.98313	0.641	0.80003	.	.	.	.	.	.	5.402014	0.90472	31.0	0.9994229631683478	0.99824	0.731722	0.67754	D	0.953849966561016	0.94104	12.5292	0.867844537858018	0.93982	12.44217	5.74	5.74	0.90056	.	.	5.053	0.6417	7.610000	0.61936	0.549	0.27038	1.0	0.71675	1.0	0.68239	0.935	0.4738	139	0.94485	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10	1613508	6.197680e-06	0	3	74880	4.006410e-05	0	3	74880	4.006410e-05	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29590	0.000000e+00	0	0	44854	0.000000e+00	0	0	63978	0.000000e+00	0	0	6082	0.000000e+00	0	6	1179678	5.086130e-06	0	1	91078	1.097960e-05	0	0	19722	0	0	298	0	0	86	0	2	7418	2.6961445133459155E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1922	0	2	7716	2.592016588906169E-4	0	112	0	2	30326	6.595000989250148E-5	Conflicting_classifications_of_pathogenicity	Familial_cancer_of_breast|Neurodevelopmental_delay|Fanconi_anemia_complementation_group_J|Ovarian_neoplasm|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.61693462C>T	ClinGen:CA165626	C0346153|C4022738|C1836860|C0919267|C3661900|C0027672	114480|609054	227535|84|140162	.	Arg	His	151213.0	single nucleotide variant	NM_032043.3(BRIP1):c.2543G>A (p.Arg848His)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	1.0	Dec 22, 2024	374334794.0	-	RCV000130056|RCV000699539|RCV001194712|RCV000663220|RCV001255230|RCV004760390|RCV002273958|RCV003460909	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MedGen:C3661900|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia complementation group J|not provided|Ovarian neoplasm;Fanconi anemia complementation group J|Fanconi anemia complementation group J|Hereditary breast ovarian cancer syndrome|Neurodevelopmental delay|Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61693462.0	61693462.0	17q23.2	criteria provided, conflicting classifications	13.0	-	N	ClinGen:CA165626	2.0	141499.0	61693462.0	C	T	-	-	-	-	-	-	SCV000184883|SCV000786407|SCV000828254|SCV000896650|SCV000909762|SCV001777038|SCV002558935|SCV004217033|SCV005205363|SCV005373762|SCV005416787	-	-	2543G>A 	Arg848His	NM_032043.3	1.0	3_Conflicting	92.54	0.1370967741935483	['114480', '609054', '609054', '609054', '114480']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCONI ANEMIA, COMPLEMENTATION GROUP J; BREAST CANCER	92.54	0.13709678	10-90	>90						R	34			92.54	Positively-charged	Arginine		Fanconi anemia group J protein										-4.5								R848-A662, R848-N852; PAE: 2.5, 3.0		R848-N852, R848-Y856; PAE: 3.0, 2.0		R848-D846; PAE: 1.0						175									-57.9				-31.8						H (helix)	H (α-helix)																																																																				true	BRIP1Arg848His																																																																																																																																																																																																																																		
BRAF	BRAF_Lys499Asn	-4.944762682826767	0.0016661142958100037	5.574798126697147	0.0008377883870810507	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7515045745002084	0.5618501017237378	0.7252339534646635	0.7047119474869248	0.6624070928397985	0.6633039561986507	0.6996246581318293	0.7623872845325846	0.5442598720342052	0.7713521227339928	0.6615102294809463	0.7097992368420202	0.6880806223967423	0.5794403314132704	0.7316570262664239	BRAF	-4.944762682826767	0.0016661142958100037	5.574798126697147	0.0008377883870810507	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7515045745002084	0.5618501017237378	0.7252339534646635	0.7047119474869248	0.6624070928397985	0.6633039561986507	0.6996246581318293	0.7623872845325846	0.5442598720342052	0.7713521227339928	0.6615102294809463	0.7097992368420202	0.6880806223967423	0.5794403314132704	0.7316570262664239	BRAF	ENSG00000157764	71969	220608.0	CCSBVarC003166	ALE00003166	NC_000007.14:140778011:T:G	1497A>C	Lys499Asn	CEGS2	CegsMutGDEh1012	C01	GDEhDisVCh_40058	H03	2.0									1.0	5.0	0.0		0.0			0.0			0.0			7.0	140778011.0	T	G	7	N	N	N	N	N	7-140778011-T-G	48841.0	single nucleotide variant	NM_004333.6(BRAF):c.1497A>C (p.Lys499Asn)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 23, 2015	397507476.0	-	RCV000207509|RCV001814021	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	not provided|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140778011.0	140778011.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA281974,UniProtKB:P15056#VAR_058625	2.0	40371.0	140778011.0	T	G	-	-	-	-	-	-	SCV000057218|SCV000263064	-	-	1497A>C 	Lys499Asn	NM_004333.6	2.0	1_Pathogenic		40371.0	7	140778011.0	T	G	K	N	rs397507476	7	140477811.0	7	140124280.0	499.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1497A>C	p.Lys499Asn	c.1497A>C	p.Lys499Asn	principal4	Y	.	YES	Select	-	AAA	3.0	2.0	T	T/T	T/T	T/T	T/T	.	.	.	.	.	.	0.947	0.53490	P	0.688	0.53696	P	.	0.97926	.	.	.	.	0.965	0.23851	L	.	.	.	.	.	0.1071	0.84236	D	0.5198	0.81988	D	10.0	0.9434156	0.93596	D	0.1256	0.80658	D	.	0.88818	0.889	0.97257	P15056	K499N	Loss of methylation at K499 (P = 0.0305)| Loss of MoRF binding (P = 0.0517)| Loss of ubiquitination at K499 (P = 0.0546)| Gain of helix (P = 0.2059)| Gain of disorder (P = 0.292)	.	0.81448	.	0.87500	.	0.95599	0.913059830666	0.97749	D	0.824469	0.95710	D	0.110668	0.65175	D	-0.078809	0.64743	T	0.9956134557724	0.87648	D	0.958804	0.84469	D	0.97060555	0.98288	0.9186677	0.96252	0.9693646	0.98171	0.9186677	0.96252	-12.924	0.89071	D	0.9993	0.99393	P	0.999246574469187	0.96052	0.99575126	0.97865	0.98	0.99294	.	.	.	.	.	.	4.441576	0.69029	25.3	0.9986593872669197	0.94371	0.620121	0.60389	D	0.22632943565752	0.52240	3.421713	0.30192289424299	0.55416	3.728117	4.96	4.96	0.65108	4.21	0.80015	3.119	0.50212	4.195000	0.42508	0.605	0.46302	1.0	0.71675	1.0	0.68239	1.0	0.97202	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778011T>G	ClinGen:CA281974|UniProtKB:P15056#VAR_058625	C1275081|C3661900	PS115150	1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Lys	Asn	48841.0	single nucleotide variant	NM_004333.6(BRAF):c.1497A>C (p.Lys499Asn)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 23, 2015	397507476.0	-	RCV000207509|RCV001814021	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	not provided|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140778011.0	140778011.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA281974,UniProtKB:P15056#VAR_058625	2.0	40371.0	140778011.0	T	G	-	-	-	-	-	-	SCV000057218|SCV000263064	-	-	1497A>C 	Lys499Asn	NM_004333.6	2.0	1_Pathogenic	78.83	0.2048780487804878		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		78.83	0.20487805	10-90	70-90						K	42			78.83	Positively-charged	Lysine		Serine/threonine-protein kinase B-raf							Protein kinase			-3.9								K499-G503, K499-D448, K499-L495, K499-S447; PAE: 1.0, 8.0, 1.0, 10.0	69 interactions	K499-G503, K499-L495, K499-S447; PAE: 1.0, 1.0, 10.0	69 interactions	K499-D448; PAE: 8.0						147									-59.1				-39.0						H (helix)	H (α-helix)	Helix																																																																			true	BRAFLys499Asn																																																																																																																																																																																																																																		
BRIP1	BRIP1_Gln255His	0.732346824162546	0.5112396507139866	-0.8359911693403168	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7943743364411087	0.7101349582585574	0.8259909968224303	0.7978721183391031	0.7836722507491773	0.7502156437554368	0.7841145318724635	0.7927843692248923	0.6969966491731286	0.8066482874246345	0.8171288577429179	0.8116297048057426	0.8591976244199683	0.7232732673439862	0.782100385457583	BRIP1	0.732346824162546	0.5112396507139866	-0.8359911693403168	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7943743364411087	0.7101349582585574	0.8259909968224303	0.7978721183391031	0.7836722507491773	0.7502156437554368	0.7841145318724635	0.7927843692248923	0.6969966491731286	0.8066482874246345	0.8171288577429179	0.8116297048057426	0.8591976244199683	0.7232732673439862	0.782100385457583	BRIP1		55128		CCSBVarC031354		NC_000017.11:61808620:C:A	765G>T	Gln255His																												17.0	61808620.0	C	A	17						17-61808620-C-A	917865.0	single nucleotide variant	NM_032043.3(BRIP1):c.765G>T (p.Gln255His)	83990.0	BRIP1	HGNC:20473	Pathogenic	1.0	Feb 07, 2011	2078111971.0	-	RCV001194716	MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	Fanconi anemia complementation group J	germline	germline	GRCh38	NC_000017.11	17	61808620.0	61808620.0	17q23.2	no assertion criteria provided	1.0	-	N	ClinGen:CA400484955	2.0	929523.0	61808620.0	C	A	-	-	-	-	-	-	SCV001364483	-	-	765G>T 	Gln255His	NM_032043.3		1_Pathogenic		929523.0	17	61808620.0	C	A	Q	H	rs2078111971	17	59885981.0	17	57240763.0	255.0	BRIP1	ENSG00000136492	ENST00000682453	ENSP00000506943	Q9BX63	FANCJ_HUMAN	.	.	c.765G>T	p.Gln255His	principal2	Y	.	.	.	-	CAG	3.0	2.0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.76775	.	1.0	0.90580	D	0.999	0.92348	D	.	0.90832	.	.	.	.	4.365	0.98493	H	.	0.79862	.	.	0.99419	0.5765	0.91558	D	0.6879	0.89189	D	9.0	.	0.98250	.	0.227769	0.88077	D	.	0.93600	0.913	0.98298	Q9BX63	Q255H	Gain of phosphorylation at T252 (P = 0.1383)| Gain of catalytic residue at K254 (P = 0.178)| Loss of methylation at K254 (P = 0.1938)| Loss of disorder (P = 0.2059)| Gain of helix (P = 0.2294)	.	0.97798	.	0.96706	.	0.58020	0.720037281513	0.70000	T	0.799612	0.94832	D	0.393787	0.8948	D	0.327871	0.89348	D	0.999322414398193	0.96939	D	0.918508	0.70644	D	0.92846745	0.93994	0.8937532	0.94458	0.9292196	0.94071	0.88003564	0.93477	-14.306	0.94021	D	.	0.97151	.	0.999870395781411	0.98499	0.98894000	0.96574	0.738	0.85485	.	.	.	.	.	.	4.62463	0.73515	26.0	0.9976467273363989	0.85348	0.713631	0.66516	D	0.878838601052151	0.90632	10.51746	0.789515383178468	0.88995	9.820491	5.29	5.29	0.74394	.	.	4.371	0.5938	5.995000	0.52465	0.549	0.27038	1.0	0.71675	1.0	0.68239	0.999	0.91597	46	0.97740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Fanconi_anemia_complementation_group_J	no_assertion_criteria_provided	NC_000017.11:g.61808620C>A	.	C1836860	609054	84	.	Gln	His	917865.0	single nucleotide variant	NM_032043.3(BRIP1):c.765G>T (p.Gln255His)	83990.0	BRIP1	HGNC:20473	Pathogenic	1.0	Feb 07, 2011	2078111971.0	-	RCV001194716	MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	Fanconi anemia complementation group J	germline	germline	GRCh38	NC_000017.11	17	61808620.0	61808620.0	17q23.2	no assertion criteria provided	1.0	-	N	ClinGen:CA400484955	2.0	929523.0	61808620.0	C	A	-	-	-	-	-	-	SCV001364483	-	-	765G>T 	Gln255His	NM_032043.3		1_Pathogenic	87.04	0.1464646464646464	['609054']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	FANCONI ANEMIA, COMPLEMENTATION GROUP J	87.04	0.14646465	10-90	70-90						Q	29			87.04	Polar/Neutral	Glutamine		Fanconi anemia group J protein							Helicase ATP-binding	0.0242		-3.5								Q255-I259; PAE: 1.0		Q255-I259; PAE: 1.0								146									-73.7		Pocket 5: Mean pLDDT: 71.11, Volume: 1880.97 Å³, Druggability score: 0.02		-37.1				dbSNP: -; Variant type: LP/P; AA change: Gln255His; PTM type: Ubiquitylation; PTM morphology: GTRTHkQ*IAQI; Var class: II		H (helix)	H (α-helix)																																																																				true	BRIP1Gln255His																																																																																																																																																																																																																																		
LMNA	LMNA_Arg335Trp	4.583862108039076	0.0025321301333144763	-0.9255931267106533	0.385456246323218	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7741630340852412	0.6081953202204338	0.6834959533238236	0.748664838385952	0.6510994386752087	0.711489638930998	0.8279131353541587	0.6641384677519655	0.6181679353333233	0.768175515004324	0.5907092384194192	0.6694165414177452	0.7028534388956819	0.5982227051075442	0.7801505531661583	LMNA	4.583862108039076	0.0025321301333144763	-0.9255931267106533	0.385456246323218	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7741630340852412	0.6081953202204338	0.6834959533238236	0.748664838385952	0.6510994386752087	0.711489638930998	0.8279131353541587	0.6641384677519655	0.6181679353333233	0.768175515004324	0.5907092384194192	0.6694165414177452	0.7028534388956819	0.5982227051075442	0.7801505531661583	LMNA	ENSG00000160789	3903	201328.0	CCSBVarC003620	ALE00003620	NC_000001.11:156135967:C:T	1003C>T	Arg335Trp	CEGS2	CegsMutGDEh1047	B06	GDEhDisVCh_40057	G10	1.0	CegsMutGDDh1047	B06							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	156135967.0	C	T	1	Y	Y	N	N	N	1-156135967-C-T	45135.0	single nucleotide variant	NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	4000.0	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1.0	Sep 12, 2024	386134243.0	-	RCV000030145|RCV000182368|RCV000721960|RCV000546102|RCV000852407|RCV003492303|RCV000844672|RCV001196390|RCV003149579|RCV002477025|RCV004532421|RCV000620788|RCV000845456	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900|MONDO:MONDO:0012417,MedGen:C1857829,OMIM:610140,Orphanet:168796|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247|MONDO:MONDO:0016333,MedGen:C0340427,OMIM:PS115200,Orphanet:217607|MONDO:MONDO:0021106,MedGen:C5392094,Orphanet:98301;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0007269,MedGen:C1449563,OMIM:115200,Orphanet:300751|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|11 conditions||MedGen:CN230736|Human Phenotype Ontology:HP:0030682,MONDO:MONDO:0018901,MedGen:C1960469,OMIM:PS604169,Orphanet:54260	Primary dilated cardiomyopathy|not provided|Heart-hand syndrome, Slovenian type|Charcot-Marie-Tooth disease type 2|Arrhythmogenic right ventricular cardiomyopathy|Primary familial dilated cardiomyopathy|Laminopathy;Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiomyopathy|11 conditions|LMNA-related disorder|Cardiovascular phenotype|Left ventricular noncompaction	germline;unknown	germline	GRCh38	NC_000001.11	1	156135967.0	156135967.0	1q22	criteria provided, multiple submitters, no conflicts	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016426,OMIM:150330.0058	3.0	36473.0	156135967.0	C	T	-	-	-	-	-	-	SCV000052800|SCV000064996|SCV000234691|SCV000611277|SCV000657788|SCV000736761|SCV000927154|SCV000987545|SCV000995090|SCV001366997|SCV001715569|SCV003838810|SCV004112973|SCV004240883|SCV005196726|SCV005427697	-	-	1003C>T 	Arg335Trp	NM_170707.4	2.0	1_Pathogenic		36473.0	1	156135967.0	C	T	R	W	rs386134243	1	156105758.0	1	154372382.0	335.0	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.1003C>T	p.Arg335Trp	c.1003C>T	p.Arg335Trp	principal1	Y	1	YES	Select	+	CGG	1.0	2.0	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.003	0.92967	D	1.0	0.90580	D	0.964	0.76461	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.775	0.95135	H	-6.78	0.93600	D	0.96	0.97765	0.9382	0.96209	D	0.8766	0.95894	D	10.0	0.9271074	0.91967	D	0.816539	0.98568	D	0.819	0.94182	0.588	0.71518	P02545	R335W	Loss of solvent accessibility (P = 0.1077)| Gain of MoRF binding (P = 0.1637)| Loss of relative solvent accessibility (P = 0.3219)| Loss of methylation at R331 (P = 0.4354)| Loss of glycosylation at S334 (P = 0.5435)	0.964334009803	0.96363	0.9541123517558469	0.95368	2.09983672442	0.94792	0.747377514839	0.74014	T	0.978141	0.99804	D	0.458005	0.92783	D	0.420116	0.92694	D	0.997435510158539	0.91475	D	0.962604	0.86719	D	0.8800445	0.89526	0.80577844	0.88487	0.8201633	0.85040	0.8051204	0.88446	-12.785	0.89664	D	0.5886	0.68353	P	0.99922285455029	0.96001	0.99997473	0.99978	0.78	0.87822	.	.	.	.	.	.	5.395437	0.90388	31.0	0.9992203917276604	0.98853	0.948098	0.95922	D	0.829224154962615	0.87830	9.3793	0.777752911999856	0.88143	9.496604	5.87	5.87	0.94257	.	.	2.013	0.40665	4.774000	0.44870	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.992	0.67791	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613920	6.196090e-07	0	1	1180030	8.474360e-07	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29604	0.000000e+00	0	0	44890	0.000000e+00	0	0	63884	0.000000e+00	0	0	6082	0.000000e+00	0	1	1180030	8.474360e-07	0	0	91088	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4588	2.1795989537925023E-4	0	2918	0	0	112	0	2	35432	5.644615037254459E-5	Pathogenic/Likely_pathogenic	LMNA-related_disorder|Cardiovascular_phenotype|Left_ventricular_noncompaction|Cardiomyopathy|Primary_familial_dilated_cardiomyopathy|not_provided|Arrhythmogenic_right_ventricular_cardiomyopathy|Charcot-Marie-Tooth_disease_type_2B1|Emery-Dreifuss_muscular_dystrophy_2,_autosomal_dominant|Mandibuloacral_dysplasia_with_type_A_lipodystrophy|Dilated_cardiomyopathy-hypergonadotropic_hypogonadism_syndrome|Dilated_cardiomyopathy_1A|Heart-hand_syndrome,_Slovenian_type|Hutchinson-Gilford_syndrome|Emery-Dreifuss_muscular_dystrophy_3,_autosomal_recessive|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Familial_partial_lipodystrophy,_Dunnigan_type|Restrictive_dermopathy_2|Primary_dilated_cardiomyopathy|Laminopathy|Charcot-Marie-Tooth_disease_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156135967C>T	ClinGen:CA016426|OMIM:150330.0058	CN230736|C1960469|C0878544|C0340427|C3661900|C0349788|C1854154|C0410190|C5399785|C0796031|C1449563|C1857829|C0033300|C2750035|C2750785|C1720860|C5676942|C0007193|C5392094|C0270914	PS604169|PS115200|605588|181350|248370|212112|115200|610140|176670|616516|613205|151660|619793	54260|167848|217607|247|98856|261|264|2457|90153|2229|300751|168796|740|261|98855|157973|2348|217604|98301|64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Trp	45135.0	single nucleotide variant	NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	4000.0	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1.0	Sep 12, 2024	386134243.0	-	RCV000030145|RCV000182368|RCV000721960|RCV000546102|RCV000852407|RCV003492303|RCV000844672|RCV001196390|RCV003149579|RCV002477025|RCV004532421|RCV000620788|RCV000845456	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900|MONDO:MONDO:0012417,MedGen:C1857829,OMIM:610140,Orphanet:168796|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247|MONDO:MONDO:0016333,MedGen:C0340427,OMIM:PS115200,Orphanet:217607|MONDO:MONDO:0021106,MedGen:C5392094,Orphanet:98301;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0007269,MedGen:C1449563,OMIM:115200,Orphanet:300751|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|11 conditions||MedGen:CN230736|Human Phenotype Ontology:HP:0030682,MONDO:MONDO:0018901,MedGen:C1960469,OMIM:PS604169,Orphanet:54260	Primary dilated cardiomyopathy|not provided|Heart-hand syndrome, Slovenian type|Charcot-Marie-Tooth disease type 2|Arrhythmogenic right ventricular cardiomyopathy|Primary familial dilated cardiomyopathy|Laminopathy;Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiomyopathy|11 conditions|LMNA-related disorder|Cardiovascular phenotype|Left ventricular noncompaction	germline;unknown	germline	GRCh38	NC_000001.11	1	156135967.0	156135967.0	1q22	criteria provided, multiple submitters, no conflicts	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016426,OMIM:150330.0058	3.0	36473.0	156135967.0	C	T	-	-	-	-	-	-	SCV000052800|SCV000064996|SCV000234691|SCV000611277|SCV000657788|SCV000736761|SCV000927154|SCV000987545|SCV000995090|SCV001366997|SCV001715569|SCV003838810|SCV004112973|SCV004240883|SCV005196726|SCV005427697	-	-	1003C>T 	Arg335Trp	NM_170707.4	2.0	1_Pathogenic	95.78	0.6048387096774194	['610140', '115200']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9	HEART-HAND SYNDROME, SLOVENIAN TYPE; CARDIOMYOPATHY, DILATED, 1A	95.78	0.6048387	10-90	>90						R	150			95.78	Positively-charged	Arginine		Prelamin-A/C; Lamin-A/C							IF rod			-4.5								R335-R331, R335-A339; PAE: 3.5, 3.0	5 interactions	R335-R331, R335-A339; PAE: 3.5, 3.0	5 interactions	R335-D332; PAE: 3.0						175									-61.6				-44.0	Coil 2					H (helix)	H (α-helix)	Helix																																																																			true	LMNAArg335Trp																																																																																																																																																																																																																																		
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5774829440065505	0.619979233890782	0.630432172164868	0.6139086915424442	0.6581225100425153	0.7460344492262554	0.7492680935785165	0.7642515512449607	0.6574226292404438	0.6368043165107827	0.5702105708587752	0.47854928950637193	0.49661279308477535	0.5825358385411202	0.5181615715023183	F9	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5774829440065505	0.619979233890782	0.630432172164868	0.6139086915424442	0.6581225100425153	0.7460344492262554	0.7492680935785165	0.7642515512449607	0.6574226292404438	0.6368043165107827	0.5702105708587752	0.47854928950637193	0.49661279308477535	0.5825358385411202	0.5181615715023183	F9	ENSG00000101981	52861	204394.0	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139562009.0	G	A	X	Y	N	N	N	N	X-139562009-G-A	25663.0	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 11, 2013	137852267.0	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009.0	139562009.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1.0	10624.0	139562009.0	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic		10624.0	X	139562009.0	G	A	G	R	rs137852267	X	138644168.0	X	138471834.0	442.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10.0	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.9992730836360176	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663.0	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 11, 2013	137852267.0	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009.0	139562009.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1.0	10624.0	139562009.0	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic	90.12	0.0	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	90.12	0.0	<10	>90						G	0			90.12	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.4								G442-A397; PAE: 1.0	3 interactions	G442-A397, G442-D405; PAE: 1.0, 6.5	6 interactions							75									-67.9				141.7						B (undefined)	E (parallel sheets)	Beta strand																													1.05		0.861		0.844	1 mutation(s) (Gly442Ter: -0.015)	0.823		0.845																														true	F9Gly442Arg																																																																																																																																																																																																																																		
KRAS	KRAS_Thr58Ile	-0.39527774123572407	0.7044069422700285	1.3907484853397487	0.20691013190075047	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7187518229642839	0.7044606909104751	0.8405295346581736	0.8411712800458675	0.8417676501090672	0.7960650923919101	0.8465006346220918	0.7589450425882613	0.6643028810530798	0.6496548415989407	0.8874702078262242	0.8358419254696432	0.922114026728086	0.7446185007678706	0.787848804329627	KRAS	-0.39527774123572407	0.7044069422700285	1.3907484853397487	0.20691013190075047	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7187518229642839	0.7044606909104751	0.8405295346581736	0.8411712800458675	0.8417676501090672	0.7960650923919101	0.8465006346220918	0.7589450425882613	0.6643028810530798	0.6496548415989407	0.8874702078262242	0.8358419254696432	0.922114026728086	0.7446185007678706	0.787848804329627	KRAS	ENSG00000133703	3084	214487.0	CCSBVarC006096	ALE00006096	NC_000012.12:25227351:G:A	173C>T	Thr58Ile	CEGS2	CegsMutGDEh1040	G09	GDEhDisVCh_40061	H09	1.0	CegsMutGDDh1040	G09							1.0	1.0	1.0	2.0	0.0			0.0			0.0			12.0	25227351.0	G	A	12	Y	Y	N	N	N	12-25227351-G-A	27627.0	single nucleotide variant	NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894364.0	-	RCV000013419|RCV000157933|RCV000211785|RCV000704828	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 3|not provided|Noonan syndrome|RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227351.0	25227351.0	12p12.1	reviewed by expert panel	7.0	-	N	ClinGen:CA256480,UniProtKB:P01116#VAR_026111,OMIM:190070.0011	3.0	12588.0	25227351.0	G	A	-	-	-	-	-	-	SCV000616369	-	-	173C>T 	Thr58Ile	NM_004985.5	3.0	1_Pathogenic	6.8411e-7	12588.0	12	25227351.0	G	A	T	I	rs104894364	12	25380285.0	12	25271552.0	58.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.173C>T	p.Thr58Ile	c.173C>T	p.Thr58Ile	alternative1	Y	1	.	Plus_Clinical	-	ACA	2.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.87	0.90832	A	simple_aae	13.0	87.0	2.76	0.80456	M	-5.82	0.88318	D	0.985	0.99419	0.9591	0.96522	D	0.8519	0.95052	D	9.0	0.95001256	0.94271	D	0.262968	0.89556	D	0.921	0.98001	0.826	0.93687	P01116	T58I	Gain of catalytic residue at A59 (P = 0)| Loss of glycosylation at T58 (P = 0.0493)| Loss of disorder (P = 0.0697)| Loss of sheet (P = 0.1398)| Loss of phosphorylation at T58 (P = 0.1979)	0.993069005404	0.99291	0.9692766844020148	0.96898	2.79487049805	0.98863	0.928796410561	0.98917	D	0.892475	0.97806	D	0.461113	0.9292	D	0.42458	0.92832	D	0.997460722923279	0.91549	D	0.931307	0.74400	D	0.98686	0.99577	0.96777624	0.99355	0.98655695	0.99559	0.97297084	0.99581	-12.877	0.90103	D	0.9994	0.99054	P	0.999977356359875	0.99427	0.99922788	0.99231	0.997	0.99892	.	.	.	.	.	.	5.459501	0.91162	32.0	0.9988997876552835	0.96438	0.874898	0.79727	D	0.989759110368124	0.95396	13.60356	0.904634796992952	0.95748	13.95184	5.77	4.87	0.6283	3.17	0.57548	9.985	0.99185	9.977000	0.82927	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613990	6.195830e-07	0	1	64002	1.562450e-05	0	0	75010	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29598	0.000000e+00	0	0	44872	0.000000e+00	0	1	64002	1.562450e-05	0	0	6060	0.000000e+00	0	0	1179936	0.000000e+00	0	0	91080	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	Noonan_syndrome|RASopathy|Noonan_syndrome_3|not_provided	reviewed_by_expert_panel	NC_000012.12:g.25227351G>A	ClinGen:CA256480|OMIM:190070.0011|UniProtKB:P01116#VAR_026111	C0028326|C5555857|C1860991|C3661900	PS163950|609942	648|536391|648	Small GTP-binding domain	Thr	Ile	27627.0	single nucleotide variant	NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894364.0	-	RCV000013419|RCV000157933|RCV000211785|RCV000704828	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 3|not provided|Noonan syndrome|RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227351.0	25227351.0	12p12.1	reviewed by expert panel	7.0	-	N	ClinGen:CA256480,UniProtKB:P01116#VAR_026111,OMIM:190070.0011	3.0	12588.0	25227351.0	G	A	-	-	-	-	-	-	SCV000616369	-	-	173C>T 	Thr58Ile	NM_004985.5	3.0	1_Pathogenic	94.05	0.0070422535211267	['609942']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3	94.05	0.0070422534	<10	>90																																																																																																																																		true	KRASThr58Ile																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Ala157Thr	-10.081278927908906	0.00002028191414801023	9.593570090277995	0.000028105857841895354	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9483739003283926	0.7244896379208832	0.9243976681979726	0.899883056461795	0.7673007260649709	0.8225176987191085	0.8795583823130079	0.9021636911526654	0.7383830096110535	0.9207357200542785	0.7120837534108332	0.920207730610582	0.9466316452432798	0.7105962662307128	0.9760120806025069	ZC4H2	-10.081278927908906	0.00002028191414801023	9.593570090277995	0.000028105857841895354	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9483739003283926	0.7244896379208832	0.9243976681979726	0.899883056461795	0.7673007260649709	0.8225176987191085	0.8795583823130079	0.9021636911526654	0.7383830096110535	0.9207357200542785	0.7120837534108332	0.920207730610582	0.9466316452432798	0.7105962662307128	0.9760120806025069	ZC4H2		4320		CCSBVarC009160		NC_000023.11:64919134:C:T	469G>A	Ala157Thr																												23.0	64919134.0	C	T	X						X-64919134-C-T	1195791.0	single nucleotide variant	NM_018684.4(ZC4H2):c.469G>A (p.Ala157Thr)	55906.0	ZC4H2	HGNC:24931	Conflicting classifications of pathogenicity	0.0	Mar 01, 2023	756615930.0	-	RCV001572168	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000023.11	X	64919134.0	64919134.0	Xq11.2	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA10433405	2.0	1205492.0	64919134.0	C	T	-	-	-	-	-	-	SCV001796760|SCV004674635	-	-	469G>A 	Ala157Thr	NM_018684.4	1.0	3_Conflicting		1205492.0	X	64919134.0	C	T	A	T	rs756615930	X	64139014.0	X	64055739.0	157.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.469G>A	p.Ala157Thr	c.469G>A	p.Ala157Thr	principal1	Y	1	YES	Select	-	GCT	1.0	0.0	C	./.	./.	./.	./.	0.345	0.12584	T	0.671	0.08074	T	0.999	0.77914	D	0.994	0.82066	D	0.07	0.44282	N	simple_aae	93.0	7.0	1.59	0.40152	L	-0.2	0.10073	N	0.56	0.58756	-0.5882	0.6514	T	0.3458	0.70954	T	9.0	0.355225	0.51923	D	0.179905	0.85417	D	0.212	0.50121	.	.	.	.	.	0.496162226526	0.48888	0.696682045515307	0.69455	0.00654792661685	0.00552	0.645161211491	0.59234	T	0.270772	0.64106	T	0.0837489	0.6221	D	-0.117477	0.61741	T	0.376825159565334	0.27756	T	0.927207	0.73106	D	0.30280557	0.52822	0.3234439	0.58049	0.30280557	0.52822	0.3234439	0.58048	-5.678	0.44103	T	0.4207	0.60657	A	0.690180673695841	0.66695	0.97556907	0.95109	0.138	0.36230	.	.	.	.	.	.	3.698819	0.52818	23.3	0.9979353332596635	0.87938	.	.	.	.	.	.	.	.	.	5.36	5.36	0.7659	.	.	7.638	0.82522	7.554000	0.60397	0.595	0.32887	1.0	0.71675	0.999	0.35501	0.966	0.53174	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	4	77492	5.161820e-05	0	4	145397	2.751090e-05	0	4	164610	2.429990e-05	0	0	5627	0.000000e+00	0	1	13221	7.563720e-05	0	0	1650	0.000000e+00	0	1	6793	1.472100e-04	0	0	9769	0.000000e+00	0	2	29771	6.717950e-05	0	0	9288	0.000000e+00	0	1	6793	1.472100e-04	0	0	12905	0.000000e+00	0	1	23514	4.252790e-05	0	0	4286	0.000000e+00	0	1	9851	1.015130e-04	0	0	11944	0.000000e+00	0	2	61889	3.231590e-05	0	0	17571	0.000000e+00	0	1	9851	1.015130e-04	0	0	11834	0.000000e+00	0	1	26175	3.820440e-05	0	0	6515	0.000000e+00	0	1	12811	7.805790e-05	0	0	15672	0.000000e+00	0	2	70182	2.849730e-05	0	0	17506	0.000000e+00	0	1	12811	7.805790e-05	0	.	14	1205217	1.161620e-05	0	3	45240	6.631300e-05	0	3	57025	5.260850e-05	0	0	685	0.000000e+00	0	3	45240	6.631300e-05	0	0	21757	0.000000e+00	0	1	33605	2.975750e-05	0	0	46483	0.000000e+00	0	0	4345	0.000000e+00	0	6	892775	6.720620e-06	0	0	55969	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.64919134C>T	.	C3661900	.	.	.	Ala	Thr	1195791.0	single nucleotide variant	NM_018684.4(ZC4H2):c.469G>A (p.Ala157Thr)	55906.0	ZC4H2	HGNC:24931	Conflicting classifications of pathogenicity	0.0	Mar 01, 2023	756615930.0	-	RCV001572168	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000023.11	X	64919134.0	64919134.0	Xq11.2	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA10433405	2.0	1205492.0	64919134.0	C	T	-	-	-	-	-	-	SCV001796760|SCV004674635	-	-	469G>A 	Ala157Thr	NM_018684.4	1.0	3_Conflicting	66.51	0.5849056603773585		unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		66.51	0.5849057	10-90	50-70						A	62			66.51	Aliphatic	Alanine		Zinc finger C4H2 domain-containing protein										1.8								A157-A161, A157-E153; PAE: 2.0, 3.0		A157-A161, A157-E153; PAE: 2.0, 3.0								89									-62.8				-40.2						H (helix)	H (α-helix)																																																																				true	ZC4H2Ala157Thr																																																																																																																																																																																																																																		
BRCA1	BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.2777054491482396	0.056828180249927085	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.8722085911191721	0.8865191451530433	0.9190049478036881	0.9036052053724655	0.9270470895032172	0.9374086932621492	0.9212174631292718	0.8871382643932934	0.920129200991745	0.8452376868441218	0.9166854857442854	0.8859929476156592	0.9508716312140828	0.8529090893143416	0.8991794953942224	BRCA1	1.6193629120142436	0.14940127798338723	2.2777054491482396	0.056828180249927085	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.8722085911191721	0.8865191451530433	0.9190049478036881	0.9036052053724655	0.9270470895032172	0.9374086932621492	0.9212174631292718	0.8871382643932934	0.920129200991745	0.8452376868441218	0.9166854857442854	0.8859929476156592	0.9508716312140828	0.8529090893143416	0.8991794953942224	BRCA1	ENSG00000012048	14613	218428.0	CCSBVarC003305	ALE00003305	NC_000017.11:43063941:A:T	1773T>A	Phe591Leu	CEGS2	CegsMutGDEh1019	H03	GDEhDisVCh_40059	F06	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43063941.0	A	T	17	Y	N	N	N	N	17-43063941-A-T	70056.0	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672.0	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0.0	Apr 26, 2023	80357387.0	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941.0	43063941.0	17q21.31	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2.0	55389.0	43063941.0	A	T	-	-	-	-	-	-	SCV000660974|SCV002187048	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1.0	3_Conflicting		55389.0	17	43063941.0	A	T	F	L	rs80357387	17	41215958.0	17	38469484.0	1695.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5085T>A	p.Phe1695Leu	principal2	Y	1	.	.	-	TTT	3.0	2.0	A	A/A	A/A	A/A	A/A	.	0.25997	.	.	0.09167	.	0.237	0.30812	B	0.107	0.31213	B	.	.	.	.	.	.	0.135	0.08601	N	.	0.42578	.	.	0.55139	0.4353	0.89578	D	0.6291	0.86934	D	10.0	.	0.54565	.	0.768432	0.98164	D	.	0.77150	.	.	.	.	.	.	0.82922	.	0.46484	.	0.27990	0.637575030327	0.58154	T	0.133578	0.46135	T	0.169896	0.709	D	0.00626705	0.70525	D	0.324614346916885	0.25715	T	.	0.56037	.	0.2819536	0.50902	0.15177552	0.35630	0.2757978	0.50311	0.17792259	0.40291	-3.59	0.38578	T	.	0.80507	.	0.151693788840998	0.47210	0.99911267	0.99153	0.531	0.73422	.	.	.	.	.	.	1.972208	0.25095	16.62	0.918993205517774	0.21471	0.371736	0.45580	N	-0.338194724745546	0.27430	1.522421	-0.156317829821601	0.32854	1.89438	5.83	4.74	0.59667	1.84	0.37836	1.51	0.35504	2.150000	0.30988	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.996	0.76032	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109358	0.000000e+00	0	0	207972	0.000000e+00	0	1	236754	4.223790e-06	0	0	7154	0.000000e+00	0	0	17104	0.000000e+00	0	0	2314	0.000000e+00	0	0	9038	0.000000e+00	0	0	13394	0.000000e+00	0	0	42754	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30508	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16734	0.000000e+00	0	0	89470	0.000000e+00	0	0	30600	0.000000e+00	0	.	.	.	.	0	14886	0.000000e+00	0	0	34246	0.000000e+00	0	0	9556	0.000000e+00	0	0	17682	0.000000e+00	0	0	21628	0.000000e+00	0	1	102632	9.743550e-06	0	0	30518	0.000000e+00	0	1	102632	9.743550e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000017.11:g.43063941A>T	ClinGen:CA003223	C0677776|C0027672|C2676676	604370	145|140162|145	BRCT domain|BRCT domain|BRCT domain	Phe	Leu	70056.0	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672.0	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0.0	Apr 26, 2023	80357387.0	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941.0	43063941.0	17q21.31	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2.0	55389.0	43063941.0	A	T	-	-	-	-	-	-	SCV000660974|SCV002187048	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1.0	3_Conflicting	94.82	0.1421319796954314	['604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	94.82	0.14213198	10-90	>90																																																																																																																																		true	BRCA1Phe591Leu																																																																																																																																																																																																																																		
RAF1	RAF1_Thr145Pro	-6.387994716345845	0.1333777500132942	3.706074644344897	0.04897839094117087	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6824342108869526	0.6706865399264045	0.7621559555489222	0.7380571248875574	0.7368016110544434	0.6948395624861297	0.7812129413187235	0.7411965198648527	0.6776063686022727	0.8303045437251851	0.7787636596227572	0.6949013084563911	0.7831153912329918	0.6637667112505362	0.5345638780487201	RAF1	-6.387994716345845	0.1333777500132942	3.706074644344897	0.04897839094117087	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6824342108869526	0.6706865399264045	0.7621559555489222	0.7380571248875574	0.7368016110544434	0.6948395624861297	0.7812129413187235	0.7411965198648527	0.6776063686022727	0.8303045437251851	0.7787636596227572	0.6949013084563911	0.7831153912329918	0.6637667112505362	0.5345638780487201	RAF1		732		CCSBVarC008929		NC_000003.12:12608914:T:G	433A>C	Thr145Pro																												3.0	12608914.0	T	G	3						3-12608914-T-G	359447.0	single nucleotide variant	NM_002880.4(RAF1):c.433A>C (p.Thr145Pro)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Nov 03, 2016	1057518155.0	-	RCV000414587	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000003.12	3	12608914.0	12608914.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA16042457	2.0	373032.0	12608914.0	T	G	-	-	-	-	-	-	SCV000491591	-	-	433A>C 	Thr145Pro	NM_002880.4	1.0	1_Pathogenic		373032.0	3	12608914.0	T	G	T	P	rs1057518155	3	12650413.0	3	12625413.0	145.0	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.433A>C	p.Thr145Pro	principal3	Y	.	.	.	-	ACG	1.0	0.0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.79703	.	0.884	0.48632	P	0.651	0.52493	P	.	0.94378	.	.	.	.	3.94	0.96320	H	.	0.76607	.	.	0.66620	1.087	0.99121	D	0.9288	0.97644	D	10.0	.	0.92727	.	0.77786	0.98245	D	.	0.99189	0.737	0.86913	P04049	T145P	Gain of glycosylation at T145 (P = 0.0599)| Gain of methylation at K144 (P = 0.1056)| Loss of MoRF binding (P = 0.1062)| Loss of ubiquitination at K144 (P = 0.1287)| Loss of stability (P = 0.1872)	.	0.96289	.	0.91688	.	0.82338	0.8487200737	0.89403	D	0.964761	0.99568	D	0.532258	0.9516	D	0.526776	0.95088	D	0.999636769294739	0.98238	D	.	0.87265	.	0.9750533	0.98689	0.9437567	0.97981	0.97559345	0.98735	0.95809036	0.98851	-11.037	0.80472	D	.	0.93458	.	0.999952511305676	0.99183	0.98135380	0.95656	0.995	0.99826	.	.	.	.	.	.	5.106479	0.85379	28.6	0.994001331148419	0.628	0.965951	0.98828	D	0.899566054000196	0.91692	11.03838	0.836522703996796	0.92161	11.29401	5.62	5.62	0.85695	5.35	0.93259	8.012	0.88241	7.910000	0.74019	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.994	0.71086	646	0.63408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.12608914T>G	ClinGen:CA16042457	CN517202	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Thr	Pro	359447.0	single nucleotide variant	NM_002880.4(RAF1):c.433A>C (p.Thr145Pro)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Nov 03, 2016	1057518155.0	-	RCV000414587	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000003.12	3	12608914.0	12608914.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA16042457	2.0	373032.0	12608914.0	T	G	-	-	-	-	-	-	SCV000491591	-	-	433A>C 	Thr145Pro	NM_002880.4	1.0	1_Pathogenic	90.82	0.5563380281690141		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		90.82	0.556338	10-90	>90						T	79			90.82	Polar/Neutral	Threonine		RAF proto-oncogene serine/threonine-protein kinase										-0.7								T145-N161; PAE: 1.5	6 interactions		3 interactions							119									-93.8				125.8						B (undefined)	E (parallel sheets)	Beta strand										Phorbol-ester/DAG-type																																																									true	RAF1Thr145Pro																																																																																																																																																																																																																																		
RET	RET_Gly321Arg	1.6968224836440589	0.13354425044658957	6.221935624960898	0.00043585464276858364	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8019248152759191	0.759045421526985	0.8500405161128783	0.8354381067874153	0.8257382270041278	0.9773253630312239	0.9133247694306528	0.9512187140707647	0.8969964654655831	0.8509189221520284	0.6741510909770319	0.7575514441441777	0.7488623181549918	0.6210943775883868	0.7529307083998097	RET	1.6968224836440589	0.13354425044658957	6.221935624960898	0.00043585464276858364	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8019248152759191	0.759045421526985	0.8500405161128783	0.8354381067874153	0.8257382270041278	0.9773253630312239	0.9133247694306528	0.9512187140707647	0.8969964654655831	0.8509189221520284	0.6741510909770319	0.7575514441441777	0.7488623181549918	0.6210943775883868	0.7529307083998097	RET	ENSG00000165731	8858	202955.0	CCSBVarC006879	ALE00006877	NC_000010.11:43106469:G:A	961G>A	Gly321Arg	CEGS2	CegsMutGDEh1026	B06	GDEhDisVCh_40066	D05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43106469.0	G	A	10	Y	N	N	N	N	10-43106469-G-A	36222.0	single nucleotide variant	NM_020975.6(RET):c.961G>A (p.Gly321Arg)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	377767388.0	-	RCV000148776|RCV000679758|RCV000709104|RCV000567555|RCV000231209|RCV001818171|RCV003460487|RCV004528128	Human Phenotype Ontology:HP:0002865,MONDO:MONDO:0015277,MeSH:C536914,MedGen:C0238462,Orphanet:1332|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|	Medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43106469.0	43106469.0	10q11.21	criteria provided, conflicting classifications	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009403	2.0	24881.0	43106469.0	G	A	-	-	-	-	-	-	SCV000190513|SCV000290569|SCV000674744|SCV000807066|SCV000838373|SCV002011439|SCV002069391|SCV002527937|SCV004208632|SCV004243365|SCV004699800|SCV005623126	-	-	961G>A 	Gly321Arg	NM_020975.6	1.0	3_Conflicting	0.0000499656	24881.0	10	43106469.0	G	A	G	R	rs377767388	10	43601917.0	10	42921923.0	321.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.961G>A	p.Gly321Arg	c.961G>A	p.Gly321Arg	principal4	Y	5	YES	Select	+	GGG	1.0	0.0	G	G/G	G/G	G/G	G/G	0.231	0.18346	T	0.565	0.09199	T	0.007	0.16277	B	0.003	0.12129	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.1	0.27864	L	-1.64	0.39308	N	0.222	0.27952	-0.9759	0.35787	T	0.1969	0.54992	T	10.0	0.103147626	0.18741	T	0.032094	0.53831	D	0.428	0.73376	0.69	0.82670	P07949	G321R	Gain of solvent accessibility (P = 0.019)| Gain of sheet (P = 0.0477)| Gain of MoRF binding (P = 0.0483)| Gain of phosphorylation at T323 (P = 0.1426)| Loss of catalytic residue at W324 (P = 0.1943)	0.940005915424	0.93891	0.6768714346963912	0.67466	0.238921890069	0.26162	0.346982002258	0.17459	T	0.435003	0.78028	T	-0.129129	0.31279	T	-0.186593	0.55604	T	0.0158652041221491	0.00371	T	0.673133	0.27914	T	0.1105618	0.25900	0.06433436	0.12879	0.07723053	0.17355	0.065889634	0.13420	-5.573	0.42597	T	0.0874	0.13936	B	0.0249176742024401	0.31262	0.99895360	0.99055	0.232	0.50061	.	.	.	.	.	.	0.991371	0.1371	10.23	0.905705273679359	0.20078	0.047661	0.07918	N	-1.07470700909571	0.07027	0.3294123	-1.05180989670877	0.08525	0.4273997	5.32	-1.32	0.087	-4.57	0.05201	0.268	0.18399	0.913000	0.22725	-0.752	0.03581	0.0	0.06393	0.204	0.23666	0.251	0.23335	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	31	264690	1.17118136E-4	.	9	108388	8.303500e-05	0	14	205672	6.806950e-05	0	18	234342	7.681080e-05	0	0	7006	0.000000e+00	0	1	17008	5.879590e-05	0	0	2296	0.000000e+00	0	2	8970	2.229650e-04	0	0	13298	0.000000e+00	0	6	42326	1.417570e-04	0	0	15586	0.000000e+00	0	2	8970	2.229650e-04	0	1	15894	6.291680e-05	0	1	30330	3.297070e-05	0	0	6148	0.000000e+00	0	1	13284	7.527850e-05	0	0	16620	0.000000e+00	0	11	88210	1.247020e-04	0	0	30384	0.000000e+00	0	11	88210	1.247020e-04	0	0	14646	0.000000e+00	0	1	34086	2.933760e-05	0	0	9534	0.000000e+00	0	2	17588	1.137140e-04	0	0	20960	0.000000e+00	0	15	101642	1.475770e-04	0	0	30312	0.000000e+00	0	15	101642	1.475770e-04	0	.	86	1613150	5.331180e-05	0	8	44842	1.784040e-04	0	7	74884	9.347790e-05	0	0	912	0.000000e+00	0	6	59956	1.000730e-04	0	0	29578	0.000000e+00	0	8	44842	1.784040e-04	0	0	63818	0.000000e+00	0	0	6078	0.000000e+00	0	61	1179700	5.170810e-05	0	1	90932	1.099720e-05	0	5	31942	1.5653371736271994E-4	0	306	0	0	112	0	2	8442	2.3691068467187872E-4	0	146	0	0	610	0	0	56	0	0	98	0	0	4502	0	2	8748	2.2862368541380886E-4	0	168	0	7	46214	1.514692517418964E-4	Conflicting_classifications_of_pathogenicity	RET-related_disorder|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|not_specified|not_provided|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Medullary_thyroid_carcinoma	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106469G>A	ClinGen:CA009403	C0025268|C3888239|CN169374|C3661900|C4048306|C0027672|C0238462	171400|142623	247698|653|388|653|140162|1332	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Gly	Arg	36222.0	single nucleotide variant	NM_020975.6(RET):c.961G>A (p.Gly321Arg)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	377767388.0	-	RCV000148776|RCV000679758|RCV000709104|RCV000567555|RCV000231209|RCV001818171|RCV003460487|RCV004528128	Human Phenotype Ontology:HP:0002865,MONDO:MONDO:0015277,MeSH:C536914,MedGen:C0238462,Orphanet:1332|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|	Medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43106469.0	43106469.0	10q11.21	criteria provided, conflicting classifications	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009403	2.0	24881.0	43106469.0	G	A	-	-	-	-	-	-	SCV000190513|SCV000290569|SCV000674744|SCV000807066|SCV000838373|SCV002011439|SCV002069391|SCV002527937|SCV004208632|SCV004243365|SCV004699800|SCV005623126	-	-	961G>A 	Gly321Arg	NM_020975.6	1.0	3_Conflicting	85.2	0.988095238095238	['171400', '142623']	autosomal dominant	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	85.2	0.9880952	$\geqslant$90	70-90						G	83			85.2	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-0.4									1 interaction		2 interactions							75									-166.6				-51.7	Cadherin-like region 3 (CLD3)					C (loop/coil)	S (bend)							Extracellular																																																													true	RETGly321Arg																																																																																																																																																																																																																																		
RAD51D	RAD51D_Val28Leu	-0.90363915640805	0.3962182548910523	11.911894475594515	6.680577611790558e-6	2025_01_Batch_13-14	false	false	true	false	false	false	false	false	false	false	0.947548482585512	0.8261002526349338	0.9578654553558794	0.903442921160879	0.9003979003764573	0.8519265761309345	0.8839725446363323	0.9477089800607024	0.7668278317963809	0.9382073875115703	0.9488692246219802	0.9229132976854257	0.9680219306510565	0.8853726734734867	0.9568895776594537	RAD51D	-0.90363915640805	0.3962182548910523	11.911894475594515	6.680577611790558e-6	2025_01_Batch_13-14	false	false	true	false	false	false	false	false	false	false	0.947548482585512	0.8261002526349338	0.9578654553558794	0.903442921160879	0.9003979003764573	0.8519265761309345	0.8839725446363323	0.9477089800607024	0.7668278317963809	0.9382073875115703	0.9488692246219802	0.9229132976854257	0.9680219306510565	0.8853726734734867	0.9568895776594537	RAD51D		7201		CCSBVarC024750		NC_000017.11:35119532:C:G	82G>C	Val28Leu																												17.0	35119532.0	C	G	17						17-35119532-C-G	1813922.0	single nucleotide variant	NM_002878.4(RAD51D):c.82G>C (p.Val28Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	1.0	Nov 06, 2023	-1.0	-	RCV002430340|RCV003454215	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	germline;unknown	germline	GRCh38	NC_000017.11	17	35119532.0	35119532.0	17q12	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA399092236	2.0	1762829.0	35119532.0	C	G	-	-	-	-	-	-	SCV002681932|SCV004189682	-	-	82G>C 	Val28Leu	NM_002878.4	1.0	3_Conflicting		1762829.0	17	35119532.0	C	G	V	L	rs2142480064	17	33446551.0	17	30470664.0	28.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.82G>C	p.Val28Leu	c.82G>C	p.Val28Leu	principal1	Y	5	.	.	-	GTG	1.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.106	0.92967	T	1.0	0.90580	D	0.996	0.84488	D	.	.	.	.	.	.	2.71	0.79120	M	-2.45	0.56973	N	0.495	0.55314	-0.3621	0.73082	T	0.3608	0.7213	T	9.0	0.57687366	0.65335	D	0.226204	0.88003	D	0.229	0.52699	0.463	0.53105	O75771	V28L	Loss of sheet (P = 0.0126)| Gain of helix (P = 0.027)| Gain of loop (P = 0.0851)| Gain of ubiquitination at K26 (P = 0.1504)| Loss of phosphorylation at T27 (P = 0.2477)	0.834963111294	0.83208	.	0.68920	.	0.39860	.	.	.	0.485341	0.81083	T	0.0746214	0.61132	D	-0.130588	0.60646	T	0.984222710132599	0.75431	D	0.90461	0.67517	D	0.593787	0.72069	0.3945471	0.63896	0.593787	0.72070	0.3945471	0.63896	-8.931	0.67329	D	0.7085	0.75430	P	0.00939506599652921	0.23451	0.90928640	0.91550	0.676	0.82005	.	.	.	.	.	.	7.247327	0.96318	36.0	0.9980075429760781	0.88559	0.836844	0.75365	D	0.678883385112307	0.78132	6.833586	0.616344378564284	0.75995	6.433988	4.5	4.5	0.54328	.	.	3.379	0.52266	7.344000	0.58328	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.947	0.4917	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119532C>G	.	C0027672|C3280345	614291	140162|145	RAD51D, N-terminal domain	Val	Leu	1813922.0	single nucleotide variant	NM_002878.4(RAD51D):c.82G>C (p.Val28Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	1.0	Nov 06, 2023	-1.0	-	RCV002430340|RCV003454215	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	germline;unknown	germline	GRCh38	NC_000017.11	17	35119532.0	35119532.0	17q12	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA399092236	2.0	1762829.0	35119532.0	C	G	-	-	-	-	-	-	SCV002681932|SCV004189682	-	-	82G>C 	Val28Leu	NM_002878.4	1.0	3_Conflicting	89.91	0.0704225352112676	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	89.91	0.07042254	<10	70-90						V	10			89.91	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2								V28-G2, V28-V32; PAE: 3.0, 1.0	5 interactions	V28-G2, V28-V32; PAE: 3.0, 1.0	7 interactions							117									-57.1				-39.1	preferentially binds ssDNA					H (helix)	H (α-helix)	Helix																																																																			true	RAD51DVal28Leu																																																																																																																																																																																																																																		
LMNA	LMNA_Arg349Leu	1.0956468444891008	0.3094917419063528	4.167510144450547	0.00420217915215487	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9056807456101992	0.5989341809403117	0.7927038536584616	0.7825426049991538	0.5663751697083431	0.5475822828122247	0.8102874186572842	0.773820649870661	0.6142904451750753	0.9257224225340441	0.5851680566044616	0.7547977913410235	0.8115870574462624	0.583577916705548	0.8856390686863543	LMNA	1.0956468444891008	0.3094917419063528	4.167510144450547	0.00420217915215487	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9056807456101992	0.5989341809403117	0.7927038536584616	0.7825426049991538	0.5663751697083431	0.5475822828122247	0.8102874186572842	0.773820649870661	0.6142904451750753	0.9257224225340441	0.5851680566044616	0.7547977913410235	0.8115870574462624	0.583577916705548	0.8856390686863543	LMNA	ENSG00000160789	3903	201322.0	CCSBVarC003621	ALE00003621	NC_000001.11:156136010:G:T	1046G>T	Arg349Leu	CEGS2	CegsMutGDEh1042	E02	GDEhDisVCh_40057	B10	1.0	CegsMutGDDh1042	E02							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	156136010.0	G	T	1	Y	Y	N	N	N	1-156136010-G-T	77660.0	single nucleotide variant	NM_170707.4(LMNA):c.1046G>T (p.Arg349Leu)	4000.0	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1.0	Sep 27, 2024	58789393.0	-	RCV000057219|RCV001854172|RCV003343625	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	germline	germline	GRCh38	NC_000001.11	1	156136010.0	156136010.0	1q22	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016488,UniProtKB:P02545#VAR_039776	2.0	66763.0	156136010.0	G	T	-	-	-	-	-	-	SCV001715571|SCV002262706|SCV004074698	-	-	1046G>T 	Arg349Leu	NM_170707.4	1.0	3_Conflicting		66763.0	1	156136010.0	G	T	R	L	rs58789393	1	156105801.0	1	154372425.0	349.0	LMNA	ENSG00000160789	ENST00000361308	ENSP00000355292	P02545	LMNA_HUMAN	c.1046G>T	p.Arg349Leu	c.1046G>T	p.Arg349Leu	principal1	Y	5	.	.	+	CGG	2.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.003	0.79703	D	0.775	0.90580	P	0.896	0.86259	P	0.97	0.97016	D	simple_aae	3.0	97.0	3.8	0.95330	H	-6.56	0.91889	D	0.965	0.98762	0.9518	0.9641	D	0.8633	0.95442	D	10.0	0.97176325	0.96764	D	0.755624	0.98052	D	0.871	0.96123	0.801	0.91975	P02545	R349L	Loss of MoRF binding (P = 0.0632)| Loss of methylation at R349 (P = 0.2199)| Gain of stability (P = 0.2765)| Loss of catalytic residue at M345 (P = 0.6375)| Loss of solvent accessibility (P = 0.6392)	0.966327329089	0.96566	.	0.98457	.	0.96624	0.813560366631	0.84010	D	0.967344	0.99617	D	0.495723	0.94117	D	0.474295	0.94039	D	0.992853701114655	0.83317	D	.	0.96357	.	0.7229245	0.79081	0.65043724	0.79322	0.6761609	0.76503	0.61561835	0.77388	-8.52	0.71001	D	0.9091	0.83342	LP	0.999839382529083	0.98239	0.99996722	0.99978	0.981	0.99334	.	.	.	.	.	.	5.301637	0.89027	29.8	0.9984669047389269	0.92668	0.974698	0.99573	D	0.899982601079214	0.91714	11.04923	0.832866080674497	0.91933	11.169	5.74	4.83	0.61832	4.47	0.83830	10.003	0.9969	11.671000	0.94110	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.955	0.50625	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|not_provided	criteria_provided,_conflicting_classifications	NC_000001.11:g.156136010G>T	ClinGen:CA016488|UniProtKB:P02545#VAR_039776	C0270914|CN230736|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Leu	77660.0	single nucleotide variant	NM_170707.4(LMNA):c.1046G>T (p.Arg349Leu)	4000.0	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1.0	Sep 27, 2024	58789393.0	-	RCV000057219|RCV001854172|RCV003343625	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	germline	germline	GRCh38	NC_000001.11	1	156136010.0	156136010.0	1q22	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016488,UniProtKB:P02545#VAR_039776	2.0	66763.0	156136010.0	G	T	-	-	-	-	-	-	SCV001715571|SCV002262706|SCV004074698	-	-	1046G>T 	Arg349Leu	NM_170707.4	1.0	3_Conflicting	94.82	0.6451612903225806		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		94.82	0.6451613	10-90	>90						R	160			94.82	Positively-charged	Arginine		Prelamin-A/C; Lamin-A/C							IF rod			-4.5								R349-Q353, R349-M345; PAE: 3.5, 2.5	3 interactions	R349-Q353, R349-M345; PAE: 3.5, 2.5	4 interactions							175									-63.9				-41.9	Coil 2					H (helix)	H (α-helix)																																																																				true	LMNAArg349Leu																																																																																																																																																																																																																																		
SDHD	SDHD_Ile31Val	4.150235795989882	0.009338842715277238	1.667033369287295	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8443874023966711	0.7423970858844429	0.7870980906552614	0.85764651989402	0.8072850058865859	0.8632571331477497	0.9092146244980089	0.7855611845527318	0.759573299204002	0.8648443535593294	0.7513128786254221	0.8060784152900309	0.788634996757791	0.7252208725648839	0.8239304512340127	SDHD	4.150235795989882	0.009338842715277238	1.667033369287295	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8443874023966711	0.7423970858844429	0.7870980906552614	0.85764651989402	0.8072850058865859	0.8632571331477497	0.9092146244980089	0.7855611845527318	0.759573299204002	0.8648443535593294	0.7513128786254221	0.8060784152900309	0.788634996757791	0.7252208725648839	0.8239304512340127	SDHD		6363		CCSBVarC023265		NC_000011.10:112087895:A:G	91A>G	Ile31Val																												11.0	112087895.0	A	G	11						11-112087895-A-G	837951.0	single nucleotide variant	NM_003002.4(SDHD):c.91A>G (p.Ile31Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	May 11, 2024	1865653068.0	-	RCV002240532|RCV002374977|RCV003151276|RCV004000160	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Pheochromocytoma;Cowden syndrome 3;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss|Hereditary cancer-predisposing syndrome|not specified|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112087895.0	112087895.0	11q23.1	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382616974	2.0	860158.0	112087895.0	A	G	-	-	-	-	-	-	SCV001231428|SCV002688111|SCV004822330	-	-	91A>G 	Ile31Val	NM_003002.4	1.0	3_Conflicting		860158.0	11	112087895.0	A	G	I	V	rs1865653068	11	111958619.0	11	111463829.0	31.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.91A>G	p.Ile31Val	c.91A>G	p.Ile31Val	principal1	Y	1	YES	Select	+	ATC	1.0	0.0	A	./.	./.	./.	./.	1.0	0.00968	T	1.0	0.03973	T	0.0	0.02950	B	0.0	0.01384	B	0.08	0.31989	N	simple_aae	92.0	8.0	-1.025	0.01134	N	0.18	0.05010	N	0.085	0.06176	-0.5465	0.66773	T	0.4158	0.76166	T	10.0	0.04787895	0.04166	T	0.031946	0.53719	D	0.476	0.76693	0.381	0.39663	O14521	I31V	Gain of sheet (P = 0.1208)| Gain of methylation at R27 (P = 0.1334)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2754)| Gain of catalytic residue at I31 (P = 0.2808)	0.786847784675	0.78318	0.43965305476109695	0.43682	0.15461328637	0.17194	0.309365063906	0.11802	T	0.146378	0.48116	T	0.0852895	0.6239	D	-0.115264	0.61922	T	0.0309518799185753	0.02125	T	0.533947	0.19158	T	0.02366694	0.01119	0.026847782	0.00805	0.02366694	0.01119	0.026847782	0.00805	-2.33	0.06038	T	0.0626	0.12187	B	0.00494223008028627	0.18766	0.92538464	0.92192	0.029	0.05809	.	.	.	.	.	.	0.134814	0.05315	1.791	0.747064287509916	0.10972	0.118743	0.22993	N	-1.22373084351358	0.04605	0.2106841	-1.06657851552802	0.08227	0.4109787	4.81	2.78	0.3162	.	.	0.472	0.21905	2.708000	0.34295	-0.743	0.03658	0.37	0.26012	0.994	0.32271	0.663	0.33093	635	0.64545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_specified|Hereditary_pheochromocytoma-paraganglioma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112087895A>G	.	CN169374|C1708353|CN166604|C1847319|C0031511|C1868633|C0027672	606864|171300	29072|201|97286|29072|140162	.	Ile	Val	837951.0	single nucleotide variant	NM_003002.4(SDHD):c.91A>G (p.Ile31Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	May 11, 2024	1865653068.0	-	RCV002240532|RCV002374977|RCV003151276|RCV004000160	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Pheochromocytoma;Cowden syndrome 3;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss|Hereditary cancer-predisposing syndrome|not specified|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112087895.0	112087895.0	11q23.1	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382616974	2.0	860158.0	112087895.0	A	G	-	-	-	-	-	-	SCV001231428|SCV002688111|SCV004822330	-	-	91A>G 	Ile31Val	NM_003002.4	1.0	3_Conflicting	46.82	0.9112426035502958	['171300', '606864']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	46.82	0.9112426	$\geqslant$90	<=50						I	154			46.82	Aliphatic	Isoleucine												4.5																		131									-73.7				92.7						C (loop/coil)	C (loop/coil)								Mitochondrion																																																												true	SDHDIle31Val																																																																																																																																																																																																																																		
BRCA1	BRCA1_His239Arg	1.417428348829569	0.1992960548370097	3.0457234726586297	0.018695506167409306	2025_01_Batch_13-14	false	true	true	false	true	false	true	false	false	true	0.931956614027402	0.9288704150613851	0.9608066396505645	0.9233539026370335	0.978941096572921	0.9834822561252834	0.9312856180684361	0.9549275984709393	0.9457601553816197	0.9240071908703403	0.9743999370205588	0.915422187205631	0.9666856808301896	0.9119806747411504	0.9399060371844637	BRCA1	1.417428348829569	0.1992960548370097	3.0457234726586297	0.018695506167409306	2025_01_Batch_13-14	false	true	true	false	true	false	true	false	false	true	0.931956614027402	0.9288704150613851	0.9608066396505645	0.9233539026370335	0.978941096572921	0.9834822561252834	0.9312856180684361	0.9549275984709393	0.9457601553816197	0.9240071908703403	0.9743999370205588	0.915422187205631	0.9666856808301896	0.9119806747411504	0.9399060371844637	BRCA1		14613		CCSBVarC013119		NC_000017.11:43094815:T:C	716A>G	His239Arg																												17.0	43094815.0	T	C	17						17-43094815-T-C	70344.0	single nucleotide variant	NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	80357396.0	-	RCV000112775|RCV000212160|RCV000509604|RCV001284302|RCV001339091|RCV004730865	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43094815.0	43094815.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003832,UniProtKB:P38398#VAR_007760	2.0	55677.0	43094815.0	T	C	-	-	-	-	-	-	SCV001161506	-	-	716A>G 	His239Arg	NM_007294.4	3.0	2_Benign		55677.0	17	43094815.0	T	C	H	R	rs80357396	17	41246832.0	17	38500358.0	239.0	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.716A>G	p.His239Arg	principal2	Y	.	.	.	-	CAT	2.0	0.0	T	T/T	T/T	T/T	T/T	.	0.32128	.	.	0.54888	.	0.246	0.31119	B	0.088	0.29689	B	.	0.37131	.	.	.	.	1.685	0.43087	L	.	0.47184	.	.	0.46309	-0.9591	0.39179	T	0.1025	0.37609	T	10.0	.	0.21054	.	0.091977	0.75728	D	.	0.84105	0.1	0.01473	E9PFC7	H239R	Gain of helix (P = 0.0496)| Loss of loop (P = 0.0603)| Gain of phosphorylation at S242 (P = 0.0822)| Gain of catalytic residue at H239 (P = 0.1099)| Loss of glycosylation at S242 (P = 0.135)	.	0.84735	.	0.23229	.	0.28222	0.27954185009	0.07426	T	0.185323	0.53598	T	0.239413	0.77438	D	0.12161	0.78181	D	0.148020625114441	0.16733	T	.	0.43633	.	0.035958365	0.04291	0.04630083	0.06439	0.035795223	0.04242	0.04520483	0.06046	-3.317	0.13969	T	.	0.10254	.	0.0751285277574732	0.40751	0.99015945	0.96756	0.062	0.17126	.	.	.	.	.	.	0.040361	0.04582	1.25	0.7929382912457673	0.12881	0.152364	0.27488	N	-0.571032691664479	0.19588	1.040847	-0.739922874726497	0.15702	0.8425785	4.64	-1.76	0.07559	2.57E-4	0.21563	-0.794	0.04696	-0.577000	0.08433	0.609	0.47831	0.004	0.16649	0.001	0.17376	0.804	0.3794	494	0.76469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109054	9.169770e-06	0	2	206786	9.671830e-06	0	2	235362	8.497550e-06	0	0	7154	0.000000e+00	0	0	16994	0.000000e+00	0	0	2310	0.000000e+00	0	0	9020	0.000000e+00	0	0	13374	0.000000e+00	0	1	42666	2.343790e-05	0	0	15632	0.000000e+00	0	1	42666	2.343790e-05	0	0	15854	0.000000e+00	0	0	30300	0.000000e+00	0	0	6190	0.000000e+00	0	0	13376	0.000000e+00	0	0	16690	0.000000e+00	0	2	89080	2.245170e-05	0	0	30498	0.000000e+00	0	2	89080	2.245170e-05	0	0	14542	0.000000e+00	0	0	34032	0.000000e+00	0	0	9544	0.000000e+00	0	0	17632	0.000000e+00	0	0	21568	0.000000e+00	0	2	102084	1.959170e-05	0	0	30416	0.000000e+00	0	2	102084	1.959170e-05	0	.	5	1613714	3.098440e-06	0	5	1179908	4.237620e-06	0	0	74988	0.000000e+00	0	0	912	0.000000e+00	0	0	59900	0.000000e+00	0	0	29590	0.000000e+00	0	0	44872	0.000000e+00	0	0	63992	0.000000e+00	0	0	6060	0.000000e+00	0	5	1179908	4.237620e-06	0	0	91010	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign	not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43094815T>C	ClinGen:CA003832|UniProtKB:P38398#VAR_007760	C3661900|CN169374|C0677776|C2676676|C0027672	604370	145|145|140162	.	His	Arg	70344.0	single nucleotide variant	NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	80357396.0	-	RCV000112775|RCV000212160|RCV000509604|RCV001284302|RCV001339091|RCV004730865	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43094815.0	43094815.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003832,UniProtKB:P38398#VAR_007760	2.0	55677.0	43094815.0	T	C	-	-	-	-	-	-	SCV001161506	-	-	716A>G 	His239Arg	NM_007294.4	3.0	2_Benign	32.01	0.8913043478260869	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	32.01	0.8913044	10-90	<=50																																																																																																																																		true	BRCA1His239Arg																																																																																																																																																																																																																																		
F9	F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7479024360841889	0.5832833363494987	0.7469473415764403	0.6301823085816638	0.6400983547782287	0.7006583857956397	0.6349475052381794	0.7575240541543928	0.5895147161593801	0.7446486183877772	0.5795383237608178	0.6254171119251482	0.7363706289984878	0.5770519565396172	0.7511562537806007	F9	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7479024360841889	0.5832833363494987	0.7469473415764403	0.6301823085816638	0.6400983547782287	0.7006583857956397	0.6349475052381794	0.7575240541543928	0.5895147161593801	0.7446486183877772	0.5795383237608178	0.6254171119251482	0.7363706289984878	0.5770519565396172	0.7511562537806007	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C	1328T>C	Ile443Thr																												23.0	139562013.0	T	C	X						X-139562013-T-C	25666.0	single nucleotide variant	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Aug 21, 2024	137852268.0	-	RCV000011371|RCV001810850|RCV005042032|RCV001382695	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562013.0	139562013.0	Xq27.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	3.0	10627.0	139562013.0	T	C	-	-	-	-	-	-	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	-	-	1328T>C 	Ile443Thr	NM_000133.4	2.0	1_Pathogenic		10627.0	X	139562013.0	T	C	I	T	rs137852268	X	138644172.0	X	138471838.0	443.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1328T>C	p.Ile443Thr	c.1328T>C	p.Ile443Thr	principal1	Y	1	YES	Select	+	ATA	2.0	0.0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.003	0.76775	D	0.973	0.57613	D	0.951	0.68937	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.195	0.61650	M	-4.11	0.75007	D	0.704	0.93024	0.7153	0.93342	D	0.7847	0.92672	D	10.0	0.9883479	0.99241	D	0.919322	0.99403	D	0.905	0.97394	0.953	0.99464	P00740	I443T	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.999526675672	0.99951	0.9967505453949344	0.99673	1.8200784132	0.91900	0.708432018757	0.68313	T	0.894511	0.97862	D	0.538835	0.95331	D	0.536223	0.95261	D	0.993006281329265	0.83514	D	0.931207	0.78302	D	0.9132074	0.92487	0.92443126	0.96661	0.92416036	0.93561	0.8973755	0.94718	-10.184	0.79899	D	0.7773	0.84877	P	0.99926867450489	0.96103	0.99998903	0.99996	0.986	0.99524	.	.	.	.	.	.	4.4192	0.68492	25.2	0.9985035315891414	0.93018	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	5.23	0.92191	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210935	8.258080e-07	0	1	895048	1.117260e-06	0	0	57682	0.000000e+00	0	0	688	0.000000e+00	0	0	45970	0.000000e+00	0	0	22027	0.000000e+00	0	0	33829	0.000000e+00	0	0	46791	0.000000e+00	0	0	4350	0.000000e+00	0	1	895048	1.117260e-06	0	0	56919	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139562013T>C	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	C0008533|C2749016|C3661900	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	25666.0	single nucleotide variant	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Aug 21, 2024	137852268.0	-	RCV000011371|RCV001810850|RCV005042032|RCV001382695	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562013.0	139562013.0	Xq27.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	3.0	10627.0	139562013.0	T	C	-	-	-	-	-	-	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	-	-	1328T>C 	Ile443Thr	NM_000133.4	2.0	1_Pathogenic	93.18	0.0355029585798816	['306900', '301052', '300807', '306900', '300807', '306900']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; WARFARIN SENSITIVITY, X-LINKED; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	93.18	0.03550296	<10	>90						I	6			93.18	Aliphatic	Isoleucine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			4.5								I443-S430, I443-W431; PAE: 1.0, 1.0	4 interactions	I443-W431; PAE: 1.0	7 interactions							131									-110.3				129.7						B (undefined)	E (parallel sheets)	Beta strand																													0.844		0.611		0.553		0.519		0.523																														true	F9Ile443Thr																																																																																																																																																																																																																																		
BAP1	BAP1_Ser596Gly	0.351957833731541	0.7352272520962135	0.8767858936876382	0.40968206922602535	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5230030168188609	0.5233610042433017	0.5116058320437751	0.597877275094881	0.5205569621563404	0.5532073414376034	0.6796596792339478	0.5627001908311333	0.5423182660052609	0.5646293238417727	0.48790658287507727	0.5160948709558142	0.4605114732564167	0.5044037424813426	0.48137670979594915	BAP1	0.351957833731541	0.7352272520962135	0.8767858936876382	0.40968206922602535	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5230030168188609	0.5233610042433017	0.5116058320437751	0.597877275094881	0.5205569621563404	0.5532073414376034	0.6796596792339478	0.5627001908311333	0.5423182660052609	0.5646293238417727	0.48790658287507727	0.5160948709558142	0.4605114732564167	0.5044037424813426	0.48137670979594915	BAP1		3760		CCSBVarC009473		NC_000003.12:52403242:T:C	1786A>G	Ser596Gly																												3.0	52403242.0	T	C	3						3-52403242-T-C	137403.0	single nucleotide variant	NM_004656.4(BAP1):c.1786A>G (p.Ser596Gly)	8314.0	BAP1	HGNC:950	Benign	0.0	Mar 04, 2025	79014342.0	-	RCV000120192|RCV000569518|RCV003315731|RCV000396271|RCV003654201	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900	not specified|Hereditary cancer-predisposing syndrome|Melanoma, uveal, susceptibility to, 2|BAP1-related tumor predisposition syndrome|not provided	germline;unknown	germline	GRCh38	NC_000003.12	3	52403242.0	52403242.0	3p21.1	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA157253	2.0	133664.0	52403242.0	T	C	-	-	-	-	-	-	SCV000310599|SCV000445464|SCV000518938|SCV000563727|SCV000602623|SCV000664595|SCV000682598|SCV002046889|SCV002537267|SCV002550709|SCV004016329|SCV005306435|SCV005404611	-	-	1786A>G 	Ser596Gly	NM_004656.4	2.0	2_Benign		133664.0	3	52403242.0	T	C	S	G	rs79014342	3	52437258.0	3	52412298.0	596.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.1786A>G	p.Ser596Gly	c.1786A>G	p.Ser596Gly	principal1	Y	1	YES	Select	-	AGC	1.0	0.0	T	T/T	T/T	T/T	T/T	0.393	0.10794	T	0.485	0.14890	T	0.0	0.02950	B	0.0	0.01384	B	0.02	0.08015	P	simple_aae	98.0	2.0	1.39	0.34781	L	0.01	0.15507	N	0.119	0.10867	-1.0601	0.1174	T	0.0022	0.007	T	10.0	0.0015929043	0.00018	T	.	.	.	0.046	0.12499	.	.	.	.	.	0.40146981186	0.39360	0.27734753240827054	0.27451	0.342242573836	0.35868	0.283363044262	0.07963	T	0.019939	0.15680	T	-0.690695	0.0004	T	-0.70984	0.0512	T	0.000335560480817249	0.00003	T	0.556544	0.19051	T	0.023078172	0.01012	0.035254005	0.02755	0.030649683	0.02742	0.042524464	0.05097	-4.038	0.24393	T	0.0674	0.02645	B	0.0411517187189644	0.35503	0.98504820	0.96067	0.024	0.04173	.	.	.	.	.	.	0.911982	0.12883	9.376	0.771878420735368	0.11964	0.066346	0.12810	N	-1.03807936463251	0.07730	0.3647541	-0.89131888610997	0.12086	0.6318495	5.94	-0.682	0.1074	0.733	0.26955	0.015	0.13291	0.443000	0.18516	-0.12	0.14111	0.001	0.13799	0.545	0.25517	0.339	0.25458	68	0.97129	135	0.026956869009584664	132	0.09984871406959153	1	9.940357852882703E-4	2	0.002881844380403458	0	0.0	0	0.0	6540	264690	0.02470815	.	683	109386	6.243940e-03	18	1445	208072	6.944710e-03	43	1393	236900	5.880120e-03	40	535	7164	7.467900e-02	18	122	17112	7.129500e-03	0	3	2320	1.293100e-03	0	0	9046	0.000000e+00	0	0	13372	0.000000e+00	0	20	42768	4.676390e-04	0	0	15690	0.000000e+00	0	535	7164	7.467900e-02	18	1203	16216	7.418600e-02	43	175	30514	5.735070e-03	0	7	6210	1.127210e-03	0	0	13416	0.000000e+00	0	0	16712	0.000000e+00	0	42	89532	4.691060e-04	0	2	30608	6.534240e-05	0	1203	16216	7.418600e-02	43	1108	14902	7.435240e-02	40	203	34250	5.927010e-03	0	15	9572	1.567070e-03	0	0	17692	0.000000e+00	0	0	21610	0.000000e+00	0	50	102730	4.867130e-04	0	2	30526	6.551790e-05	0	1108	14902	7.435240e-02	40	.	7156	1614170	4.433240e-03	250	5750	75034	7.663190e-02	242	5750	75034	7.663190e-02	242	0	912	0.000000e+00	0	419	60032	6.979610e-03	1	32	29608	1.080790e-03	0	1	44884	2.227970e-05	0	0	64004	0.000000e+00	0	36	6062	5.938630e-03	0	484	1180040	4.101560e-04	1	15	91084	1.646830e-04	0	75	190482	3.937379909912748E-4	29	370	0.07837837837837838	0	4510	0	681	9628	0.07073120066472788	21	812	0.02586206896551724	9	1042	0.008637236084452975	0	1850	0	0	296	0	79	17940	0.004403567447045708	710	9998	0.07101420284056811	0	6360	0	894	226930	0.0039395408275679725	Benign	not_specified|Hereditary_cancer-predisposing_syndrome|BAP1-related_tumor_predisposition_syndrome|Melanoma,_uveal,_susceptibility_to,_2|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52403242T>C	ClinGen:CA157253	CN169374|C0027672|C3280492|C1847723|C3661900	614327|606661	140162|289539|39044	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Ser	Gly	137403.0	single nucleotide variant	NM_004656.4(BAP1):c.1786A>G (p.Ser596Gly)	8314.0	BAP1	HGNC:950	Benign	0.0	Mar 04, 2025	79014342.0	-	RCV000120192|RCV000569518|RCV003315731|RCV000396271|RCV003654201	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900	not specified|Hereditary cancer-predisposing syndrome|Melanoma, uveal, susceptibility to, 2|BAP1-related tumor predisposition syndrome|not provided	germline;unknown	germline	GRCh38	NC_000003.12	3	52403242.0	52403242.0	3p21.1	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA157253	2.0	133664.0	52403242.0	T	C	-	-	-	-	-	-	SCV000310599|SCV000445464|SCV000518938|SCV000563727|SCV000602623|SCV000664595|SCV000682598|SCV002046889|SCV002537267|SCV002550709|SCV004016329|SCV005306435|SCV005404611	-	-	1786A>G 	Ser596Gly	NM_004656.4	2.0	2_Benign	37.93	0.8076923076923077	['606661', '614327']	unknown		0	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2; TUMOR PREDISPOSITION SYNDROME 1	37.93	0.8076923	10-90	<=50						S	105			37.93	Polar/Neutral	Serine		Ubiquitin carboxyl-terminal hydrolase BAP1		Polar residues								-0.8																		105									-162.1	Morphology: IQGsQGsssPVEKEV			173.9	Disordered; Interaction with BRCA1					C (loop/coil)	C (loop/coil)																																																																				true	BAP1Ser596Gly																																																																																																																																																																																																																																		
BRCA1	BRCA1_Arg71Gly	-1.183279693007538	0.275321882540562	5.634491429600971	0.0007870863265976704	2025_01_Batch_13-14	false	true	false	true	true	false	false	false	false	false	0.892438949072815	0.8882921968761427	0.9464421408849136	0.9403750159905584	0.9579992718750772	0.9304760710892357	0.940321856870626	0.9119236688191354	0.8374062887316356	0.8585648206893093	0.9855224726609187	0.9404281751104907	0.9809606129506918	0.9391781050206498	0.9263130774563206	BRCA1	-1.183279693007538	0.275321882540562	5.634491429600971	0.0007870863265976704	2025_01_Batch_13-14	false	true	false	true	true	false	false	false	false	false	0.892438949072815	0.8882921968761427	0.9464421408849136	0.9403750159905584	0.9579992718750772	0.9304760710892357	0.940321856870626	0.9119236688191354	0.8374062887316356	0.8585648206893093	0.9855224726609187	0.9404281751104907	0.9809606129506918	0.9391781050206498	0.9263130774563206	BRCA1		14613		CCSBVarC011856		NC_000017.11:43106457:T:C	211A>G	Arg71Gly																												17.0	43106457.0	T	C	17						17-43106457-T-C	32732.0	single nucleotide variant	NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80357382.0	-	RCV000047713|RCV000131899|RCV000195359|RCV000019263|RCV000469732|RCV000763009|RCV000508177|RCV004758595|RCV004802945	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN169374||MONDO:MONDO:0700268,MedGen:CN377757	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1;Familial cancer of breast|not specified|BRCA1-related disorder|BRCA1-related cancer predisposition	germline;not applicable;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	43106457.0	43106457.0	17q21.31	reviewed by expert panel	33.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001398,OMIM:113705.0034	3.0	17693.0	43106457.0	T	C	-	-	-	-	-	-	SCV001161539	-	-	211A>G 	Arg71Gly	NM_007294.4	3.0	1_Pathogenic		17693.0	17	43106457.0	T	C	R	G	rs80357382	17	41258474.0	17	38512000.0	71.0	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.211A>G	p.Arg71Gly	principal2	Y	.	.	.	-	AGG	1.0	2.0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.83643	.	0.956	0.59057	P	0.444	0.68273	B	.	0.99291	.	.	.	.	2.455	0.71058	M	.	0.92366	.	.	0.86054	0.8364	0.94843	D	0.8394	0.94619	D	10.0	.	0.92374	.	0.80066	0.98437	D	.	0.95939	0.809	0.92541	E9PFC7	R71G	Gain of ubiquitination at K70 (P = 0.0519)| Loss of solvent accessibility (P = 0.0807)| Loss of phosphorylation at T69 (P = 0.1027)| Gain of relative solvent accessibility (P = 0.1684)| Loss of disorder (P = 0.1823)	.	0.93459	.	0.57140	.	0.24793	0.550648927689	0.45883	T	0.325403	0.69435	T	0.464929	0.93082	D	0.430062	0.92996	D	0.867488086223602	0.51486	D	.	0.86835	.	0.7237265	0.79126	0.32902288	0.58556	0.63329226	0.74199	0.31909144	0.57647	-13.862	0.93673	D	.	0.89378	.	0.999229197308064	0.96001	0.99944407	0.99387	0.931	0.96596	.	.	.	.	.	.	5.274462	0.88579	29.6	0.9988738445191147	0.96206	0.840976	0.75732	D	0.586117233560111	0.72160	5.78522	0.5471513750929	0.71040	5.618586	4.64	4.64	0.57348	5.61	0.95042	4.16	0.58035	7.857000	0.71293	0.588	0.31377	1.0	0.71675	1.0	0.68239	0.994	0.71086	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	108704	0.000000e+00	0	1	206546	4.841540e-06	0	1	235294	4.250000e-06	0	0	7112	0.000000e+00	0	0	16894	0.000000e+00	0	0	2294	0.000000e+00	0	0	9040	0.000000e+00	0	0	13388	0.000000e+00	0	0	42620	0.000000e+00	0	0	15456	0.000000e+00	0	.	.	.	.	0	16078	0.000000e+00	0	0	30222	0.000000e+00	0	0	6166	0.000000e+00	0	0	13382	0.000000e+00	0	0	16704	0.000000e+00	0	1	89038	1.123120e-05	0	0	30132	0.000000e+00	0	1	89038	1.123120e-05	0	0	14770	0.000000e+00	0	0	33946	0.000000e+00	0	0	9522	0.000000e+00	0	0	17632	0.000000e+00	0	0	21592	0.000000e+00	0	1	102222	9.782630e-06	0	0	30050	0.000000e+00	0	1	102222	9.782630e-06	0	.	2	1580162	1.265690e-06	0	2	1150962	1.737680e-06	0	0	74308	0.000000e+00	0	0	912	0.000000e+00	0	0	59768	0.000000e+00	0	0	29370	0.000000e+00	0	0	44596	0.000000e+00	0	0	63918	0.000000e+00	0	0	5674	0.000000e+00	0	2	1150962	1.737680e-06	0	0	89324	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|not_specified|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|not_provided|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43106457T>C	ClinGen:CA001398|OMIM:113705.0034	C2676676|C0027672|CN169374|C0346153|C3280442|C4554406|C3661900|C0677776	604370|114480|614320|617883	145|140162|227535|1333|145	.	Arg	Gly	32732.0	single nucleotide variant	NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80357382.0	-	RCV000047713|RCV000131899|RCV000195359|RCV000019263|RCV000469732|RCV000763009|RCV000508177|RCV004758595|RCV004802945	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN169374||MONDO:MONDO:0700268,MedGen:CN377757	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1;Familial cancer of breast|not specified|BRCA1-related disorder|BRCA1-related cancer predisposition	germline;not applicable;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	43106457.0	43106457.0	17q21.31	reviewed by expert panel	33.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001398,OMIM:113705.0034	3.0	17693.0	43106457.0	T	C	-	-	-	-	-	-	SCV001161539	-	-	211A>G 	Arg71Gly	NM_007294.4	3.0	1_Pathogenic	82.37	0.9758064516129032	['604370', '114480', '617883', '614320', '604370', '114480']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER	82.37	0.9758065	$\geqslant$90	70-90																																																																																																																																		true	BRCA1Arg71Gly																																																																																																																																																																																																																																		
BRIP1	BRIP1_Thr266Lys	2.4151939589858755	0.10172105859617687	-2.8097461543970716	0.1251885088372282	2025_01_Batch_13-14	true	true	false	false	false	false	true	false	false	false	0.9777893004573297	0.9580039856242055	0.9435972021193435	0.9176700742473956	0.7356669134778155	0.7205994418325682	0.9278881751694511	0.9367839182156471	0.9552154710492178	0.9779481071676986	0.7507343851230628	0.90745197332534	0.9504104860230399	0.9607925001991933	0.9776304937469608	BRIP1	2.4151939589858755	0.10172105859617687	-2.8097461543970716	0.1251885088372282	2025_01_Batch_13-14	true	true	false	false	false	false	true	false	false	false	0.9777893004573297	0.9580039856242055	0.9435972021193435	0.9176700742473956	0.7356669134778155	0.7205994418325682	0.9278881751694511	0.9367839182156471	0.9552154710492178	0.9779481071676986	0.7507343851230628	0.90745197332534	0.9504104860230399	0.9607925001991933	0.9776304937469608	BRIP1		55128		CCSBVarC031356		NC_000017.11:61808588:G:T	797C>A	Thr266Lys																												17.0	61808588.0	G	T	17						17-61808588-G-T	2419129.0	single nucleotide variant	NM_032043.3(BRIP1):c.797C>A (p.Thr266Lys)	83990.0	BRIP1	HGNC:20473	Likely pathogenic	1.0	Jan 01, 2022	-1.0	-	RCV003154813	MONDO:MONDO:0008170,MedGen:C1140680,OMIM:167000,Orphanet:213500	Ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	61808588.0	61808588.0	17q23.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA400484892	2.0	2445403.0	61808588.0	G	T	-	-	-	-	-	-	SCV003843811	-	-	797C>A 	Thr266Lys	NM_032043.3	1.0	1_Pathogenic		2445403.0	17	61808588.0	G	T	T	K	.	17	59885949.0	17	57240731.0	266.0	BRIP1	ENSG00000136492	ENST00000682453	ENSP00000506943	Q9BX63	FANCJ_HUMAN	.	.	c.797C>A	p.Thr266Lys	principal2	Y	.	.	.	-	ACG	2.0	0.0	G	G/G	G/G	G/G	G/G	.	0.72322	.	.	0.74454	.	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4	0.96696	H	.	0.85874	.	.	0.91621	0.4095	0.89196	D	0.6264	0.86824	D	9.0	.	0.90945	.	0.281209	0.90215	D	.	0.94975	0.679	0.81610	Q9BX63	T266K	Gain of MoRF binding (P = 0.0353)| Loss of phosphorylation at T266 (P = 0.0447)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1066)| Loss of glycosylation at S269 (P = 0.1314)	.	0.95729	.	0.92109	.	0.62958	0.605375230312	0.53597	T	0.789212	0.94460	D	0.37424	0.88252	D	0.299793	0.88104	D	0.999525785446167	0.97739	D	0.90121	0.65586	D	0.92582095	0.93727	0.89155954	0.94301	0.92582095	0.93728	0.89155954	0.94301	-16.593	0.98525	D	.	0.87809	.	0.982054469378051	0.85829	0.98299720	0.95833	0.767	0.87099	.	.	.	.	.	.	4.777777	0.77458	26.7	0.9935436582004362	0.60794	0.906865	0.85967	D	0.929815744903823	0.93103	11.84782	0.873075489682459	0.94258	12.64629	5.29	5.29	0.74394	.	.	9.212	0.94247	11.864000	0.98400	0.618	0.50684	1.0	0.71675	1.0	0.68239	0.878	0.41977	46	0.97740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Ovarian_cancer	criteria_provided,_single_submitter	NC_000017.11:g.61808588G>T	.	C1140680	167000	213500	.	Thr	Lys	2419129.0	single nucleotide variant	NM_032043.3(BRIP1):c.797C>A (p.Thr266Lys)	83990.0	BRIP1	HGNC:20473	Likely pathogenic	1.0	Jan 01, 2022	-1.0	-	RCV003154813	MONDO:MONDO:0008170,MedGen:C1140680,OMIM:167000,Orphanet:213500	Ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	61808588.0	61808588.0	17q23.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA400484892	2.0	2445403.0	61808588.0	G	T	-	-	-	-	-	-	SCV003843811	-	-	797C>A 	Thr266Lys	NM_032043.3	1.0	1_Pathogenic	93.02	0.0140845070422535	['167000']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	OVARIAN CANCER	93.02	0.014084507	<10	>90						T	2			93.02	Polar/Neutral	Threonine		Fanconi anemia group J protein							Helicase ATP-binding			-0.7										T266-E262; PAE: 1.0								119									-96.1				166.8						C (loop/coil)	S (bend)																																																																				true	BRIP1Thr266Lys																																																																																																																																																																																																																																		
BRCA1	BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904402	0.6449300602568308	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6858482687105789	0.497402501474575	0.6816117950645211	0.6630151080049407	0.6200689945648612	0.6971719961665781	0.7869883368284541	0.834891704386117	0.49776189252515146	0.8313592527357382	0.5429659929631443	0.5390418791814273	0.5283318857429251	0.49704311042399857	0.5403372846854197	BRCA1	0.7722291595565172	0.4652467741162628	-0.4813800816904402	0.6449300602568308	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6858482687105789	0.497402501474575	0.6816117950645211	0.6630151080049407	0.6200689945648612	0.6971719961665781	0.7869883368284541	0.834891704386117	0.49776189252515146	0.8313592527357382	0.5429659929631443	0.5390418791814273	0.5283318857429251	0.49704311042399857	0.5403372846854197	BRCA1	ENSG00000012048	14613	218449.0	CCSBVarC003309	ALE00003309	NC_000017.11:43051104:A:G	1979T>C	Leu660Pro	CEGS2	CegsMutGDEh1027	B03	GDEhDisVCh_40059	B09	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43051104.0	A	G	17	Y	N	N	N	N	17-43051104-A-G	70177.0	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357281.0	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104.0	43051104.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2.0	55510.0	43051104.0	A	G	-	-	-	-	-	-	SCV000244395	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3.0	1_Pathogenic		55510.0	17	43051104.0	A	G	L	P	rs80357281	17	41203121.0	17	38456647.0	1764.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5291T>C	p.Leu1764Pro	principal2	Y	1	.	.	-	CTA	2.0	0.0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.79703	.	0.999	0.90580	D	0.937	0.77493	D	.	0.99291	.	.	.	.	2.255	0.63995	M	.	0.80457	.	.	0.93732	0.6256	0.92204	D	0.7595	0.91786	D	10.0	.	0.90949	.	0.852334	0.98860	D	.	0.88008	.	.	.	.	.	.	0.98778	.	0.82492	.	0.52805	0.554721057415	0.46456	T	0.394982	0.75228	T	0.436743	0.91807	D	0.389575	0.91707	D	0.994264304637909	0.85335	D	0.89611	0.63951	D	0.8910151	0.90460	0.6202942	0.77645	0.89131314	0.90488	0.55023813	0.73742	-11.462	0.82186	D	.	0.84401	.	0.997750985165462	0.93509	0.99987125	0.99835	0.96	0.98304	.	.	.	.	.	.	4.871541	0.79856	27.2	0.9989876250763176	0.97125	0.796452	0.72256	D	0.591172089691292	0.72477	5.834971	0.566318150584601	0.72388	5.826055	5.06	5.06	0.67796	5.33	0.93090	5.026	0.63961	11.097000	0.86063	0.756	0.943	1.0	0.71675	1.0	0.68239	0.96	0.51684	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051104A>G	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	C3661900|C0677776|C0027672|C2676676	604370	145|140162|145	.	Leu	Pro	70177.0	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357281.0	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104.0	43051104.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2.0	55510.0	43051104.0	A	G	-	-	-	-	-	-	SCV000244395	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3.0	1_Pathogenic	93.27	0.1646341463414634	['604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	93.27	0.16463415	10-90	>90																																																																																																																																		true	BRCA1Leu660Pro																																																																																																																																																																																																																																		
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5984972596557196	0.6092975844018562	0.650202878905044	0.6055681366443812	0.6272050795344148	0.5945518994223825	0.582100584468294	0.5442982248196072	0.5778750828460288	0.5316904259621111	0.6598582596464473	0.6290356888204685	0.7561075329904808	0.6407200859576836	0.665304093349328	F9	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5984972596557196	0.6092975844018562	0.650202878905044	0.6055681366443812	0.6272050795344148	0.5945518994223825	0.582100584468294	0.5442982248196072	0.5778750828460288	0.5316904259621111	0.6598582596464473	0.6290356888204685	0.7561075329904808	0.6407200859576836	0.665304093349328	F9	ENSG00000101981	52861	204380.0	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561754.0	G	A	X	Y	N	N	N	N	X-139561754-G-A	25650.0	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Sep 01, 2022	137852257.0	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754.0	139561754.0	Xq27.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3.0	10611.0	139561754.0	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2.0	1_Pathogenic		10611.0	X	139561754.0	G	A	G	R	rs137852257	X	138643913.0	X	138471579.0	357.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10.0	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747	0.9845	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.0	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650.0	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Sep 01, 2022	137852257.0	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754.0	139561754.0	Xq27.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3.0	10611.0	139561754.0	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2.0	1_Pathogenic	74.08	0.0357142857142857	['306900', '306700']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA A	74.08	0.035714287	<10	70-90						G	3			74.08	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.4								G357-D410, G357-A366; PAE: 3.0, 4.0	4 interactions	G357-D410, G357-A366; PAE: 3.0, 4.0	7 interactions							75									-61.1				176.2						C (loop/coil)	C (loop/coil)	Beta strand																													1.105		1.013		1.001		0.991		1.028																														true	F9Gly357Arg																																																																																																																																																																																																																																		
RAD51D	RAD51D_Val132Ile	1.1951833385138684	0.270931637294705	11.407170550504395	8.926785329176513e-6	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9635282052458122	0.7629520069142783	0.9355671526298636	0.9019900261847349	0.8355703915902188	0.852293666669155	0.8857411452603304	0.9427350272896435	0.8044850193577774	0.958227488959117	0.8188471165112827	0.9182389071091395	0.9283992779700836	0.7214189944707794	0.9688289215325073	RAD51D	1.1951833385138684	0.270931637294705	11.407170550504395	8.926785329176513e-6	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9635282052458122	0.7629520069142783	0.9355671526298636	0.9019900261847349	0.8355703915902188	0.852293666669155	0.8857411452603304	0.9427350272896435	0.8044850193577774	0.958227488959117	0.8188471165112827	0.9182389071091395	0.9283992779700836	0.7214189944707794	0.9688289215325073	RAD51D		7201		CCSBVarC024822		NC_000017.11:35107074:C:T	394G>A	Val132Ile																												17.0	35107074.0	C	T	17						17-35107074-C-T	184833.0	single nucleotide variant	NM_002878.4(RAD51D):c.394G>A (p.Val132Ile)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jan 19, 2025	201141245.0	-	RCV000458927|RCV000164547|RCV000588322|RCV004764772|RCV001356158	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	35107074.0	35107074.0	17q12	criteria provided, conflicting classifications	15.0	-	N	ClinGen:CA191240	2.0	185178.0	35107074.0	C	T	-	-	-	-	-	-	SCV000215203|SCV000292678|SCV000551340|SCV000698100|SCV000784995|SCV000822177|SCV000886447|SCV000910748|SCV001470090|SCV002534813|SCV004017742|SCV004208066|SCV005374642	-	-	394G>A 	Val132Ile	NM_002878.4	1.0	3_Conflicting		185178.0	17	35107074.0	C	T	V	I	rs201141245	17	33434093.0	17	30458206.0	132.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.394G>A	p.Val132Ile	c.394G>A	p.Val132Ile	principal1	Y	5	.	.	-	GTC	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.44188	.	0.039	0.53076	D	0.424	0.35468	B	0.382	0.43907	B	0.05	0.18971	N	simple_aae	95.0	5.0	2.62	0.76477	M	.	0.22672	.	0.216	0.24096	-0.3916	0.72168	T	0.3597	0.72046	T	10.0	0.109271616	0.20146	T	0.071049	0.71066	D	0.229	0.52699	.	.	.	.	.	0.62430428174	0.61834	.	0.37837	.	0.25574	.	.	.	0.15308	0.49109	T	-0.122049	0.32431	T	-0.107115	0.62576	T	0.0757847073892739	0.09324	T	0.738826	0.35767	T	0.08056444	0.18299	0.09804036	0.23318	0.08056444	0.18299	0.09804036	0.23318	-7.63	0.58592	D	0.1016	0.17936	B	0.000961144535626309	0.09382	0.62951803	0.84609	0.122	0.32993	.	.	.	.	.	.	1.358257	0.17693	13.3	0.7270908762019215	0.1023	0.067676	0.13137	N	-0.614819935582183	0.18271	0.9608728	-0.673516161556329	0.17340	0.9379878	4.65	2.66	0.3059	0.89	0.28255	1.984	0.40383	-0.207000	0.10935	-0.939	0.02107	0.942	0.32811	0.0	0.08389	0.696	0.34057	921	0.19236	2	3.9936102236421724E-4	1	7.564296520423601E-4	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	30	264690	1.1334013E-4	.	6	109402	5.484360e-05	0	14	208126	6.726690e-05	0	15	236922	6.331200e-05	0	2	7164	2.791740e-04	0	3	17112	1.753160e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	1	13388	7.469380e-05	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	2	7164	2.791740e-04	0	5	16218	3.082990e-04	0	4	30524	1.310440e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	1	16728	5.978000e-05	0	4	89554	4.466580e-05	0	0	30608	0.000000e+00	0	5	16218	3.082990e-04	0	4	14902	2.684200e-04	0	5	34260	1.459430e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	1	21626	4.624060e-05	0	5	102724	4.867410e-05	0	0	30526	0.000000e+00	0	4	14902	2.684200e-04	0	.	72	1614046	4.460840e-05	0	3	6060	4.950500e-04	0	8	74988	1.066840e-04	0	0	912	0.000000e+00	0	7	60010	1.166470e-04	0	0	29606	0.000000e+00	0	4	44860	8.916630e-05	0	1	64012	1.562210e-05	0	3	6060	4.950500e-04	0	42	1180002	3.559320e-05	0	2	91086	2.195730e-05	0	12	179916	6.669779230307477E-5	0	360	0	0	2712	0	1	9384	1.0656436487638534E-4	0	796	0	0	968	0	0	682	0	0	278	0	0	15410	0	1	9744	1.0262725779967159E-4	0	3394	0	13	210506	6.175595945008693E-5	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35107074C>T	ClinGen:CA191240	C3661900|C0027672|C0006142|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Val	Ile	184833.0	single nucleotide variant	NM_002878.4(RAD51D):c.394G>A (p.Val132Ile)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jan 19, 2025	201141245.0	-	RCV000458927|RCV000164547|RCV000588322|RCV004764772|RCV001356158	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	35107074.0	35107074.0	17q12	criteria provided, conflicting classifications	15.0	-	N	ClinGen:CA191240	2.0	185178.0	35107074.0	C	T	-	-	-	-	-	-	SCV000215203|SCV000292678|SCV000551340|SCV000698100|SCV000784995|SCV000822177|SCV000886447|SCV000910748|SCV001470090|SCV002534813|SCV004017742|SCV004208066|SCV005374642	-	-	394G>A 	Val132Ile	NM_002878.4	1.0	3_Conflicting	97.74	0.0	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	97.74	0.0	<10	>90						V	0			97.74	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2								V132-Q168, V132-R166; PAE: 1.0, 1.0	5 interactions	V132-Q168; PAE: 1.0	9 interactions							117									-123.4				129.5						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	RAD51DVal132Ile																																																																																																																																																																																																																																		
F9	F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5785542039004976	0.5221306800407002	0.5976664055167911	0.6490448535598249	0.5866399608767865	0.6190484411596221	0.6324728600124633	0.5529304178271445	0.5644077790297184	0.5614231522157421	0.5542314805939508	0.6656168471071865	0.6424023932064375	0.47985358105168185	0.5956852555852532	F9	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5785542039004976	0.5221306800407002	0.5976664055167911	0.6490448535598249	0.5866399608767865	0.6190484411596221	0.6324728600124633	0.5529304178271445	0.5644077790297184	0.5614231522157421	0.5542314805939508	0.6656168471071865	0.6424023932064375	0.47985358105168185	0.5956852555852532	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A	8G>A	Arg3His																												23.0	139530772.0	G	A	X						X-139530772-G-A	684952.0	single nucleotide variant	NM_000133.4(F9):c.8G>A (p.Arg3His)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	148060786.0	-	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530772.0	139530772.0	Xq27.1	reviewed by expert panel	7.0	-	N	ClinGen:CA10529706	2.0	695909.0	139530772.0	G	A	-	-	-	-	-	-	SCV004363691	-	-	8G>A 	Arg3His	NM_000133.4	3.0	2_Benign		695909.0	X	139530772.0	G	A	R	H	rs148060786	X	138612931.0	X	138440597.0	3.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.8G>A	p.Arg3His	c.8G>A	p.Arg3His	principal1	Y	1	YES	Select	+	CGC	2.0	0.0	G	G/G	G/G	G/G	G/G	0.54	0.06843	T	0.623	0.07487	T	0.001	0.07480	B	0.001	0.04348	B	0.02	0.08015	N	simple_aae	98.0	2.0	0.205	0.09279	N	0.19	0.05100	N	0.091	0.23222	-0.6784	0.61281	T	0.3975	0.74876	T	10.0	0.012512207	0.00265	T	0.062861	0.68674	D	0.532	0.80205	.	.	.	.	.	0.989276777832	0.98903	0.607146497614182	0.60467	0.0904167817641	0.09995	0.199505895376	0.00444	T	0.285427	0.65629	T	-0.230633	0.16278	T	-0.111328	0.62239	T	0.00217856688188496	0.00022	T	0.586841	0.21248	T	0.04500583	0.07223	0.04018554	0.04300	0.04972076	0.08789	0.0453144	0.06085	-4.362	0.29885	T	0.0795	0.23673	B	0.255918012225158	0.52475	0.99980062	0.99739	0.04	0.09634	.	.	.	.	.	.	0.548254	0.09195	5.951	0.44299318418515177	0.03427	.	.	.	.	.	.	.	.	.	5.08	0.559	0.16423	0.286	0.23548	0.553	0.2318	0.503000	0.19087	0.674	0.70877	0.081	0.22441	0.01	0.20072	0.697	0.34088	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	144	264690	5.4403266E-4	.	22	80300	2.739730e-04	0	40	151765	2.635650e-04	0	42	171840	2.444130e-04	0	11	5701	1.929490e-03	0	0	13657	0.000000e+00	0	0	1767	0.000000e+00	0	3	6914	4.339020e-04	0	0	9911	0.000000e+00	0	5	30950	1.615510e-04	0	3	9950	3.015080e-04	0	11	5701	1.929490e-03	0	24	13132	1.827600e-03	0	1	24348	4.107110e-05	0	0	4649	0.000000e+00	0	4	10120	3.952570e-04	0	0	12166	0.000000e+00	0	7	64659	1.082600e-04	0	4	19068	2.097760e-04	0	24	13132	1.827600e-03	0	22	12062	1.823910e-03	0	1	27124	3.686770e-05	0	0	7072	0.000000e+00	0	5	13311	3.756290e-04	0	0	15968	0.000000e+00	0	10	73164	1.366790e-04	0	4	19003	2.104930e-04	0	22	12062	1.823910e-03	0	.	185	1208214	1.531190e-04	2	78	57381	1.359330e-03	0	78	57381	1.359330e-03	0	0	687	0.000000e+00	0	11	45755	2.404110e-04	0	0	22010	0.000000e+00	0	18	33770	5.330170e-04	0	0	46663	0.000000e+00	0	1	4346	2.300970e-04	0	49	893284	5.485380e-05	1	21	56779	3.698550e-04	1	5	152892	3.270282290767339E-5	0	176	0	5	4502	0.0011106175033318525	10	4710	0.0021231422505307855	0	442	0	0	950	0	5	1848	0.0027056277056277055	0	280	0	4	11712	3.4153005464480874E-4	10	4886	0.002046663937781416	10	6350	0.0015748031496062992	29	177512	1.6336923700932895E-4	Benign	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	reviewed_by_expert_panel	NC_000023.11:g.139530772G>A	.	C0008533|C5393318|C2749016|C3661900|CN169374	306900|301052|300807	98879	.	Arg	His	684952.0	single nucleotide variant	NM_000133.4(F9):c.8G>A (p.Arg3His)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	148060786.0	-	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530772.0	139530772.0	Xq27.1	reviewed by expert panel	7.0	-	N	ClinGen:CA10529706	2.0	695909.0	139530772.0	G	A	-	-	-	-	-	-	SCV004363691	-	-	8G>A 	Arg3His	NM_000133.4	3.0	2_Benign	34.0	0.9717741935483872	['306900', '300807', '306900', '300807', '301052', '306900']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; WARFARIN SENSITIVITY, X-LINKED; HEMOPHILIA B	34.0	0.9717742	$\geqslant$90	<=50						R	241			34.0	Positively-charged	Arginine												-4.5																		175									52.1				135.6						C (loop/coil)	C (loop/coil)				Signal																										0.951		0.953		0.977		1.014		0.968																														true	F9Arg3His																																																																																																																																																																																																																																		
RAD51D	RAD51D_Ser46Cys	0.7829957094149949	0.4592952894564183	2.61629208398007	0.03459523845265817	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6647466228485643	0.4904998736781364	0.6172242484278883	0.6512685849411923	0.5276155414107366	0.4904067758180217	0.646948468082983	0.5838162373290128	0.4417403194913215	0.6251686851710547	0.5648243070034515	0.6555887017994018	0.6506322595267637	0.5392594278649514	0.704324560526074	RAD51D	0.7829957094149949	0.4592952894564183	2.61629208398007	0.03459523845265817	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6647466228485643	0.4904998736781364	0.6172242484278883	0.6512685849411923	0.5276155414107366	0.4904067758180217	0.646948468082983	0.5838162373290128	0.4417403194913215	0.6251686851710547	0.5648243070034515	0.6555887017994018	0.6506322595267637	0.5392594278649514	0.704324560526074	RAD51D		7201		CCSBVarC024795		NC_000017.11:35119118:G:C	137C>G	Ser46Cys																												17.0	35119118.0	G	C	17						17-35119118-G-C	133339.0	single nucleotide variant	NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	587780102.0	-	RCV000115808|RCV000212953|RCV000228533|RCV000656964|RCV003492493|RCV001354278|RCV001798341	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:C1333600|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer|Malignant tumor of breast|Breast and/or ovarian cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	35119118.0	35119118.0	17q12	criteria provided, conflicting classifications	18.0	-	N	ClinGen:CA287956	2.0	127882.0	35119118.0	G	C	-	-	-	-	-	-	SCV000149717|SCV000185614|SCV000287698|SCV000604997|SCV000686419|SCV000784997|SCV000839197|SCV002043210|SCV002534771|SCV002760915|SCV002819352|SCV004017757|SCV004208087|SCV004220162|SCV005641839	-	-	137C>G 	Ser46Cys	NM_002878.4	1.0	3_Conflicting		127882.0	17	35119118.0	G	C	S	C	rs587780102	17	33446137.0	17	30470250.0	46.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.137C>G	p.Ser46Cys	c.137C>G	p.Ser46Cys	principal1	Y	5	.	.	-	TCT	2.0	0.0	G	G/G	G/G	G/G	G/G	0.007	0.63383	D	0.023	0.79703	D	1.0	0.90580	D	0.956	0.86259	D	.	0.68318	.	.	.	.	2.72	0.79369	M	-3.45	0.72035	D	0.683	0.70828	-0.3645	0.73009	T	0.3321	0.69833	T	10.0	0.7786217	0.77446	D	0.048765	0.63381	D	0.456	0.75352	.	.	.	.	.	0.947946397878	0.94697	.	0.54121	.	0.43501	.	.	.	0.683251	0.90627	D	-0.0213529	0.48331	T	-0.0134026	0.69239	D	0.823957562446594	0.47789	D	0.883212	0.68570	D	0.53418267	0.68768	0.28243348	0.54022	0.5920361	0.71975	0.31285465	0.57062	-10.77	0.78452	D	0.2118	0.50240	B	0.0651732501033949	0.39495	0.96507460	0.94298	0.545	0.74295	.	.	.	.	.	.	5.349603	0.89758	31.0	0.991384472580047	0.53541	0.928860	0.91342	D	0.802452879217227	0.86184	8.828211	0.769679193341177	0.87549	9.284908	5.02	5.02	0.66699	.	.	5.745	0.68382	11.447000	0.92795	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.96	0.51684	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	31	264690	1.17118136E-4	.	8	109378	7.314090e-05	0	16	208038	7.690900e-05	0	18	236818	7.600770e-05	0	0	7160	0.000000e+00	0	1	17104	5.846590e-05	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	7	42754	1.637270e-04	0	0	15690	0.000000e+00	0	7	42754	1.637270e-04	0	0	16198	0.000000e+00	0	3	30514	9.831550e-05	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	12	89498	1.340810e-04	0	0	30608	0.000000e+00	0	12	89498	1.340810e-04	0	0	14886	0.000000e+00	0	4	34250	1.167880e-04	0	0	9572	0.000000e+00	0	0	17688	0.000000e+00	0	0	21562	0.000000e+00	0	13	102716	1.265630e-04	0	0	30526	0.000000e+00	0	13	102716	1.265630e-04	0	.	169	1613388	1.047490e-04	0	9	59998	1.500050e-04	0	0	74900	0.000000e+00	0	0	912	0.000000e+00	0	9	59998	1.500050e-04	0	0	29604	0.000000e+00	0	0	44884	0.000000e+00	0	0	64038	0.000000e+00	0	0	6084	0.000000e+00	0	155	1179426	1.314200e-04	0	0	91082	0.000000e+00	0	13	32650	3.9816232771822357E-4	0	122	0	0	112	0	0	3390	0	1	500	0.002	0	628	0	0	56	0	0	98	0	0	6864	0	0	3512	0	0	168	0	14	44420	3.1517334533993696E-4	Conflicting_classifications_of_pathogenicity	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119118G>C	ClinGen:CA287956	C0006142|CN221562|C0027672|C3280345|C1333600|CN169374|C3661900	614291	140162|145	RAD51D, N-terminal domain	Ser	Cys	133339.0	single nucleotide variant	NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	587780102.0	-	RCV000115808|RCV000212953|RCV000228533|RCV000656964|RCV003492493|RCV001354278|RCV001798341	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:C1333600|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer|Malignant tumor of breast|Breast and/or ovarian cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	35119118.0	35119118.0	17q12	criteria provided, conflicting classifications	18.0	-	N	ClinGen:CA287956	2.0	127882.0	35119118.0	G	C	-	-	-	-	-	-	SCV000149717|SCV000185614|SCV000287698|SCV000604997|SCV000686419|SCV000784997|SCV000839197|SCV002043210|SCV002534771|SCV002760915|SCV002819352|SCV004017757|SCV004208087|SCV004220162|SCV005641839	-	-	137C>G 	Ser46Cys	NM_002878.4	1.0	3_Conflicting	92.03	0.5692307692307692	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	92.03	0.5692308	10-90	>90						S	74			92.03	Polar/Neutral	Serine		DNA repair protein RAD51 homolog 4										-0.8								S46-L50; PAE: 1.0	4 interactions	S46-L50; PAE: 1.0	4 interactions							105									-64.4				120.5	preferentially binds ssDNA					C (loop/coil)	C (loop/coil)																																																																				true	RAD51DSer46Cys																																																																																																																																																																																																																																		
F9	F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5275470970162297	0.538089861011952	0.46689930054502815	0.4701075036511166	0.5421431362976536	0.5280128373869296	0.46416947893294586	0.3994524764064396	0.5252284119334957	0.4610660797706094	0.5562734352083778	0.4760455283692873	0.5343461246836168	0.5509513100904082	0.59402811426185	F9	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5275470970162297	0.538089861011952	0.46689930054502815	0.4701075036511166	0.5421431362976536	0.5280128373869296	0.46416947893294586	0.3994524764064396	0.5252284119334957	0.4610660797706094	0.5562734352083778	0.4760455283692873	0.5343461246836168	0.5509513100904082	0.59402811426185	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G	116A>G	Lys39Arg																												23.0	139537037.0	A	G	X						X-139537037-A-G	1150443.0	single nucleotide variant	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	2158.0	F9	HGNC:3551	Likely benign	0.0	Jan 30, 2024	200505648.0	-	RCV001504446	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537037.0	139537037.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10529738	2.0	1160362.0	139537037.0	A	G	-	-	-	-	-	-	SCV001709323	-	-	116A>G 	Lys39Arg	NM_000133.4	1.0	2_Benign		1160362.0	X	139537037.0	A	G	K	R	rs200505648	X	138619196.0	X	138446862.0	39.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.116A>G	p.Lys39Arg	c.116A>G	p.Lys39Arg	principal1	Y	1	YES	Select	+	AAA	2.0	0.0	A	A/A	A/A	A/A	A/A	0.323	0.15597	T	0.417	0.17147	T	0.056	0.22821	B	0.032	0.22132	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.92	0.51123	L	-0.64	0.18812	N	0.312	0.37163	-0.2568	0.76067	T	0.6381	0.87296	D	10.0	0.014453173	0.00300	T	0.149573	0.83090	D	0.344	0.66405	.	.	.	.	.	0.939239796073	0.93813	0.7314597189117038	0.72948	0.19312899725	0.21378	0.393836945295	0.24181	T	0.357661	0.72262	T	-0.236865	0.15471	T	-0.208103	0.53563	T	0.124255164463254	0.14653	T	0.0863914	0.00987	T	0.113306604	0.26523	0.103917405	0.24897	0.113306604	0.26523	0.103917405	0.24896	-4.174	0.26400	T	0.0743	0.06973	B	0.923986090574331	0.77876	0.99985337	0.99806	0.28	0.55009	.	.	.	.	.	.	3.13775	0.42504	21.5	0.9970173899409455	0.80679	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	1.14	0.30476	1.162	0.31498	9.182000	0.79117	0.756	0.943	0.0	0.06393	1.0	0.68239	0.997	0.79771	924	0.18019	6	0.0015894039735099338	0	0.0	0	0.0	0	0.0	6	0.007853403141361256	0	0.0	2	264690	7.5560088E-6	.	8	79213	1.009940e-04	0	13	148583	8.749320e-05	0	10	168667	5.928840e-05	0	0	5673	0.000000e+00	0	0	13352	0.000000e+00	0	0	1739	0.000000e+00	0	8	6881	1.162620e-03	0	0	9930	0.000000e+00	0	0	30817	0.000000e+00	0	0	9392	0.000000e+00	0	8	6881	1.162620e-03	0	0	12622	0.000000e+00	0	0	23895	0.000000e+00	0	0	4559	0.000000e+00	0	13	10057	1.292630e-03	0	0	12177	0.000000e+00	0	0	63838	0.000000e+00	0	0	17902	0.000000e+00	0	13	10057	1.292630e-03	0	0	11551	0.000000e+00	0	0	26591	0.000000e+00	0	0	6965	0.000000e+00	0	10	13222	7.563150e-04	0	0	15966	0.000000e+00	0	0	72498	0.000000e+00	0	0	17837	0.000000e+00	0	10	13222	7.563150e-04	0	.	16	1207839	1.324680e-05	0	16	33690	4.749180e-04	0	0	57354	0.000000e+00	0	0	687	0.000000e+00	0	0	45673	0.000000e+00	0	0	21969	0.000000e+00	0	16	33690	4.749180e-04	0	0	46597	0.000000e+00	0	0	4334	0.000000e+00	0	0	894043	0.000000e+00	0	0	55963	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139537037A>G	.	C2749016|C0008533	300807|306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Lys	Arg	1150443.0	single nucleotide variant	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	2158.0	F9	HGNC:3551	Likely benign	0.0	Jan 30, 2024	200505648.0	-	RCV001504446	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537037.0	139537037.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10529738	2.0	1160362.0	139537037.0	A	G	-	-	-	-	-	-	SCV001709323	-	-	116A>G 	Lys39Arg	NM_000133.4	1.0	2_Benign	74.17	0.6439024390243903	['300807', '306900']	unknown	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	74.17	0.6439024	10-90	70-90						K	132			74.17	Positively-charged	Lysine												-3.9										K39-E35; PAE: 3.5								147									-72.1			Propeptide	-30.7						H (helix)	H (α-helix)																														1.01	1 mutation(s) (Lys39Pro: 1.421)	0.974		0.928		0.876		0.972																														true	F9Lys39Arg																																																																																																																																																																																																																																		
CTCF	CTCF_Tyr407Cys	2.2604531941423103	0.058292407096491645	5.642049992400373	0.0007809142606724553	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6534930740992244	0.587954735210138	0.704138354101575	0.7338730820480786	0.6451276137990857	0.5832082165597294	0.8062520727072294	0.6578961621597847	0.5755667279191388	0.6881772674260671	0.7070470110384419	0.6614940913889276	0.7503805460433652	0.6003427425011371	0.6188088807723816	CTCF	2.2604531941423103	0.058292407096491645	5.642049992400373	0.0007809142606724553	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6534930740992244	0.587954735210138	0.704138354101575	0.7338730820480786	0.6451276137990857	0.5832082165597294	0.8062520727072294	0.6578961621597847	0.5755667279191388	0.6881772674260671	0.7070470110384419	0.6614940913889276	0.7503805460433652	0.6003427425011371	0.6188088807723816	CTCF		6173		CCSBVarC010870		NC_000016.10:67621454:A:G	1220A>G	Tyr407Cys																												16.0	67621454.0	A	G	16						16-67621454-A-G	260121.0	single nucleotide variant	NM_006565.4(CTCF):c.1220A>G (p.Tyr407Cys)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Jan 06, 2025	886039600.0	-	RCV000255519	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000016.10	16	67621454.0	67621454.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10588621	2.0	265526.0	67621454.0	A	G	-	-	-	-	-	-	SCV000322502	-	-	1220A>G 	Tyr407Cys	NM_006565.4	1.0	1_Pathogenic		265526.0	16	67621454.0	A	G	Y	C	rs886039600	16	67655357.0	16	66212858.0	407.0	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.1220A>G	p.Tyr407Cys	c.1220A>G	p.Tyr407Cys	principal4	Y	.	.	.	+	TAT	2.0	0.0	A	A/A	A/A	A/A	A/A	.	0.78662	.	.	0.92967	.	0.914	0.50540	P	0.665	0.52957	P	.	0.86984	.	.	.	.	3.095	0.87372	M	.	0.96158	.	.	0.77038	-0.7497	0.57774	T	0.1518	0.47848	T	10.0	0.84561706	0.83554	D	0.084978	0.74353	D	.	0.78861	0.615	0.74786	P49711	Y407C	Loss of phosphorylation at Y407 (P = 0.0811)| Gain of ubiquitination at K405 (P = 0.1079)| Gain of disorder (P = 0.1124)| Gain of glycosylation at K405 (P = 0.1594)| Loss of MoRF binding (P = 0.1621)	.	0.78538	.	0.94871	.	0.99706	0.954362869263	0.99834	D	0.875329	0.97318	D	0.258403	0.79229	D	0.133401	0.7896	D	0.997824430465698	0.9245	D	.	0.93500	.	0.8909639	0.90456	0.6975476	0.81981	0.8259339	0.85435	0.7453358	0.84765	-16.773	0.98709	D	.	0.96717	.	0.999749203930458	0.97751	0.97100700	0.94734	0.889	0.94066	.	.	.	.	.	.	5.434312	0.90871	32.0	0.9977078724647703	0.8593	0.932506	0.92271	D	0.717981494107391	0.80704	7.377784	0.688130749716732	0.81373	7.535864	5.83	4.72	0.59198	4.73	0.87084	9.325	0.96016	11.234000	0.90219	0.756	0.943	1.0	0.71675	1.0	0.68239	0.998	0.85369	54	0.97580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67621454A>G	ClinGen:CA10588621	CN517202	.	.	.	Tyr	Cys	260121.0	single nucleotide variant	NM_006565.4(CTCF):c.1220A>G (p.Tyr407Cys)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Jan 06, 2025	886039600.0	-	RCV000255519	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000016.10	16	67621454.0	67621454.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10588621	2.0	265526.0	67621454.0	A	G	-	-	-	-	-	-	SCV000322502	-	-	1220A>G 	Tyr407Cys	NM_006565.4	1.0	1_Pathogenic	85.11	0.3333333333333333		unknown		0		85.11	0.33333334	10-90	70-90						Y	74			85.11	Aromatic	Tyrosine		Transcriptional repressor CTCF								0.2481		-1.3								Y407-F416; PAE: 2.0	15 interactions	Y407-Q418, Y407-S419, Y407-F416; PAE: 2.0, 2.5, 2.0	19 interactions							181									-113.7	Morphology: tHsGEKPyECyICHA	Pocket 2: Mean pLDDT: 83.64, Volume: 523.05 Å³, Druggability score: 0.25		108.8						B (undefined)	E (parallel sheets)	Beta strand										C2H2-type 6																																																									true	CTCFTyr407Cys																																																																																																																																																																																																																																		
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7118203495319111	0.7035818102206959	0.6853863840055787	0.6008234393706247	0.7712615764520082	0.8364748256595527	0.6270908471789142	0.7374140901317079	0.7358415374727499	0.7480363250775551	0.7060483272444638	0.574556031562335	0.6333586778794495	0.6713220829686419	0.6756043739862669	F9	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7118203495319111	0.7035818102206959	0.6853863840055787	0.6008234393706247	0.7712615764520082	0.8364748256595527	0.6270908471789142	0.7374140901317079	0.7358415374727499	0.7480363250775551	0.7060483272444638	0.574556031562335	0.6333586778794495	0.6713220829686419	0.6756043739862669	F9	ENSG00000101981	52861	204348.0	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139537139.0	A	T	X	Y	N	N	N	N	X-139537139-A-T	25610.0	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 19, 1990	137852226.0	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139.0	139537139.0	Xq27.1	no assertion criteria provided	1.0	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1.0	10571.0	139537139.0	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic		10571.0	X	139537139.0	A	T	E	V	rs137852226	X	138619298.0	X	138446964.0	73.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2.0	0.0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10.0	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.9930352914502176	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.0	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610.0	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 19, 1990	137852226.0	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139.0	139537139.0	Xq27.1	no assertion criteria provided	1.0	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1.0	10571.0	139537139.0	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic	86.94	0.4072164948453608	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	86.94	0.4072165	10-90	70-90						E	79			86.94	Negatively-charged	Glutamic Acid	Ca(2+); Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain							Gla			-3.5										E73-V77; PAE: 1.5							4-carboxyglutamate	146									-62.5				-41.0						H (helix)	H (α-helix)	Helix																													1.004		0.808		0.84		0.061	5 mutation(s) (Glu73Lys: -0.019, Glu73Trp: -0.013, Glu73Ala: -0.005, Glu73Tyr: -0.005, Glu73Cys: -0.004)	0.964	4 mutation(s) (Glu73Thr: 1.256, Glu73Asn: 1.284, Glu73Gly: 1.293, Glu73Ser: 1.308)																													true	F9Glu73Val																																																																																																																																																																																																																																		
F9	F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.9263901662496768	0.8474365051310222	0.8927955725308716	0.846905153923833	0.8125415721210048	0.8696055339288283	0.8054023729403156	0.8784566601927848	0.8156113504953498	0.9015045582024344	0.7554776103131811	0.8884079349073506	0.9071344848689584	0.8792616597666947	0.9512757742969193	F9	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.9263901662496768	0.8474365051310222	0.8927955725308716	0.846905153923833	0.8125415721210048	0.8696055339288283	0.8054023729403156	0.8784566601927848	0.8156113504953498	0.9015045582024344	0.7554776103131811	0.8884079349073506	0.9071344848689584	0.8792616597666947	0.9512757742969193	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G	482A>G	Tyr161Cys																												23.0	139548453.0	A	G	X						X-139548453-A-G	951629.0	single nucleotide variant	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Sep 09, 2019	1927768329.0	-	RCV001238122	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548453.0	139548453.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414439233	2.0	963994.0	139548453.0	A	G	-	-	-	-	-	-	SCV001410919	-	-	482A>G 	Tyr161Cys	NM_000133.4	1.0	1_Pathogenic		963994.0	X	139548453.0	A	G	Y	C	rs1927768329	X	138630612.0	X	138458278.0	161.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.482A>G	p.Tyr161Cys	c.482A>G	p.Tyr161Cys	principal1	Y	1	YES	Select	+	TAT	2.0	0.0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.505	0.98972	H	-7.54	0.95177	D	0.86	0.94798	1.0827	0.98968	D	0.9698	0.99044	D	9.0	0.9925639	0.99791	D	0.727081	0.97795	D	0.969	0.99622	0.948	0.99364	P00740	Y161C	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.999628882684	0.99961	0.9993750153719172	0.99937	3.35052041495	0.99644	0.548684835434	0.45607	T	0.947563	0.99211	D	0.709682	0.99937	D	0.781633	0.99937	D	0.999352633953094	0.97053	D	0.907809	0.67286	D	0.98005635	0.99098	0.9677569	0.99354	0.9801722	0.99107	0.95718026	0.98799	-13.466	0.91210	D	0.817	0.87118	P	0.999984402408099	0.99579	0.99999213	0.99996	0.989	0.99628	.	.	.	.	.	.	4.195203	0.63338	24.6	0.9978729767279205	0.87318	.	.	.	.	.	.	.	.	.	4.94	4.94	0.646	4.69	0.86632	6.975	0.7597	9.248000	0.79501	0.691	0.84104	1.0	0.71675	1.0	0.68239	0.954	0.50428	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139548453A>G	.	C0008533|C2749016	306900|300807	98879	.	Tyr	Cys	951629.0	single nucleotide variant	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Sep 09, 2019	1927768329.0	-	RCV001238122	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548453.0	139548453.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414439233	2.0	963994.0	139548453.0	A	G	-	-	-	-	-	-	SCV001410919	-	-	482A>G 	Tyr161Cys	NM_000133.4	1.0	1_Pathogenic	95.8	0.1081081081081081	['300807', '306900']	unknown	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	95.8	0.10810811	10-90	>90						Y	24			95.8	Aromatic	Tyrosine		Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 2			-1.3								Y161-C178; PAE: 1.5	12 interactions									181									-121.4				150.1						B (undefined)	E (parallel sheets)	Beta strand																													0.327		0.249	1 mutation(s) (Tyr161Cys: -0.005)	0.25		0.256		0.232	1 mutation(s) (Tyr161Asn: -0.004)																													true	F9Tyr161Cys																																																																																																																																																																																																																																		
CTCF	CTCF_Asp46Asn	-2.5556236375766055	0.04316233733910241	2.5264609447668644	0.039436363219745474	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6261375326141839	0.7558717291950918	0.6849293602383606	0.7665540549667489	0.7960041671381287	0.8442630357834994	0.772836679383644	0.7164137896266487	0.8403217673680176	0.660723892135822	0.7477452984927581	0.7602714305498538	0.6534449308500725	0.6714216910221661	0.5915511730925458	CTCF	-2.5556236375766055	0.04316233733910241	2.5264609447668644	0.039436363219745474	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6261375326141839	0.7558717291950918	0.6849293602383606	0.7665540549667489	0.7960041671381287	0.8442630357834994	0.772836679383644	0.7164137896266487	0.8403217673680176	0.660723892135822	0.7477452984927581	0.7602714305498538	0.6534449308500725	0.6714216910221661	0.5915511730925458	CTCF		6173		CCSBVarC010823		NC_000016.10:67610968:G:A	136G>A	Asp46Asn																												16.0	67610968.0	G	A	16						16-67610968-G-A	963811.0	single nucleotide variant	NM_006565.4(CTCF):c.136G>A (p.Asp46Asn)	10664.0	CTCF	HGNC:13723	Likely benign	0.0	Jan 01, 2019	2052054114.0	-	RCV001252212	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability	inherited	germline	GRCh38	NC_000016.10	16	67610968.0	67610968.0	16q22.1	no assertion criteria provided	1.0	-	N	ClinGen:CA396302067	2.0	975529.0	67610968.0	G	A	-	-	-	-	-	-	SCV001427963	-	-	136G>A 	Asp46Asn	NM_006565.4		2_Benign		975529.0	16	67610968.0	G	A	D	N	rs2052054114	16	67644871.0	16	66202372.0	46.0	CTCF	ENSG00000102974	ENST00000642819	ENSP00000494408	P49711	CTCF_HUMAN	c.136G>A	p.Asp46Asn	c.136G>A	p.Asp46Asn	principal4	Y	.	.	.	+	GAT	1.0	0.0	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.24550	.	0.18	0.29064	B	0.057	0.26282	B	.	0.23785	.	.	.	.	1.1	0.27864	L	.	0.17556	.	.	0.34213	-1.0391	0.17573	T	0.0244	0.10333	T	10.0	0.26070982	0.43135	D	0.008032	0.21016	T	.	0.29456	0.222	0.14439	P49711	D46N	Gain of loop (P = 0.069)| Loss of helix (P = 0.079)| Loss of catalytic residue at G48 (P = 0.1983)| Loss of sheet (P = 0.302)| Gain of MoRF binding (P = 0.4494)	.	0.54510	.	0.33770	.	0.47360	0.533664166927	0.43488	T	0.37863	0.73981	T	-0.237905	0.15337	T	-0.579511	0.14308	T	0.711651020290767	0.4098	D	.	0.78261	.	0.14355613	0.32709	0.14724985	0.34752	0.14355613	0.32709	0.14724985	0.34751	-4.76	0.34161	T	0.1119	0.24667	LB	0.911406707488065	0.76873	0.35239035	0.78355	0.338	0.59995	.	.	.	.	.	.	4.066878	0.60464	24.2	0.9978644389905249	0.8723	0.903411	0.85191	D	0.173584497680614	0.49687	3.18842	0.363672439989046	0.59120	4.110524	5.19	5.19	0.71389	.	.	8.296	0.89889	11.831000	0.97527	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.946	0.49004	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1595754	6.266630e-07	0	1	1165574	8.579460e-07	0	0	74694	0.000000e+00	0	0	912	0.000000e+00	0	0	59396	0.000000e+00	0	0	29152	0.000000e+00	0	0	44342	0.000000e+00	0	0	63822	0.000000e+00	0	0	5992	0.000000e+00	0	1	1165574	8.579460e-07	0	0	90282	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Intellectual_disability	no_assertion_criteria_provided	NC_000016.10:g.67610968G>A	.	C3714756	.	.	.	Asp	Asn	963811.0	single nucleotide variant	NM_006565.4(CTCF):c.136G>A (p.Asp46Asn)	10664.0	CTCF	HGNC:13723	Likely benign	0.0	Jan 01, 2019	2052054114.0	-	RCV001252212	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability	inherited	germline	GRCh38	NC_000016.10	16	67610968.0	67610968.0	16q22.1	no assertion criteria provided	1.0	-	N	ClinGen:CA396302067	2.0	975529.0	67610968.0	G	A	-	-	-	-	-	-	SCV001427963	-	-	136G>A 	Asp46Asn	NM_006565.4		2_Benign	37.43	0.9570552147239264		unknown		0		37.43	0.9570552	$\geqslant$90	<=50						D	156			37.43	Negatively-charged	Aspartic Acid		Transcriptional repressor CTCF										-3.5																		132									-165.0				170.2						C (loop/coil)	C (loop/coil)																																																																				true	CTCFAsp46Asn																																																																																																																																																																																																																																		
RAD51D	RAD51D_Val66Met	-0.545546479468292	0.6023201818835449	9.486270453812256	0.00003025630828943128	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8550317880177425	0.6015777615320816	0.7826732455069626	0.7666936114568561	0.640681162726245	0.7562182404004095	0.8179277119701884	0.8268199895224255	0.6855978670709192	0.8685760632494186	0.5251440850520803	0.7154595109435239	0.7385265014914997	0.5175576559932441	0.8414875127860665	RAD51D	-0.545546479468292	0.6023201818835449	9.486270453812256	0.00003025630828943128	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8550317880177425	0.6015777615320816	0.7826732455069626	0.7666936114568561	0.640681162726245	0.7562182404004095	0.8179277119701884	0.8268199895224255	0.6855978670709192	0.8685760632494186	0.5251440850520803	0.7154595109435239	0.7385265014914997	0.5175576559932441	0.8414875127860665	RAD51D		7201		CCSBVarC024804		NC_000017.11:35118568:C:T	196G>A	Val66Met																												17.0	35118568.0	C	T	17						17-35118568-C-T	151292.0	single nucleotide variant	NM_002878.4(RAD51D):c.196G>A (p.Val66Met)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	56026142.0	-	RCV000130161|RCV000238834|RCV000225779|RCV001030594|RCV001284344|RCV001798441|RCV003952682	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35118568.0	35118568.0	17q12	criteria provided, conflicting classifications	16.0	-	N	ClinGen:CA165840	2.0	141578.0	35118568.0	C	T	-	-	-	-	-	-	SCV000184996|SCV000287700|SCV000297127|SCV000489108|SCV000515953|SCV000686426|SCV000920125|SCV001193731|SCV001470086|SCV002043215|SCV002534780|SCV004017746|SCV004024299	-	-	196G>A 	Val66Met	NM_002878.4	1.0	3_Conflicting		141578.0	17	35118568.0	C	T	V	M	rs56026142	17	33445587.0	17	30469700.0	66.0	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.196G>A	p.Val66Met	c.196G>A	p.Val66Met	principal1	Y	1	YES	Select	-	GTG	1.0	0.0	C	C/C	C/C	C/C	C/C	0.095	0.34240	T	0.066	0.44850	T	0.476	0.36683	P	0.365	0.43339	B	0.05	0.16373	N	simple_aae	95.0	5.0	1.2	0.30152	L	-0.54	0.16529	N	0.358	0.39815	-0.9936	0.31561	T	0.1126	0.40048	T	10.0	0.010412663	0.00228	T	0.024861	0.47635	T	0.088	0.25383	0.532	0.63879	O75771	V66M	Loss of catalytic residue at V66 (P = 0.1757)| Gain of disorder (P = 0.2016)| Gain of relative solvent accessibility (P = 0.2816)| Loss of glycosylation at S62 (P = 0.3483)| Gain of loop (P = 0.3485)	0.485420873983	0.47807	.	.	.	.	.	.	.	0.159822	0.50082	T	-0.540521	0.00322	T	-0.547555	0.17258	T	0.0349691153311283	0.02783	T	.	0.67135	.	0.085984245	0.19788	0.05022742	0.07854	0.085984245	0.19787	0.05022742	0.07854	-4.122	0.28513	T	0.1196	0.24734	LB	0.000394112558413836	0.06034	0.88900130	0.90830	0.035	0.07875	.	.	.	.	.	.	1.488353	0.19181	14.12	0.8529669670784525	0.16045	0.093680	0.18747	N	-0.868469024722056	0.11459	0.5605822	-0.881724750457004	0.12311	0.6448988	4.79	-0.163	0.12675	-5.85	0.03264	0.004	0.13047	0.681000	0.20762	-1.926	0.00504	0.001	0.13799	0.444	0.24998	0.443	0.27788	926	0.17784	3	5.990415335463259E-4	1	7.564296520423601E-4	0	0.0	0	0.0	2	0.001984126984126984	0	0.0	53	264690	2.0023424E-4	.	30	109376	2.742830e-04	0	60	208066	2.883700e-04	0	76	236884	3.208320e-04	0	1	7164	1.395870e-04	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	24	9044	2.653690e-03	0	0	13366	0.000000e+00	0	2	42766	4.676610e-05	0	1	15690	6.373490e-05	0	24	9044	2.653690e-03	0	1	16218	6.165990e-05	0	2	30524	6.552220e-05	0	0	6212	0.000000e+00	0	48	13414	3.578350e-03	0	0	16706	0.000000e+00	0	4	89522	4.468180e-05	0	1	30608	3.267120e-05	0	48	13414	3.578350e-03	0	1	14902	6.710510e-05	0	4	34260	1.167540e-04	0	0	9572	0.000000e+00	0	65	17690	3.674390e-03	0	0	21604	0.000000e+00	0	2	102710	1.947230e-05	0	1	30526	3.275900e-05	0	65	17690	3.674390e-03	0	.	420	1614178	2.601940e-04	1	374	44872	8.334820e-03	1	1	75058	1.332300e-05	0	0	912	0.000000e+00	0	5	60016	8.331110e-05	0	1	29608	3.377470e-05	0	374	44872	8.334820e-03	1	0	64024	0.000000e+00	0	1	6062	1.649620e-04	0	9	1180038	7.626870e-06	0	17	91078	1.866530e-04	0	1	153016	6.535264286087729E-6	0	176	0	18	4498	0.004001778568252557	0	4724	0	0	442	0	0	950	0	6	1848	0.003246753246753247	0	280	0	9	11718	7.680491551459293E-4	0	4900	0	24	6346	0.003781909864481563	34	177652	1.9138540517416071E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|RAD51D-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118568C>T	ClinGen:CA165840	C0027672|CN221562|C3661900|C0677776|CN169374|C3280345	614291	140162|145|145	.	Val	Met	151292.0	single nucleotide variant	NM_002878.4(RAD51D):c.196G>A (p.Val66Met)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	56026142.0	-	RCV000130161|RCV000238834|RCV000225779|RCV001030594|RCV001284344|RCV001798441|RCV003952682	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35118568.0	35118568.0	17q12	criteria provided, conflicting classifications	16.0	-	N	ClinGen:CA165840	2.0	141578.0	35118568.0	C	T	-	-	-	-	-	-	SCV000184996|SCV000287700|SCV000297127|SCV000489108|SCV000515953|SCV000686426|SCV000920125|SCV001193731|SCV001470086|SCV002043215|SCV002534780|SCV004017746|SCV004024299	-	-	196G>A 	Val66Met	NM_002878.4	1.0	3_Conflicting	87.61	0.647887323943662	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	87.61	0.64788735	10-90	70-90						V	92			87.61	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2			4 interactions	5 interactions														117									-109.1				144.7	preferentially binds ssDNA					C (loop/coil)	C (loop/coil)																																																																				true	RAD51DVal66Met																																																																																																																																																																																																																																		
FARS2	FARS2_Asn280Ser	-1.5655811200139778	1.0	-0.6127928774573419	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7523324219642757	0.7025478351459254	0.7998652894262647	0.8030255317629689	0.807126189381839	0.7753062704216713	0.8364156324435186	0.7567184616927626	0.7212074588575044	0.7536954439410324	0.8389461083420067	0.769635431082419	0.8430121171597668	0.6838882114343465	0.750969399987519	FARS2	-1.5655811200139778	1.0	-0.6127928774573419	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7523324219642757	0.7025478351459254	0.7998652894262647	0.8030255317629689	0.807126189381839	0.7753062704216713	0.8364156324435186	0.7567184616927626	0.7212074588575044	0.7536954439410324	0.8389461083420067	0.769635431082419	0.8430121171597668	0.6838882114343465	0.750969399987519	FARS2		12653		CCSBVarC011867		NC_000006.12:5431107:A:G	839A>G	Asn280Ser																												6.0	5431107.0	A	G	6						6-5431107-A-G	140995.0	single nucleotide variant	NM_006567.5(FARS2):c.839A>G (p.Asn280Ser)	10667.0	FARS2	HGNC:21062	Benign	0.0	Feb 04, 2025	11243011.0	-	RCV000124983|RCV000677020|RCV001701760|RCV000714927	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not specified|not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	germline;unknown	germline	GRCh38	NC_000006.12	6	5431107.0	5431107.0	6p25.1	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA290845,UniProtKB:O95363#VAR_052643	2.0	137292.0	5431107.0	A	G	-	-	-	-	-	-	SCV000168423|SCV000311536|SCV000845693|SCV001731157|SCV001933312|SCV001933313|SCV005091750	-	-	839A>G 	Asn280Ser	NM_006567.5	2.0	2_Benign		137292.0	6	5431107.0	A	G	N	S	rs11243011	6	5431340.0	6	5376339.0	280.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.839A>G	p.Asn280Ser	c.839A>G	p.Asn280Ser	principal1	Y	1	YES	Select	+	AAC	2.0	0.0	A	A/A	A/A	A/A	A/A	0.355	0.12180	T	0.358	0.17298	T	0.001	0.07480	B	0.001	0.04348	B	0.35	0.59775	P	simple_aae	65.0	35.0	-1.405	0.00593	N	-0.85	0.23101	N	0.057	0.02855	-1.069	0.09648	T	0.0343	0.14655	T	9.0	0.0024745166	0.00036	T	.	.	.	0.045	0.12154	.	.	.	.	.	.	.	.	0.37527	.	0.13639	0.263113975525	0.05267	T	0.039256	0.24861	T	-0.686866	0.00042	T	-0.615592	0.11282	T	0.00545995115788096	0.00059	T	0.873413	0.59719	D	0.13583922	0.31242	0.081693865	0.18565	0.14538196	0.33047	0.072034046	0.15483	-4.658	0.32930	T	0.071	0.11803	B	0.0760332499692323	0.40859	0.01150617	0.42971	0.104	0.28905	.	.	.	.	.	.	1.830349	0.23297	15.95	0.9632618610336557	0.2964	0.180003	0.30517	N	-0.50634435902713	0.21618	1.164074	-0.278242492394687	0.28498	1.60963	5.5	3.13	0.35013	3.86	0.72457	3.397	0.52411	0.661000	0.20583	0.691	0.84104	1.0	0.71675	0.887	0.2786	0.997	0.79771	957	0.09723	1178	0.23522364217252395	73	0.05521936459909228	162	0.1610337972166998	163	0.23487031700288186	481	0.4771825396825397	299	0.3057259713701431	45111	264690	0.17042956	.	24540	109368	2.243800e-01	3377	45917	208058	2.206930e-01	6059	52920	236782	2.234970e-01	7082	475	7162	6.632230e-02	25	4417	17098	2.583340e-01	595	655	2320	2.823280e-01	91	4291	9038	4.747730e-01	1044	2111	13394	1.576080e-01	164	7831	42760	1.831380e-01	746	4354	15682	2.776430e-01	667	4291	9038	4.747730e-01	1044	1162	16216	7.165760e-02	53	8147	30502	2.670970e-01	1117	1797	6212	2.892790e-01	257	6295	13402	4.697060e-01	1503	2609	16734	1.559100e-01	200	16375	89532	1.828960e-01	1525	8468	30596	2.767680e-01	1279	6295	13402	4.697060e-01	1503	1054	14900	7.073830e-02	49	8942	34234	2.612020e-01	1211	2718	9568	2.840720e-01	370	8428	17676	4.768050e-01	2039	3422	21632	1.581920e-01	262	18713	102644	1.823100e-01	1743	8452	30514	2.769880e-01	1276	8428	17676	4.768050e-01	2039	.	308230	1613374	1.910470e-01	32055	17868	44846	3.984300e-01	3721	5480	75004	7.306280e-02	224	286	912	3.135960e-01	39	14268	59996	2.378160e-01	1793	8354	29588	2.823440e-01	1158	17868	44846	3.984300e-01	3721	10087	63978	1.576640e-01	749	1150	6058	1.898320e-01	124	213144	1179548	1.807000e-01	19229	24843	90970	2.730900e-01	3623	52614	287826	0.1827979404223385	18	410	0.04390243902439024	2047	4918	0.4162261081740545	734	11560	0.06349480968858132	145	1244	0.11655948553054662	2175	9118	0.23853915332309716	891	1978	0.4504550050556117	1355	5196	0.26077752117013087	4344	18732	0.2319026265214606	752	11970	0.06282372598162071	2938	6896	0.42604408352668216	64323	340982	0.1886404560944566	Benign	not_specified|Hereditary_spastic_paraplegia_77|Combined_oxidative_phosphorylation_defect_type_14|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5431107A>G	ClinGen:CA290845|UniProtKB:O95363#VAR_052643	CN169374|C5569007|C4755312|C3661900	617046|614946	466722|319519	Aminoacyl-tRNA synthetase, class II	Asn	Ser	140995.0	single nucleotide variant	NM_006567.5(FARS2):c.839A>G (p.Asn280Ser)	10667.0	FARS2	HGNC:21062	Benign	0.0	Feb 04, 2025	11243011.0	-	RCV000124983|RCV000677020|RCV001701760|RCV000714927	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not specified|not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	germline;unknown	germline	GRCh38	NC_000006.12	6	5431107.0	5431107.0	6p25.1	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA290845,UniProtKB:O95363#VAR_052643	2.0	137292.0	5431107.0	A	G	-	-	-	-	-	-	SCV000168423|SCV000311536|SCV000845693|SCV001731157|SCV001933312|SCV001933313|SCV005091750	-	-	839A>G 	Asn280Ser	NM_006567.5	2.0	2_Benign	96.15	0.3121019108280254	['617046', '614946']	unknown		0	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	96.15	0.3121019	10-90	>90						N	49			96.15	Polar/Neutral	Asparagine												-3.5								N280-E260; PAE: 1.0	9 interactions	N280-E260, N280-E284; PAE: 1.0, 1.0	13 interactions							132									-76.8				115.8						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	FARS2Asn280Ser																																																																																																																																																																																																																																		
BRCA1	BRCA1_Thr587Arg	-0.4548873787721197	0.6629621326061451	7.926953340626398	0.00009664275201696522	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.892646509351166	0.8246576900414754	0.927566918722474	0.9022218265117656	0.9183229591400186	0.9122962314024994	0.914388731015901	0.9193700972050594	0.8179770783922686	0.8807865638647172	0.9243496868775378	0.8900549220076304	0.9357637402398886	0.8313383016906821	0.9045064548376147	BRCA1	-0.4548873787721197	0.6629621326061451	7.926953340626398	0.00009664275201696522	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.892646509351166	0.8246576900414754	0.927566918722474	0.9022218265117656	0.9183229591400186	0.9122962314024994	0.914388731015901	0.9193700972050594	0.8179770783922686	0.8807865638647172	0.9243496868775378	0.8900549220076304	0.9357637402398886	0.8313383016906821	0.9045064548376147	BRCA1	ENSG00000012048	14613	218425.0	CCSBVarC003304	ALE00003304	NC_000017.11:43067610:G:C	1760C>G	Thr587Arg	CEGS2	CegsMutGDEh1003	H05	GDEhDisVCh_40059	C01	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43067610.0	G	C	17	Y	N	N	N	N	17-43067610-G-C	70040.0	single nucleotide variant	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	672.0	BRCA1	HGNC:1100	Likely pathogenic	1.0	Oct 04, 2021	80357034.0	-	RCV000577017|RCV001077998|RCV002257395	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067610.0	43067610.0	17q21.31	criteria provided, multiple submitters, no conflicts	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003189	3.0	55373.0	43067610.0	G	C	-	-	-	-	-	-	SCV002537807|SCV002644099	-	-	5072C>G 	Thr1691Arg	NM_007294.4	2.0	1_Pathogenic		55373.0	17	43067610.0	G	C	T	R	rs80357034	17	41219627.0	17	38473153.0	1691.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5072C>G	p.Thr1691Arg	principal2	Y	1	.	.	-	ACA	2.0	0.0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.585	0.90580	P	0.218	0.92348	B	.	.	.	.	.	.	3.175	0.88626	M	.	0.81626	.	.	0.90585	0.5201	0.90791	D	0.6944	0.89429	D	10.0	.	0.86953	.	0.786117	0.98314	D	.	0.94900	.	.	.	.	.	.	0.94962	.	0.79901	.	0.15475	0.765162229538	0.76658	T	0.292953	0.76109	T	0.409641	0.90394	D	0.350645	0.90276	D	0.983474791049957	0.7495	D	0.952305	0.85727	D	0.955418	0.96765	0.8308187	0.90111	0.950228	0.96231	0.7571084	0.85471	-6.573	0.63425	T	.	0.88256	.	0.991494696303718	0.89054	0.99986839	0.99835	0.994	0.99793	.	.	.	.	.	.	4.249871	0.64569	24.7	0.995002398050606	0.68015	0.838290	0.75493	D	0.775208299271413	0.84447	8.314456	0.736429675756228	0.85057	8.492664	5.24	5.24	0.72825	.	.	6.008	0.70468	11.808000	0.96854	0.569	0.28905	1.0	0.71675	1.0	0.68239	0.985	0.61072	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43067610G>C	ClinGen:CA003189	C0346153|C0027672|C2676676	114480|604370	227535|140162|145	BRCT domain|BRCT domain|BRCT domain	Thr	Arg	70040.0	single nucleotide variant	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	672.0	BRCA1	HGNC:1100	Likely pathogenic	1.0	Oct 04, 2021	80357034.0	-	RCV000577017|RCV001077998|RCV002257395	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067610.0	43067610.0	17q21.31	criteria provided, multiple submitters, no conflicts	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003189	3.0	55373.0	43067610.0	G	C	-	-	-	-	-	-	SCV002537807|SCV002644099	-	-	5072C>G 	Thr1691Arg	NM_007294.4	2.0	1_Pathogenic	96.65	0.1126760563380281	['114480', '604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	96.65	0.112676054	10-90	>90																																																																																																																																		true	BRCA1Thr587Arg																																																																																																																																																																																																																																		
SHOC2	SHOC2_Ser4Arg	-2.115892778315492	0.07215780633141851	-0.3869856389427147	0.7102627631544373	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8109546256181748	0.75349580402942	0.8265968079772316	0.8630964543671289	0.7967470862926626	0.9179761181055074	0.9180943736465743	0.9142199019956667	0.866539458520815	0.8794101522916892	0.6755180544798177	0.8080985350876836	0.7389737139587964	0.6404521495380249	0.7424990989446605	SHOC2	-2.115892778315492	0.07215780633141851	-0.3869856389427147	0.7102627631544373	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8109546256181748	0.75349580402942	0.8265968079772316	0.8630964543671289	0.7967470862926626	0.9179761181055074	0.9180943736465743	0.9142199019956667	0.866539458520815	0.8794101522916892	0.6755180544798177	0.8080985350876836	0.7389737139587964	0.6404521495380249	0.7424990989446605	SHOC2		11602		CCSBVarC027999		NC_000010.11:110964368:A:C	10A>C	Ser4Arg																												10.0	110964368.0	A	C	10						10-110964368-A-C	49105.0	single nucleotide variant	NM_007373.4(SHOC2):c.10A>C (p.Ser4Arg)	8036.0	SHOC2	HGNC:15454	Benign	0.0	Sep 17, 2024	397517231.0	-	RCV000680308|RCV003914899|RCV000038777|RCV000518991|RCV001286384	MedGen:C3661900||MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	not provided|SHOC2-related disorder|not specified|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1	germline;unknown	germline	GRCh38	NC_000010.11	10	110964368.0	110964368.0	10q25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA136657	2.0	40635.0	110964368.0	A	C	-	-	-	-	-	-	SCV000616429	-	-	10A>C 	Ser4Arg	NM_007373.4	3.0	2_Benign		40635.0	10	110964368.0	A	C	S	R	rs397517231	10	112724126.0	10	112714116.0	4.0	SHOC2	ENSG00000108061	ENST00000688928	ENSP00000509273	Q9UQ13	SHOC2_HUMAN	.	.	c.10A>C	p.Ser4Arg	principal1	Y	.	.	.	+	AGT	1.0	0.0	A	A/A	A/A	A/A	A/A	.	0.56615	.	.	0.41419	.	0.079	0.24484	B	0.023	0.19965	B	.	0.68318	.	.	.	.	1.39	0.34781	L	.	0.27215	.	.	0.39714	-1.0816	0.07056	T	0.0556	0.23288	T	10.0	.	0.00200	.	0.006028	0.15489	T	.	0.31580	0.368	0.37543	Q9UQ13	S4R	Loss of phosphorylation at S4 (P = 9e-04)| Gain of MoRF binding (P = 0.0056)| Loss of sheet (P = 0.0315)| Gain of loop (P = 0.069)| Loss of ubiquitination at K7 (P = 0.0702)	.	0.13132	.	0.01051	.	0.52424	0.607206702232	0.53855	T	0.200839	0.55638	T	-0.417862	0.01658	T	-0.376684	0.3575	T	0.0736649466610808	0.09046	T	.	0.74124	.	0.267935	0.49535	0.2938221	0.55197	0.32933065	0.55084	0.33612105	0.59185	-3.61	0.18016	T	.	0.64952	.	0.164860101419667	0.48012	0.00392193	0.30410	0.247	0.51713	.	.	.	.	.	.	3.701145	0.52871	23.3	0.9949388012688521	0.67671	0.875239	0.79781	D	-0.0156583439103937	0.40882	2.456036	0.218876124825274	0.50640	3.276892	5.62	5.62	0.85695	.	.	7.104	0.76723	9.339000	0.80231	0.751	0.87726	1.0	0.71675	1.0	0.68239	1.0	0.97202	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	47	264690	1.7756621E-4	.	56	108758	5.149050e-04	0	101	205586	4.912790e-04	0	104	233670	4.450720e-04	0	0	7132	0.000000e+00	0	54	16920	3.191490e-03	0	0	2310	0.000000e+00	0	0	8928	0.000000e+00	0	0	13386	0.000000e+00	0	0	42570	0.000000e+00	0	0	15610	0.000000e+00	0	54	16920	3.191490e-03	0	0	15362	0.000000e+00	0	99	30182	3.280100e-03	0	0	6158	0.000000e+00	0	0	13368	0.000000e+00	0	0	16712	0.000000e+00	0	0	88600	0.000000e+00	0	0	30440	0.000000e+00	0	99	30182	3.280100e-03	0	0	14110	0.000000e+00	0	102	33912	3.007780e-03	0	0	9530	0.000000e+00	0	0	17430	0.000000e+00	0	0	21590	0.000000e+00	0	0	101240	0.000000e+00	0	0	30358	0.000000e+00	0	102	33912	3.007780e-03	0	.	125	1613066	7.749220e-05	0	124	59742	2.075590e-03	0	0	74862	0.000000e+00	0	0	912	0.000000e+00	0	124	59742	2.075590e-03	0	0	29586	0.000000e+00	0	0	44892	0.000000e+00	0	0	63988	0.000000e+00	0	0	6080	0.000000e+00	0	0	1179630	0.000000e+00	0	0	90932	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	2	610	0.003278688524590164	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	2	14710	1.3596193065941537E-4	Benign	SHOC2-related_disorder|not_provided|RASopathy|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	reviewed_by_expert_panel	NC_000010.11:g.110964368A>C	ClinGen:CA136657	C3661900|C5555857|C4478716|CN169374	607721	536391|2701	.	Ser	Arg	49105.0	single nucleotide variant	NM_007373.4(SHOC2):c.10A>C (p.Ser4Arg)	8036.0	SHOC2	HGNC:15454	Benign	0.0	Sep 17, 2024	397517231.0	-	RCV000680308|RCV003914899|RCV000038777|RCV000518991|RCV001286384	MedGen:C3661900||MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	not provided|SHOC2-related disorder|not specified|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1	germline;unknown	germline	GRCh38	NC_000010.11	10	110964368.0	110964368.0	10q25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA136657	2.0	40635.0	110964368.0	A	C	-	-	-	-	-	-	SCV000616429	-	-	10A>C 	Ser4Arg	NM_007373.4	3.0	2_Benign	44.22	0.8692307692307693	['607721']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	44.22	0.86923075	10-90	<=50						S	113			44.22	Polar/Neutral	Serine		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-0.8																		105									-179.0				104.7	Disordered					C (loop/coil)	C (loop/coil)																																																																				true	SHOC2Ser4Arg																																																																																																																																																																																																																																		
RAF1	RAF1_Asn140His	-0.04961800914186328	1.0	-0.26453384717819656	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.754411109052332	0.710056321687258	0.8059919300545818	0.7958428482250779	0.8133600514364883	0.8768500439669253	0.8008637628205076	0.8566458710111035	0.7498309272648557	0.7526688883548288	0.7498700589060513	0.7908219336296483	0.7553379890980602	0.6702817161096603	0.7561533297498351	RAF1	-0.04961800914186328	1.0	-0.26453384717819656	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.754411109052332	0.710056321687258	0.8059919300545818	0.7958428482250779	0.8133600514364883	0.8768500439669253	0.8008637628205076	0.8566458710111035	0.7498309272648557	0.7526688883548288	0.7498700589060513	0.7908219336296483	0.7553379890980602	0.6702817161096603	0.7561533297498351	RAF1		732		CCSBVarC008912		NC_000003.12:12609238:T:G	418A>C	Asn140His																												3.0	12609238.0	T	G	3						3-12609238-T-G	49060.0	single nucleotide variant	NM_002880.4(RAF1):c.418A>C (p.Asn140His)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Oct 03, 2012	730881009.0	-	RCV000159094	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000003.12	3	12609238.0	12609238.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA297148	2.0	40590.0	12609238.0	T	G	-	-	-	-	-	-	SCV000209037	-	-	418A>C 	Asn140His	NM_002880.4	1.0	1_Pathogenic		40590.0	3	12609238.0	T	G	N	H	rs730881009	3	12650737.0	3	12625737.0	140.0	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.418A>C	p.Asn140His	principal3	Y	.	.	.	-	AAC	1.0	0.0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.50294	.	1.0	0.90580	D	0.994	0.82066	D	.	0.76851	.	.	.	.	1.78	0.46014	L	.	0.72035	.	.	0.89342	0.8725	0.95294	D	0.8467	0.94874	D	10.0	.	0.81918	.	0.486445	0.94918	D	.	0.92184	0.507	0.60104	P04049	N140H	Loss of loop (P = 0.0374)| Loss of glycosylation at T138 (P = 0.0472)| Loss of catalytic residue at N140 (P = 0.0473)| Gain of sheet (P = 0.1208)| Gain of methylation at K144 (P = 0.1389)	.	0.93906	.	0.78656	.	0.84295	0.864215731621	0.91719	D	0.90447	0.98131	D	0.19048	0.72806	D	0.0358342	0.72452	D	0.969879031181335	0.6854	D	.	0.92893	.	0.7594829	0.81195	0.8015472	0.88218	0.8018196	0.83820	0.7257919	0.83611	-10.417	0.76444	D	.	0.80100	.	0.999536362008549	0.96903	0.94453880	0.93084	0.975	0.99076	.	.	.	.	.	.	4.983822	0.82606	27.8	0.995567192944565	0.71556	0.925488	0.90478	D	0.743491548643859	0.82383	7.773029	0.718547825165139	0.83700	8.114436	5.84	5.84	0.93363	5.35	0.93259	8.012	0.88241	7.876000	0.72273	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.998	0.85369	646	0.63408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.12609238T>G	ClinGen:CA297148	CN517202	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Asn	His	49060.0	single nucleotide variant	NM_002880.4(RAF1):c.418A>C (p.Asn140His)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Oct 03, 2012	730881009.0	-	RCV000159094	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000003.12	3	12609238.0	12609238.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA297148	2.0	40590.0	12609238.0	T	G	-	-	-	-	-	-	SCV000209037	-	-	418A>C 	Asn140His	NM_002880.4	1.0	1_Pathogenic	79.03	0.535031847133758		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		79.03	0.53503186	10-90	70-90						N	84			79.03	Polar/Neutral	Asparagine		RAF proto-oncogene serine/threonine-protein kinase										-3.5								N140-Q166; PAE: 2.0	9 interactions	N140-Q166, N140-C165; PAE: 2.0, 1.5	14 interactions							132									-91.2				86.9						C (loop/coil)	C (loop/coil)											Phorbol-ester/DAG-type																																																									true	RAF1Asn140His																																																																																																																																																																																																																																		
G6PD	G6PD_Ile48Thr	-0.2620179732240577	0.8008506093363101	-5.13568429567412	0.0013451510736389762	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8960831866830073	0.6488971547717548	0.8320103107667962	0.7934483112514196	0.7300614863660573	0.4981020516734341	0.6773726472083663	0.690890275113418	0.4686694704507386	0.8752138130416006	0.9620209210586804	0.9095239752944728	0.9731303464201745	0.8291248390927711	0.9169525603244141	G6PD	-0.2620179732240577	0.8008506093363101	-5.13568429567412	0.0013451510736389762	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8960831866830073	0.6488971547717548	0.8320103107667962	0.7934483112514196	0.7300614863660573	0.4981020516734341	0.6773726472083663	0.690890275113418	0.4686694704507386	0.8752138130416006	0.9620209210586804	0.9095239752944728	0.9731303464201745	0.8291248390927711	0.9169525603244141	G6PD		4006		CCSBVarC021436		NC_000023.11:154536156:A:G	143T>C	Ile48Thr																												23.0	154536156.0	A	G	X						X-154536156-A-G	25441.0	single nucleotide variant	NM_000402.4(G6PD):c.233T>C (p.Ile78Thr)	2539.0	G6PD	HGNC:4057	Pathogenic/Likely pathogenic	1.0	Dec 06, 2024	76645461.0	-	RCV000011145|RCV000704108|RCV001796957|RCV002482854|RCV003466850|RCV004748514|RCV000224890	|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MONDO:MONDO:0005775,MedGen:C2939465|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026;MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673|MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673||MedGen:C3661900	G6PD AURES|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	154536156.0	154536156.0	Xq28	criteria provided, multiple submitters, no conflicts	16.0	-	N	ClinGen:CA121021,OMIM:305900.0043,ClinVar:1722711,ClinVar:1722739	3.0	10402.0	154536156.0	A	G	-	-	-	-	-	-	SCV000280664|SCV000833043|SCV001142115|SCV001523185|SCV001793238|SCV002025185|SCV002038576|SCV002506148|SCV002599318|SCV002788373|SCV004195384|SCV004805193|SCV005186094|SCV005413462	-	-	233T>C 	Ile78Thr	NM_000402.4	2.0	1_Pathogenic		10402.0	X	154536156.0	A	G	I	T	rs76645461	X	153764371.0	X	153417565.0	48.0	G6PD	ENSG00000160211	ENST00000393564	ENSP00000377194	P11413	G6PD_HUMAN	c.143T>C	p.Ile48Thr	c.143T>C	p.Ile48Thr	principal4	Y	5	.	.	-	ATC	2.0	0.0	A	A/A	A/A	A/A	A/A	1.0	0.06776	T	0.771	0.06347	T	0.985	0.61134	D	0.964	0.71005	D	0.99	0.97926	A	simple_aae	1.0	99.0	1.365	0.34008	L	-3.37	0.66695	D	0.796	0.86268	0.9127	0.9584	D	0.9334	0.97801	D	10.0	0.9249425	0.91752	D	0.178446	0.85319	D	0.800	0.93443	0.956	0.99517	P11413	I48T	Gain of disorder (P = 0.0198)| Loss of stability (P = 0.024)| Loss of catalytic residue at P50 (P = 0.0321)| Gain of glycosylation at P50 (P = 0.0902)| Loss of methylation at K47 (P = 0.1012)	0.999291972508	0.99927	.	.	.	0.66127	0.810541808605	0.83546	D	0.864655	0.97001	D	0.423939	0.91161	D	0.630861	0.9765	D	0.353604669620596	0.26859	T	.	0.93807	.	0.83749527	0.86250	0.6371406	0.78580	0.7755391	0.82164	0.66341555	0.80049	-5.158	0.46017	T	0.8079	0.82620	P	0.998863967322053	0.95207	0.99580365	0.97879	0.66	0.81095	.	.	.	.	.	.	4.373753	0.67426	25.1	0.8760799230816463	0.17599	.	.	.	.	.	.	.	.	.	5.38	4.19	0.48586	.	.	7.094	0.76658	9.206000	0.79242	0.751	0.87726	1.0	0.71675	1.0	0.68239	0.998	0.85369	80	0.96675	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	4	264690	1.51120175E-5	.	1	80339	1.244730e-05	0	2	151847	1.317120e-05	0	2	172177	1.161600e-05	0	0	5699	0.000000e+00	0	0	13664	0.000000e+00	0	0	1767	0.000000e+00	0	1	6917	1.445710e-04	0	0	9932	0.000000e+00	0	0	30958	0.000000e+00	0	0	9952	0.000000e+00	0	1	6917	1.445710e-04	0	0	13129	0.000000e+00	0	0	24387	0.000000e+00	0	0	4649	0.000000e+00	0	2	10129	1.974530e-04	0	0	12190	0.000000e+00	0	0	64662	0.000000e+00	0	0	19075	0.000000e+00	0	2	10129	1.974530e-04	0	0	12061	0.000000e+00	0	0	27165	0.000000e+00	0	0	7072	0.000000e+00	0	2	13320	1.501500e-04	0	0	15974	0.000000e+00	0	0	73427	0.000000e+00	0	0	19010	0.000000e+00	0	2	13320	1.501500e-04	0	.	17	1209926	1.405040e-05	0	10	4355	2.296210e-03	0	1	57219	1.747670e-05	0	0	678	0.000000e+00	0	0	45816	0.000000e+00	0	0	22029	0.000000e+00	0	2	33749	5.926100e-05	0	0	46637	0.000000e+00	0	10	4355	2.296210e-03	0	0	895021	0.000000e+00	0	0	56799	0.000000e+00	0	0	18236	0	0	122	0	0	342	0	0	3122	0	0	178	0	0	780	0	0	58	0	0	116	0	0	516	0	0	3244	0	0	400	0	0	23470	0	Pathogenic/Likely_pathogenic	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency|Malaria,_susceptibility_to|G6PD_AURES|G6PD_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.154536156A>G	ClinGen:CA121021|OMIM:305900.0043	C2720289|C1970028|C2939465|C3661900	300908|611162	466026|673	Glucose-6-phosphate dehydrogenase, NAD-binding	Ile	Thr	25441.0	single nucleotide variant	NM_000402.4(G6PD):c.233T>C (p.Ile78Thr)	2539.0	G6PD	HGNC:4057	Pathogenic/Likely pathogenic	1.0	Dec 06, 2024	76645461.0	-	RCV000011145|RCV000704108|RCV001796957|RCV002482854|RCV003466850|RCV004748514|RCV000224890	|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MONDO:MONDO:0005775,MedGen:C2939465|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026;MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673|MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673||MedGen:C3661900	G6PD AURES|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	154536156.0	154536156.0	Xq28	criteria provided, multiple submitters, no conflicts	16.0	-	N	ClinGen:CA121021,OMIM:305900.0043,ClinVar:1722711,ClinVar:1722739	3.0	10402.0	154536156.0	A	G	-	-	-	-	-	-	SCV000280664|SCV000833043|SCV001142115|SCV001523185|SCV001793238|SCV002025185|SCV002038576|SCV002506148|SCV002599318|SCV002788373|SCV004195384|SCV004805193|SCV005186094|SCV005413462	-	-	233T>C 	Ile78Thr	NM_000402.4	2.0	1_Pathogenic	98.02	0.0	['300908', '300908', '611162', '611162']	unknown	Rare genetic hematologic disease	1	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1; ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1; MALARIA, SUSCEPTIBILITY TO; MALARIA, SUSCEPTIBILITY TO	98.02	0.0	<10	>90						I	0			98.02	Aliphatic	Isoleucine		Glucose-6-phosphate 1-dehydrogenase										4.5								I48-I52, I48-L43; PAE: 1.0, 1.0	12 interactions	I48-I52, I48-L43, I48-A44; PAE: 1.0, 1.0, 1.0	16 interactions							131									-70.9				-47.5						H (helix)	I (π-helix)	Helix																																																																			true	G6PDIle48Thr																																																																																																																																																																																																																																		
CTCF	CTCF_Arg342Cys	4.0251147636350355	0.005026859283026853	3.346590636205559	0.012308068398097118	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7138337679923981	0.624709154938435	0.7025021260908193	0.7384968807353391	0.6879591174469971	0.7323616410391203	0.7980792108414768	0.6956161388840096	0.7051673427152019	0.7414395687576792	0.643556593854874	0.6789145506292014	0.709388113297629	0.5442509671616682	0.686227967227117	CTCF	4.0251147636350355	0.005026859283026853	3.346590636205559	0.012308068398097118	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7138337679923981	0.624709154938435	0.7025021260908193	0.7384968807353391	0.6879591174469971	0.7323616410391203	0.7980792108414768	0.6956161388840096	0.7051673427152019	0.7414395687576792	0.643556593854874	0.6789145506292014	0.709388113297629	0.5442509671616682	0.686227967227117	CTCF		6173		CCSBVarC010851		NC_000016.10:67616816:C:T	1024C>T	Arg342Cys																												16.0	67616816.0	C	T	16						16-67616816-C-T	422102.0	single nucleotide variant	NM_006565.4(CTCF):c.1024C>T (p.Arg342Cys)	10664.0	CTCF	HGNC:13723	Pathogenic/Likely pathogenic	1.0	Aug 31, 2022	1131691283.0	-	RCV000494182|RCV001253429|RCV004535549	MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|	not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|CTCF-related disorder	de novo;germline	germline	GRCh38	NC_000016.10	16	67616816.0	67616816.0	16q22.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA396312251	2.0	429261.0	67616816.0	C	T	-	-	-	-	-	-	SCV000581783|SCV001429134|SCV001449853|SCV004117060	-	-	1024C>T 	Arg342Cys	NM_006565.4	2.0	1_Pathogenic		429261.0	16	67616816.0	C	T	R	C	rs1131691283	16	67650719.0	16	66208220.0	342.0	CTCF	ENSG00000102974	ENST00000642819	ENSP00000494408	P49711	CTCF_HUMAN	c.1024C>T	p.Arg342Cys	c.1024C>T	p.Arg342Cys	principal4	Y	.	.	.	+	CGT	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.996	0.84488	D	.	0.91795	.	.	.	.	2.925	0.84244	M	.	0.94690	.	.	0.66102	-0.5414	0.66965	T	0.2195	0.58068	T	10.0	0.90816814	0.90073	D	0.072612	0.71478	D	.	0.81796	0.799	0.91830	P49711	R342C	Loss of MoRF binding (P = 0.0286)| Loss of disorder (P = 0.0417)| Gain of methylation at K344 (P = 0.0462)| Loss of loop (P = 0.0804)| Loss of solvent accessibility (P = 0.1077)	.	0.78989	.	0.92611	.	0.99749	0.963747024536	0.99943	D	0.874794	0.97303	D	0.243152	0.77795	D	0.111494	0.77506	D	0.998596012592316	0.94546	D	.	0.91755	.	0.8758145	0.89177	0.75798017	0.85523	0.79036707	0.83088	0.75543875	0.85370	-13.341	0.91976	D	0.9958	0.95928	LP	0.999472519562105	0.96705	0.95648080	0.93745	0.846	0.91546	.	.	.	.	.	.	5.456603	0.91125	32.0	0.999120800629616	0.98096	0.927208	0.90917	D	0.872885598481848	0.90318	10.37319	0.805277495105465	0.90104	10.28159	4.89	4.89	0.63341	.	.	7.701	0.83585	7.609000	0.61899	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.995	0.73271	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614136	6.195260e-07	0	1	1180010	8.474500e-07	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64030	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180010	8.474500e-07	0	0	91086	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder	criteria_provided,_conflicting_classifications	NC_000016.10:g.67616816C>T	ClinGen:CA396312251	C3661900|C3809686	615502	363611	.	Arg	Cys	422102.0	single nucleotide variant	NM_006565.4(CTCF):c.1024C>T (p.Arg342Cys)	10664.0	CTCF	HGNC:13723	Pathogenic/Likely pathogenic	1.0	Aug 31, 2022	1131691283.0	-	RCV000494182|RCV001253429|RCV004535549	MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|	not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|CTCF-related disorder	de novo;germline	germline	GRCh38	NC_000016.10	16	67616816.0	67616816.0	16q22.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA396312251	2.0	429261.0	67616816.0	C	T	-	-	-	-	-	-	SCV000581783|SCV001429134|SCV001449853|SCV004117060	-	-	1024C>T 	Arg342Cys	NM_006565.4	2.0	1_Pathogenic	86.65	0.407258064516129	['615502']	unknown		0	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	86.65	0.40725806	10-90	70-90						R	101			86.65	Positively-charged	Arginine		Transcriptional repressor CTCF										-4.5								R342-V338; PAE: 1.0	9 interactions	R342-H347, R342-E348, R342-V338, R342-T346; PAE: 3.0, 4.5, 1.0, 3.0	12 interactions							175									-65.5				-35.5				dbSNP: -; Variant type: US; AA change: Arg342His; PTM type: Phosphorylation; PTM morphology: VRHRR*yKHtHE; Var class: II&-		H (helix)	H (α-helix)	Helix										C2H2-type 3																																																									true	CTCFArg342Cys																																																																																																																																																																																																																																		
BRCA1	BRCA1_Met671Lys	2.267013845164269	0.05773114204962296	0.8349415031917332	0.43132063358320416	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.9214305993331576	0.8539956294602719	0.9406021666133201	0.887616044703547	0.9605211529359583	0.9704484609385355	0.9116781681071608	0.9403527782700145	0.9102883342188165	0.9469280859184088	0.9505938449333812	0.8635539212999332	0.9408515549566256	0.7977029247017272	0.8959331127479064	BRCA1	2.267013845164269	0.05773114204962296	0.8349415031917332	0.43132063358320416	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.9214305993331576	0.8539956294602719	0.9406021666133201	0.887616044703547	0.9605211529359583	0.9704484609385355	0.9116781681071608	0.9403527782700145	0.9102883342188165	0.9469280859184088	0.9505938449333812	0.8635539212999332	0.9408515549566256	0.7977029247017272	0.8959331127479064	BRCA1		14613		CCSBVarC011871		NC_000017.11:43051071:A:T	2012T>A	Met671Lys																												17.0	43051071.0	A	T	17						17-43051071-A-T	32734.0	single nucleotide variant	NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	41293463.0	-	RCV000019265|RCV000496817|RCV001526335	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43051071.0	43051071.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00110,ClinGen:CA003476,UniProtKB:P38398#VAR_063212,OMIM:113705.0036	3.0	17695.0	43051071.0	A	T	-	-	-	-	-	-	SCV000244397	-	-	5324T>A 	Met1775Lys	NM_007294.4	3.0	1_Pathogenic		17695.0	17	43051071.0	A	T	M	K	rs41293463	17	41203088.0	17	38456614.0	1775.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.5324T>A	p.Met1775Lys	c.5324T>A	p.Met1775Lys	principal2	Y	1	YES	Select	-	ATG	2.0	0.0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.99	0.90580	D	0.798	0.86259	P	0.95	0.99291	A	simple_aae	5.0	95.0	2.33	0.66629	M	-1.1	0.77340	N	0.878	0.98669	0.6922	0.93053	D	0.7837	0.92637	D	10.0	0.8988125	0.89121	D	0.804846	0.98472	D	0.734	0.90683	.	.	.	.	.	0.963482532597	0.96276	.	0.86847	.	0.52277	0.562978863716	0.47621	T	0.234774	0.59973	T	0.436191	0.91778	D	0.388781	0.91677	D	0.990923941135406	0.81018	D	.	0.83947	.	0.9531011	0.96527	0.80974793	0.88742	0.9654434	0.97787	0.735878	0.84203	-12.423	0.89812	D	0.8787	0.86232	P	0.996656271029341	0.92339	0.99989700	0.99879	0.957	0.98136	.	.	.	.	.	.	3.769401	0.54208	23.4	0.9855845907033972	0.43068	0.719653	0.66927	D	0.693440170392724	0.79088	7.028289	0.666244745644706	0.79713	7.165023	5.21	5.21	0.71966	.	.	5.026	0.63961	11.142000	0.87118	0.756	0.943	1.0	0.71675	1.0	0.68239	0.997	0.79771	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43051071A>T	BRCA1-HCI:BRCA1_00110|ClinGen:CA003476|OMIM:113705.0036|UniProtKB:P38398#VAR_063212	C2676676|C0027672|C0677776	604370	145|140162|145	.	Met	Lys	32734.0	single nucleotide variant	NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	41293463.0	-	RCV000019265|RCV000496817|RCV001526335	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43051071.0	43051071.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00110,ClinGen:CA003476,UniProtKB:P38398#VAR_063212,OMIM:113705.0036	3.0	17695.0	43051071.0	A	T	-	-	-	-	-	-	SCV000244397	-	-	5324T>A 	Met1775Lys	NM_007294.4	3.0	1_Pathogenic	90.88	0.0797872340425532	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	90.88	0.07978723	<10	>90																																																																																																																																		true	BRCA1Met671Lys																																																																																																																																																																																																																																		
KRAS	KRAS_Gly60Ser	-0.09720436679761342	0.9252887309563864	1.0463836155630009	0.33016491483243277	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7310315054406336	0.6356087676949997	0.7574312850091847	0.6839613858589917	0.6900089966847243	0.922883940850429	0.9301994656009873	0.9536311326762618	0.8033730258089217	0.8885677701163717	0.4571340525190196	0.4377233061169961	0.5612314373421075	0.4678445095810778	0.5734952407648954	KRAS	-0.09720436679761342	0.9252887309563864	1.0463836155630009	0.33016491483243277	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7310315054406336	0.6356087676949997	0.7574312850091847	0.6839613858589917	0.6900089966847243	0.922883940850429	0.9301994656009873	0.9536311326762618	0.8033730258089217	0.8885677701163717	0.4571340525190196	0.4377233061169961	0.5612314373421075	0.4678445095810778	0.5734952407648954	KRAS	ENSG00000133703	3084	214489.0	CCSBVarC006098	ALE00006098	NC_000012.12:25227346:C:T	178G>A	Gly60Ser	CEGS2	CegsMutGDEh1036	F02	GDEhDisVCh_40061	A09	1.0	CegsMutGDDh1036	F02							1.0	1.0	1.0	3.0	0.0			0.0			0.0			12.0	25227346.0	C	T	12	Y	N	N	N	N	12-25227346-C-T	27636.0	single nucleotide variant	NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Mar 29, 2024	104894359.0	-	RCV000013428|RCV000157934|RCV000689097|RCV002470709	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2	de novo;germline	germline	GRCh38	NC_000012.12	12	25227346.0	25227346.0	12p12.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	OMIM:190070.0020,ClinGen:CA256484,UniProtKB:P01116#VAR_065146	3.0	12597.0	25227346.0	C	T	-	-	-	-	-	-	SCV000207869|SCV000816735|SCV002318974|SCV002768383	-	-	178G>A 	Gly60Ser	NM_033360.4	2.0	1_Pathogenic		12597.0	12	25227346.0	C	T	G	S	rs104894359	12	25380280.0	12	25271547.0	60.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.178G>A	p.Gly60Ser	c.178G>A	p.Gly60Ser	alternative1	Y	1	.	Plus_Clinical	-	GGT	1.0	0.0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.195	0.88911	M	-5.82	0.88318	D	0.958	0.96773	1.0665	0.98496	D	0.9342	0.97828	D	10.0	0.9487096	0.94136	D	0.407238	0.93510	D	0.943	0.98815	0.776	0.90105	P01116	G60S	Gain of catalytic residue at L56 (P = 0.0034)| Gain of disorder (P = 0.0769)| Gain of phosphorylation at G60 (P = 0.0926)| Loss of sheet (P = 0.1398)| Loss of helix (P = 0.2022)	0.996255802933	0.99616	0.9459025843081321	0.94539	2.69341285729	0.98552	0.926605463028	0.98783	D	0.929646	0.98786	D	0.524795	0.94982	D	0.516055	0.94909	D	0.999157786369324	0.96329	D	0.966103	0.87543	D	0.98016226	0.99107	0.96225566	0.99077	0.9698139	0.98214	0.94146484	0.97832	-12.139	0.87851	D	0.9985	0.98500	P	0.999680939266056	0.97477	0.99929273	0.99274	0.997	0.99892	.	.	.	.	.	.	5.28558	0.88766	29.7	0.9989031345780135	0.96438	0.908603	0.86363	D	1.06893418515311	0.97500	16.26098	0.997770489382923	0.98575	18.70474	5.77	5.77	0.91065	3.95	0.75212	7.892	0.85894	7.701000	0.66341	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	not_provided|RASopathy|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25227346C>T	ClinGen:CA256484|OMIM:190070.0020|UniProtKB:P01116#VAR_065146	C3661900|C5555857|C1860991|C3809005	609942|615278	536391|648|1340	Small GTP-binding domain	Gly	Ser	27636.0	single nucleotide variant	NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Mar 29, 2024	104894359.0	-	RCV000013428|RCV000157934|RCV000689097|RCV002470709	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2	de novo;germline	germline	GRCh38	NC_000012.12	12	25227346.0	25227346.0	12p12.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	OMIM:190070.0020,ClinGen:CA256484,UniProtKB:P01116#VAR_065146	3.0	12597.0	25227346.0	C	T	-	-	-	-	-	-	SCV000207869|SCV000816735|SCV002318974|SCV002768383	-	-	178G>A 	Gly60Ser	NM_033360.4	2.0	1_Pathogenic	82.99	0.1071428571428571	['609942', '615278']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3; CARDIOFACIOCUTANEOUS SYNDROME 2	82.99	0.10714286	10-90	70-90																																																																																																																																		true	KRASGly60Ser																																																																																																																																																																																																																																		
FH	FH_Ala308Thr	-0.7120971186723563	0.5031403010535435	-11.394484282268747	8.993403746646915e-6	2025_01_Batch_13-14	true	false	true	false	false	false	false	false	false	false	0.982594161777217	0.7415698319845145	0.9534908015419465	0.9307758731108188	0.677568172006145	0.752578540982823	0.9337486622872755	0.9518229092496397	0.7970626847446404	0.9810411602833721	0.6025578030294673	0.9278030839343621	0.9551586938342534	0.6860769792243886	0.984147163271062	FH	-0.7120971186723563	0.5031403010535435	-11.394484282268747	8.993403746646915e-6	2025_01_Batch_13-14	true	false	true	false	false	false	false	false	false	false	0.982594161777217	0.7415698319845145	0.9534908015419465	0.9307758731108188	0.677568172006145	0.752578540982823	0.9337486622872755	0.9518229092496397	0.7970626847446404	0.9810411602833721	0.6025578030294673	0.9278030839343621	0.9551586938342534	0.6860769792243886	0.984147163271062	FH	ENSG00000091483	3408	5873.0	CCSBVarC000454	ALE00000454	NC_000001.11:241504228:C:T	922G>A	Ala308Thr	RC4	RC4_Mut_GDEh1025	A03	GDEhDisVCh_40065	A12	1.0	RC4_Mut_GDDh1025	A03							1.0	7.0	1.0	7.0	0.0			0.0			0.0			1.0	241504228.0	C	T	1	N	N	N	N	N	1-241504228-C-T	1314669.0	single nucleotide variant	NM_000143.4(FH):c.922G>A (p.Ala308Thr)	2271.0	FH	HGNC:3700	Pathogenic	1.0	Sep 24, 2022	121913118.0	-	RCV001781102	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000001.11	1	241504228.0	241504228.0	1q43	criteria provided, single submitter	1.0	-	N	ClinGen:CA40327917	2.0	1324397.0	241504228.0	C	T	-	-	-	-	-	-	SCV003523960	-	-	922G>A 	Ala308Thr	NM_000143.4	1.0	1_Pathogenic		1324397.0	1	241504228.0	C	T	A	T	rs121913118	1	241667528.0	1	239734151.0	308.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.922G>A	p.Ala308Thr	c.922G>A	p.Ala308Thr	principal1	Y	1	YES	Select	-	GCT	1.0	0.0	C	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	0.996	0.68795	D	0.958	0.70027	D	0.95	0.94956	D	simple_aae	5.0	95.0	3.44	0.92016	M	-3.59	0.69272	D	0.934	0.93968	1.0591	0.98315	D	0.9836	0.99499	D	9.0	0.9391092	0.93162	D	0.83885	0.98751	D	0.946	0.98921	0.647	0.78347	P07954	A308T	Gain of glycosylation at A308 (P = 0.0142)| Gain of phosphorylation at A308 (P = 0.0426)| Gain of ubiquitination at K311 (P = 0.1092)| Gain of methylation at K311 (P = 0.1332)| Gain of disorder (P = 0.3258)	0.973295160969	0.97274	0.9325441300373446	0.93191	0.952392643853	0.72524	0.740001261234	0.72926	T	0.976808	0.99782	D	0.554402	0.95837	D	0.558584	0.95773	D	0.981637419267628	0.73841	D	0.979469	0.92945	D	0.9160993	0.92765	0.86255217	0.92251	0.9160993	0.92766	0.86255217	0.92252	-12.206	0.85877	D	0.5677	0.67484	P	0.993749286198762	0.90224	0.95155084	0.93461	0.964	0.98523	.	.	.	.	.	.	5.006822	0.83151	28.0	0.999303991227756	0.99334	0.921872	0.89561	D	0.931844876423458	0.93192	11.90403	0.895432979793859	0.95345	13.55806	5.73	5.73	0.89714	6.28	0.98834	5.666	0.67804	7.627000	0.62620	0.599	0.40292	1.0	0.71675	1.000000	0.68239	1.0	0.97202	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	criteria_provided,_single_submitter	NC_000001.11:g.241504228C>T	.	C3661900	.	.	Fumarate lyase, N-terminal	Ala	Thr	1314669.0	single nucleotide variant	NM_000143.4(FH):c.922G>A (p.Ala308Thr)	2271.0	FH	HGNC:3700	Pathogenic	1.0	Sep 24, 2022	121913118.0	-	RCV001781102	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000001.11	1	241504228.0	241504228.0	1q43	criteria provided, single submitter	1.0	-	N	ClinGen:CA40327917	2.0	1324397.0	241504228.0	C	T	-	-	-	-	-	-	SCV003523960	-	-	922G>A 	Ala308Thr	NM_000143.4	1.0	1_Pathogenic	98.79	0.0188679245283018		unknown	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6		98.79	0.018867925	<10	>90						A	2			98.79	Aliphatic	Alanine		Fumarate hydratase, mitochondrial										1.8								A308-L272; PAE: 1.0	4 interactions	A308-L272; PAE: 1.0	4 interactions							89									-61.6				130.1						C (loop/coil)	C (loop/coil)																																																																				true	FHAla308Thr																																																																																																																																																																																																																																		
FARS2	FARS2_His84Pro	-0.6685215350519559	1.0	-1.9143491804649417	0.11887068523584414	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8973445107029393	0.6837414803140003	0.8019575795471414	0.7646745450390382	0.649650426254343	0.6909273743374506	0.8085540786477744	0.8066052962232809	0.7564985110978174	0.9130441035248813	0.6083734781712353	0.7207950114303019	0.797309862871002	0.6109844495301832	0.8816449178809973	FARS2	-0.6685215350519559	1.0	-1.9143491804649417	0.11887068523584414	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8973445107029393	0.6837414803140003	0.8019575795471414	0.7646745450390382	0.649650426254343	0.6909273743374506	0.8085540786477744	0.8066052962232809	0.7564985110978174	0.9130441035248813	0.6083734781712353	0.7207950114303019	0.797309862871002	0.6109844495301832	0.8816449178809973	FARS2		12653		CCSBVarC011910		NC_000006.12:5368821:A:C	251A>C	His84Pro																												6.0	5368821.0	A	C	6						6-5368821-A-C	962036.0	single nucleotide variant	NM_006567.5(FARS2):c.251A>C (p.His84Pro)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Dec 12, 2019	1758844499.0	-	RCV001250396	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5368821.0	5368821.0	6p25.1	no assertion criteria provided	1.0	-	N	ClinGen:CA362734878	2.0	973746.0	5368821.0	A	C	-	-	-	-	-	-	SCV001424747	-	-	251A>C 	His84Pro	NM_006567.5		1_Pathogenic		973746.0	6	5368821.0	A	C	H	P	rs1758844499	6	5369054.0	6	5314053.0	84.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.251A>C	p.His84Pro	c.251A>C	p.His84Pro	principal1	Y	1	YES	Select	+	CAC	2.0	0.0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.98	0.99849	H	-9.18	0.98237	D	0.929	0.93495	0.5682	0.91447	D	0.6119	0.86217	D	10.0	0.97114253	0.96682	D	0.337595	0.91908	D	0.841	0.95012	0.815	0.92954	O95363	H84P	Gain of catalytic residue at H84 (P = 0.0281)| Gain of glycosylation at H84 (P = 0.0433)| Loss of MoRF binding (P = 0.0679)| Loss of helix (P = 0.079)| Loss of disorder (P = 0.1597)	0.958043335942	0.95723	.	0.96295	.	0.68072	0.523846149445	0.42108	T	0.640816	0.88872	D	0.362787	0.87376	D	0.283342	0.87214	D	0.999933004379272	0.9978	D	0.922108	0.71602	D	0.9622549	0.97466	0.9041385	0.95204	0.9622549	0.97466	0.9041385	0.95205	-13.227	0.90296	D	0.7894	0.77044	P	0.999515333251888	0.96835	0.96594020	0.94359	0.95	0.97732	.	.	.	.	.	.	4.99072	0.82771	27.9	0.9885900585301116	0.47542	0.956935	0.97572	D	1.04327041522056	0.96912	15.34014	0.934733790292807	0.96898	15.32305	5.33	5.33	0.75646	3.49	0.63201	8.916	0.92352	11.098000	0.86082	0.756	0.943	1.0	0.71675	1.0	0.68239	0.986	0.61779	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Combined_oxidative_phosphorylation_defect_type_14	no_assertion_criteria_provided	NC_000006.12:g.5368821A>C	.	C4755312	614946	319519	Phenylalanyl-tRNA synthetase	His	Pro	962036.0	single nucleotide variant	NM_006567.5(FARS2):c.251A>C (p.His84Pro)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Dec 12, 2019	1758844499.0	-	RCV001250396	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5368821.0	5368821.0	6p25.1	no assertion criteria provided	1.0	-	N	ClinGen:CA362734878	2.0	973746.0	5368821.0	A	C	-	-	-	-	-	-	SCV001424747	-	-	251A>C 	His84Pro	NM_006567.5		1_Pathogenic	98.41	0.0054347826086956	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	98.41	0.0054347827	<10	>90						H	1			98.41	Positively-charged	Histidine												-3.2								H84-L88, H84-F332; PAE: 1.0, 1.0	11 interactions	H84-L78, H84-L88; PAE: 1.0, 1.0	11 interactions							155									-72.5				141.5						C (loop/coil)	C (loop/coil)	Beta strand																																																																			true	FARS2His84Pro																																																																																																																																																																																																																																		
F9	F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6878637509608541	0.6708012889709556	0.7961791887209522	0.7029713194683769	0.7740974475748301	0.7809611787373808	0.650771112292108	0.7778573689367987	0.7013014941919294	0.6642850168139603	0.7672337164122793	0.7551715266446457	0.8145010085051057	0.6403010837499816	0.7114424851077479	F9	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6878637509608541	0.6708012889709556	0.7961791887209522	0.7029713194683769	0.7740974475748301	0.7809611787373808	0.650771112292108	0.7778573689367987	0.7013014941919294	0.6642850168139603	0.7672337164122793	0.7551715266446457	0.8145010085051057	0.6403010837499816	0.7114424851077479	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T	844C>T	His282Tyr																												23.0	139561529.0	C	T	X						X-139561529-C-T	1150446.0	single nucleotide variant	NM_000133.4(F9):c.844C>T (p.His282Tyr)	2158.0	F9	HGNC:3551	Likely benign	0.0	Feb 14, 2024	763399530.0	-	RCV001480159	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561529.0	139561529.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10529850	2.0	1142361.0	139561529.0	C	T	-	-	-	-	-	-	SCV001684474	-	-	844C>T 	His282Tyr	NM_000133.4	1.0	2_Benign		1142361.0	X	139561529.0	C	T	H	Y	rs763399530	X	138643688.0	X	138471354.0	282.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.844C>T	p.His282Tyr	c.844C>T	p.His282Tyr	principal1	Y	1	YES	Select	+	CAT	1.0	0.0	C	C/C	C/C	C/C	C/C	0.68	0.06480	T	0.512	0.16506	T	0.015	0.17100	B	0.058	0.26454	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.8	0.19557	N	-2.55	0.55206	D	0.148	0.14965	-0.5954	0.64851	T	0.514	0.81707	D	10.0	0.18958774	0.34189	T	0.054279	0.65667	D	0.393	0.70688	0.78	0.90415	P00740	H282Y	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.96162791622	0.96087	0.9940287968305028	0.99398	0.807526858809	0.66347	0.379336297512	0.22139	T	0.829846	0.95894	D	-0.23264	0.16016	T	-0.302648	0.44102	T	0.117615622490317	0.14014	T	0.768423	0.39558	T	0.4559485	0.64101	0.36480957	0.61600	0.4559485	0.64101	0.36480957	0.61600	-3.409	0.15190	T	0.0731	0.06927	B	0.48480680668397	0.60322	0.99983406	0.99778	0.675	0.81949	.	.	.	.	.	.	0.540746	0.0912	5.876	0.5281119984824632	0.04879	.	.	.	.	.	.	.	.	.	5.42	1.91	0.24773	1.6	0.35226	0.11	0.1532	0.134000	0.15149	0.549	0.27038	0.051	0.21521	0.427	0.24915	0.615	0.31811	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	77986	2.564560e-05	0	4	145968	2.740330e-05	0	4	165649	2.414740e-05	0	0	5683	0.000000e+00	0	0	13111	0.000000e+00	0	0	1665	0.000000e+00	0	0	6903	0.000000e+00	0	0	9844	0.000000e+00	0	0	30415	0.000000e+00	0	1	8955	1.116690e-04	0	1	8955	1.116690e-04	0	0	13056	0.000000e+00	0	0	23376	0.000000e+00	0	0	4328	0.000000e+00	0	0	10097	0.000000e+00	0	0	12043	0.000000e+00	0	0	62696	0.000000e+00	0	3	16890	1.776200e-04	0	3	16890	1.776200e-04	0	0	11986	0.000000e+00	0	0	26076	0.000000e+00	0	0	6612	0.000000e+00	0	0	13127	0.000000e+00	0	0	15766	0.000000e+00	0	0	71276	0.000000e+00	0	3	16825	1.783060e-04	0	3	16825	1.783060e-04	0	.	13	1200931	1.082490e-05	0	11	55470	1.983050e-04	0	0	56966	0.000000e+00	0	0	687	0.000000e+00	0	0	45208	0.000000e+00	0	0	21785	0.000000e+00	0	0	33709	0.000000e+00	0	0	46466	0.000000e+00	0	0	4344	0.000000e+00	0	0	889011	0.000000e+00	0	11	55470	1.983050e-04	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561529C>T	.	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	1150446.0	single nucleotide variant	NM_000133.4(F9):c.844C>T (p.His282Tyr)	2158.0	F9	HGNC:3551	Likely benign	0.0	Feb 14, 2024	763399530.0	-	RCV001480159	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561529.0	139561529.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10529850	2.0	1142361.0	139561529.0	C	T	-	-	-	-	-	-	SCV001684474	-	-	844C>T 	His282Tyr	NM_000133.4	1.0	2_Benign	93.76	0.1304347826086956	['306900', '300807']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	93.76	0.13043478	10-90	>90						H	24			93.76	Positively-charged	Histidine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-3.2								H282-W356, H282-E288, H282-L369; PAE: 1.5, 3.0, 1.0	4 interactions	H282-P235, H282-L369; PAE: 1.0, 1.0	7 interactions							155									-128.8				-44.1						C (loop/coil)	S (bend)	Beta strand																													0.941		0.888		0.9		0.877		0.878																														true	F9His282Tyr																																																																																																																																																																																																																																		
KRAS	KRAS_Met72Leu	-2.4492678134739627	0.04415464746417742	4.235830569813894	0.0038601676600614906	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8004421593940887	0.6542980137135048	0.7431706127666842	0.7496527173531529	0.7103170897150236	0.46574253540484	0.6313495228635834	0.5598039567361075	0.4527555289657161	0.7353367754214719	0.9548916440252072	0.8679559118427225	0.9265372687972608	0.8558404984612935	0.8655475433667056	KRAS	-2.4492678134739627	0.04415464746417742	4.235830569813894	0.0038601676600614906	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8004421593940887	0.6542980137135048	0.7431706127666842	0.7496527173531529	0.7103170897150236	0.46574253540484	0.6313495228635834	0.5598039567361075	0.4527555289657161	0.7353367754214719	0.9548916440252072	0.8679559118427225	0.9265372687972608	0.8558404984612935	0.8655475433667056	KRAS	ENSG00000133703	3084	214491.0	CCSBVarC006100	ALE00006100	NC_000012.12:25227310:T:G	214A>C	Met72Leu	CEGS2	CegsMutGDEh1041	F08	GDEhDisVCh_40061	B10	1.0	CegsMutGDDh1041	F08							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25227310.0	T	G	12	Y	Y	N	N	N	12-25227310-T-G	1010371.0	single nucleotide variant	NM_004985.5(KRAS):c.214A>C (p.Met72Leu)	3845.0	KRAS	HGNC:6407	Likely pathogenic	1.0	Jun 19, 2022	727504662.0	-	RCV001315183	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227310.0	25227310.0	12p12.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA384151976	2.0	1016209.0	25227310.0	T	G	-	-	-	-	-	-	SCV001505744	-	-	214A>C 	Met72Leu	NM_004985.5	1.0	1_Pathogenic		1016209.0	12	25227310.0	T	G	M	L	rs727504662	12	25380244.0	12	25271511.0	72.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.214A>C	p.Met72Leu	c.214A>C	p.Met72Leu	alternative1	Y	1	.	Plus_Clinical	-	ATG	1.0	0.0	T	T/T	T/T	T/T	T/T	0.029	0.46288	D	0.083	0.41751	T	0.236	0.30787	B	0.256	0.39260	B	0.97	0.96253	D	simple_aae	3.0	97.0	0.855	0.21196	L	-2.55	0.55206	D	0.755	0.75268	-0.4018	0.71845	T	0.3464	0.71002	T	10.0	0.6263549	0.67986	D	0.0458	0.62008	D	0.658	0.87125	0.665	0.80215	P01116	M72L	Gain of catalytic residue at T74 (P = 0.0197)| Loss of phosphorylation at Y71 (P = 0.0909)| Loss of disorder (P = 0.0926)| Loss of helix (P = 0.2271)| Loss of sheet (P = 0.302)	0.869051532231	0.86675	0.8560956093177353	0.85484	1.59547003884	0.88549	0.892316937447	0.95540	D	0.810422	0.95217	D	0.353299	0.86638	D	0.269713	0.86464	D	0.740672528743744	0.42477	D	0.939506	0.77609	D	0.9555017	0.96774	0.87500864	0.93122	0.9538084	0.96601	0.89415234	0.94486	-8.664	0.66608	D	0.8556	0.80172	P	0.999925671145259	0.98892	0.99469410	0.97604	0.986	0.99524	.	.	.	.	.	.	4.690966	0.75207	26.3	0.9757841748395701	0.34888	0.885317	0.81506	D	0.259874108519936	0.53898	3.579291	0.425460968171894	0.62956	4.543828	5.77	5.77	0.91065	3.95	0.75212	8.004	0.88091	7.919000	0.74463	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.999	0.91597	856	0.34333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	RASopathy	criteria_provided,_single_submitter	NC_000012.12:g.25227310T>G	.	C5555857	.	536391	Small GTP-binding domain	Met	Leu	1010371.0	single nucleotide variant	NM_004985.5(KRAS):c.214A>C (p.Met72Leu)	3845.0	KRAS	HGNC:6407	Likely pathogenic	1.0	Jun 19, 2022	727504662.0	-	RCV001315183	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227310.0	25227310.0	12p12.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA384151976	2.0	1016209.0	25227310.0	T	G	-	-	-	-	-	-	SCV001505744	-	-	214A>C 	Met72Leu	NM_004985.5	1.0	1_Pathogenic	93.98	0.0		unknown	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13		93.98	0.0	<10	>90																																																																																																																																		true	KRASMet72Leu																																																																																																																																																																																																																																		
SDHD	SDHD_Asp92Gly	8.432612836805006	0.00007012093234778765	-4.989321535931711	0.027997159194273955	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8601518266782308	0.7561557579794063	0.8378152325414896	0.8588251385514885	0.8205370528449965	0.8382648617100562	0.9018121459491316	0.9084642845176677	0.7545022585795033	0.894444117072103	0.8028092439799367	0.8158381311538452	0.7671661805653115	0.7578092573793094	0.8258595362843585	SDHD	8.432612836805006	0.00007012093234778765	-4.989321535931711	0.027997159194273955	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8601518266782308	0.7561557579794063	0.8378152325414896	0.8588251385514885	0.8205370528449965	0.8382648617100562	0.9018121459491316	0.9084642845176677	0.7545022585795033	0.894444117072103	0.8028092439799367	0.8158381311538452	0.7671661805653115	0.7578092573793094	0.8258595362843585	SDHD		6363		CCSBVarC023312		NC_000011.10:112088972:A:G	275A>G	Asp92Gly																												11.0	112088972.0	A	G	11						11-112088972-A-G	178768.0	single nucleotide variant	NM_003002.4(SDHD):c.275A>G (p.Asp92Gly)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	May 26, 2015	786205436.0	-	RCV000171136|RCV000186596	MedGen:C3532243|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167	Fatal infantile mitochondrial cardiomyopathy|Mitochondrial complex 2 deficiency, nuclear type 3	germline	germline	GRCh38	NC_000011.10	11	112088972.0	112088972.0	11q23.1	no assertion criteria provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016709,UniProtKB:O14521#VAR_074106,OMIM:602690.0031	3.0	180590.0	112088972.0	A	G	-	-	-	-	-	-	SCV000196921|SCV000240203	-	-	275A>G 	Asp92Gly	NM_003002.4		1_Pathogenic		180590.0	11	112088972.0	A	G	D	G	rs786205436	11	111959696.0	11	111464906.0	92.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.275A>G	p.Asp92Gly	c.275A>G	p.Asp92Gly	principal1	Y	1	YES	Select	+	GAC	2.0	0.0	A	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97926	A	simple_aae	2.0	98.0	3.9	0.96054	H	-6.8	0.92923	D	0.998	0.99987	1.0131	0.97405	D	0.9872	0.99622	D	10.0	0.99263144	0.99798	D	0.822633	0.98618	D	0.976	0.99783	0.96	0.99581	O14521	D92G	Loss of stability (P = 0.0632)| Gain of glycosylation at S89 (P = 0.0743)| Gain of catalytic residue at D92 (P = 0.078)| Gain of helix (P = 0.2294)| Gain of disorder (P = 0.6219)	0.981310432533	0.98091	0.9625151340225994	0.96216	0.852731849783	0.68423	0.656035840511	0.60780	T	0.980289	0.99837	D	0.583575	0.97037	D	0.600488	0.96988	D	0.999705016613007	0.98567	D	0.842116	0.51695	T	0.9904235	0.99782	0.970635	0.99484	0.99101526	0.99812	0.97202027	0.99543	-12.11	0.85423	D	0.8975	0.82539	P	0.993190100922059	0.89912	0.99926764	0.99259	0.997	0.99892	.	.	.	.	.	.	5.193893	0.8714	29.1	0.9986669211494795	0.94461	0.957097	0.97598	D	0.854382185558375	0.89298	9.938285	0.777690480254967	0.88139	9.494944	5.04	5.04	0.6725	.	.	8.791	0.91503	9.300000	0.79897	0.691	0.84104	1.0	0.71675	1.0	0.68239	0.964	0.52647	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Fatal_infantile_mitochondrial_cardiomyopathy|Mitochondrial_complex_2_deficiency,_nuclear_type_3	no_assertion_criteria_provided	NC_000011.10:g.112088972A>G	ClinGen:CA016709|OMIM:602690.0031|UniProtKB:O14521#VAR_074106	C3532243|C5436934	619167	.	.	Asp	Gly	178768.0	single nucleotide variant	NM_003002.4(SDHD):c.275A>G (p.Asp92Gly)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	May 26, 2015	786205436.0	-	RCV000171136|RCV000186596	MedGen:C3532243|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167	Fatal infantile mitochondrial cardiomyopathy|Mitochondrial complex 2 deficiency, nuclear type 3	germline	germline	GRCh38	NC_000011.10	11	112088972.0	112088972.0	11q23.1	no assertion criteria provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016709,UniProtKB:O14521#VAR_074106,OMIM:602690.0031	3.0	180590.0	112088972.0	A	G	-	-	-	-	-	-	SCV000196921|SCV000240203	-	-	275A>G 	Asp92Gly	NM_003002.4		1_Pathogenic	98.68	0.0797546012269938	['619167']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3	98.68	0.0797546	<10	>90						D	13			98.68	Negatively-charged	Aspartic Acid		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										-3.5								D92-C88, D92-C150, D92-A96; PAE: 1.0, 1.0, 1.0	3 interactions	D92-N143, D92-C88, D92-I149, D92-C150, D92-A96; PAE: 1.0, 1.0, 1.0, 1.0, 1.0	4 interactions							132									-58.8				-46.1						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDAsp92Gly																																																																																																																																																																																																																																		
BRCA1	BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.1586367936470939	0.8784347489809712	2025_01_Batch_13-14	false	false	true	false	true	false	false	false	false	true	0.9213122650626981	0.8571091860163442	0.9670357213819983	0.918189406188478	0.9555780160962768	0.9316618456321133	0.9092375600621425	0.9617341429430188	0.8089472055930808	0.93286056207861	0.9794941865604404	0.9271412523148135	0.9723372998209778	0.9052711664396076	0.9097639680467864	BRCA1	2.1265294642858166	0.07103329880869202	-0.1586367936470939	0.8784347489809712	2025_01_Batch_13-14	false	false	true	false	true	false	false	false	false	true	0.9213122650626981	0.8571091860163442	0.9670357213819983	0.918189406188478	0.9555780160962768	0.9316618456321133	0.9092375600621425	0.9617341429430188	0.8089472055930808	0.93286056207861	0.9794941865604404	0.9271412523148135	0.9723372998209778	0.9052711664396076	0.9097639680467864	BRCA1	ENSG00000012048	14613	218422.0	CCSBVarC003303	ALE00003303	NC_000017.11:43067628:G:A	1742C>T	Thr581Ile	CEGS2	CegsMutGDEh1018	D09	GDEhDisVCh_40059	C06	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43067628.0	G	A	17	Y	N	N	N	N	17-43067628-G-A	70032.0	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357043.0	-	RCV000112476|RCV001853017|RCV002336188|RCV004998172	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43067628.0	43067628.0	17q21.31	reviewed by expert panel	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2.0	55365.0	43067628.0	G	A	-	-	-	-	-	-	SCV000244380	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3.0	1_Pathogenic	1.36983e-6	55365.0	17	43067628.0	G	A	T	I	rs80357043	17	41219645.0	17	38473171.0	1685.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5054C>T	p.Thr1685Ile	principal2	Y	1	.	.	-	ACT	2.0	0.0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.89	0.90580	P	0.329	0.92348	B	.	0.99291	.	.	.	.	3.31	0.90471	M	.	0.82367	.	.	0.95034	0.76	0.93898	D	0.7898	0.92853	D	10.0	.	0.85827	.	0.72506	0.97777	D	.	0.96457	.	.	.	.	.	.	0.96144	.	0.90972	.	0.19319	0.753464519978	0.74914	T	0.409904	0.82120	T	0.438305	0.91883	D	0.391819	0.91782	D	0.983474791049957	0.7495	D	0.958004	0.85541	D	0.88979423	0.90355	0.6439081	0.78957	0.9066492	0.91869	0.62467957	0.77890	-14.562	0.94802	D	.	0.91617	.	0.991231594940223	0.88934	0.99987290	0.99835	0.987	0.99559	.	.	.	.	.	.	4.1672	0.62705	24.5	0.9990436228200248	0.97578	0.771366	0.70495	D	0.813238141695724	0.86857	9.04512	0.757877512501455	0.86669	8.988454	5.24	5.24	0.72825	.	.	6.008	0.70468	11.804000	0.96740	0.569	0.28905	1.0	0.71675	1.0	0.68239	0.976	0.56441	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1612146	1.860870e-06	0	1	44884	2.227970e-05	0	0	74826	0.000000e+00	0	0	912	0.000000e+00	0	0	59984	0.000000e+00	0	0	29592	0.000000e+00	0	1	44884	2.227970e-05	0	0	64008	0.000000e+00	0	0	6078	0.000000e+00	0	2	1178384	1.697240e-06	0	0	91058	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067628G>A	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ile	70032.0	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357043.0	-	RCV000112476|RCV001853017|RCV002336188|RCV004998172	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43067628.0	43067628.0	17q21.31	reviewed by expert panel	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2.0	55365.0	43067628.0	G	A	-	-	-	-	-	-	SCV000244380	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3.0	1_Pathogenic	94.85	0.352112676056338	['604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	94.85	0.35211268	10-90	>90																																																																																																																																		true	BRCA1Thr581Ile																																																																																																																																																																																																																																		
KRAS	KRAS_Gly12Asp	-1.282954401654033	0.24035037393394657	6.504027749209328	0.00033287040797068537	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9004203541652411	0.7894556745476111	0.8874665386966136	0.9150621807492578	0.8713181739444738	0.7891330351514627	0.9019244309890346	0.8194808192304905	0.6907045859261781	0.857924198148612	0.9535033127374848	0.9281999305094811	0.9554522581627367	0.8882067631690442	0.9429165101818704	KRAS	-1.282954401654033	0.24035037393394657	6.504027749209328	0.00033287040797068537	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9004203541652411	0.7894556745476111	0.8874665386966136	0.9150621807492578	0.8713181739444738	0.7891330351514627	0.9019244309890346	0.8194808192304905	0.6907045859261781	0.857924198148612	0.9535033127374848	0.9281999305094811	0.9554522581627367	0.8882067631690442	0.9429165101818704	KRAS	ENSG00000133703	3084	214484.0	CCSBVarC006090	ALE00006090	NC_000012.12:25245350:C:T	35G>A	Gly12Asp	CEGS2	CegsMutGDEh1034	G11	GDEhDisVCh_40061	F08	1.0	CegsMutGDDh1034	G11							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25245350.0	C	T	12	Y	Y	N	N	N	12-25245350-C-T	27621.0	single nucleotide variant	NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Oct 07, 2024	121913529.0	-	RCV000272938|RCV000433573|RCV000013411|RCV000856666|RCV001799604|RCV000548006|RCV000585796|RCV000662266|RCV002508117|RCV003327361|RCV004018620|RCV000022799|RCV000029214|RCV000029215|RCV000144969|RCV000144970|RCV000150896|RCV000150897|RCV005007840|RCV001839445|RCV004554600|RCV004668724	MedGen:C3661900|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C4302356|MONDO:MONDO:0020783,MedGen:C4747394,OMIM:608354,Orphanet:137667,Orphanet:90307|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724||Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0006096,MedGen:C0349579;MONDO:MONDO:0006193,MedGen:C1516855|MedGen:CN230736|Human Phenotype Ontology:HP:0010816,MONDO:MONDO:0008093,MedGen:C0334082,OMIM:162900,Orphanet:79414|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|12 conditions|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396||Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	not provided|Acute myeloid leukemia|Carcinoma of pancreas|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|RASopathy|Cerebral arteriovenous malformation|Vascular Tumors Including Pyogenic Granuloma|Gastric cancer|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|12 conditions|Encephalocraniocutaneous lipomatosis|Congenital Pulmonary Airway Malformations|Neoplasm	de novo;germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350.0	25245350.0	12p12.1	criteria provided, multiple submitters, no conflicts	24.0	-	N	ClinGen:CA122538,UniProtKB:P01116#VAR_016026,OMIM:190070.0005,OMIM:190070.0025	3.0	12582.0	25245350.0	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000329383|SCV000659085|SCV001736991|SCV002318898|SCV002525678|SCV002601600|SCV002821689|SCV004176950|SCV005023563|SCV005044128|SCV005414064|SCV005634967	-	SCV005094257	35G>A 	Gly12Asp	NM_004985.5	2.0	1_Pathogenic	2.73867e-6	12582.0	12	25245350.0	C	T	G	D	rs121913529	12	25398284.0	12	25289551.0	12.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.35G>A	p.Gly12Asp	c.35G>A	p.Gly12Asp	alternative1	Y	1	.	Plus_Clinical	-	GGT	2.0	0.0	C	./.	./.	./.	./.	0.01	0.56615	D	0.0	0.92967	D	0.517	0.37470	P	0.361	0.43233	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.685	0.78379	M	-5.37	0.90914	D	0.915	0.91737	0.267	0.86969	D	0.5809	0.84869	D	10.0	0.897719	0.89008	D	0.164646	0.84329	D	0.875	0.96271	0.772	0.89792	P01116	G12D	Gain of catalytic residue at G13 (P = 0.001)| Gain of ubiquitination at K16 (P = 0.1181)| Loss of methylation at K16 (P = 0.1388)| Gain of solvent accessibility (P = 0.2192)| Loss of sheet (P = 0.302)	0.957447700615	0.95662	0.9871709593781199	0.98706	2.25690945348	0.96132	0.929049253464	0.98932	D	0.839213	0.96205	D	0.397866	0.89719	D	0.33373	0.89591	D	0.965350031852722	0.67026	D	0.331367	0.19106	T	0.92127717	0.93272	0.924745	0.96683	0.9358444	0.94746	0.9112568	0.95720	-14.566	0.96931	D	0.9984	0.98378	P	0.999983137957112	0.99579	0.99778840	0.98508	0.995	0.99826	.	.	.	.	.	.	4.925041	0.81187	27.5	0.9977665546908844	0.86444	0.891815	0.82751	D	0.605638712679719	0.73388	5.981318	0.66049645547495	0.79283	7.073244	5.68	5.68	0.88004	.	.	7.892	0.85894	7.698000	0.66189	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	108342	9.230030e-06	0	1	206404	4.844870e-06	0	1	234992	4.255460e-06	0	0	7046	0.000000e+00	0	0	17030	0.000000e+00	0	0	2232	0.000000e+00	0	0	9026	0.000000e+00	0	0	13384	0.000000e+00	0	1	42218	2.368660e-05	0	0	15506	0.000000e+00	0	1	42218	2.368660e-05	0	0	16014	0.000000e+00	0	0	30376	0.000000e+00	0	0	6112	0.000000e+00	0	0	13384	0.000000e+00	0	0	16720	0.000000e+00	0	1	88728	1.127040e-05	0	0	30232	0.000000e+00	0	1	88728	1.127040e-05	0	0	14710	0.000000e+00	0	0	34116	0.000000e+00	0	0	9462	0.000000e+00	0	0	17666	0.000000e+00	0	0	21592	0.000000e+00	0	1	101710	9.831870e-06	0	0	30152	0.000000e+00	0	1	101710	9.831870e-06	0	.	6	1612744	3.720370e-06	0	5	1179306	4.239780e-06	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	0	59938	0.000000e+00	0	0	29524	0.000000e+00	0	0	44868	0.000000e+00	0	0	63988	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179306	4.239780e-06	0	0	90798	0.000000e+00	0	0	90742	0	0	162	0	0	2680	0	0	3944	0	0	436	0	0	928	0	0	624	0	0	276	0	1	2036	4.911591355599214E-4	0	4106	0	0	3304	0	1	101828	9.820481596417489E-6	Pathogenic/Likely_pathogenic	Juvenile_myelomonocytic_leukemia|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Acute_myeloid_leukemia|Gastric_cancer|Congenital_Pulmonary_Airway_Malformations|not_provided|Carcinoma_of_pancreas|Cardiovascular_phenotype|Ovarian_neoplasm|RASopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|Non-small_cell_lung_carcinoma|Capillary_malformation-arteriovenous_malformation_1|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|Linear_nevus_sebaceous_syndrome|Vascular_Tumors_Including_Pyogenic_Granuloma|Atypical_endometrial_hyperplasia|Endometrial_hyperplasia_without_atypia|Cerebral_arteriovenous_malformation|Lung_carcinoma|Epidermal_nevus	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245350C>T	ClinGen:CA122538|OMIM:190070.0005|OMIM:190070.0025|UniProtKB:P01116#VAR_016026	C0349639|C0406612|C0009404|C0040136|C0023467|C0024623|C3661900|C0235974|CN230736|C0919267|C5555857|C4302356|C0007131|C4747394|C2674723|C3854181|C4552097|C0349579|C1516855|C0917804|C0684249|C0334082	607785|613001|601626|613659|608354|614470|163200|108010|162900	86834|2396|100087|519|1333|217074|536391|137667|90307|268114|2612|46724|79414	Small GTP-binding domain	Gly	Asp	27621.0	single nucleotide variant	NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Oct 07, 2024	121913529.0	-	RCV000272938|RCV000433573|RCV000013411|RCV000856666|RCV001799604|RCV000548006|RCV000585796|RCV000662266|RCV002508117|RCV003327361|RCV004018620|RCV000022799|RCV000029214|RCV000029215|RCV000144969|RCV000144970|RCV000150896|RCV000150897|RCV005007840|RCV001839445|RCV004554600|RCV004668724	MedGen:C3661900|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C4302356|MONDO:MONDO:0020783,MedGen:C4747394,OMIM:608354,Orphanet:137667,Orphanet:90307|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724||Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0006096,MedGen:C0349579;MONDO:MONDO:0006193,MedGen:C1516855|MedGen:CN230736|Human Phenotype Ontology:HP:0010816,MONDO:MONDO:0008093,MedGen:C0334082,OMIM:162900,Orphanet:79414|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|12 conditions|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396||Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	not provided|Acute myeloid leukemia|Carcinoma of pancreas|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|RASopathy|Cerebral arteriovenous malformation|Vascular Tumors Including Pyogenic Granuloma|Gastric cancer|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|12 conditions|Encephalocraniocutaneous lipomatosis|Congenital Pulmonary Airway Malformations|Neoplasm	de novo;germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350.0	25245350.0	12p12.1	criteria provided, multiple submitters, no conflicts	24.0	-	N	ClinGen:CA122538,UniProtKB:P01116#VAR_016026,OMIM:190070.0005,OMIM:190070.0025	3.0	12582.0	25245350.0	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000329383|SCV000659085|SCV001736991|SCV002318898|SCV002525678|SCV002601600|SCV002821689|SCV004176950|SCV005023563|SCV005044128|SCV005414064|SCV005634967	-	SCV005094257	35G>A 	Gly12Asp	NM_004985.5	2.0	1_Pathogenic	94.86	0.2261904761904762	['601626', '608354', '108010', '613659', '162900', '163200', '607785', '614470', '613001']	somatic	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	LEUKEMIA, ACUTE MYELOID; CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1; ARTERIOVENOUS MALFORMATIONS OF THE BRAIN; GASTRIC CANCER; NEVUS, EPIDERMAL; SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; JUVENILE MYELOMONOCYTIC LEUKEMIA; RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	94.86	0.22619048	10-90	>90																																																																																																																																		true	KRASGly12Asp																																																																																																																																																																																																																																		
BRCA1	BRCA1_Pro533Leu	-0.7528200911783965	0.47610774311243165	5.735636261825845	0.0007088088193576657	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.8865111135155864	0.8554759351065632	0.9342509998939533	0.9083718193318858	0.9439718030599331	0.8966973181666507	0.9046777827911453	0.8836138891142781	0.846603016213943	0.8366561191366582	0.9912462879532156	0.9120658558726263	0.9848881106736286	0.8643488539991834	0.9363661078945147	BRCA1	-0.7528200911783965	0.47610774311243165	5.735636261825845	0.0007088088193576657	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.8865111135155864	0.8554759351065632	0.9342509998939533	0.9083718193318858	0.9439718030599331	0.8966973181666507	0.9046777827911453	0.8836138891142781	0.846603016213943	0.8366561191366582	0.9912462879532156	0.9120658558726263	0.9848881106736286	0.8643488539991834	0.9363661078945147	BRCA1		14613		CCSBVarC013043		NC_000017.11:43071004:G:A	1598C>T	Pro533Leu																												17.0	43071004.0	G	A	17						17-43071004-G-A	69981.0	single nucleotide variant	NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357048.0	-	RCV000048691|RCV000077589|RCV000162989|RCV000586145|RCV001084321|RCV001358461|RCV004554683	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|BRCA1-related disorder	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43071004.0	43071004.0	17q21.31	reviewed by expert panel	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00090,ClinGen:CA003076,UniProtKB:P38398#VAR_007794	2.0	55314.0	43071004.0	G	A	-	-	-	-	-	-	SCV000244372	-	-	4910C>T 	Pro1637Leu	NM_007294.4	3.0	2_Benign		55314.0	17	43071004.0	G	A	P	L	rs80357048	17	41223021.0	17	38476547.0	1637.0	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.4910C>T	p.Pro1637Leu	principal2	Y	.	.	.	-	CCA	2.0	0.0	G	G/G	G/G	G/G	G/G	.	0.58783	.	.	0.79703	.	0.364	0.66535	B	0.057	0.65195	B	.	0.53339	.	.	.	.	1.935	0.51654	L	.	0.81462	.	.	0.43554	0.4923	0.90403	D	0.7232	0.90488	D	10.0	.	0.62760	.	0.458461	0.94460	D	.	0.82485	.	.	.	.	.	.	0.90380	.	0.27141	.	0.09620	0.296533286572	0.09880	T	0.271505	0.64184	T	0.206619	0.74322	D	0.189468	0.82413	D	0.231254577636719	0.21745	T	.	0.48325	.	0.038577784	0.05118	0.050610814	0.07993	0.046824034	0.07827	0.055308446	0.09687	-3.524	0.18016	T	.	0.23603	.	0.544346036701319	0.62126	0.99945563	0.99403	0.431	0.66835	.	.	.	.	.	.	2.130503	0.27171	17.35	0.9845192756151604	0.41758	0.144722	0.26561	N	0.0679651651785688	0.44715	2.761733	-0.0712680779194096	0.36281	2.130881	4.82	4.82	0.61594	2.66	0.48641	0.768	0.26344	6.732000	0.56527	-0.105	0.15707	0.75	0.29224	1.0	0.68239	0.031	0.13278	543	0.72771	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109402	9.140600e-06	0	7	208052	3.364540e-05	0	5	236818	2.111330e-05	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	7	89482	7.822800e-05	0	0	30608	0.000000e+00	0	7	89482	7.822800e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21626	0.000000e+00	0	5	102628	4.871960e-05	0	0	30526	0.000000e+00	0	5	102628	4.871960e-05	0	.	60	1614068	3.717320e-05	0	57	1180046	4.830320e-05	0	0	74916	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29608	0.000000e+00	0	0	44898	0.000000e+00	0	0	64024	0.000000e+00	0	0	6084	0.000000e+00	0	57	1180046	4.830320e-05	0	0	91086	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	0	7864	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	0	8162	0	0	112	0	1	30890	3.237293622531564E-5	Benign	Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|BRCA1-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43071004G>A	BRCA1-HCI:BRCA1_00090|ClinGen:CA003076|UniProtKB:P38398#VAR_007794	C0027672|C0006142|C3661900|C0677776|C2676676|CN169374	604370	140162|145|145	.	Pro	Leu	69981.0	single nucleotide variant	NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357048.0	-	RCV000048691|RCV000077589|RCV000162989|RCV000586145|RCV001084321|RCV001358461|RCV004554683	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|BRCA1-related disorder	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43071004.0	43071004.0	17q21.31	reviewed by expert panel	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00090,ClinGen:CA003076,UniProtKB:P38398#VAR_007794	2.0	55314.0	43071004.0	G	A	-	-	-	-	-	-	SCV000244372	-	-	4910C>T 	Pro1637Leu	NM_007294.4	3.0	2_Benign	27.9	0.8455882352941176	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	27.9	0.8455882	10-90	<=50																																																																																																																																		true	BRCA1Pro533Leu																																																																																																																																																																																																																																		
BRAF	BRAF_Gly469Glu	1.200036246927843	0.2691587309971123	-2.4349535695068565	0.04509157625446467	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9009265552580805	0.6598203640525953	0.8942879135167232	0.88252084177326	0.764279125158017	0.7584429920405253	0.8194662027841655	0.8787096855905449	0.6660433758168792	0.8675298357279375	0.7701152582755088	0.9455754807623543	0.9098661414429015	0.6535973522883113	0.9343232747882235	BRAF	1.200036246927843	0.2691587309971123	-2.4349535695068565	0.04509157625446467	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9009265552580805	0.6598203640525953	0.8942879135167232	0.88252084177326	0.764279125158017	0.7584429920405253	0.8194662027841655	0.8787096855905449	0.6660433758168792	0.8675298357279375	0.7701152582755088	0.9455754807623543	0.9098661414429015	0.6535973522883113	0.9343232747882235	BRAF	ENSG00000157764	71969	220598.0	CCSBVarC003160	ALE00003160	NC_000007.14:140781602:C:T	1406G>A	Gly469Glu	CEGS2	CegsMutGDEh1028	A09	GDEhDisVCh_40058	F10	2.0									1.0	5.0	0.0		0.0			0.0			0.0			7.0	140781602.0	C	T	7	N	N	N	N	N	7-140781602-C-T	29013.0	single nucleotide variant	NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Sep 17, 2024	121913355.0	-	RCV000015008|RCV000033307|RCV000211748|RCV000212152|RCV000506575|RCV002287336|RCV001813209|RCV003450641	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Cardiofaciocutaneous syndrome 1|RASopathy|Cardio-facio-cutaneous syndrome|not provided|not specified|Noonan syndrome 7|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140781602.0	140781602.0	7q34	reviewed by expert panel	18.0	-	N	ClinGen:CA279970,UniProtKB:P15056#VAR_018621,OMIM:164757.0014	3.0	13974.0	140781602.0	C	T	-	-	-	-	-	-	SCV000616361	-	-	1406G>A 	Gly469Glu	NM_004333.6	3.0	1_Pathogenic	0.0	13974.0	7	140781602.0	C	T	G	E	rs121913355	7	140481402.0	7	140127871.0	469.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1406G>A	p.Gly469Glu	c.1406G>A	p.Gly469Glu	principal4	Y	.	YES	Select	-	GGA	2.0	0.0	C	./.	./.	./.	./.	.	.	.	.	.	.	0.999	0.77914	D	0.999	0.92348	D	.	0.95575	.	.	.	.	3.445	0.92067	M	.	.	.	.	.	1.076	0.98756	D	0.9172	0.97252	D	10.0	0.992007	0.99733	D	0.612203	0.96612	D	.	0.98001	0.992	0.99914	P15056	G469E	Loss of MoRF binding (P = 0.0591)| Gain of catalytic residue at G469 (P = 0.1084)| Gain of methylation at K473 (P = 0.1128)| Gain of phosphorylation at Y472 (P = 0.1612)| Gain of ubiquitination at K473 (P = 0.1827)	.	0.97730	.	0.97263	.	0.96811	0.941216766834	0.99500	D	0.964899	0.99571	D	0.481639	0.93706	D	0.454064	0.93626	D	0.999017953872681	0.95854	D	0.990601	0.97084	D	0.99422306	0.99940	0.9877916	0.99959	0.9873307	0.99607	0.98307276	0.99888	-13.528	0.91438	D	1.0	0.99952	P	0.999985580220805	0.99579	0.99919707	0.99211	1	0.99985	.	.	.	.	.	.	5.508136	0.91667	32.0	0.9979691158926658	0.88204	0.905235	0.85598	D	1.07569399882665	0.97644	16.51806	0.981768342919213	0.98233	17.76874	5.62	5.62	0.85695	.	.	7.886	0.85829	7.656000	0.64019	0.549	0.27038	1.0	0.71675	1.0	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	13024	0	0	92	0	0	110	0	0	3222	0	0	146	0	0	610	0	0	54	0	0	94	0	0	2794	0	0	3314	0	0	164	0	0	20146	0	Pathogenic	not_specified|Squamous_cell_carcinoma_of_the_skin|Transitional_cell_carcinoma_of_the_bladder|Melanoma|Prostate_adenocarcinoma|Neoplasm_of_the_large_intestine|not_provided|Cardio-facio-cutaneous_syndrome|Malignant_melanoma_of_skin|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1|RASopathy|Noonan_syndrome_7|Multiple_myeloma|Squamous_cell_lung_carcinoma	reviewed_by_expert_panel	NC_000007.14:g.140781602C>T	ClinGen:CA279970|OMIM:164757.0014|UniProtKB:P15056#VAR_018621	CN169374|C0553723|C0279680|C0025202|C0007112|C0009404|C3661900|C1275081|C0151779|C4551602|C5681679|C0152013|CN029449|C5555857|C3150970|C0026764|C0149782	PS115150|163950|115150|613706|254500	1340|648|98733|1340|536391|648|29073|85443	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Glu	29013.0	single nucleotide variant	NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Sep 17, 2024	121913355.0	-	RCV000015008|RCV000033307|RCV000211748|RCV000212152|RCV000506575|RCV002287336|RCV001813209|RCV003450641	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Cardiofaciocutaneous syndrome 1|RASopathy|Cardio-facio-cutaneous syndrome|not provided|not specified|Noonan syndrome 7|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140781602.0	140781602.0	7q34	reviewed by expert panel	18.0	-	N	ClinGen:CA279970,UniProtKB:P15056#VAR_018621,OMIM:164757.0014	3.0	13974.0	140781602.0	C	T	-	-	-	-	-	-	SCV000616361	-	-	1406G>A 	Gly469Glu	NM_004333.6	3.0	1_Pathogenic	75.46	0.0	['115150', '613706', '163950']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1; NOONAN SYNDROME 7; NOONAN SYNDROME 1	75.46	0.0	<10	70-90						G	0			75.46	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	ATP	Serine/threonine-protein kinase B-raf							Protein kinase			-0.4									7 interactions	G469-N486; PAE: 3.0	30 interactions							75									168.4				175.0				dbSNP: rs121913355; Variant type: LP/P; AA change: Gly469Ala; PTM type: Ubiquitylation; PTM morphology: FG*tVYkGkWHG; Var class: II&rs121913355		B (undefined)	E (parallel sheets)	Beta strand																																																																			true	BRAFGly469Glu																																																																																																																																																																																																																																		
G6PD	G6PD_Glu398Lys	-2.2270130039444096	0.061240193067420415	-0.8074387696543632	0.44597881965233355	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6579336772069859	0.6081129620859809	0.7014009411298499	0.6711691462194245	0.6432803131104896	0.6375150811257665	0.6857507416320532	0.754685069336219	0.5817260749943405	0.6899031274081147	0.6490455450952126	0.6565875508067958	0.6481168129234808	0.6344998491776213	0.6259642270058572	G6PD	-2.2270130039444096	0.061240193067420415	-0.8074387696543632	0.44597881965233355	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6579336772069859	0.6081129620859809	0.7014009411298499	0.6711691462194245	0.6432803131104896	0.6375150811257665	0.6857507416320532	0.754685069336219	0.5817260749943405	0.6899031274081147	0.6490455450952126	0.6565875508067958	0.6481168129234808	0.6344998491776213	0.6259642270058572	G6PD	ENSG00000160211	4006	214971.0	CCSBVarC004025	ALE00004025	NC_000023.11:154532662:C:T	1192G>A	Glu398Lys	CEGS2	CegsMutGDEh1002	A11	GDEhDisVCh_40035	E04	1.0									1.0	7.0	0.0		0.0			0.0			0.0			23.0	154532662.0	C	T	X	N	N	N	N	N	X-154532662-C-T	792173.0	single nucleotide variant	NM_001360016.2(G6PD):c.1192G>A (p.Glu398Lys)	2539.0	G6PD	HGNC:4057	Pathogenic	1.0	May 20, 2023	137852325.0	-	RCV000991012	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	154532662.0	154532662.0	Xq28	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA337316269	2.0	804134.0	154532662.0	C	T	-	-	-	-	-	-	SCV001142103|SCV002599372|SCV005373641	-	-	1192G>A 	Glu398Lys	NM_001360016.2	2.0	1_Pathogenic		804134.0	X	154532662.0	C	T	E	K	rs137852325	X	153760877.0	X	153414071.0	398.0	G6PD	ENSG00000160211	ENST00000696430	ENSP00000512625	P11413	G6PD_HUMAN	.	.	c.1192G>A	p.Glu398Lys	principal4	Y	.	.	.	-	GAG	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	1.0	0.90580	D	1.0	0.97365	D	.	0.94956	.	.	.	.	4.61	0.99266	H	.	0.69872	.	.	0.73617	0.9214	0.95965	D	0.996	0.99908	D	10.0	.	0.98957	.	0.848963	0.98832	D	.	0.97849	0.949	0.99385	P11413	E398K	Gain of MoRF binding (P = 0.0029)| Gain of methylation at E398 (P = 0.0073)| Loss of stability (P = 0.1334)| Gain of phosphorylation at T402 (P = 0.1773)| Loss of loop (P = 0.2237)	.	0.99692	.	.	.	0.95480	0.819497585297	0.84925	D	0.972763	0.99714	D	0.667932	0.999	D	0.721661	0.99899	D	0.999545991420746	0.97827	D	0.99725	0.98926	D	0.95874125	0.97108	0.9285496	0.96951	0.9683203	0.98071	0.90745586	0.95445	-11.128	0.80418	D	.	0.90566	.	0.999990459212003	0.99831	0.99881110	0.98976	0.989	0.99628	.	.	.	.	.	.	4.526718	0.71085	25.6	0.9991493614711219	0.9831	.	.	.	.	.	.	.	.	.	5.82	4.96	0.65108	3.01	0.55043	5.668	0.67818	5.880000	0.50706	0.585	0.3052	1.0	0.71675	1.000000	0.68239	0.977	0.56847	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.154532662C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Glu	Lys	792173.0	single nucleotide variant	NM_001360016.2(G6PD):c.1192G>A (p.Glu398Lys)	2539.0	G6PD	HGNC:4057	Pathogenic	1.0	May 20, 2023	137852325.0	-	RCV000991012	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	154532662.0	154532662.0	Xq28	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA337316269	2.0	804134.0	154532662.0	C	T	-	-	-	-	-	-	SCV001142103|SCV002599372|SCV005373641	-	-	1192G>A 	Glu398Lys	NM_001360016.2	2.0	1_Pathogenic	97.56	0.2989690721649484	['300908']	x-linked	Rare genetic hematologic disease	1	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1	97.56	0.29896906	10-90	>90						E	58			97.56	Negatively-charged	Glutamic Acid		Glucose-6-phosphate 1-dehydrogenase										-3.5								E398-Y424; PAE: 1.0	4 interactions	E398-Y424; PAE: 1.0	12 interactions							146									-46.2				121.4				dbSNP: rs137852325; Variant type: LP/P; AA change: Glu398Lys; PTM type: Phosphorylation; PTM morphology: NE*AVytkMMTK; Var class: II&rs137852325		C (loop/coil)	C (loop/coil)																																																																				true	G6PDGlu398Lys																																																																																																																																																																																																																																		
F9	F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5639199546247403	0.6361526823418402	0.5880652627182306	0.518983497367929	0.693389980645856	0.7806735852079176	0.5729967658920669	0.6641688898577275	0.6567913956539897	0.5805918120440388	0.6061063760837944	0.464970228843791	0.5119616355787338	0.6155139690296906	0.5472480972054419	F9	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5639199546247403	0.6361526823418402	0.5880652627182306	0.518983497367929	0.693389980645856	0.7806735852079176	0.5729967658920669	0.6641688898577275	0.6567913956539897	0.5805918120440388	0.6061063760837944	0.464970228843791	0.5119616355787338	0.6155139690296906	0.5472480972054419	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A	224G>A	Arg75Gln																												23.0	139537145.0	G	A	X						X-139537145-G-A	25612.0	single nucleotide variant	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 11, 2024	137852228.0	-	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139537145.0	139537145.0	Xq27.1	reviewed by expert panel	9.0	-	N	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	3.0	10573.0	139537145.0	G	A	-	-	-	-	-	-	SCV005437139	-	-	224G>A 	Arg75Gln	NM_000133.4	3.0	1_Pathogenic		10573.0	X	139537145.0	G	A	R	Q	rs137852228	X	138619304.0	X	138446970.0	75.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.224G>A	p.Arg75Gln	c.224G>A	p.Arg75Gln	principal1	Y	1	YES	Select	+	CGA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.004	0.74454	D	1.0	0.90580	D	0.997	0.86259	D	0.87	0.91311	A	simple_aae	13.0	87.0	2.865	0.82980	M	-3.08	0.64159	D	0.619	0.83632	1.0936	0.99385	D	0.9754	0.99231	D	10.0	0.9611795	0.95480	D	0.450308	0.94319	D	0.904	0.97356	0.922	0.98631	P00740	R75Q	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.998839519055	0.99881	0.9873855396371272	0.98728	0.164289705123	0.18266	0.501060843468	0.38922	T	0.964669	0.99567	D	0.400284	0.89858	D	0.449695	0.93519	D	0.917611181735992	0.57309	D	0.667233	0.27380	T	0.83249354	0.85893	0.6057016	0.76837	0.7617112	0.81330	0.6656928	0.80179	-8.736	0.66059	D	0.1299	0.32639	B	0.994754450870779	0.90854	0.99998808	0.99996	0.941	0.97199	.	.	.	.	.	.	4.359394	0.67086	25.0	0.9995325296558251	0.99957	.	.	.	.	.	.	.	.	.	5.19	4.33	0.51026	4.22	0.80172	7.322	0.78419	9.750000	0.81498	-0.113	0.14846	1.0	0.71675	1.0	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80303	1.245280e-05	0	1	151610	6.595870e-06	0	1	171789	5.821090e-06	0	0	5701	0.000000e+00	0	1	13652	7.324930e-05	0	0	1767	0.000000e+00	0	0	6911	0.000000e+00	0	0	9932	0.000000e+00	0	0	30951	0.000000e+00	0	0	9939	0.000000e+00	0	1	13652	7.324930e-05	0	0	13067	0.000000e+00	0	1	24361	4.104920e-05	0	0	4642	0.000000e+00	0	0	10118	0.000000e+00	0	0	12188	0.000000e+00	0	0	64582	0.000000e+00	0	0	19047	0.000000e+00	0	1	24361	4.104920e-05	0	0	11996	0.000000e+00	0	1	27139	3.684730e-05	0	0	7069	0.000000e+00	0	0	13313	0.000000e+00	0	0	15991	0.000000e+00	0	0	73179	0.000000e+00	0	0	18982	0.000000e+00	0	1	27139	3.684730e-05	0	.	4	1211104	3.302770e-06	0	1	45990	2.174390e-05	0	0	57788	0.000000e+00	0	0	689	0.000000e+00	0	1	45990	2.174390e-05	0	0	22029	0.000000e+00	0	0	33765	0.000000e+00	0	0	46861	0.000000e+00	0	0	4343	0.000000e+00	0	3	895062	3.351720e-06	0	0	56959	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139537145G>A	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	C0008533|C2749016|C0019069|C5393318|C3661900	306900|300807|134500|306700|301052	98879|98878	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Arg	Gln	25612.0	single nucleotide variant	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 11, 2024	137852228.0	-	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139537145.0	139537145.0	Xq27.1	reviewed by expert panel	9.0	-	N	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	3.0	10573.0	139537145.0	G	A	-	-	-	-	-	-	SCV005437139	-	-	224G>A 	Arg75Gln	NM_000133.4	3.0	1_Pathogenic	87.64	0.375	['300807', '301052', '306900', '306700', '306900', '300807', '306900']	unknown	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; WARFARIN SENSITIVITY, X-LINKED; HEMOPHILIA B; HEMOPHILIA A; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	87.64	0.375	10-90	70-90						R	93			87.64	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa light chain							Gla			-4.5								R75-E79, R75-F71; PAE: 3.5, 1.0	3 interactions	R75-E79, R75-F71, R75-T84; PAE: 3.5, 1.0, 2.0	6 interactions							175									-64.7				-39.7						H (helix)	H (α-helix)	Helix																													1.061	1 mutation(s) (Arg75Asp: 1.392)	0.92	1 mutation(s) (Arg75Asp: 1.186)	0.944	2 mutation(s) (Arg75Gly: 1.143, Arg75Asp: 1.171)	0.83	1 mutation(s) (Arg75Asp: 1.099)	1.053	5 mutation(s) (Arg75Lys: 1.270, Arg75Asn: 1.277, Arg75His: 1.287, Arg75Asp: 1.310, Arg75Gly: 1.315)																													true	F9Arg75Gln																																																																																																																																																																																																																																		
F9	F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7027793417301136	0.6325589285909701	0.7677935728973174	0.6542303929949432	0.732002498159462	0.780442232559193	0.6633273479065258	0.7618889422663242	0.628972195681177	0.7173445559633124	0.683562763759731	0.6451334380833607	0.7736982035283106	0.636145661500763	0.6882141274969147	F9	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7027793417301136	0.6325589285909701	0.7677935728973174	0.6542303929949432	0.732002498159462	0.780442232559193	0.6633273479065258	0.7618889422663242	0.628972195681177	0.7173445559633124	0.683562763759731	0.6451334380833607	0.7736982035283106	0.636145661500763	0.6882141274969147	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G	580A>G	Thr194Ala																												23.0	139551121.0	A	G	X						X-139551121-A-G	25627.0	single nucleotide variant	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	6048.0	-	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551121.0	139551121.0	Xq27.1	reviewed by expert panel	10.0	-	N	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	3.0	10588.0	139551121.0	A	G	-	-	-	-	-	-	SCV004363688	-	-	580A>G 	Thr194Ala	NM_000133.4	3.0	2_Benign		10588.0	X	139551121.0	A	G	T	A	rs6048	X	138633280.0	X	138460946.0	194.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.580A>G	p.Thr194Ala	c.580A>G	p.Thr194Ala	principal1	Y	1	YES	Select	+	ACT	1.0	0.0	A	A/A	A/A	A/A	A/A	0.648	0.04909	T	0.745	0.09544	T	0.0	0.02950	B	0.003	0.08696	B	0.01	0.30097	P	simple_aae	99.0	1.0	1.52	0.38202	L	-0.92	0.26798	N	0.064	0.03607	-1.053	0.13578	T	0.0001	0.00038	T	9.0	0.0049726367	0.00105	T	.	.	.	0.255	0.56351	.	.	.	.	.	.	.	0.9285000041175393	0.92783	0.622737437607	0.56240	0.353132814169	0.18363	T	0.375	0.73694	T	-0.540244	0.00324	T	-0.40498	0.32443	T	0.00193173800424148	0.0002	T	0.315368	0.07400	T	0.058962863	0.11817	0.061581787	0.11917	0.060261868	0.12229	0.08421645	0.19334	-3.651	0.18612	T	0.0698	0.03453	B	0.167231588560137	0.48150	0.97858846	0.95383	0.285	0.55474	.	.	.	.	.	.	-0.17694	0.03219	0.533	0.38829522857183274	0.02657	.	.	.	.	.	.	.	.	.	4.94	1.21	0.20193	2.13	0.41176	0.555	0.23211	1.468000	0.26817	0.756	0.943	0.0	0.06393	0.0	0.08389	0.058	0.15862	924	0.18019	550	0.1456953642384106	137	0.1365902293120638	225	0.293733681462141	72	0.13740458015267176	1	0.0013089005235602095	115	0.16016713091922005	54902	264690	0.20742	.	16623	80228	2.071970e-01	1323	32071	151686	2.114300e-01	2535	36870	172056	2.142910e-01	2944	770	5700	1.350880e-01	38	1374	13659	1.005930e-01	66	414	1765	2.345610e-01	38	16	6917	2.313140e-03	0	2622	9924	2.642080e-01	201	9294	30871	3.010590e-01	869	1776	9944	1.786000e-01	80	9294	30871	3.010590e-01	869	1728	13131	1.315970e-01	83	2323	24376	9.529870e-02	115	1078	4646	2.320280e-01	82	21	10126	2.073870e-03	0	3254	12177	2.672250e-01	252	19457	64547	3.014390e-01	1795	3334	19061	1.749120e-01	136	19457	64547	3.014390e-01	1795	1589	12061	1.317470e-01	71	2740	27155	1.009020e-01	137	1692	7081	2.389490e-01	131	34	13319	2.552740e-03	0	4254	15975	2.662910e-01	352	22239	73329	3.032770e-01	2037	3328	18996	1.751950e-01	135	22239	73329	3.032770e-01	2037	.	324101	1208948	2.680850e-01	31752	270320	894493	3.022050e-01	27999	7371	57124	1.290350e-01	343	182	680	2.676470e-01	14	5349	45709	1.170230e-01	284	5254	22031	2.384820e-01	418	56	33762	1.658670e-03	0	12521	46443	2.695990e-01	1065	1194	4346	2.747350e-01	111	270320	894493	3.022050e-01	27999	10024	56776	1.765530e-01	425	75761	252184	0.3004195349427402	34	410	0.08292682926829269	8	4970	0.0016096579476861167	1539	11229	0.13705583756345177	252	1072	0.23507462686567165	395	3150	0.1253968253968254	7	1968	0.003556910569105691	946	5224	0.18108728943338437	3661	16561	0.22106153010083932	1573	11639	0.13514906778932897	15	6938	0.0021620063418852694	82603	296768	0.27834200452879015	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	reviewed_by_expert_panel	NC_000023.11:g.139551121A>G	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	C0008533|C2749016|C3661900|CN169374|C3275410	306900|300807	98879	.	Thr	Ala	25627.0	single nucleotide variant	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	6048.0	-	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551121.0	139551121.0	Xq27.1	reviewed by expert panel	10.0	-	N	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	3.0	10588.0	139551121.0	A	G	-	-	-	-	-	-	SCV004363688	-	-	580A>G 	Thr194Ala	NM_000133.4	3.0	2_Benign	33.7	0.8309859154929577	['300807', '306900', '300807', '306900']	unknown	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	33.7	0.8309859	10-90	<=50						T	118			33.7	Polar/Neutral	Threonine		Coagulation factor IX										-0.7																		119									-142.6			Activation peptide	101.6						C (loop/coil)	C (loop/coil)																														0.986		0.983		1.004		0.97		0.985																														true	F9Thr194Ala																																																																																																																																																																																																																																		
F9	F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6780428122789353	0.6512429028085289	0.6891248674664419	0.7524326575269135	0.7141815318727899	0.6833168035932747	0.7400107309035774	0.673030648296955	0.6138560801947897	0.6656868709286089	0.745046260152305	0.7648545841502495	0.7052190866359288	0.6886297254222683	0.6903987536292615	F9	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6780428122789353	0.6512429028085289	0.6891248674664419	0.7524326575269135	0.7141815318727899	0.6833168035932747	0.7400107309035774	0.673030648296955	0.6138560801947897	0.6656868709286089	0.745046260152305	0.7648545841502495	0.7052190866359288	0.6886297254222683	0.6903987536292615	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C	407T>C	Ile136Thr																												23.0	139548378.0	T	C	X						X-139548378-T-C	615665.0	single nucleotide variant	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Nov 01, 2024	1603265481.0	-	RCV000851938|RCV004812364	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139548378.0	139548378.0	Xq27.1	reviewed by expert panel	2.0	-	N	ClinGen:CA414438824	2.0	627177.0	139548378.0	T	C	-	-	-	-	-	-	SCV005437143	-	-	407T>C 	Ile136Thr	NM_000133.4	3.0	1_Pathogenic		627177.0	X	139548378.0	T	C	I	T	rs1603265481	X	138630537.0	X	138458203.0	136.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.407T>C	p.Ile136Thr	c.407T>C	p.Ile136Thr	principal1	Y	1	YES	Select	+	ATT	2.0	0.0	T	T/T	T/T	T/T	T/T	0.184	0.22252	T	0.145	0.33327	T	0.007	0.14196	B	0.018	0.18486	B	0.82	0.88440	A	simple_aae	18.0	82.0	0.92	0.23286	L	-1.59	0.42193	N	0.323	0.68623	0.0233	0.82642	D	0.6609	0.8818	D	10.0	0.61334246	0.67284	D	0.215404	0.87475	D	0.634	0.85909	0.864	0.95972	P00740	I136T	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.999803421972	0.99980	0.9571971461018347	0.95679	1.94467123622	0.93269	0.526858687401	0.42531	T	0.638754	0.88783	D	0.47971	0.9364	D	0.451294	0.93561	D	0.265829622745514	0.2329	T	0.725127	0.33926	T	0.45117912	0.63798	0.22186896	0.46839	0.54474115	0.69365	0.33303738	0.58914	-5.866	0.45201	T	0.1348	0.38457	B	0.982214726841226	0.85871	0.99995446	0.99953	0.745	0.85875	.	.	.	.	.	.	1.886718	0.24009	16.22	0.918151379772795	0.21374	.	.	.	.	.	.	.	.	.	4.94	3.75	0.42169	3.53	0.64053	1.274	0.32841	6.148000	0.54222	0.609	0.47831	0.759	0.29323	1.0	0.68239	0.912	0.44761	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_VIII_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139548378T>C	.	C0019069	134500|306700	98878	.	Ile	Thr	615665.0	single nucleotide variant	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Nov 01, 2024	1603265481.0	-	RCV000851938|RCV004812364	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139548378.0	139548378.0	Xq27.1	reviewed by expert panel	2.0	-	N	ClinGen:CA414438824	2.0	627177.0	139548378.0	T	C	-	-	-	-	-	-	SCV005437143	-	-	407T>C 	Ile136Thr	NM_000133.4	3.0	1_Pathogenic	78.46	0.3727810650887574	['306700', '306900']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA A; HEMOPHILIA B	78.46	0.37278107	10-90	70-90						I	63			78.46	Aliphatic	Isoleucine		Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 2			4.5									1 interaction		4 interactions							131									-109.4				114.7						C (loop/coil)	T (turn)	Turn																													1.023		0.991		0.953		0.967		0.888																														true	F9Ile136Thr																																																																																																																																																																																																																																		
SHOC2	SHOC2_Met173Val	-0.3926407601204963	0.7062668529828494	5.87423967430277	0.0006152936639761048	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7996078841328016	0.7329360677752873	0.8334832752568484	0.8932576849801237	0.8489726895578096	0.9420425639126733	0.9443311232849014	0.9191645209764896	0.8315313073499484	0.8642483312693653	0.7559028152029459	0.842184246675346	0.7478020295372072	0.6343408282006262	0.734967436996238	SHOC2	-0.3926407601204963	0.7062668529828494	5.87423967430277	0.0006152936639761048	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7996078841328016	0.7329360677752873	0.8334832752568484	0.8932576849801237	0.8489726895578096	0.9420425639126733	0.9443311232849014	0.9191645209764896	0.8315313073499484	0.8642483312693653	0.7559028152029459	0.842184246675346	0.7478020295372072	0.6343408282006262	0.734967436996238	SHOC2		11602		CCSBVarC028030		NC_000010.11:110964875:A:G	517A>G	Met173Val																												10.0	110964875.0	A	G	10						10-110964875-A-G	359795.0	single nucleotide variant	NM_007373.4(SHOC2):c.517A>G (p.Met173Val)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	1.0	Jun 12, 2024	1057518206.0	-	RCV000413825|RCV002272224|RCV001584108|RCV003539878|RCV003922677	MedGen:C3661900|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	not provided|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome-like disorder with loose anagen hair|RASopathy|SHOC2-related disorder	de novo;germline	germline	GRCh38	NC_000010.11	10	110964875.0	110964875.0	10q25.2	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA16042684	2.0	373090.0	110964875.0	A	G	-	-	-	-	-	-	SCV000491653|SCV001821436|SCV002073493|SCV002581433|SCV004267682|SCV005086295	-	-	517A>G 	Met173Val	NM_007373.4	1.0	3_Conflicting		373090.0	10	110964875.0	A	G	M	V	rs1057518206	10	112724633.0	10	112714623.0	173.0	SHOC2	ENSG00000108061	ENST00000369452	ENSP00000358464	Q9UQ13	SHOC2_HUMAN	c.517A>G	p.Met173Val	c.517A>G	p.Met173Val	principal1	Y	1	YES	Select	+	ATG	1.0	0.0	A	A/A	A/A	A/A	A/A	0.877	0.02574	T	0.71	0.05615	T	0.001	0.22981	B	0.002	0.23834	B	0.17	0.49097	A	simple_aae	83.0	17.0	-0.795	0.01632	N	0.96	0.01825	N	0.72	0.76196	-1.0948	0.04794	T	0.0449	0.19131	T	10.0	0.2705949	0.44206	D	0.099806	0.77096	D	0.428	0.73376	0.322	0.30091	Q9UQ13	M173V	Loss of catalytic residue at M173 (P = 0.0099)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K170 (P = 0.0863)| Gain of relative solvent accessibility (P = 0.09)| Loss of disorder (P = 0.0906)	0.660270521957	0.65475	0.6131685434429178	0.61071	0.514162079924	0.49084	0.843939304352	0.88676	D	0.106314	0.41460	T	-0.000997988	0.51194	T	-0.23921	0.50551	T	0.874729037284851	0.52197	D	.	0.77035	.	0.08041208	0.18257	0.10913989	0.26242	0.06424035	0.13484	0.11111266	0.26739	-7.545	0.57998	D	0.2724	0.59484	B	0.973092210519985	0.83842	0.00909550	0.40214	0.251	0.52136	.	.	.	.	.	.	2.561362	0.33237	19.26	0.3013507273315131	0.01631	0.893472	0.83085	D	-0.639719032405484	0.17541	0.9166258	-0.425424558940744	0.23937	1.327136	5.79	3.44	0.38414	.	.	9.325	0.96016	11.206000	0.89238	0.751	0.87726	1.0	0.71675	1.0	0.68239	0.997	0.79771	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_provided|SHOC2-related_disorder|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|Noonan_syndrome-like_disorder_with_loose_anagen_hair|RASopathy	criteria_provided,_conflicting_classifications	NC_000010.11:g.110964875A>G	ClinGen:CA16042684	C3661900|C4478716|C1843181|C5555857	607721|PS607721	2701|2701|536391	.	Met	Val	359795.0	single nucleotide variant	NM_007373.4(SHOC2):c.517A>G (p.Met173Val)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	1.0	Jun 12, 2024	1057518206.0	-	RCV000413825|RCV002272224|RCV001584108|RCV003539878|RCV003922677	MedGen:C3661900|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	not provided|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome-like disorder with loose anagen hair|RASopathy|SHOC2-related disorder	de novo;germline	germline	GRCh38	NC_000010.11	10	110964875.0	110964875.0	10q25.2	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA16042684	2.0	373090.0	110964875.0	A	G	-	-	-	-	-	-	SCV000491653|SCV001821436|SCV002073493|SCV002581433|SCV004267682|SCV005086295	-	-	517A>G 	Met173Val	NM_007373.4	1.0	3_Conflicting	98.65	0.2393617021276596	['607721']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	98.65	0.2393617	10-90	>90						M	45			98.65	Aliphatic	Methionine		Leucine-rich repeat protein SHOC-2										1.9								M173-L151, M173-M149; PAE: 1.0, 1.0	9 interactions	M173-M149; PAE: 1.0	8 interactions							149									-127.2				125.5			LRR 4			B (undefined)	E (parallel sheets)	Beta strand																																																																			true	SHOC2Met173Val																																																																																																																																																																																																																																		
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6923203500245614	0.5802868998609383	0.7287805928258865	0.673946673342741	0.644299034803606	0.6303119289172239	0.6151733421401693	0.6830241641625603	0.6333698623598298	0.6960345407864246	0.6582861406899879	0.7327200045453127	0.7745370214892127	0.5272039373620467	0.6886061592626981	F9	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6923203500245614	0.5802868998609383	0.7287805928258865	0.673946673342741	0.644299034803606	0.6303119289172239	0.6151733421401693	0.6830241641625603	0.6333698623598298	0.6960345407864246	0.6582861406899879	0.7327200045453127	0.7745370214892127	0.5272039373620467	0.6886061592626981	F9	ENSG00000101981	52861	204387.0	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561913.0	G	C	X	Y	N	N	N	N	X-139561913-G-C	25690.0	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Mar 01, 1992	137852278.0	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913.0	139561913.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1.0	10651.0	139561913.0	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic		10651.0	X	139561913.0	G	C	D	H	rs137852278	X	138644072.0	X	138471738.0	410.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10.0	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.9941694169904474	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690.0	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Mar 01, 1992	137852278.0	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913.0	139561913.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1.0	10651.0	139561913.0	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic	76.62	0.0736196319018405	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	76.62	0.073619634	<10	70-90						D	12			76.62	Negatively-charged	Aspartic Acid		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-3.5								D410-G357; PAE: 3.0	4 interactions	D410-G357; PAE: 3.0	7 interactions							132									-81.4				-10.3						C (loop/coil)	C (loop/coil)	Turn																													1.03		0.954		0.974		0.971		0.984																														true	F9Asp410His																																																																																																																																																																																																																																		
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7327929577073504	0.5824439225427427	0.7527798067299967	0.7691102605685216	0.6491488216911996	0.6651388699955143	0.7518339615445655	0.7258636421458928	0.5698504015309318	0.718484451067893	0.633158773386885	0.7863865595924778	0.7796959713141005	0.5950374435545536	0.7471014643468078	F9	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7327929577073504	0.5824439225427427	0.7527798067299967	0.7691102605685216	0.6491488216911996	0.6651388699955143	0.7518339615445655	0.7258636421458928	0.5698504015309318	0.718484451067893	0.633158773386885	0.7863865595924778	0.7796959713141005	0.5950374435545536	0.7471014643468078	F9	ENSG00000101981	52861	204360.0	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139551113.0	G	A	X	Y	N	N	N	N	X-139551113-G-A	25624.0	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 09, 2024	137852238.0	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113.0	139551113.0	Xq27.1	reviewed by expert panel	8.0	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3.0	10585.0	139551113.0	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3.0	1_Pathogenic	2.73283e-6	10585.0	X	139551113.0	G	A	R	H	rs137852238	X	138633272.0	X	138460938.0	191.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2.0	0.0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.991	0.9703	D	0.8837	0.96132	D	10.0	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.938	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.9988720457950564	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.646	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.0	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624.0	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 09, 2024	137852238.0	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113.0	139551113.0	Xq27.1	reviewed by expert panel	8.0	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3.0	10585.0	139551113.0	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3.0	1_Pathogenic	42.03	1.0	['306900', '306700', '300807', '306900', '300807']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA A; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	42.03	1.0	$\geqslant$90	<=50						R	259			42.03	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa light chain										-4.5											1 interaction							175									-68.1				40.0						C (loop/coil)	S (bend)					Cleavage; by factor XIa																									1.012		1.008		1.004		0.988	1 mutation(s) (Arg191Pro: 1.100)	0.978																														true	F9Arg191His																																																																																																																																																																																																																																		
RAF1	RAF1_Asp381Asn	0.5714162180205059	1.0	0.5200707489892997	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6351656573211253	0.5913491800682251	0.6609205928100914	0.6158826039753303	0.6179811087667898	0.5916507293648502	0.554141112266058	0.5972816925458017	0.5882689811653663	0.603505251033311	0.6443114881687294	0.6776240956846027	0.7245594930743811	0.5944293789710839	0.6668260636089396	RAF1	0.5714162180205059	1.0	0.5200707489892997	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6351656573211253	0.5913491800682251	0.6609205928100914	0.6158826039753303	0.6179811087667898	0.5916507293648502	0.554141112266058	0.5972816925458017	0.5882689811653663	0.603505251033311	0.6443114881687294	0.6776240956846027	0.7245594930743811	0.5944293789710839	0.6668260636089396	RAF1		732		CCSBVarC008844		NC_000003.12:12591760:C:T	1141G>A	Asp381Asn																												3.0	12591760.0	C	T	3						3-12591760-C-T	179051.0	single nucleotide variant	NM_002880.4(RAF1):c.1141G>A (p.Asp381Asn)	5894.0	RAF1	HGNC:9829	Benign	0.0	Apr 18, 2017	559632360.0	-	RCV000159079|RCV000522135|RCV001813412|RCV001261134|RCV002453552	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	not specified|RASopathy|Noonan syndrome and Noonan-related syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000003.12	3	12591760.0	12591760.0	3p25.2	reviewed by expert panel	7.0	-	N	ClinGen:CA297118	2.0	181509.0	12591760.0	C	T	-	-	-	-	-	-	SCV000616485	-	-	1141G>A 	Asp381Asn	NM_002880.4	3.0	2_Benign		181509.0	3	12591760.0	C	T	D	N	rs559632360	3	12633259.0	3	12608259.0	381.0	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1141G>A	p.Asp381Asn	c.1141G>A	p.Asp381Asn	principal3	Y	1	YES	Select	-	GAC	1.0	0.0	c	C/C	C/C	C/C	C/C	0.741	0.05469	T	0.631	0.07289	T	0.0	0.02950	B	0.002	0.06938	B	0.09	0.26006	N	simple_aae	91.0	9.0	0.725	0.18664	N	-1.58	0.42002	N	0.141	0.15800	-0.8085	0.54456	T	0.2621	0.63163	T	10.0	0.012194514	0.00259	T	.	.	.	0.164	0.41991	0.348	0.34294	P04049	D381N	Gain of glycosylation at T383 (P = 0.0563)| Gain of MoRF binding (P = 0.0665)| Gain of methylation at K378 (P = 0.0678)| Gain of ubiquitination at K378 (P = 0.1989)| Gain of phosphorylation at T383 (P = 0.2411)	0.324009150485	0.31597	.	0.71714	1.20632500761	0.80616	0.628370404243	0.56847	T	0.710307	0.91654	D	-0.470963	0.00789	T	-0.45545	0.26743	T	0.0264849085100513	0.01464	T	.	0.37334	.	0.08191876	0.18674	0.063901514	0.12728	0.058604848	0.11702	0.05158828	0.08346	-4.384	0.37036	T	0.096	0.17894	B	0.00775539406038167	0.22004	0.70292550	0.86141	0.31	0.57690	.	.	.	.	.	.	1.897587	0.24145	16.27	0.693818736957218	0.09095	0.104954	0.20775	N	-0.798101639362588	0.13197	0.6575577	-0.628625637051928	0.18464	1.003532	5.15	2.44	0.28799	0.329	0.23862	2.247	0.42906	2.200000	0.31363	-3.876	0.00054	0.959	0.33632	0.976	0.30138	0.034	0.13647	685	0.5936	3	5.990415335463259E-4	0	0.0	0	0.0	0	0.0	0	0.0	3	0.003067484662576687	6	264690	2.2668026E-5	.	31	109408	2.833430e-04	0	70	208130	3.363280e-04	0	70	236836	2.955630e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	30	15690	1.912050e-03	0	30	15690	1.912050e-03	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89556	1.116620e-05	0	69	30608	2.254310e-03	0	69	30608	2.254310e-03	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	1	102644	9.742410e-06	0	69	30526	2.260370e-03	0	69	30526	2.260370e-03	0	.	249	1614126	1.542630e-04	4	230	91082	2.525200e-03	4	0	75020	0.000000e+00	0	0	910	0.000000e+00	0	1	60020	1.666110e-05	0	0	29608	0.000000e+00	0	0	44880	0.000000e+00	0	0	64028	0.000000e+00	0	0	6062	0.000000e+00	0	11	1180012	9.321940e-06	0	230	91082	2.525200e-03	4	0	9902	0	0	114	0	0	120	0	1	3266	3.061849357011635E-4	0	146	0	0	610	0	0	26	0	1	104	0.009615384615384616	0	792	0	1	3380	2.958579881656805E-4	0	146	0	2	15080	1.326259946949602E-4	Benign	Cardiovascular_phenotype|RASopathy|not_specified|Noonan_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome	reviewed_by_expert_panel	NC_000003.12:g.12591760C>T	ClinGen:CA297118	CN230736|C5555857|CN169374|C0028326|C0175704|C5681679	PS163950|PS151100	536391|648|500|98733	Protein kinase domain|Protein kinase domain|Protein kinase domain	Asp	Asn	179051.0	single nucleotide variant	NM_002880.4(RAF1):c.1141G>A (p.Asp381Asn)	5894.0	RAF1	HGNC:9829	Benign	0.0	Apr 18, 2017	559632360.0	-	RCV000159079|RCV000522135|RCV001813412|RCV001261134|RCV002453552	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	not specified|RASopathy|Noonan syndrome and Noonan-related syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000003.12	3	12591760.0	12591760.0	3p25.2	reviewed by expert panel	7.0	-	N	ClinGen:CA297118	2.0	181509.0	12591760.0	C	T	-	-	-	-	-	-	SCV000616485	-	-	1141G>A 	Asp381Asn	NM_002880.4	3.0	2_Benign	81.48	0.8711656441717791		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		81.48	0.87116563	10-90	70-90						D	142			81.48	Negatively-charged	Aspartic Acid		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			-3.5																		132									-125.2				94.9						C (loop/coil)	S (bend)																																																																				true	RAF1Asp381Asn																																																																																																																																																																																																																																		
SDHD	SDHD_Leu139Arg	3.798682331808146	0.014136237819953438	3.6405640563005033	0.05718059390456844	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8321781881595116	0.7725782254173577	0.8041937039235948	0.8410724082732929	0.8472422308526386	0.8235345660865709	0.8461560115031072	0.7586154412052757	0.7453884050906837	0.8174137578528592	0.8709498956187063	0.8359888050434786	0.8497719666419139	0.7997680457440315	0.8469426184661639	SDHD	3.798682331808146	0.014136237819953438	3.6405640563005033	0.05718059390456844	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8321781881595116	0.7725782254173577	0.8041937039235948	0.8410724082732929	0.8472422308526386	0.8235345660865709	0.8461560115031072	0.7586154412052757	0.7453884050906837	0.8174137578528592	0.8709498956187063	0.8359888050434786	0.8497719666419139	0.7997680457440315	0.8469426184661639	SDHD		6363		CCSBVarC023371		NC_000011.10:112094906:T:G	416T>G	Leu139Arg																												11.0	112094906.0	T	G	11						11-112094906-T-G	564429.0	single nucleotide variant	NM_003002.4(SDHD):c.416T>G (p.Leu139Arg)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	Jun 09, 2022	80338847.0	-	RCV002532294	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss	germline	germline	GRCh38	NC_000011.10	11	112094906.0	112094906.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382619304	2.0	573651.0	112094906.0	T	G	-	-	-	-	-	-	SCV000823868	-	-	416T>G 	Leu139Arg	NM_003002.4	1.0	1_Pathogenic		573651.0	11	112094906.0	T	G	L	R	rs80338847	11	111965630.0	11	111470840.0	139.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.416T>G	p.Leu139Arg	c.416T>G	p.Leu139Arg	principal1	Y	1	YES	Select	+	CTT	2.0	0.0	T	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	3.855	0.95736	H	-5.45	0.85499	D	0.982	0.99346	1.0402	0.9791	D	0.9834	0.99493	D	10.0	0.9803145	0.97976	D	0.815524	0.98560	D	0.988	0.99961	0.84	0.94573	O14521	L139R	Gain of methylation at L139 (P = 0.0075)| Gain of sheet (P = 0.1208)| Gain of relative solvent accessibility (P = 0.1259)| Loss of helix (P = 0.1299)| Gain of solvent accessibility (P = 0.1319)	0.983425624168	0.98307	0.9940455699504791	0.99400	0.916340064084	0.71077	0.841523647308	0.88307	D	0.976158	0.99771	D	0.5783	0.9694	D	0.592912	0.9689	D	0.99942147731781	0.97327	D	0.929107	0.73846	D	0.9855054	0.99491	0.9717924	0.99533	0.9855054	0.99491	0.9717924	0.99533	-17.005	0.98918	D	0.9277	0.84786	P	0.999298612534229	0.96182	0.99940443	0.99356	0.994	0.99793	.	.	.	.	.	.	4.963449	0.82116	27.7	0.9975714405031479	0.84785	0.951878	0.96672	D	0.890230994464423	0.91223	10.80072	0.800832412790881	0.89794	10.14829	4.85	4.85	0.62327	.	.	7.682	0.8343	7.853000	0.71102	0.661	0.55789	1.0	0.71675	1.0	0.68239	0.999	0.91597	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Cowden_syndrome_3|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma	criteria_provided,_single_submitter	NC_000011.10:g.112094906T>G	.	CN166604|C1847319|C1868633|C0031511	606864|171300	201|97286|29072	.	Leu	Arg	564429.0	single nucleotide variant	NM_003002.4(SDHD):c.416T>G (p.Leu139Arg)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	Jun 09, 2022	80338847.0	-	RCV002532294	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss	germline	germline	GRCh38	NC_000011.10	11	112094906.0	112094906.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382619304	2.0	573651.0	112094906.0	T	G	-	-	-	-	-	-	SCV000823868	-	-	416T>G 	Leu139Arg	NM_003002.4	1.0	1_Pathogenic	98.79	0.2804878048780488	['606864', '171300']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	98.79	0.2804878	10-90	>90						L	46			98.79	Aliphatic	Leucine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0134		3.8				1 interaction				L139-T135, L139-N143; PAE: 1.0, 1.0	2 interactions	L139-T135, L139-N143; PAE: 1.0, 1.0	4 interactions							131									-67.6		Pocket 3: Mean pLDDT: 99.91, Volume: 203.66 Å³, Druggability score: 0.01		-41.5						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDLeu139Arg																																																																																																																																																																																																																																		
BRCA1	BRCA1_Asp67Tyr	2.5125896208651195	0.04024421782312692	-0.9756740391325566	0.3617299832806896	2025_01_Batch_13-14	false	false	true	true	true	false	false	false	false	false	0.9475302653024813	0.8621030817273844	0.965647296596526	0.924772675008498	0.9535875736429946	0.9909520492431141	0.9587707827180625	0.9870750278331963	0.9642158549481505	0.975413541128114	0.9162230980428752	0.8907745672989336	0.9442195653598557	0.7599903085066182	0.9196469894768488	BRCA1	2.5125896208651195	0.04024421782312692	-0.9756740391325566	0.3617299832806896	2025_01_Batch_13-14	false	false	true	true	true	false	false	false	false	false	0.9475302653024813	0.8621030817273844	0.965647296596526	0.924772675008498	0.9535875736429946	0.9909520492431141	0.9587707827180625	0.9870750278331963	0.9642158549481505	0.975413541128114	0.9162230980428752	0.8907745672989336	0.9442195653598557	0.7599903085066182	0.9196469894768488	BRCA1		14613		CCSBVarC013083		NC_000017.11:43106469:C:A	199G>T	Asp67Tyr																												17.0	43106469.0	C	A	17						17-43106469-C-A	69098.0	single nucleotide variant	NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357102.0	-	RCV000047675|RCV000083176|RCV000148404|RCV000162582|RCV000195312|RCV000589035|RCV001353503|RCV002490619	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Malignant tumor of breast|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106469.0	43106469.0	17q21.31	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00052,ClinGen:CA001328,UniProtKB:P38398#VAR_070460	2.0	54431.0	43106469.0	C	A	-	-	-	-	-	-	SCV000244311	-	-	199G>T 	Asp67Tyr	NM_007294.4	3.0	2_Benign		54431.0	17	43106469.0	C	A	D	Y	rs80357102	17	41258486.0	17	38512012.0	67.0	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.199G>T	p.Asp67Tyr	principal2	Y	.	.	.	-	GAT	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.72322	.	.	0.79703	.	0.868	0.47756	P	0.24	0.38861	B	.	0.51279	.	.	.	.	1.25	0.31597	L	.	0.75325	.	.	0.67836	-0.062	0.80864	T	0.6621	0.88225	D	10.0	.	0.34335	.	0.282437	0.90256	D	.	0.87125	.	.	.	.	.	.	0.86240	.	0.43573	.	0.11448	0.42940607667	0.29092	T	0.14757	0.48293	T	0.108459	0.64942	D	0.173063	0.81457	D	0.0394584648311138	0.03564	T	.	0.83345	.	0.28895706	0.51563	0.10798522	0.25949	0.378384	0.58872	0.13106883	0.31396	-6.164	0.51688	T	.	0.56478	.	0.956250935363193	0.81217	0.99734180	0.98344	0.64	0.79945	.	.	.	.	.	.	2.280806	0.29216	18.03	0.9931814725118198	0.59339	0.233566	0.35440	N	-0.260466381601807	0.30407	1.713454	-0.295009425429782	0.27944	1.574398	4.64	-1.4	0.08479	1.19	0.30954	0.033	0.13684	-0.025000	0.12924	0.531	0.24877	0.943	0.32853	0.0	0.08389	0.993	0.69292	459	0.78836	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	10	264690	3.7780046E-5	.	8	109008	7.338910e-05	0	14	207104	6.759890e-05	0	17	235908	7.206200e-05	0	0	7140	0.000000e+00	0	1	16978	5.889980e-05	0	0	2308	0.000000e+00	0	0	9042	0.000000e+00	0	0	13390	0.000000e+00	0	7	42690	1.639730e-04	0	0	15548	0.000000e+00	0	7	42690	1.639730e-04	0	0	16118	0.000000e+00	0	2	30338	6.592390e-05	0	0	6186	0.000000e+00	0	0	13394	0.000000e+00	0	0	16710	0.000000e+00	0	12	89212	1.345110e-04	0	0	30298	0.000000e+00	0	12	89212	1.345110e-04	0	0	14808	0.000000e+00	0	2	34062	5.871650e-05	0	0	9548	0.000000e+00	0	0	17668	0.000000e+00	0	0	21604	0.000000e+00	0	15	102410	1.464700e-04	0	0	30216	0.000000e+00	0	15	102410	1.464700e-04	0	.	132	1596780	8.266640e-05	0	126	1165696	1.080900e-04	0	1	74666	1.339300e-05	0	0	912	0.000000e+00	0	2	59860	3.341130e-05	0	0	29466	0.000000e+00	0	0	44696	0.000000e+00	0	0	63924	0.000000e+00	0	0	5778	0.000000e+00	0	126	1165696	1.080900e-04	0	0	89912	0.000000e+00	0	12	129722	9.250551178674396E-5	0	352	0	0	2726	0	0	8264	0	0	790	0	0	946	0	0	626	0	0	280	0	0	7514	0	0	8616	0	0	3352	0	12	151220	7.935458272715249E-5	Benign	Malignant_tumor_of_breast|not_provided|not_specified|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43106469C>A	BRCA1-HCI:BRCA1_00052|ClinGen:CA001328|UniProtKB:P38398#VAR_070460	C0006142|C3661900|CN169374|CN221562|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672	114480|617883|604370|614320	145|227535|145|1333|140162	.	Asp	Tyr	69098.0	single nucleotide variant	NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357102.0	-	RCV000047675|RCV000083176|RCV000148404|RCV000162582|RCV000195312|RCV000589035|RCV001353503|RCV002490619	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Malignant tumor of breast|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106469.0	43106469.0	17q21.31	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00052,ClinGen:CA001328,UniProtKB:P38398#VAR_070460	2.0	54431.0	43106469.0	C	A	-	-	-	-	-	-	SCV000244311	-	-	199G>T 	Asp67Tyr	NM_007294.4	3.0	2_Benign	82.51	0.6073619631901841	['604370', '114480', '617883', '604370', '614320']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	82.51	0.607362	10-90	70-90																																																																																																																																		true	BRCA1Asp67Tyr																																																																																																																																																																																																																																		
BRCA1	BRCA1_Arg391Met	0.12346703943560886	0.9052076336151375	-6.583652048919765	0.00030897140928174874	2025_01_Batch_13-14	true	false	true	true	true	false	false	false	false	false	0.9816930310116219	0.7688356182207741	0.982040314415231	0.9258844159953883	0.930283052825779	0.9299075772210594	0.9497984108090004	0.9866899917271708	0.7585291153116679	0.9853237433825538	0.9306585284304987	0.9019704211817761	0.9773906371032913	0.7791421211298803	0.97806231864069	BRCA1	0.12346703943560886	0.9052076336151375	-6.583652048919765	0.00030897140928174874	2025_01_Batch_13-14	true	false	true	true	true	false	false	false	false	false	0.9816930310116219	0.7688356182207741	0.982040314415231	0.9258844159953883	0.930283052825779	0.9299075772210594	0.9497984108090004	0.9866899917271708	0.7585291153116679	0.9853237433825538	0.9306585284304987	0.9019704211817761	0.9773906371032913	0.7791421211298803	0.97806231864069	BRCA1	ENSG00000012048	14613	23651.0	CCSBVarC002123	ALE00002123	NC_000017.11:43076488:C:A	1172G>T	Arg391Met	RC4	RC4_Mut_GDEh1029	E02	GDEhDisVCh_40059	B12	1.0	RC4_Mut_GDDh1029	E02							1.0	6.0	1.0	4.0	0.0			0.0			0.0			17.0	43076488.0	C	A	17	N	N	N	N	N	17-43076488-C-A	46154.0	single nucleotide variant	NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jan 23, 2025	80357389.0	-	RCV000131886|RCV000159992|RCV000770739|RCV005016310|RCV000031179|RCV000048576|RCV000462940|RCV001171414|RCV000238601	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374	Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Hereditary breast ovarian cancer syndrome|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	43076488.0	43076488.0	17q21.31	criteria provided, multiple submitters, no conflicts	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	Breast Cancer Information Core (BIC) (BRCA1):4603&base_change=G to T,ClinGen:CA002876,UniProtKB:P38398#VAR_063900	2.0	37598.0	43076488.0	C	A	-	-	-	-	-	-	SCV000076589|SCV000186941|SCV000210177|SCV000223754|SCV000296380|SCV000296803|SCV000325979|SCV000537652|SCV000540946|SCV000605750|SCV000699152|SCV000902222|SCV001140523|SCV002512513|SCV002515213|SCV002537753|SCV004215024|SCV004817666|SCV005647134	-	-	4484G>T 	Arg1495Met	NM_007294.4	2.0	1_Pathogenic	2.7372e-6	37598.0	17	43076488.0	C	A	R	M	rs80357389	17	41228505.0	17	38482031.0	1495.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4484G>T	p.Arg1495Met	principal2	Y	1	.	.	-	AGG	2.0	0.0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.69466	.	0.468	0.63438	P	0.215	0.73159	B	.	0.99291	.	.	.	.	1.895	0.50187	L	.	0.58927	.	.	0.80306	0.5123	0.90684	D	0.7437	0.91227	D	9.0	.	0.65625	.	0.825771	0.98644	D	.	0.89238	.	.	.	.	.	.	0.88343	.	0.29073	.	0.18057	0.296483755112	0.09873	T	0.157106	0.49694	T	0.355325	0.86796	D	0.272623	0.86624	D	0.845764636993408	0.49533	D	.	0.55938	.	0.11150219	0.26113	0.10292555	0.24633	0.13314977	0.30712	0.09751014	0.23171	-3.944	0.23826	T	.	0.37685	.	0.925453315994447	0.78001	0.99961948	0.99542	0.915	0.95626	.	.	.	.	.	.	5.032274	0.83736	28.1	0.9583175594755186	0.28156	0.813047	0.73465	D	0.417212491786565	0.62173	4.451626	0.412864384325496	0.62163	4.450753	4.97	4.97	0.65374	5.07	0.90660	3.879	0.55941	5.667000	0.49316	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.977	0.56847	527	0.73883	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	1	109282	9.150640e-06	0	1	207956	4.808710e-06	0	1	236646	4.225720e-06	0	0	7160	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13292	0.000000e+00	0	1	42760	2.338630e-05	0	0	15688	0.000000e+00	0	1	42760	2.338630e-05	0	0	16212	0.000000e+00	0	0	30518	0.000000e+00	0	0	6210	0.000000e+00	0	0	13408	0.000000e+00	0	0	16632	0.000000e+00	0	1	89510	1.117190e-05	0	0	30604	0.000000e+00	0	1	89510	1.117190e-05	0	0	14896	0.000000e+00	0	0	34254	0.000000e+00	0	0	9564	0.000000e+00	0	0	17684	0.000000e+00	0	0	21528	0.000000e+00	0	1	102588	9.747730e-06	0	0	30522	0.000000e+00	0	1	102588	9.747730e-06	0	.	4	1613516	2.479060e-06	0	4	1179796	3.390420e-06	0	0	74976	0.000000e+00	0	0	912	0.000000e+00	0	0	59986	0.000000e+00	0	0	29594	0.000000e+00	0	0	44826	0.000000e+00	0	0	63812	0.000000e+00	0	0	6058	0.000000e+00	0	4	1179796	3.390420e-06	0	0	91068	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	Familial_cancer_of_breast|not_specified|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43076488C>A	Breast_Cancer_Information_Core_(BIC)_(BRCA1):4603&base_change%3DG_to_T|ClinGen:CA002876|UniProtKB:P38398#VAR_063900	C0346153|CN169374|CN221562|C3661900|C2676676|C0677776|C0027672	114480|604370	227535|145|145|140162	.	Arg	Met	46154.0	single nucleotide variant	NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jan 23, 2025	80357389.0	-	RCV000131886|RCV000159992|RCV000770739|RCV005016310|RCV000031179|RCV000048576|RCV000462940|RCV001171414|RCV000238601	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374	Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Hereditary breast ovarian cancer syndrome|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	43076488.0	43076488.0	17q21.31	criteria provided, multiple submitters, no conflicts	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	Breast Cancer Information Core (BIC) (BRCA1):4603&base_change=G to T,ClinGen:CA002876,UniProtKB:P38398#VAR_063900	2.0	37598.0	43076488.0	C	A	-	-	-	-	-	-	SCV000076589|SCV000186941|SCV000210177|SCV000223754|SCV000296380|SCV000296803|SCV000325979|SCV000537652|SCV000540946|SCV000605750|SCV000699152|SCV000902222|SCV001140523|SCV002512513|SCV002515213|SCV002537753|SCV004215024|SCV004817666|SCV005647134	-	-	4484G>T 	Arg1495Met	NM_007294.4	2.0	1_Pathogenic	29.59	0.8588709677419355	['604370', '614320', '617883', '604370', '114480', '604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	29.59	0.858871	10-90	<=50																																																																																																																																		true	BRCA1Arg391Met																																																																																																																																																																																																																																		
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.887264670757679	0.607608379636504	0.8630308778217323	0.7949810853524013	0.5388602027997552	0.5545451181694817	0.7444868444254592	0.8371838794420442	0.5250681058540909	0.8364464089596053	0.5231752874300287	0.8454753262793433	0.8888778762014203	0.6901486534189172	0.9380829325557527	F9	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.887264670757679	0.607608379636504	0.8630308778217323	0.7949810853524013	0.5388602027997552	0.5545451181694817	0.7444868444254592	0.8371838794420442	0.5250681058540909	0.8364464089596053	0.5231752874300287	0.8454753262793433	0.8888778762014203	0.6901486534189172	0.9380829325557527	F9	ENSG00000101981	52861	204368.0	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561874.0	G	C	X	Y	N	N	N	N	X-139561874-G-C	25701.0	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158.0	F9	HGNC:3551	Pathogenic	1.0	May 01, 1998	137852281.0	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874.0	139561874.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1.0	10662.0	139561874.0	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic		10662.0	X	139561874.0	G	C	A	P	rs137852281	X	138644033.0	X	138471699.0	397.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10.0	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.9993	D	0.770766	0.9993	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.9981016586049596	0.8945	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701.0	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158.0	F9	HGNC:3551	Pathogenic	1.0	May 01, 1998	137852281.0	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874.0	139561874.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1.0	10662.0	139561874.0	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic	92.51	0.0	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	92.51	0.0	<10	>90						A	0			92.51	Aliphatic	Alanine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			1.8								A397-G442; PAE: 1.0	3 interactions	A397-G442; PAE: 1.0	6 interactions							89									-142.1				146.8						B (undefined)	E (parallel sheets)	Beta strand																													0.487		0.307		0.251		0.239		0.247																														true	F9Ala397Pro																																																																																																																																																																																																																																		
BRCA1	BRCA1_Asn132Lys	2.212585170847975	0.06255809591849197	2.057481779620184	0.0786569367910109	2025_01_Batch_13-14	false	true	true	true	true	false	true	false	false	true	0.9308600967297949	0.944296408140204	0.9765614854275313	0.93047057824142	0.9847876016781	0.989883589297884	0.9544798674417163	0.9817695717721739	0.9685390552154329	0.9515149578296669	0.979691614058316	0.9064612890411237	0.9713533990828885	0.920053761064975	0.9102052356299227	BRCA1	2.212585170847975	0.06255809591849197	2.057481779620184	0.0786569367910109	2025_01_Batch_13-14	false	true	true	true	true	false	true	false	false	true	0.9308600967297949	0.944296408140204	0.9765614854275313	0.93047057824142	0.9847876016781	0.989883589297884	0.9544798674417163	0.9817695717721739	0.9685390552154329	0.9515149578296669	0.979691614058316	0.9064612890411237	0.9713533990828885	0.920053761064975	0.9102052356299227	BRCA1		14613		CCSBVarC013093		NC_000017.11:43104167:G:T	396C>A	Asn132Lys																												17.0	43104167.0	G	T	17						17-43104167-G-T	69731.0	single nucleotide variant	NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357413.0	-	RCV000083203|RCV000162966|RCV000212156|RCV000587325|RCV001083972|RCV001353495	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	43104167.0	43104167.0	17q21.31	reviewed by expert panel	20.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00119,ClinGen:CA002545,UniProtKB:P38398#VAR_070462	2.0	55064.0	43104167.0	G	T	-	-	-	-	-	-	SCV000244350	-	-	396C>A 	Asn132Lys	NM_007294.4	3.0	2_Benign		55064.0	17	43104167.0	G	T	N	K	rs80357413	17	41256184.0	17	38509710.0	132.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.396C>A	p.Asn132Lys	c.396C>A	p.Asn132Lys	principal2	Y	1	YES	Select	-	AAC	3.0	2.0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.014	0.74454	D	0.844	0.70687	P	0.23	0.76920	B	0.48	0.78014	N	simple_aae	52.0	48.0	2.535	0.73728	M	-0.84	0.74082	N	0.728	0.84989	-0.7539	0.57554	T	0.2504	0.61845	T	10.0	0.49917424	0.61126	D	0.537965	0.95677	D	0.661	0.87273	0.734	0.86654	E9PFC7	N132K	Gain of methylation at N132 (P = 0.0115)| Loss of ubiquitination at K135 (P = 0.027)| Gain of helix (P = 0.0325)| Gain of MoRF binding (P = 0.0503)| Loss of loop (P = 0.0804)	0.91044858891	0.90887	.	0.38932	.	0.14104	0.593114554882	0.51867	T	0.312083	0.68213	T	0.105641	0.64645	D	0.0998727	0.76727	D	0.220903346759768	0.21247	T	.	0.79579	.	0.22508949	0.44837	0.18978201	0.42198	0.24349055	0.46959	0.2039367	0.44334	0.181	0.01204	T	0.5123	0.66770	A	0.633096537117509	0.64846	0.99506503	0.97691	0.111	0.30556	.	.	.	.	.	.	1.435024	0.18568	13.79	0.99611497861979	0.74843	0.533451	0.55132	D	-0.178148358989986	0.33768	1.938592	-0.156487260348686	0.32848	1.893925	5.32	2.3	0.2766	1.8	0.37395	1.172	0.3162	0.730000	0.21161	-0.727	0.03758	1.0	0.71675	0.998	0.34068	0.941	0.48226	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	8	264690	3.0224035E-5	.	5	109376	4.571390e-05	0	10	208078	4.805890e-05	0	9	236888	3.799260e-05	0	0	7164	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13386	0.000000e+00	0	5	42766	1.169150e-04	0	0	15682	0.000000e+00	0	5	42766	1.169150e-04	0	0	16218	0.000000e+00	0	0	30508	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16726	0.000000e+00	0	10	89540	1.116820e-04	0	0	30594	0.000000e+00	0	10	89540	1.116820e-04	0	0	14902	0.000000e+00	0	0	34238	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	9	102730	8.760830e-05	0	0	30512	0.000000e+00	0	9	102730	8.760830e-05	0	.	60	1613926	3.717640e-05	0	58	1179978	4.915350e-05	0	1	74908	1.334970e-05	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29606	0.000000e+00	0	0	44890	0.000000e+00	0	0	64002	0.000000e+00	0	0	6082	0.000000e+00	0	58	1179978	4.915350e-05	0	0	91078	0.000000e+00	0	2	31050	6.44122383252818E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4596	0	0	2918	0	0	112	0	2	39902	5.0122800862112174E-5	Benign	Hereditary_cancer-predisposing_syndrome|not_specified|Malignant_tumor_of_breast|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43104167G>T	BRCA1-HCI:BRCA1_00119|ClinGen:CA002545|UniProtKB:P38398#VAR_070462	C0027672|CN169374|C0006142|C0677776|C3661900|C2676676	604370	140162|145|145	.	Asn	Lys	69731.0	single nucleotide variant	NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357413.0	-	RCV000083203|RCV000162966|RCV000212156|RCV000587325|RCV001083972|RCV001353495	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	43104167.0	43104167.0	17q21.31	reviewed by expert panel	20.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00119,ClinGen:CA002545,UniProtKB:P38398#VAR_070462	2.0	55064.0	43104167.0	G	T	-	-	-	-	-	-	SCV000244350	-	-	396C>A 	Asn132Lys	NM_007294.4	3.0	2_Benign	36.56	1.0	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	36.56	1.0	$\geqslant$90	<=50																																																																																																																																		true	BRCA1Asn132Lys																																																																																																																																																																																																																																		
FARS2	FARS2_Ser57Cys	1.8559224483749528	1.0	-0.6872432004263447	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6306627335481678	0.47153818499622535	0.6500391089333948	0.6334241378797543	0.5608231030065792	0.6962621920646235	0.6479026046562409	0.6904932126070964	0.5069699651989267	0.6005724849895941	0.425384013948535	0.6189456711032676	0.6095850052596933	0.436106404793524	0.6607529821067415	FARS2	1.8559224483749528	1.0	-0.6872432004263447	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6306627335481678	0.47153818499622535	0.6500391089333948	0.6334241378797543	0.5608231030065792	0.6962621920646235	0.6479026046562409	0.6904932126070964	0.5069699651989267	0.6005724849895941	0.425384013948535	0.6189456711032676	0.6095850052596933	0.436106404793524	0.6607529821067415	FARS2		12653		CCSBVarC011870		NC_000006.12:5368740:C:G	170C>G	Ser57Cys																												6.0	5368740.0	C	G	6						6-5368740-C-G	211248.0	single nucleotide variant	NM_006567.5(FARS2):c.170C>G (p.Ser57Cys)	10667.0	FARS2	HGNC:21062	Benign/Likely benign	0.0	Jan 30, 2025	34382405.0	-	RCV000196113|RCV000539812|RCV004705026	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	not specified|Combined oxidative phosphorylation defect type 14|not provided	germline	germline	GRCh38	NC_000006.12	6	5368740.0	5368740.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA320525,UniProtKB:O95363#VAR_052642	2.0	214327.0	5368740.0	C	G	-	-	-	-	-	-	SCV000251367|SCV000652839|SCV000845669|SCV005222705	-	-	170C>G 	Ser57Cys	NM_006567.5	2.0	2_Benign		214327.0	6	5368740.0	C	G	S	C	rs34382405	6	5368973.0	6	5313972.0	57.0	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.170C>G	p.Ser57Cys	c.170C>G	p.Ser57Cys	principal1	Y	1	.	.	+	TCC	2.0	0.0	C	C/C	C/C	C/C	C/C	0.02	0.49772	D	0.028	0.55281	D	0.533	0.37784	P	0.062	0.26932	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.625	0.41446	L	-2.77	0.58763	D	0.439	0.47612	-1.0166	0.24757	T	0.0532	0.22381	T	10.0	0.0069410205	0.00155	T	.	.	.	0.081	0.23465	.	.	.	.	.	0.650100694605	0.64445	0.6181731990165388	0.61574	0.193570370082	0.21414	0.456006199121	0.32723	T	0.255173	0.62383	T	-0.4711	0.00788	T	-0.429882	0.2959	T	0.0278036979532336	0.0165	T	.	0.50927	.	0.19544396	0.41017	0.09490794	0.22449	0.18928379	0.40151	0.09419375	0.22246	-8.409	0.63900	D	0.0774	0.06880	LB	0.305673527694043	0.54432	0.28674290	0.76416	0.65	0.80521	.	.	.	.	.	.	3.426274	0.47684	22.5	0.9802876632191779	0.37846	0.207729	0.33177	N	-0.0754966821653467	0.38198	2.253606	0.0205336924994149	0.40378	2.430867	5.45	5.45	0.7966	3.61	0.66044	1.388	0.34154	4.823000	0.45211	0.599	0.40292	0.001	0.13799	1.0	0.68239	0.985	0.61072	944	0.12756	41	0.008186900958466454	37	0.02798789712556732	0	0.0	3	0.004322766570605188	1	9.92063492063492E-4	0	0.0	2308	264690	0.008719634	.	257	109370	2.349820e-03	1	520	207938	2.500750e-03	5	500	236460	2.114520e-03	4	190	7160	2.653630e-02	1	56	17106	3.273710e-03	0	0	2320	0.000000e+00	0	0	9032	0.000000e+00	0	0	13392	0.000000e+00	0	9	42758	2.104870e-04	0	1	15688	6.374300e-05	0	190	7160	2.653630e-02	1	397	16210	2.449110e-02	5	96	30512	3.146300e-03	0	0	6208	0.000000e+00	0	0	13386	0.000000e+00	0	0	16732	0.000000e+00	0	18	89426	2.012840e-04	0	2	30606	6.534670e-05	0	397	16210	2.449110e-02	5	368	14898	2.470130e-02	4	105	34248	3.065870e-03	0	0	9554	0.000000e+00	0	0	17666	0.000000e+00	0	0	21626	0.000000e+00	0	19	102338	1.856590e-04	0	2	30524	6.552220e-05	0	368	14898	2.470130e-02	4	.	2436	1614106	1.509190e-03	25	1902	75000	2.536000e-02	24	1902	75000	2.536000e-02	24	0	912	0.000000e+00	0	213	60010	3.549410e-03	0	0	29604	0.000000e+00	0	0	44870	0.000000e+00	0	0	64040	0.000000e+00	0	6	6062	9.897720e-04	1	181	1180024	1.533870e-04	0	4	91074	4.392030e-05	0	15	92548	1.620780567921511E-4	9	174	0.05172413793103448	0	2676	0	93	4216	0.022058823529411766	6	794	0.007556675062972292	1	958	0.0010438413361169101	0	656	0	0	274	0	16	8052	0.001987083954297069	102	4390	0.023234624145785875	0	3332	0	140	110348	0.001268713524486171	Benign/Likely_benign	not_specified|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5368740C>G	ClinGen:CA320525|UniProtKB:O95363#VAR_052642	CN169374|C4755312	614946	319519	.	Ser	Cys	211248.0	single nucleotide variant	NM_006567.5(FARS2):c.170C>G (p.Ser57Cys)	10667.0	FARS2	HGNC:21062	Benign/Likely benign	0.0	Jan 30, 2025	34382405.0	-	RCV000196113|RCV000539812|RCV004705026	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	not specified|Combined oxidative phosphorylation defect type 14|not provided	germline	germline	GRCh38	NC_000006.12	6	5368740.0	5368740.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA320525,UniProtKB:O95363#VAR_052642	2.0	214327.0	5368740.0	C	G	-	-	-	-	-	-	SCV000251367|SCV000652839|SCV000845669|SCV005222705	-	-	170C>G 	Ser57Cys	NM_006567.5	2.0	2_Benign	96.89	0.4769230769230769	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	96.89	0.47692308	10-90	>90						S	62			96.89	Polar/Neutral	Serine												-0.8										S57-V50; PAE: 2.0	9 interactions							105									-111.0	Morphology: VVELLGksYPQDDHS			123.6				dbSNP: rs34382405; Variant type: LB/B; AA change: Ser57Cys; PTM type: Phosphorylation; PTM morphology: ELLGksYPQDD; Var class: I&rs34382405		B (undefined)	E (parallel sheets)	Beta strand																																																																			true	FARS2Ser57Cys																																																																																																																																																																																																																																		
BCL10	BCL10_Ala5Ser	-2.11002446113385	0.08861914220244649	-0.22462787367078096	0.8286849004700589	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7755573497864549	0.6477876148099557	0.7674033205311196	0.7680178788578524	0.7845607276865518	0.8007408407158935	0.707528895168196	0.7226784793589274	0.7541221803752104	0.7844662272572069	0.7683806146572103	0.8285068625475089	0.8121281617033118	0.541453049244701	0.7666484723157028	BCL10	-2.11002446113385	0.08861914220244649	-0.22462787367078096	0.8286849004700589	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7755573497864549	0.6477876148099557	0.7674033205311196	0.7680178788578524	0.7845607276865518	0.8007408407158935	0.707528895168196	0.7226784793589274	0.7541221803752104	0.7844662272572069	0.7683806146572103	0.8285068625475089	0.8121281617033118	0.541453049244701	0.7666484723157028	BCL10	ENSG00000142867	11832	20120.0	CCSBVarC001763	ALE00001763	NC_000001.11:85276340:C:A	13G>T	Ala5Ser	RC4	RC4_Mut_GDEh1005	H03	GDEhDisVCh_40010	D03	2.0	RC4_Mut_GDDh1005	H03			VUSMutpDEST2_09	F09	VUSmut_GDEh12	B07	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	1.0	85276340.0	C	A	1	Y	Y	N	Y	Y	1-85276340-C-A	448386.0	single nucleotide variant	NM_003921.5(BCL10):c.13G>T (p.Ala5Ser)	8915.0	BCL10	HGNC:989	Benign	0.0	Feb 03, 2025	12037217.0	-	RCV000532322|RCV004714073|RCV003915633	MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098|MedGen:C3661900|	Immunodeficiency 37|not provided|BCL10-related disorder	germline	germline	GRCh38	NC_000001.11	1	85276340.0	85276340.0	1p22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA929838	2.0	475271.0	85276340.0	C	A	-	-	-	-	-	-	SCV000655451|SCV005280959	-	-	13G>T 	Ala5Ser	NM_003921.5	2.0	2_Benign	0.0247372	475271.0	1	85276340.0	C	A	A	S	rs12037217	1	85742023.0	1	85514611.0	5.0	BCL10	ENSG00000142867	ENST00000648566	ENSP00000498104	O95999	BCL10_HUMAN	c.13G>T	p.Ala5Ser	c.13G>T	p.Ala5Ser	principal1	Y	.	YES	Select	-	GCA	1.0	0.0	C	C/C	C/C	C/C	C/C	.	.	.	.	0.07361	.	0.0	0.02950	B	0.001	0.04348	B	.	.	.	.	.	.	0.69	0.16877	N	.	.	.	.	0.00874	-1.0105	0.26684	T	0.0231	0.0975	T	9.0	0.0015875101	0.00018	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.494869709015	0.38062	T	0.305241	0.67569	T	-0.689941	0.00041	T	-0.667112	0.07582	T	0.0156444791003721	0.00357	T	0.726327	0.33844	T	0.12828135	0.29734	0.16866185	0.38716	0.11355482	0.26579	0.17036171	0.39010	-2.553	0.06160	T	0.0874	0.11803	B	0.00201335097249276	0.13098	0.00011795	0.01318	0.124	0.33416	.	.	.	.	.	.	2.748674	0.36089	20.1	0.995109762208338	0.68658	0.140710	0.26053	N	-0.418389870164214	0.24553	1.343174	-0.230976240330979	0.30116	1.713435	5.12	3.19	0.35642	2.73	0.49939	1.77	0.38267	3.253000	0.37120	0.599	0.40292	0.983	0.35756	1.0	0.68239	0.99	0.65338	839	0.37627	175	0.03494408945686901	0	0.0	27	0.0268389662027833	16	0.023054755043227664	118	0.11706349206349206	14	0.014314928425357873	6745	264690	0.02548264	.	3040	109350	2.780060e-02	98	5798	206954	2.801590e-02	191	7068	235746	2.998140e-02	231	28	7152	3.914990e-03	0	320	17098	1.871560e-02	1	191	2320	8.232760e-02	7	1071	9042	1.184470e-01	70	55	13382	4.110000e-03	0	1026	42754	2.399780e-02	12	294	15690	1.873800e-02	7	1071	9042	1.184470e-01	70	67	16198	4.136310e-03	0	551	30502	1.806440e-02	1	519	6202	8.368270e-02	23	1591	13408	1.186610e-01	114	71	16722	4.245900e-03	1	2251	88452	2.544880e-02	33	572	30608	1.868790e-02	14	1591	13408	1.186610e-01	114	61	14888	4.097260e-03	0	655	34240	1.912970e-02	2	845	9560	8.838910e-02	32	2112	17686	1.194160e-01	139	98	21594	4.538300e-03	1	2528	101642	2.487160e-02	38	572	30526	1.873810e-02	14	2112	17686	1.194160e-01	139	.	39674	1613546	2.458810e-02	780	2701	29582	9.130550e-02	124	369	75002	4.919870e-03	2	55	912	6.030700e-02	2	1324	59992	2.206960e-02	15	2701	29582	9.130550e-02	124	3907	44842	8.712810e-02	225	342	64010	5.342920e-03	1	390	6048	6.448410e-02	19	26788	1179642	2.270860e-02	305	1821	91032	2.000400e-02	41	4527	162754	0.027814984577952	1	360	0.002777777777777778	379	4430	0.0855530474040632	90	9000	0.01	29	786	0.03689567430025445	21	966	0.021739130434782608	261	1826	0.1429353778751369	5	274	0.01824817518248175	725	14392	0.05037520844913841	91	9360	0.009722222222222222	640	6256	0.10230179028132992	6038	194788	0.030997802739388465	Benign	BCL10-related_disorder|Immunodeficiency_37	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.85276340C>A	ClinGen:CA929838	C4015195	616098	.	.	Ala	Ser	448386.0	single nucleotide variant	NM_003921.5(BCL10):c.13G>T (p.Ala5Ser)	8915.0	BCL10	HGNC:989	Benign	0.0	Feb 03, 2025	12037217.0	-	RCV000532322|RCV004714073|RCV003915633	MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098|MedGen:C3661900|	Immunodeficiency 37|not provided|BCL10-related disorder	germline	germline	GRCh38	NC_000001.11	1	85276340.0	85276340.0	1p22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA929838	2.0	475271.0	85276340.0	C	A	-	-	-	-	-	-	SCV000655451|SCV005280959	-	-	13G>T 	Ala5Ser	NM_003921.5	2.0	2_Benign	55.69	0.6981132075471698	['616098']	autosomal recessive		0	IMMUNODEFICIENCY 37	55.69	0.6981132	10-90	50-70	-1.385871414203439	Uncertain	Increase			A	74			55.69	Aliphatic	Alanine		B-cell lymphoma/leukemia 10								0.2502		1.8																		89									-46.4		Pocket 1: Mean pLDDT: 47.42, Volume: 351.14 Å³, Druggability score: 0.25		140.7				dbSNP: rs12037217; Variant type: US; AA change: Ala5Ser; PTM type: Phosphorylation; PTM morphology: __MEPtA*PSLT; Var class: II		C (loop/coil)	C (loop/coil)																																																																				true	BCL10Ala5Ser																																																																																																																																																																																																																																		
RET	RET_Arg67His	0.8659334758591015	0.4152170581728022	6.886187755373604	0.0002342201970283017	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7704609214749432	0.6863595151579271	0.7836517320201809	0.7453321038627179	0.785243056082157	0.9388740507962934	0.8188458712910882	0.9125810420403285	0.7370609418645981	0.7395946779055604	0.6316120613680206	0.6718183364343475	0.6547224220000333	0.6356580884512563	0.801327165044326	RET	0.8659334758591015	0.4152170581728022	6.886187755373604	0.0002342201970283017	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7704609214749432	0.6863595151579271	0.7836517320201809	0.7453321038627179	0.785243056082157	0.9388740507962934	0.8188458712910882	0.9125810420403285	0.7370609418645981	0.7395946779055604	0.6316120613680206	0.6718183364343475	0.6547224220000333	0.6356580884512563	0.801327165044326	RET	ENSG00000165731	8858	202945.0	CCSBVarC006873	ALE00006871	NC_000010.11:43100585:G:A	200G>A	Arg67His	CEGS2	CegsMutGDEh1027	E08	GDEhDisVCh_40066	H05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43100585.0	G	A	10	Y	N	N	N	N	10-43100585-G-A	50278.0	single nucleotide variant	NM_020975.6(RET):c.200G>A (p.Arg67His)	5979.0	RET	HGNC:9967	Benign/Likely benign	0.0	Feb 02, 2025	192489011.0	-	RCV000034768|RCV000121986|RCV000271726|RCV000311573|RCV000368621|RCV000393823|RCV000563975|RCV001080638|RCV002307371	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653	not provided|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	germline	germline	GRCh38	NC_000010.11	10	43100585.0	43100585.0	10q11.21	criteria provided, multiple submitters, no conflicts	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008548,UniProtKB:P07949#VAR_018153	2.0	41839.0	43100585.0	G	A	-	-	-	-	-	-	SCV000261427|SCV000362226|SCV000362227|SCV000362228|SCV000362229|SCV000610899|SCV000674752|SCV000807018|SCV000890954|SCV002067190|SCV002529960|SCV002572021|SCV004357215	-	-	200G>A 	Arg67His	NM_020975.6	2.0	2_Benign	0.000380405	41839.0	10	43100585.0	G	A	R	H	rs192489011	10	43596033.0	10	42916039.0	67.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.200G>A	p.Arg67His	c.200G>A	p.Arg67His	principal4	Y	5	YES	Select	+	CGC	2.0	0.0	G	G/G	G/G	G/G	G/G	0.611	0.05754	T	0.58	0.29952	T	0.002	0.13655	B	0.001	0.06938	B	0.08	0.23785	N	simple_aae	92.0	8.0	0.905	0.23113	L	-0.47	0.15106	N	0.028	0.02855	-0.973	0.36417	T	0.1253	0.42817	T	10.0	0.0068158507	0.00152	T	.	.	.	0.125	0.34250	.	.	.	.	.	0.47083157667	0.46339	0.5109484406135018	0.50823	0.934419907037	0.71797	0.233786687255	0.02262	T	0.367069	0.73048	T	-0.494179	0.00587	T	-0.473236	0.2482	T	0.0107988245138953	0.00152	T	0.59724	0.21954	T	0.026211439	0.01639	0.032374926	0.01973	0.043690175	0.06790	0.026637115	0.00770	-4.548	0.31573	T	0.0675	0.06414	B	0.00636577096918478	0.20556	0.98813590	0.96462	0.021	0.03256	.	.	.	.	.	.	0.923631	0.13006	9.492	0.773240547780898	0.12021	0.064517	0.12358	N	-0.737658851988375	0.14788	0.7503831	-0.60610869746005	0.19037	1.036945	5.51	-0.21	0.12496	-1.31	0.14328	0.08	0.14701	0.062000	0.14201	-0.71	0.03958	0.899	0.31494	0.001	0.17376	0.362	0.25981	862	0.33096	28	0.005591054313099041	0	0.0	0	0.0	0	0.0	27	0.026785714285714284	1	0.0010224948875255625	139	264690	5.2514265E-4	.	130	109312	1.189260e-03	0	206	207774	9.914620e-04	0	270	236724	1.140570e-03	0	0	7156	0.000000e+00	0	1	17100	5.847950e-05	0	0	2310	0.000000e+00	0	110	9044	1.216280e-02	0	4	13368	2.992220e-04	0	9	42734	2.106050e-04	0	6	15688	3.824580e-04	0	110	9044	1.216280e-02	0	0	16184	0.000000e+00	0	2	30500	6.557380e-05	0	0	6194	0.000000e+00	0	168	13406	1.253170e-02	0	7	16708	4.189610e-04	0	15	89320	1.679360e-04	0	11	30604	3.594300e-04	0	168	13406	1.253170e-02	0	0	14884	0.000000e+00	0	2	34240	5.841120e-05	0	0	9558	0.000000e+00	0	218	17690	1.232330e-02	0	15	21600	6.944440e-04	0	22	102612	2.144000e-04	0	11	30522	3.603960e-04	0	218	17690	1.232330e-02	0	.	646	1613870	4.002800e-04	6	377	44876	8.400930e-03	3	2	75036	2.665390e-05	0	0	912	0.000000e+00	0	8	60018	1.332930e-04	0	0	29604	0.000000e+00	0	377	44876	8.400930e-03	3	53	63766	8.311640e-04	0	2	6060	3.300330e-04	0	116	1180022	9.830330e-05	0	45	91076	4.940930e-04	3	16	174478	9.170210570960235E-5	0	176	0	39	4500	0.008666666666666666	0	4792	0	0	796	0	0	968	0	8	1848	0.004329004329004329	0	280	0	22	16002	0.0013748281464816899	0	4968	0	47	6348	0.0074039067422810335	85	203840	4.1699372056514916E-4	Benign/Likely_benign	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|not_provided|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Pheochromocytoma|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43100585G>A	ClinGen:CA008548|UniProtKB:P07949#VAR_018153	C1619700|C0027662|C4048306|C3661900|C0027672|C0025268|C3888239|C0031511|CN169374	191830|PS131100|171400|142623|171300	411709|276161|653|140162|247698|653|388|29072	Ret, cadherin like domain 1	Arg	His	50278.0	single nucleotide variant	NM_020975.6(RET):c.200G>A (p.Arg67His)	5979.0	RET	HGNC:9967	Benign/Likely benign	0.0	Feb 02, 2025	192489011.0	-	RCV000034768|RCV000121986|RCV000271726|RCV000311573|RCV000368621|RCV000393823|RCV000563975|RCV001080638|RCV002307371	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653	not provided|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	germline	germline	GRCh38	NC_000010.11	10	43100585.0	43100585.0	10q11.21	criteria provided, multiple submitters, no conflicts	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008548,UniProtKB:P07949#VAR_018153	2.0	41839.0	43100585.0	G	A	-	-	-	-	-	-	SCV000261427|SCV000362226|SCV000362227|SCV000362228|SCV000362229|SCV000610899|SCV000674752|SCV000807018|SCV000890954|SCV002067190|SCV002529960|SCV002572021|SCV004357215	-	-	200G>A 	Arg67His	NM_020975.6	2.0	2_Benign	90.15	0.282258064516129	['142623', '191830', '171300', '171400']	multiple	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; RENAL HYPODYSPLASIA/APLASIA 1; PHEOCHROMOCYTOMA; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	90.15	0.28225806	10-90	>90						R	70			90.15	Positively-charged	Arginine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-4.5								R67-T130, R67-S128, R67-F126; PAE: 6.0, 4.0, 1.5	4 interactions	R67-F126; PAE: 1.5	5 interactions		1 interaction					175									-126.5				140.4	Cadherin-like region 1 (CLD1)			dbSNP: rs192489011; Variant type: LB/B; AA change: Arg67His; PTM type: Phosphorylation; PTM morphology: PEEVPsFR*LGQ; Var class: II		B (undefined)	E (parallel sheets)							Extracellular																																																													true	RETArg67His																																																																																																																																																																																																																																		
BRCA1	BRCA1_His299Tyr	-2.033763125966286	0.08145918034371533	6.185243760707367	0.00045170431666583454	2025_01_Batch_13-14	false	true	true	true	true	false	false	false	false	true	0.9424133666461356	0.8804431959899585	0.9807263751699259	0.9467630437209911	0.9795882444844936	0.9752599466533104	0.9407185611386177	0.9749079994982701	0.8284316359193244	0.9348006054634483	0.9839165423156767	0.9528075263033645	0.9865447508415817	0.9324547560605925	0.9500261278288228	BRCA1	-2.033763125966286	0.08145918034371533	6.185243760707367	0.00045170431666583454	2025_01_Batch_13-14	false	true	true	true	true	false	false	false	false	true	0.9424133666461356	0.8804431959899585	0.9807263751699259	0.9467630437209911	0.9795882444844936	0.9752599466533104	0.9407185611386177	0.9749079994982701	0.8284316359193244	0.9348006054634483	0.9839165423156767	0.9528075263033645	0.9865447508415817	0.9324547560605925	0.9500261278288228	BRCA1		14613		CCSBVarC011806		NC_000017.11:43082557:G:A	895C>T	His299Tyr																												17.0	43082557.0	G	A	17						17-43082557-G-A	69807.0	single nucleotide variant	NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357365.0	-	RCV000048486|RCV000083205|RCV000162983|RCV000254639|RCV001087632|RCV004803996|RCV004554674	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43082557.0	43082557.0	17q21.31	reviewed by expert panel	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00085,ClinGen:CA002707	2.0	55140.0	43082557.0	G	A	-	-	-	-	-	-	SCV000244356	-	-	4204C>T 	His1402Tyr	NM_007294.4	3.0	2_Benign		55140.0	17	43082557.0	G	A	H	Y	rs80357365	17	41234574.0	17	38488100.0	1402.0	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.4204C>T	p.His1402Tyr	principal2	Y	1	.	.	-	CAT	1.0	0.0	C	G/G	G/G	G/G	G/G	.	0.27673	.	.	0.37649	.	0.019	0.18002	B	0.023	0.19965	B	.	0.21442	.	.	.	.	-0.345	0.03334	N	.	0.40464	.	.	0.37578	-0.7649	0.56959	T	0.3229	0.69047	T	10.0	.	0.14597	.	0.075011	0.72087	D	.	0.70364	0.173	0.07846	E9PFC7	H1402Y	Loss of catalytic residue at L1404 (P = 0.0693)| Loss of ubiquitination at K1406 (P = 0.071)| Gain of methylation at K1406 (P = 0.1374)| Loss of disorder (P = 0.146)| Loss of phosphorylation at T1399 (P = 0.2256)	.	0.55302	.	0.05014	.	0.12517	0.428560256958	0.28977	T	0.086384	0.37435	T	0.0446199	0.57354	T	-0.173683	0.56807	T	0.169085681438446	0.18287	T	.	0.31359	.	0.035931196	0.04282	0.049696308	0.07661	0.032783277	0.03337	0.04356669	0.05464	-4.172	0.39583	T	.	0.23217	.	0.00428760772610033	0.17785	0.96681190	0.94420	0.22	0.48657	.	.	.	.	.	.	3.245445	0.44401	21.9	0.9757896927978936	0.34893	0.283041	0.39425	N	-0.564913128253644	0.19776	1.052213	-0.336469916680358	0.26612	1.490904	5.35	4.38	0.51962	3.41	0.61757	1.739	0.37947	2.733000	0.34485	-0.805	0.03126	0.996	0.3946	1.0	0.68239	0.79	0.37345	520	0.74375	.	.	.	.	.	.	.	.	.	.	.	.	7	264690	2.644603E-5	.	1	109398	9.140930e-06	0	1	208096	4.805470e-06	0	1	236816	4.222690e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13388	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13404	0.000000e+00	0	0	16728	0.000000e+00	0	0	89540	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	0	17680	0.000000e+00	0	0	21626	0.000000e+00	0	0	102644	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	45	1614020	2.788070e-05	0	41	1180040	3.474460e-05	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	1	29606	3.377690e-05	0	0	44900	0.000000e+00	0	0	63994	0.000000e+00	0	0	6084	0.000000e+00	0	41	1180040	3.474460e-05	0	0	91084	0.000000e+00	0	1	24490	4.083299305839118E-5	0	108	0	0	84	0	0	2728	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4552	0	0	2836	0	0	108	0	1	33208	3.0113225728740063E-5	Benign	Hereditary_cancer-predisposing_syndrome|BRCA1-related_disorder|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43082557G>A	BRCA1-HCI:BRCA1_00085|ClinGen:CA002707	C0027672|C0677776|C3661900|C2676676|CN169374	604370	140162|145|145	.	His	Tyr	69807.0	single nucleotide variant	NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357365.0	-	RCV000048486|RCV000083205|RCV000162983|RCV000254639|RCV001087632|RCV004803996|RCV004554674	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43082557.0	43082557.0	17q21.31	reviewed by expert panel	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00085,ClinGen:CA002707	2.0	55140.0	43082557.0	G	A	-	-	-	-	-	-	SCV000244356	-	-	4204C>T 	His1402Tyr	NM_007294.4	3.0	2_Benign	89.18	0.6521739130434783	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	89.18	0.65217394	10-90	70-90																																																																																																																																		true	BRCA1His299Tyr																																																																																																																																																																																																																																		
BAP1	BAP1_Cys91Ser	0.5371858858067884	0.607783622798212	-2.6931062589231534	0.0309462574441354	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6480043160290715	0.7704629264228079	0.7297507766850269	0.70525270615688	0.793753109675104	0.933352987170181	0.7779180969243228	0.7990596626902846	0.8911419451288887	0.6547280169440957	0.6541532321800272	0.6325873153894371	0.6604418906797691	0.6497839077167271	0.6412806151140473	BAP1	0.5371858858067884	0.607783622798212	-2.6931062589231534	0.0309462574441354	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6480043160290715	0.7704629264228079	0.7297507766850269	0.70525270615688	0.793753109675104	0.933352987170181	0.7779180969243228	0.7990596626902846	0.8911419451288887	0.6547280169440957	0.6541532321800272	0.6325873153894371	0.6604418906797691	0.6497839077167271	0.6412806151140473	BAP1		3760		CCSBVarC009484		NC_000003.12:52408061:C:G	272G>C	Cys91Ser																												3.0	52408061.0	C	G	3						3-52408061-C-G	1162263.0	single nucleotide variant	NM_004656.4(BAP1):c.272G>C (p.Cys91Ser)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Apr 06, 2024	1559591264.0	-	RCV001797187|RCV004762154	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	Neurodevelopmental disorder|not provided	de novo;germline	germline	GRCh38	NC_000003.12	3	52408061.0	52408061.0	3p21.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA353112607	2.0	1173081.0	52408061.0	C	G	-	-	-	-	-	-	SCV005373284	-	-	272G>C 	Cys91Ser	NM_004656.4	1.0	1_Pathogenic		1173081.0	3	52408061.0	C	G	C	S	rs1559591264	3	52442077.0	3	52417117.0	91.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.272G>C	p.Cys91Ser	c.272G>C	p.Cys91Ser	principal1	Y	1	YES	Select	-	TGT	2.0	0.0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.145	0.97505	H	-9.46	0.98771	D	0.955	0.96431	1.0958	0.9948	D	0.9489	0.98331	D	10.0	0.9872064	0.99064	D	0.596811	0.96431	D	0.962	0.99434	0.905	0.97974	Q92560	C91S	Gain of disorder (P = 0.0084)| Loss of stability (P = 0.0799)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2045)| Loss of catalytic residue at T93 (P = 0.2182)	0.955221855794	0.95437	0.9595328650281908	0.95915	2.72839044085	0.98645	0.864477872849	0.91757	D	0.614019	0.87693	D	0.541235	0.95439	D	0.53967	0.95371	D	0.999951362609863	0.99873	D	0.998731	0.99346	D	0.94517225	0.95709	0.93077695	0.97107	0.94517225	0.95709	0.93077695	0.97108	-12.137	0.85551	D	0.9993	0.98761	P	0.999965302743864	0.99297	0.99989426	0.99864	0.869	0.92884	.	.	.	.	.	.	5.171826	0.86714	29.0	0.9941480862172674	0.63503	0.954506	0.97155	D	1.0231602614017	0.96393	14.66464	0.934896275402238	0.96904	15.33076	5.49	5.49	0.80997	.	.	7.657	0.82777	7.613000	0.62049	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.998	0.85369	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52408061C>G	.	C1535926	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Cys	Ser	1162263.0	single nucleotide variant	NM_004656.4(BAP1):c.272G>C (p.Cys91Ser)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Apr 06, 2024	1559591264.0	-	RCV001797187|RCV004762154	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	Neurodevelopmental disorder|not provided	de novo;germline	germline	GRCh38	NC_000003.12	3	52408061.0	52408061.0	3p21.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA353112607	2.0	1173081.0	52408061.0	C	G	-	-	-	-	-	-	SCV005373284	-	-	272G>C 	Cys91Ser	NM_004656.4	1.0	1_Pathogenic	93.1	0.1481481481481481		unknown		0		93.1	0.14814815	10-90	>90						C	20		Nucleophile	93.1	Special, a very reactive sulfhydryl group	Cysteine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			2.5								C91-A95; PAE: 1.0	1 interaction	C91-Q85, C91-A95; PAE: 1.5, 1.0	4 interactions							121		Mutation: C -> A. Abolishes deubiquitinase activity. Has no effect on interaction with HCFC1.							-59.3				-46.3						H (helix)	H (α-helix)	Helix																																																																			true	BAP1Cys91Ser																																																																																																																																																																																																																																		
FARS2	FARS2_Ile388Ser	1.0162955675066876	1.0	-4.23530096770175	0.007658698829097526	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8460632491755824	0.5283189700456539	0.7720517737867707	0.737102803597812	0.5358487798186116	0.6256694420392739	0.7512853222117405	0.7678373906321424	0.6186307284129027	0.8307693779158166	0.4460281175979493	0.7229202849838836	0.7762661569413991	0.43800721167840495	0.8613571204353483	FARS2	1.0162955675066876	1.0	-4.23530096770175	0.007658698829097526	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8460632491755824	0.5283189700456539	0.7720517737867707	0.737102803597812	0.5358487798186116	0.6256694420392739	0.7512853222117405	0.7678373906321424	0.6186307284129027	0.8307693779158166	0.4460281175979493	0.7229202849838836	0.7762661569413991	0.43800721167840495	0.8613571204353483	FARS2		12653		CCSBVarC011922		NC_000006.12:5613266:T:G	1163T>G	Ile388Ser																												6.0	5613266.0	T	G	6						6-5613266-T-G	481384.0	single nucleotide variant	NM_006567.5(FARS2):c.1163T>G (p.Ile388Ser)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Nov 15, 2017	1407198979.0	-	RCV000578458	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5613266.0	5613266.0	6p25.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA362736964	2.0	488516.0	5613266.0	T	G	-	-	-	-	-	-	SCV000680228	-	-	1163T>G 	Ile388Ser	NM_006567.5	1.0	1_Pathogenic		488516.0	6	5613266.0	T	G	I	S	rs1407198979	6	5613499.0	6	5558498.0	388.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1163T>G	p.Ile388Ser	c.1163T>G	p.Ile388Ser	principal1	Y	1	YES	Select	+	ATT	2.0	0.0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.002	0.79703	D	0.714	0.42184	P	0.367	0.43429	B	.	.	.	.	.	.	2.125	0.58867	M	-4.96	0.82015	D	0.84	0.83632	-0.4338	0.7081	T	0.2675	0.63745	T	10.0	0.8248781	0.81483	D	0.051707	0.64640	D	0.511	0.78922	0.559	0.67707	O95363	I388S	Loss of stability (P = 0.0161)| Gain of disorder (P = 0.0363)| Gain of glycosylation at I388 (P = 0.0591)| Gain of helix (P = 0.0854)| Gain of relative solvent accessibility (P = 0.09)	0.935486347505	0.93431	.	0.78077	.	0.44430	0.315835446119	0.12779	T	0.571252	0.85676	D	0.0869603	0.62581	D	-0.112864	0.62116	T	0.979173302650452	0.72507	D	0.978802	0.92613	D	0.7625783	0.81381	0.80076313	0.88169	0.80483794	0.84016	0.7604622	0.85673	-13.402	0.90970	D	0.2564	0.49112	B	0.980686339579557	0.85480	0.83609140	0.89259	0.977	0.99166	.	.	.	.	.	.	4.872277	0.79869	27.2	0.9923544124334334	0.56442	0.866864	0.78564	D	0.407863502934099	0.61656	4.392269	0.462304649405172	0.65325	4.833016	5.53	5.53	0.82506	3.23	0.58548	7.299	0.78213	6.134000	0.54028	0.665	0.62996	0.997	0.40243	0.978	0.30284	0.903	0.43926	976	0.04721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5613266T>G	ClinGen:CA362736964	C4755312	614946	319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Ile	Ser	481384.0	single nucleotide variant	NM_006567.5(FARS2):c.1163T>G (p.Ile388Ser)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Nov 15, 2017	1407198979.0	-	RCV000578458	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5613266.0	5613266.0	6p25.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA362736964	2.0	488516.0	5613266.0	T	G	-	-	-	-	-	-	SCV000680228	-	-	1163T>G 	Ile388Ser	NM_006567.5	1.0	1_Pathogenic	97.64	0.3195266272189349	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	97.64	0.3195266	10-90	>90						I	54			97.64	Aliphatic	Isoleucine									FDX-ACB			4.5								I388-L384; PAE: 1.0	9 interactions	I388-L384, I388-L437; PAE: 1.0, 1.0	9 interactions							131									-87.8				-49.4						H (helix)	H (α-helix)	Helix																																																																			true	FARS2Ile388Ser																																																																																																																																																																																																																																		
GSS	GSS_Arg125Cys	1.7103934935991731	0.4472984897884251	-1.1129963527507523	0.5390576811122689	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6560894919759033	0.5328830564075191	0.6864438720347572	0.6362635025955832	0.5706541906909917	0.6020717464597054	0.6530716599756321	0.7237004988017183	0.5664566229065157	0.7632120678816032	0.539236634922278	0.6194553452155342	0.649187245267796	0.49930948990852253	0.5489669160702033	GSS	1.7103934935991731	0.4472984897884251	-1.1129963527507523	0.5390576811122689	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6560894919759033	0.5328830564075191	0.6864438720347572	0.6362635025955832	0.5706541906909917	0.6020717464597054	0.6530716599756321	0.7237004988017183	0.5664566229065157	0.7632120678816032	0.539236634922278	0.6194553452155342	0.649187245267796	0.49930948990852253	0.5489669160702033	GSS	ENSG00000100983	5132	215352.0	CCSBVarC006739	ALE00006737	NC_000020.11:34942606:G:A	373C>T	Arg125Cys	CEGS2	CegsMutGDEh1044	F03	GDEhDisVCh_40044	H01	2.0	CegsMutGDDh1044	F03	VUSN2Hmut_GDN2h_09	D05	VUSMutpDEST2_04	F12	VUSmut_GDEh09	D05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	20.0	34942606.0	G	A	20	Y	Y	Y	Y	Y	20-34942606-G-A	23568.0	single nucleotide variant	NM_000178.4(GSS):c.373C>T (p.Arg125Cys)	2937.0	GSS	HGNC:4624	Pathogenic/Likely pathogenic	1.0	Feb 14, 2024	28936396.0	-	RCV000009055|RCV003488332|RCV004566701|RCV005025041	MONDO:MONDO:0017909,MedGen:CN030166,Orphanet:32|MedGen:C3661900|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846;MONDO:MONDO:0009284,MedGen:C1856399,OMIM:231900,Orphanet:289849,Orphanet:32	Inherited glutathione synthetase deficiency|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria	germline	germline	GRCh38	NC_000020.11	20	34942606.0	34942606.0	20q11.22	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA119694,OMIM:601002.0005	3.0	8529.0	34942606.0	G	A	-	-	-	-	-	-	SCV002204728|SCV002819864|SCV004238234|SCV005661820	-	-	373C>T 	Arg125Cys	NM_000178.4	2.0	1_Pathogenic	0.0000205224	8529.0	20	34942606.0	G	A	R	C	rs28936396	20	33530409.0	20	32994070.0	125.0	GSS	ENSG00000100983	ENST00000651619	ENSP00000498303	P48637	GSHB_HUMAN	c.373C>T	p.Arg125Cys	c.373C>T	p.Arg125Cys	principal1	Y	.	YES	Select	-	CGC	1.0	0.0	G	G/G	G/G	G/G	G/G	.	.	.	.	.	.	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	3.785	0.95215	H	.	.	.	.	.	1.0907	0.99266	D	0.9543	0.98514	D	9.0	.	0.91808	.	0.366447	0.92624	D	.	.	.	.	.	.	.	.	.	.	0.93149	.	.	0.761953830719	0.76178	T	0.979491	0.99825	D	0.272164	0.80492	D	0.567727	0.96156	D	0.988271415233612	0.78469	D	.	0.92613	.	0.96310127	0.97551	0.8506926	0.91438	0.96134293	0.97374	0.837919	0.90580	-12.5	0.87232	D	.	0.85836	.	0.998758874737846	0.94998	0.98256360	0.95785	0.884	0.93768	.	.	.	.	.	.	6.177047	0.94738	34.0	0.9994469099776084	0.99886	0.948579	0.96020	D	1.09872351892217	0.98099	17.45189	1.02848604687915	0.99100	20.69962	5.77	5.77	0.91065	3.8	0.70283	9.908	0.98664	11.765000	0.95724	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.994	0.71086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	67	264690	2.531263E-4	.	6	109394	5.484760e-05	0	13	208114	6.246580e-05	0	13	236900	5.487550e-05	0	5	7162	6.981290e-04	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	0	42768	0.000000e+00	0	1	15690	6.373490e-05	0	5	7162	6.981290e-04	0	10	16216	6.166750e-04	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	2	16724	1.195890e-04	0	0	89554	0.000000e+00	0	1	30606	3.267330e-05	0	10	16216	6.166750e-04	0	10	14900	6.711410e-04	0	0	34256	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	2	21622	9.249840e-05	0	0	102716	0.000000e+00	0	1	30524	3.276110e-05	0	10	14900	6.711410e-04	0	.	67	1613906	4.151420e-05	0	56	74906	7.476040e-04	0	56	74906	7.476040e-04	0	0	910	0.000000e+00	0	0	59982	0.000000e+00	0	0	29600	0.000000e+00	0	0	44882	0.000000e+00	0	2	64012	3.124410e-05	0	0	6084	0.000000e+00	0	4	1179972	3.389910e-06	0	2	91078	2.195920e-05	0	2	30460	6.565988181221274E-5	0	298	0	0	120	0	5	7872	6.351626016260162E-4	0	146	0	0	610	0	0	26	0	0	104	0	0	2294	0	5	8170	6.119951040391676E-4	0	146	0	7	41930	1.669449081803005E-4	Pathogenic/Likely_pathogenic	Glutathione_synthetase_deficiency_with_5-oxoprolinuria|Inherited_glutathione_synthetase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000020.11:g.34942606G>A	ClinGen:CA119694|OMIM:601002.0005	C0398746|CN030166|C3661900	266130	289846|32	.	Arg	Cys	23568.0	single nucleotide variant	NM_000178.4(GSS):c.373C>T (p.Arg125Cys)	2937.0	GSS	HGNC:4624	Pathogenic/Likely pathogenic	1.0	Feb 14, 2024	28936396.0	-	RCV000009055|RCV003488332|RCV004566701|RCV005025041	MONDO:MONDO:0017909,MedGen:CN030166,Orphanet:32|MedGen:C3661900|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846;MONDO:MONDO:0009284,MedGen:C1856399,OMIM:231900,Orphanet:289849,Orphanet:32	Inherited glutathione synthetase deficiency|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria	germline	germline	GRCh38	NC_000020.11	20	34942606.0	34942606.0	20q11.22	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA119694,OMIM:601002.0005	3.0	8529.0	34942606.0	G	A	-	-	-	-	-	-	SCV002204728|SCV002819864|SCV004238234|SCV005661820	-	-	373C>T 	Arg125Cys	NM_000178.4	2.0	1_Pathogenic	98.3	0.0483870967741935	['266130', '266130', '231900']	autosomal recessive	Rare genetic hematologic disease; Rare inborn errors of metabolism	2	GLUTATHIONE SYNTHETASE DEFICIENCY; GLUTATHIONE SYNTHETASE DEFICIENCY; ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 6	98.3	0.048387095	<10	>90	-0.3388282617516329	N	Increase			R	12			98.3	Positively-charged	Arginine	substrate	Glutathione synthetase								0.1778		-4.5								R125-N146, R125-S151; PAE: 1.0, 1.0	1 interaction	R125-N146; PAE: 1.0	2 interactions		1 interaction					175									-132.5		Pocket 2: Mean pLDDT: 79.41, Volume: 936.21 Å³, Druggability score: 0.18		114.9						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	GSSArg125Cys																																																																																																																																																																																																																																		
RAD51D	RAD51D_Glu307Lys	-3.404294044082903	0.011375795993745073	0.8497515553009464	0.4235704158061365	2025_01_Batch_13-14	false	true	true	true	true	false	true	false	false	false	0.9672288832680017	0.9301217210011836	0.9795045870859254	0.9641706447910451	0.9622888691074283	0.9947048700755531	0.9590398418311258	0.9765785759640803	0.9819097374301679	0.9502312770001002	0.9298728681393036	0.9693014477509644	0.9824305982077703	0.8783337045721995	0.9842264895359032	RAD51D	-3.404294044082903	0.011375795993745073	0.8497515553009464	0.4235704158061365	2025_01_Batch_13-14	false	true	true	true	true	false	true	false	false	false	0.9672288832680017	0.9301217210011836	0.9795045870859254	0.9641706447910451	0.9622888691074283	0.9947048700755531	0.9590398418311258	0.9765785759640803	0.9819097374301679	0.9502312770001002	0.9298728681393036	0.9693014477509644	0.9824305982077703	0.8783337045721995	0.9842264895359032	RAD51D		7201		CCSBVarC024889		NC_000017.11:35101021:C:T	919G>A	Glu307Lys																												17.0	35101021.0	C	T	17						17-35101021-C-T	133352.0	single nucleotide variant	NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 02, 2025	115031549.0	-	RCV000115821|RCV000212975|RCV000656966|RCV000989829|RCV001354385|RCV003149803|RCV003905100|RCV004700423	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562||MedGen:C1333600	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Malignant tumor of breast|Breast and/or ovarian cancer|RAD51D-related disorder|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	35101021.0	35101021.0	17q12	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA287990	2.0	127895.0	35101021.0	C	T	-	-	-	-	-	-	SCV000149730|SCV000185235|SCV000287733|SCV000602170|SCV000859940|SCV000910718|SCV000918142|SCV001140404|SCV002527051|SCV003838853	-	-	919G>A 	Glu307Lys	NM_002878.4	1.0	3_Conflicting		127895.0	17	35101021.0	C	T	E	K	rs115031549	17	33428040.0	17	30452153.0	307.0	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.919G>A	p.Glu307Lys	c.919G>A	p.Glu307Lys	principal1	Y	1	YES	Select	-	GAG	1.0	0.0	C	C/C	C/C	C/C	C/C	0.178	0.22252	T	1.0	0.28071	T	0.001	0.15546	B	0.003	0.17739	B	0.04	0.16373	N	simple_aae	96.0	4.0	0.975	0.24371	L	-1.37	0.33974	N	0.183	0.40913	-1.075	0.08363	T	0.0695	0.28228	T	10.0	0.005851954	0.00128	T	0.009794	0.25268	T	0.146	0.38573	.	.	.	.	.	0.607307720492	0.60114	.	0.58340	.	0.10516	.	.	.	0.12397	0.44563	T	-0.436555	0.01267	T	-0.402908	0.32684	T	0.0220424253485093	0.0091	T	.	0.44143	.	0.06279154	0.13032	0.07841017	0.17544	0.06279154	0.13031	0.07841017	0.17544	-3.296	0.19068	T	0.2196	0.48302	LB	0.00210343958860793	0.13347	0.64807075	0.84992	0.024	0.04173	.	.	.	.	.	.	2.74903	0.36098	20.1	0.9538847366525546	0.27048	0.227759	0.34944	N	-0.451516097100692	0.23421	1.273859	-0.296002730575465	0.27912	1.572344	5.16	4.19	0.48586	1.06	0.29739	2.03	0.40832	4.830000	0.45268	-0.187	0.09644	1.0	0.71675	1.0	0.68239	0.789	0.37304	913	0.21155	3	5.990415335463259E-4	3	0.0022692889561270802	0	0.0	0	0.0	0	0.0	0	0.0	238	264690	8.9916505E-4	.	20	109408	1.828020e-04	0	55	208134	2.642530e-04	0	56	236948	2.363390e-04	0	17	7164	2.372980e-03	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	17	7164	2.372980e-03	0	46	16218	2.836350e-03	0	8	30524	2.620890e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89556	0.000000e+00	0	0	30608	0.000000e+00	0	46	16218	2.836350e-03	0	45	14902	3.019730e-03	0	9	34260	2.626970e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102744	0.000000e+00	0	0	30526	0.000000e+00	0	45	14902	3.019730e-03	0	.	251	1613792	1.555340e-04	2	217	75054	2.891250e-03	2	217	75054	2.891250e-03	2	0	912	0.000000e+00	0	20	60010	3.332780e-04	0	0	29602	0.000000e+00	0	0	44888	0.000000e+00	0	0	64046	0.000000e+00	0	0	6062	0.000000e+00	0	3	1179658	2.543110e-06	0	0	91070	0.000000e+00	0	1	167370	5.9747864013861505E-6	3	362	0.008287292817679558	0	4488	0	28	8974	0.0031201248049922	0	460	0	0	1024	0	0	1820	0	0	296	0	0	11378	0	31	9336	0.0033204798628963155	0	6308	0	32	196172	1.6312215810615173E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|RAD51D-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101021C>T	ClinGen:CA287990	C0027672|CN169374|C3661900|C3280345|C0006142|CN221562	614291	140162|145	.	Glu	Lys	133352.0	single nucleotide variant	NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 02, 2025	115031549.0	-	RCV000115821|RCV000212975|RCV000656966|RCV000989829|RCV001354385|RCV003149803|RCV003905100|RCV004700423	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562||MedGen:C1333600	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Malignant tumor of breast|Breast and/or ovarian cancer|RAD51D-related disorder|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	35101021.0	35101021.0	17q12	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA287990	2.0	127895.0	35101021.0	C	T	-	-	-	-	-	-	SCV000149730|SCV000185235|SCV000287733|SCV000602170|SCV000859940|SCV000910718|SCV000918142|SCV001140404|SCV002527051|SCV003838853	-	-	919G>A 	Glu307Lys	NM_002878.4	1.0	3_Conflicting	93.44	0.1752577319587628	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	93.44	0.17525773	10-90	>90						E	34			93.44	Negatively-charged	Glutamic Acid		DNA repair protein RAD51 homolog 4										-3.5								E307-K91, E307-A293; PAE: 2.0, 1.0	4 interactions	E307-A293; PAE: 1.0	6 interactions							146									-137.1				145.0						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	RAD51DGlu307Lys																																																																																																																																																																																																																																		
F9	F9_Ile210Thr	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8644715886891701	0.7962798944817868	0.8282133925707165	0.7870730942042935	0.8593606299070935	0.8642193932432928	0.7772071254523895	0.8106279239489359	0.8591761497090777	0.8242607574809934	0.8545018665708942	0.7969390629561975	0.8457988611924971	0.7333836392544959	0.9046824198973468	F9	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8644715886891701	0.7962798944817868	0.8282133925707165	0.7870730942042935	0.8593606299070935	0.8642193932432928	0.7772071254523895	0.8106279239489359	0.8591761497090777	0.8242607574809934	0.8545018665708942	0.7969390629561975	0.8457988611924971	0.7333836392544959	0.9046824198973468	F9		52861					767T>C	Ile210Thr																																																																																				5_Others																																																																																																																																																																																																																																																																																																																																																																																																																																																	unknown	Rare genetic hematologic disease	1				10-90	>90						I	171			32.18	Aliphatic	Isoleucine		Coagulation factor IX										4.5																		131									-99.6			Activation peptide	115.5						C (loop/coil)	C (loop/coil)																														0.978		0.982		0.989		0.974		0.972																														true	F9Ile210Thr																																																																																																																																																																																																																																		
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8502002957902698	0.6163244928809966	0.9283119296947473	0.8265494150601236	0.8711103685431433	0.8686866330475287	0.8682703369041973	0.9321126801043825	0.5143195256126359	0.8697860864383293	0.8735341040387579	0.78482849321605	0.924511179285112	0.7183294601493571	0.8306145051422102	F9	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8502002957902698	0.6163244928809966	0.9283119296947473	0.8265494150601236	0.8711103685431433	0.8686866330475287	0.8682703369041973	0.9321126801043825	0.5143195256126359	0.8697860864383293	0.8735341040387579	0.78482849321605	0.924511179285112	0.7183294601493571	0.8306145051422102	F9	ENSG00000101981	52861	204356.0	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139541127.0	A	G	X	Y	N	N	N	N	X-139541127-A-G	25619.0	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 01, 1989	137852234.0	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127.0	139541127.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255331,OMIM:300746.0023	1.0	10580.0	139541127.0	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic		10580.0	X	139541127.0	A	G	D	G	rs137852234	X	138623286.0	X	138450952.0	110.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2.0	0.0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10.0	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.9981601058173548	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.0	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619.0	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 01, 1989	137852234.0	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127.0	139541127.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255331,OMIM:300746.0023	1.0	10580.0	139541127.0	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic	87.17	0.1840490797546012	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	87.17	0.18404908	10-90	70-90						D	30			87.17	Negatively-charged	Aspartic Acid	Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 1; calcium-binding			-3.5			5 interactions	3 interactions				D110-Q96; PAE: 2.0	5 interactions	D110-C97; PAE: 1.5	5 interactions						(3R)-3-hydroxyaspartate	132									-72.1				143.4				dbSNP: rs137852274; Variant type: LP/P; AA change: Asp110Asn; PTM type: Phosphorylation; PTM morphology: KD*DINsYECWC; Var class: II		B (undefined)	E (parallel sheets)	Beta strand																													1.153	2 mutation(s) (Asp110Gly: 1.356, Asp110Lys: 1.359)	1.078	7 mutation(s) (Asp110Thr: 1.169, Asp110Ala: 1.172, Asp110Pro: 1.179, Asp110His: 1.180, Asp110Gln: 1.192, Asp110Gly: 1.196, Asp110Lys: 1.206)	0.924	1 mutation(s) (Asp110Ser: 1.135)	0.967		0.706																														true	F9Asp110Gly																																																																																																																																																																																																																																		
RAF1	RAF1_Gly361Ala	1.155499028633321	0.5403518469840319	-8.632887687864953	0.04258493446313849	2025_01_Batch_13-14	true	false	true	false	false	false	false	false	false	false	0.9758176547108324	0.8142905336478168	0.9584935868713313	0.9244255077497825	0.8166345301515319	0.7595018226539966	0.9272565960609439	0.9780376829289873	0.7507258763780502		0.873767237649067	0.9215944194386212	0.9389494908136753	0.8778551909175832	0.9758176547108324	RAF1	1.155499028633321	0.5403518469840319	-8.632887687864953	0.04258493446313849	2025_01_Batch_13-14	true	false	true	false	false	false	false	false	false	false	0.9758176547108324	0.8142905336478168	0.9584935868713313	0.9244255077497825	0.8166345301515319	0.7595018226539966	0.9272565960609439	0.9780376829289873	0.7507258763780502		0.873767237649067	0.9215944194386212	0.9389494908136753	0.8778551909175832	0.9758176547108324	RAF1		732		CCSBVarC008862		NC_000003.12:12599717:C:G	1082G>C	Gly361Ala																												3.0	12599717.0	C	G	3						3-12599717-C-G	49083.0	single nucleotide variant	NM_002880.4(RAF1):c.1082G>C (p.Gly361Ala)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Apr 03, 2017	397516813.0	-	RCV000037671|RCV000159081|RCV000473341|RCV001542563|RCV000987116	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500	Noonan syndrome|not provided|RASopathy|Noonan syndrome 5|LEOPARD syndrome 2	germline;unknown	germline	GRCh38	NC_000003.12	3	12599717.0	12599717.0	3p25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA134687	2.0	40613.0	12599717.0	C	G	-	-	-	-	-	-	SCV000616425	-	-	1082G>C 	Gly361Ala	NM_002880.4	3.0	1_Pathogenic		40613.0	3	12599717.0	C	G	G	A	rs397516813	3	12641216.0	3	12616216.0	361.0	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.1082G>C	p.Gly361Ala	principal3	Y	.	.	.	-	GGA	2.0	0.0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.51463	.	0.997	0.70687	D	0.977	0.73823	D	.	0.94956	.	.	.	.	1.905	0.50677	L	.	0.87174	.	.	0.97765	0.711	0.93289	D	0.7939	0.92997	D	10.0	.	0.98222	.	0.320475	0.91439	D	.	0.97773	0.932	0.98955	P04049	G361A	Gain of glycosylation at T362 (P = 0.0323)| Loss of methylation at K365 (P = 0.0936)| Gain of catalytic residue at G361 (P = 0.1011)| Gain of MoRF binding (P = 0.1018)| Loss of disorder (P = 0.134)	.	0.98954	.	0.94466	.	0.97266	0.90528345108	0.97002	D	0.939635	0.99031	D	0.455678	0.92679	D	0.416773	0.92588	D	0.996657013893127	0.89711	D	.	0.97197	.	0.9621787	0.97458	0.92825574	0.96930	0.9493423	0.96139	0.9189513	0.96273	-12.08	0.85279	D	.	0.96519	.	0.999868252519254	0.98431	0.99697757	0.98223	0.967	0.98682	.	.	.	.	.	.	5.440165	0.9094	32.0	0.9986517533703667	0.94371	0.911494	0.87038	D	0.841710195614201	0.88569	9.651506	0.835976326801195	0.92127	11.27517	5.52	5.52	0.82128	.	.	7.9	0.86061	7.697000	0.66139	0.596	0.33565	1.0	0.71675	1.0	0.68239	0.999	0.91597	677	0.60231	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|RASopathy|Noonan_syndrome|Noonan_syndrome_5|LEOPARD_syndrome_2	reviewed_by_expert_panel	NC_000003.12:g.12599717C>G	ClinGen:CA134687	C3661900|C5555857|C0028326|C1969057|C1969056	PS163950|611553|611554	536391|648|648|500	Protein kinase domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Ala	49083.0	single nucleotide variant	NM_002880.4(RAF1):c.1082G>C (p.Gly361Ala)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Apr 03, 2017	397516813.0	-	RCV000037671|RCV000159081|RCV000473341|RCV001542563|RCV000987116	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500	Noonan syndrome|not provided|RASopathy|Noonan syndrome 5|LEOPARD syndrome 2	germline;unknown	germline	GRCh38	NC_000003.12	3	12599717.0	12599717.0	3p25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA134687	2.0	40613.0	12599717.0	C	G	-	-	-	-	-	-	SCV000616425	-	-	1082G>C 	Gly361Ala	NM_002880.4	3.0	1_Pathogenic	81.02	0.0119047619047619	['611553', '611554']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	NOONAN SYNDROME 5; LEOPARD SYNDROME 2	81.02	0.011904762	<10	70-90						G	1			81.02	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	ATP	RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			-0.4											2 interactions							75									-173.7				164.0						B (undefined)	E (parallel sheets)																																																																				true	RAF1Gly361Ala																																																																																																																																																																																																																																		
BAP1	BAP1_Thr93Ala	-0.6567658065858207	0.5323213743048774	-1.8287496773019911	0.11014705290189507	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7417915235852883	0.6247629278983761	0.6621791109128389	0.5994901206356564	0.5781643522291045	0.6202397851478961	0.6362000012952241	0.6892093396316892	0.6153877231073421	0.7512034716753719	0.5360889193103129	0.5627802399760888	0.6351488821939886	0.63413813268941	0.7323795754952047	BAP1	-0.6567658065858207	0.5323213743048774	-1.8287496773019911	0.11014705290189507	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7417915235852883	0.6247629278983761	0.6621791109128389	0.5994901206356564	0.5781643522291045	0.6202397851478961	0.6362000012952241	0.6892093396316892	0.6153877231073421	0.7512034716753719	0.5360889193103129	0.5627802399760888	0.6351488821939886	0.63413813268941	0.7323795754952047	BAP1		3760		CCSBVarC009507		NC_000003.12:52408056:T:C	277A>G	Thr93Ala																												3.0	52408056.0	T	C	3						3-52408056-T-C	70527.0	single nucleotide variant	NM_004656.4(BAP1):c.277A>G (p.Thr93Ala)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Dec 03, 2022	375129361.0	-	RCV000049290|RCV002433548	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000003.12	3	52408056.0	52408056.0	3p21.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA143983,OMIM:603089.0008	3.0	55879.0	52408056.0	T	C	-	-	-	-	-	-	SCV002746333|SCV004293103	-	-	277A>G 	Thr93Ala	NM_004656.4	2.0	4_VUS		55879.0	3	52408056.0	T	C	T	A	rs375129361	3	52442072.0	3	52417112.0	93.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.277A>G	p.Thr93Ala	c.277A>G	p.Thr93Ala	principal1	Y	1	YES	Select	-	ACT	1.0	0.0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.004	0.74454	D	0.999	0.77914	D	0.989	0.78402	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.105	0.97294	H	-4.56	0.80799	D	0.983	0.99488	0.4694	0.90073	D	0.5815	0.84895	D	10.0	0.9710113	0.96665	D	0.320929	0.91452	D	0.829	0.94563	0.874	0.96509	Q92560	T93A	Gain of helix (P = 0.132)| Loss of glycosylation at T93 (P = 0.3182)| Loss of stability (P = 0.3249)| Loss of catalytic residue at N89 (P = 0.4948)| Gain of disorder (P = 0.6407)	0.838735026799	0.83592	0.8901470396696406	0.88915	2.40817712881	0.97198	0.833551824093	0.87085	D	0.577416	0.85979	D	0.251032	0.78538	D	0.295271	0.87893	D	0.995927274227142	0.88231	D	0.994601	0.98251	D	0.9059349	0.91801	0.8396252	0.90693	0.8751512	0.89125	0.8592254	0.92021	-14.822	0.95431	D	0.9945	0.95276	P	0.999630510295007	0.97271	0.99965429	0.99571	0.818	0.89950	.	.	.	.	.	.	7.074994	0.96116	35.0	0.9980772058777344	0.89183	0.908893	0.86431	D	0.954170017245365	0.94117	12.5385	0.865996819397726	0.93882	12.37055	5.49	5.49	0.80997	3.34	0.60572	7.766	0.84189	7.827000	0.70012	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.995	0.73271	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	106374	0.000000e+00	0	0	202728	0.000000e+00	0	1	231230	4.324700e-06	0	0	6610	0.000000e+00	0	0	16808	0.000000e+00	0	0	2194	0.000000e+00	0	0	8894	0.000000e+00	0	0	13292	0.000000e+00	0	0	41496	0.000000e+00	0	0	15212	0.000000e+00	0	.	.	.	.	0	15408	0.000000e+00	0	0	29904	0.000000e+00	0	0	5990	0.000000e+00	0	0	13312	0.000000e+00	0	0	16576	0.000000e+00	0	0	87104	0.000000e+00	0	0	29660	0.000000e+00	0	.	.	.	.	0	14150	0.000000e+00	0	0	33660	0.000000e+00	0	0	9380	0.000000e+00	0	1	17510	5.711020e-05	0	0	21264	0.000000e+00	0	0	100148	0.000000e+00	0	0	29584	0.000000e+00	0	1	17510	5.711020e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Uncertain_significance	BAP1-related_tumor_predisposition_syndrome|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52408056T>C	ClinGen:CA143983|OMIM:603089.0008	C3280492|C0027672	614327	289539|140162	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Thr	Ala	70527.0	single nucleotide variant	NM_004656.4(BAP1):c.277A>G (p.Thr93Ala)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Dec 03, 2022	375129361.0	-	RCV000049290|RCV002433548	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000003.12	3	52408056.0	52408056.0	3p21.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA143983,OMIM:603089.0008	3.0	55879.0	52408056.0	T	C	-	-	-	-	-	-	SCV002746333|SCV004293103	-	-	277A>G 	Thr93Ala	NM_004656.4	2.0	4_VUS	96.63	0.0	['614327']	unknown		0	TUMOR PREDISPOSITION SYNDROME 1	96.63	0.0	<10	>90						T	0			96.63	Polar/Neutral	Threonine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			-0.7								T93-L97, T93-H141; PAE: 1.0, 1.0	2 interactions	T93-H141, T93-L97; PAE: 1.0, 1.0	2 interactions							119									-72.1				-39.9						H (helix)	H (α-helix)	Helix																																																																			true	BAP1Thr93Ala																																																																																																																																																																																																																																		
BRAF	BRAF_Val600Gly	3.466058469875043	0.010461482848769289	-2.3131620225658573	0.05393497039622505	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8398066318419654	0.7372813490005639	0.8349014467237346	0.8860703104503926	0.7704206716544667	0.7373529082522765	0.8261058599222147	0.742019466013257	0.6857756328655163	0.7598807105682761	0.8034884350566569	0.9460347609785704	0.9277834274342123	0.7887870651356114	0.9197325531156546	BRAF	3.466058469875043	0.010461482848769289	-2.3131620225658573	0.05393497039622505	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8398066318419654	0.7372813490005639	0.8349014467237346	0.8860703104503926	0.7704206716544667	0.7373529082522765	0.8261058599222147	0.742019466013257	0.6857756328655163	0.7598807105682761	0.8034884350566569	0.9460347609785704	0.9277834274342123	0.7887870651356114	0.9197325531156546	BRAF	ENSG00000157764	71969	220618.0	CCSBVarC003172	ALE00003172	NC_000007.14:140753336:A:C	1799T>G	Val600Gly	CEGS2	CegsMutGDEh1021	A01	GDEhDisVCh_40058	A09	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140753336.0	A	C	7	Y	N	N	N	N	7-140753336-A-C	48859.0	single nucleotide variant	NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Jun 25, 2020	113488022.0	-	RCV000208774|RCV001354831|RCV000798913	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardio-facio-cutaneous syndrome|not provided|RASopathy	germline;unknown	germline	GRCh38	NC_000007.14	7	140753336.0	140753336.0	7q34	reviewed by expert panel	4.0	-	Y	ClinGen:CA281998	3.0	40389.0	140753336.0	A	C	-	-	-	-	-	-	SCV001424737	-	-	1799T>G 	Val600Gly	NM_004333.6	3.0	1_Pathogenic		40389.0	7	140753336.0	A	C	V	G	rs113488022	7	140453136.0	7	140099605.0	600.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1799T>G	p.Val600Gly	c.1799T>G	p.Val600Gly	principal4	Y	.	YES	Select	-	GTG	2.0	0.0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.822	0.45782	P	0.963	0.70837	D	.	0.99291	.	.	.	.	1.53	0.38641	L	.	.	.	.	.	-0.373	0.72748	T	0.3689	0.72751	T	10.0	0.9087879	0.90136	D	0.179839	0.85412	D	.	0.98152	0.749	0.87927	P15056	V600G	Loss of stability (P = 0.0081)| Gain of disorder (P = 0.0094)| Gain of ubiquitination at K601 (P = 0.0582)| Gain of phosphorylation at S605 (P = 0.152)| Loss of sheet (P = 0.1907)	.	0.98536	.	0.95955	.	0.91438	0.836802065372	0.87585	D	0.854038	0.96676	D	0.414274	0.90651	D	0.357299	0.90535	D	0.995703637599945	0.87816	D	0.874613	0.58418	D	0.9755868	0.98734	0.95782745	0.98836	0.9773177	0.98880	0.9476951	0.98232	-15.5	0.96920	D	0.9773	0.94797	P	0.999897984516839	0.98645	0.99933314	0.99303	1	0.99985	.	.	.	.	.	.	5.376319	0.90129	31.0	0.9963799964354424	0.76475	0.917884	0.88572	D	0.535279311356242	0.69026	5.322119	0.606101544715016	0.75248	6.300693	5.65	5.65	0.86862	.	.	9.236	0.94487	11.216000	0.89597	0.75	0.87077	1.0	0.71675	1.0	0.68239	0.999	0.91597	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardio-facio-cutaneous_syndrome|RASopathy|Melanoma|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140753336A>C	ClinGen:CA281998|Genetic_Testing_Registry_(GTR):GTR000522729|Genetic_Testing_Registry_(GTR):GTR000569880	C1275081|C5555857|C0025202|C3661900	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Val	Gly	48859.0	single nucleotide variant	NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Jun 25, 2020	113488022.0	-	RCV000208774|RCV001354831|RCV000798913	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardio-facio-cutaneous syndrome|not provided|RASopathy	germline;unknown	germline	GRCh38	NC_000007.14	7	140753336.0	140753336.0	7q34	reviewed by expert panel	4.0	-	Y	ClinGen:CA281998	3.0	40389.0	140753336.0	A	C	-	-	-	-	-	-	SCV001424737	-	-	1799T>G 	Val600Gly	NM_004333.6	3.0	1_Pathogenic	49.51	0.0352112676056338		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		49.51	0.03521127	<10	<=50						V	5			49.51	Aliphatic	Valine		Serine/threonine-protein kinase B-raf							Protein kinase			4.2								V600-W604; PAE: 5.0	9 interactions	V600-E501, V600-W604; PAE: 7.5, 5.0	15 interactions							117									-61.3				-57.9				dbSNP: rs121913377; Variant type: US; AA change: Val600Asp; PTM type: Ubiquitylation; PTM morphology: GLAtV*ksRWsG; Var class: II&rs113488022		H (helix)	H (α-helix)	Turn																																																																			true	BRAFVal600Gly																																																																																																																																																																																																																																		
BRCA1	BRCA1_Ser408Ile	0.010557865224829883	0.9918707968983869	7.5905087590606035	0.0001272838197150418	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8662088968036574	0.6867958214260674	0.9071672459690385	0.8188740439168337	0.8329131727213925	0.9181762445456895	0.9086261201690247	0.9506161820158945	0.7015349709065566	0.9073856712001231	0.7476501008970957	0.7291219676646428	0.8637183099221826	0.6720566719455782	0.8250321224071917	BRCA1	0.010557865224829883	0.9918707968983869	7.5905087590606035	0.0001272838197150418	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8662088968036574	0.6867958214260674	0.9071672459690385	0.8188740439168337	0.8329131727213925	0.9181762445456895	0.9086261201690247	0.9506161820158945	0.7015349709065566	0.9073856712001231	0.7476501008970957	0.7291219676646428	0.8637183099221826	0.6720566719455782	0.8250321224071917	BRCA1		14613		CCSBVarC011797		NC_000017.11:43074471:C:A	1223G>T	Ser408Ile																												17.0	43074471.0	C	A	17						17-43074471-C-A	50265.0	single nucleotide variant	NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	1800744.0	-	RCV000034752|RCV000112356|RCV000048591|RCV000120258|RCV000162492|RCV004803118|RCV002490467	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0700268,MedGen:CN377757|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|BRCA1-related cancer predisposition|Familial cancer of breast;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1	germline;unknown	germline	GRCh38	NC_000017.11	17	43074471.0	43074471.0	17q21.31	reviewed by expert panel	40.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00016,ClinGen:CA002898,UniProtKB:P38398#VAR_007788	2.0	41826.0	43074471.0	C	A	-	-	-	-	-	-	SCV000244362	-	-	4535G>T 	Ser1512Ile	NM_007294.4	3.0	2_Benign		41826.0	17	43074471.0	C	A	S	I	rs1800744	17	41226488.0	17	38480014.0	1512.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.4535G>T	p.Ser1512Ile	principal2	Y	1	.	.	-	AGT	2.0	0.0	c	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	0.337	0.48353	B	0.133	0.44046	B	.	0.30097	.	.	.	.	1.895	0.50187	L	.	0.69035	.	.	0.51076	-0.12	0.79542	T	0.6215	0.8662	D	10.0	.	0.01326	.	0.681988	0.97361	D	.	0.79231	.	.	.	.	.	.	0.85105	.	0.41210	.	0.11066	0.293080568314	0.09368	T	0.248577	0.61629	T	-0.0795722	0.39433	T	0.113053	0.7761	D	0.0327816211501777	0.02419	T	0.844516	0.52040	T	0.08077421	0.18357	0.10349156	0.24785	0.12831177	0.29740	0.1181652	0.28456	-5.059	0.39100	T	.	0.43431	.	0.215013996355067	0.50654	0.99944790	0.99395	0.237	0.50624	.	.	.	.	.	.	2.346036	0.30125	18.32	0.9929848958011777	0.58603	0.255502	0.37258	N	-0.32701834229789	0.27846	1.548759	-0.413545015947272	0.24281	1.347945	4.95	3.98	0.4532	2.01	0.39759	3.214	0.50958	1.912000	0.29737	0.591	0.32125	0.012	0.18747	0.005	0.19288	0.122	0.19292	534	0.73376	3	5.990415335463259E-4	1	7.564296520423601E-4	1	9.940357852882703E-4	1	0.001440922190201729	0	0.0	0	0.0	637	264690	0.0024065888	.	244	109396	2.230430e-03	0	497	208108	2.388180e-03	1	554	236830	2.339230e-03	1	4	7164	5.583470e-04	0	37	17112	2.162230e-03	0	14	2320	6.034480e-03	0	0	9040	0.000000e+00	0	23	13390	1.717700e-03	0	154	42766	3.600990e-03	0	11	15690	7.010830e-04	0	154	42766	3.600990e-03	0	12	16218	7.399190e-04	0	58	30524	1.900140e-03	0	29	6210	4.669890e-03	0	0	13410	0.000000e+00	0	27	16730	1.613870e-03	0	348	89544	3.886360e-03	1	15	30608	4.900680e-04	0	348	89544	3.886360e-03	1	12	14902	8.052610e-04	0	59	34260	1.722120e-03	0	42	9568	4.389630e-03	0	0	17686	0.000000e+00	0	31	21628	1.433330e-03	0	387	102648	3.770170e-03	1	15	30526	4.913840e-04	0	387	102648	3.770170e-03	1	.	4969	1614128	3.078440e-03	17	164	29606	5.539420e-03	2	49	75028	6.530900e-04	1	0	912	0.000000e+00	0	87	60012	1.449710e-03	0	164	29606	5.539420e-03	2	0	44892	0.000000e+00	0	86	64022	1.343290e-03	1	12	6060	1.980200e-03	0	4340	1180008	3.677940e-03	10	61	91076	6.697700e-04	2	833	200638	0.004151755898683201	0	360	0	0	2756	0	12	9432	0.001272264631043257	1	796	0.001256281407035176	3	968	0.0030991735537190084	0	682	0	1	280	0.0035714285714285713	57	15836	0.0035993937863096743	12	9792	0.0012254901960784314	0	3438	0	907	231748	0.003913733883356059	Benign	Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43074471C>A	BRCA1-HCI:BRCA1_00016|ClinGen:CA002898|UniProtKB:P38398#VAR_007788	C0346153|C3280442|C2676676|C4554406|CN169374|C3661900|C0027672|C0677776	114480|614320|604370|617883	227535|1333|145|140162|145	.	Ser	Ile	50265.0	single nucleotide variant	NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	1800744.0	-	RCV000034752|RCV000112356|RCV000048591|RCV000120258|RCV000162492|RCV004803118|RCV002490467	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0700268,MedGen:CN377757|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|BRCA1-related cancer predisposition|Familial cancer of breast;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1	germline;unknown	germline	GRCh38	NC_000017.11	17	43074471.0	43074471.0	17q21.31	reviewed by expert panel	40.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00016,ClinGen:CA002898,UniProtKB:P38398#VAR_007788	2.0	41826.0	43074471.0	C	A	-	-	-	-	-	-	SCV000244362	-	-	4535G>T 	Ser1512Ile	NM_007294.4	3.0	2_Benign	32.51	0.823076923076923	['604370', '114480', '614320', '617883', '604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	32.51	0.8230769	10-90	<=50																																																																																																																																		true	BRCA1Ser408Ile																																																																																																																																																																																																																																		
BRAF	BRAF_Gln262Lys	-3.3290490377403623	0.012607505897050326	1.4713633473538252	0.18466553940209554	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6972719932281002	0.5457349485214346	0.7107894682221154	0.6448410583622923	0.6049659648839113	0.7673606758750543	0.7418021366726815	0.8146385969778781	0.656309645689469	0.7824119719135454	0.44257125389276825	0.5478799800519032	0.6069403394663526	0.4351602513534001	0.6121320145426549	BRAF	-3.3290490377403623	0.012607505897050326	1.4713633473538252	0.18466553940209554	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6972719932281002	0.5457349485214346	0.7107894682221154	0.6448410583622923	0.6049659648839113	0.7673606758750543	0.7418021366726815	0.8146385969778781	0.656309645689469	0.7824119719135454	0.44257125389276825	0.5478799800519032	0.6069403394663526	0.4351602513534001	0.6121320145426549	BRAF	ENSG00000157764	71969	220594.0	CCSBVarC003157	ALE00003157	NC_000007.14:140801488:G:T	784C>A	Gln262Lys	CEGS2	CegsMutGDEh1017	C07	GDEhDisVCh_40058	A06	2.0									1.0	2.0	0.0		0.0			0.0			0.0			7.0	140801488.0	G	T	7	Y	N	N	N	N	7-140801488-G-T	48822.0	single nucleotide variant	NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Nov 22, 2024	397507470.0	-	RCV000033290|RCV001193980	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140801488.0	140801488.0	7q34	criteria provided, multiple submitters, no conflicts	2.0	-	N	UniProtKB:P15056#VAR_065172,ClinGen:CA281957	2.0	40352.0	140801488.0	G	T	-	-	-	-	-	-	SCV000057195|SCV001363182	-	-	784C>A 	Gln262Lys	NM_004333.6	2.0	1_Pathogenic		40352.0	7	140801488.0	G	T	Q	K	rs397507470	7	140501288.0	7	140147757.0	262.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.784C>A	p.Gln262Lys	c.784C>A	p.Gln262Lys	principal4	Y	.	YES	Select	-	CAA	1.0	0.0	G	./.	./.	./.	./.	.	0.31974	.	.	0.25963	.	0.476	0.36683	P	0.145	0.33873	B	.	0.92786	.	.	.	.	0.335	0.10354	N	.	0.39882	.	.	0.92789	0.1437	0.84883	D	0.5754	0.84624	D	10.0	0.9098774	0.90245	D	0.119437	0.79914	D	.	0.88724	0.854	0.95408	P15056	Q262K	Gain of methylation at Q262 (P = 0.0013)| Gain of MoRF binding (P = 0.034)| Loss of sheet (P = 0.0457)| Gain of catalytic residue at Q262 (P = 0.0492)| Gain of helix (P = 0.0854)	.	0.99108	.	0.89159	.	0.83165	0.890452325344	0.95311	D	0.767013	0.93678	D	0.433189	0.91632	D	0.384469	0.91529	D	0.877448976039886	0.52474	D	0.972478	0.90100	D	0.7150027	0.78637	0.36088184	0.61282	0.69711965	0.77646	0.29162404	0.54973	-8.711	0.65895	D	0.9841	0.91998	P	0.999639817524742	0.97271	0.98278390	0.95809	0.783	0.87990	.	.	.	.	.	.	4.792683	0.77833	26.8	0.9952008416085809	0.692	0.875019	0.79748	D	0.229428578319334	0.52393	3.435949	0.399610595300935	0.61333	4.355617	5.21	5.21	0.71966	5.79	0.96129	9.943	0.9894	11.707000	0.94599	0.672	0.70176	1.0	0.71675	1.0	0.68239	0.996	0.76032	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140801488G>T	ClinGen:CA281957|UniProtKB:P15056#VAR_065172	CN517202|C5555857	.	536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Gln	Lys	48822.0	single nucleotide variant	NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Nov 22, 2024	397507470.0	-	RCV000033290|RCV001193980	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140801488.0	140801488.0	7q34	criteria provided, multiple submitters, no conflicts	2.0	-	N	UniProtKB:P15056#VAR_065172,ClinGen:CA281957	2.0	40352.0	140801488.0	G	T	-	-	-	-	-	-	SCV000057195|SCV001363182	-	-	784C>A 	Gln262Lys	NM_004333.6	2.0	1_Pathogenic	87.3	0.5707070707070707		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		87.3	0.5707071	10-90	70-90						Q	113			87.3	Polar/Neutral	Glutamine		Serine/threonine-protein kinase B-raf										-3.5								Q262-N236; PAE: 2.0	4 interactions	Q262-V238, Q262-N236; PAE: 3.0, 2.0	6 interactions							146									-64.0				-45.1						C (loop/coil)	T (turn)											Phorbol-ester/DAG-type																																																									true	BRAFGln262Lys																																																																																																																																																																																																																																		
BRCA1	BRCA1_Ser186Tyr	1.7603534804730556	0.12173945667616726	-2.567524632668086	0.03714171283359245	2025_01_Batch_13-14	true	true	true	true	true	false	true	false	false	true	0.9828098486558843	0.9679378757937998	0.9879302007534179	0.9679451238953509	0.9893417780662793	0.9895433550447515	0.9737788841307277	0.9891091271413341	0.9755578642730985	0.9879681792570353	0.9891402010878071	0.9621113636599743	0.9867512743655017	0.9603178873145011	0.9776515180547332	BRCA1	1.7603534804730556	0.12173945667616726	-2.567524632668086	0.03714171283359245	2025_01_Batch_13-14	true	true	true	true	true	false	true	false	false	true	0.9828098486558843	0.9679378757937998	0.9879302007534179	0.9679451238953509	0.9893417780662793	0.9895433550447515	0.9737788841307277	0.9891091271413341	0.9755578642730985	0.9879681792570353	0.9891402010878071	0.9621113636599743	0.9867512743655017	0.9603178873145011	0.9776515180547332	BRCA1		14613		CCSBVarC013090		NC_000017.11:43097280:G:T	557C>A	Ser186Tyr																												17.0	43097280.0	G	T	17						17-43097280-G-T	70302.0	single nucleotide variant	NM_007294.4(BRCA1):c.557C>A (p.Ser186Tyr)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	55688530.0	-	RCV000049057|RCV000077630|RCV000162532|RCV000120269|RCV000224107|RCV000470710|RCV001170826|RCV001353515	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN221562|MONDO:MONDO:0007254,MedGen:C0006142	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	43097280.0	43097280.0	17q21.31	reviewed by expert panel	35.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00057,ClinGen:CA003732,UniProtKB:P38398#VAR_070467	2.0	55635.0	43097280.0	G	T	-	-	-	-	-	-	SCV000244407	-	-	557C>A 	Ser186Tyr	NM_007294.4	3.0	2_Benign		55635.0	17	43097280.0	G	T	S	Y	rs55688530	17	41249297.0	17	38502823.0	186.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.557C>A	p.Ser186Tyr	principal2	Y	1	.	.	-	TCT	2.0	0.0	G	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.956	0.80453	D	.	0.23785	.	.	.	.	2.535	0.73728	M	.	0.76284	.	.	0.68711	0.9031	0.95704	D	0.9635	0.98828	D	10.0	.	0.00228	.	.	.	.	.	0.92474	.	.	.	.	.	.	0.96689	.	0.57312	.	0.47613	0.504873514175	0.39453	T	0.222563	0.58431	T	0.0490491	0.5793	T	0.304786	0.88335	D	0.0335924297408818	0.02552	T	0.962504	0.88031	D	0.47664887	0.65384	0.49632788	0.70615	0.4938498	0.66423	0.5691173	0.74804	-6.751	0.52305	T	.	0.70541	.	0.995660278977707	0.91503	0.99941337	0.99364	0.231	0.49947	.	.	.	.	.	.	5.082168	0.84844	28.4	0.9942526464897026	0.64033	0.805499	0.72908	D	0.703775773492025	0.79770	7.17216	0.670198265778078	0.80013	7.229281	4.96	4.96	0.65108	5.79	0.96129	4.066	0.57326	11.485000	0.92915	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.998	0.85369	473	0.77929	15	0.0029952076677316293	15	0.0113464447806354	0	0.0	0	0.0	0	0.0	0	0.0	820	264690	0.0030979638	.	81	109338	7.408220e-04	3	172	207834	8.275840e-04	3	160	236664	6.760640e-04	3	71	7158	9.918970e-03	3	8	17072	4.686040e-04	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	1	42756	2.338850e-05	0	0	15680	0.000000e+00	0	71	7158	9.918970e-03	3	153	16170	9.461970e-03	3	11	30478	3.609160e-04	0	0	6208	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	4	89398	4.474370e-05	0	0	30586	0.000000e+00	0	153	16170	9.461970e-03	3	142	14856	9.558430e-03	3	10	34210	2.923120e-04	0	0	9568	0.000000e+00	0	0	17688	0.000000e+00	0	0	21630	0.000000e+00	0	4	102608	3.898330e-05	0	0	30504	0.000000e+00	0	142	14856	9.558430e-03	3	.	790	1613484	4.896240e-04	5	685	75010	9.132120e-03	5	685	75010	9.132120e-03	5	0	912	0.000000e+00	0	44	60008	7.332360e-04	0	0	29596	0.000000e+00	0	0	44832	0.000000e+00	0	0	64006	0.000000e+00	0	3	6060	4.950500e-04	0	12	1179650	1.017250e-05	0	1	90940	1.099630e-05	0	11	173906	6.325256172875002E-5	0	352	0	0	2654	0	82	8428	0.009729473184622686	2	804	0.0024875621890547263	0	974	0	0	654	0	0	274	0	8	13470	5.939123979213066E-4	82	8780	0.009339407744874715	0	3308	0	103	201516	5.111256674407988E-4	Benign	Malignant_tumor_of_breast|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_and/or_ovarian_cancer|not_specified|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43097280G>T	BRCA1-HCI:BRCA1_00057|ClinGen:CA003732|UniProtKB:P38398#VAR_070467	C0006142|C0677776|C0027672|C0346153|C2676676|CN221562|CN169374|C3661900	114480|604370	145|140162|227535|145	.	Ser	Tyr	70302.0	single nucleotide variant	NM_007294.4(BRCA1):c.557C>A (p.Ser186Tyr)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	55688530.0	-	RCV000049057|RCV000077630|RCV000162532|RCV000120269|RCV000224107|RCV000470710|RCV001170826|RCV001353515	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN221562|MONDO:MONDO:0007254,MedGen:C0006142	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	43097280.0	43097280.0	17q21.31	reviewed by expert panel	35.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00057,ClinGen:CA003732,UniProtKB:P38398#VAR_070467	2.0	55635.0	43097280.0	G	T	-	-	-	-	-	-	SCV000244407	-	-	557C>A 	Ser186Tyr	NM_007294.4	3.0	2_Benign	30.71	0.7384615384615385	['604370', '114480']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER	30.71	0.73846155	10-90	<=50																																																																																																																																		true	BRCA1Ser186Tyr																																																																																																																																																																																																																																		
LMNA	LMNA_Arg41His	4.266345707886469	0.0037173824125443845	-7.249892521424595	0.00016994557101229237	2025_01_Batch_13-14	false	true	false	true	true	false	true	false	false	false	0.9587920410808479	0.931442027953997	0.9505900497922062	0.9502981417015307	0.9523520720664533	0.9685184608031402	0.9546879748106982	0.9287920510754318	0.9546152002699522	0.9518480534400747	0.9361856833297664	0.9459083085923632	0.9723880485089806	0.9082688556380418	0.965736028721621	LMNA	4.266345707886469	0.0037173824125443845	-7.249892521424595	0.00016994557101229237	2025_01_Batch_13-14	false	true	false	true	true	false	true	false	false	false	0.9587920410808479	0.931442027953997	0.9505900497922062	0.9502981417015307	0.9523520720664533	0.9685184608031402	0.9546879748106982	0.9287920510754318	0.9546152002699522	0.9518480534400747	0.9361856833297664	0.9459083085923632	0.9723880485089806	0.9082688556380418	0.965736028721621	LMNA		3903		CCSBVarC021100		NC_000001.11:156115040:G:A	122G>A	Arg41His																												1.0	156115040.0	G	A	1						1-156115040-G-A	390827.0	single nucleotide variant	NM_170707.4(LMNA):c.122G>A (p.Arg41His)	4000.0	LMNA	HGNC:6636	Pathogenic	1.0	Mar 14, 2023	1060502215.0	-	RCV000457713|RCV000994129	MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:C3661900	Charcot-Marie-Tooth disease type 2|not provided	germline	germline	GRCh38	NC_000001.11	1	156115040.0	156115040.0	1q22	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA16609885	2.0	408994.0	156115040.0	G	A	-	-	-	-	-	-	SCV000548863|SCV001147454	-	-	122G>A 	Arg41His	NM_170707.4	2.0	1_Pathogenic		408994.0	1	156115040.0	G	A	R	H	rs1060502215	1	156084831.0	1	154351455.0	41.0	LMNA	ENSG00000160789	ENST00000675939	ENSP00000502256	P02545	LMNA_HUMAN	.	.	c.122G>A	p.Arg41His	principal1	Y	.	.	.	+	CGC	2.0	0.0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	0.997	0.86259	D	.	0.99291	.	.	.	.	3.65	0.94095	H	.	0.76931	.	.	0.94442	1.0096	0.97344	D	0.8998	0.96669	D	10.0	.	0.95527	.	0.697456	0.97514	D	.	0.98921	0.839	0.94511	P02545	R41H	Loss of disorder (P = 0.0408)| Loss of MoRF binding (P = 0.0657)| Loss of stability (P = 0.0853)| Gain of catalytic residue at Y45 (P = 0.2364)| Gain of phosphorylation at Y45 (P = 0.3525)	.	0.98195	.	0.99019	.	0.96618	0.826536655426	0.86008	D	0.981432	0.99855	D	0.543151	0.95472	D	0.542423	0.95404	D	0.998799562454224	0.95146	D	.	0.60605	.	0.8277698	0.85561	0.67164475	0.80513	0.7031715	0.77980	0.6304929	0.78213	-11.691	0.83363	D	.	0.93873	.	0.999670505958946	0.97434	0.99995460	0.99953	0.989	0.99628	.	.	.	.	.	.	5.697397	0.93103	33.0	0.9993945085558718	0.99734	0.969077	0.99147	D	0.920677880494411	0.92694	11.59756	0.8501245464411	0.92984	11.77651	4.77	4.77	0.60376	5.21	0.92006	9.725	0.9802	11.667000	0.94064	0.59	0.31918	1.0	0.71675	1.0	0.68239	0.996	0.76032	420	0.81453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Charcot-Marie-Tooth_disease_type_2|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156115040G>A	ClinGen:CA16609885	C0270914|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	His	390827.0	single nucleotide variant	NM_170707.4(LMNA):c.122G>A (p.Arg41His)	4000.0	LMNA	HGNC:6636	Pathogenic	1.0	Mar 14, 2023	1060502215.0	-	RCV000457713|RCV000994129	MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:C3661900	Charcot-Marie-Tooth disease type 2|not provided	germline	germline	GRCh38	NC_000001.11	1	156115040.0	156115040.0	1q22	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA16609885	2.0	408994.0	156115040.0	G	A	-	-	-	-	-	-	SCV000548863|SCV001147454	-	-	122G>A 	Arg41His	NM_170707.4	2.0	1_Pathogenic	87.29	0.6895161290322581		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		87.29	0.6895161	10-90	70-90						R	171			87.29	Positively-charged	Arginine		Prelamin-A/C; Lamin-A/C							IF rod			-4.5								R41-Y45, R41-E37; PAE: 3.5, 5.5	2 interactions	R41-Y45, R41-E37; PAE: 3.5, 5.5	2 interactions		1 interaction			Morphology: DLQELNDrLAVyIDr; Domain: Filament		175		Mutation: R -> H. Impaired lamin assembly.							-62.3				-40.5	Interaction with MLIP; Coil 1A					H (helix)	H (α-helix)	Helix																																																																			true	LMNAArg41His																																																																																																																																																																																																																																		
RPS19	RPS19_Gly127Glu	-7.707857851852217	0.0001154978914415701	-7.085159878747123	0.00019620691459792407	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9520589090724295	0.7276376042499257	0.9029931831874323	0.8573315849872112	0.7590104721728489	0.7881639125929127	0.8742458682336376	0.9121475347492455	0.719791289438861	0.9556596922239629	0.729857031752785	0.8404173017407848	0.8938388316256192	0.7354839190609905	0.9484581259208962	RPS19	-7.707857851852217	0.0001154978914415701	-7.085159878747123	0.00019620691459792407	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9520589090724295	0.7276376042499257	0.9029931831874323	0.8573315849872112	0.7590104721728489	0.7881639125929127	0.8742458682336376	0.9121475347492455	0.719791289438861	0.9556596922239629	0.729857031752785	0.8404173017407848	0.8938388316256192	0.7354839190609905	0.9484581259208962	RPS19	ENSG00000105372	3441	6078.0	CCSBVarC000469	ALE00000469	NC_000019.10:41869722:G:A	380G>A	Gly127Glu	RC4	RC4_Mut_GDEh1010	H11	GDEhDisVCh_40042	E02	2.0	RC4_Mut_GDDh1010	H11							1.0	2.0	1.0	1.0	0.0			0.0			0.0			19.0	41869722.0	G	A	19	Y	Y	N	N	N	19-41869722-G-A	21359.0	single nucleotide variant	NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	6223.0	RPS19	HGNC:10402	Likely pathogenic	1.0	Jan 12, 2022	786200936.0	-	RCV000033189|RCV002512845	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124	Diamond-Blackfan anemia 1|Diamond-Blackfan anemia	germline	germline	GRCh38	NC_000019.10	19	41869722.0	41869722.0	19q13.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA130769,UniProtKB:P39019#VAR_055444,OMIM:603474.0008	3.0	6320.0	41869722.0	G	A	-	-	-	-	-	-	SCV003443917	-	-	380G>A 	Gly127Glu	NM_001022.4	1.0	1_Pathogenic		6320.0	19	41869722.0	G	A	G	E	rs786200936	19	42373792.0	19	47065632.0	127.0	RPS19	ENSG00000105372	ENST00000593863	ENSP00000470004	P39019	RS19_HUMAN	c.380G>A	p.Gly127Glu	c.380G>A	p.Gly127Glu	principal1	Y	3	.	.	+	GGA	2.0	0.0	G	./.	./.	./.	./.	.	.	.	0.034	0.53076	D	0.988	0.62341	D	0.996	0.84488	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.73	0.79671	M	.	.	.	0.985	0.99419	0.2563	0.86794	D	0.5614	0.83981	D	9.0	0.9862165	0.98908	D	0.407513	0.93515	D	.	0.91208	0.984	0.99843	P39019	G127E	Loss of MoRF binding (P = 0.0171)| Gain of relative solvent accessibility (P = 0.09)| Gain of solvent accessibility (P = 0.0971)| Gain of methylation at K122 (P = 0.1056)| Gain of sheet (P = 0.1451)	0.972294440432	0.97173	.	0.99657	.	0.96144	0.76795142889	0.77078	T	0.98826	0.99938	D	0.558625	0.96031	D	0.56465	0.95968	D	0.991606083214429	0.8178	D	0.847515	0.52781	T	0.97176737	0.98397	0.93296444	0.97258	0.9559469	0.96820	0.9024854	0.95086	-13.608	0.91730	D	0.9981	0.97478	P	0.999816468006815	0.98120	0.99993120	0.99924	0.683	0.82402	.	.	.	.	.	.	4.995052	0.82873	27.9	0.9980988294530321	0.89361	0.952808	0.96846	D	0.931537152194926	0.93180	11.89543	0.874714639492237	0.94342	12.711	5.24	5.24	0.72825	.	.	8.506	0.90371	11.829000	0.97469	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	747	0.52199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Diamond-Blackfan_anemia|Diamond-Blackfan_anemia_1	criteria_provided,_single_submitter	NC_000019.10:g.41869722G>A	ClinGen:CA130769|OMIM:603474.0008|UniProtKB:P39019#VAR_055444	C1260899|C2676137	PS105650|105650	124|124	.	Gly	Glu	21359.0	single nucleotide variant	NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	6223.0	RPS19	HGNC:10402	Likely pathogenic	1.0	Jan 12, 2022	786200936.0	-	RCV000033189|RCV002512845	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124	Diamond-Blackfan anemia 1|Diamond-Blackfan anemia	germline	germline	GRCh38	NC_000019.10	19	41869722.0	41869722.0	19q13.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA130769,UniProtKB:P39019#VAR_055444,OMIM:603474.0008	3.0	6320.0	41869722.0	G	A	-	-	-	-	-	-	SCV003443917	-	-	380G>A 	Gly127Glu	NM_001022.4	1.0	1_Pathogenic	93.5	0.0	['105650']	autosomal dominant	Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare inborn errors of metabolism; Inherited cancer-predisposing syndrome	4	DIAMOND-BLACKFAN ANEMIA 1	93.5	0.0	<10	>90						G	0			93.5	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Small ribosomal subunit protein eS19										-0.4								G127-L131; PAE: 1.0	30 interactions	G127-L131; PAE: 1.0	36 interactions							75									-61.0				-38.3				dbSNP: rs786200936; Variant type: LP/P; AA change: Gly127Glu; PTM type: Ubiquitylation; PTM morphology: QDGGRkLTPQG*; Var class: II		H (helix)	H (α-helix)	Helix																																																																			true	RPS19Gly127Glu																																																																																																																																																																																																																																		
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14	true	true	false	true	false	true	false	false	false	false	0.9805115281620245	0.8480305496058552	0.9315337174178693	0.8876100772023314	0.8173212006324524						0.8173212006324524	0.8876100772023314	0.9315337174178693	0.8480305496058552	0.9805115281620245	F9	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14	true	true	false	true	false	true	false	false	false	false	0.9805115281620245	0.8480305496058552	0.9315337174178693	0.8876100772023314	0.8173212006324524						0.8173212006324524	0.8876100772023314	0.9315337174178693	0.8480305496058552	0.9805115281620245	F9	ENSG00000101981	52861	204374.0	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561683.0	C	T	X	Y	N	N	N	N	X-139561683-C-T	25644.0	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852252.0	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683.0	139561683.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255375,OMIM:300746.0048	1.0	10605.0	139561683.0	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic		10605.0	X	139561683.0	C	T	P	L	rs137852252	X	138643842.0	X	138471508.0	333.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2.0	0.0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10.0	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.9971417962265576	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.0	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644.0	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852252.0	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683.0	139561683.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255375,OMIM:300746.0048	1.0	10605.0	139561683.0	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic	97.66	0.0955882352941176	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	97.66	0.09558824	<10	>90						P	13			97.66	Special, No backbone hydrogen	Proline		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1	0.2107		1.6			3 interactions	4 interactions				P333-G179; PAE: 1.0			2 interactions							115									-65.3		Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21		154.6						H (helix)	P (polyproline helix)																														0.386		0.287		0.258		0.243		0.258																														true	F9Pro333Leu																																																																																																																																																																																																																																		
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6683442677384381	0.6261733198648576	0.619947665630282	0.5908532878752486	0.6010777900851507	0.6391945424146872	0.5747914264922237	0.5799290743206506	0.6540329307427528	0.636436573822579	0.5629610377556141	0.6069151492582734	0.6599662569399136	0.5983137089869622	0.7002519616542973	F9	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6683442677384381	0.6261733198648576	0.619947665630282	0.5908532878752486	0.6010777900851507	0.6391945424146872	0.5747914264922237	0.5799290743206506	0.6540329307427528	0.636436573822579	0.5629610377556141	0.6069151492582734	0.6599662569399136	0.5983137089869622	0.7002519616542973	F9	ENSG00000101981	52861	204369.0	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561836.0	G	T	X	Y	N	N	N	N	X-139561836-G-T	25707.0	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 22, 2009	137852283.0	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836.0	139561836.0	Xq27.1	no assertion criteria provided	2.0	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1.0	10668.0	139561836.0	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic		10668.0	X	139561836.0	G	T	R	L	rs137852283	X	138643995.0	X	138471661.0	384.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10.0	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.996304792956376	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.3282	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.0	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707.0	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 22, 2009	137852283.0	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836.0	139561836.0	Xq27.1	no assertion criteria provided	2.0	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1.0	10668.0	139561836.0	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic	94.23	0.7620967741935484	['306900', '300807']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	94.23	0.76209676	10-90	>90						R	189			94.23	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-4.5			3 interactions	4 interactions				R384-A380; PAE: 1.0	3 interactions	R384-A380; PAE: 1.0	3 interactions							175									-78.1				-25.4				dbSNP: rs137852283; Variant type: LP/P; AA change: Arg384Leu; PTM type: Phosphorylation; PTM morphology: LVDRAtCLR*ST; Var class: II		H (helix)	H (α-helix)	Helix																													1.099		0.946		0.91	1 mutation(s) (Arg384Asn: 1.152)	0.889	1 mutation(s) (Arg384Asn: 1.142)	0.889																														true	F9Arg384Leu																																																																																																																																																																																																																																		
G6PD	G6PD_Arg365His	-0.12537883577312148	0.9037485339254261	-0.030512229050507184	0.9765102707417327	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5900615366817313	0.5082065784957188	0.6067100541291025	0.6226706890461056	0.5251393732095171	0.5453099664505856	0.740656644322949	0.6880198318154094	0.49923219256387213	0.6136202157862378	0.5049687799684487	0.504684733769262	0.5254002764427956	0.5171809644275656	0.5665028575772248	G6PD	-0.12537883577312148	0.9037485339254261	-0.030512229050507184	0.9765102707417327	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5900615366817313	0.5082065784957188	0.6067100541291025	0.6226706890461056	0.5251393732095171	0.5453099664505856	0.740656644322949	0.6880198318154094	0.49923219256387213	0.6136202157862378	0.5049687799684487	0.504684733769262	0.5254002764427956	0.5171809644275656	0.5665028575772248	G6PD		4006		CCSBVarC021512		NC_000023.11:154532760:C:T	1094G>A	Arg365His																												23.0	154532760.0	C	T	X						X-154532760-C-T	1780128.0	single nucleotide variant	NM_001360016.2(G6PD):c.1094G>A (p.Arg365His)	2539.0	G6PD	HGNC:4057	Likely pathogenic	1.0	Aug 12, 2022	-1.0	-	RCV002305722	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	unknown	unknown	GRCh38	NC_000023.11	X	154532760.0	154532760.0	Xq28	criteria provided, single submitter	1.0	-	N	ClinGen:CA10566079	2.0	1722612.0	154532760.0	C	T	-	-	-	-	-	-	SCV002599266	-	-	1094G>A 	Arg365His	NM_001360016.2	1.0	1_Pathogenic		1722612.0	X	154532760.0	C	T	R	H	rs781967767	X	153760975.0	X	153414169.0	365.0	G6PD	ENSG00000160211	ENST00000393562	ENSP00000377192	P11413	G6PD_HUMAN	c.1094G>A	p.Arg365His	c.1094G>A	p.Arg365His	principal4	Y	1	YES	Select	-	CGC	2.0	0.0	C	C/C	C/C	C/C	C/C	.	0.48345	.	.	0.52739	.	0.535	0.37823	P	0.12	0.32232	B	0.87	0.91311	D	simple_aae	13.0	87.0	3.26	0.89820	M	.	0.75883	.	.	0.68273	1.0246	0.97612	D	0.9807	0.99405	D	10.0	0.8802651	0.87196	D	0.613028	0.96622	D	0.798	0.93363	0.603	0.73365	P11413	R365H	Loss of solvent accessibility (P = 0.0364)| Loss of stability (P = 0.0369)| Gain of ubiquitination at K360 (P = 0.0542)| Loss of MoRF binding (P = 0.0803)| Loss of methylation at K360 (P = 0.1029)	0.998371958706	0.99832	.	.	1.20514760124	0.80587	0.833622932434	0.87096	D	0.967016	0.99611	D	0.594247	0.97356	D	0.615818	0.97313	D	0.961354553699493	0.65842	D	.	0.95367	.	0.8231586	0.85244	0.6705637	0.80452	0.8231586	0.85245	0.6705637	0.80453	-9.6	0.75018	D	0.5174	0.69466	A	0.997402931741911	0.93099	0.99792010	0.98559	0.947	0.97555	.	.	.	.	.	.	3.345784	0.46204	22.2	0.9980608522849609	0.89004	.	.	.	.	.	.	.	.	.	5.73	4.87	0.6283	.	.	5.68	0.67905	3.272000	0.37248	0.535	0.24985	1.0	0.71675	1.0	0.68239	0.906	0.44196	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210393	8.261780e-07	0	1	45926	2.177420e-05	0	0	57896	0.000000e+00	0	0	686	0.000000e+00	0	1	45926	2.177420e-05	0	0	22013	0.000000e+00	0	0	33766	0.000000e+00	0	0	46693	0.000000e+00	0	0	4352	0.000000e+00	0	0	894734	0.000000e+00	0	0	56740	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_pathogenic	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_single_submitter	NC_000023.11:g.154532760C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Arg	His	1780128.0	single nucleotide variant	NM_001360016.2(G6PD):c.1094G>A (p.Arg365His)	2539.0	G6PD	HGNC:4057	Likely pathogenic	1.0	Aug 12, 2022	-1.0	-	RCV002305722	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	unknown	unknown	GRCh38	NC_000023.11	X	154532760.0	154532760.0	Xq28	criteria provided, single submitter	1.0	-	N	ClinGen:CA10566079	2.0	1722612.0	154532760.0	C	T	-	-	-	-	-	-	SCV002599266	-	-	1094G>A 	Arg365His	NM_001360016.2	1.0	1_Pathogenic	98.02	0.4233870967741935	['300908']	unknown	Rare genetic hematologic disease	1	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1	98.02	0.4233871	10-90	>90						R	105			98.02	Positively-charged	Arginine	D-glucose 6-phosphate	Glucose-6-phosphate 1-dehydrogenase										-4.5								R365-Q395; PAE: 1.5	5 interactions	R365-Q395, R365-P240; PAE: 1.5, 1.0	17 interactions							175									-85.1				117.7						C (loop/coil)	C (loop/coil)																																																																				true	G6PDArg365His																																																																																																																																																																																																																																		
BRCA1	BRCA1_Cys39Arg	0.8472010433103342	0.4248979667525149	4.1294175576416	0.004407203445207837	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.9155526399071886	0.8604439001541024	0.9493444048699451	0.9153952221216088	0.9382891850375588	0.9113364851976637	0.9137217340058423	0.9371120204690024	0.7799000081227152	0.9073086621204074	0.9652418848774538	0.9170687102373754	0.9615767892708877	0.9409877921854897	0.9237966176939698	BRCA1	0.8472010433103342	0.4248979667525149	4.1294175576416	0.004407203445207837	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.9155526399071886	0.8604439001541024	0.9493444048699451	0.9153952221216088	0.9382891850375588	0.9113364851976637	0.9137217340058423	0.9371120204690024	0.7799000081227152	0.9073086621204074	0.9652418848774538	0.9170687102373754	0.9615767892708877	0.9409877921854897	0.9237966176939698	BRCA1		14613		CCSBVarC011862		NC_000017.11:43115745:A:G	115T>C	Cys39Arg																												17.0	43115745.0	A	G	17						17-43115745-A-G	68819.0	single nucleotide variant	NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357164.0	-	RCV000077483|RCV000496824|RCV000570028|RCV000985365|RCV001270963	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115745.0	43115745.0	17q21.31	reviewed by expert panel	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00113,ClinGen:CA000766	2.0	54152.0	43115745.0	A	G	-	-	-	-	-	-	SCV000244296	-	-	115T>C 	Cys39Arg	NM_007294.4	3.0	1_Pathogenic		54152.0	17	43115745.0	A	G	C	R	rs80357164	17	41267762.0	17	38521288.0	39.0	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.115T>C	p.Cys39Arg	principal2	Y	.	.	.	-	TGT	1.0	0.0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	0.987	0.90580	D	0.879	0.92348	P	.	0.99291	.	.	.	.	4.355	0.98454	H	.	0.99400	.	.	0.97441	0.9518	0.9641	D	0.9931	0.99838	D	10.0	.	0.99503	.	0.908305	0.99312	D	.	0.98488	0.996	0.99957	E9PFC7	C39R	Gain of catalytic residue at C39 (P = 0.0465)| Gain of phosphorylation at T37 (P = 0.077)| Gain of helix (P = 0.132)| Gain of MoRF binding (P = 0.136)| Gain of glycosylation at T37 (P = 0.1377)	.	0.99932	.	0.93989	.	0.50598	0.773955702782	0.77978	T	0.409909	0.93004	T	0.564887	0.96297	D	0.573645	0.96237	D	0.998840510845184	0.95303	D	.	0.97903	.	0.98947704	0.99732	0.93276787	0.97245	0.97528833	0.98709	0.93651694	0.97501	-13.367	0.98539	D	.	0.97565	.	0.999949474096148	0.99079	0.99980813	0.99752	0.992	0.99727	.	.	.	.	.	.	4.933548	0.81398	27.5	0.9970537757485916	0.80955	0.797421	0.72325	D	0.971278320987367	0.94761	13.04323	0.87581144299615	0.94398	12.75438	5.97	5.97	0.96929	3.64	0.66725	4.109	0.57651	11.102000	0.86162	0.756	0.943	1.0	0.71675	1.0	0.68239	0.998	0.85369	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613730	6.196820e-07	0	1	1179810	8.475940e-07	0	0	75044	0.000000e+00	0	0	910	0.000000e+00	0	0	59942	0.000000e+00	0	0	29584	0.000000e+00	0	0	44862	0.000000e+00	0	0	64014	0.000000e+00	0	0	6060	0.000000e+00	0	1	1179810	8.475940e-07	0	0	91016	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43115745A>G	BRCA1-HCI:BRCA1_00113|ClinGen:CA000766	C0677776|CN221562|C3661900|C2676676|C0027672	604370	145|145|140162	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Arg	68819.0	single nucleotide variant	NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357164.0	-	RCV000077483|RCV000496824|RCV000570028|RCV000985365|RCV001270963	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115745.0	43115745.0	17q21.31	reviewed by expert panel	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00113,ClinGen:CA000766	2.0	54152.0	43115745.0	A	G	-	-	-	-	-	-	SCV000244296	-	-	115T>C 	Cys39Arg	NM_007294.4	3.0	1_Pathogenic	88.54	0.1555555555555555	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	88.54	0.15555556	10-90	70-90																																																																																																																																		true	BRCA1Cys39Arg																																																																																																																																																																																																																																		
BAP1	BAP1_Leu49Pro	1.5336173628501408	0.16899235826402517	-3.5941090630658135	0.008808725066084462	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7222208857040313	0.6111780046475856	0.7291998362801497	0.6911568239760859	0.6320914535653628	0.6714650514021713	0.7249915388752513	0.7357994038965971	0.6612148620052707	0.7211160899220241	0.5927178557285544	0.6573221090769205	0.7226002686637022	0.5611411472899007	0.7233256814860385	BAP1	1.5336173628501408	0.16899235826402517	-3.5941090630658135	0.008808725066084462	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7222208857040313	0.6111780046475856	0.7291998362801497	0.6911568239760859	0.6320914535653628	0.6714650514021713	0.7249915388752513	0.7357994038965971	0.6612148620052707	0.7211160899220241	0.5927178557285544	0.6573221090769205	0.7226002686637022	0.5611411472899007	0.7233256814860385	BAP1		3760		CCSBVarC009492		NC_000003.12:52408583:A:G	146T>C	Leu49Pro																												3.0	52408583.0	A	G	3						3-52408583-A-G	1162266.0	single nucleotide variant	NM_004656.4(BAP1):c.146T>C (p.Leu49Pro)	8314.0	BAP1	HGNC:950	Likely pathogenic	1.0	Sep 28, 2022	2153228340.0	-	RCV001797185|RCV003161062	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	Neurodevelopmental disorder|not provided	de novo;germline	germline	GRCh38	NC_000003.12	3	52408583.0	52408583.0	3p21.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA353113658	2.0	1173079.0	52408583.0	A	G	-	-	-	-	-	-	SCV003915265	-	-	146T>C 	Leu49Pro	NM_004656.4	1.0	1_Pathogenic		1173079.0	3	52408583.0	A	G	L	P	rs2153228340	3	52442599.0	3	52417639.0	49.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.146T>C	p.Leu49Pro	c.146T>C	p.Leu49Pro	principal1	Y	1	YES	Select	-	CTG	2.0	0.0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.14	0.97479	H	-6.34	0.91806	D	0.964	0.97441	0.4731	0.90127	D	0.5835	0.84984	D	10.0	0.9803013	0.97974	D	0.465198	0.94573	D	0.830	0.94600	0.911	0.98220	Q92560	L49P	Loss of stability (P = 0.0111)| Gain of sheet (P = 0.0477)| Loss of MoRF binding (P = 0.0633)| Gain of disorder (P = 0.1336)| Gain of glycosylation at Y44 (P = 0.1882)	0.919171306595	0.91774	0.9942708640742988	0.99423	3.28525368344	0.99563	0.917951464653	0.98162	D	0.61312	0.87653	D	0.399268	0.89798	D	0.335745	0.89671	D	0.999857425689697	0.99358	D	0.998712	0.99310	D	0.98750603	0.99618	0.97671837	0.99717	0.98750603	0.99618	0.97671837	0.99718	-17.779	0.99425	D	0.9998	0.99584	P	0.999944798679913	0.99079	0.99983054	0.99778	0.979	0.99252	.	.	.	.	.	.	5.605936	0.92502	32.0	0.9990087100266127	0.97276	0.961659	0.98292	D	1.02132438138349	0.96342	14.6051	0.93110546969636	0.96774	15.15042	5.43	5.43	0.78977	3.34	0.60572	9.279	0.94993	9.358000	0.80383	0.756	0.943	1.0	0.71675	1.0	0.68239	0.995	0.73271	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Neurodevelopmental_disorder|not_provided	criteria_provided,_single_submitter	NC_000003.12:g.52408583A>G	.	C1535926|C3661900	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Leu	Pro	1162266.0	single nucleotide variant	NM_004656.4(BAP1):c.146T>C (p.Leu49Pro)	8314.0	BAP1	HGNC:950	Likely pathogenic	1.0	Sep 28, 2022	2153228340.0	-	RCV001797185|RCV003161062	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	Neurodevelopmental disorder|not provided	de novo;germline	germline	GRCh38	NC_000003.12	3	52408583.0	52408583.0	3p21.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA353113658	2.0	1173079.0	52408583.0	A	G	-	-	-	-	-	-	SCV003915265	-	-	146T>C 	Leu49Pro	NM_004656.4	1.0	1_Pathogenic	92.13	0.073170731707317		unknown		0		92.13	0.07317073	<10	>90						L	12			92.13	Aliphatic	Leucine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			3.8								L49-N229; PAE: 1.5	1 interaction	L49-H169, L49-N229; PAE: 1.0, 1.5	6 interactions							131									-103.1				135.5						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	BAP1Leu49Pro																																																																																																																																																																																																																																		
BRCA1	BRCA1_Leu460Pro	1.3818159885120436	0.20951653672145118	0.01042038511580422	0.9919766475766167	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.8942335872256117	0.8725905289556398	0.9204171059519322	0.899240978566131	0.9418724442311313	0.9059796392194736	0.8746551314367813	0.8649401026154384	0.8901004495246302	0.8376263836210487	0.9777652492427891	0.9238268256954807	0.975894109288426	0.8550806083866495	0.9508407908301749	BRCA1	1.3818159885120436	0.20951653672145118	0.01042038511580422	0.9919766475766167	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.8942335872256117	0.8725905289556398	0.9204171059519322	0.899240978566131	0.9418724442311313	0.9059796392194736	0.8746551314367813	0.8649401026154384	0.8901004495246302	0.8376263836210487	0.9777652492427891	0.9238268256954807	0.975894109288426	0.8550806083866495	0.9508407908301749	BRCA1		14613		CCSBVarC013122		NC_000017.11:43071223:A:G	1379T>C	Leu460Pro																												17.0	43071223.0	A	G	17						17-43071223-A-G	69929.0	single nucleotide variant	NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	56119278.0	-	RCV000112385|RCV000148377|RCV000120262|RCV000162687|RCV000587835|RCV001082228|RCV002483063|RCV004804006|RCV004758629	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43071223.0	43071223.0	17q21.31	reviewed by expert panel	19.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00023,ClinGen:CA002980	2.0	55262.0	43071223.0	A	G	-	-	-	-	-	-	SCV000244368	-	-	4691T>C 	Leu1564Pro	NM_007294.4	3.0	2_Benign		55262.0	17	43071223.0	A	G	L	P	rs56119278	17	41223240.0	17	38476766.0	1564.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4691T>C	p.Leu1564Pro	c.4691T>C	p.Leu1564Pro	principal2	Y	1	YES	Select	-	CTG	2.0	0.0	A	A/A	A/A	A/A	A/A	0.167	0.45915	T	0.241	0.38212	T	0.828	0.46036	P	0.221	0.37838	B	0.22	0.57141	N	simple_aae	78.0	22.0	1.935	0.51654	L	-1.07	0.60859	N	0.501	0.60290	-0.1563	0.78666	T	0.671	0.8856	D	10.0	0.047209352	0.04012	T	0.323959	0.91538	D	0.554	0.81507	.	.	.	.	.	0.776336265085	0.77250	.	0.35316	.	0.15464	0.41346591711	0.26905	T	0.151297	0.48845	T	0.0819011	0.61994	D	0.339011	0.89807	D	0.0181525713158331	0.00535	T	.	0.39375	.	0.15756732	0.35205	0.12383379	0.29781	0.0936192	0.21792	0.106218696	0.25497	-3.859	0.21903	T	0.1809	0.54067	B	0.77319198328768	0.69688	0.99947375	0.99411	0.651	0.80578	.	.	.	.	.	.	2.053966	0.26159	17.0	0.9705037119163367	0.32337	0.297615	0.40519	N	-0.391511225925735	0.25494	1.401419	-0.372425254023125	0.25504	1.422447	4.78	3.71	0.41665	3.93	0.74723	1.355	0.33777	1.823000	0.29140	0.756	0.943	0.825	0.30151	0.0	0.08389	0.036	0.13876	543	0.72771	6	0.0011980830670926517	6	0.0045385779122541605	0	0.0	0	0.0	0	0.0	0	0.0	184	264690	6.9515285E-4	.	12	109386	1.097030e-04	0	41	207618	1.974780e-04	0	37	236280	1.565940e-04	0	11	7162	1.535880e-03	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9034	0.000000e+00	0	0	13392	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	11	7162	1.535880e-03	0	38	16132	2.355570e-03	0	2	30520	6.553080e-05	0	0	6210	0.000000e+00	0	0	13404	0.000000e+00	0	0	16732	0.000000e+00	0	0	89154	0.000000e+00	0	0	30608	0.000000e+00	0	38	16132	2.355570e-03	0	35	14818	2.361990e-03	0	2	34254	5.838730e-05	0	0	9562	0.000000e+00	0	0	17680	0.000000e+00	0	0	21630	0.000000e+00	0	0	102206	0.000000e+00	0	0	30526	0.000000e+00	0	35	14818	2.361990e-03	0	.	168	1614174	1.040780e-04	1	161	75050	2.145240e-03	1	161	75050	2.145240e-03	1	0	912	0.000000e+00	0	2	60026	3.331890e-05	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64030	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180006	0.000000e+00	0	0	91088	0.000000e+00	0	0	173958	0	0	352	0	0	2686	0	18	8832	0.0020380434782608695	0	796	0	0	968	0	0	652	0	0	280	0	1	13314	7.51089079164789E-5	18	9184	0.00195993031358885	0	3338	0	19	201838	9.41349002665504E-5	Benign	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast_neoplasm|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43071223A>G	BRCA1-HCI:BRCA1_00023|ClinGen:CA002980	C3661900|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672|C1458155|CN169374	114480|617883|604370|614320	145|227535|145|1333|140162	.	Leu	Pro	69929.0	single nucleotide variant	NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	56119278.0	-	RCV000112385|RCV000148377|RCV000120262|RCV000162687|RCV000587835|RCV001082228|RCV002483063|RCV004804006|RCV004758629	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43071223.0	43071223.0	17q21.31	reviewed by expert panel	19.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00023,ClinGen:CA002980	2.0	55262.0	43071223.0	A	G	-	-	-	-	-	-	SCV000244368	-	-	4691T>C 	Leu1564Pro	NM_007294.4	3.0	2_Benign	28.7	0.7560975609756098	['604370', '114480', '617883', '614320', '604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	28.7	0.75609756	10-90	<=50																																																																																																																																		true	BRCA1Leu460Pro																																																																																																																																																																																																																																		
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7076680509478896	0.6510927629002327	0.8170921334305392	0.7204449809635733	0.7585779227588121	0.8826315476452683	0.7436241295810764	0.87815365726247	0.7278939020798749	0.7550144892876768	0.6345242978723558	0.6972658323460702	0.7560306095986086	0.5742916237205904	0.6603216126081026	F9	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7076680509478896	0.6510927629002327	0.8170921334305392	0.7204449809635733	0.7585779227588121	0.8826315476452683	0.7436241295810764	0.87815365726247	0.7278939020798749	0.7550144892876768	0.6345242978723558	0.6972658323460702	0.7560306095986086	0.5742916237205904	0.6603216126081026	F9	ENSG00000101981	52861	204357.0	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139541126.0	G	A	X	Y	N	N	N	N	X-139541126-G-A	25682.0	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852274.0	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126.0	139541126.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1.0	10643.0	139541126.0	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic		10643.0	X	139541126.0	G	A	D	N	rs137852274	X	138623285.0	X	138450951.0	110.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1.0	0.0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10.0	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.9992716494601128	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682.0	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852274.0	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126.0	139541126.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1.0	10643.0	139541126.0	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic	87.17	0.1840490797546012	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	87.17	0.18404908	10-90	70-90						D	30			87.17	Negatively-charged	Aspartic Acid	Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 1; calcium-binding			-3.5			5 interactions	3 interactions				D110-Q96; PAE: 2.0	5 interactions	D110-C97; PAE: 1.5	5 interactions						(3R)-3-hydroxyaspartate	132									-72.1				143.4				dbSNP: rs137852274; Variant type: LP/P; AA change: Asp110Asn; PTM type: Phosphorylation; PTM morphology: KD*DINsYECWC; Var class: II		B (undefined)	E (parallel sheets)	Beta strand																													1.153	2 mutation(s) (Asp110Gly: 1.356, Asp110Lys: 1.359)	1.078	7 mutation(s) (Asp110Thr: 1.169, Asp110Ala: 1.172, Asp110Pro: 1.179, Asp110His: 1.180, Asp110Gln: 1.192, Asp110Gly: 1.196, Asp110Lys: 1.206)	0.924	1 mutation(s) (Asp110Ser: 1.135)	0.967		0.706																														true	F9Asp110Asn																																																																																																																																																																																																																																		
BAP1	BAP1_Cys91Gly	1.5164097053786887	0.17319848524644227	-4.617978065799683	0.0024319418319997716	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8076873469516388	0.5828880059430546	0.8454611638691085	0.7668928641651982	0.6961569410000803	0.5863642072617119	0.7187541665516547	0.795822950306513	0.6109290087208261	0.8351907724968624	0.8059496747384488	0.8150315617787417	0.8950993774317042	0.5548470031652829	0.7801839214064152	BAP1	1.5164097053786887	0.17319848524644227	-4.617978065799683	0.0024319418319997716	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8076873469516388	0.5828880059430546	0.8454611638691085	0.7668928641651982	0.6961569410000803	0.5863642072617119	0.7187541665516547	0.795822950306513	0.6109290087208261	0.8351907724968624	0.8059496747384488	0.8150315617787417	0.8950993774317042	0.5548470031652829	0.7801839214064152	BAP1		3760		CCSBVarC009482		NC_000003.12:52408062:A:C	271T>G	Cys91Gly																												3.0	52408062.0	A	C	3						3-52408062-A-C	1162264.0	single nucleotide variant	NM_004656.4(BAP1):c.271T>G (p.Cys91Gly)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Sep 14, 2021	1705222655.0	-	RCV001797188|RCV002424967	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52408062.0	52408062.0	3p21.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA353112613	2.0	1173082.0	52408062.0	A	C	-	-	-	-	-	-	SCV002743592	-	-	271T>G 	Cys91Gly	NM_004656.4	1.0	4_VUS		1173082.0	3	52408062.0	A	C	C	G	rs1705222655	3	52442078.0	3	52417118.0	91.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.271T>G	p.Cys91Gly	c.271T>G	p.Cys91Gly	principal1	Y	1	YES	Select	-	TGT	1.0	0.0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.145	0.97505	H	-11.35	0.99595	D	0.974	0.98575	1.1018	0.99732	D	0.9443	0.98173	D	10.0	0.99121475	0.99640	D	0.655758	0.97092	D	0.979	0.99840	0.923	0.98665	Q92560	C91G	Loss of stability (P = 0.0176)| Gain of disorder (P = 0.0416)| Gain of sheet (P = 0.1208)| Loss of helix (P = 0.1299)| Gain of loop (P = 0.2045)	0.981038681151	0.98064	0.9635444637645938	0.96320	2.76950302636	0.98787	0.846445500851	0.89059	D	0.614019	0.87693	D	0.551935	0.95794	D	0.55504	0.9573	D	0.999918460845947	0.99678	D	0.998744	0.99359	D	0.97112095	0.98337	0.9594046	0.98923	0.97112095	0.98337	0.9594046	0.98923	-13.296	0.90565	D	0.9988	0.98152	P	0.999985923692613	0.99579	0.99989021	0.99864	0.951	0.97790	.	.	.	.	.	.	5.258269	0.88304	29.5	0.978704513399739	0.36682	0.954137	0.97089	D	1.0074398562281	0.95947	14.15777	0.917979903155774	0.96288	14.54242	5.49	5.49	0.80997	3.34	0.60572	9.031	0.93237	11.129000	0.86768	0.756	0.943	1.0	0.71675	1.0	0.68239	0.999	0.91597	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Neurodevelopmental_disorder	criteria_provided,_single_submitter	NC_000003.12:g.52408062A>C	.	C0027672|C1535926	.	140162	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Cys	Gly	1162264.0	single nucleotide variant	NM_004656.4(BAP1):c.271T>G (p.Cys91Gly)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Sep 14, 2021	1705222655.0	-	RCV001797188|RCV002424967	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52408062.0	52408062.0	3p21.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA353112613	2.0	1173082.0	52408062.0	A	C	-	-	-	-	-	-	SCV002743592	-	-	271T>G 	Cys91Gly	NM_004656.4	1.0	4_VUS	93.1	0.1481481481481481		unknown		0		93.1	0.14814815	10-90	>90						C	20		Nucleophile	93.1	Special, a very reactive sulfhydryl group	Cysteine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			2.5								C91-A95; PAE: 1.0	1 interaction	C91-Q85, C91-A95; PAE: 1.5, 1.0	4 interactions							121		Mutation: C -> A. Abolishes deubiquitinase activity. Has no effect on interaction with HCFC1.							-59.3				-46.3						H (helix)	H (α-helix)	Helix																																																																			true	BAP1Cys91Gly																																																																																																																																																																																																																																		
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7494366002858712	0.6171482965165139	0.8380872380070628	0.7472678645210815	0.7489771812224947	0.6602951949209586	0.7706772275201149	0.805557100309681	0.5015753048406917	0.7778306102934508	0.8376591675240308	0.7238585015220481	0.8706173757044446	0.7327212881923362	0.7210425902782918	F9	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7494366002858712	0.6171482965165139	0.8380872380070628	0.7472678645210815	0.7489771812224947	0.6602951949209586	0.7706772275201149	0.805557100309681	0.5015753048406917	0.7778306102934508	0.8376591675240308	0.7238585015220481	0.8706173757044446	0.7327212881923362	0.7210425902782918	F9	ENSG00000101981	52861	204362.0	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139551218.0	G	A	X	Y	N	N	N	N	X-139551218-G-A	25630.0	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 21, 2024	137852241.0	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218.0	139551218.0	Xq27.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3.0	10591.0	139551218.0	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2.0	1_Pathogenic		10591.0	X	139551218.0	G	A	R	Q	rs137852241	X	138633377.0	X	138461043.0	226.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2.0	0.0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10.0	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.9994896923960532	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.0	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630.0	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 21, 2024	137852241.0	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218.0	139551218.0	Xq27.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3.0	10591.0	139551218.0	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2.0	1_Pathogenic	43.81	0.3024193548387097	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	43.81	0.30241936	10-90	<=50						R	75			43.81	Positively-charged	Arginine		Coagulation factor IX										-4.5								R226-D232; PAE: 12.5		R226-Q370; PAE: 12.0								175									-94.8			Activation peptide	-2.3						C (loop/coil)	S (bend)					Cleavage; by factor XIa																									0.972		0.967		0.961		0.958		0.955																														true	F9Arg226Gln																																																																																																																																																																																																																																		
SHOC2	SHOC2_Ser403Gly	-3.861317166307788	0.006200919790985726	9.153768286343025	0.00003820144936004182	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8112338175897367	0.7071654700548557	0.8594328423701469	0.9081923854283305	0.8609914160898401	0.8598607476040003	0.9190794412170451	0.8293676270278348	0.660643654159381	0.802151747828081	0.8621220845756798	0.8973053296396158	0.8894980577124589	0.7536872859503306	0.8203158873513924	SHOC2	-3.861317166307788	0.006200919790985726	9.153768286343025	0.00003820144936004182	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8112338175897367	0.7071654700548557	0.8594328423701469	0.9081923854283305	0.8609914160898401	0.8598607476040003	0.9190794412170451	0.8293676270278348	0.660643654159381	0.802151747828081	0.8621220845756798	0.8973053296396158	0.8894980577124589	0.7536872859503306	0.8203158873513924	SHOC2		11602		CCSBVarC028051		NC_000010.11:111007576:A:G	1207A>G	Ser403Gly																												10.0	111007576.0	A	G	10						10-111007576-A-G	969662.0	single nucleotide variant	NM_007373.4(SHOC2):c.1207A>G (p.Ser403Gly)	8036.0	SHOC2	HGNC:15454	Likely benign	0.0	-	-1.0	-	RCV001261152	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	paternal	germline	GRCh38	NC_000010.11	10	111007576.0	111007576.0	10q25.2	no assertion criteria provided	1.0	-	N	ClinGen:CA378523403	2.0	981611.0	111007576.0	A	G	-	-	-	-	-	-	SCV001438561	-	-	1207A>G 	Ser403Gly	NM_007373.4		2_Benign		981611.0	10	111007576.0	A	G	S	G	rs1564730663	10	112767334.0	10	112757324.0	403.0	SHOC2	ENSG00000108061	ENST00000689300	ENSP00000510639	Q9UQ13	SHOC2_HUMAN	.	.	c.1207A>G	p.Ser403Gly	principal1	Y	.	.	.	+	AGT	1.0	0.0	A	A/A	A/A	A/A	A/A	.	0.61594	.	.	0.65108	.	0.775	0.47335	P	0.184	0.51811	B	.	.	.	.	.	.	1.495	0.37283	L	.	0.52959	.	.	0.78751	0.3038	0.87567	D	0.6246	0.86749	D	10.0	.	0.73599	.	0.076346	0.72413	D	.	0.55539	0.484	0.56487	Q9UQ13	S403G	Loss of sheet (P = 0.0817)| Loss of stability (P = 0.1306)| Loss of helix (P = 0.1706)| Gain of catalytic residue at T402 (P = 0.2032)| Loss of solvent accessibility (P = 0.4436)	.	0.74036	.	0.36956	.	0.65897	0.847841501236	0.89271	D	0.621119	0.88010	D	0.15632	0.69638	D	-0.0132338	0.6925	D	0.921698868274689	0.57905	D	.	0.86146	.	0.3641711	0.57823	0.28831485	0.54635	0.3641711	0.57823	0.28831485	0.54634	-5.834	0.44926	T	.	0.24834	.	0.987016332867827	0.87295	0.03628605	0.56043	0.571	0.75882	.	.	.	.	.	.	4.291712	0.65528	24.8	0.9984385826490396	0.92408	0.922270	0.89662	D	0.593668272867563	0.72634	5.859629	0.665622303315765	0.79668	7.154942	5.82	5.82	0.9273	.	.	9.271	0.94934	11.099000	0.86103	0.756	0.943	1.0	0.71675	1.0	0.68239	1.0	0.97202	919	0.19492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Noonan_syndrome	no_assertion_criteria_provided	NC_000010.11:g.111007576A>G	.	C0028326	PS163950	648	.	Ser	Gly	969662.0	single nucleotide variant	NM_007373.4(SHOC2):c.1207A>G (p.Ser403Gly)	8036.0	SHOC2	HGNC:15454	Likely benign	0.0	-	-1.0	-	RCV001261152	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	paternal	germline	GRCh38	NC_000010.11	10	111007576.0	111007576.0	10q25.2	no assertion criteria provided	1.0	-	N	ClinGen:CA378523403	2.0	981611.0	111007576.0	A	G	-	-	-	-	-	-	SCV001438561	-	-	1207A>G 	Ser403Gly	NM_007373.4		2_Benign	97.54	0.1769230769230769		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5		97.54	0.17692308	10-90	>90						S	23			97.54	Polar/Neutral	Serine		Leucine-rich repeat protein SHOC-2								0.0065		-0.8								S403-L381, S403-S382; PAE: 1.0, 1.0	6 interactions	S403-L381, S403-K379; PAE: 1.0, 2.0	7 interactions							105									-86.9		Pocket 3: Mean pLDDT: 96.3, Volume: 362.12 Å³, Druggability score: 0.01		-7.8			LRR 14			C (loop/coil)	T (turn)																																																																				true	SHOC2Ser403Gly																																																																																																																																																																																																																																		
SDHD	SDHD_Leu107Pro	0.2849529271708783	1.0	-2.025220716499999	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8350817199069114	0.7858586249667325	0.8726074524974285	0.8391627048651964	0.8330620834085387	0.8333986418202681	0.8569743213124418	0.8993651620405937	0.7837756991153474	0.8474656162013808	0.8327255249968093	0.821351088417951	0.8458497429542634	0.7879415508181176	0.8226978236124418	SDHD	0.2849529271708783	1.0	-2.025220716499999	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8350817199069114	0.7858586249667325	0.8726074524974285	0.8391627048651964	0.8330620834085387	0.8333986418202681	0.8569743213124418	0.8993651620405937	0.7837756991153474	0.8474656162013808	0.8327255249968093	0.821351088417951	0.8458497429542634	0.7879415508181176	0.8226978236124418	SDHD		6363		CCSBVarC023335		NC_000011.10:112094810:T:C	320T>C	Leu107Pro																												11.0	112094810.0	T	C	11						11-112094810-T-C	1785214.0	single nucleotide variant	NM_003002.4(SDHD):c.320T>C (p.Leu107Pro)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	May 30, 2024	-1.0	-	RCV002324587	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000011.10	11	112094810.0	112094810.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382618744	2.0	1728924.0	112094810.0	T	C	-	-	-	-	-	-	SCV002609368	-	-	320T>C 	Leu107Pro	NM_003002.4	1.0	1_Pathogenic		1728924.0	11	112094810.0	T	C	L	P	.	11	111965534.0	11	111470744.0	107.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.320T>C	p.Leu107Pro	c.320T>C	p.Leu107Pro	principal1	Y	1	YES	Select	+	CTT	2.0	0.0	T	./.	./.	./.	./.	0.002	0.72322	D	0.006	0.74454	D	0.989	0.62839	D	0.926	0.66089	D	0.96	0.95575	D	simple_aae	4.0	96.0	.	.	.	-5.05	0.82724	D	0.769	0.81497	1.0953	0.99459	D	0.9673	0.98959	D	10.0	0.91400754	0.90660	D	0.636512	0.96886	D	0.920	0.97963	0.667	0.80417	O14521	L107P	Loss of stability (P = 0.0278)| Gain of sheet (P = 0.039)| Loss of helix (P = 0.079)| Loss of catalytic residue at L107 (P = 0.0817)| Gain of loop (P = 0.0851)	0.93826696464	0.93714	0.9866521081126458	0.98654	0.939674812069	0.72002	0.464732289314	0.33914	T	0.966942	0.99610	D	0.510562	0.94567	D	0.49561	0.94487	D	0.983124061519632	0.7473	D	0.839116	0.51220	T	0.9550924	0.96731	0.9385074	0.97635	0.9550924	0.96731	0.9385074	0.97635	-14.207	0.94089	D	0.8325	0.78811	P	0.995669802072404	0.91503	0.99935895	0.99325	0.994	0.99793	.	.	.	.	.	.	4.675112	0.74806	26.2	0.9989136903010769	0.96515	0.966134	0.98849	D	0.781789244315126	0.84870	8.434356	0.709516226177353	0.83010	7.934285	4.53	4.53	0.54956	.	.	7.682	0.8343	7.854000	0.71149	0.661	0.55789	1.0	0.71675	1.0	0.68239	0.999	0.91597	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_cancer-predisposing_syndrome	criteria_provided,_single_submitter	NC_000011.10:g.112094810T>C	.	C0027672	.	140162	.	Leu	Pro	1785214.0	single nucleotide variant	NM_003002.4(SDHD):c.320T>C (p.Leu107Pro)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	May 30, 2024	-1.0	-	RCV002324587	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000011.10	11	112094810.0	112094810.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382618744	2.0	1728924.0	112094810.0	T	C	-	-	-	-	-	-	SCV002609368	-	-	320T>C 	Leu107Pro	NM_003002.4	1.0	1_Pathogenic	98.67	0.5182926829268293		unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7		98.67	0.51829267	10-90	>90						L	85			98.67	Aliphatic	Leucine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0134		3.8				1 interaction				L107-G103, L107-V111; PAE: 1.0, 1.0	2 interactions	L107-G103, L107-V111; PAE: 1.0, 1.0	3 interactions							131									-64.2		Pocket 3: Mean pLDDT: 99.91, Volume: 203.66 Å³, Druggability score: 0.01		-30.7						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDLeu107Pro																																																																																																																																																																																																																																		
RPS19	RPS19_Val15Phe	-2.3726616409620696	0.0765985741724703	-5.512693220591865	0.0008944402490659259	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.946629040044858	0.6606349213422994	0.9077207771725936	0.8332875404537949	0.6669561214682707	0.684109794739754	0.8354004220502114	0.8981160057662907	0.6773948020766469	0.9476236131613452	0.6498024481967875	0.8311746588573784	0.9173255485788965	0.6438750406079519	0.9456344669283709	RPS19	-2.3726616409620696	0.0765985741724703	-5.512693220591865	0.0008944402490659259	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.946629040044858	0.6606349213422994	0.9077207771725936	0.8332875404537949	0.6669561214682707	0.684109794739754	0.8354004220502114	0.8981160057662907	0.6773948020766469	0.9476236131613452	0.6498024481967875	0.8311746588573784	0.9173255485788965	0.6438750406079519	0.9456344669283709	RPS19	ENSG00000105372	3441	6053.0	CCSBVarC000466	ALE00000466	NC_000019.10:41860817:G:T	43G>T	Val15Phe	RC4	RC4_Mut_GDEh1010	E11	GDEhDisVCh_40042	B02	2.0	RC4_Mut_GDDh1010	E11							1.0	1.0	1.0	1.0	0.0			0.0			0.0			19.0	41860817.0	G	T	19	Y	Y	N	N	N	19-41860817-G-T	21358.0	single nucleotide variant	NM_001022.4(RPS19):c.43G>T (p.Val15Phe)	6223.0	RPS19	HGNC:10402	Pathogenic	1.0	Aug 03, 2015	104894717.0	-	RCV000482973	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000019.10	19	41860817.0	41860817.0	19q13.2	criteria provided, single submitter	1.0	-	N	ClinVar:6319,ClinGen:CA045535,UniProtKB:P39019#VAR_018438,OMIM:603474.0007	2.0	242804.0	41860817.0	G	T	-	-	-	-	-	-	SCV000567615	-	-	43G>T 	Val15Phe	NM_001022.4	1.0	1_Pathogenic		242804.0	19	41860817.0	G	T	V	F	rs104894717	19	42364887.0	19	47056727.0	15.0	RPS19	ENSG00000105372	ENST00000598742	ENSP00000470972	P39019	RS19_HUMAN	c.43G>T	p.Val15Phe	c.43G>T	p.Val15Phe	principal1	Y	1	YES	Select	+	GTC	1.0	0.0	G	./.	./.	./.	./.	.	.	.	0.002	0.83643	D	0.997	0.70687	D	0.961	0.70481	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.395	0.91508	M	.	.	.	0.966	0.97658	-0.2458	0.76366	T	0.383	0.73812	T	9.0	0.9739928	0.97062	D	0.40126	0.93389	D	.	.	0.909	0.98139	P39019	V15F	Loss of MoRF binding (P = 0.0787)| Loss of stability (P = 0.3828)| Loss of disorder (P = 0.4358)| Gain of methylation at R16 (P = 0.5521)| Loss of catalytic residue at F14 (P = 0.6366)	0.991857985221	0.99167	0.9614224850641426	0.96106	1.80914359211	0.91745	0.8935765028	0.95692	D	0.984477	0.99897	D	0.554303	0.95835	D	0.558441	0.95771	D	0.983127236366272	0.7473	D	.	0.56568	.	0.9801354	0.99104	0.91802967	0.96206	0.97457075	0.98647	0.9133168	0.95867	-13.184	0.90127	D	0.9629	0.91158	LP	0.997229277562924	0.92904	0.99992170	0.99909	0.795	0.88659	.	.	.	.	.	.	5.206373	0.87374	29.2	0.9941259995110968	0.63408	0.939381	0.93969	D	0.630628753833532	0.74985	6.250244	0.550537727116612	0.71277	5.654391	4.53	3.49	0.38994	.	.	6.938	0.75774	11.663000	0.94018	0.662	0.56385	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	criteria_provided,_single_submitter	NC_000019.10:g.41860817G>T	ClinGen:CA045535|OMIM:603474.0007|UniProtKB:P39019#VAR_018438	C3661900	.	.	.	Val	Phe	21358.0	single nucleotide variant	NM_001022.4(RPS19):c.43G>T (p.Val15Phe)	6223.0	RPS19	HGNC:10402	Pathogenic	1.0	Aug 03, 2015	104894717.0	-	RCV000482973	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000019.10	19	41860817.0	41860817.0	19q13.2	criteria provided, single submitter	1.0	-	N	ClinVar:6319,ClinGen:CA045535,UniProtKB:P39019#VAR_018438,OMIM:603474.0007	2.0	242804.0	41860817.0	G	T	-	-	-	-	-	-	SCV000567615	-	-	43G>T 	Val15Phe	NM_001022.4	1.0	1_Pathogenic	96.18	0.1549295774647887		unknown	Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare inborn errors of metabolism; Inherited cancer-predisposing syndrome	4		96.18	0.15492958	10-90	>90						V	22			96.18	Aliphatic	Valine		Small ribosomal subunit protein eS19								0.032		4.2								V15-Q11, V15-A19; PAE: 1.0, 1.0	33 interactions	V15-Q11, V15-A19; PAE: 1.0, 1.0	36 interactions							117									-63.3		Pocket 4: Mean pLDDT: 95.63, Volume: 462.36 Å³, Druggability score: 0.03		-41.1						H (helix)	H (α-helix)	Helix																																																																			true	RPS19Val15Phe																																																																																																																																																																																																																																		
FH	FH_Arg101Pro	4.936823787103087	0.0026122475521523467	-6.3120881858677516	0.00039949333367175175	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.9496543087641056	0.8728970663398579	0.9275951267206426	0.8869097955758005	0.7868126101520836	0.7591463818735216	0.8801537331098237	0.9219469434032179	0.8487166714701131	0.9445807184794202	0.8144788384306456	0.8936658580417775	0.9332433100380673	0.8970774612096026	0.9547278990487912	FH	4.936823787103087	0.0026122475521523467	-6.3120881858677516	0.00039949333367175175	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.9496543087641056	0.8728970663398579	0.9275951267206426	0.8869097955758005	0.7868126101520836	0.7591463818735216	0.8801537331098237	0.9219469434032179	0.8487166714701131	0.9445807184794202	0.8144788384306456	0.8936658580417775	0.9332433100380673	0.8970774612096026	0.9547278990487912	FH	ENSG00000091483	3408	214591.0	CCSBVarC004047	ALE00004047	NC_000001.11:241513679:C:G	302G>C	Arg101Pro	CEGS2	CegsMutGDEh1039	A01	GDEhDisVCh_40065	B08	1.0	CegsMutGDDh1039	A01							1.0	1.0	1.0	2.0	0.0			0.0			0.0			1.0	241513679.0	C	G	1	Y	Y	N	N	N	1-241513679-C-G	31277.0	single nucleotide variant	NM_000143.4(FH):c.302G>C (p.Arg101Pro)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Mar 20, 2024	75086406.0	-	RCV000017625|RCV002433458|RCV000489422	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000001.11	1	241513679.0	241513679.0	1q43	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA341389,OMIM:136850.0009	3.0	16238.0	241513679.0	C	G	-	-	-	-	-	-	SCV000576624|SCV002753171|SCV004292025	-	-	302G>C 	Arg101Pro	NM_000143.4	2.0	1_Pathogenic		16238.0	1	241513679.0	C	G	R	P	rs75086406	1	241676979.0	1	239743602.0	101.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.302G>C	p.Arg101Pro	c.302G>C	p.Arg101Pro	principal1	Y	1	YES	Select	-	CGA	2.0	0.0	C	C/C	C/C	C/C	C/C	0.005	0.63383	D	0.005	0.72530	D	0.953	0.54293	P	0.743	0.55796	P	0.87	0.90832	A	simple_aae	13.0	87.0	2.92	0.84163	M	-3.0	0.62369	D	0.956	0.96546	1.0727	0.98661	D	0.9706	0.99071	D	10.0	0.96818995	0.96307	D	0.570217	0.96104	D	0.900	0.97205	0.787	0.90945	P07954	R101P	Loss of MoRF binding (P = 0.0088)| Loss of methylation at R101 (P = 0.0316)| Gain of glycosylation at K100 (P = 0.1926)| Gain of ubiquitination at K100 (P = 0.3295)| Gain of disorder (P = 0.3433)	0.975473075571	0.97496	0.9653000365510797	0.96498	1.0454015372	0.75799	0.572783589363	0.49004	T	0.987676	0.99933	D	0.506134	0.94418	D	0.48925	0.94338	D	0.986802875995636	0.77268	D	0.984402	0.94657	D	0.98190993	0.99239	0.8988987	0.94827	0.98190993	0.99239	0.8988987	0.94828	-17.284	0.99132	D	0.9862	0.92510	P	0.99935590898668	0.96346	0.91557670	0.91792	0.853	0.91950	.	.	.	.	.	.	4.726614	0.76136	26.4	0.9975495780967858	0.84551	0.799097	0.72445	D	0.524983923222637	0.68407	5.235626	0.513199196236598	0.68706	5.281088	5.85	4.95	0.64849	.	.	1.844	0.39015	4.873000	0.45664	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.852	0.40339	965	0.07233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241513679C>G	ClinGen:CA341389|OMIM:136850.0009	C0027672|C3661900|C1708350	150800	140162|523	Fumarate lyase, N-terminal	Arg	Pro	31277.0	single nucleotide variant	NM_000143.4(FH):c.302G>C (p.Arg101Pro)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Mar 20, 2024	75086406.0	-	RCV000017625|RCV002433458|RCV000489422	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000001.11	1	241513679.0	241513679.0	1q43	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA341389,OMIM:136850.0009	3.0	16238.0	241513679.0	C	G	-	-	-	-	-	-	SCV000576624|SCV002753171|SCV004292025	-	-	302G>C 	Arg101Pro	NM_000143.4	2.0	1_Pathogenic	98.84	0.1451612903225806	['150800']	autosomal dominant	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	98.84	0.14516129	10-90	>90						R	36			98.84	Positively-charged	Arginine		Fumarate hydratase, mitochondrial										-4.5								R101-E105, R101-G97, R101-D125; PAE: 1.0, 1.0, 1.0	6 interactions	R101-E105, R101-G97; PAE: 1.0, 1.0	6 interactions		3 interactions					175									-58.7				-46.9						H (helix)	H (α-helix)	Helix																																																																			true	FHArg101Pro																																																																																																																																																																																																																																		
RHO	RHO_Pro267Thr	-6.437157064447852	0.0003545519851312502	-11.95420622579369	6.523550915399581e-6	2025_01_Batch_13-14	true	true	true	false	false	true	true	false	false	false	0.9965365151757515	0.9315993431762515	0.9872361816171712	0.9370453823613505	0.9034900427549339	0.8513456128397525	0.9025171263040506	0.9802752080130739	0.9175107261259643	0.994589753999556	0.9556344726701155	0.9715736384186505	0.9941971552212685	0.9456879602265387	0.998483276351947	RHO	-6.437157064447852	0.0003545519851312502	-11.95420622579369	6.523550915399581e-6	2025_01_Batch_13-14	true	true	true	false	false	true	true	false	false	false	0.9965365151757515	0.9315993431762515	0.9872361816171712	0.9370453823613505	0.9034900427549339	0.8513456128397525	0.9025171263040506	0.9802752080130739	0.9175107261259643	0.994589753999556	0.9556344726701155	0.9715736384186505	0.9941971552212685	0.9456879602265387	0.998483276351947	RHO		40080645		CCSBVarC013575		NC_000003.12:129532635:C:A	799C>A	Pro267Thr																												3.0	129532635.0	C	A	3						3-129532635-C-A	827539.0	single nucleotide variant	NM_000539.3(RHO):c.799C>A (p.Pro267Thr)	6010.0	RHO	HGNC:10012	Pathogenic	1.0	Nov 18, 2024	2084789550.0	-	RCV001058214	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000003.12	3	129532635.0	129532635.0	3q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA354470391	2.0	853413.0	129532635.0	C	A	-	-	-	-	-	-	SCV001222770	-	-	799C>A 	Pro267Thr	NM_000539.3	1.0	1_Pathogenic		853413.0	3	129532635.0	C	A	P	T	rs2084789550	3	129251478.0	3	130734168.0	267.0	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.799C>A	p.Pro267Thr	c.799C>A	p.Pro267Thr	principal1	Y	1	YES	Select	+	CCC	1.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	4.65	0.99359	H	-7.12	0.94038	D	0.965	0.97550	0.9999	0.97178	D	0.8404	0.94654	D	10.0	0.99142945	0.99666	D	0.443179	0.94193	D	0.946	0.98921	0.926	0.98766	P08100	P267T	Loss of glycosylation at S270 (P = 0.1504)| Gain of helix (P = 0.1736)| Gain of catalytic residue at P267 (P = 0.1854)| Loss of loop (P = 0.2897)| Loss of sheet (P = 0.302)	0.990985566321	0.99077	0.9222913745428601	0.92157	0.915089302012	0.71030	0.700365960598	0.67140	T	0.905498	0.98159	D	0.464614	0.93069	D	0.429609	0.92983	D	0.999821364879608	0.99193	D	0.989501	0.96561	D	0.9601639	0.97253	0.9319166	0.97186	0.9601639	0.97253	0.9319166	0.97186	-13.396	0.90947	D	0.9653	0.88720	P	0.999611079235613	0.97193	0.99991560	0.99909	0.995	0.99826	.	.	.	.	.	.	4.83405	0.78897	27.0	0.9980383365858795	0.88826	0.897847	0.83988	D	1.09702721159454	0.98067	17.37958	0.975528194122127	0.98084	17.41673	5.51	5.51	0.81744	.	.	7.9	0.86061	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.798	0.37682	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.129532635C>A	.	C3661900	.	.	GPCR, rhodopsin-like, 7TM	Pro	Thr	827539.0	single nucleotide variant	NM_000539.3(RHO):c.799C>A (p.Pro267Thr)	6010.0	RHO	HGNC:10012	Pathogenic	1.0	Nov 18, 2024	2084789550.0	-	RCV001058214	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000003.12	3	129532635.0	129532635.0	3q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA354470391	2.0	853413.0	129532635.0	C	A	-	-	-	-	-	-	SCV001222770	-	-	799C>A 	Pro267Thr	NM_000539.3	1.0	1_Pathogenic	97.49	0.3602941176470588		unknown		0		97.49	0.3602941	10-90	>90						P	49			97.49	Special, No backbone hydrogen	Proline		Rhodopsin										1.6								P267-V271; PAE: 1.0	1 interaction	P267-V271; PAE: 1.0	1 interaction							115									-57.7				-43.4						H (helix)	H (α-helix)	Helix								Helical; Name=6																																																											true	RHOPro267Thr																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Ala162Thr	-4.370447319580962	0.0032722768210010993	8.395631701605742	0.0000668881355903243	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8840753551907382	0.6775533952657523	0.8409337227939073	0.8284703708534987	0.7414081219549855	0.6325524172812277	0.7885922907571303	0.7413113322146364	0.6491819734900327	0.8245184478802221	0.8502638266287432	0.8683484509498671	0.9405561133731781	0.7059248170414719	0.9436322625012543	ZC4H2	-4.370447319580962	0.0032722768210010993	8.395631701605742	0.0000668881355903243	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8840753551907382	0.6775533952657523	0.8409337227939073	0.8284703708534987	0.7414081219549855	0.6325524172812277	0.7885922907571303	0.7413113322146364	0.6491819734900327	0.8245184478802221	0.8502638266287432	0.8683484509498671	0.9405561133731781	0.7059248170414719	0.9436322625012543	ZC4H2		4320		CCSBVarC009153		NC_000023.11:64919119:C:T	484G>A	Ala162Thr																												23.0	64919119.0	C	T	X						X-64919119-C-T	786889.0	single nucleotide variant	NM_018684.4(ZC4H2):c.484G>A (p.Ala162Thr)	55906.0	ZC4H2	HGNC:24931	Benign/Likely benign	0.0	Nov 21, 2024	763229158.0	-	RCV000976591|RCV002548407	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64919119.0	64919119.0	Xq11.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA10433399	2.0	793408.0	64919119.0	C	T	-	-	-	-	-	-	SCV001124496|SCV001875100|SCV003704074	-	-	484G>A 	Ala162Thr	NM_018684.4	2.0	2_Benign		793408.0	X	64919119.0	C	T	A	T	rs763229158	X	64138999.0	X	64055724.0	162.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.484G>A	p.Ala162Thr	c.484G>A	p.Ala162Thr	principal1	Y	1	YES	Select	-	GCC	1.0	0.0	C	C/C	C/C	C/C	C/C	0.585	0.05935	T	0.549	0.09609	T	0.253	0.31264	B	0.042	0.24116	B	0.02	0.13669	N	simple_aae	98.0	2.0	0.975	0.24371	L	-0.73	0.20514	N	0.563	0.59694	-0.9631	0.38422	T	0.1409	0.45885	T	9.0	0.17710975	0.32362	T	0.276816	0.90062	D	0.118	0.32711	0.433	0.48193	Q9NQZ6	A162T	Gain of glycosylation at A162 (P = 0.048)| Gain of phosphorylation at A162 (P = 0.0546)| Gain of MoRF binding (P = 0.1162)| Loss of stability (P = 0.5478)| Gain of catalytic residue at A162 (P = 0.5863)	0.396617757867	0.38874	0.7068802814843511	0.70480	0.002779115915	0.00229	0.73517537117	0.72215	T	0.364445	0.72831	T	-0.170336	0.24842	T	-0.141903	0.59671	T	0.0535271790125423	0.06045	T	0.921908	0.71557	D	0.39003843	0.59709	0.37242544	0.62207	0.39003843	0.59709	0.37242544	0.62207	-5.158	0.38896	T	0.5862	0.68255	P	0.7151635813138	0.67549	0.89157920	0.90918	0.294	0.56292	.	.	.	.	.	.	3.063865	0.41235	21.3	0.9914703064625521	0.53786	.	.	.	.	.	.	.	.	.	5.4	5.4	0.77927	.	.	7.641	0.82558	7.492000	0.59446	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.996	0.76032	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	12	264690	4.533605E-5	.	9	76130	1.182190e-04	0	24	143121	1.676900e-04	0	23	162094	1.418930e-04	0	0	5609	0.000000e+00	0	6	13184	4.550970e-04	0	0	1586	0.000000e+00	0	0	6756	0.000000e+00	0	0	9673	0.000000e+00	0	1	29040	3.443530e-05	0	0	8936	0.000000e+00	0	6	13184	4.550970e-04	0	0	12852	0.000000e+00	0	18	23519	7.653390e-04	0	0	4116	0.000000e+00	0	0	9768	0.000000e+00	0	0	11828	0.000000e+00	0	1	60750	1.646090e-05	0	0	16908	0.000000e+00	0	18	23519	7.653390e-04	0	0	11779	0.000000e+00	0	17	26098	6.513910e-04	0	0	6264	0.000000e+00	0	0	12772	0.000000e+00	0	0	15504	0.000000e+00	0	1	68992	1.449440e-05	0	0	16843	0.000000e+00	0	17	26098	6.513910e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Benign/Likely_benign	Inborn_genetic_diseases|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64919119C>T	.	C0950123|C3661900	.	.	.	Ala	Thr	786889.0	single nucleotide variant	NM_018684.4(ZC4H2):c.484G>A (p.Ala162Thr)	55906.0	ZC4H2	HGNC:24931	Benign/Likely benign	0.0	Nov 21, 2024	763229158.0	-	RCV000976591|RCV002548407	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64919119.0	64919119.0	Xq11.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA10433399	2.0	793408.0	64919119.0	C	T	-	-	-	-	-	-	SCV001124496|SCV001875100|SCV003704074	-	-	484G>A 	Ala162Thr	NM_018684.4	2.0	2_Benign	60.88	0.4056603773584906		unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		60.88	0.4056604	10-90	50-70						A	43			60.88	Aliphatic	Alanine		Zinc finger C4H2 domain-containing protein								0.0136		1.8								A162-A158; PAE: 2.5		A162-Q166, A162-A158; PAE: 5.0, 2.5								89									-62.8		Pocket 3: Mean pLDDT: 80.71, Volume: 332.58 Å³, Druggability score: 0.01		-36.4						H (helix)	H (α-helix)																																																																				true	ZC4H2Ala162Thr																																																																																																																																																																																																																																		
BRAF	BRAF_Glu501Val	0.06923700484882474	0.9467373185822208	0.8012197285196747	0.4493411824264216	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6652397913862851	0.5495293211680655	0.5821859107138729	0.5324964420125894	0.5464821729170268	0.668419559676502	0.5162034704749344	0.6066647733033534	0.6591434827390193	0.6813451882258486	0.42454478615755165	0.5487894135502444	0.5577070481243924	0.4399151595971117	0.6491343945467217	BRAF	0.06923700484882474	0.9467373185822208	0.8012197285196747	0.4493411824264216	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6652397913862851	0.5495293211680655	0.5821859107138729	0.5324964420125894	0.5464821729170268	0.668419559676502	0.5162034704749344	0.6066647733033534	0.6591434827390193	0.6813451882258486	0.42454478615755165	0.5487894135502444	0.5577070481243924	0.4399151595971117	0.6491343945467217	BRAF	ENSG00000157764	71969	220607.0	CCSBVarC003169	ALE00003169	NC_000007.14:140778006:T:A	1502A>T	Glu501Val	CEGS2	CegsMutGDEh1028	A12	GDEhDisVCh_40058	G10	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140778006.0	T	A	7	Y	N	N	N	N	7-140778006-T-A	48844.0	single nucleotide variant	NM_004333.6(BRAF):c.1502A>T (p.Glu501Val)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	May 18, 2022	180177039.0	-	RCV000037924|RCV001852671|RCV000033318|RCV001775071	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	Cardio-facio-cutaneous syndrome|RASopathy|not provided|Cardiofaciocutaneous syndrome 1	germline;unknown	germline	GRCh38	NC_000007.14	7	140778006.0	140778006.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA280013	2.0	40374.0	140778006.0	T	A	-	-	-	-	-	-	SCV000057223|SCV000061588|SCV002011970|SCV002233097	-	-	1502A>T 	Glu501Val	NM_004333.6	2.0	1_Pathogenic		40374.0	7	140778006.0	T	A	E	V	rs180177039	7	140477806.0	7	140124275.0	501.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1502A>T	p.Glu501Val	c.1502A>T	p.Glu501Val	principal4	Y	.	YES	Select	-	GAA	2.0	0.0	T	T/T	T/T	T/T	T/T	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97016	.	.	.	.	3.175	0.88626	M	.	.	.	.	.	0.4949	0.90439	D	0.6087	0.86082	D	10.0	0.9891212	0.99356	D	0.575626	0.96172	D	.	0.99995	0.984	0.99843	P15056	E501V	Gain of MoRF binding (P = 0.016)| Gain of methylation at K499 (P = 0.0368)| Gain of catalytic residue at Q496 (P = 0.0688)| Loss of disorder (P = 0.1462)| Loss of ubiquitination at K499 (P = 0.255)	.	0.99555	.	0.97864	.	0.96099	0.905288159847	0.97002	D	0.959346	0.99462	D	0.583525	0.97036	D	0.600417	0.96988	D	0.999093770980835	0.96125	D	0.984901	0.94804	D	0.970521	0.98280	0.8958858	0.94611	0.9600396	0.97241	0.9024512	0.95083	-13.783	0.92345	D	0.9998	0.99795	P	0.999948727464199	0.99079	0.99934202	0.99310	1	0.99985	.	.	.	.	.	.	5.908522	0.94033	33.0	0.990464736000248	0.51225	0.901308	0.84728	D	0.603356423307565	0.73242	5.957777	0.588108124975153	0.73943	6.077588	4.96	4.96	0.65108	.	.	7.981	0.87756	7.857000	0.71293	0.605	0.46302	1.0	0.71675	1.0	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Cardiofaciocutaneous_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778006T>A	ClinGen:CA280013	C1275081|C3661900|C5555857|CN029449	PS115150|115150	1340|536391|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Glu	Val	48844.0	single nucleotide variant	NM_004333.6(BRAF):c.1502A>T (p.Glu501Val)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	May 18, 2022	180177039.0	-	RCV000037924|RCV001852671|RCV000033318|RCV001775071	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	Cardio-facio-cutaneous syndrome|RASopathy|not provided|Cardiofaciocutaneous syndrome 1	germline;unknown	germline	GRCh38	NC_000007.14	7	140778006.0	140778006.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA280013	2.0	40374.0	140778006.0	T	A	-	-	-	-	-	-	SCV000057223|SCV000061588|SCV002011970|SCV002233097	-	-	1502A>T 	Glu501Val	NM_004333.6	2.0	1_Pathogenic	70.99	0.0463917525773195	['115150']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	70.99	0.04639175	<10	70-90						E	9			70.99	Negatively-charged	Glutamic Acid		Serine/threonine-protein kinase B-raf							Protein kinase			-3.5								E501-T599, E501-L505, E501-A497; PAE: 7.0, 1.5, 1.0	70 interactions	E501-T599, E501-A497, E501-L597, E501-L505, E501-V600; PAE: 7.0, 1.0, 7.0, 1.5, 7.5	70 interactions		7 interactions					146									-74.9				-38.7						H (helix)	H (α-helix)	Helix																									2.038																																										true	BRAFGlu501Val																																																																																																																																																																																																																																		
BRIP1	BRIP1_Val76Ile	0.573151287218121	0.5988089065274734	-0.15019282853357918	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6943538518593567	0.7056123717414433	0.6748186197775419	0.6795046164128171	0.7402037054353587	0.8091988361109888	0.6844133981290228	0.6731480580521042	0.7665337621531135	0.6783701732387314	0.6712085747597286	0.6745958346966116	0.6764891815029795	0.644690981329773	0.710337530479982	BRIP1	0.573151287218121	0.5988089065274734	-0.15019282853357918	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6943538518593567	0.7056123717414433	0.6748186197775419	0.6795046164128171	0.7402037054353587	0.8091988361109888	0.6844133981290228	0.6731480580521042	0.7665337621531135	0.6783701732387314	0.6712085747597286	0.6745958346966116	0.6764891815029795	0.644690981329773	0.710337530479982	BRIP1		55128		CCSBVarC031290		NC_000017.11:61857211:C:T	226G>A	Val76Ile																												17.0	61857211.0	C	T	17						17-61857211-C-T	402301.0	single nucleotide variant	NM_032043.3(BRIP1):c.226G>A (p.Val76Ile)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0.0	Nov 10, 2024	769573395.0	-	RCV000562576|RCV000473938|RCV002056711	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia complementation group J|not provided	germline	germline	GRCh38	NC_000017.11	17	61857211.0	61857211.0	17q23.2	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA16615534	2.0	407851.0	61857211.0	C	T	-	-	-	-	-	-	SCV000547345|SCV000666205|SCV000911292|SCV002496263|SCV002531402	-	-	226G>A 	Val76Ile	NM_032043.3	1.0	3_Conflicting		407851.0	17	61857211.0	C	T	V	I	rs769573395	17	59934572.0	17	57289354.0	76.0	BRIP1	ENSG00000136492	ENST00000259008	ENSP00000259008	Q9BX63	FANCJ_HUMAN	c.226G>A	p.Val76Ile	c.226G>A	p.Val76Ile	principal2	Y	1	YES	Select	-	GTA	1.0	0.0	C	C/C	C/C	C/C	C/C	0.279	0.15648	T	0.352	0.19614	T	0.0	0.02950	B	0.0	0.01384	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.55	0.14367	N	0.03	0.06578	N	0.068	0.08480	-0.9732	0.36374	T	0.1619	0.49568	T	9.0	0.046871662	0.03935	T	0.039492	0.58683	D	0.127	0.34681	0.421	0.46221	Q9BX63	V76I	Gain of loop (P = 0.1069)| Loss of disorder (P = 0.1257)| Gain of helix (P = 0.132)| Loss of catalytic residue at V76 (P = 0.1841)| Loss of phosphorylation at S77 (P = 0.1941)	0.233150807113	0.22520	0.11234678450338882	0.11014	0.129564647105	0.14353	0.25607085228	0.04436	T	0.067288	0.32914	T	-0.358382	0.04058	T	-0.57104	0.15067	T	0.064310478718449	0.07741	T	.	0.05921	.	0.021931265	0.00820	0.01949408	0.00093	0.021931265	0.00820	0.01949408	0.00093	-3.56	0.17295	T	0.0643	0.01788	B	0.000209254300804412	0.04287	0.13816178	0.69646	0.033	0.07179	.	.	.	.	.	.	-0.178575	0.0321	0.53	0.5782612318994237	0.05936	0.021994	0.01033	N	-1.75017022248378	0.00673	0.02929016	-1.70554440226488	0.01101	0.05002578	5.24	-1.16	0.09157	-8.68	0.00559	0.283	0.18669	-0.247000	0.10584	-1.852	0.00571	0.001	0.13799	0.0	0.08389	0.003	0.0525	42	0.97870	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	0	109368	0.000000e+00	0	1	208030	4.807000e-06	0	1	236816	4.222690e-06	0	0	7164	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	0	13386	0.000000e+00	0	0	42760	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	1	16218	6.165990e-05	0	0	30504	0.000000e+00	0	0	6212	0.000000e+00	0	0	13400	0.000000e+00	0	0	16726	0.000000e+00	0	0	89504	0.000000e+00	0	0	30604	0.000000e+00	0	1	16218	6.165990e-05	0	1	14902	6.710510e-05	0	0	34242	0.000000e+00	0	0	9570	0.000000e+00	0	0	17678	0.000000e+00	0	0	21620	0.000000e+00	0	0	102668	0.000000e+00	0	0	30522	0.000000e+00	0	1	14902	6.710510e-05	0	.	6	1613616	3.718360e-06	0	1	29598	3.378610e-05	0	2	74908	2.669940e-05	0	0	912	0.000000e+00	0	0	59992	0.000000e+00	0	1	29598	3.378610e-05	0	0	44880	0.000000e+00	0	0	63982	0.000000e+00	0	0	6084	0.000000e+00	0	3	1179728	2.542960e-06	0	0	91058	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia_complementation_group_J	criteria_provided,_conflicting_classifications	NC_000017.11:g.61857211C>T	ClinGen:CA16615534	C0027672|C3661900|C0346153|C1836860	114480|609054	140162|227535|84	.	Val	Ile	402301.0	single nucleotide variant	NM_032043.3(BRIP1):c.226G>A (p.Val76Ile)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0.0	Nov 10, 2024	769573395.0	-	RCV000562576|RCV000473938|RCV002056711	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia complementation group J|not provided	germline	germline	GRCh38	NC_000017.11	17	61857211.0	61857211.0	17q23.2	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA16615534	2.0	407851.0	61857211.0	C	T	-	-	-	-	-	-	SCV000547345|SCV000666205|SCV000911292|SCV002496263|SCV002531402	-	-	226G>A 	Val76Ile	NM_032043.3	1.0	3_Conflicting	32.86	0.8309859154929577	['114480', '609054']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP J	32.86	0.8309859	10-90	<=50						V	118			32.86	Aliphatic	Valine		Fanconi anemia group J protein							Helicase ATP-binding			4.2																		117									-147.5				118.4						C (loop/coil)	S (bend)																																																																				true	BRIP1Val76Ile																																																																																																																																																																																																																																		
RPS19	RPS19_Arg101His	-2.407724429948076	0.04693058430635163	-2.3751250467398184	0.049233749168006886	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.863419198553439	0.6068466334199374	0.6687629798839735	0.6614648959118544	0.5744587750583562	0.6359937086482906	0.7028646139639885	0.6890256185775911	0.6304028995520288	0.8764398964711966	0.5129238414684217	0.6200651778597204	0.6485003411903558	0.5832903672878459	0.8503985006356812	RPS19	-2.407724429948076	0.04693058430635163	-2.3751250467398184	0.049233749168006886	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.863419198553439	0.6068466334199374	0.6687629798839735	0.6614648959118544	0.5744587750583562	0.6359937086482906	0.7028646139639885	0.6890256185775911	0.6304028995520288	0.8764398964711966	0.5129238414684217	0.6200651778597204	0.6485003411903558	0.5832903672878459	0.8503985006356812	RPS19	ENSG00000105372	3441	6074.0	CCSBVarC000468	ALE00000468	NC_000019.10:41869160:G:A	302G>A	Arg101His	RC4	RC4_Mut_GDEh1010	G11	GDEhDisVCh_40042	D02	2.0	RC4_Mut_GDDh1010	G11							1.0	1.0	1.0	1.0	0.0			0.0			0.0			19.0	41869160.0	G	A	19	Y	Y	N	N	N	19-41869160-G-A	1329648.0	single nucleotide variant	NM_001022.4(RPS19):c.302G>A (p.Arg101His)	6223.0	RPS19	HGNC:10402	Pathogenic/Likely pathogenic	1.0	Sep 20, 2024	2123284131.0	-	RCV001818012|RCV004594595	MedGen:C3661900|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124	not provided|Diamond-Blackfan anemia 1	germline	germline	GRCh38	NC_000019.10	19	41869160.0	41869160.0	19q13.2	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA406030502	2.0	1338641.0	41869160.0	G	A	-	-	-	-	-	-	SCV002065830|SCV005087142	-	-	302G>A 	Arg101His	NM_001022.4	2.0	1_Pathogenic		1338641.0	19	41869160.0	G	A	R	H	rs2123284131	19	42373230.0	19	47065070.0	101.0	RPS19	ENSG00000105372	ENST00000593863	ENSP00000470004	P39019	RS19_HUMAN	c.302G>A	p.Arg101His	c.302G>A	p.Arg101His	principal1	Y	3	.	.	+	CGC	2.0	0.0	G	./.	./.	./.	./.	.	.	.	0.043	0.50294	D	0.576	0.38738	P	0.098	0.30481	B	0.98	0.97016	D	simple_aae	2.0	98.0	2.455	0.71058	M	.	.	.	0.85	0.84569	-0.6497	0.62566	T	0.1836	0.53023	T	9.0	0.9784213	0.97692	D	0.232972	0.88316	D	.	0.78612	0.944	0.99276	P39019	R101H	Loss of stability (P = 0.0435)| Loss of MoRF binding (P = 0.0519)| Loss of phosphorylation at S98 (P = 0.0846)| Loss of disorder (P = 0.1018)| Loss of methylation at K97 (P = 0.1559)	0.990308341565	0.99009	.	0.88980	.	0.79939	0.621480226517	0.55873	T	0.973089	0.99719	D	0.540061	0.95419	D	0.537984	0.95351	D	0.973375916481018	0.6987	D	0.919808	0.70916	D	0.7501296	0.80644	0.5398206	0.73150	0.59962654	0.72387	0.4817109	0.69730	-12.948	0.89171	D	0.9394	0.85818	P	0.998556217770197	0.94646	0.99979788	0.99739	0.552	0.74727	.	.	.	.	.	.	4.811919	0.78331	26.9	0.9976738256655149	0.85596	0.938159	0.93672	D	0.169104588964979	0.49474	3.169182	0.184437639525419	0.48733	3.108112	4.3	4.3	0.50482	.	.	6.962	0.75901	9.866000	0.82120	0.658	0.54518	1.0	0.71675	1.000000	0.68239	0.789	0.37304	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Diamond-Blackfan_anemia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.41869160G>A	.	C3661900|C2676137	105650	124	Small ribosomal subunit protein eS19, conserved site	Arg	His	1329648.0	single nucleotide variant	NM_001022.4(RPS19):c.302G>A (p.Arg101His)	6223.0	RPS19	HGNC:10402	Pathogenic/Likely pathogenic	1.0	Sep 20, 2024	2123284131.0	-	RCV001818012|RCV004594595	MedGen:C3661900|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124	not provided|Diamond-Blackfan anemia 1	germline	germline	GRCh38	NC_000019.10	19	41869160.0	41869160.0	19q13.2	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA406030502	2.0	1338641.0	41869160.0	G	A	-	-	-	-	-	-	SCV002065830|SCV005087142	-	-	302G>A 	Arg101His	NM_001022.4	2.0	1_Pathogenic	95.0	0.4919354838709677	['105650']	autosomal dominant	Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare inborn errors of metabolism; Inherited cancer-predisposing syndrome	4	DIAMOND-BLACKFAN ANEMIA 1	95.0	0.4919355	10-90	>90						R	122			95.0	Positively-charged	Arginine		Small ribosomal subunit protein eS19										-4.5								R101-Q105, R101-K97; PAE: 1.0, 1.5	32 interactions	R101-Q105, R101-K97; PAE: 1.0, 1.5	37 interactions							175									-65.2				-48.4						H (helix)	H (α-helix)	Helix																																																																			true	RPS19Arg101His																																																																																																																																																																																																																																		
SDHD	SDHD_His50Asp	5.2045723369280035	0.003547308842902077	-5.489031542982944	0.11438868033215185	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8849187658399376	0.8172191712246866	0.93176193554247	0.9075086286366292	0.9161303759407262	0.9296084092898397	0.9341050188181299	0.9562213211632515	0.8488139186065639	0.9083678801835474	0.9026523425916128	0.8809122384551284	0.9073025499216885	0.7856244238428094	0.8614696514963278	SDHD	5.2045723369280035	0.003547308842902077	-5.489031542982944	0.11438868033215185	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8849187658399376	0.8172191712246866	0.93176193554247	0.9075086286366292	0.9161303759407262	0.9296084092898397	0.9341050188181299	0.9562213211632515	0.8488139186065639	0.9083678801835474	0.9026523425916128	0.8809122384551284	0.9073025499216885	0.7856244238428094	0.8614696514963278	SDHD		6363		CCSBVarC023279		NC_000011.10:112087952:C:G	148C>G	His50Asp																												11.0	112087952.0	C	G	11						11-112087952-C-G	425903.0	single nucleotide variant	NM_003002.4(SDHD):c.148C>G (p.His50Asp)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Oct 04, 2024	779249550.0	-	RCV000497964|RCV000505346|RCV000569506|RCV002230973	MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome	germline	germline	GRCh38	NC_000011.10	11	112087952.0	112087952.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617089	2.0	431847.0	112087952.0	C	G	-	-	-	-	-	-	SCV000589392|SCV000664535|SCV000762665|SCV005424120	-	-	148C>G 	His50Asp	NM_003002.4	1.0	3_Conflicting		431847.0	11	112087952.0	C	G	H	D	rs779249550	11	111958676.0	11	111463886.0	50.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.148C>G	p.His50Asp	c.148C>G	p.His50Asp	principal1	Y	1	YES	Select	+	CAC	1.0	0.0	C	./.	./.	./.	./.	0.018	0.91343	D	0.008	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	.	.	.	.	.	.	2.875	0.83215	M	-3.14	0.89554	D	0.772	0.76851	0.9245	0.96011	D	0.8997	0.96666	D	10.0	0.84643626	0.83639	D	0.436238	0.94066	D	0.758	0.91722	0.534	0.64172	O14521	H50D	Loss of glycosylation at P53 (P = 0.0815)| Loss of sheet (P = 0.1398)| Loss of catalytic residue at S54 (P = 0.1704)| Gain of disorder (P = 0.1919)| Gain of relative solvent accessibility (P = 0.2363)	0.957064088694	0.95623	0.9054445795321721	0.90457	0.67055262571	0.59146	0.511507630348	0.40377	T	0.704104	0.91424	D	0.460795	0.92907	D	0.424123	0.92818	D	0.960621476173401	0.65639	D	0.862614	0.55690	D	0.41402334	0.61368	0.35787314	0.61034	0.41402334	0.61369	0.35787314	0.61034	-2.133	0.12713	T	0.3169	0.65739	B	0.974774869969241	0.84170	0.99681085	0.98169	0.574	0.76062	.	.	.	.	.	.	4.177101	0.62924	24.5	0.9903299367693627	0.50938	0.784431	0.71408	D	0.635376796190383	0.75292	6.303636	0.556168196419146	0.71674	5.714621	4.9	4.9	0.63598	.	.	3.351	0.52041	5.674000	0.49343	0.599	0.40292	0.999	0.42732	1.0	0.68239	0.808	0.38116	635	0.64545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	0	109370	0.000000e+00	0	1	208096	4.805470e-06	0	0	236920	0.000000e+00	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13356	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16696	0.000000e+00	0	1	89556	1.116620e-05	0	0	30608	0.000000e+00	0	1	89556	1.116620e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21594	0.000000e+00	0	0	102754	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|not_provided|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112087952C>G	ClinGen:CA382617089	C0027672|C1847319|C0031511|C1868633|CN166604|C3661900|C1708353	606864|171300	140162|97286|29072|201|29072	.	His	Asp	425903.0	single nucleotide variant	NM_003002.4(SDHD):c.148C>G (p.His50Asp)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Oct 04, 2024	779249550.0	-	RCV000497964|RCV000505346|RCV000569506|RCV002230973	MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome	germline	germline	GRCh38	NC_000011.10	11	112087952.0	112087952.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617089	2.0	431847.0	112087952.0	C	G	-	-	-	-	-	-	SCV000589392|SCV000664535|SCV000762665|SCV005424120	-	-	148C>G 	His50Asp	NM_003002.4	1.0	3_Conflicting	76.82	0.9619565217391304	['171300', '606864']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	76.82	0.9619565	$\geqslant$90	70-90						H	177			76.82	Positively-charged	Histidine												-3.2																		155									-68.9				106.7						C (loop/coil)	C (loop/coil)								Mitochondrion																																																												true	SDHDHis50Asp																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Pro201Ser	-5.809680916000794	0.002975023338819346	3.658069769647808	0.034243655203901685	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8023211310292585	0.6676737289157271	0.7809724510911431	0.7762209432653351	0.7065827338645437	0.6317258544338402	0.7175626828034266	0.7237190711631107	0.6348000809610653	0.7067604538877507	0.7814396132952472	0.8348792037272437	0.8382258310191754	0.7005473768703887	0.8978818081707663	ZC4H2	-5.809680916000794	0.002975023338819346	3.658069769647808	0.034243655203901685	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8023211310292585	0.6676737289157271	0.7809724510911431	0.7762209432653351	0.7065827338645437	0.6317258544338402	0.7175626828034266	0.7237190711631107	0.6348000809610653	0.7067604538877507	0.7814396132952472	0.8348792037272437	0.8382258310191754	0.7005473768703887	0.8978818081707663	ZC4H2	ENSG00000126970	4320	215107.0	CCSBVarC005917	ALE00005917	NC_000023.11:64917857:G:A	601C>T	Pro201Ser	CEGS2	CegsMutGDEh1032	E08	GDEhDisVCh_40034	A12	2.0	CegsMutGDDh1032	E08							1.0	1.0	1.0	1.0	0.0			0.0			0.0			23.0	64917857.0	G	A	X	Y	Y	N	N	N	X-64917857-G-A	65653.0	single nucleotide variant	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	55906.0	ZC4H2	HGNC:24931	Likely pathogenic	1.0	Jun 24, 2020	398122939.0	-	RCV000043678|RCV001374903	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Wieacker-Wolff syndrome|Neurodevelopmental disorder	germline	germline	GRCh38	NC_000023.11	X	64917857.0	64917857.0	Xq11.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	3.0	50982.0	64917857.0	G	A	-	-	-	-	-	-	SCV001572190	-	-	601C>T 	Pro201Ser	NM_018684.4	1.0	1_Pathogenic		50982.0	X	64917857.0	G	A	P	S	rs398122939	X	64137737.0	X	64054462.0	201.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.601C>T	p.Pro201Ser	c.601C>T	p.Pro201Ser	principal1	Y	1	YES	Select	-	CCT	1.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.96	0.95575	A	simple_aae	4.0	96.0	.	.	.	-6.88	0.93237	D	0.933	0.93850	-0.0166	0.81829	T	0.4584	0.78867	T	8.0	0.9272647	0.91983	D	0.879436	0.99079	D	0.949	0.99024	0.568	0.68924	Q9NQZ6	P201S	Gain of MoRF binding (P = 0.0359)| Gain of phosphorylation at P201 (P = 0.0595)| Loss of loop (P = 0.0603)| Loss of stability (P = 0.0799)| Gain of helix (P = 0.132)	0.924160061229	0.92281	0.717222727726295	0.71518	3.14057088863	0.99417	0.90233540535	0.96691	D	0.841119	0.96267	D	0.579811	0.96963	D	0.595082	0.96914	D	0.99885880947113	0.95336	D	0.959004	0.85727	D	0.9243852	0.93582	0.9158107	0.96047	0.90647143	0.91852	0.90109336	0.94986	-12.964	0.90166	D	1.0	0.99952	P	0.999295186201027	0.96182	0.99900264	0.99084	0.997	0.99892	.	.	.	.	.	.	4.866916	0.79733	27.2	0.999237380928834	0.98918	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	9.224	0.94382	11.614000	0.93576	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.999	0.91597	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Likely_pathogenic	Wieacker-Wolff_syndrome|Neurodevelopmental_disorder	criteria_provided,_single_submitter	NC_000023.11:g.64917857G>A	ClinGen:CA143908|OMIM:300897.0003|UniProtKB:Q9NQZ6#VAR_069623	C0796200|C1535926	314580	3454|85283	Zinc finger C4H2-type	Pro	Ser	65653.0	single nucleotide variant	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	55906.0	ZC4H2	HGNC:24931	Likely pathogenic	1.0	Jun 24, 2020	398122939.0	-	RCV000043678|RCV001374903	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Wieacker-Wolff syndrome|Neurodevelopmental disorder	germline	germline	GRCh38	NC_000023.11	X	64917857.0	64917857.0	Xq11.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	3.0	50982.0	64917857.0	G	A	-	-	-	-	-	-	SCV001572190	-	-	601C>T 	Pro201Ser	NM_018684.4	1.0	1_Pathogenic	87.12	0.7720588235294118	['314580']	x-linked recessive	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	87.12	0.77205884	10-90	70-90						P	105			87.12	Special, No backbone hydrogen	Proline		Zinc finger C4H2 domain-containing protein										1.6								P201-S210; PAE: 3.0		P201-S210; PAE: 3.0								115									-75.8				-27.6						C (loop/coil)	S (bend)											C4H2-type																																																									true	ZC4H2Pro201Ser																																																																																																																																																																																																																																		
BAP1	BAP1_Thr423Lys	-1.3565825611557805	0.21703700719903737	-4.239050177833455	0.003844822069613415	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6799120582351484	0.49486093922951035	0.6141113172325929	0.5561506448556437	0.47722675322455954	0.5366318780047523	0.6153002905177806	0.6202442813261588	0.5530089525647295	0.7218464078878021	0.4178216284443667	0.4970009991935067	0.607978353139027	0.4367129258942913	0.6379777085824948	BAP1	-1.3565825611557805	0.21703700719903737	-4.239050177833455	0.003844822069613415	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6799120582351484	0.49486093922951035	0.6141113172325929	0.5561506448556437	0.47722675322455954	0.5366318780047523	0.6153002905177806	0.6202442813261588	0.5530089525647295	0.7218464078878021	0.4178216284443667	0.4970009991935067	0.607978353139027	0.4367129258942913	0.6379777085824948	BAP1		3760		CCSBVarC009476		NC_000003.12:52403877:G:T	1268C>A	Thr423Lys																												3.0	52403877.0	G	T	3						3-52403877-G-T	239268.0	single nucleotide variant	NM_004656.4(BAP1):c.1268C>A (p.Thr423Lys)	8314.0	BAP1	HGNC:950	Benign/Likely benign	0.0	Feb 04, 2025	115109161.0	-	RCV000228893|RCV000563367|RCV000844571|RCV001818616|RCV003316284	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Melanoma, uveal, susceptibility to, 2	germline;unknown	germline	GRCh38	NC_000003.12	3	52403877.0	52403877.0	3p21.1	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA2436837	2.0	240045.0	52403877.0	G	T	-	-	-	-	-	-	SCV000288737|SCV000445471|SCV000664594|SCV000682561|SCV000986622|SCV002064677|SCV002537251|SCV004016346|SCV005404632	-	-	1268C>A 	Thr423Lys	NM_004656.4	2.0	2_Benign		240045.0	3	52403877.0	G	T	T	K	rs115109161	3	52437893.0	3	52412933.0	423.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.1268C>A	p.Thr423Lys	c.1268C>A	p.Thr423Lys	principal1	Y	1	YES	Select	-	ACA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.034	0.44516	D	0.017	0.60671	D	0.002	0.09864	B	0.002	0.06938	B	0.06	0.18971	N	simple_aae	94.0	6.0	0	0.06502	N	-1.03	0.27007	N	0.324	0.37371	-1.025	0.2204	T	0.0638	0.2628	T	10.0	0.007293403	0.00163	T	.	.	.	0.054	0.15198	.	.	.	.	.	0.671732637855	0.66638	0.19555129210449032	0.19291	0.453964407394	0.44793	0.347844183445	0.17586	T	0.024049	0.18095	T	-0.488477	0.00629	T	-0.472382	0.24913	T	0.00967223067305719	0.00125	T	0.729627	0.34303	T	0.07225229	0.15912	0.09052727	0.21201	0.0865195	0.19931	0.09277198	0.21846	-0.415	0.00535	T	0.0922	0.16120	B	0.0551843815255829	0.38039	0.99352360	0.97351	0.092	0.25882	.	.	.	.	.	.	2.376386	0.30551	18.46	0.974649564021286	0.34277	0.073686	0.14558	N	-0.147163113713975	0.35080	2.029722	0.0881182991556912	0.43669	2.686219	6.04	5.1	0.68875	3.9	0.73887	2.575	0.4579	6.351000	0.55560	0.676	0.76753	0.94	0.32731	1.0	0.68239	0.994	0.71086	68	0.97129	16	0.003194888178913738	16	0.012102874432677761	0	0.0	0	0.0	0	0.0	0	0.0	445	264690	0.001681212	.	52	109312	4.757030e-04	0	93	207980	4.471580e-04	0	91	236828	3.842450e-04	0	43	7164	6.002230e-03	0	8	17106	4.676720e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13304	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	43	7164	6.002230e-03	0	79	16212	4.872930e-03	0	12	30518	3.932110e-04	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16644	0.000000e+00	0	1	89508	1.117220e-05	0	0	30608	0.000000e+00	0	79	16212	4.872930e-03	0	75	14902	5.032880e-03	0	14	34252	4.087350e-04	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21542	0.000000e+00	0	1	102726	9.734630e-06	0	0	30526	0.000000e+00	0	75	14902	5.032880e-03	0	.	427	1614100	2.645440e-04	3	363	75032	4.837940e-03	3	363	75032	4.837940e-03	3	0	912	0.000000e+00	0	31	60026	5.164430e-04	0	0	29598	0.000000e+00	0	0	44890	0.000000e+00	0	0	63940	0.000000e+00	0	0	6062	0.000000e+00	0	11	1180040	9.321720e-06	0	0	91088	0.000000e+00	0	1	173836	5.752548378931867E-6	3	360	0.008333333333333333	0	4504	0	32	9418	0.0033977489912932683	1	796	0.001256281407035176	0	974	0	0	1850	0	0	280	0	4	17418	2.2964749110115972E-4	35	9778	0.003579464103088566	0	6354	0	41	209436	1.9576386103630704E-4	Benign/Likely_benign	not_specified|BAP1-related_tumor_predisposition_syndrome|not_provided|Hereditary_cancer-predisposing_syndrome|Melanoma,_uveal,_susceptibility_to,_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52403877G>T	ClinGen:CA2436837	CN169374|C3280492|C3661900|C0027672|C1847723	614327|606661	289539|140162|39044	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Thr	Lys	239268.0	single nucleotide variant	NM_004656.4(BAP1):c.1268C>A (p.Thr423Lys)	8314.0	BAP1	HGNC:950	Benign/Likely benign	0.0	Feb 04, 2025	115109161.0	-	RCV000228893|RCV000563367|RCV000844571|RCV001818616|RCV003316284	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Melanoma, uveal, susceptibility to, 2	germline;unknown	germline	GRCh38	NC_000003.12	3	52403877.0	52403877.0	3p21.1	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA2436837	2.0	240045.0	52403877.0	G	T	-	-	-	-	-	-	SCV000288737|SCV000445471|SCV000664594|SCV000682561|SCV000986622|SCV002064677|SCV002537251|SCV004016346|SCV005404632	-	-	1268C>A 	Thr423Lys	NM_004656.4	2.0	2_Benign	32.94	1.0	['614327', '606661']	unknown		0	TUMOR PREDISPOSITION SYNDROME 1; MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2	32.94	1.0	$\geqslant$90	<=50						T	147			32.94	Polar/Neutral	Threonine		Ubiquitin carboxyl-terminal hydrolase BAP1										-0.7																		119									-113.5				124.5	Disordered					C (loop/coil)	C (loop/coil)																																																																				true	BAP1Thr423Lys																																																																																																																																																																																																																																		
FH	FH_Pro174Arg	10.162270857596216	0.000052836229120136614	-7.281739576538825	0.00016533890191996532	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8607648878207168	0.5720850641276243	0.8843137993744704	0.7848065989828991	0.6762706853155396	0.6762706853155396	0.7848065989828991	0.8843137993744704	0.5720850641276243	0.8607648878207168						FH	10.162270857596216	0.000052836229120136614	-7.281739576538825	0.00016533890191996532	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8607648878207168	0.5720850641276243	0.8843137993744704	0.7848065989828991	0.6762706853155396	0.6762706853155396	0.7848065989828991	0.8843137993744704	0.5720850641276243	0.8607648878207168						FH	ENSG00000091483	3408	214592.0	CCSBVarC004048	ALE00004048	NC_000001.11:241512001:G:C	521C>G	Pro174Arg	CEGS2	CegsMutGDEh1039	D09	GDEhDisVCh_40065	C08	1.0	CegsMutGDDh1039	D09							1.0	3.0	1.0	3.0	0.0			0.0			0.0			1.0	241512001.0	G	C	1	N	N	N	N	N	1-241512001-G-C	38660.0	single nucleotide variant	NM_000143.4(FH):c.521C>G (p.Pro174Arg)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Jan 13, 2025	199822819.0	-	RCV000022554|RCV000078149|RCV000492836|RCV003335052|RCV003483435	MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523;MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome|FH-related disorder|Hereditary leiomyomatosis and renal cell cancer;Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241512001.0	241512001.0	1q43	criteria provided, multiple submitters, no conflicts	19.0	-	N	ClinGen:CA220381,OMIM:136850.0010	3.0	29705.0	241512001.0	G	C	-	-	-	-	-	-	SCV000109987|SCV000283674|SCV000356713|SCV000516751|SCV000581681|SCV000992190|SCV002012378|SCV002048740|SCV004046437|SCV004197294|SCV004218884|SCV005184523|SCV005874269	-	-	521C>G 	Pro174Arg	NM_000143.4	2.0	1_Pathogenic	0.000157353	29705.0	1	241512001.0	G	C	P	R	rs199822819	1	241675301.0	1	239741924.0	174.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.521C>G	p.Pro174Arg	c.521C>G	p.Pro174Arg	principal1	Y	1	YES	Select	-	CCT	2.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.016	0.61305	D	0.999	0.77914	D	0.981	0.75172	D	0.6	0.76851	A	simple_aae	40.0	60.0	2.505	0.72748	M	-7.67	0.95559	D	0.969	0.97975	1.0331	0.97771	D	0.9867	0.99604	D	10.0	0.9749284	0.97191	D	0.717923	0.97710	D	0.961	0.99405	.	.	.	.	.	0.987495772737	0.98721	0.8682662705529591	0.86710	0.978554424983	0.73484	0.763472080231	0.76405	T	0.951848	0.99304	D	0.469226	0.93253	D	0.566685	0.96142	D	0.918809771537781	0.5748	D	0.976702	0.91928	D	0.8966469	0.90957	0.89710534	0.94698	0.8966469	0.90959	0.89710534	0.94699	-13.629	0.91805	D	0.8317	0.78770	P	0.969616269158006	0.83212	0.92770165	0.92291	0.975	0.99076	.	.	.	.	.	.	5.112622	0.85504	28.6	0.9981003855289049	0.8945	0.904483	0.85431	D	0.949310228068722	0.93923	12.39802	0.89439856430428	0.95298	13.5147	5.24	5.24	0.72825	.	.	9.079	0.9345	11.757000	0.95546	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	968	0.07020	.	.	.	.	.	.	.	.	.	.	.	.	8	264690	3.0224035E-5	.	3	109368	2.743030e-05	0	3	208072	1.441810e-05	0	5	236768	2.111770e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13354	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16694	0.000000e+00	0	3	89538	3.350530e-05	0	0	30608	0.000000e+00	0	3	89538	3.350530e-05	0	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21592	0.000000e+00	0	5	102618	4.872440e-05	0	0	30526	0.000000e+00	0	5	102618	4.872440e-05	0	.	234	1613826	1.449970e-04	0	230	1179928	1.949270e-04	0	0	74900	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29598	0.000000e+00	0	0	44872	0.000000e+00	0	0	63972	0.000000e+00	0	0	6082	0.000000e+00	0	230	1179928	1.949270e-04	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	1	2784	3.5919540229885057E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	1	2898	3.450655624568668E-4	0	112	0	1	14050	7.117437722419929E-5	Pathogenic/Likely_pathogenic	Fumarase_deficiency|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|FH-related_disorder|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241512001G>C	ClinGen:CA220381|OMIM:136850.0010	C0342770|C1708350|C0027672|C3661900	606812|150800	24|523|140162	Fumarate lyase, N-terminal	Pro	Arg	38660.0	single nucleotide variant	NM_000143.4(FH):c.521C>G (p.Pro174Arg)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Jan 13, 2025	199822819.0	-	RCV000022554|RCV000078149|RCV000492836|RCV003335052|RCV003483435	MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523;MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome|FH-related disorder|Hereditary leiomyomatosis and renal cell cancer;Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241512001.0	241512001.0	1q43	criteria provided, multiple submitters, no conflicts	19.0	-	N	ClinGen:CA220381,OMIM:136850.0010	3.0	29705.0	241512001.0	G	C	-	-	-	-	-	-	SCV000109987|SCV000283674|SCV000356713|SCV000516751|SCV000581681|SCV000992190|SCV002012378|SCV002048740|SCV004046437|SCV004197294|SCV004218884|SCV005184523|SCV005874269	-	-	521C>G 	Pro174Arg	NM_000143.4	2.0	1_Pathogenic	98.34	0.3529411764705882	['606812', '150800', '606812']	multiple	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	FUMARASE DEFICIENCY; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; FUMARASE DEFICIENCY	98.34	0.3529412	10-90	>90						P	48			98.34	Special, No backbone hydrogen	Proline		Fumarate hydratase, mitochondrial										1.6																		115									-83.9				-2.6						C (loop/coil)	S (bend)																																																																				true	FHPro174Arg																																																																																																																																																																																																																																		
FH	FH_Leu507Pro	4.283741584521042	0.005184294876647455	-9.275306049641868	0.000035051027926109044	2025_01_Batch_13-14	true	true	true	true	true	true	false	false	false	false	0.9910505348182328	0.8190445976873685	0.9782635227503732	0.941708509775386	0.9233232839906323	0.9233232839906323	0.941708509775386	0.9782635227503732	0.8190445976873685	0.9910505348182328						FH	4.283741584521042	0.005184294876647455	-9.275306049641868	0.000035051027926109044	2025_01_Batch_13-14	true	true	true	true	true	true	false	false	false	false	0.9910505348182328	0.8190445976873685	0.9782635227503732	0.941708509775386	0.9233232839906323	0.9233232839906323	0.941708509775386	0.9782635227503732	0.8190445976873685	0.9910505348182328						FH	ENSG00000091483	3408	5905.0	CCSBVarC000455	ALE00000455	NC_000001.11:241497841:A:G	1520T>C	Leu507Pro	RC4	RC4_Mut_GDEh1025	B03	GDEhDisVCh_40065	B12	1.0	RC4_Mut_GDDh1025	B03							1.0	6.0	1.0	7.0	0.0			0.0			0.0			1.0	241497841.0	A	G	1	N	N	N	N	N	1-241497841-A-G	493075.0	single nucleotide variant	NM_000143.4(FH):c.1520T>C (p.Leu507Pro)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Nov 07, 2023	1425094515.0	-	RCV000597494|RCV002395536|RCV003336091	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241497841.0	241497841.0	1q43	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA345450002	2.0	501651.0	241497841.0	A	G	-	-	-	-	-	-	SCV001577113|SCV002705312|SCV004045439	-	-	1520T>C 	Leu507Pro	NM_000143.4	2.0	1_Pathogenic	2.0591e-6	501651.0	1	241497841.0	A	G	L	P	rs1425094515	1	241661141.0	1	239727764.0	507.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1520T>C	p.Leu507Pro	c.1520T>C	p.Leu507Pro	principal1	Y	1	YES	Select	-	CTG	2.0	0.0	A	./.	./.	./.	./.	0.0	0.91343	D	0.003	0.76775	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.97926	D	simple_aae	1.0	99.0	4.165	0.97608	H	-6.03	0.89738	D	0.891	0.89007	0.9009	0.95672	D	0.8489	0.9495	D	10.0	0.9082073	0.90077	D	0.334363	0.91822	D	0.871	0.96123	0.602	0.73245	P07954	L507P	Gain of disorder (P = 0.0241)| Loss of stability (P = 0.0351)| Gain of ubiquitination at K502 (P = 0.0548)| Gain of glycosylation at L507 (P = 0.0656)| Loss of loop (P = 0.1258)	0.957075880139	0.95625	0.994625853800694	0.99458	1.25285983881	0.81756	0.733992934227	0.72042	T	0.828262	0.95840	D	0.476607	0.93531	D	0.446837	0.93451	D	0.999450027942657	0.97447	D	0.984202	0.94624	D	0.9785105	0.98976	0.96005136	0.98958	0.97985315	0.99083	0.9652735	0.99233	-13.176	0.90095	D	0.8863	0.81817	P	0.999840444787748	0.98301	0.92898947	0.92347	0.974	0.99029	.	.	.	.	.	.	5.100479	0.8524	28.5	0.9993044605108422	0.99334	0.972825	0.99451	D	0.97296511661057	0.94822	13.09385	0.931949475285706	0.96802	15.19072	6.02	6.02	0.97555	5.2	0.91904	7.047	0.76373	10.988000	0.84682	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.999	0.91597	973	0.05579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1609240	1.864230e-06	0	3	1178088	2.546500e-06	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59480	0.000000e+00	0	0	29572	0.000000e+00	0	0	44734	0.000000e+00	0	0	63920	0.000000e+00	0	0	4674	0.000000e+00	0	3	1178088	2.546500e-06	0	0	90726	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_conflicting_classifications	NC_000001.11:g.241497841A>G	ClinGen:CA345450002	C0027672|C3661900|C1708350	150800	140162|523	Fumarase C, C-terminal	Leu	Pro	493075.0	single nucleotide variant	NM_000143.4(FH):c.1520T>C (p.Leu507Pro)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Nov 07, 2023	1425094515.0	-	RCV000597494|RCV002395536|RCV003336091	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241497841.0	241497841.0	1q43	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA345450002	2.0	501651.0	241497841.0	A	G	-	-	-	-	-	-	SCV001577113|SCV002705312|SCV004045439	-	-	1520T>C 	Leu507Pro	NM_000143.4	2.0	1_Pathogenic	97.94	0.2804878048780488	['150800']	autosomal dominant	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	97.94	0.2804878	10-90	>90						L	46			97.94	Aliphatic	Leucine		Fumarate hydratase, mitochondrial										3.8									2 interactions									131									-114.0				9.2						C (loop/coil)	S (bend)	Beta strand																																																																			true	FHLeu507Pro																																																																																																																																																																																																																																		
FH	FH_Arg233Cys	0.840040754452072	0.4330774414127768	-0.5768098835051846	0.5821337323712967	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7701763751025108	0.5276346968270296	0.7589857559210429	0.6394231587304899	0.5834752403693435	0.5681956161990315	0.591142855004605	0.7275652312524326	0.4790616233228787	0.7443955154689178	0.5987548645396555	0.687703462456375	0.7904062805896533	0.5762077703311804	0.7959572347361038	FH	0.840040754452072	0.4330774414127768	-0.5768098835051846	0.5821337323712967	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7701763751025108	0.5276346968270296	0.7589857559210429	0.6394231587304899	0.5834752403693435	0.5681956161990315	0.591142855004605	0.7275652312524326	0.4790616233228787	0.7443955154689178	0.5987548645396555	0.687703462456375	0.7904062805896533	0.5762077703311804	0.7959572347361038	FH	ENSG00000091483	3408	214594.0	CCSBVarC004049	ALE00004049	NC_000001.11:241508644:G:A	697C>T	Arg233Cys	CEGS2	CegsMutGDEh1039	B12	GDEhDisVCh_40065	D08	1.0	CegsMutGDDh1039	B12							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	241508644.0	G	A	1	Y	Y	N	N	N	1-241508644-G-A	151069.0	single nucleotide variant	NM_000143.4(FH):c.697C>T (p.Arg233Cys)	2271.0	FH	HGNC:3700	Pathogenic	1.0	Dec 18, 2024	587781682.0	-	RCV000129845|RCV000153237|RCV000549060	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241508644.0	241508644.0	1q43	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA165194	2.0	141355.0	241508644.0	G	A	-	-	-	-	-	-	SCV000184662|SCV000230852|SCV000251418|SCV000632484|SCV002535569|SCV002544394|SCV004197373|SCV005625599|SCV005727144	-	-	697C>T 	Arg233Cys	NM_000143.4	2.0	1_Pathogenic	3.42099e-6	141355.0	1	241508644.0	G	A	R	C	rs587781682	1	241671944.0	1	239738567.0	233.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.697C>T	p.Arg233Cys	c.697C>T	p.Arg233Cys	principal1	Y	1	YES	Select	-	CGT	1.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	5.07	0.99905	H	-7.81	0.95967	D	0.962	0.97221	0.9273	0.96051	D	0.9945	0.99874	D	10.0	0.9892357	0.99374	D	0.699957	0.97538	D	0.949	0.99024	0.89	0.97304	P07954	R233C	Loss of catalytic residue at R233 (P = 0.0152)| Loss of phosphorylation at T236 (P = 0.0683)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of MoRF binding (P = 0.0767)| Loss of methylation at K230 (P = 0.1519)	0.967472502496	0.96682	0.9655328358886819	0.96521	1.15023203385	0.79062	0.858424127102	0.90864	D	0.994652	0.99988	D	0.592007	0.97345	D	0.612601	0.97303	D	0.999971151351929	0.99958	D	0.994141	0.98073	D	0.97714406	0.98865	0.9070807	0.95418	0.97714406	0.98865	0.9070807	0.95418	-13.351	0.90777	D	0.9741	0.90045	P	0.999896646635663	0.98645	0.93132580	0.92451	1	0.99985	.	.	.	.	.	.	5.655055	0.92846	33.0	0.9992570779690382	0.99043	0.944500	0.95149	D	1.1397818748542	0.98799	19.44741	1.00471014856407	0.98709	19.13286	5.65	5.65	0.86862	5.55	0.94672	9.516	0.97049	8.562000	0.77604	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.947	0.4917	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613696	3.718170e-06	0	1	29598	3.378610e-05	0	1	74894	1.335220e-05	0	0	912	0.000000e+00	0	0	59986	0.000000e+00	0	1	29598	3.378610e-05	0	0	44874	0.000000e+00	0	0	64016	0.000000e+00	0	0	6080	0.000000e+00	0	3	1179784	2.542840e-06	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241508644G>A	ClinGen:CA165194	C0342770|C0027672|C3661900	606812	24|140162	Fumarate lyase, N-terminal	Arg	Cys	151069.0	single nucleotide variant	NM_000143.4(FH):c.697C>T (p.Arg233Cys)	2271.0	FH	HGNC:3700	Pathogenic	1.0	Dec 18, 2024	587781682.0	-	RCV000129845|RCV000153237|RCV000549060	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241508644.0	241508644.0	1q43	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA165194	2.0	141355.0	241508644.0	G	A	-	-	-	-	-	-	SCV000184662|SCV000230852|SCV000251418|SCV000632484|SCV002535569|SCV002544394|SCV004197373|SCV005625599|SCV005727144	-	-	697C>T 	Arg233Cys	NM_000143.4	2.0	1_Pathogenic	98.76	0.2983870967741935	['606812']	autosomal recessive	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	FUMARASE DEFICIENCY	98.76	0.2983871	10-90	>90						R	74			98.76	Positively-charged	Arginine		Fumarate hydratase, mitochondrial								0.0745		-4.5			4 interactions	4 interactions				R233-E355; PAE: 1.0	4 interactions			R233-E355; PAE: 1.0	4 interactions					175									-131.5		Pocket 2: Mean pLDDT: 99.39, Volume: 605.37 Å³, Druggability score: 0.07		124.2				dbSNP: rs121913123; Variant type: LP/P; AA change: Arg233His; PTM type: Ubiquitylation; PTM morphology: FAQIIkIGR*TH; Var class: II&rs121913123		B (undefined)	E (parallel sheets)	Beta strand																																																																			true	FHArg233Cys																																																																																																																																																																																																																																		
G6PD	G6PD_Gly378Ser	0.44980261220938383	0.6664511291342612	-4.885624293312452	0.001782128546597905	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6963180927629631	0.48943145932509036	0.6154922655511277	0.5605128813650763	0.4720788044319635	0.4090582069321435	0.5162071505102306	0.5846796562437677	0.4342564757227669	0.6487625345346948	0.5350994019317835	0.604818612219922	0.6463048748584876	0.5446064429274138	0.7438736509912314	G6PD	0.44980261220938383	0.6664511291342612	-4.885624293312452	0.001782128546597905	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6963180927629631	0.48943145932509036	0.6154922655511277	0.5605128813650763	0.4720788044319635	0.4090582069321435	0.5162071505102306	0.5846796562437677	0.4342564757227669	0.6487625345346948	0.5350994019317835	0.604818612219922	0.6463048748584876	0.5446064429274138	0.7438736509912314	G6PD		4006		CCSBVarC021515		NC_000023.11:154532722:C:T	1132G>A	Gly378Ser																												23.0	154532722.0	C	T	X						X-154532722-C-T	1780130.0	single nucleotide variant	NM_001360016.2(G6PD):c.1132G>A (p.Gly378Ser)	2539.0	G6PD	HGNC:4057	Conflicting classifications of pathogenicity	1.0	Jan 16, 2025	-1.0	-	RCV002305724|RCV004700721	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MedGen:C3661900	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	154532722.0	154532722.0	Xq28	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA10566075	2.0	1722614.0	154532722.0	C	T	-	-	-	-	-	-	SCV002599268|SCV004299708|SCV005201601	-	-	1132G>A 	Gly378Ser	NM_001360016.2	1.0	3_Conflicting		1722614.0	X	154532722.0	C	T	G	S	rs371489738	X	153760937.0	X	153414131.0	378.0	G6PD	ENSG00000160211	ENST00000696430	ENSP00000512625	P11413	G6PD_HUMAN	.	.	c.1132G>A	p.Gly378Ser	principal4	Y	.	.	.	-	GGC	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.20791	.	.	0.31345	.	1.0	0.90580	D	0.983	0.75798	D	.	0.95575	.	.	.	.	1.855	0.48991	L	.	0.80118	.	.	0.69502	1.0912	0.99286	D	0.9601	0.98711	D	10.0	.	0.90197	.	0.683657	0.97378	D	.	0.92639	.	.	.	.	.	.	0.98330	.	.	.	0.94444	0.661729335785	0.61595	T	0.964038	0.99554	D	0.491478	0.93997	D	0.520035	0.94954	D	0.929728746414185	0.59158	D	0.913609	0.69172	D	0.86035365	0.87950	0.81130373	0.88841	0.857077	0.87700	0.76723653	0.86083	-8.453	0.67258	D	.	0.57080	.	0.987461282210342	0.87449	0.99859923	0.98864	0.905	0.95023	.	.	.	.	.	.	3.113311	0.42085	21.5	0.9960745996289186	0.74605	.	.	.	.	.	.	.	.	.	5.82	5.82	0.9273	4.13	0.78719	7.406	0.79294	3.963000	0.40843	0.585	0.3052	1.0	0.71675	0.999	0.35501	0.232	0.22834	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	79875	0.000000e+00	0	2	150869	1.325650e-05	0	1	171104	5.844400e-06	0	0	5668	0.000000e+00	0	0	13617	0.000000e+00	0	0	1760	0.000000e+00	0	0	6853	0.000000e+00	0	0	9912	0.000000e+00	0	0	30728	0.000000e+00	0	0	9893	0.000000e+00	0	.	.	.	.	0	13060	0.000000e+00	0	0	24309	0.000000e+00	0	0	4622	0.000000e+00	0	0	10047	0.000000e+00	0	0	12156	0.000000e+00	0	2	64114	3.119440e-05	0	0	18959	0.000000e+00	0	2	64114	3.119440e-05	0	0	12003	0.000000e+00	0	0	27090	0.000000e+00	0	0	7058	0.000000e+00	0	0	13231	0.000000e+00	0	0	15912	0.000000e+00	0	1	72783	1.373950e-05	0	0	18893	0.000000e+00	0	1	72783	1.373950e-05	0	.	12	1210896	9.910020e-06	0	1	46682	2.142150e-05	0	0	57586	0.000000e+00	0	0	683	0.000000e+00	0	0	45931	0.000000e+00	0	0	22045	0.000000e+00	0	0	33786	0.000000e+00	0	1	46682	2.142150e-05	0	0	4374	0.000000e+00	0	11	895342	1.228580e-05	0	0	56870	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_conflicting_classifications	NC_000023.11:g.154532722C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Gly	Ser	1780130.0	single nucleotide variant	NM_001360016.2(G6PD):c.1132G>A (p.Gly378Ser)	2539.0	G6PD	HGNC:4057	Conflicting classifications of pathogenicity	1.0	Jan 16, 2025	-1.0	-	RCV002305724|RCV004700721	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MedGen:C3661900	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	154532722.0	154532722.0	Xq28	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA10566075	2.0	1722614.0	154532722.0	C	T	-	-	-	-	-	-	SCV002599268|SCV004299708|SCV005201601	-	-	1132G>A 	Gly378Ser	NM_001360016.2	1.0	3_Conflicting	96.99	0.8571428571428571	['300908']	unknown	Rare genetic hematologic disease	1	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1	96.99	0.85714287	10-90	>90						G	72			96.99	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Glucose-6-phosphate 1-dehydrogenase								0.2364		-0.4			9 interactions	5 interactions														75									69.2		Pocket 4: Mean pLDDT: 97.1, Volume: 445.2 Å³, Druggability score: 0.24		50.9						C (loop/coil)	S (bend)																																																																				true	G6PDGly378Ser																																																																																																																																																																																																																																		
RET	RET_Val292Met	-6.302622328210597	0.00040314669841361	5.126137385468295	0.0013594595445485806	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8549172584177551	0.6681299062495636	0.7834518540724644	0.7300619617316176	0.6060217559944419	0.5597747988299053	0.7418593421567587	0.8053184200824319	0.6489271164433885	0.8696012586804667	0.6522687131589785	0.7182645813064765	0.7615852880624969	0.6873326960557387	0.8402332581550437	RET	-6.302622328210597	0.00040314669841361	5.126137385468295	0.0013594595445485806	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8549172584177551	0.6681299062495636	0.7834518540724644	0.7300619617316176	0.6060217559944419	0.5597747988299053	0.7418593421567587	0.8053184200824319	0.6489271164433885	0.8696012586804667	0.6522687131589785	0.7182645813064765	0.7615852880624969	0.6873326960557387	0.8402332581550437	RET	ENSG00000165731	8858	202956.0	CCSBVarC006880	ALE00006878	NC_000010.11:43106382:G:A	874G>A	Val292Met	CEGS2	CegsMutGDEh1026	H07	GDEhDisVCh_40066	E05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43106382.0	G	A	10	Y	N	N	N	N	10-43106382-G-A	36221.0	single nucleotide variant	NM_020975.6(RET):c.874G>A (p.Val292Met)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Jan 30, 2025	34682185.0	-	RCV000034779|RCV000121992|RCV000276548|RCV000333869|RCV000354891|RCV000755685|RCV000367517|RCV000565970|RCV001083006|RCV003492298	MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C1333600	not provided|not specified|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000010.11	10	43106382.0	43106382.0	10q11.21	criteria provided, conflicting classifications	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009374,UniProtKB:P07949#VAR_041764	2.0	24880.0	43106382.0	G	A	-	-	-	-	-	-	SCV000218577|SCV000362271|SCV000362272|SCV000362273|SCV000362274|SCV000609569|SCV000616852|SCV000674801|SCV000692679|SCV000807063|SCV000838372|SCV000883098|SCV002011440|SCV002527933|SCV002572022|SCV004220049	-	-	874G>A 	Val292Met	NM_020975.6	1.0	3_Conflicting	0.000211869	24880.0	10	43106382.0	G	A	V	M	rs34682185	10	43601830.0	10	42921836.0	292.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.874G>A	p.Val292Met	c.874G>A	p.Val292Met	principal4	Y	5	YES	Select	+	GTG	1.0	0.0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.032	0.53775	D	1.0	0.90580	D	0.935	0.73565	D	0.12	0.31989	N	simple_aae	88.0	12.0	2.615	0.76302	M	-1.09	0.28250	N	0.558	0.60971	0.4163	0.893	D	0.5416	0.83044	D	10.0	0.010467678	0.00229	T	.	.	.	0.409	0.71949	.	.	.	.	.	0.888871705788	0.88692	0.788903358267811	0.78722	1.83343156079	0.92045	0.564820885658	0.47880	T	0.467186	0.80012	T	-0.0978649	0.36423	T	0.0917746	0.76187	D	0.0599002876036932	0.07075	T	0.681032	0.28743	T	0.17939073	0.38700	0.13158411	0.31509	0.22824927	0.45215	0.13554715	0.32360	-8.694	0.65784	D	0.1243	0.33824	B	0.936206762942958	0.78979	0.99984658	0.99806	0.706	0.83697	.	.	.	.	.	.	4.280368	0.6527	24.8	0.9974841052842939	0.84091	0.558315	0.56606	D	0.404318965602062	0.61459	4.370004	0.288787131538424	0.54646	3.6522	4.86	4.86	0.62577	2.99	0.54692	6.727	0.74634	6.639000	0.56245	-0.168	0.1142	0.998	0.41403	1.0	0.68239	0.08	0.17286	862	0.33096	19	0.0037939297124600637	0	0.0	1	9.940357852882703E-4	0	0.0	17	0.016865079365079364	1	0.0010224948875255625	81	264690	3.0601837E-4	.	78	107468	7.257970e-04	0	120	203952	5.883740e-04	0	149	233194	6.389530e-04	0	2	7086	2.822470e-04	0	2	17040	1.173710e-04	0	0	2316	0.000000e+00	0	65	9000	7.222220e-03	0	0	11960	0.000000e+00	0	3	42544	7.051520e-05	0	6	15632	3.838280e-04	0	65	9000	7.222220e-03	0	2	15900	1.257860e-04	0	4	30412	1.315270e-04	0	0	6136	0.000000e+00	0	95	13298	7.143930e-03	0	0	15296	0.000000e+00	0	5	87600	5.707760e-05	0	11	30514	3.604900e-04	0	95	13298	7.143930e-03	0	2	14664	1.363880e-04	0	4	34166	1.170750e-04	0	0	9544	0.000000e+00	0	123	17646	6.970420e-03	0	0	19796	0.000000e+00	0	6	101376	5.918560e-05	0	11	30434	3.614380e-04	0	123	17646	6.970420e-03	0	.	365	1610770	2.266000e-04	5	199	44880	4.434050e-03	2	7	75016	9.331340e-05	0	0	912	0.000000e+00	0	4	60016	6.664890e-05	0	2	29608	6.754930e-05	0	199	44880	4.434050e-03	2	1	61774	1.618800e-05	0	1	5300	1.886790e-04	0	73	1179870	6.187120e-05	0	39	91004	4.285530e-04	3	15	159894	9.381215054973921E-5	0	242	0	21	4726	0.004443504020313161	0	5982	0	0	1146	0	0	1160	0	5	1878	0.0026624068157614484	0	322	0	10	15512	6.446621970087674E-4	0	6224	0	26	6604	0.003937007874015748	51	190862	2.6720876863912143E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer|Multiple_endocrine_neoplasia,_type_2|Hirschsprung_disease,_susceptibility_to,_1|not_provided|not_specified|Multiple_endocrine_neoplasia_type_2B|Pheochromocytoma|Multiple_endocrine_neoplasia|Hereditary_cancer-predisposing_syndrome|Renal_hypodysplasia/aplasia_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106382G>A	ClinGen:CA009374|UniProtKB:P07949#VAR_041764	C1333600|C4048306|C3888239|C3661900|CN169374|C0025269|C0031511|C0027662|C0027672|C1619700	142623|162300|171300|PS131100|191830	653|388|247709|653|29072|276161|140162|411709	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Val	Met	36221.0	single nucleotide variant	NM_020975.6(RET):c.874G>A (p.Val292Met)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Jan 30, 2025	34682185.0	-	RCV000034779|RCV000121992|RCV000276548|RCV000333869|RCV000354891|RCV000755685|RCV000367517|RCV000565970|RCV001083006|RCV003492298	MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C1333600	not provided|not specified|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000010.11	10	43106382.0	43106382.0	10q11.21	criteria provided, conflicting classifications	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009374,UniProtKB:P07949#VAR_041764	2.0	24880.0	43106382.0	G	A	-	-	-	-	-	-	SCV000218577|SCV000362271|SCV000362272|SCV000362273|SCV000362274|SCV000609569|SCV000616852|SCV000674801|SCV000692679|SCV000807063|SCV000838372|SCV000883098|SCV002011440|SCV002527933|SCV002572022|SCV004220049	-	-	874G>A 	Val292Met	NM_020975.6	1.0	3_Conflicting	96.26	0.4718309859154929	['171300', '142623', '191830', '162300']	multiple	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	PHEOCHROMOCYTOMA; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; RENAL HYPODYSPLASIA/APLASIA 1; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	96.26	0.471831	10-90	>90						V	67			96.26	Aliphatic	Valine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										4.2											2 interactions							117									-64.4				123.6	Cadherin-like region 3 (CLD3)					B (undefined)	E (parallel sheets)							Extracellular																																																													true	RETVal292Met																																																																																																																																																																																																																																		
FARS2	FARS2_Gly309Ser	0.9477119419492293	1.0	-3.676692343777721	0.008971916021034814	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9103039678048539	0.6364082683121783	0.8356307801803016	0.8371336980272894	0.7278413145345068	0.8870193180070034	0.8998650905263066	0.9057682218651986	0.7143682582373676	0.9351462181651714	0.5686633110620103	0.7744023055282723	0.7654933384954046	0.5584482783869892	0.8854617174445364	FARS2	0.9477119419492293	1.0	-3.676692343777721	0.008971916021034814	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9103039678048539	0.6364082683121783	0.8356307801803016	0.8371336980272894	0.7278413145345068	0.8870193180070034	0.8998650905263066	0.9057682218651986	0.7143682582373676	0.9351462181651714	0.5686633110620103	0.7744023055282723	0.7654933384954046	0.5584482783869892	0.8854617174445364	FARS2		12653		CCSBVarC011917		NC_000006.12:5545200:G:A	925G>A	Gly309Ser																												6.0	5545200.0	G	A	6						6-5545200-G-A	578624.0	single nucleotide variant	NM_006567.5(FARS2):c.925G>A (p.Gly309Ser)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Feb 23, 2023	746746116.0	-	RCV001092144|RCV000714943	MedGen:C3661900|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not provided|Combined oxidative phosphorylation defect type 14	germline;unknown	germline	GRCh38	NC_000006.12	6	5545200.0	5545200.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA362736415	2.0	587672.0	5545200.0	G	A	-	-	-	-	-	-	SCV000845713|SCV001248521|SCV001582544|SCV003842096	-	-	925G>A 	Gly309Ser	NM_006567.5	2.0	1_Pathogenic		587672.0	6	5545200.0	G	A	G	S	rs746746116	6	5545433.0	6	5490432.0	309.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.925G>A	p.Gly309Ser	c.925G>A	p.Gly309Ser	principal1	Y	1	YES	Select	+	GGC	1.0	0.0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.009	0.67073	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.685	0.94401	H	-5.03	0.82599	D	0.947	0.95504	0.3946	0.88971	D	0.5964	0.85552	D	10.0	0.9779998	0.97630	D	0.369966	0.92707	D	0.885	0.96643	0.858	0.95637	O95363	G309S	Loss of sheet (P = 0.0817)| Gain of disorder (P = 0.1887)| Gain of loop (P = 0.2045)| Loss of catalytic residue at L314 (P = 0.2562)| Gain of MoRF binding (P = 0.4653)	0.888883061527	0.88693	.	0.92879	.	0.58884	0.59725445509	0.52451	T	0.449003	0.78909	T	0.390908	0.89307	D	0.323736	0.89172	D	0.998481690883636	0.94233	D	0.986551	0.95437	D	0.8830356	0.89777	0.78077585	0.86915	0.86086655	0.87992	0.7646657	0.85927	-10.138	0.74812	D	0.436	0.63025	A	0.990712134343876	0.88703	0.96428716	0.94244	0.855	0.92066	.	.	.	.	.	.	5.233765	0.87878	29.4	0.9989230129954837	0.96592	0.940941	0.94336	D	0.851669104685455	0.89143	9.876117	0.738735397986046	0.85233	8.543429	5.27	5.27	0.73761	.	.	9.507	0.96998	11.605000	0.93514	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.947	0.4917	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613742	1.239360e-06	0	1	75024	1.332910e-05	0	1	75024	1.332910e-05	0	0	912	0.000000e+00	0	0	59968	0.000000e+00	0	0	29600	0.000000e+00	0	0	44878	0.000000e+00	0	0	64020	0.000000e+00	0	0	6058	0.000000e+00	0	1	1179784	8.476130e-07	0	0	91016	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5545200G>A	.	C4755312|C3661900	614946	319519	Aminoacyl-tRNA synthetase, class II	Gly	Ser	578624.0	single nucleotide variant	NM_006567.5(FARS2):c.925G>A (p.Gly309Ser)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Feb 23, 2023	746746116.0	-	RCV001092144|RCV000714943	MedGen:C3661900|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not provided|Combined oxidative phosphorylation defect type 14	germline;unknown	germline	GRCh38	NC_000006.12	6	5545200.0	5545200.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA362736415	2.0	587672.0	5545200.0	G	A	-	-	-	-	-	-	SCV000845713|SCV001248521|SCV001582544|SCV003842096	-	-	925G>A 	Gly309Ser	NM_006567.5	2.0	1_Pathogenic	98.62	0.0	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	98.62	0.0	<10	>90						G	0			98.62	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine												-0.4								G309-M294; PAE: 1.0	9 interactions		5 interactions							75									-150.8				167.2						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	FARS2Gly309Ser																																																																																																																																																																																																																																		
F9	F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7688319236128545	0.6229629113384743	0.8089467734818112	0.833398017731984	0.7781896675287779	0.7023750789365777	0.775574737902366	0.7182219560398473	0.6291410557136246	0.7125669134133822	0.8540042561209782	0.8912212975616018	0.8996715909237751	0.6167847669633241	0.8250969338123266	F9	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7688319236128545	0.6229629113384743	0.8089467734818112	0.833398017731984	0.7781896675287779	0.7023750789365777	0.775574737902366	0.7182219560398473	0.6291410557136246	0.7125669134133822	0.8540042561209782	0.8912212975616018	0.8996715909237751	0.6167847669633241	0.8250969338123266	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A	697G>A	Ala233Thr																												23.0	139551238.0	G	A	X						X-139551238-G-A	25640.0	single nucleotide variant	NM_000133.4(F9):c.697G>A (p.Ala233Thr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	387906478.0	-	RCV000011347	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551238.0	139551238.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255365,OMIM:300746.0042	1.0	10601.0	139551238.0	G	A	-	-	-	-	-	-	SCV000031579	-	-	697G>A 	Ala233Thr	NM_000133.4		1_Pathogenic		10601.0	X	139551238.0	G	A	A	T	rs387906478	X	138633397.0	X	138461063.0	233.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.697G>A	p.Ala233Thr	c.697G>A	p.Ala233Thr	principal1	Y	1	YES	Select	+	GCC	1.0	0.0	G	G/G	G/G	G/G	G/G	0.009	0.57638	D	0.02	0.58950	D	0.835	0.46269	P	0.508	0.47888	P	0.81	0.89397	A	simple_aae	19.0	81.0	1.585	0.39718	L	-1.68	0.40077	N	0.205	0.25325	0.2747	0.87093	D	0.8126	0.93664	D	10.0	0.7169125	0.73158	D	0.551716	0.95863	D	0.601	0.84159	0.837	0.94387	P00740	A233T	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.996876262872	0.99680	0.9744568104967672	0.97421	0.692767066121	0.60419	0.402713298798	0.25417	T	0.679272	0.90470	D	0.294947	0.82433	D	0.185895	0.82207	D	0.590011954307556	0.35695	D	0.912709	0.71602	D	0.42786407	0.62291	0.38942766	0.63514	0.37815922	0.58855	0.36422572	0.61553	-7.14	0.59571	T	0.2233	0.46513	B	0.990832113786758	0.88755	0.99996746	0.99978	0.798	0.88827	.	.	.	.	.	.	3.182106	0.43284	21.7	0.998931118990622	0.96668	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	3.93	0.74723	2.501	0.4515	6.519000	0.55895	0.676	0.76753	0.906	0.31665	1.0	0.68239	0.98	0.58201	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139551238G>A	ClinGen:CA255365|OMIM:300746.0042	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Thr	25640.0	single nucleotide variant	NM_000133.4(F9):c.697G>A (p.Ala233Thr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	387906478.0	-	RCV000011347	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551238.0	139551238.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255365,OMIM:300746.0042	1.0	10601.0	139551238.0	G	A	-	-	-	-	-	-	SCV000031579	-	-	697G>A 	Ala233Thr	NM_000133.4		1_Pathogenic	91.81	0.0377358490566037	['306900']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B	91.81	0.03773585	<10	>90						A	4			91.81	Aliphatic	Alanine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			1.8								A233-L369; PAE: 1.0	4 interactions		5 interactions							89									-68.6				153.5						H (helix)	P (polyproline helix)																														0.943		0.832		0.825		0.79		0.821																														true	F9Ala233Thr																																																																																																																																																																																																																																		
KRAS	KRAS_Ile36Met	-3.4018910795778345	0.011413064402871407	6.974814863521124	0.00021634943402749327	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9682996660523797	0.7698090986459005	0.9329100430800257	0.9340733024266595	0.834957656076644	0.6809761632421119	0.8800282469012882	0.8722517432348413	0.5789516080948736	0.9480094506081909	0.9889391489111761	0.9881183579520308	0.9935683429252101	0.9606665891969275	0.9885898814965686	KRAS	-3.4018910795778345	0.011413064402871407	6.974814863521124	0.00021634943402749327	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9682996660523797	0.7698090986459005	0.9329100430800257	0.9340733024266595	0.834957656076644	0.6809761632421119	0.8800282469012882	0.8722517432348413	0.5789516080948736	0.9480094506081909	0.9889391489111761	0.9881183579520308	0.9935683429252101	0.9606665891969275	0.9885898814965686	KRAS	ENSG00000133703	3084	214479.0	CCSBVarC006095	ALE00006095	NC_000012.12:25245277:T:C	108A>G	Ile36Met	CEGS2	CegsMutGDEh1040	D09	GDEhDisVCh_40061	G09	1.0	CegsMutGDDh1040	D09							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25245277.0	T	C	12	Y	Y	N	N	N	12-25245277-T-C	175716.0	single nucleotide variant	NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Oct 23, 2024	727503109.0	-	RCV000150891|RCV000260877|RCV000844636|RCV000856729|RCV002444616|RCV004551310	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:CN230736|	RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Cardiovascular phenotype|KRAS-related disorder	germline;unknown	germline	GRCh38	NC_000012.12	12	25245277.0	25245277.0	12p12.1	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA273162,UniProtKB:P01116#VAR_064854	2.0	163768.0	25245277.0	T	C	-	-	-	-	-	-	SCV000198471|SCV000329772|SCV000919564|SCV000927544|SCV000939441|SCV000999274|SCV002733242	-	-	108A>G 	Ile36Met	NM_004985.5	2.0	1_Pathogenic		163768.0	12	25245277.0	T	C	I	M	rs727503109	12	25398211.0	12	25289478.0	36.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.108A>G	p.Ile36Met	c.108A>G	p.Ile36Met	alternative1	Y	1	.	Plus_Clinical	-	ATA	3.0	3.0	T	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.92967	D	0.999	0.77914	D	0.982	0.75481	D	0.83	0.88920	A	simple_aae	17.0	83.0	3.16	0.88393	M	-2.35	0.60859	N	0.866	0.95970	0.6818	0.92922	D	0.7745	0.92315	D	10.0	0.90810716	0.90066	D	0.260605	0.89466	D	0.864	0.95865	0.768	0.89476	P01116	I36M	Gain of catalytic residue at E31 (P = 0.0146)| Gain of disorder (P = 0.0401)| Gain of phosphorylation at Y40 (P = 0.0722)| Gain of glycosylation at T35 (P = 0.271)| Loss of sheet (P = 0.302)	0.957860125292	0.95704	0.8805200537522034	0.87945	2.38980543874	0.97077	0.802328705788	0.82287	T	0.899405	0.97995	D	0.388059	0.89138	D	0.319644	0.89001	D	0.964436054229736	0.66744	D	0.819518	0.90586	T	0.9472728	0.95925	0.8332933	0.90274	0.9514009	0.96352	0.7634177	0.85851	-13.662	0.93015	D	0.9755	0.92907	P	0.999853564238121	0.98365	0.99868040	0.98905	0.979	0.99252	.	.	.	.	.	.	3.518299	0.49383	22.8	0.9953910662710375	0.70435	0.242004	0.36148	N	0.613285447805062	0.73875	6.061257	0.51615875806198	0.68905	5.309093	5.68	4.51	0.54535	1.47	0.33823	0.81	0.26933	2.363000	0.32466	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.998	0.85369	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardiovascular_phenotype|Cardiofaciocutaneous_syndrome_1|RASopathy|not_provided|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|KRAS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245277T>C	ClinGen:CA273162|UniProtKB:P01116#VAR_064854	CN230736|CN029449|C5555857|C3661900|C0028326|C1275081	115150|PS163950|PS115150	1340|536391|648|1340	Small GTP-binding domain	Ile	Met	175716.0	single nucleotide variant	NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Oct 23, 2024	727503109.0	-	RCV000150891|RCV000260877|RCV000844636|RCV000856729|RCV002444616|RCV004551310	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:CN230736|	RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Cardiovascular phenotype|KRAS-related disorder	germline;unknown	germline	GRCh38	NC_000012.12	12	25245277.0	25245277.0	12p12.1	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA273162,UniProtKB:P01116#VAR_064854	2.0	163768.0	25245277.0	T	C	-	-	-	-	-	-	SCV000198471|SCV000329772|SCV000919564|SCV000927544|SCV000939441|SCV000999274|SCV002733242	-	-	108A>G 	Ile36Met	NM_004985.5	2.0	1_Pathogenic	83.3	0.621301775147929	['115150']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 1	83.3	0.6213018	10-90	70-90																																																																																																																																		true	KRASIle36Met																																																																																																																																																																																																																																		
SDHD	SDHD_Gly106Val	3.3461453651413797	0.013103277931052443	-1.3929891888092047	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7845533360464242	0.6848007828976678	0.8257331149792714	0.8207154502758078	0.7666654492013867	0.7781633021684375	0.8343392162525063	0.8582827131921871	0.6972959118318091	0.7996012165652717	0.7551675962343357	0.8070916842991093	0.7931835167663557	0.6723056539635265	0.7695054555275767	SDHD	3.3461453651413797	0.013103277931052443	-1.3929891888092047	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7845533360464242	0.6848007828976678	0.8257331149792714	0.8207154502758078	0.7666654492013867	0.7781633021684375	0.8343392162525063	0.8582827131921871	0.6972959118318091	0.7996012165652717	0.7551675962343357	0.8070916842991093	0.7931835167663557	0.6723056539635265	0.7695054555275767	SDHD		6363		CCSBVarC023331		NC_000011.10:112094807:G:T	317G>T	Gly106Val																												11.0	112094807.0	G	T	11						11-112094807-G-T	476439.0	single nucleotide variant	NM_003002.4(SDHD):c.317G>T (p.Gly106Val)	6392.0	SDHD	HGNC:10683	Pathogenic/Likely pathogenic	1.0	Sep 01, 2024	1555187574.0	-	RCV000561906|RCV000660262|RCV002232089|RCV004808786|RCV003420005	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|not provided|SDHD-related disorder	germline	germline	GRCh38	NC_000011.10	11	112094807.0	112094807.0	11q23.1	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382618730	2.0	480806.0	112094807.0	G	T	-	-	-	-	-	-	SCV000664565|SCV000782286|SCV000961779|SCV004107262|SCV005434052	-	-	317G>T 	Gly106Val	NM_003002.4	2.0	1_Pathogenic		480806.0	11	112094807.0	G	T	G	V	rs1555187574	11	111965531.0	11	111470741.0	106.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.317G>T	p.Gly106Val	c.317G>T	p.Gly106Val	principal1	Y	1	YES	Select	+	GGC	2.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.006	0.70891	D	1.0	0.90580	D	0.99	0.78943	D	0.78	0.86494	A	simple_aae	22.0	78.0	.	.	.	-8.4	0.97150	D	0.975	0.98575	0.8648	0.95197	D	0.9966	0.9992	D	10.0	0.99544626	0.99985	D	0.45813	0.94454	D	0.929	0.98302	0.982	0.99827	O14521	G106V	Loss of sheet (P = 0.0817)| Gain of helix (P = 0.132)| Loss of catalytic residue at L107 (P = 0.1641)| Loss of loop (P = 0.2237)| Loss of relative solvent accessibility (P = 0.3219)	0.957054369045	0.95622	0.98444967902886	0.98430	0.842846843757	0.67951	0.55555254221	0.46573	T	0.980291	0.99837	D	0.324438	0.84673	D	0.228256	0.84473	D	0.993092656135559	0.83635	D	0.79822	0.47259	T	0.94609135	0.95803	0.9640038	0.99168	0.9659864	0.97841	0.9694429	0.99432	-12.833	0.90765	D	0.8109	0.77749	P	0.998577411365903	0.94680	0.99942360	0.99371	0.988	0.99594	.	.	.	.	.	.	4.321877	0.66223	24.9	0.988150456440217	0.46791	0.966887	0.98931	D	0.927619938196907	0.93007	11.78742	0.847271321840749	0.92817	11.67327	4.53	4.53	0.54956	.	.	9.578	0.97363	9.853000	0.82031	0.672	0.70176	1.0	0.71675	1.0	0.68239	0.998	0.85369	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Paragangliomas_1|SDHD-related_disorder|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112094807G>T	ClinGen:CA382618730	C3494181|C1847319|C0031511|CN166604|C1868633|C0027672	168000|606864|171300	29072|97286|29072|201|140162	.	Gly	Val	476439.0	single nucleotide variant	NM_003002.4(SDHD):c.317G>T (p.Gly106Val)	6392.0	SDHD	HGNC:10683	Pathogenic/Likely pathogenic	1.0	Sep 01, 2024	1555187574.0	-	RCV000561906|RCV000660262|RCV002232089|RCV004808786|RCV003420005	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|not provided|SDHD-related disorder	germline	germline	GRCh38	NC_000011.10	11	112094807.0	112094807.0	11q23.1	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382618730	2.0	480806.0	112094807.0	G	T	-	-	-	-	-	-	SCV000664565|SCV000782286|SCV000961779|SCV004107262|SCV005434052	-	-	317G>T 	Gly106Val	NM_003002.4	2.0	1_Pathogenic	98.58	0.4642857142857143	['168000', '606864', '171300']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	98.58	0.4642857	10-90	>90						G	39			98.58	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-0.4								G106-V110, G106-H102; PAE: 1.0, 1.0	2 interactions	G106-V110, G106-H102; PAE: 1.0, 1.0	2 interactions							75									-59.6		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-51.8						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDGly106Val																																																																																																																																																																																																																																		
FARS2	FARS2_His135Asp	2.635252319289227	1.0	-1.036882426271927	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6329965681587391	0.5594846308642165	0.7404482441046034	0.6507351842963519	0.7128990832586051	0.785308606661879	0.6754433308184951	0.8122260731565495	0.569307399872398	0.664676040723288	0.6404895598553311	0.6260270377742088	0.6686704150526575	0.5496618618560352	0.6013170955941902	FARS2	2.635252319289227	1.0	-1.036882426271927	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6329965681587391	0.5594846308642165	0.7404482441046034	0.6507351842963519	0.7128990832586051	0.785308606661879	0.6754433308184951	0.8122260731565495	0.569307399872398	0.664676040723288	0.6404895598553311	0.6260270377742088	0.6686704150526575	0.5496618618560352	0.6013170955941902	FARS2		12653		CCSBVarC011938		NC_000006.12:5368973:C:G	403C>G	His135Asp																												6.0	5368973.0	C	G	6						6-5368973-C-G	211250.0	single nucleotide variant	NM_006567.5(FARS2):c.403C>G (p.His135Asp)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	1554169353.0	-	RCV000714939	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5368973.0	5368973.0	6p25.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA321889	2.0	214339.0	5368973.0	C	G	-	-	-	-	-	-	SCV000845706	-	-	403C>G 	His135Asp	NM_006567.5	1.0	1_Pathogenic		214339.0	6	5368973.0	C	G	H	D	rs1554169353	6	5369206.0	6	5314205.0	135.0	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.403C>G	p.His135Asp	c.403C>G	p.His135Asp	principal1	Y	1	.	.	+	CAC	1.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.485	0.98910	H	-8.41	0.97166	D	0.959	0.96886	0.5303	0.90933	D	0.6251	0.8677	D	10.0	0.9888847	0.99321	D	0.373027	0.92777	D	0.882	0.96531	0.912	0.98259	O95363	H135D	Gain of ubiquitination at K140 (P = 0.0395)| Gain of methylation at K140 (P = 0.0835)| Gain of phosphorylation at S137 (P = 0.1076)| Gain of disorder (P = 0.1088)| Gain of relative solvent accessibility (P = 0.1571)	0.967068046118	0.96641	0.9676189548153906	0.96731	0.789096686981	0.65457	0.638907074928	0.58343	T	0.608311	0.87433	D	0.392218	0.89385	D	0.325617	0.8925	D	0.999627828598022	0.98192	D	.	0.69489	.	0.9517225	0.96384	0.93154466	0.97160	0.93853235	0.95023	0.92687786	0.96834	-9.08	0.68288	D	0.9357	0.85478	LP	0.999854978671078	0.98365	0.97500426	0.95060	0.978	0.99209	.	.	.	.	.	.	4.904405	0.80679	27.4	0.9938643746606328	0.62166	0.882442	0.80986	D	1.00590361464167	0.95901	14.10817	0.89920352941961	0.95512	13.71825	5.38	5.38	0.77246	.	.	7.564	0.81354	7.594000	0.61402	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.67	0.33292	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5368973C>G	.	C4755312	614946	319519	Phenylalanyl-tRNA synthetase	His	Asp	211250.0	single nucleotide variant	NM_006567.5(FARS2):c.403C>G (p.His135Asp)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	1554169353.0	-	RCV000714939	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5368973.0	5368973.0	6p25.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA321889	2.0	214339.0	5368973.0	C	G	-	-	-	-	-	-	SCV000845706	-	-	403C>G 	His135Asp	NM_006567.5	1.0	1_Pathogenic	96.5	0.1358695652173913	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	96.5	0.13586956	10-90	>90						H	25			96.5	Positively-charged	Histidine												-3.2											1 interaction							155									-63.0				132.7						C (loop/coil)	C (loop/coil)																																																																				true	FARS2His135Asp																																																																																																																																																																																																																																		
SDHD	SDHD_Gly138Val	4.8838800111042024	0.0027079461804252287	-12.876055682927632	0.000013797877181555869	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8744542438788495	0.6715336785411932	0.854713851177642	0.8536417553780986	0.8110807466746801	0.7797279374041838	0.842939506578824	0.8371611674748377	0.6466604887656755	0.8372653544475047	0.8424335559451765	0.8643440041773732	0.8722665348804463	0.696406868316711	0.9116431333101943	SDHD	4.8838800111042024	0.0027079461804252287	-12.876055682927632	0.000013797877181555869	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8744542438788495	0.6715336785411932	0.854713851177642	0.8536417553780986	0.8110807466746801	0.7797279374041838	0.842939506578824	0.8371611674748377	0.6466604887656755	0.8372653544475047	0.8424335559451765	0.8643440041773732	0.8722665348804463	0.696406868316711	0.9116431333101943	SDHD		6363		CCSBVarC023367		NC_000011.10:112094903:G:T	413G>T	Gly138Val																												11.0	112094903.0	G	T	11						11-112094903-G-T	461681.0	single nucleotide variant	NM_003002.4(SDHD):c.413G>T (p.Gly138Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Nov 24, 2024	1401695686.0	-	RCV002526127|RCV003999154	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112094903.0	112094903.0	11q23.1	criteria provided, conflicting classifications	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382619290	2.0	465238.0	112094903.0	G	T	-	-	-	-	-	-	SCV000640163|SCV004830039	-	-	413G>T 	Gly138Val	NM_003002.4	1.0	3_Conflicting		465238.0	11	112094903.0	G	T	G	V	rs1401695686	11	111965627.0	11	111470837.0	138.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.413G>T	p.Gly138Val	c.413G>T	p.Gly138Val	principal1	Y	1	YES	Select	+	GGG	2.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.003	0.76775	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	3.83	0.95555	H	-7.91	0.96234	D	0.976	0.99026	0.9995	0.97172	D	0.989	0.99688	D	10.0	0.98711103	0.99050	D	0.662484	0.97162	D	0.973	0.99718	0.895	0.97537	O14521	G138V	Loss of sheet (P = 0.0315)| Gain of helix (P = 0.062)| Gain of catalytic residue at G138 (P = 0.2062)| Loss of stability (P = 0.6621)| Gain of MoRF binding (P = 0.7378)	0.994972793835	0.99485	0.986906335179873	0.98679	0.842846843757	0.67951	0.839876294136	0.88056	D	0.976803	0.99782	D	0.585153	0.97294	D	0.602755	0.97251	D	0.999767601490021	0.98872	D	0.944306	0.78902	D	0.9838489	0.99378	0.979656	0.99806	0.9838489	0.99378	0.979656	0.99807	-15.193	0.98253	D	0.7584	0.75365	P	0.999416088640572	0.96520	0.99923384	0.99231	0.965	0.98576	.	.	.	.	.	.	4.689578	0.75179	26.3	0.9977590809294831	0.86358	0.951372	0.96574	D	0.993936175157801	0.95530	13.73274	0.911916477651707	0.96049	14.27025	4.85	4.85	0.62327	.	.	9.578	0.97363	11.775000	0.95964	0.672	0.70176	1.0	0.71675	1.0	0.68239	1.0	0.97202	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_conflicting_classifications	NC_000011.10:g.112094903G>T	ClinGen:CA382619290	C1847319|C0031511|CN166604|C1868633|C1708353	606864|171300	97286|29072|201|29072	.	Gly	Val	461681.0	single nucleotide variant	NM_003002.4(SDHD):c.413G>T (p.Gly138Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Nov 24, 2024	1401695686.0	-	RCV002526127|RCV003999154	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112094903.0	112094903.0	11q23.1	criteria provided, conflicting classifications	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382619290	2.0	465238.0	112094903.0	G	T	-	-	-	-	-	-	SCV000640163|SCV004830039	-	-	413G>T 	Gly138Val	NM_003002.4	1.0	3_Conflicting	98.81	0.4761904761904761	['606864', '171300']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	98.81	0.47619048	10-90	>90						G	40			98.81	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										-0.4				3 interactions				G138-F142, G138-L134; PAE: 1.0, 1.0	2 interactions	G138-F142, G138-L134; PAE: 1.0, 1.0	2 interactions							75									-63.5				-41.9						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDGly138Val																																																																																																																																																																																																																																		
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9619565310873566	0.7966381301891121	0.8761988313260338	0.855096171245849	0.6829798738936956	0.6795327325368467	0.7698384278762065	0.8354864060599599	0.7273285479599236	0.945990142142907	0.6864270152505447	0.9403539146154916	0.9169112565921076	0.8659477124183007	0.977922920031806	F9	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9619565310873566	0.7966381301891121	0.8761988313260338	0.855096171245849	0.6829798738936956	0.6795327325368467	0.7698384278762065	0.8354864060599599	0.7273285479599236	0.945990142142907	0.6864270152505447	0.9403539146154916	0.9169112565921076	0.8659477124183007	0.977922920031806	F9	ENSG00000101981	52861	204396.0	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139562042.0	T	C	X	Y	N	N	N	N	X-139562042-T-C	25667.0	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852269.0	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042.0	139562042.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1.0	10628.0	139562042.0	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic		10628.0	X	139562042.0	T	C	W	R	rs137852269	X	138644201.0	X	138471867.0	453.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1.0	0.0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10.0	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.9978	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667.0	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852269.0	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042.0	139562042.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1.0	10628.0	139562042.0	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic	97.31	0.0969162995594713	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	97.31	0.0969163	<10	>90						W	22			97.31	Aromatic	Tryptophan		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.9								W453-K457; PAE: 1.0	2 interactions	W453-K457; PAE: 1.0	3 interactions							204									-66.9				-41.7						H (helix)	H (α-helix)	Helix																													0.112	1 mutation(s) (Trp453Arg: 0.005)	0.073	1 mutation(s) (Trp453Lys: -0.000)	0.035	4 mutation(s) (Trp453Pro: -0.021, Trp453His: -0.008, Trp453Val: -0.007, Trp453Lys: -0.005)	0.041	1 mutation(s) (Trp453Pro: -0.004)	0.041	6 mutation(s) (Trp453Pro: -0.049, Trp453Lys: -0.008, Trp453Glu: -0.007, Trp453Ile: -0.005, Trp453Cys: -0.002, Trp453Gln: -0.002)																													true	F9Trp453Arg																																																																																																																																																																																																																																		
BRAF	BRAF_Asp565Glu	-2.6309360210738006	0.0338665149617909	2.7720035823390834	0.027614311127530596	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6802288408842598	0.5159900886793527	0.6579515589015809	0.6313349499659824	0.526406222494298	0.552685161673155	0.6687514949660767	0.6391403118674894	0.5217539669056006	0.7068440226909102	0.5001272833154411	0.5939184049658881	0.6767628059356723	0.5102262104531048	0.6536136590776095	BRAF	-2.6309360210738006	0.0338665149617909	2.7720035823390834	0.027614311127530596	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6802288408842598	0.5159900886793527	0.6579515589015809	0.6313349499659824	0.526406222494298	0.552685161673155	0.6687514949660767	0.6391403118674894	0.5217539669056006	0.7068440226909102	0.5001272833154411	0.5939184049658881	0.6767628059356723	0.5102262104531048	0.6536136590776095	BRAF	ENSG00000157764	71969	220613.0	CCSBVarC003170	ALE00003170	NC_000007.14:140754233:A:C	1695T>G	Asp565Glu	CEGS2	CegsMutGDEh1012	F06	GDEhDisVCh_40058	F04	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140754233.0	A	C	7	Y	N	N	N	N	7-140754233-A-C	48853.0	single nucleotide variant	NM_004333.6(BRAF):c.1695T>G (p.Asp565Glu)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Dec 29, 2016	397507480.0	-	RCV000037927|RCV000207514|RCV001813224	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733	Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome and Noonan-related syndrome	de novo;germline	germline	GRCh38	NC_000007.14	7	140754233.0	140754233.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA280016	2.0	40383.0	140754233.0	A	C	-	-	-	-	-	-	SCV000061591|SCV000263068|SCV002060706	-	-	1695T>G 	Asp565Glu	NM_004333.6	2.0	1_Pathogenic		40383.0	7	140754233.0	A	C	D	E	rs397507480	7	140454033.0	7	140100502.0	565.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1695T>G	p.Asp565Glu	c.1695T>G	p.Asp565Glu	principal4	Y	.	YES	Select	-	GAT	3.0	2.0	A	A/A	A/A	A/A	A/A	.	.	.	.	.	.	0.008	0.14667	B	0.025	0.20509	B	.	0.76851	.	.	.	.	-0.19	0.04221	N	.	.	.	.	.	-1.062	0.11274	T	0.0795	0.31365	T	10.0	0.86869705	0.85975	D	.	.	.	.	0.82085	0.809	0.92541	P15056	D565E	Gain of catalytic residue at D565 (P = 0.0544)| Gain of ubiquitination at K570 (P = 0.1162)| Gain of methylation at K570 (P = 0.1449)| Gain of disorder (P = 0.2432)| Loss of helix (P = 0.3949)	.	0.97114	.	0.85572	.	0.71418	0.891400456429	0.95428	D	0.799272	0.94819	D	0.275835	0.80817	D	0.158442	0.8057	D	0.875816404819489	0.52308	D	0.918508	0.70644	D	0.80036193	0.83724	0.73096305	0.83912	0.8693574	0.88657	0.7036775	0.82332	-8.348	0.63492	D	0.9665	0.94256	P	0.983874848762311	0.86325	0.99816126	0.98658	0.689	0.82741	.	.	.	.	.	.	4.448549	0.69197	25.3	0.9930513692806591	0.58857	0.621801	0.60495	D	0.388200223436253	0.60579	4.271038	0.431391921300296	0.63332	4.588634	5.26	4.11	0.4729	5.52	0.94476	3.206	0.50896	9.383000	0.80559	0.756	0.943	1.0	0.71675	1.0	0.68239	1.0	0.97202	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	2	426	0.004694835680751174	0	0	0	0	0	0	0	0	0	0	0	0	1	52	0.019230769230769232	2	426	0.004694835680751174	0	0	0	3	478	0.006276150627615063	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140754233A>C	ClinGen:CA280016	C1275081|C5681679|C3661900	PS115150	1340|98733	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Asp	Glu	48853.0	single nucleotide variant	NM_004333.6(BRAF):c.1695T>G (p.Asp565Glu)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Dec 29, 2016	397507480.0	-	RCV000037927|RCV000207514|RCV001813224	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733	Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome and Noonan-related syndrome	de novo;germline	germline	GRCh38	NC_000007.14	7	140754233.0	140754233.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA280016	2.0	40383.0	140754233.0	A	C	-	-	-	-	-	-	SCV000061591|SCV000263068|SCV002060706	-	-	1695T>G 	Asp565Glu	NM_004333.6	2.0	1_Pathogenic	98.17	0.2515337423312883		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		98.17	0.25153375	10-90	>90						D	41			98.17	Negatively-charged	Aspartic Acid		Serine/threonine-protein kinase B-raf							Protein kinase			-3.5			39 interactions	41 interactions				D565-A569, D565-A561; PAE: 1.0, 1.0	72 interactions	D565-A569, D565-A561; PAE: 1.0, 1.0	73 interactions							132									-57.1				-46.0						H (helix)	H (α-helix)	Helix																																																																			true	BRAFAsp565Glu																																																																																																																																																																																																																																		
BRAF	BRAF_Leu485Phe	-3.8216848768826113	0.006527941362460827	3.8578981633103693	0.006228415739546075	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6517280676640009	0.5162358940038911	0.642723689256728	0.5718590262572807	0.5544082852957748	0.5105169863396426	0.5661450889840837	0.6268169169653752	0.5124263589993301	0.6849601012265331	0.598299584251907	0.5775729635304778	0.6586304615480807	0.5200454290084522	0.6184960341014689	BRAF	-3.8216848768826113	0.006527941362460827	3.8578981633103693	0.006228415739546075	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6517280676640009	0.5162358940038911	0.642723689256728	0.5718590262572807	0.5544082852957748	0.5105169863396426	0.5661450889840837	0.6268169169653752	0.5124263589993301	0.6849601012265331	0.598299584251907	0.5775729635304778	0.6586304615480807	0.5200454290084522	0.6184960341014689	BRAF	ENSG00000157764	71969	220605.0	CCSBVarC003163	ALE00003163	NC_000007.14:140778053:C:G	1455G>C	Leu485Phe	CEGS2	CegsMutGDEh1018	H07	GDEhDisVCh_40058	A07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140778053.0	C	G	7	Y	N	N	N	N	7-140778053-C-G	29014.0	single nucleotide variant	NM_004333.6(BRAF):c.1455G>C (p.Leu485Phe)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Feb 28, 2020	180177036.0	-	RCV000208764|RCV001172276|RCV003415705|RCV004018629|RCV000680805|RCV000015009|RCV001849264|RCV000211749	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Cardio-facio-cutaneous syndrome|RASopathy|BRAF-related disorder|Cardiovascular phenotype|not provided|Cardiofaciocutaneous syndrome 1|Ataxia-telangiectasia syndrome|Noonan syndrome;Cardio-facio-cutaneous syndrome	germline	germline	GRCh38	NC_000007.14	7	140778053.0	140778053.0	7q34	reviewed by expert panel	13.0	-	N	ClinGen:CA273414,UniProtKB:P15056#VAR_026115,OMIM:164757.0015	3.0	13975.0	140778053.0	C	G	-	-	-	-	-	-	SCV001335323	-	-	1455G>C 	Leu485Phe	NM_004333.6	3.0	1_Pathogenic		13975.0	7	140778053.0	C	G	L	F	rs180177036	7	140477853.0	7	140124322.0	485.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1455G>C	p.Leu485Phe	c.1455G>C	p.Leu485Phe	principal4	Y	.	YES	Select	-	TTG	3.0	2.0	C	./.	./.	./.	./.	.	0.20412	.	.	.	.	0.264	0.31620	B	0.309	0.41361	B	.	0.97926	.	.	.	.	1.13	0.28751	L	.	0.43153	.	.	.	-0.7046	0.60048	T	0.177	0.52004	T	9.0	0.94275165	0.93527	D	0.08652	0.74669	D	.	0.91679	0.859	0.95694	P15056	L485F	Gain of catalytic residue at L485 (P = 0.046)| Loss of ubiquitination at K483 (P = 0.1322)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.1405)| Loss of glycosylation at P490 (P = 0.2882)	.	0.99026	.	0.81127	.	0.95017	0.899181604385	0.96345	D	0.854571	0.96693	D	0.40148	0.89929	D	0.338922	0.89804	D	0.993222117424011	0.8381	D	0.993067	0.97789	D	0.9472474	0.95923	0.87014675	0.92780	0.94315636	0.95501	0.88148624	0.93580	-10.017	0.74092	D	0.9978	0.97942	P	0.999864334331402	0.98431	0.99597543	0.97927	0.953	0.97907	.	.	.	.	.	.	4.137508	0.6203	24.4	0.9989276897146067	0.96668	0.649139	0.62235	D	0.19994089429288	0.50957	3.302872	0.260588829807926	0.53010	3.495244	5.03	4.14	0.47761	4.1	0.78208	5.0	0.63767	4.860000	0.45538	0.545	0.25635	1.0	0.71675	1.0	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	BRAF-related_disorder|Ataxia-telangiectasia_syndrome|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiofaciocutaneous_syndrome_1|Cardiovascular_phenotype|not_provided|RASopathy	reviewed_by_expert_panel	NC_000007.14:g.140778053C>G	ClinGen:CA273414|OMIM:164757.0015|UniProtKB:P15056#VAR_026115	C0004135|C0028326|C1275081|CN029449|CN230736|C3661900|C5555857	208900|PS163950|PS115150|115150	100|648|1340|1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Leu	Phe	29014.0	single nucleotide variant	NM_004333.6(BRAF):c.1455G>C (p.Leu485Phe)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Feb 28, 2020	180177036.0	-	RCV000208764|RCV001172276|RCV003415705|RCV004018629|RCV000680805|RCV000015009|RCV001849264|RCV000211749	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Cardio-facio-cutaneous syndrome|RASopathy|BRAF-related disorder|Cardiovascular phenotype|not provided|Cardiofaciocutaneous syndrome 1|Ataxia-telangiectasia syndrome|Noonan syndrome;Cardio-facio-cutaneous syndrome	germline	germline	GRCh38	NC_000007.14	7	140778053.0	140778053.0	7q34	reviewed by expert panel	13.0	-	N	ClinGen:CA273414,UniProtKB:P15056#VAR_026115,OMIM:164757.0015	3.0	13975.0	140778053.0	C	G	-	-	-	-	-	-	SCV001335323	-	-	1455G>C 	Leu485Phe	NM_004333.6	3.0	1_Pathogenic	82.49	0.0304878048780487	['115150', '208900']	multiple	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1; ATAXIA-TELANGIECTASIA	82.49	0.030487806	<10	70-90						L	5			82.49	Aliphatic	Leucine		Serine/threonine-protein kinase B-raf							Protein kinase			3.8								L485-L525; PAE: 1.5	56 interactions		38 interactions							131									-81.5				147.6						B (undefined)	E (parallel sheets)																										6.959																																										true	BRAFLeu485Phe																																																																																																																																																																																																																																		
RAD51D	RAD51D_Thr328Ile	0.5151692477436156	0.6222994408448728	18.307890143801558	3.5923133391567124e-7	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9727112122888528	0.8379999304698407	0.9257155415156472	0.9259802467499594	0.8366962476282629	0.7437025918455918	0.9031293954033862	0.8935058931837492	0.7639484780788016	0.9760822387039301	0.929689903410934	0.9488310980965327	0.9579251898475452	0.9120513828608797	0.9693401858737757	RAD51D	0.5151692477436156	0.6222994408448728	18.307890143801558	3.5923133391567124e-7	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9727112122888528	0.8379999304698407	0.9257155415156472	0.9259802467499594	0.8366962476282629	0.7437025918455918	0.9031293954033862	0.8935058931837492	0.7639484780788016	0.9760822387039301	0.929689903410934	0.9488310980965327	0.9579251898475452	0.9120513828608797	0.9693401858737757	RAD51D		7201		CCSBVarC024896		NC_000017.11:35100957:G:A	983C>T	Thr328Ile																												17.0	35100957.0	G	A	17						17-35100957-G-A	151057.0	single nucleotide variant	NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 03, 2025	138969595.0	-	RCV000129828|RCV000254688|RCV000411668|RCV000859034|RCV003935215	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35100957.0	35100957.0	17q12	criteria provided, conflicting classifications	11.0	-	N	ClinGen:CA294126	2.0	141343.0	35100957.0	G	A	-	-	-	-	-	-	SCV000184643|SCV000211662|SCV000488575|SCV000551327|SCV000902869|SCV001134809|SCV001140402|SCV001363868|SCV002527059|SCV004017733	-	-	983C>T 	Thr328Ile	NM_002878.4	1.0	3_Conflicting		141343.0	17	35100957.0	G	A	T	I	rs138969595	17	33427976.0	17	30452089.0	328.0	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.983C>T	p.Thr328Ile	c.983C>T	p.Thr328Ile	principal1	Y	1	YES	Select	-	ACA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.0	0.02950	B	0.001	0.04348	B	0.0	0.01751	N	simple_aae	100.0	0.0	0.145	0.08752	N	-1.32	0.32965	N	0.053	0.21823	-1.0435	0.16258	T	0.0417	0.17815	T	10.0	0.009995133	0.00221	T	0.006771	0.17625	T	0.026	0.05575	.	.	.	.	.	0.207176502487	0.19935	.	0.26638	.	0.45724	.	.	.	0.115639	0.43135	T	-0.601611	0.00139	T	-0.677482	0.06933	T	0.075320455379959	0.09265	T	.	0.22097	.	0.08105616	0.18434	0.09681502	0.22979	0.08105616	0.18434	0.09681502	0.22979	-4.387	0.29411	T	0.1002	0.28639	LB	4.77421596645541e-05	0.01873	0.28552076	0.76376	0.032	0.06833	.	.	.	.	.	.	1.075211	0.14598	11.14	0.5994044997703651	0.06433	0.051862	0.09058	N	-1.19812197881439	0.04971	0.2282938	-1.22724989160509	0.05389	0.2610204	5.12	-1.75	0.07582	-1.09	0.15326	-0.5	0.065	-0.087000	0.12155	-0.119	0.14328	0.0	0.06393	0.0	0.08389	0.07	0.16685	914	0.21043	4	7.987220447284345E-4	4	0.0030257186081694403	0	0.0	0	0.0	0	0.0	0	0.0	76	264690	2.8712835E-4	.	6	109408	5.484060e-05	0	19	208136	9.128650e-05	0	17	236950	7.174510e-05	0	6	7164	8.375210e-04	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	6	7164	8.375210e-04	0	17	16218	1.048220e-03	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89558	0.000000e+00	0	1	30608	3.267120e-05	0	17	16218	1.048220e-03	0	14	14902	9.394710e-04	0	2	34260	5.837710e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102746	0.000000e+00	0	1	30526	3.275900e-05	0	14	14902	9.394710e-04	0	.	96	1611324	5.957830e-05	1	80	74978	1.066980e-03	1	80	74978	1.066980e-03	1	0	912	0.000000e+00	0	4	60018	6.664670e-05	0	0	29586	0.000000e+00	0	0	44862	0.000000e+00	0	0	64034	0.000000e+00	0	2	6032	3.315650e-04	0	0	1177472	0.000000e+00	0	2	91016	2.197420e-05	0	1	163022	6.13414140422765E-6	0	360	0	0	2712	0	9	9362	9.613330484939116E-4	0	442	0	0	950	0	0	682	0	0	280	0	0	11320	0	9	9722	9.257354453816088E-4	0	3394	0	10	189130	5.287368476709142E-5	Conflicting_classifications_of_pathogenicity	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|RAD51D-related_disorder|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35100957G>A	ClinGen:CA294126	C3280345|C0027672|CN169374|C3661900	614291	145|140162	.	Thr	Ile	151057.0	single nucleotide variant	NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 03, 2025	138969595.0	-	RCV000129828|RCV000254688|RCV000411668|RCV000859034|RCV003935215	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35100957.0	35100957.0	17q12	criteria provided, conflicting classifications	11.0	-	N	ClinGen:CA294126	2.0	141343.0	35100957.0	G	A	-	-	-	-	-	-	SCV000184643|SCV000211662|SCV000488575|SCV000551327|SCV000902869|SCV001134809|SCV001140402|SCV001363868|SCV002527059|SCV004017733	-	-	983C>T 	Thr328Ile	NM_002878.4	1.0	3_Conflicting	39.66	1.0	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	39.66	1.0	$\geqslant$90	<=50						T	217			39.66	Polar/Neutral	Threonine		DNA repair protein RAD51 homolog 4										-0.7																		119									63.9				360.0						C (loop/coil)	C (loop/coil)																																																																				true	RAD51DThr328Ile																																																																																																																																																																																																																																		
FH	FH_Arg160Gly	7.053545849662073	0.00040631942806925705	-6.7751149070571115	0.0002590061663729525	2025_01_Batch_13-14	true	true	true	true	true	true	true	true	true	true	0.9975807407127623	0.993994406740671	0.9927809552237875	0.9837924347182717	0.9376294565533879	0.9376294565533879	0.9837924347182717	0.9927809552237875	0.993994406740671	0.9975807407127623						FH	7.053545849662073	0.00040631942806925705	-6.7751149070571115	0.0002590061663729525	2025_01_Batch_13-14	true	true	true	true	true	true	true	true	true	true	0.9975807407127623	0.993994406740671	0.9927809552237875	0.9837924347182717	0.9376294565533879	0.9376294565533879	0.9837924347182717	0.9927809552237875	0.993994406740671	0.9975807407127623						FH	ENSG00000091483	3408	5856.0	CCSBVarC000453	ALE00000453	NC_000001.11:241512044:T:C	478A>G	Arg160Gly	RC4	RC4_Mut_GDEh1025	H02	GDEhDisVCh_40065	H11	1.0	RC4_Mut_GDDh1025	H02							1.0	7.0	1.0	99.0	0.0			0.0			0.0			1.0	241512044.0	T	C	1	N	N	N	N	N	1-241512044-T-C	238260.0	single nucleotide variant	NM_000143.4(FH):c.478A>G (p.Arg160Gly)	2271.0	FH	HGNC:3700	Pathogenic	1.0	Nov 16, 2023	878853694.0	-	RCV001782719|RCV001023046	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000001.11	1	241512044.0	241512044.0	1q43	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA10581784	2.0	237116.0	241512044.0	T	C	-	-	-	-	-	-	SCV000283673|SCV001184862	-	-	478A>G 	Arg160Gly	NM_000143.4	2.0	1_Pathogenic	6.84158e-7	237116.0	1	241512044.0	T	C	R	G	rs878853694	1	241675344.0	1	239741967.0	160.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.478A>G	p.Arg160Gly	c.478A>G	p.Arg160Gly	principal1	Y	1	YES	Select	-	AGA	1.0	2.0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.0	0.92967	D	0.998	0.73231	D	0.975	0.73364	D	0.71	0.82936	A	simple_aae	29.0	71.0	4.81	0.99656	H	-6.64	0.92238	D	0.943	0.95034	0.9804	0.96857	D	0.9928	0.99829	D	10.0	0.9792192	0.97811	D	0.851385	0.98852	D	0.920	0.97963	0.813	0.92818	P07954	R160G	Loss of catalytic residue at R160 (P = 0.0886)| Gain of loop (P = 0.1069)| Loss of stability (P = 0.1215)| Gain of disorder (P = 0.1881)| Loss of helix (P = 0.2022)	0.979233309591	0.97880	0.9654764021894513	0.96515	1.07981011161	0.76970	0.771721363068	0.77643	T	0.98538	0.99908	D	0.550818	0.95775	D	0.553435	0.95711	D	0.998749494552612	0.94994	D	0.991801	0.97448	D	0.975441	0.98723	0.9348335	0.97387	0.975441	0.98723	0.9348335	0.97387	-13.725	0.92144	D	0.982	0.91531	P	0.999915695951876	0.98806	0.93021200	0.92401	0.976	0.99121	.	.	.	.	.	.	4.663639	0.74516	26.2	0.9985201130691997	0.93107	0.644088	0.61910	D	0.765365713599	0.83814	8.140567	0.616020889310283	0.75972	6.42976	5.24	4.1	0.47135	4.75	0.87304	2.846	0.4806	3.698000	0.39597	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	968	0.07020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613996	6.195800e-07	0	1	1179892	8.475350e-07	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60028	0.000000e+00	0	0	29596	0.000000e+00	0	0	44868	0.000000e+00	0	0	64008	0.000000e+00	0	0	6060	0.000000e+00	0	1	1179892	8.475350e-07	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241512044T>C	ClinGen:CA10581784	C0027672|C3661900	.	140162	Fumarate lyase, N-terminal	Arg	Gly	238260.0	single nucleotide variant	NM_000143.4(FH):c.478A>G (p.Arg160Gly)	2271.0	FH	HGNC:3700	Pathogenic	1.0	Nov 16, 2023	878853694.0	-	RCV001782719|RCV001023046	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000001.11	1	241512044.0	241512044.0	1q43	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA10581784	2.0	237116.0	241512044.0	T	C	-	-	-	-	-	-	SCV000283673|SCV001184862	-	-	478A>G 	Arg160Gly	NM_000143.4	2.0	1_Pathogenic	98.84	0.1975806451612903		unknown	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6		98.84	0.19758065	10-90	>90						R	49			98.84	Positively-charged	Arginine		Fumarate hydratase, mitochondrial										-4.5								R160-E126, R160-V156, R160-M164; PAE: 1.0, 1.0, 1.0	8 interactions	R160-V156, R160-M164, R160-Y67; PAE: 1.0, 1.0, 1.0	8 interactions	R160-E163; PAE: 1.0	4 interactions					175									-66.7				-39.8						H (helix)	H (α-helix)	Helix																																																																			true	FHArg160Gly																																																																																																																																																																																																																																		
CTCF	CTCF_Arg567Leu	1.1800602714906496	0.2765194233427633	2.874101838925229	0.023851750906581655	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.568433647741605	0.5818646686361186	0.5407438122704269	0.5380645043119832	0.5840753754354838	0.5725732678815956	0.4704783921339683	0.518320484133521	0.5643612753700188	0.5519199379916447	0.5955774829893721	0.605650616489998	0.5631671404073328	0.5993680619022184	0.5849473574915652	CTCF	1.1800602714906496	0.2765194233427633	2.874101838925229	0.023851750906581655	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.568433647741605	0.5818646686361186	0.5407438122704269	0.5380645043119832	0.5840753754354838	0.5725732678815956	0.4704783921339683	0.518320484133521	0.5643612753700188	0.5519199379916447	0.5955774829893721	0.605650616489998	0.5631671404073328	0.5993680619022184	0.5849473574915652	CTCF		6173		CCSBVarC010820		NC_000016.10:67628551:G:T	1700G>T	Arg567Leu																												16.0	67628551.0	G	T	16						16-67628551-G-T	445598.0	single nucleotide variant	NM_006565.4(CTCF):c.1700G>T (p.Arg567Leu)	10664.0	CTCF	HGNC:13723	Likely benign	0.0	Dec 18, 2020	761621858.0	-	RCV000521064	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000016.10	16	67628551.0	67628551.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA396321079	2.0	450577.0	67628551.0	G	T	-	-	-	-	-	-	SCV000619177	-	-	1700G>T 	Arg567Leu	NM_006565.4	1.0	2_Benign		450577.0	16	67628551.0	G	T	R	L	rs761621858	16	67662454.0	16	66219955.0	567.0	CTCF	ENSG00000102974	ENST00000645699	ENSP00000495348	P49711	CTCF_HUMAN	c.1700G>T	p.Arg567Leu	c.1700G>T	p.Arg567Leu	principal4	Y	.	.	.	+	CGG	2.0	0.0	G	G/G	G/G	G/G	G/G	.	0.29555	.	.	0.29853	.	0.997	0.70687	D	0.993	0.81117	D	.	0.94378	.	.	.	.	1.59	0.40152	L	.	0.24626	.	.	0.90815	-0.0875	0.80295	T	0.5199	0.81993	D	10.0	0.6048416	0.66830	D	0.14978	0.83108	D	.	0.79046	0.52	0.62092	P49711	R567L	Loss of disorder (P = 0.0233)| Loss of glycosylation at T565 (P = 0.0575)| Loss of ubiquitination at K562 (P = 0.0666)| Loss of MoRF binding (P = 0.0734)| Loss of phosphorylation at T565 (P = 0.1284)	.	0.92815	.	0.88570	.	0.96651	0.925170183182	0.98690	D	0.711178	0.91685	D	0.317932	0.84211	D	0.218911	0.84006	D	0.84126740694046	0.49158	D	0.872913	0.60159	D	0.48211032	0.65717	0.3656615	0.61669	0.48211032	0.65717	0.3656615	0.61669	-8.963	0.67536	D	0.9523	0.88385	P	0.841414727856592	0.72676	0.95337390	0.93563	0.379	0.63130	.	.	.	.	.	.	5.346011	0.89703	31.0	0.9984049475124993	0.92149	0.947009	0.95695	D	0.451229343520457	0.64086	4.67813	0.577215871047949	0.73164	5.949525	5.72	5.72	0.89363	4.59	0.85410	9.972	0.99137	11.725000	0.94893	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.998	0.85369	53	0.97599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67628551G>T	ClinGen:CA396321079	CN517202	.	.	.	Arg	Leu	445598.0	single nucleotide variant	NM_006565.4(CTCF):c.1700G>T (p.Arg567Leu)	10664.0	CTCF	HGNC:13723	Likely benign	0.0	Dec 18, 2020	761621858.0	-	RCV000521064	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000016.10	16	67628551.0	67628551.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA396321079	2.0	450577.0	67628551.0	G	T	-	-	-	-	-	-	SCV000619177	-	-	1700G>T 	Arg567Leu	NM_006565.4	1.0	2_Benign	82.48	0.6693548387096774		unknown		0		82.48	0.66935486	10-90	70-90						R	166			82.48	Positively-charged	Arginine		Transcriptional repressor CTCF										-4.5								R567-A571; PAE: 1.5	4 interactions	R567-F555, R567-A571; PAE: 3.0, 1.5	6 interactions							175									-55.5				-43.1				dbSNP: rs879255516; Variant type: LP/P; AA change: Arg567Trp; PTM type: Phosphorylation; PTM morphology: CGKTFtRR*NTM; Var class: II&rs879255516		H (helix)	H (α-helix)	Helix										C2H2-type 11; atypical																																																									true	CTCFArg567Leu																																																																																																																																																																																																																																		
FLCN	FLCN_Arg239Cys	0.9174070101483766	0.38944335444511674	-15.695201041940072	1.0316623825275126e-6	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9450154862226734	0.558026577789912	0.894496256910599	0.8532659652478218	0.6235967424124575	0.6408863296451378	0.8484363666697667	0.9041886224631396	0.5304129016913728	0.9442798550729118	0.6063071551797774	0.858095563825877	0.8848038913580585	0.5856402538884513	0.9457511173724349	FLCN	0.9174070101483766	0.38944335444511674	-15.695201041940072	1.0316623825275126e-6	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9450154862226734	0.558026577789912	0.894496256910599	0.8532659652478218	0.6235967424124575	0.6408863296451378	0.8484363666697667	0.9041886224631396	0.5304129016913728	0.9442798550729118	0.6063071551797774	0.858095563825877	0.8848038913580585	0.5856402538884513	0.9457511173724349	FLCN	ENSG00000154803	7588	13751.0	CCSBVarC001199	ALE00001199	NC_000017.11:17222565:G:A	715C>T	Arg239Cys	RC4	RC4_Mut_GDEh1002	H08	GDEhDisVCh_40008	C09	2.0	RC4_Mut_GDDh1002	H08							1.0	1.0	1.0	1.0	0.0			0.0			0.0			17.0	17222565.0	G	A	17	Y	Y	N	N	N	17-17222565-G-A	138166.0	single nucleotide variant	NM_144997.7(FLCN):c.715C>T (p.Arg239Cys)	201163.0	FLCN	HGNC:27310	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	78683075.0	-	RCV000163388|RCV000121104|RCV000148504|RCV000656850|RCV003945073	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0800444,MedGen:C0346010,OMIM:PS135150,Orphanet:122|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|not specified|Birt-Hogg-Dube syndrome|not provided|FLCN-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	17222565.0	17222565.0	17p11.2	criteria provided, conflicting classifications	15.0	-	N	ClinGen:CA159776,UniProtKB:Q8NFG4#VAR_066026	2.0	134427.0	17222565.0	G	A	-	-	-	-	-	-	SCV000190215|SCV000213928|SCV000291452|SCV000298054|SCV000401012|SCV000616724|SCV001140313|SCV002009831|SCV002530153|SCV002551355|SCV002774598|SCV004142321|SCV005412678	-	-	715C>T 	Arg239Cys	NM_144997.7	1.0	3_Conflicting	0.000457627	134427.0	17	17222565.0	G	A	R	C	rs78683075	17	17125879.0	17	17066604.0	239.0	FLCN	ENSG00000154803	ENST00000285071	ENSP00000285071	Q8NFG4	FLCN_HUMAN	c.715C>T	p.Arg239Cys	c.715C>T	p.Arg239Cys	principal1	Y	1	YES	Select	-	CGC	1.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	.	0.71237	.	.	.	.	2.82	0.81940	M	-5.68	0.90996	D	0.99	0.99730	0.9576	0.96499	D	0.8908	0.96369	D	10.0	0.8112291	0.80205	D	0.269279	0.89792	D	0.914	0.97735	.	.	.	.	.	0.92713276706	0.92582	0.8131863604073064	0.81164	1.37465409467	0.84558	0.877251982689	0.93578	D	0.965284	0.99578	D	0.232675	0.768	D	0.441383	0.93307	D	0.409195610064091	0.2898	T	0.963104	0.86253	D	0.8436355	0.86694	0.653225	0.79478	0.8809669	0.89604	0.6441645	0.78972	-4.512	0.31080	T	0.9888	0.95096	P	0.987758183785664	0.87550	0.95808370	0.93842	0.906	0.95083	.	.	.	.	.	.	5.485253	0.91433	32.0	0.999366252252742	0.99621	0.883493	0.81176	D	0.838685424223754	0.88390	9.584683	0.79110123621525	0.89107	9.865392	5.71	5.71	0.89013	3.64	0.66725	7.113	0.76785	11.729000	0.94967	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.875	0.41772	794	0.45529	3	5.990415335463259E-4	0	0.0	2	0.0019880715705765406	1	0.001440922190201729	0	0.0	0	0.0	61	264690	2.3045827E-4	.	29	109404	2.650730e-04	0	52	208032	2.499620e-04	0	60	236936	2.532330e-04	0	1	7164	1.395870e-04	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	25	42768	5.845490e-04	0	2	15690	1.274700e-04	0	25	42768	5.845490e-04	0	2	16216	1.233350e-04	0	1	30516	3.276970e-05	0	0	6206	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	44	89476	4.917520e-04	0	3	30608	9.801360e-05	0	44	89476	4.917520e-04	0	2	14902	1.342100e-04	0	2	34254	5.838730e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	52	102740	5.061320e-04	0	3	30526	9.827690e-05	0	52	102740	5.061320e-04	0	.	707	1614232	4.379790e-04	1	660	1180052	5.592970e-04	0	6	75048	7.994880e-05	0	0	912	0.000000e+00	0	5	60034	8.328610e-05	0	1	29602	3.378150e-05	0	1	44880	2.228160e-05	0	1	64044	1.561430e-05	0	1	6062	1.649620e-04	0	660	1180052	5.592970e-04	0	10	91086	1.097860e-04	1	34	50198	6.773178214271485E-4	0	306	0	0	132	0	0	8844	0	0	524	0	0	668	0	0	62	0	0	114	0	7	11386	6.147900930967855E-4	0	9150	0	0	194	0	41	72234	5.675997452723095E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Birt-Hogg-Dube_syndrome|not_specified|not_provided|FLCN-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.17222565G>A	ClinGen:CA159776|UniProtKB:Q8NFG4#VAR_066026	C0027672|C0346010|CN169374|C3661900	PS135150	140162|122	Folliculin/SMCR8, longin domain|Folliculin/SMCR8, tripartite DENN domain	Arg	Cys	138166.0	single nucleotide variant	NM_144997.7(FLCN):c.715C>T (p.Arg239Cys)	201163.0	FLCN	HGNC:27310	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	78683075.0	-	RCV000163388|RCV000121104|RCV000148504|RCV000656850|RCV003945073	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0800444,MedGen:C0346010,OMIM:PS135150,Orphanet:122|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|not specified|Birt-Hogg-Dube syndrome|not provided|FLCN-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	17222565.0	17222565.0	17p11.2	criteria provided, conflicting classifications	15.0	-	N	ClinGen:CA159776,UniProtKB:Q8NFG4#VAR_066026	2.0	134427.0	17222565.0	G	A	-	-	-	-	-	-	SCV000190215|SCV000213928|SCV000291452|SCV000298054|SCV000401012|SCV000616724|SCV001140313|SCV002009831|SCV002530153|SCV002551355|SCV002774598|SCV004142321|SCV005412678	-	-	715C>T 	Arg239Cys	NM_144997.7	1.0	3_Conflicting	88.51	0.1048387096774193		unknown	Rare genetic tumor; Inherited cancer-predisposing syndrome	2		88.51	0.10483871	10-90	70-90						R	26			88.51	Positively-charged	Arginine		Folliculin							uDENN FLCN/SMCR8-type			-4.5								R239-E211, R239-D160; PAE: 4.0, 3.0	1 interaction	R239-S243; PAE: 4.0		R239-E211; PAE: 4.0						175									-68.9				142.3						C (loop/coil)	C (loop/coil)																																																																				true	FLCNArg239Cys																																																																																																																																																																																																																																		
BAP1	BAP1_Glu31Lys	0.06824504354142172	0.9474990528833314	-2.0298025778770206	0.08193664202063412	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5285817121482426	0.5984144485902207	0.6105761450146598	0.560101445321775	0.638202978336596	0.5646853145735389	0.5190594261515206	0.5492657033647534	0.5517911511141563	0.4923047687112512	0.7117206420996531	0.6011434644920295	0.6718865866645662	0.6450377460662851	0.5648586555852341	BAP1	0.06824504354142172	0.9474990528833314	-2.0298025778770206	0.08193664202063412	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5285817121482426	0.5984144485902207	0.6105761450146598	0.560101445321775	0.638202978336596	0.5646853145735389	0.5190594261515206	0.5492657033647534	0.5517911511141563	0.4923047687112512	0.7117206420996531	0.6011434644920295	0.6718865866645662	0.6450377460662851	0.5648586555852341	BAP1		3760		CCSBVarC009499		NC_000003.12:52409585:C:T	91G>A	Glu31Lys																												3.0	52409585.0	C	T	3						3-52409585-C-T	1162267.0	single nucleotide variant	NM_004656.4(BAP1):c.91G>A (p.Glu31Lys)	8314.0	BAP1	HGNC:950	Conflicting classifications of pathogenicity	1.0	Jan 21, 2024	2153228535.0	-	RCV001797184|RCV002305612|RCV002568139	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	Neurodevelopmental disorder|not provided|BAP1-related tumor predisposition syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52409585.0	52409585.0	3p21.1	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA353114656	2.0	1173078.0	52409585.0	C	T	-	-	-	-	-	-	SCV002599838|SCV003525331	-	-	91G>A 	Glu31Lys	NM_004656.4	1.0	3_Conflicting		1173078.0	3	52409585.0	C	T	E	K	rs2153228535	3	52443601.0	3	52418641.0	31.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.91G>A	p.Glu31Lys	c.91G>A	p.Glu31Lys	principal1	Y	1	YES	Select	-	GAG	1.0	0.0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.045	0.96963	H	-3.77	0.72856	D	0.925	0.93495	0.4363	0.89592	D	0.5505	0.8347	D	10.0	0.9600752	0.95355	D	0.307408	0.91057	D	0.692	0.88771	0.866	0.96082	Q92560	E31K	Gain of glycosylation at Y33 (P = 0.0136)| Gain of ubiquitination at E31 (P = 0.0238)| Gain of methylation at E31 (P = 0.1374)| Loss of stability (P = 0.1598)| Loss of catalytic residue at E31 (P = 0.2264)	0.862246886347	0.85983	0.9484795993003543	0.94798	2.56847412068	0.97995	0.905887842178	0.97064	D	0.595912	0.86858	D	0.379185	0.88575	D	0.306897	0.88431	D	0.999779880046844	0.98923	D	0.989034	0.96357	D	0.95834297	0.97067	0.9142625	0.95935	0.95834297	0.97067	0.9142625	0.95936	-18.084	0.99558	D	0.9998	0.99584	P	0.986962859459876	0.87278	0.99976045	0.99689	0.896	0.94485	.	.	.	.	.	.	5.710604	0.93179	33.0	0.9993220785235696	0.99439	0.929216	0.91432	D	0.986620787527088	0.95291	13.50747	0.884071350561727	0.94811	13.08669	4.97	4.97	0.65374	2.7	0.49372	7.695	0.83532	7.645000	0.63450	0.596	0.33565	1.0	0.71675	1.0	0.68239	0.999	0.91597	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Neurodevelopmental_disorder|not_provided|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_conflicting_classifications	NC_000003.12:g.52409585C>T	.	C1535926|C3661900|C3280492	614327	289539	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Glu	Lys	1162267.0	single nucleotide variant	NM_004656.4(BAP1):c.91G>A (p.Glu31Lys)	8314.0	BAP1	HGNC:950	Conflicting classifications of pathogenicity	1.0	Jan 21, 2024	2153228535.0	-	RCV001797184|RCV002305612|RCV002568139	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	Neurodevelopmental disorder|not provided|BAP1-related tumor predisposition syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52409585.0	52409585.0	3p21.1	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA353114656	2.0	1173078.0	52409585.0	C	T	-	-	-	-	-	-	SCV002599838|SCV003525331	-	-	91G>A 	Glu31Lys	NM_004656.4	1.0	3_Conflicting	93.71	0.2938144329896907	['614327']	unknown		0	TUMOR PREDISPOSITION SYNDROME 1	93.71	0.29381442	10-90	>90						E	57			93.71	Negatively-charged	Glutamic Acid		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			-3.5					1 interaction			E31-N229; PAE: 1.5		E31-N229; PAE: 1.5	1 interaction							146									-87.3				135.7						B (undefined)	E (parallel sheets)																																																																				true	BAP1Glu31Lys																																																																																																																																																																																																																																		
F9	F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6532650626125115	0.4622770888773744	0.7113310365482672	0.593059403483588	0.6070303903003949	0.6658774891976692	0.6045212236661197	0.7516638087602934	0.47011848476019796	0.6804156175327694	0.5481832914031204	0.5815975833010563	0.6709982643362411	0.4544356929945508	0.6261145076922536	F9	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6532650626125115	0.4622770888773744	0.7113310365482672	0.593059403483588	0.6070303903003949	0.6658774891976692	0.6045212236661197	0.7516638087602934	0.47011848476019796	0.6804156175327694	0.5481832914031204	0.5815975833010563	0.6709982643362411	0.4544356929945508	0.6261145076922536	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T	19A>T	Ile7Phe																												23.0	139530783.0	A	T	X						X-139530783-A-T	348532.0	single nucleotide variant	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	150190385.0	-	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530783.0	139530783.0	Xq27.1	reviewed by expert panel	10.0	-	N	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	3.0	367997.0	139530783.0	A	T	-	-	-	-	-	-	SCV004363695	-	-	19A>T 	Ile7Phe	NM_000133.4	3.0	2_Benign		367997.0	X	139530783.0	A	T	I	F	rs150190385	X	138612942.0	X	138440608.0	7.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.19A>T	p.Ile7Phe	c.19A>T	p.Ile7Phe	principal1	Y	1	YES	Select	+	ATC	1.0	0.0	A	A/A	A/A	A/A	A/A	0.006	0.61594	D	0.056	0.49207	T	0.003	0.11208	B	0.002	0.06938	B	0.14	0.35500	P	simple_aae	86.0	14.0	2.08	0.57221	M	-0.35	0.13539	N	0.495	0.79233	-0.279	0.75458	T	0.5839	0.85002	D	10.0	0.025558144	0.00744	T	0.100824	0.77263	D	0.582	0.83109	.	.	.	.	.	0.997412915613	0.99734	0.7807951246571943	0.77906	0.154389061079	0.17172	0.449907898903	0.31890	T	0.32948	0.69801	T	-0.0400873	0.45599	T	0.164093	0.80917	D	0.0293591555932887	0.01881	T	0.762524	0.38598	T	0.09779945	0.22850	0.098687075	0.23494	0.115587294	0.27032	0.089293085	0.20840	-4.69	0.33321	T	0.0753	0.14905	B	0.920702462215045	0.77602	0.99992085	0.99909	0.237	0.50624	.	.	.	.	.	.	1.98797	0.25303	16.7	0.9197213938187907	0.21554	.	.	.	.	.	.	.	.	.	4.55	2.05	0.2579	2.76	0.50502	3.489	0.53093	6.602000	0.56127	0.754	0.88385	0.994	0.38383	1.0	0.68239	0.903	0.43926	937	0.14592	3	7.947019867549669E-4	0	0.0	3	0.0039164490861618795	0	0.0	0	0.0	0	0.0	239	264690	9.029431E-4	.	62	80318	7.719320e-04	0	134	151801	8.827350e-04	0	154	171897	8.958850e-04	0	0	5701	0.000000e+00	0	9	13660	6.588580e-04	0	0	1767	0.000000e+00	0	0	6915	0.000000e+00	0	4	9922	4.031450e-04	0	46	30953	1.486120e-03	0	0	9950	0.000000e+00	0	46	30953	1.486120e-03	0	1	13132	7.614990e-05	0	14	24359	5.747360e-04	0	0	4647	0.000000e+00	0	0	10123	0.000000e+00	0	6	12179	4.926510e-04	0	109	64670	1.685480e-03	0	0	19068	0.000000e+00	0	109	64670	1.685480e-03	0	1	12062	8.290500e-05	0	17	27135	6.264970e-04	0	0	7073	0.000000e+00	0	0	13314	0.000000e+00	0	8	15983	5.005320e-04	0	125	73191	1.707860e-03	0	0	19003	0.000000e+00	0	125	73191	1.707860e-03	0	.	1538	1209789	1.271300e-03	2	1437	894566	1.606370e-03	2	10	57439	1.740980e-04	0	0	685	0.000000e+00	0	20	45789	4.367860e-04	0	0	22018	0.000000e+00	0	0	33784	0.000000e+00	0	21	46726	4.494290e-04	0	4	4352	9.191180e-04	0	1437	894566	1.606370e-03	2	0	56833	0.000000e+00	0	142	79906	0.0017770880784922284	0	174	0	0	2672	0	0	4118	0	0	436	0	2	928	0.0021551724137931034	0	656	0	0	272	0	4	3764	0.0010626992561105207	0	4292	0	0	3328	0	148	92926	0.0015926651313948733	Benign	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139530783A>T	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	C0008533|C2749016|C5393318|C3661900	306900|300807|301052	98879	.	Ile	Phe	348532.0	single nucleotide variant	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	150190385.0	-	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530783.0	139530783.0	Xq27.1	reviewed by expert panel	10.0	-	N	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	3.0	367997.0	139530783.0	A	T	-	-	-	-	-	-	SCV004363695	-	-	19A>T 	Ile7Phe	NM_000133.4	3.0	2_Benign	38.98	0.7810650887573964	['306900', '306900', '300807', '306900', '300807', '301052']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; WARFARIN SENSITIVITY, X-LINKED	38.98	0.7810651	10-90	<=50						I	132			38.98	Aliphatic	Isoleucine												4.5																		131									76.1				123.8						C (loop/coil)	C (loop/coil)				Signal																										0.984		1.013		0.998		1.002		0.999																														true	F9Ile7Phe																																																																																																																																																																																																																																		
BRCA1	BRCA1_Cys44Tyr	-0.8137193508629426	0.4426010528135844	5.676268140463764	0.0007536407364486894	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8675611254987949	0.7863064734355162	0.8946961206404973	0.8898213453296506	0.887673699853964	0.8311486279859869	0.9066524143661844	0.8244578506765782	0.7124769240548263	0.8216178034576009	0.9441987717219412	0.8729902762931168	0.9649343906044164	0.860136022816206	0.9135044475399889	BRCA1	-0.8137193508629426	0.4426010528135844	5.676268140463764	0.0007536407364486894	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8675611254987949	0.7863064734355162	0.8946961206404973	0.8898213453296506	0.887673699853964	0.8311486279859869	0.9066524143661844	0.8244578506765782	0.7124769240548263	0.8216178034576009	0.9441987717219412	0.8729902762931168	0.9649343906044164	0.860136022816206	0.9135044475399889	BRCA1	ENSG00000012048	14613	218386.0	CCSBVarC003296	ALE00003296	NC_000017.11:43115729:C:T	131G>A	Cys44Tyr	CEGS2	CegsMutGDEh1010	C05	GDEhDisVCh_40059	D03	1.0									1.0	7.0	0.0		0.0			0.0			0.0			17.0	43115729.0	C	T	17	N	N	N	N	N	17-43115729-C-T	68866.0	single nucleotide variant	NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357446.0	-	RCV000077486|RCV000235119|RCV000509871|RCV001386839	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115729.0	43115729.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00114,ClinGen:CA000861	2.0	54199.0	43115729.0	C	T	-	-	-	-	-	-	SCV000244299	-	-	131G>A 	Cys44Tyr	NM_007294.4	3.0	1_Pathogenic		54199.0	17	43115729.0	C	T	C	Y	rs80357446	17	41267746.0	17	38521272.0	44.0	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.131G>A	p.Cys44Tyr	c.131G>A	p.Cys44Tyr	principal2	Y	1	.	.	-	TGC	2.0	0.0	C	C/C	C/C	C/C	C/C	0.016	0.91343	D	0.0	0.92967	D	0.994	0.66535	D	0.84	0.60164	P	.	0.99291	.	.	.	.	4.005	0.96727	H	-2.52	0.98949	D	.	0.95504	1.0538	0.98195	D	0.9802	0.99389	D	10.0	0.99267334	0.99802	D	0.72305	0.97758	D	0.853	0.95458	0.99	0.99894	E9PFC7	C44Y	Loss of disorder (P = 0.0407)| Loss of helix (P = 0.1299)| Loss of catalytic residue at I42 (P = 0.1404)| Loss of stability (P = 0.2362)| Loss of ubiquitination at K45 (P = 0.2592)	0.998941922364	0.99891	.	0.91966	.	0.18552	0.729841411114	0.71433	T	0.47499	0.93038	T	0.562886	0.96259	D	0.57077	0.96199	D	0.987259089946747	0.77622	D	.	0.90786	.	0.92106634	0.93252	0.6351263	0.78468	0.91385037	0.92549	0.69650024	0.81922	-13.581	0.94506	D	0.9966	0.97393	LP	0.999496437666765	0.96769	0.99973255	0.99655	0.94	0.97139	.	.	.	.	.	.	5.096311	0.85159	28.5	0.9922808718824678	0.56189	0.829447	0.74743	D	0.895383086000917	0.91485	10.93124	0.837834818254792	0.92242	11.33957	5.97	5.97	0.96929	.	.	3.475	0.52993	7.600000	0.61593	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.996	0.76032	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43115729C>T	BRCA1-HCI:BRCA1_00114|ClinGen:CA000861	C3661900|C0027672|C0677776|C2676676	604370	140162|145|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Tyr	68866.0	single nucleotide variant	NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357446.0	-	RCV000077486|RCV000235119|RCV000509871|RCV001386839	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115729.0	43115729.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00114,ClinGen:CA000861	2.0	54199.0	43115729.0	C	T	-	-	-	-	-	-	SCV000244299	-	-	131G>A 	Cys44Tyr	NM_007294.4	3.0	1_Pathogenic	92.79	0.0296296296296296	['604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	92.79	0.02962963	<10	>90																																																																																																																																		true	BRCA1Cys44Tyr																																																																																																																																																																																																																																		
SDHD	SDHD_His102Pro	4.677318243891225	0.0025703667270182804	0.47594409396764115	1.0	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8799841376255997	0.8057113353184473	0.9221214824840682	0.8981120004007361	0.9053701445912475	0.9100589801042143	0.911754221775473	0.9480011311043718	0.8233505215836364	0.8796519729598896	0.9006813090782808	0.8844697790259992	0.8962418338637648	0.7880721490532581	0.8803163022913099	SDHD	4.677318243891225	0.0025703667270182804	0.47594409396764115	1.0	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8799841376255997	0.8057113353184473	0.9221214824840682	0.8981120004007361	0.9053701445912475	0.9100589801042143	0.911754221775473	0.9480011311043718	0.8233505215836364	0.8796519729598896	0.9006813090782808	0.8844697790259992	0.8962418338637648	0.7880721490532581	0.8803163022913099	SDHD		6363		CCSBVarC023321		NC_000011.10:112089002:A:C	305A>C	His102Pro																												11.0	112089002.0	A	C	11						11-112089002-A-C	926123.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>C (p.His102Pro)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	May 06, 2021	104894302.0	-	RCV002241296	MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072	Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma	germline	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617414	2.0	950869.0	112089002.0	A	C	-	-	-	-	-	-	SCV001394789	-	-	305A>C 	His102Pro	NM_003002.4	1.0	1_Pathogenic		950869.0	11	112089002.0	A	C	H	P	rs104894302	11	111959726.0	11	111464936.0	102.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>C	p.His102Pro	c.305A>C	p.His102Pro	principal1	Y	1	YES	Select	+	CAT	2.0	0.0	A	./.	./.	./.	./.	0.003	0.91343	D	0.006	0.92967	D	0.999	0.77914	D	0.986	0.76920	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.925	0.96220	H	-9.9	0.98744	D	0.974	0.99419	0.8482	0.9499	D	0.9986	0.99961	D	10.0	0.99432874	0.99941	D	0.720051	0.97730	D	0.929	0.98302	0.983	0.99835	O14521	H102P	Loss of loop (P = 0.2237)| Loss of helix (P = 0.2271)| Loss of catalytic residue at L101 (P = 0.3531)| Loss of stability (P = 0.4934)| Gain of glycosylation at H102 (P = 0.6204)	0.994429284596	0.99430	0.994954265430575	0.99492	0.94536333913	0.72230	0.556130588055	0.46655	T	0.976804	0.99782	D	0.567998	0.9654	D	0.578113	0.96482	D	0.99975723028183	0.98821	D	0.911209	0.68451	D	0.9729964	0.98507	0.93879443	0.97654	0.9567221	0.96900	0.9501346	0.98384	-12.078	0.92404	D	0.7574	0.75321	P	0.999806621831839	0.98063	0.99926025	0.99252	0.984	0.99450	.	.	.	.	.	.	4.880315	0.80073	27.2	0.9546000802402227	0.27217	0.982646	0.99906	D	0.671343308934847	0.77635	6.736192	0.508240574032574	0.68372	5.234679	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.0	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	criteria_provided,_single_submitter	NC_000011.10:g.112089002A>C	.	C1847319|CN166604|C0031511|C1868633	606864|171300	97286|201|29072	.	His	Pro	926123.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>C (p.His102Pro)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	May 06, 2021	104894302.0	-	RCV002241296	MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072	Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma	germline	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617414	2.0	950869.0	112089002.0	A	C	-	-	-	-	-	-	SCV001394789	-	-	305A>C 	His102Pro	NM_003002.4	1.0	1_Pathogenic	98.8	0.3858695652173913	['606864', '171300']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	98.8	0.38586956	10-90	>90						H	71			98.8	Positively-charged	Histidine	heme b	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-3.2								H102-G106, H102-A98; PAE: 1.0, 1.0	2 interactions	H102-S73, H102-G106, H102-A98; PAE: 1.0, 1.0, 1.0	4 interactions							155									-59.3		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-46.5						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDHis102Pro																																																																																																																																																																																																																																		
BCL10	BCL10_Leu8Leu	-1.7211901931387237	0.16221823612285052	1.6174995855992562	0.15607053577138466	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7140053509996125	0.5365242672974291	0.7565539784376354	0.6972652991827526	0.7090534215274067	0.5357539018783427	0.6352976459867357	0.6918685112520384	0.4938630142328672	0.6633090920136241	0.8823529411764706	0.7592329523787694	0.8212394456232323	0.579185520361991	0.7647016099856008	BCL10	-1.7211901931387237	0.16221823612285052	1.6174995855992562	0.15607053577138466	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7140053509996125	0.5365242672974291	0.7565539784376354	0.6972652991827526	0.7090534215274067	0.5357539018783427	0.6352976459867357	0.6918685112520384	0.4938630142328672	0.6633090920136241	0.8823529411764706	0.7592329523787694	0.8212394456232323	0.579185520361991	0.7647016099856008	BCL10	ENSG00000142867	11832	20121.0	CCSBVarC001764	ALE00001764	NC_000001.11:85276329:G:C	24C>G	Leu8Leu	RC4	RC4_Mut_GDEh1005	A04	GDEhDisVCh_40010	E03	2.0	RC4_Mut_GDDh1005	A04			VUSMutpDEST2_09	G09	VUSmut_GDEh12	C07	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	1.0	85276329.0	G	C	1	Y	Y	N	Y	Y	1-85276329-G-C	389441.0	single nucleotide variant	NM_003921.5(BCL10):c.24C>G (p.Leu8=)	8915.0	BCL10	HGNC:989	Benign	0.0	Feb 03, 2025	11576939.0	-	RCV000455048|RCV001510946|RCV004713977	MedGen:CN169374|MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098|MedGen:C3661900	not specified|Immunodeficiency 37|not provided	germline	germline	GRCh38	NC_000001.11	1	85276329.0	85276329.0	1p22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA929835	2.0	402411.0	85276329.0	G	C	-	-	-	-	-	-	SCV000538397|SCV001718107|SCV005280957	-	-	24C>G 	Leu8=	NM_003921.5	2.0	2_Benign	0.295966																																																																																																																																																																																																																																																																																																																																																																																																																																															['616098']	autosomal recessive		0	IMMUNODEFICIENCY 37			10-90	>90	-0.1114172862813321	N	Increase			L	29			66.81	Aliphatic	Leucine		B-cell lymphoma/leukemia 10								0.2502		3.8																		131									-55.5		Pocket 1: Mean pLDDT: 47.42, Volume: 351.14 Å³, Druggability score: 0.25		125.3						C (loop/coil)	C (loop/coil)																																																																				true	BCL10Leu8Leu																																																																																																																																																																																																																																		
RHO	RHO_Asp190Gly	-2.929431263260496	0.022042111608632748	-16.30915772533287	7.936833693923803e-7	2025_01_Batch_13-14	true	true	true	true	false	true	true	true	true	false	0.9994548592176349	0.9770929368426109	0.9980068875561408	0.9767014272857454	0.7734918521405172	0.783341073946874	0.973871326723488	0.9976678451985929	0.9739839064032518	0.9993510763772249	0.7636426303341604	0.9795315278480028	0.9983459299136886	0.98020196728197	0.9995586420580448	RHO	-2.929431263260496	0.022042111608632748	-16.30915772533287	7.936833693923803e-7	2025_01_Batch_13-14	true	true	true	true	false	true	true	true	true	false	0.9994548592176349	0.9770929368426109	0.9980068875561408	0.9767014272857454	0.7734918521405172	0.783341073946874	0.973871326723488	0.9976678451985929	0.9739839064032518	0.9993510763772249	0.7636426303341604	0.9795315278480028	0.9983459299136886	0.98020196728197	0.9995586420580448	RHO		40080645		CCSBVarC013544		NC_000003.12:129532289:A:G	569A>G	Asp190Gly																												3.0	129532289.0	A	G	3						3-129532289-A-G	28065.0	single nucleotide variant	NM_000539.3(RHO):c.569A>G (p.Asp190Gly)	6010.0	RHO	HGNC:10012	Pathogenic/Likely pathogenic	1.0	Oct 01, 2023	104893777.0	-	RCV000013900|RCV001386998|RCV003887863	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Retinitis pigmentosa 4|not provided|Retinal dystrophy	germline	germline	GRCh38	NC_000003.12	3	129532289.0	129532289.0	3q22.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA256673,UniProtKB:P08100#VAR_004814,OMIM:180380.0014	3.0	13026.0	129532289.0	A	G	-	-	-	-	-	-	SCV001587465|SCV004705665	-	-	569A>G 	Asp190Gly	NM_000539.3	2.0	1_Pathogenic		13026.0	3	129532289.0	A	G	D	G	rs104893777	3	129251132.0	3	130733822.0	190.0	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.569A>G	p.Asp190Gly	c.569A>G	p.Asp190Gly	principal1	Y	1	YES	Select	+	GAC	2.0	0.0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.018	0.60067	D	0.754	0.43372	P	0.826	0.59366	P	0.93	0.93829	A	simple_aae	7.0	93.0	3.785	0.95215	H	-5.64	0.86945	D	0.993	0.99866	-0.0993	0.80024	T	0.3223	0.68995	T	9.0	0.9891775	0.99365	D	0.192539	0.86214	D	0.664	0.87421	0.937	0.99098	P08100	D190G	Loss of ubiquitination at K195 (P = 0.0596)| Gain of catalytic residue at G188 (P = 0.097)| Loss of stability (P = 0.1082)| Gain of sheet (P = 0.1208)| Gain of methylation at K195 (P = 0.1246)	0.775995073384	0.77216	0.9390784996612188	0.93850	0.888851575013	0.69945	0.75512355566	0.75160	T	0.836933	0.96131	D	0.326972	0.84848	D	0.231896	0.8465	D	0.995872437953949	0.88134	D	0.983802	0.94524	D	0.9865587	0.99559	0.97526824	0.99667	0.9865587	0.99559	0.97526824	0.99668	-13.655	0.91898	D	0.9863	0.92535	P	0.999678264541609	0.97434	0.99981183	0.99752	0.961	0.98360	.	.	.	.	.	.	4.848578	0.79269	27.1	0.9974007749125071	0.83425	0.915171	0.87913	D	0.415179912855261	0.62061	4.438596	0.317870176801044	0.56361	3.822499	5.19	4.02	0.45905	.	.	9.32	0.95493	11.251000	0.90759	-0.083	0.16243	1.0	0.71675	1.0	0.68239	0.259	0.23539	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	106	0	0	434	0	0	34	0	0	658	0	Pathogenic/Likely_pathogenic	not_provided|Retinitis_pigmentosa_4|Retinal_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129532289A>G	ClinGen:CA256673|OMIM:180380.0014|UniProtKB:P08100#VAR_004814	C3661900|C3151001|C0854723	613731	791|71862	GPCR, rhodopsin-like, 7TM	Asp	Gly	28065.0	single nucleotide variant	NM_000539.3(RHO):c.569A>G (p.Asp190Gly)	6010.0	RHO	HGNC:10012	Pathogenic/Likely pathogenic	1.0	Oct 01, 2023	104893777.0	-	RCV000013900|RCV001386998|RCV003887863	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Retinitis pigmentosa 4|not provided|Retinal dystrophy	germline	germline	GRCh38	NC_000003.12	3	129532289.0	129532289.0	3q22.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA256673,UniProtKB:P08100#VAR_004814,OMIM:180380.0014	3.0	13026.0	129532289.0	A	G	-	-	-	-	-	-	SCV001587465|SCV004705665	-	-	569A>G 	Asp190Gly	NM_000539.3	2.0	1_Pathogenic	96.4	0.0	['613731']	unknown		0	RETINITIS PIGMENTOSA 4	96.4	0.0	<10	>90						D	0			96.4	Negatively-charged	Aspartic Acid		Rhodopsin										-3.5								D190-N200, D190-R177; PAE: 1.0, 1.0		D190-N200, D190-R177; PAE: 1.0, 1.0	1 interaction							132									-68.6				98.1						C (loop/coil)	C (loop/coil)							Extracellular																																																													true	RHOAsp190Gly																																																																																																																																																																																																																																		
SOS2	SOS2_Val869Ile	-1.6906881260572169	0.13473984727334107	24.562323565003886	4.723899389812003e-8	2025_01_Batch_13-14	true	false	true	true	false	true	false	false	true	false	0.9967327290549339	0.7062574985795032	0.9871374455983369	0.9846420067905605	0.7300258061268597	0.6605410020244871	0.9818388517981322	0.9811042106268615	0.6985221185630515	0.9961885034785765	0.7995106102292324	0.9874451617829887	0.9931706805698124	0.7139928785959548	0.9972769546312914	SOS2	-1.6906881260572169	0.13473984727334107	24.562323565003886	4.723899389812003e-8	2025_01_Batch_13-14	true	false	true	true	false	true	false	false	true	false	0.9967327290549339	0.7062574985795032	0.9871374455983369	0.9846420067905605	0.7300258061268597	0.6605410020244871	0.9818388517981322	0.9811042106268615	0.6985221185630515	0.9961885034785765	0.7995106102292324	0.9874451617829887	0.9931706805698124	0.7139928785959548	0.9972769546312914	SOS2		55187		CCSBVarC013733		NC_000014.9:50145232:C:T	2605G>A	Val869Ile																												14.0	50145232.0	C	T	14						14-50145232-C-T	572804.0	single nucleotide variant	NM_006939.4(SOS2):c.2605G>A (p.Val869Ile)	6655.0	SOS2	HGNC:11188	Benign/Likely benign	0.0	Jan 05, 2025	373143128.0	-	RCV002282338|RCV003928173|RCV000701667	MedGen:CN169374||MONDO:MONDO:0014691,MedGen:C4225282,OMIM:616559,Orphanet:648	not specified|SOS2-related disorder|Noonan syndrome 9	germline	germline	GRCh38	NC_000014.9	14	50145232.0	50145232.0	14q21.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA7177001	2.0	578603.0	50145232.0	C	T	-	-	-	-	-	-	SCV000830479|SCV002572201|SCV002763034	-	-	2605G>A 	Val869Ile	NM_006939.4	2.0	2_Benign		578603.0	14	50145232.0	C	T	V	I	rs373143128	14	50611950.0	14	49681700.0	869.0	SOS2	ENSG00000100485	ENST00000216373	ENSP00000216373	Q07890	SOS2_HUMAN	c.2605G>A	p.Val869Ile	c.2605G>A	p.Val869Ile	principal1	Y	1	YES	Select	-	GTA	1.0	0.0	C	C/C	C/C	C/C	C/C	0.186	0.21830	T	0.193	0.28516	T	0.806	0.45244	P	0.067	0.27544	B	0.03	0.13669	N	simple_aae	97.0	3.0	1.69	0.43161	L	-0.57	0.17141	N	0.62	0.64125	-1.0875	0.05974	T	0.0626	0.25856	T	10.0	0.033977717	0.01592	T	0.00909	0.23643	T	0.119	0.32934	.	.	.	.	.	0.287411543184	0.27937	0.29752872176459394	0.29466	0.438499540432	0.43595	0.60063201189	0.52926	T	0.261454	0.63086	T	-0.250105	0.13817	T	-0.337356	0.40293	T	0.0685817938580168	0.08353	T	0.980102	0.93270	D	0.13867286	0.31788	0.11979879	0.28843	0.14083904	0.32200	0.11895819	0.28644	-11.018	0.79822	D	0.1295	0.27854	B	0.330054574296633	0.55316	0.93892770	0.92805	0.24	0.50956	.	.	.	.	.	.	4.283071	0.65331	24.8	0.9914519365080016	0.53732	0.819462	0.73952	D	0.283462274563088	0.55083	3.695113	0.376110327940654	0.59881	4.193457	5.64	4.74	0.59667	3.55	0.64634	7.851	0.85271	7.653000	0.63864	0.549	0.27038	1.0	0.71675	1.0	0.68239	0.997	0.79771	467	0.78304	.	.	.	.	.	.	.	.	.	.	.	.	33	264690	1.2467414E-4	.	20	109304	1.829760e-04	0	40	207850	1.924460e-04	1	62	236538	2.621140e-04	1	0	7156	0.000000e+00	0	2	17068	1.171780e-04	0	11	2318	4.745470e-03	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	7	42762	1.636970e-04	0	0	15650	0.000000e+00	0	7	42762	1.636970e-04	0	0	16182	0.000000e+00	0	2	30470	6.563830e-05	0	21	6208	3.382730e-03	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	15	89446	1.676990e-04	0	0	30546	0.000000e+00	0	15	89446	1.676990e-04	0	0	14866	0.000000e+00	0	2	34194	5.848980e-05	0	39	9564	4.077790e-03	0	0	17690	0.000000e+00	0	0	21622	0.000000e+00	0	18	102542	1.755380e-04	0	0	30464	0.000000e+00	0	18	102542	1.755380e-04	0	.	208	1610334	1.291660e-04	1	111	29576	3.753040e-03	0	0	74774	0.000000e+00	0	0	912	0.000000e+00	0	4	59956	6.671560e-05	0	111	29576	3.753040e-03	0	0	44786	0.000000e+00	0	0	63994	0.000000e+00	0	4	6070	6.589790e-04	0	73	1176958	6.202430e-05	0	3	90944	3.298730e-05	1	15	42740	3.5095928872250817E-4	0	306	0	0	112	0	0	8044	0	0	500	0	0	628	0	0	56	0	0	98	0	3	8298	3.6153289949385393E-4	0	8350	0	0	168	0	18	60782	2.9614030469546907E-4	Benign/Likely_benign	not_specified|SOS2-related_disorder|Noonan_syndrome_9	criteria_provided,_multiple_submitters,_no_conflicts	NC_000014.9:g.50145232C>T	.	CN169374|C4225282	616559	648	Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain	Val	Ile	572804.0	single nucleotide variant	NM_006939.4(SOS2):c.2605G>A (p.Val869Ile)	6655.0	SOS2	HGNC:11188	Benign/Likely benign	0.0	Jan 05, 2025	373143128.0	-	RCV002282338|RCV003928173|RCV000701667	MedGen:CN169374||MONDO:MONDO:0014691,MedGen:C4225282,OMIM:616559,Orphanet:648	not specified|SOS2-related disorder|Noonan syndrome 9	germline	germline	GRCh38	NC_000014.9	14	50145232.0	50145232.0	14q21.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA7177001	2.0	578603.0	50145232.0	C	T	-	-	-	-	-	-	SCV000830479|SCV002572201|SCV002763034	-	-	2605G>A 	Val869Ile	NM_006939.4	2.0	2_Benign	98.28	0.0070422535211267	['616559']	unknown		0	NOONAN SYNDROME 9	98.28	0.0070422534	<10	>90						V	1			98.28	Aliphatic	Valine		Son of sevenless homolog 2							Ras-GEF			4.2								V869-N865, V869-V873; PAE: 1.0, 1.0	7 interactions	V869-F860, V869-N865, V869-V873; PAE: 1.0, 1.0, 1.0	10 interactions							117									-58.6				-48.6						H (helix)	H (α-helix)	Helix																																																																			true	SOS2Val869Ile																																																																																																																																																																																																																																		
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.875748709977453	0.7311334319544585	0.8454807852128686	0.7617341177488715	0.6420223551373424	0.6673805631651736	0.7320721929340855	0.802352315962314	0.758954517487859	0.8295208387386563	0.6166641471095112	0.7913960425636573	0.8886092544634232	0.703312346421058	0.9219765812162496	F9	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.875748709977453	0.7311334319544585	0.8454807852128686	0.7617341177488715	0.6420223551373424	0.6673805631651736	0.7320721929340855	0.802352315962314	0.758954517487859	0.8295208387386563	0.6166641471095112	0.7913960425636573	0.8886092544634232	0.703312346421058	0.9219765812162496	F9	ENSG00000101981	52861	204381.0	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561805.0	G	T	X	Y	N	N	N	N	X-139561805-G-T	25678.0	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Dec 18, 2018	137852271.0	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805.0	139561805.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255427,OMIM:300746.0083	3.0	10639.0	139561805.0	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1.0	1_Pathogenic		10639.0	X	139561805.0	G	T	V	F	rs137852271	X	138643964.0	X	138471630.0	374.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10.0	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.9928894931530728	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678.0	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Dec 18, 2018	137852271.0	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805.0	139561805.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255427,OMIM:300746.0083	3.0	10639.0	139561805.0	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1.0	1_Pathogenic	91.21	0.0	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	91.21	0.0	<10	>90						V	0			91.21	Aliphatic	Valine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			4.2								V374-G351; PAE: 1.5	3 interactions	V374-G351; PAE: 1.5	3 interactions							117									-115.9				133.2						B (undefined)	E (parallel sheets)	Beta strand																													0.739		0.491		0.426		0.397		0.401																														true	F9Val374Phe																																																																																																																																																																																																																																		
SHOC2	SHOC2_Thr205Ala	-0.7932454090740622	0.45367827402196725	2.8298723604947678	0.025410841904029143	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7037263895911471	0.6852423595302577	0.7757118039173434	0.8168366299702378	0.7438625518536668	0.8085083031253772	0.8430397534984986	0.7631580315275811	0.7875180084414044	0.6808613914511137	0.6792168005819562	0.7906335064419769	0.7882655763071058	0.582966710619111	0.7265913877311805	SHOC2	-0.7932454090740622	0.45367827402196725	2.8298723604947678	0.025410841904029143	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7037263895911471	0.6852423595302577	0.7757118039173434	0.8168366299702378	0.7438625518536668	0.8085083031253772	0.8430397534984986	0.7631580315275811	0.7875180084414044	0.6808613914511137	0.6792168005819562	0.7906335064419769	0.7882655763071058	0.582966710619111	0.7265913877311805	SHOC2		11602		CCSBVarC028039		NC_000010.11:110964971:A:G	613A>G	Thr205Ala																												10.0	110964971.0	A	G	10						10-110964971-A-G	442530.0	single nucleotide variant	NM_007373.4(SHOC2):c.613A>G (p.Thr205Ala)	8036.0	SHOC2	HGNC:15454	Likely benign	0.0	Apr 18, 2017	768411950.0	-	RCV000521093|RCV004984937	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	RASopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	110964971.0	110964971.0	10q25.2	reviewed by expert panel	2.0	-	N	ClinGen:CA5689601	2.0	448933.0	110964971.0	A	G	-	-	-	-	-	-	SCV000616496	-	-	613A>G 	Thr205Ala	NM_007373.4	3.0	2_Benign		448933.0	10	110964971.0	A	G	T	A	rs768411950	10	112724729.0	10	112714719.0	205.0	SHOC2	ENSG00000108061	ENST00000691441	ENSP00000509686	Q9UQ13	SHOC2_HUMAN	.	.	c.613A>G	p.Thr205Ala	principal1	Y	.	.	.	+	ACT	1.0	0.0	A	A/A	A/A	A/A	A/A	.	0.34240	.	.	0.39834	.	0.485	0.57842	P	0.23	0.72002	B	.	0.60618	.	.	.	.	2.615	0.76302	M	.	0.43722	.	.	0.71096	-0.9193	0.45454	T	0.1724	0.51276	T	10.0	.	0.48935	.	0.017149	0.38486	T	.	0.57011	0.293	0.25438	Q9UQ13	T205A	Loss of methylation at K209 (P = 0.1135)| Gain of MoRF binding (P = 0.1344)| Loss of disorder (P = 0.1735)| Gain of helix (P = 0.1736)| Gain of ubiquitination at K209 (P = 0.2261)	.	0.40260	.	0.63105	.	0.84207	0.790986120701	0.80559	T	0.271683	0.64203	T	-0.154376	0.2728	T	-0.137561	0.6005	T	0.258627751812722	0.2298	T	.	0.68925	.	0.22402976	0.44711	0.24907	0.50279	0.20188108	0.41895	0.23230855	0.48205	-5.149	0.42680	T	.	0.31635	.	0.875279691495204	0.74491	0.02179968	0.50361	0.554	0.74849	.	.	.	.	.	.	3.467778	0.48451	22.6	0.9971788196141174	0.81861	0.899008	0.84235	D	0.573813009677373	0.71391	5.666972	0.63331388771494	0.77249	6.666899	5.66	5.66	0.87274	.	.	9.325	0.96016	11.226000	0.89948	0.751	0.87726	1.0	0.71675	1.0	0.68239	1.0	0.97202	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	109120	5.498530e-05	0	13	207686	6.259450e-05	0	13	236340	5.500550e-05	0	0	7158	0.000000e+00	0	0	17086	0.000000e+00	0	0	2320	0.000000e+00	0	0	9036	0.000000e+00	0	0	13172	0.000000e+00	0	0	42756	0.000000e+00	0	6	15686	3.825070e-04	0	6	15686	3.825070e-04	0	0	16178	0.000000e+00	0	0	30454	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16512	0.000000e+00	0	1	89492	1.117420e-05	0	12	30600	3.921570e-04	0	12	30600	3.921570e-04	0	0	14862	0.000000e+00	0	0	34190	0.000000e+00	0	0	9564	0.000000e+00	0	0	17678	0.000000e+00	0	0	21384	0.000000e+00	0	1	102560	9.750390e-06	0	12	30518	3.932110e-04	0	12	30518	3.932110e-04	0	.	31	1613690	1.921060e-05	0	30	91078	3.293880e-04	0	0	75032	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	63774	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179874	8.475480e-07	0	30	91078	3.293880e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	RASopathy	reviewed_by_expert_panel	NC_000010.11:g.110964971A>G	ClinGen:CA5689601	C5555857	.	536391	.	Thr	Ala	442530.0	single nucleotide variant	NM_007373.4(SHOC2):c.613A>G (p.Thr205Ala)	8036.0	SHOC2	HGNC:15454	Likely benign	0.0	Apr 18, 2017	768411950.0	-	RCV000521093|RCV004984937	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	RASopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	110964971.0	110964971.0	10q25.2	reviewed by expert panel	2.0	-	N	ClinGen:CA5689601	2.0	448933.0	110964971.0	A	G	-	-	-	-	-	-	SCV000616496	-	-	613A>G 	Thr205Ala	NM_007373.4	3.0	2_Benign	97.64	0.5070422535211268		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5		97.64	0.5070422	10-90	>90						T	72			97.64	Polar/Neutral	Threonine		Leucine-rich repeat protein SHOC-2								0.0068		-0.7									1 interaction	T205-R182, T205-K228; PAE: 2.0, 1.0	9 interactions							119									-108.6		Pocket 2: Mean pLDDT: 98.33, Volume: 310.95 Å³, Druggability score: 0.01		-23.8			LRR 5			C (loop/coil)	C (loop/coil)																																																																				true	SHOC2Thr205Ala																																																																																																																																																																																																																																		
BRCA1	BRCA1_Phe558Ser	1.6111167737238428	0.15118946477997378	4.615270970171342	0.0024397297238219016	2025_01_Batch_13-14	false	true	true	false	true	false	false	false	false	true	0.9193319707656409	0.8875893363902452	0.9694318548687729	0.9304218899793452	0.9677253156271488	0.9498482441279532	0.9308024365566823	0.9572502165200717	0.8165718573701302	0.9137788511755762	0.9856023871263443	0.9300413434020081	0.9816134932174742	0.9586068154103601	0.9248850903557055	BRCA1	1.6111167737238428	0.15118946477997378	4.615270970171342	0.0024397297238219016	2025_01_Batch_13-14	false	true	true	false	true	false	false	false	false	true	0.9193319707656409	0.8875893363902452	0.9694318548687729	0.9304218899793452	0.9677253156271488	0.9498482441279532	0.9308024365566823	0.9572502165200717	0.8165718573701302	0.9137788511755762	0.9856023871263443	0.9300413434020081	0.9816134932174742	0.9586068154103601	0.9248850903557055	BRCA1		14613		CCSBVarC013021		NC_000017.11:43070929:A:G	1673T>C	Phe558Ser																												17.0	43070929.0	A	G	17						17-43070929-A-G	70006.0	single nucleotide variant	NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	28897695.0	-	RCV000112441|RCV000130003|RCV000443012|RCV001421999|RCV001703954	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43070929.0	43070929.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00091,ClinGen:CA003117	2.0	55339.0	43070929.0	A	G	-	-	-	-	-	-	SCV000244375	-	-	4985T>C 	Phe1662Ser	NM_007294.4	3.0	2_Benign		55339.0	17	43070929.0	A	G	F	S	rs28897695	17	41222946.0	17	38476472.0	1662.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4985T>C	p.Phe1662Ser	c.4985T>C	p.Phe1662Ser	principal2	Y	1	YES	Select	-	TTT	2.0	0.0	A	A/A	A/A	A/A	A/A	0.324	0.13470	T	0.483	0.15624	T	0.327	0.33186	B	0.072	0.28044	B	0.26	0.51279	N	simple_aae	74.0	26.0	0	0.06502	N	-0.41	0.54888	N	0.17	0.20657	-0.8141	0.54115	T	0.2316	0.59602	T	10.0	0.08930129	0.15320	T	0.095936	0.76440	D	0.521	0.79537	.	.	.	.	.	0.346544149963	0.33848	.	0.38144	.	0.17918	0.32687741518	0.14450	T	0.127873	0.45213	T	-0.0538666	0.43515	T	-0.0894503	0.63948	T	0.0101923026540198	0.00137	T	.	0.29269	.	0.15882574	0.35418	0.05462813	0.09445	0.15678944	0.35072	0.06600715	0.13457	-2.062	0.15503	T	0.1159	0.48135	B	0.242492734673284	0.51903	0.99607220	0.97952	0.115	0.31465	.	.	.	.	.	.	1.575156	0.20196	14.62	0.6334993636748547	0.07307	0.176669	0.30175	N	-1.19592149865023	0.05004	0.2298717	-1.20530321707257	0.05732	0.2786036	4.82	-1.61	0.07934	-3.96	0.06349	0.047	0.13983	1.542000	0.27319	-0.681	0.0423	0.006	0.17427	0.0	0.08389	0.808	0.38116	544	0.72706	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109362	9.143940e-06	0	2	206954	9.663980e-06	0	3	235478	1.274000e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	1	9044	1.105710e-04	0	0	13350	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9044	1.105710e-04	0	0	16214	0.000000e+00	0	0	30522	0.000000e+00	0	0	6208	0.000000e+00	0	2	13414	1.490980e-04	0	0	16690	0.000000e+00	0	0	88440	0.000000e+00	0	0	30608	0.000000e+00	0	2	13414	1.490980e-04	0	0	14902	0.000000e+00	0	1	34258	2.919030e-05	0	0	9566	0.000000e+00	0	2	17690	1.130580e-04	0	0	21588	0.000000e+00	0	0	101348	0.000000e+00	0	0	30526	0.000000e+00	0	2	17690	1.130580e-04	0	.	21	1614022	1.301100e-05	0	17	44902	3.786020e-04	0	1	74928	1.334610e-05	0	0	912	0.000000e+00	0	1	60004	1.666560e-05	0	0	29608	0.000000e+00	0	17	44902	3.786020e-04	0	0	63964	0.000000e+00	0	0	6084	0.000000e+00	0	2	1180042	1.694850e-06	0	0	91090	0.000000e+00	0	0	85192	0	0	238	0	0	468	0	0	5996	0	0	648	0	0	2154	0	0	126	0	0	168	0	0	2604	0	0	6234	0	0	594	0	0	97594	0	Benign	Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43070929A>G	BRCA1-HCI:BRCA1_00091|ClinGen:CA003117	C0027672|CN169374|C0677776|C3661900|C2676676	604370	140162|145|145	BRCT domain|BRCT domain|BRCT domain	Phe	Ser	70006.0	single nucleotide variant	NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	28897695.0	-	RCV000112441|RCV000130003|RCV000443012|RCV001421999|RCV001703954	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43070929.0	43070929.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00091,ClinGen:CA003117	2.0	55339.0	43070929.0	A	G	-	-	-	-	-	-	SCV000244375	-	-	4985T>C 	Phe1662Ser	NM_007294.4	3.0	2_Benign	96.18	0.0964467005076142	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	96.18	0.0964467	<10	>90																																																																																																																																		true	BRCA1Phe558Ser																																																																																																																																																																																																																																		
BRCA1	BRCA1_Met1Thr	2.6505609192138624	0.03291488248938516	-5.415058354854696	0.0009923460458709568	2025_01_Batch_13-14	true	false	true	false	false	false	false	false	false	false	0.9747525839707805	0.8028920403019829	0.960114981855982	0.9075437595495317	0.8862103328877481	0.9188140326650334	0.9527153734968281	0.984750990435898	0.793637090171406	0.9840460552581236	0.8536066331104628	0.8623721456022353	0.9354789732760659	0.8121469904325598	0.9654591126834374	BRCA1	2.6505609192138624	0.03291488248938516	-5.415058354854696	0.0009923460458709568	2025_01_Batch_13-14	true	false	true	false	false	false	false	false	false	false	0.9747525839707805	0.8028920403019829	0.960114981855982	0.9075437595495317	0.8862103328877481	0.9188140326650334	0.9527153734968281	0.984750990435898	0.793637090171406	0.9840460552581236	0.8536066331104628	0.8623721456022353	0.9354789732760659	0.8121469904325598	0.9654591126834374	BRCA1	ENSG00000012048	14613	218377.0	CCSBVarC003294	ALE00003294	NC_000017.11:43124095:A:G	2T>C	Met1Thr	CEGS2	CegsMutGDEh1015	F12	GDEhDisVCh_40059	F04	1.0									1.0	1.0	0.0		0.0			0.0			0.0			17.0	43124095.0	A	G	17	Y	N	N	N	N	17-43124095-A-G	69412.0	single nucleotide variant	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	672.0	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1.0	May 05, 2024	80357111.0	-	RCV000111545|RCV001017950|RCV001387017	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124095.0	43124095.0	17q21.31	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001954	2.0	54745.0	43124095.0	A	G	-	-	-	-	-	-	SCV000325520|SCV000785479|SCV001179120|SCV001587504	-	-	2T>C 	Met1Thr	NM_007294.4	2.0	1_Pathogenic		54745.0	17	43124095.0	A	G	M	T	rs80357111	17	41276112.0	17	38529638.0	1.0	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	c.2T>C	p.Met1?	c.2T>C	p.Met1?	principal2	Y	1	.	.	-	ATG	2.0	0.0	A	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	0.967	0.56423	D	0.916	0.65195	D	.	0.99291	.	.	.	.	.	.	.	.	0.71435	.	.	0.96886	0.4652	0.90013	D	0.7036	0.89769	D	9.0	0.98665875	0.98978	D	0.950787	0.99662	D	.	0.89789	0.987	0.99867	E9PFC7	M1T	Loss of stability (P = 2e-04)| Gain of catalytic residue at M1 (P = 0.0208)| Gain of glycosylation at M1 (P = 0.121)| Gain of disorder (P = 0.1374)| Gain of helix (P = 0.2684)	0.883389812914	0.88134	.	0.29790	.	.	.	.	.	0.298644	0.66936	T	0.3844	0.88912	D	0.314388	0.88772	D	0.991858303546906	0.82073	D	0.9	0.64967	D	0.9435044	0.95537	0.71842754	0.83181	0.9426614	0.95450	0.7257	0.83606	-9.871	0.82067	D	.	.	.	0.999999935724936	0.99831	0.99948680	0.99428	.	.	.	.	.	.	.	.	3.997208	0.58947	24.0	0.9771474788796806	0.35682	0.056815	0.10376	N	0.358832926107613	0.58998	4.098281	0.311400030491244	0.55978	3.783919	3.83	3.83	0.43219	2.37	0.44186	4.168	0.58094	11.022000	0.84990	0.634	0.51995	1.0	0.71675	1.0	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43124095A>G	ClinGen:CA001954	C0677776|C0027672|C2676676	604370	145|140162|145	.	Met	Thr	69412.0	single nucleotide variant	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	672.0	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1.0	May 05, 2024	80357111.0	-	RCV000111545|RCV001017950|RCV001387017	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124095.0	43124095.0	17q21.31	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001954	2.0	54745.0	43124095.0	A	G	-	-	-	-	-	-	SCV000325520|SCV000785479|SCV001179120|SCV001587504	-	-	2T>C 	Met1Thr	NM_007294.4	2.0	1_Pathogenic	41.59	1.0	['604370']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	41.59	1.0	$\geqslant$90	<=50																																																																																																																																		true	BRCA1Met1Thr																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Val63Leu	-3.772508957351957	0.009520442136421024	-2.514597705164753	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9208772825787447	0.6881084967494787	0.877111581323038	0.884882805565196	0.6073159287343419	0.6066181739777775	0.837648116185566	0.8099086609881108	0.7024057124056164	0.8783777829289516	0.6080136834909065	0.9321174949448261	0.9443145016579653	0.673811281093341	0.9633767822285377	ZC4H2	-3.772508957351957	0.009520442136421024	-2.514597705164753	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9208772825787447	0.6881084967494787	0.877111581323038	0.884882805565196	0.6073159287343419	0.6066181739777775	0.837648116185566	0.8099086609881108	0.7024057124056164	0.8783777829289516	0.6080136834909065	0.9321174949448261	0.9443145016579653	0.673811281093341	0.9633767822285377	ZC4H2	ENSG00000126970	4320	215106.0	CCSBVarC005916	ALE00005916	NC_000023.11:64921855:C:G	187G>C	Val63Leu	CEGS2	CegsMutGDEh1032	H01	GDEhDisVCh_40034	G11	2.0	CegsMutGDDh1032	H01							1.0	3.0	1.0	4.0	0.0			0.0			0.0			23.0	64921855.0	C	G	X	N	N	N	N	N	X-64921855-C-G	65651.0	single nucleotide variant	NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	May 02, 2013	398122938.0	-	RCV000043676	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921855.0	64921855.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA143907,UniProtKB:Q9NQZ6#VAR_069621,OMIM:300897.0001	1.0	50980.0	64921855.0	C	G	-	-	-	-	-	-	SCV000071687	-	-	187G>C 	Val63Leu	NM_018684.4		1_Pathogenic		50980.0	X	64921855.0	C	G	V	L	rs398122938	X	64141735.0	X	64058460.0	63.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.187G>C	p.Val63Leu	c.187G>C	p.Val63Leu	principal1	Y	1	YES	Select	-	GTG	1.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.052	0.92967	T	0.992	0.64752	D	0.983	0.75798	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.465	0.71362	M	-2.24	0.50191	N	0.845	0.84047	-0.1655	0.7844	T	0.4181	0.76324	T	9.0	0.84414655	0.83403	D	0.205808	0.86973	D	0.743	0.91077	0.716	0.85070	Q9NQZ6	V63L	Gain of disorder (P = 0.0736)| Loss of ubiquitination at K59 (P = 0.0816)| Gain of stability (P = 0.1765)| Gain of glycosylation at K59 (P = 0.3702)| Gain of methylation at R67 (P = 0.5403)	0.884996165071	0.88298	0.8373184595511529	0.83593	1.97721070638	0.93584	0.891219079494	0.95406	D	0.512428	0.82640	D	0.470646	0.93309	D	0.438274	0.93226	D	0.97698700428009	0.71437	D	0.969003	0.92268	D	0.85009694	0.87173	0.87122726	0.92856	0.8581468	0.87783	0.87122726	0.92856	-7.039	0.54387	T	0.9994	0.99054	P	0.996518372777224	0.92210	0.99788480	0.98543	0.933	0.96717	.	.	.	.	.	.	4.346719	0.66797	25.0	0.998218877799318	0.9051	.	.	.	.	.	.	.	.	.	5.56	5.56	0.83655	4.31	0.81542	7.641	0.82558	5.916000	0.51166	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.99	0.65338	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64921855C>G	ClinGen:CA143907|OMIM:300897.0001|UniProtKB:Q9NQZ6#VAR_069621	C0796200	314580	3454|85283	.	Val	Leu	65651.0	single nucleotide variant	NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	May 02, 2013	398122938.0	-	RCV000043676	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921855.0	64921855.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA143907,UniProtKB:Q9NQZ6#VAR_069621,OMIM:300897.0001	1.0	50980.0	64921855.0	C	G	-	-	-	-	-	-	SCV000071687	-	-	187G>C 	Val63Leu	NM_018684.4		1_Pathogenic	91.94	0.3380281690140845	['314580']	x-linked recessive	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	91.94	0.33802816	10-90	>90						V	48			91.94	Aliphatic	Valine		Zinc finger C4H2 domain-containing protein	Coiled coil							0.0136		4.2								V63-K59, V63-R67; PAE: 1.0, 1.0		V63-K59, V63-R67; PAE: 1.0, 1.0								117									-62.0		Pocket 3: Mean pLDDT: 80.71, Volume: 332.58 Å³, Druggability score: 0.01		-40.4				dbSNP: rs398122938; Variant type: LP/P; AA change: Val63Leu; PTM type: Ubiquitylation; PTM morphology: LLLQEkMAHV*E; Var class: II		H (helix)	H (α-helix)																																																																				true	ZC4H2Val63Leu																																																																																																																																																																																																																																		
KRAS	KRAS_Phe156Leu	-2.8937598314972	0.023191472239177145	0.6157222247118173	0.5575590131675932	2025_01_Batch_13-14	true	true	true	true	true	true	true	false	false	false	0.9909319386157275	0.9792498527021926	0.9824973811902327	0.9661316332652374	0.9108293859328107	0.8904038053154149	0.9708217372426282	0.9844276742428272	0.9781193592750286	0.9918403133550269	0.9312549665502065	0.9614415292878467	0.980567088137638	0.9803803461293565	0.9900235638764281	KRAS	-2.8937598314972	0.023191472239177145	0.6157222247118173	0.5575590131675932	2025_01_Batch_13-14	true	true	true	true	true	true	true	false	false	false	0.9909319386157275	0.9792498527021926	0.9824973811902327	0.9661316332652374	0.9108293859328107	0.8904038053154149	0.9708217372426282	0.9844276742428272	0.9781193592750286	0.9918403133550269	0.9312549665502065	0.9614415292878467	0.980567088137638	0.9803803461293565	0.9900235638764281	KRAS	ENSG00000133703	3084	214497.0	CCSBVarC006103	ALE00006103	NC_000012.12:25209894:G:C	468C>G	Phe156Leu	CEGS2	CegsMutGDEh1042	A06	GDEhDisVCh_40061	D10	1.0	CegsMutGDDh1042	A06							1.0	2.0	1.0	1.0	0.0			0.0			0.0			12.0	25209894.0	G	C	12	Y	Y	N	N	N	12-25209894-G-C	27634.0	single nucleotide variant	NM_033360.4(KRAS):c.*22C>G	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Mar 29, 2023	104894362.0	-	RCV000013426|RCV000157942|RCV001205658|RCV004549359	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder	germline	germline	GRCh38	NC_000012.12	12	25209894.0	25209894.0	12p12.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA279964,OMIM:190070.0018	3.0	12595.0	25209894.0	G	C	-	-	-	-	-	-	SCV000207877|SCV001376927|SCV004121369	-	-	*22C>G		NM_033360.4	2.0	1_Pathogenic		12595.0	12	25209894.0	G	C	F	L	rs104894362	12	25362828.0	12	25254095.0	131.0	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.393C>G	p.Phe131Leu	.	Y	.	.	.	-	TTC	3.0	2.0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.83643	.	.	0.55569	.	.	0.53661	.	.	0.90354	.	.	.	.	.	.	.	.	0.84554	.	.	0.87459	0.4565	0.8989	D	0.5849	0.85046	D	7.0	.	0.94504	.	0.338981	0.91944	D	.	0.94600	.	0.93225	.	.	.	.	0.97133	.	.	.	.	.	.	.	.	.	.	0.427055	0.91321	D	0.375659	0.91214	D	0.960605561733246	0.65634	D	.	0.72066	.	.	.	.	.	.	.	.	.	.	0.95241	.	.	0.98903	.	.	.	0.97816370	0.95342	0.965	0.98576	.	.	.	.	.	.	4.89283	0.80384	27.3	0.9950134605667188	0.68072	0.705408	0.65957	D	0.603185148433657	0.73232	5.956009	0.626658052516122	0.76756	6.573638	5.43	4.53	0.54956	.	.	6.216	0.72225	6.589000	0.56088	0.591	0.32125	1.0	0.71675	1.000000	0.68239	0.999	0.91597	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|not_provided|RASopathy|KRAS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25209894G>C	ClinGen:CA279964|OMIM:190070.0018	C3809005|C3661900|C5555857	615278	1340|536391	.	Phe	Leu	27634.0	single nucleotide variant	NM_033360.4(KRAS):c.*22C>G	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Mar 29, 2023	104894362.0	-	RCV000013426|RCV000157942|RCV001205658|RCV004549359	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder	germline	germline	GRCh38	NC_000012.12	12	25209894.0	25209894.0	12p12.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA279964,OMIM:190070.0018	3.0	12595.0	25209894.0	G	C	-	-	-	-	-	-	SCV000207877|SCV001376927|SCV004121369	-	-	*22C>G		NM_033360.4	2.0	1_Pathogenic			['615278']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2			10-90	>90																																																																																																																																		true	KRASPhe156Leu																																																																																																																																																																																																																																		
BAP1	BAP1_Asn290Ser	-0.3729935111171861	0.7201914707181801	0.08966665608823118	0.9310637601032032	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6057325498774384	0.5500959234521987	0.6715735402851634	0.5751819501504367	0.5831208149111815	0.5102749202430318	0.4980858979057414	0.5879716163221951	0.5234867851259092	0.5608719049035955	0.6559667095793311	0.652278002395132	0.7551754642481316	0.5767050617784881	0.6505931948512813	BAP1	-0.3729935111171861	0.7201914707181801	0.08966665608823118	0.9310637601032032	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6057325498774384	0.5500959234521987	0.6715735402851634	0.5751819501504367	0.5831208149111815	0.5102749202430318	0.4980858979057414	0.5879716163221951	0.5234867851259092	0.5608719049035955	0.6559667095793311	0.652278002395132	0.7551754642481316	0.5767050617784881	0.6505931948512813	BAP1		3760		CCSBVarC009478		NC_000003.12:52405827:T:C	869A>G	Asn290Ser																												3.0	52405827.0	T	C	3						3-52405827-T-C	453076.0	single nucleotide variant	NM_004656.4(BAP1):c.869A>G (p.Asn290Ser)	8314.0	BAP1	HGNC:950	Benign/Likely benign	0.0	Jan 31, 2025	747079481.0	-	RCV000562577|RCV001079643|RCV000843751|RCV003952834	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome|not provided|BAP1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	52405827.0	52405827.0	3p21.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA2436980	2.0	472716.0	52405827.0	T	C	-	-	-	-	-	-	SCV000651904|SCV000664731|SCV000910704|SCV000985789|SCV002537296|SCV004019766|SCV004221522	-	-	869A>G 	Asn290Ser	NM_004656.4	2.0	2_Benign		472716.0	3	52405827.0	T	C	N	S	rs747079481	3	52439843.0	3	52414883.0	290.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.869A>G	p.Asn290Ser	c.869A>G	p.Asn290Ser	principal1	Y	1	YES	Select	-	AAC	2.0	0.0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	0.697	0.05881	T	0.0	0.02950	B	0.0	0.01384	B	0.02	0.08015	N	simple_aae	98.0	2.0	-1.525	0.00486	N	-0.57	0.17141	N	0.027	0.00817	-1.0098	0.26903	T	0.0329	0.1405	T	10.0	0.004228443	0.00083	T	0.005388	0.13568	T	0.078	0.22615	0.356	0.35591	Q92560	N290S	Gain of relative solvent accessibility (P = 0.0024)| Gain of glycosylation at S285 (P = 0.0098)| Gain of solvent accessibility (P = 0.012)| Loss of sheet (P = 0.0228)| Gain of loop (P = 0.0502)	0.328222422547	0.32018	0.2007139702985778	0.19805	0.297888856719	0.31871	0.235256686807	0.02381	T	0.021852	0.16819	T	-0.644951	0.00076	T	-0.70131	0.05566	T	0.0150392539939985	0.00323	T	0.616438	0.23328	T	0.020683967	0.00634	0.020063097	0.00119	0.024449877	0.01269	0.018665047	0.00063	-2.044	0.03355	T	0.048	0.00099	B	4.71611775438763e-05	0.01873	0.94490990	0.93104	0.033	0.07179	.	.	.	.	.	.	1.173624	0.15654	11.99	0.7630045864098396	0.11599	0.027530	0.02227	N	-1.10195154957138	0.06531	0.3046936	-0.841934346995282	0.13249	0.6995833	5.38	3.55	0.397	-0.00352	0.21537	0.83	0.27208	2.762000	0.34693	-1.018	0.01749	0.826	0.30165	0.995	0.32549	0.841	0.39729	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	72	264690	2.7201633E-4	.	68	109402	6.215610e-04	0	118	208070	5.671170e-04	0	122	236922	5.149370e-04	0	0	7164	0.000000e+00	0	67	17112	3.915380e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	67	17112	3.915380e-03	0	0	16214	0.000000e+00	0	115	30522	3.767770e-03	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	0	16730	0.000000e+00	0	0	89508	0.000000e+00	0	0	30608	0.000000e+00	0	115	30522	3.767770e-03	0	0	14898	0.000000e+00	0	119	34258	3.473640e-03	0	0	9570	0.000000e+00	0	1	17692	5.652270e-05	0	0	21628	0.000000e+00	0	0	102730	0.000000e+00	0	0	30526	0.000000e+00	0	119	34258	3.473640e-03	0	.	147	1613970	9.107980e-05	0	143	60004	2.383170e-03	0	1	74936	1.334470e-05	0	0	912	0.000000e+00	0	143	60004	2.383170e-03	0	0	29608	0.000000e+00	0	0	44904	0.000000e+00	0	0	64032	0.000000e+00	0	0	5986	0.000000e+00	0	0	1180038	0.000000e+00	0	0	91082	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	2	610	0.003278688524590164	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	2	14050	1.4234875444839857E-4	Benign/Likely_benign	Hereditary_cancer-predisposing_syndrome|not_provided|BAP1-related_disorder|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52405827T>C	ClinGen:CA2436980	C0027672|C3661900|C3280492	614327	140162|289539	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Asn	Ser	453076.0	single nucleotide variant	NM_004656.4(BAP1):c.869A>G (p.Asn290Ser)	8314.0	BAP1	HGNC:950	Benign/Likely benign	0.0	Jan 31, 2025	747079481.0	-	RCV000562577|RCV001079643|RCV000843751|RCV003952834	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome|not provided|BAP1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	52405827.0	52405827.0	3p21.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA2436980	2.0	472716.0	52405827.0	T	C	-	-	-	-	-	-	SCV000651904|SCV000664731|SCV000910704|SCV000985789|SCV002537296|SCV004019766|SCV004221522	-	-	869A>G 	Asn290Ser	NM_004656.4	2.0	2_Benign	39.41	0.8407643312101911	['614327']	unknown		0	TUMOR PREDISPOSITION SYNDROME 1	39.41	0.84076434	10-90	<=50						N	132			39.41	Polar/Neutral	Asparagine		Ubiquitin carboxyl-terminal hydrolase BAP1										-3.5																		132									-174.4				153.6						C (loop/coil)	C (loop/coil)																																																																				true	BAP1Asn290Ser																																																																																																																																																																																																																																		
KRAS	KRAS_Lys5Asn	0.08584326223585399	0.9339947865923037	3.404403617783895	0.01137409970321642	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8034786921410206	0.7091727720524812	0.8233902473401864	0.8688220685069707	0.83801289915512	0.7643973846320817	0.8256332232634764	0.7182558406829578	0.7185386418366262	0.6737030480655471	0.9116284136781583	0.912010913750465	0.9285246539974151	0.6998069022683362	0.933254336216494	KRAS	0.08584326223585399	0.9339947865923037	3.404403617783895	0.01137409970321642	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8034786921410206	0.7091727720524812	0.8233902473401864	0.8688220685069707	0.83801289915512	0.7643973846320817	0.8256332232634764	0.7182558406829578	0.7185386418366262	0.6737030480655471	0.9116284136781583	0.912010913750465	0.9285246539974151	0.6998069022683362	0.933254336216494	KRAS	ENSG00000133703	3084	214478.0	CCSBVarC006087	ALE00006087	NC_000012.12:25245370:T:A	15A>T	Lys5Asn	CEGS2	CegsMutGDEh1038	C11	GDEhDisVCh_40061	C09	1.0	CegsMutGDDh1038	C11							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25245370.0	T	A	12	Y	Y	N	N	N	12-25245370-T-A	27633.0	single nucleotide variant	NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894361.0	-	RCV000153427|RCV000520745|RCV000013425|RCV000623267	MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MeSH:D030342,MedGen:C0950123	not provided|Noonan syndrome|Cardiofaciocutaneous syndrome 2|Inborn genetic diseases	germline	germline	GRCh38	NC_000012.12	12	25245370.0	25245370.0	12p12.1	reviewed by expert panel	4.0	-	N	ClinGen:CA234191,UniProtKB:P01116#VAR_064849,OMIM:190070.0017	3.0	12594.0	25245370.0	T	A	-	-	-	-	-	-	SCV000616404	-	-	15A>T 	Lys5Asn	NM_033360.4	3.0	1_Pathogenic		12594.0	12	25245370.0	T	A	K	N	rs104894361	12	25398304.0	12	25289571.0	5.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.15A>T	p.Lys5Asn	c.15A>T	p.Lys5Asn	alternative1	Y	1	.	Plus_Clinical	-	AAA	3.0	2.0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.925	0.84244	M	-3.84	0.80714	D	0.972	0.99419	0.7231	0.93439	D	0.7261	0.90593	D	9.0	0.89535224	0.88765	D	0.199646	0.86630	D	0.764	0.91975	0.746	0.87676	P01116	K5N	Gain of catalytic residue at E3 (P = 8e-04)| Loss of methylation at T5 (P = 0.0037)| Loss of ubiquitination at K5 (P = 0.021)| Gain of glycosylation at K2 (P = 0.1048)| Loss of disorder (P = 0.1189)	0.988022322716	0.98776	0.9939208319203104	0.99388	2.91440076523	0.99109	0.898385763168	0.96255	D	0.815684	0.95403	D	0.180387	0.71872	D	0.0213364	0.71506	D	0.998155415058136	0.93318	D	0.913609	0.69172	D	0.95635056	0.96861	0.89014167	0.94198	0.96346295	0.97588	0.8948088	0.94534	-11.193	0.83720	D	0.992	0.96154	P	0.999992346462973	0.99831	0.99815910	0.98658	0.995	0.99826	.	.	.	.	.	.	4.203335	0.6352	24.6	0.9985976106632319	0.93824	0.371023	0.45534	N	0.614844979912789	0.73972	6.077792	0.563747131663172	0.72208	5.797508	5.68	4.55	0.55376	2.79	0.51050	0.726	0.25745	1.824000	0.29148	-0.137	0.12603	1.0	0.71675	1.000000	0.68239	0.997	0.79771	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|not_provided|Noonan_syndrome|Inborn_genetic_diseases	reviewed_by_expert_panel	NC_000012.12:g.25245370T>A	ClinGen:CA234191|OMIM:190070.0017|UniProtKB:P01116#VAR_064849	C3809005|C3661900|C0028326|C0950123	615278|PS163950	1340|648	Small GTP-binding domain	Lys	Asn	27633.0	single nucleotide variant	NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894361.0	-	RCV000153427|RCV000520745|RCV000013425|RCV000623267	MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MeSH:D030342,MedGen:C0950123	not provided|Noonan syndrome|Cardiofaciocutaneous syndrome 2|Inborn genetic diseases	germline	germline	GRCh38	NC_000012.12	12	25245370.0	25245370.0	12p12.1	reviewed by expert panel	4.0	-	N	ClinGen:CA234191,UniProtKB:P01116#VAR_064849,OMIM:190070.0017	3.0	12594.0	25245370.0	T	A	-	-	-	-	-	-	SCV000616404	-	-	15A>T 	Lys5Asn	NM_033360.4	3.0	1_Pathogenic	98.33	0.4390243902439024	['615278']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2	98.33	0.4390244	10-90	>90																																																																																																																																		true	KRASLys5Asn																																																																																																																																																																																																																																		
RAF1	RAF1_Leu603Pro	-1.790881684197182	1.0	-2.761223855400645	0.028913933298763714	2025_01_Batch_13-14	false	false	false	true	false	false	false	false	false	false	0.9504947202254045	0.7809174831130336	0.9164747568730376	0.9272101073321573	0.7772501324293355	0.8072334686400157	0.9398959418348838	0.9276792657133388	0.8371185622746348	0.9632003901983831	0.7472667962186552	0.9145242728294307	0.9052702480327363	0.7247164039514323	0.9377890502524259	RAF1	-1.790881684197182	1.0	-2.761223855400645	0.028913933298763714	2025_01_Batch_13-14	false	false	false	true	false	false	false	false	false	false	0.9504947202254045	0.7809174831130336	0.9164747568730376	0.9272101073321573	0.7772501324293355	0.8072334686400157	0.9398959418348838	0.9276792657133388	0.8371185622746348	0.9632003901983831	0.7472667962186552	0.9145242728294307	0.9052702480327363	0.7247164039514323	0.9377890502524259	RAF1		732		CCSBVarC008861		NC_000003.12:12584653:A:G	1808T>C	Leu603Pro																												3.0	12584653.0	A	G	3						3-12584653-A-G	152010.0	single nucleotide variant	NM_002880.4(RAF1):c.1808T>C (p.Leu603Pro)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Jun 01, 2014	587777586.0	-	RCV000131334	MONDO:MONDO:0014396,MedGen:C4014656,OMIM:615916,Orphanet:154	Dilated cardiomyopathy 1NN	germline	germline	GRCh38	NC_000003.12	3	12584653.0	12584653.0	3p25.2	no assertion criteria provided	1.0	-	N	ClinGen:CA167980,UniProtKB:P04049#VAR_071847,OMIM:164760.0005	1.0	142296.0	12584653.0	A	G	-	-	-	-	-	-	SCV000186308	-	-	1808T>C 	Leu603Pro	NM_002880.4		1_Pathogenic		142296.0	3	12584653.0	A	G	L	P	rs587777586	3	12626152.0	3	12601152.0	603.0	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1808T>C	p.Leu603Pro	c.1808T>C	p.Leu603Pro	principal3	Y	1	YES	Select	-	CTG	2.0	0.0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.006	0.72530	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.055	0.86694	M	-5.94	0.89120	D	0.954	0.97221	1.0563	0.98251	D	0.982	0.99448	D	10.0	0.9554792	0.94850	D	0.905219	0.99287	D	0.986	0.99942	0.791	0.91245	P04049	L603P	Gain of disorder (P = 0.017)| Gain of helix (P = 0.0325)| Gain of glycosylation at S604 (P = 0.0488)| Loss of loop (P = 0.0804)| Loss of stability (P = 0.1069)	0.973766025508	0.97323	.	0.95923	1.08258798955	0.77046	0.886617004871	0.94825	D	0.932912	0.98867	D	0.575938	0.96897	D	0.589519	0.96846	D	0.999162554740906	0.96363	D	.	0.93270	.	0.99187005	0.99851	0.9862118	0.99940	0.9903099	0.99776	0.98532397	0.99928	-13.29	0.90541	D	0.9993	0.98761	P	0.999902317115662	0.98723	0.99897957	0.99072	0.987	0.99559	.	.	.	.	.	.	5.064217	0.84452	28.3	0.9991238832011082	0.98168	0.956235	0.97455	D	0.915325109665532	0.92448	11.45292	0.863677081222081	0.93754	12.28152	5.51	5.51	0.81744	.	.	8.809	0.91585	11.190000	0.88645	0.756	0.943	1.0	0.71675	1.0	0.68239	0.998	0.85369	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Dilated_cardiomyopathy_1NN	no_assertion_criteria_provided	NC_000003.12:g.12584653A>G	ClinGen:CA167980|OMIM:164760.0005|UniProtKB:P04049#VAR_071847	C4014656	615916	154	Protein kinase domain|Protein kinase domain|Protein kinase domain	Leu	Pro	152010.0	single nucleotide variant	NM_002880.4(RAF1):c.1808T>C (p.Leu603Pro)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Jun 01, 2014	587777586.0	-	RCV000131334	MONDO:MONDO:0014396,MedGen:C4014656,OMIM:615916,Orphanet:154	Dilated cardiomyopathy 1NN	germline	germline	GRCh38	NC_000003.12	3	12584653.0	12584653.0	3p25.2	no assertion criteria provided	1.0	-	N	ClinGen:CA167980,UniProtKB:P04049#VAR_071847,OMIM:164760.0005	1.0	142296.0	12584653.0	A	G	-	-	-	-	-	-	SCV000186308	-	-	1808T>C 	Leu603Pro	NM_002880.4		1_Pathogenic	95.67	0.1219512195121951	['615916']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOMYOPATHY, DILATED, 1NN	95.67	0.12195122	10-90	>90						L	20			95.67	Aliphatic	Leucine		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			3.8								L603-E607, L603-F599; PAE: 1.0, 1.0	8 interactions	L603-E607, L603-F599; PAE: 1.0, 1.0	8 interactions							131									-59.9				-48.2						H (helix)	H (α-helix)	Helix																																																																			true	RAF1Leu603Pro																																																																																																																																																																																																																																		
BRIP1	BRIP1_His587Arg	1.584238978026326	0.18073804788590886	0.8160682007653915	0.5462855001074963	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7207159096877555	0.6861527528802321	0.6983011670735113	0.7182268881977769	0.7126974911053819	0.7961700191551921	0.699855795832681	0.6867968081920343	0.7478837190377782	0.7171372516909297	0.6292249630555717	0.7365979805628727	0.7098055259549884	0.6244217867226861	0.7242945676845812	BRIP1	1.584238978026326	0.18073804788590886	0.8160682007653915	0.5462855001074963	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7207159096877555	0.6861527528802321	0.6983011670735113	0.7182268881977769	0.7126974911053819	0.7961700191551921	0.699855795832681	0.6867968081920343	0.7478837190377782	0.7171372516909297	0.6292249630555717	0.7365979805628727	0.7098055259549884	0.6244217867226861	0.7242945676845812	BRIP1		55128		CCSBVarC031376		NC_000017.11:61780874:T:C	1760A>G	His587Arg																												17.0	61780874.0	T	C	17						17-61780874-T-C	914095.0	single nucleotide variant	NM_032043.3(BRIP1):c.1760A>G (p.His587Arg)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0.0	Jan 11, 2024	876660646.0	-	RCV001187524|RCV004570384	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61780874.0	61780874.0	17q23.2	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA400480314	2.0	925546.0	61780874.0	T	C	-	-	-	-	-	-	SCV001354344|SCV002716735|SCV005059286	-	-	1760A>G 	His587Arg	NM_032043.3	1.0	3_Conflicting		925546.0	17	61780874.0	T	C	H	R	rs876660646	17	59858235.0	17	57213017.0	587.0	BRIP1	ENSG00000136492	ENST00000683039	ENSP00000508303	Q9BX63	FANCJ_HUMAN	.	.	c.1760A>G	p.His587Arg	principal2	Y	.	.	.	-	CAT	2.0	0.0	T	T/T	T/T	T/T	T/T	.	0.14580	.	.	0.15078	.	0.004	0.12194	B	0.002	0.06938	B	.	.	.	.	.	.	0.935	0.23470	L	.	0.51830	.	.	0.37163	-1.0328	0.19528	T	0.0418	0.17856	T	9.0	.	0.24312	.	0.004931	0.12152	T	.	0.14866	0.491	0.57600	Q9BX63	H587R	Gain of MoRF binding (P = 0.0125)| Loss of methylation at K583 (P = 0.0639)| Loss of catalytic residue at L589 (P = 0.0953)| Gain of solvent accessibility (P = 0.1133)| Loss of loop (P = 0.1242)	.	0.09769	.	0.48927	.	0.22326	0.250247567892	0.03796	T	0.210366	0.56871	T	-0.251719	0.13623	T	-0.599353	0.12601	T	0.194684848189354	0.19868	T	.	0.24645	.	0.10351601	0.24247	0.11949802	0.28773	0.10351601	0.24247	0.11949802	0.28773	-10.008	0.74039	D	.	0.07115	.	0.00139744306121536	0.11129	0.46835166	0.81192	0.123	0.33205	.	.	.	.	.	.	0.721728	0.10931	7.579	0.7716704011490151	0.11955	0.345304	0.43862	N	-0.689993184120315	0.16104	0.8295734	-0.53367226512072	0.20931	1.148141	5.42	3.2	0.35749	-0.62	0.17698	0.573	0.23486	0.301000	0.17048	-0.118	0.14421	0.958	0.33576	0.991	0.31563	0.993	0.69292	54	0.97580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614206	6.195000e-07	0	1	1180040	8.474290e-07	0	0	75066	0.000000e+00	0	0	912	0.000000e+00	0	0	60032	0.000000e+00	0	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180040	8.474290e-07	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.61780874T>C	.	C0346153|C0027672	114480	227535|140162	.	His	Arg	914095.0	single nucleotide variant	NM_032043.3(BRIP1):c.1760A>G (p.His587Arg)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0.0	Jan 11, 2024	876660646.0	-	RCV001187524|RCV004570384	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61780874.0	61780874.0	17q23.2	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA400480314	2.0	925546.0	61780874.0	T	C	-	-	-	-	-	-	SCV001354344|SCV002716735|SCV005059286	-	-	1760A>G 	His587Arg	NM_032043.3	1.0	3_Conflicting	90.54	0.1793478260869565	['114480']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	BREAST CANCER	90.54	0.17934783	10-90	>90						H	33			90.54	Positively-charged	Histidine		Fanconi anemia group J protein										-3.2								H587-E412; PAE: 2.5		H587-E412, H587-Q554; PAE: 2.5, 1.5								155									-78.0				136.5						B (undefined)	E (parallel sheets)																																																																				true	BRIP1His587Arg																																																																																																																																																																																																																																		
FARS2	FARS2_Thr246Met	-0.10148333665327636	1.0	-2.353819191627526	0.05729009060236506	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7678845256819767	0.5445122319350636	0.7858362928428497	0.7068085051066038	0.6787197362072985	0.6804102176056457	0.7023703706038089	0.7472986977081443	0.6146380679875117	0.7528933762948292	0.6770292548089514	0.7112466396093987	0.8243738879775552	0.4743863958826155	0.7828756750691243	FARS2	-0.10148333665327636	1.0	-2.353819191627526	0.05729009060236506	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7678845256819767	0.5445122319350636	0.7858362928428497	0.7068085051066038	0.6787197362072985	0.6804102176056457	0.7023703706038089	0.7472986977081443	0.6146380679875117	0.7528933762948292	0.6770292548089514	0.7112466396093987	0.8243738879775552	0.4743863958826155	0.7828756750691243	FARS2		12653		CCSBVarC011873		NC_000006.12:5404666:C:T	737C>T	Thr246Met																												6.0	5404666.0	C	T	6						6-5404666-C-T	140994.0	single nucleotide variant	NM_006567.5(FARS2):c.737C>T (p.Thr246Met)	10667.0	FARS2	HGNC:21062	Benign/Likely benign	0.0	Jan 30, 2025	116567033.0	-	RCV000124982|RCV000527403|RCV000677019	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	not specified|Combined oxidative phosphorylation defect type 14|not provided	germline;unknown	germline	GRCh38	NC_000006.12	6	5404666.0	5404666.0	6p25.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA290843	2.0	137291.0	5404666.0	C	T	-	-	-	-	-	-	SCV000168422|SCV000652852|SCV000845689|SCV001137051|SCV001154616|SCV005222709|SCV005879797	-	-	737C>T 	Thr246Met	NM_006567.5	2.0	2_Benign		137291.0	6	5404666.0	C	T	T	M	rs116567033	6	5404899.0	6	5349898.0	246.0	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.737C>T	p.Thr246Met	c.737C>T	p.Thr246Met	principal1	Y	1	.	.	+	ACG	2.0	0.0	C	C/C	C/C	C/C	C/C	0.027	0.46673	D	0.073	0.48688	T	0.996	0.68795	D	0.913	0.64880	D	0.21	0.45549	N	simple_aae	79.0	21.0	2.83	0.82191	M	-3.55	0.74296	D	0.608	0.62419	-0.7616	0.5714	T	0.2289	0.59266	T	10.0	0.0118563175	0.00254	T	0.024038	0.46809	T	0.317	0.63716	.	.	.	.	.	0.819830007893	0.81670	0.7281157812391854	0.72612	0.655512290444	0.58315	0.467225492001	0.34256	T	0.297402	0.66816	T	-0.321825	0.06557	T	-0.227665	0.51677	T	0.0169158800264063	0.00441	T	.	0.91526	.	0.26475862	0.49212	0.2838555	0.54171	0.3314129	0.55255	0.26372668	0.51982	-9.33	0.69874	D	0.0974	0.35559	LB	0.64624273715353	0.65262	0.71377310	0.86373	0.195	0.45457	.	.	.	.	.	.	4.289772	0.65479	24.8	0.9976852852855412	0.85678	0.131614	0.24846	N	0.315961225953202	0.56747	3.862512	0.173260709396764	0.48124	3.055297	5.32	4.44	0.53107	2.64	0.48287	3.703	0.54631	3.963000	0.40843	0.596	0.33565	1.0	0.71675	0.999	0.35501	0.533	0.29823	973	0.05579	16	0.003194888178913738	1	7.564296520423601E-4	6	0.005964214711729622	4	0.005763688760806916	0	0.0	5	0.005112474437627812	1306	264690	0.004934074	.	416	108230	3.843670e-03	2	849	205656	4.128250e-03	6	948	234230	4.047300e-03	5	7	7116	9.836990e-04	0	39	16534	2.358780e-03	0	2	2310	8.658010e-04	0	0	8992	0.000000e+00	0	8	13394	5.972820e-04	0	313	42624	7.343280e-03	2	45	15404	2.921320e-03	0	313	42624	7.343280e-03	2	23	16112	1.427510e-03	0	62	29418	2.107550e-03	0	5	6178	8.093230e-04	0	0	13304	0.000000e+00	0	11	16722	6.578160e-04	0	636	89182	7.131480e-03	4	102	29978	3.402500e-03	2	636	89182	7.131480e-03	4	22	14796	1.486890e-03	0	84	33134	2.535160e-03	0	8	9532	8.392780e-04	0	0	17536	0.000000e+00	0	15	21618	6.938660e-04	0	699	102210	6.838860e-03	3	101	29896	3.378380e-03	2	699	102210	6.838860e-03	3	.	10638	1606620	6.621350e-03	55	9520	1175990	8.095310e-03	43	90	74778	1.203560e-03	0	2	912	2.192980e-03	0	224	59598	3.758520e-03	3	15	29462	5.091300e-04	0	1	44762	2.234040e-05	0	70	63756	1.097940e-03	0	20	5910	3.384090e-03	1	9520	1175990	8.095310e-03	43	320	89360	3.581020e-03	5	1182	178306	0.006629053425010936	0	360	0	0	4502	0	25	9456	0.002643824027072758	3	804	0.0037313432835820895	1	974	0.001026694045174538	0	1850	0	0	280	0	87	17442	0.004987960096319229	25	9816	0.0025468622656886716	0	6352	0	1298	213974	0.006066157570545954	Benign/Likely_benign	not_specified|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5404666C>T	ClinGen:CA290843	CN169374|C3661900|C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Thr	Met	140994.0	single nucleotide variant	NM_006567.5(FARS2):c.737C>T (p.Thr246Met)	10667.0	FARS2	HGNC:21062	Benign/Likely benign	0.0	Jan 30, 2025	116567033.0	-	RCV000124982|RCV000527403|RCV000677019	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	not specified|Combined oxidative phosphorylation defect type 14|not provided	germline;unknown	germline	GRCh38	NC_000006.12	6	5404666.0	5404666.0	6p25.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA290843	2.0	137291.0	5404666.0	C	T	-	-	-	-	-	-	SCV000168422|SCV000652852|SCV000845689|SCV001137051|SCV001154616|SCV005222709|SCV005879797	-	-	737C>T 	Thr246Met	NM_006567.5	2.0	2_Benign	97.24	0.0352112676056338	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	97.24	0.03521127	<10	>90						T	5			97.24	Polar/Neutral	Threonine												-0.7								T246-D242, T246-L250; PAE: 1.0, 1.0	11 interactions	T246-D242, T246-L250, T246-Y101; PAE: 1.0, 1.0, 1.5	11 interactions							119									-62.3	Morphology: VEFDLKQtLTRLMAH; Domain: tRNA-synt_2d			-49.7						H (helix)	H (α-helix)	Helix																																																																			true	FARS2Thr246Met																																																																																																																																																																																																																																		
RHO	RHO_Cys110Tyr	-5.373754793745742	0.001037313511567956	-13.627094674258373	2.697354088123665e-6	2025_01_Batch_13-14	true	true	true	true	false	true	true	true	true	false	0.9995509392173199	0.9822787162831441	0.99666705542453	0.9791911557328632	0.8759363719723349	0.8727911260092511	0.9709315205985769	0.9960781336949563	0.9790524850900243	0.9993528754968187	0.8790816179354186	0.9874507908671495	0.9972559771541037	0.985504947476264	0.9997490029378209	RHO	-5.373754793745742	0.001037313511567956	-13.627094674258373	2.697354088123665e-6	2025_01_Batch_13-14	true	true	true	true	false	true	true	true	true	false	0.9995509392173199	0.9822787162831441	0.99666705542453	0.9791911557328632	0.8759363719723349	0.8727911260092511	0.9709315205985769	0.9960781336949563	0.9790524850900243	0.9993528754968187	0.8790816179354186	0.9874507908671495	0.9972559771541037	0.985504947476264	0.9997490029378209	RHO		40080645		CCSBVarC013625		NC_000003.12:129529062:G:A	329G>A	Cys110Tyr																												3.0	129529062.0	G	A	3						3-129529062-G-A	28074.0	single nucleotide variant	NM_000539.3(RHO):c.329G>A (p.Cys110Tyr)	6010.0	RHO	HGNC:10012	Pathogenic	1.0	Dec 19, 2020	104893787.0	-	RCV000013910|RCV001234924|RCV001073635	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Retinitis pigmentosa 4|not provided|Retinal dystrophy	germline	germline	GRCh38	NC_000003.12	3	129529062.0	129529062.0	3q22.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA256681,UniProtKB:P08100#VAR_004790,OMIM:180380.0035	3.0	13035.0	129529062.0	G	A	-	-	-	-	-	-	SCV001239186|SCV001407585|SCV001779172	-	-	329G>A 	Cys110Tyr	NM_000539.3	2.0	1_Pathogenic		13035.0	3	129529062.0	G	A	C	Y	rs104893787	3	129247905.0	3	130730595.0	110.0	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.329G>A	p.Cys110Tyr	c.329G>A	p.Cys110Tyr	principal1	Y	1	YES	Select	+	TGC	2.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.65	0.99359	H	-10.25	0.98944	D	0.973	0.98381	0.7379	0.93623	D	0.6727	0.88624	D	9.0	0.99468315	0.99956	D	0.356575	0.92389	D	0.790	0.93044	0.936	0.99070	P08100	C110Y	Loss of glycosylation at T108 (P = 0.1174)| Loss of catalytic residue at C110 (P = 0.1303)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.437)| Loss of stability (P = 0.5943)	0.98071754066	0.98031	0.9872522222524879	0.98714	1.14035379566	0.78786	0.632616996765	0.57451	T	0.872212	0.97226	D	0.401147	0.89909	D	0.338444	0.89782	D	0.999984264373779	0.99981	D	0.989657	0.96643	D	0.9926738	0.99885	0.9854278	0.99929	0.99123245	0.99822	0.9922701	0.99991	-9.757	0.72523	D	0.9978	0.97230	P	0.999956226333039	0.99183	0.99990320	0.99879	0.997	0.99892	.	.	.	.	.	.	5.01551	0.83352	28.0	0.9977197502818197	0.86015	0.938668	0.93795	D	1.15131989520089	0.98970	20.11403	1.01875670206705	0.98952	20.03965	5.31	5.31	0.75027	4.99	0.89858	9.996	0.99292	11.806000	0.96796	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.566	0.306	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	not_provided|Retinitis_pigmentosa_4|Retinal_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129529062G>A	ClinGen:CA256681|OMIM:180380.0035|UniProtKB:P08100#VAR_004790	C3661900|C3151001|C0854723	613731	791|71862	GPCR, rhodopsin-like, 7TM	Cys	Tyr	28074.0	single nucleotide variant	NM_000539.3(RHO):c.329G>A (p.Cys110Tyr)	6010.0	RHO	HGNC:10012	Pathogenic	1.0	Dec 19, 2020	104893787.0	-	RCV000013910|RCV001234924|RCV001073635	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Retinitis pigmentosa 4|not provided|Retinal dystrophy	germline	germline	GRCh38	NC_000003.12	3	129529062.0	129529062.0	3q22.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA256681,UniProtKB:P08100#VAR_004790,OMIM:180380.0035	3.0	13035.0	129529062.0	G	A	-	-	-	-	-	-	SCV001239186|SCV001407585|SCV001779172	-	-	329G>A 	Cys110Tyr	NM_000539.3	2.0	1_Pathogenic	98.33	0.0074074074074074	['613731']	unknown		0	RETINITIS PIGMENTOSA 4	98.33	0.0074074073	<10	>90						C	1			98.33	Special, a very reactive sulfhydryl group	Cysteine		Rhodopsin						Disulfide bond 110-187				2.5								C110-G106, C110-G114; PAE: 1.0, 1.0	1 interaction	C110-G106, C110-G114, C110-F103; PAE: 1.0, 1.0, 1.0	2 interactions							121									-68.1				-42.6						H (helix)	H (α-helix)	Helix						Extracellular																																																													true	RHOCys110Tyr																																																																																																																																																																																																																																		
RAD51D	RAD51D_Glu233Gly	2.0151388056522266	0.08372864851161924	-22.26053493041938	9.334055407083976e-8	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9643222974912136	0.7057745901872797	0.9191037174432628	0.8852527971829229	0.6745126839748287	0.6523177668682895	0.8737579764020821	0.9066849961213046	0.7123528900241779	0.9617439699350335	0.6967076010813679	0.8967476179637639	0.9315224387652209	0.6991962903503816	0.9669006250473935	RAD51D	2.0151388056522266	0.08372864851161924	-22.26053493041938	9.334055407083976e-8	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9643222974912136	0.7057745901872797	0.9191037174432628	0.8852527971829229	0.6745126839748287	0.6523177668682895	0.8737579764020821	0.9066849961213046	0.7123528900241779	0.9617439699350335	0.6967076010813679	0.8967476179637639	0.9315224387652209	0.6991962903503816	0.9669006250473935	RAD51D	ENSG00000185379	7201	12776.0	CCSBVarC001140	ALE00001140	NC_000017.11:35103294:T:C	698A>G	Glu233Gly	RC4	RC4_Mut_GDEh1002	C07	GDEhDisVCh_40046	H04	2.0	RC4_Mut_GDDh1002	C07			VUSMutpDEST2_06	F01	VUSmut_GDEh12	G05	1.0	2.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	17.0	35103294.0	T	C	17	Y	Y	N	Y	Y	17-35103294-T-C	142576.0	single nucleotide variant	NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	5892.0	RAD51D	HGNC:9823	Benign/Likely benign	0.0	Mar 04, 2025	28363284.0	-	RCV000128967|RCV000203773|RCV000212967|RCV001354814|RCV000588832|RCV001723701	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Malignant tumor of breast|not provided|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35103294.0	35103294.0	17q12	criteria provided, multiple submitters, no conflicts	20.0	-	N	ClinGen:CA293923,UniProtKB:O75771#VAR_020564	2.0	138873.0	35103294.0	T	C	-	-	-	-	-	-	SCV000171275|SCV000172849|SCV000262197|SCV000292107|SCV000488546|SCV000604996|SCV000698112|SCV000806585|SCV000859932|SCV000889832|SCV002550915|SCV004044167|SCV005214637	-	-	698A>G 	Glu233Gly	NM_002878.4	2.0	2_Benign	0.0174388	138873.0	17	35103294.0	T	C	E	G	rs28363284	17	33430313.0	17	30454426.0	233.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.698A>G	p.Glu233Gly	c.698A>G	p.Glu233Gly	principal1	Y	5	.	.	-	GAG	2.0	0.0	T	T/T	T/T	T/T	T/T	.	0.36459	.	0.451	0.68204	T	0.973	0.90580	D	0.785	0.86259	P	0.01	0.13669	N	simple_aae	99.0	1.0	1.85	0.48914	L	.	0.66695	.	0.562	0.63954	-0.5609	0.66221	T	0.2448	0.61193	T	10.0	0.012577295	0.00266	T	.	.	.	0.189	0.46391	.	.	.	.	.	0.911308683432	0.90975	.	0.64516	.	0.41897	.	.	.	0.290868	0.66175	T	-0.22489	0.17038	T	-0.07823	0.64785	T	0.021744398197262	0.00877	T	0.918208	0.70530	D	0.46690348	0.64786	0.5062009	0.71202	0.46690348	0.64786	0.5062009	0.71203	-7.244	0.74324	T	0.4981	0.71170	A	0.0150280587944397	0.27128	0.89164200	0.90920	0.292	0.56112	.	.	.	.	.	.	4.817542	0.78468	26.9	0.9784259549490156	0.36495	0.450689	0.50327	N	0.408714271726761	0.61704	4.397588	0.40833569100615	0.61877	4.417963	4.92	4.92	0.64102	.	.	2.999	0.49258	7.756000	0.68269	0.609	0.47831	1.0	0.71675	1.0	0.68239	0.998	0.85369	908	0.22602	22	0.00439297124600639	0	0.0	11	0.010934393638170975	9	0.012968299711815562	0	0.0	2	0.002044989775051125	2903	264690	0.010967547	.	877	106826	8.209610e-03	7	1989	203334	9.781940e-03	19	2153	232226	9.271140e-03	19	17	6852	2.481030e-03	0	139	16760	8.293560e-03	0	2	2226	8.984730e-04	0	0	8848	0.000000e+00	0	19	13238	1.435260e-03	0	642	41754	1.537580e-02	7	46	15266	3.013230e-03	0	642	41754	1.537580e-02	7	54	15672	3.445640e-03	0	220	29852	7.369690e-03	0	11	6048	1.818780e-03	0	0	13294	0.000000e+00	0	21	16462	1.275670e-03	0	1541	87382	1.763520e-02	18	94	29872	3.146760e-03	0	1541	87382	1.763520e-02	18	44	14468	3.041190e-03	0	242	33624	7.197240e-03	0	16	9428	1.697070e-03	0	0	17460	0.000000e+00	0	25	21078	1.186070e-03	0	1672	100816	1.658470e-02	18	94	29798	3.154570e-03	0	1672	100816	1.658470e-02	18	.	27113	1611638	1.682330e-02	297	24903	1179112	2.112010e-02	286	234	74922	3.123250e-03	0	10	912	1.096490e-02	0	477	59646	7.997180e-03	0	54	29510	1.829890e-03	0	1	44820	2.231150e-05	0	106	63816	1.661030e-03	0	43	6018	7.145230e-03	1	24903	1179112	2.112010e-02	286	335	90476	3.702640e-03	3	3387	201918	0.016774136035420318	0	358	0	0	4530	0	38	9444	0.004023718763235917	6	800	0.0075	12	974	0.012320328542094456	1	1850	5.405405405405405E-4	0	282	0	223	18644	0.011960952585282129	38	9802	0.0038767598449296063	1	6380	1.5673981191222572E-4	3667	238800	0.015355946398659967	Benign/Likely_benign	not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35103294T>C	ClinGen:CA293923|UniProtKB:O75771#VAR_020564	C3661900|C0027672|CN169374|C0677776|C3280345|C0006142	614291	140162|145|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Glu	Gly	142576.0	single nucleotide variant	NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	5892.0	RAD51D	HGNC:9823	Benign/Likely benign	0.0	Mar 04, 2025	28363284.0	-	RCV000128967|RCV000203773|RCV000212967|RCV001354814|RCV000588832|RCV001723701	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Malignant tumor of breast|not provided|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35103294.0	35103294.0	17q12	criteria provided, multiple submitters, no conflicts	20.0	-	N	ClinGen:CA293923,UniProtKB:O75771#VAR_020564	2.0	138873.0	35103294.0	T	C	-	-	-	-	-	-	SCV000171275|SCV000172849|SCV000262197|SCV000292107|SCV000488546|SCV000604996|SCV000698112|SCV000806585|SCV000859932|SCV000889832|SCV002550915|SCV004044167|SCV005214637	-	-	698A>G 	Glu233Gly	NM_002878.4	2.0	2_Benign	97.01	0.0618556701030927	['614291']	autosomal dominant	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	97.01	0.06185567	<10	>90	0.8718966229062447	Uncertain	Increase			E	12			97.01	Negatively-charged	Glutamic Acid		DNA repair protein RAD51 homolog 4										-3.5								E233-L237, E233-Q229; PAE: 1.0, 1.0	6 interactions	E233-L237, E233-Q229; PAE: 1.0, 1.0	7 interactions		1 interaction					146									-60.9				-43.5				dbSNP: rs28363284; Variant type: LB/B; AA change: Glu233Gly; PTM type: Phosphorylation; PTM morphology: ARE*LKtLARDL; Var class: II		H (helix)	H (α-helix)	Helix																																																																			true	RAD51DGlu233Gly																																																																																																																																																																																																																																		
FH	FH_Ser419Pro	1.6917016548170403	0.14165291060128632	-6.746355577654343	0.0002658955188190891	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9133071322395863	0.852020231922608	0.9063090807848821	0.8896087061324268	0.8968320364057718	0.9213201043130436	0.8773370007239154	0.8950052648966569	0.9097442483214611	0.9050679469217979	0.8723439684984999	0.9018804115409382	0.9176128966731075	0.7942962155237551	0.9215463175573746	FH	1.6917016548170403	0.14165291060128632	-6.746355577654343	0.0002658955188190891	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9133071322395863	0.852020231922608	0.9063090807848821	0.8896087061324268	0.8968320364057718	0.9213201043130436	0.8773370007239154	0.8950052648966569	0.9097442483214611	0.9050679469217979	0.8723439684984999	0.9018804115409382	0.9176128966731075	0.7942962155237551	0.9215463175573746	FH	ENSG00000091483	3408	214603.0	CCSBVarC004056	ALE00004056	NC_000001.11:241500572:A:G	1255T>C	Ser419Pro	CEGS2	CegsMutGDEh1042	E07	GDEhDisVCh_40065	C09	1.0	CegsMutGDDh1042	E07							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	241500572.0	A	G	1	Y	Y	N	N	N	1-241500572-A-G	98360.0	single nucleotide variant	NM_000143.4(FH):c.1255T>C (p.Ser419Pro)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Sep 23, 2024	200004220.0	-	RCV000078144|RCV000445624|RCV000492881|RCV004555536	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	not provided|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|FH-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	241500572.0	241500572.0	1q43	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA285322	2.0	92451.0	241500572.0	A	G	-	-	-	-	-	-	SCV000109982|SCV000537264|SCV000544243|SCV000581641|SCV002535539|SCV004186966|SCV005414250	-	-	1255T>C 	Ser419Pro	NM_000143.4	2.0	1_Pathogenic	1.37695e-6	92451.0	1	241500572.0	A	G	S	P	rs200004220	1	241663872.0	1	239730495.0	419.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1255T>C	p.Ser419Pro	c.1255T>C	p.Ser419Pro	principal1	Y	1	YES	Select	-	TCA	1.0	0.0	A	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.865	0.99733	H	-4.94	0.81865	D	0.942	0.94916	1.0873	0.99132	D	0.9643	0.98856	D	10.0	0.9089949	0.90156	D	0.541982	0.95732	D	0.822	0.94297	0.474	0.54885	P07954	S419P	Loss of MoRF binding (P = 0.0866)| Gain of ubiquitination at K414 (P = 0.2044)| Loss of methylation at R421 (P = 0.225)| Loss of catalytic residue at S419 (P = 0.2816)| Loss of disorder (P = 0.2882)	0.988284473714	0.98802	0.9942181623254077	0.99417	1.10507444367	0.77742	0.735592842102	0.72276	T	0.924582	0.98660	D	0.567543	0.96347	D	0.57746	0.96286	D	0.999648451805115	0.98285	D	0.987601	0.95789	D	0.94234765	0.95416	0.89128804	0.94281	0.94234765	0.95417	0.89128804	0.94282	-14.165	0.93593	D	0.9921	0.94292	P	0.999992778285156	0.99831	0.96268230	0.94135	0.992	0.99727	.	.	.	.	.	.	5.38469	0.90245	31.0	0.9989029719821418	0.96438	0.950240	0.96356	D	1.0315813013022	0.96616	14.9433	0.929047610943649	0.96701	15.05383	5.71	5.71	0.89013	5.93	0.96971	7.0	0.76103	11.015000	0.84918	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1598452	1.876820e-06	0	1	72718	1.375180e-05	0	1	72718	1.375180e-05	0	0	886	0.000000e+00	0	0	58902	0.000000e+00	0	0	29280	0.000000e+00	0	0	44352	0.000000e+00	0	0	61956	0.000000e+00	0	0	5882	0.000000e+00	0	1	1171916	8.533030e-07	0	0	90710	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic/Likely_pathogenic	FH-related_disorder|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241500572A>G	ClinGen:CA285322	C1708350|C0027672|C3661900	150800	523|140162	.	Ser	Pro	98360.0	single nucleotide variant	NM_000143.4(FH):c.1255T>C (p.Ser419Pro)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Sep 23, 2024	200004220.0	-	RCV000078144|RCV000445624|RCV000492881|RCV004555536	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	not provided|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|FH-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	241500572.0	241500572.0	1q43	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA285322	2.0	92451.0	241500572.0	A	G	-	-	-	-	-	-	SCV000109982|SCV000537264|SCV000544243|SCV000581641|SCV002535539|SCV004186966|SCV005414250	-	-	1255T>C 	Ser419Pro	NM_000143.4	2.0	1_Pathogenic	98.92	0.0	['150800']	autosomal dominant	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	98.92	0.0	<10	>90						S	0			98.92	Polar/Neutral	Serine		Fumarate hydratase, mitochondrial										-0.8								S419-N390, S419-L423, S419-N415; PAE: 1.0, 1.0, 1.0	8 interactions	S419-N390, S419-L423, S419-V387, S419-N415; PAE: 1.0, 1.0, 1.0, 1.0	10 interactions							105									-64.6				-46.6						H (helix)	H (α-helix)	Helix																																																																			true	FHSer419Pro																																																																																																																																																																																																																																		
BRAF	BRAF_Leu245Phe	-6.838409603080999	0.00024453937326696584	0.8416317444096693	0.4278071535265413	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7866959238534965	0.6916446161979496	0.7834894211053023	0.7868955910832189	0.74653046728712	0.854239827692258	0.8246017482336747	0.8005495999829777	0.7756869324123206	0.7947755656887654	0.638821106881982	0.749189433932763	0.7664292422276268	0.6076022999835786	0.7786162820182276	BRAF	-6.838409603080999	0.00024453937326696584	0.8416317444096693	0.4278071535265413	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7866959238534965	0.6916446161979496	0.7834894211053023	0.7868955910832189	0.74653046728712	0.854239827692258	0.8246017482336747	0.8005495999829777	0.7756869324123206	0.7947755656887654	0.638821106881982	0.749189433932763	0.7664292422276268	0.6076022999835786	0.7786162820182276	BRAF	ENSG00000157764	71969	220597.0	CCSBVarC003155	ALE00003155	NC_000007.14:140801537:T:A	735A>T	Leu245Phe	CEGS2	CegsMutGDEh1028	A06	GDEhDisVCh_40058	E10	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140801537.0	T	A	7	Y	N	N	N	N	7-140801537-T-A	48818.0	single nucleotide variant	NM_004333.6(BRAF):c.735A>T (p.Leu245Phe)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	May 10, 2019	397507466.0	-	RCV000055897|RCV002273939|RCV000688777|RCV000033284|RCV000788012|RCV000037957	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Noonan syndrome with multiple lentigines|Neurodevelopmental delay|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801537.0	140801537.0	7q34	reviewed by expert panel	6.0	-	N	ClinGen:CA280029,UniProtKB:P15056#VAR_058623	3.0	40348.0	140801537.0	T	A	-	-	-	-	-	-	SCV000927044	-	-	735A>T 	Leu245Phe	NM_004333.6	3.0	1_Pathogenic		40348.0	7	140801537.0	T	A	L	F	rs397507466	7	140501337.0	7	140147806.0	245.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.735A>T	p.Leu245Phe	c.735A>T	p.Leu245Phe	principal4	Y	.	YES	Select	-	TTA	3.0	2.0	T	./.	./.	./.	./.	.	0.72322	.	.	0.74454	.	0.817	0.45628	P	0.556	0.49409	P	.	0.93829	.	.	.	.	1.93	0.51259	L	.	0.59576	.	.	0.89792	0.5278	0.909	D	0.7689	0.92118	D	10.0	0.9152295	0.90783	D	0.407429	0.93514	D	.	0.94750	0.828	0.93817	P15056	L245F	Loss of ubiquitination at K240 (P = 0.1231)| Gain of MoRF binding (P = 0.2184)| Gain of methylation at K240 (P = 0.3546)| Loss of loop (P = 0.3664)| Loss of helix (P = 0.3949)	.	0.99312	.	0.87638	.	0.95469	0.921125054359	0.98407	D	0.901578	0.98053	D	0.430121	0.91476	D	0.380062	0.91371	D	0.966380715370178	0.67355	D	0.982152	0.93952	D	0.8534249	0.87422	0.7093109	0.82655	0.84129506	0.86525	0.7422232	0.84579	-9.514	0.71025	D	0.9939	0.96927	P	0.997428543660156	0.93122	0.98961290	0.96672	0.984	0.99450	.	.	.	.	.	.	4.42959	0.68734	25.3	0.9989276556989923	0.96668	0.414992	0.48227	N	0.326061389643417	0.57270	3.916485	0.339330026637409	0.57643	3.954269	5.43	4.28	0.50124	4.59	0.85410	3.384	0.5231	5.043000	0.47004	0.661	0.55789	1.0	0.71675	1.0	0.68239	1.0	0.97202	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neurodevelopmental_delay|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140801537T>A	ClinGen:CA280029|UniProtKB:P15056#VAR_058623	C4022738|C1275081|C0175704|C5681679|C5555857|C3661900	PS115150|PS151100	1340|500|98733|536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Leu	Phe	48818.0	single nucleotide variant	NM_004333.6(BRAF):c.735A>T (p.Leu245Phe)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	May 10, 2019	397507466.0	-	RCV000055897|RCV002273939|RCV000688777|RCV000033284|RCV000788012|RCV000037957	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Noonan syndrome with multiple lentigines|Neurodevelopmental delay|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801537.0	140801537.0	7q34	reviewed by expert panel	6.0	-	N	ClinGen:CA280029,UniProtKB:P15056#VAR_058623	3.0	40348.0	140801537.0	T	A	-	-	-	-	-	-	SCV000927044	-	-	735A>T 	Leu245Phe	NM_004333.6	3.0	1_Pathogenic	84.36	0.8841463414634146		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		84.36	0.88414633	10-90	70-90						L	145			84.36	Aliphatic	Leucine		Serine/threonine-protein kinase B-raf										3.8											1 interaction							131									-55.0				109.9				dbSNP: rs397507466; Variant type: LP/P; AA change: Leu245Phe; PTM type: Phosphorylation; PTM morphology: RKTFFtL*AFCD; Var class: II		C (loop/coil)	C (loop/coil)											Phorbol-ester/DAG-type																																																									true	BRAFLeu245Phe																																																																																																																																																																																																																																		
RAD51D	RAD51D_Phe305Leu	0.583403789039403	0.6005843938160091	3.733061609886038	0.033504115466645654	2025_01_Batch_13-14	true	false	true	true	true	false	false	false	false	false	0.9572311202580884	0.7934838271957201	0.9425515409215897	0.9326561923583545	0.899373938602152						0.899373938602152	0.9326561923583545	0.9425515409215897	0.7934838271957201	0.9572311202580884	RAD51D	0.583403789039403	0.6005843938160091	3.733061609886038	0.033504115466645654	2025_01_Batch_13-14	true	false	true	true	true	false	false	false	false	false	0.9572311202580884	0.7934838271957201	0.9425515409215897	0.9326561923583545	0.899373938602152						0.899373938602152	0.9326561923583545	0.9425515409215897	0.7934838271957201	0.9572311202580884	RAD51D		7201		CCSBVarC024886		NC_000017.11:35101025:G:C	915C>G	Phe305Leu																												17.0	35101025.0	G	C	17						17-35101025-G-C	478443.0	single nucleotide variant	NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Apr 20, 2024	1316114457.0	-	RCV001040689|RCV000568982|RCV004760603	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000017.11	17	35101025.0	35101025.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA399086171	2.0	480950.0	35101025.0	G	C	-	-	-	-	-	-	SCV000664927|SCV000911553|SCV001204278|SCV005369137	-	-	915C>G 	Phe305Leu	NM_002878.4	1.0	3_Conflicting		480950.0	17	35101025.0	G	C	F	L	rs1316114457	17	33428044.0	17	30452157.0	305.0	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.915C>G	p.Phe305Leu	c.915C>G	p.Phe305Leu	principal1	Y	1	YES	Select	-	TTC	3.0	2.0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.05249	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	0.83	0.20850	L	0.13	0.05476	N	0.053	0.11150	-1.0215	0.23176	T	0.1042	0.38033	T	10.0	0.040840566	0.02691	T	0.009973	0.25673	T	0.024	0.04912	0.301	0.26717	O75771	F305L	Gain of disorder (P = 0.0917)| Gain of MoRF binding (P = 0.1056)| Loss of phosphorylation at T303 (P = 0.1899)| Gain of relative solvent accessibility (P = 0.2629)| Loss of sheet (P = 0.302)	0.444807159249	0.43722	.	0.23376	.	0.10592	.	.	.	0.051884	0.28757	T	-0.259589	0.1269	T	-0.610658	0.11674	T	0.0400510121688084	0.0367	T	.	0.18007	.	0.045180835	0.07283	0.032197934	0.01928	0.045180835	0.07282	0.032197934	0.01928	-2.604	0.08768	T	0.3499	0.57023	A	4.50213563311964e-06	0.00398	0.25410953	0.75297	0.005	0.00124	.	.	.	.	.	.	1.205182	0.15999	12.23	0.8353768891362308	0.15012	0.108385	0.21352	N	-1.04489556684859	0.07596	0.357995	-0.957731270841975	0.10562	0.543092	5.16	1.6	0.22627	1.17	0.30762	-0.02	0.12505	1.312000	0.25630	-0.105	0.15707	0.788	0.29661	1.0	0.68239	0.621	0.31965	913	0.21155	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613800	1.239310e-06	0	2	1179680	1.695380e-06	0	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29606	0.000000e+00	0	0	44886	0.000000e+00	0	0	64040	0.000000e+00	0	0	6062	0.000000e+00	0	2	1179680	1.695380e-06	0	0	91072	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101025G>C	ClinGen:CA399086171	C0027672|C3280345	614291	140162|145	.	Phe	Leu	478443.0	single nucleotide variant	NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Apr 20, 2024	1316114457.0	-	RCV001040689|RCV000568982|RCV004760603	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000017.11	17	35101025.0	35101025.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA399086171	2.0	480950.0	35101025.0	G	C	-	-	-	-	-	-	SCV000664927|SCV000911553|SCV001204278|SCV005369137	-	-	915C>G 	Phe305Leu	NM_002878.4	1.0	3_Conflicting	91.25	0.3553299492385787	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	91.25	0.35532996	10-90	>90						F	70			91.25	Aromatic	Phenylalanine		DNA repair protein RAD51 homolog 4										2.8								F305-L295; PAE: 2.0	1 interaction		6 interactions							165									-60.2				136.3						C (loop/coil)	C (loop/coil)																																																																				true	RAD51DPhe305Leu																																																																																																																																																																																																																																		
BRCA1	BRCA1_Gly666Val	0.8111849338867764	0.4439619283781052	3.511235063816483	0.009843009152846196	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8602099404692202	0.7331345044493729	0.9281454655551623	0.8650992475142041	0.8817659418031343	0.8413339729777471	0.905374571810571	0.9150813611590665	0.6980768194668904	0.8714205125345021	0.9221979106285213	0.8248239232178372	0.9412095699512582	0.7681921894318554	0.8489993684039382	BRCA1	0.8111849338867764	0.4439619283781052	3.511235063816483	0.009843009152846196	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8602099404692202	0.7331345044493729	0.9281454655551623	0.8650992475142041	0.8817659418031343	0.8413339729777471	0.905374571810571	0.9150813611590665	0.6980768194668904	0.8714205125345021	0.9221979106285213	0.8248239232178372	0.9412095699512582	0.7681921894318554	0.8489993684039382	BRCA1		14613		CCSBVarC011818		NC_000017.11:43051086:C:A	1997G>T	Gly666Val																												17.0	43051086.0	C	A	17						17-43051086-C-A	404710.0	single nucleotide variant	NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jul 18, 2018	863224765.0	-	RCV000502156|RCV000477771|RCV001023895|RCV001572739|RCV001865421	MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Malignant tumor of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051086.0	43051086.0	17q21.31	reviewed by expert panel	13.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10590929	2.0	417832.0	43051086.0	C	A	-	-	-	-	-	-	SCV001161716	-	-	5309G>T 	Gly1770Val	NM_007294.4	3.0	1_Pathogenic		417832.0	17	43051086.0	C	A	G	V	rs863224765	17	41203103.0	17	38456629.0	1770.0	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.5309G>T	p.Gly1770Val	principal2	Y	1	.	.	-	GGG	2.0	0.0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	0.583	0.77914	P	0.055	0.73565	B	.	0.99291	.	.	.	.	2.215	0.62356	M	.	0.90790	.	.	0.94206	0.6824	0.9293	D	0.7985	0.9316	D	10.0	.	0.91415	.	0.786529	0.98318	D	.	0.94788	.	.	.	.	.	.	0.93785	.	0.83211	.	0.40658	0.485455960035	0.36760	T	0.327304	0.69606	T	0.420504	0.90984	D	0.366249	0.90872	D	0.977009236812592	0.71446	D	.	0.91429	.	0.58132803	0.71391	0.22660044	0.47467	0.58380777	0.71528	0.32384387	0.58085	-9.173	0.85385	D	.	0.77473	.	0.994521859597463	0.90703	0.99981505	0.99752	0.916	0.95687	.	.	.	.	.	.	3.272588	0.44882	22.0	0.9974187112043313	0.8357	0.471283	0.51522	N	0.484917239323781	0.66032	4.920639	0.444495820101055	0.64170	4.689884	5.06	4.09	0.46976	4.36	0.82260	2.72	0.47021	4.864000	0.45576	0.599	0.40292	0.981	0.35482	1.0	0.68239	0.98	0.58201	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613796	1.239310e-06	0	1	91068	1.098080e-05	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59982	0.000000e+00	0	0	29600	0.000000e+00	0	0	44870	0.000000e+00	0	0	63966	0.000000e+00	0	0	6056	0.000000e+00	0	0	1179952	0.000000e+00	0	1	91068	1.098080e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051086C>A	ClinGen:CA10590929	C0006142|C0027672|C0677776|C3661900|C2676676	604370	140162|145|145	.	Gly	Val	404710.0	single nucleotide variant	NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jul 18, 2018	863224765.0	-	RCV000502156|RCV000477771|RCV001023895|RCV001572739|RCV001865421	MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Malignant tumor of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051086.0	43051086.0	17q21.31	reviewed by expert panel	13.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10590929	2.0	417832.0	43051086.0	C	A	-	-	-	-	-	-	SCV001161716	-	-	5309G>T 	Gly1770Val	NM_007294.4	3.0	1_Pathogenic	84.89	0.3333333333333333	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	84.89	0.33333334	10-90	70-90																																																																																																																																		true	BRCA1Gly666Val																																																																																																																																																																																																																																		
SDHD	SDHD_His50Arg	3.0284841744564357	0.020352148961914243	1.55422989775168	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7949082532116394	0.7860540998905854	0.8506855070097735	0.8549204998513549	0.8221238802103852	0.8487679862963862	0.8719928321814725	0.8810832625909506	0.8441392336339028	0.8172339674526357	0.7954797741243843	0.8378481675212374	0.8202877514285964	0.7279689661472681	0.7725825389706431	SDHD	3.0284841744564357	0.020352148961914243	1.55422989775168	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7949082532116394	0.7860540998905854	0.8506855070097735	0.8549204998513549	0.8221238802103852	0.8487679862963862	0.8719928321814725	0.8810832625909506	0.8441392336339028	0.8172339674526357	0.7954797741243843	0.8378481675212374	0.8202877514285964	0.7279689661472681	0.7725825389706431	SDHD	ENSG00000204370	5678	201953.0	CCSBVarC006156	ALE00006156	NC_000011.10:112087953:A:G	149A>G	His50Arg	CEGS2	CegsMutGDEh1012	G11	GDEhDisVCh_40066	B02	2.0									1.0	1.0	0.0		0.0			0.0			0.0			11.0	112087953.0	A	G	11	Y	N	N	N	N	11-112087953-A-G	21948.0	single nucleotide variant	NM_003002.4(SDHD):c.149A>G (p.His50Arg)	6392.0	SDHD	HGNC:10683	Benign/Likely benign	0.0	Mar 04, 2025	11214077.0	-	RCV000023207|RCV000129149|RCV000238643|RCV000007318|RCV000034696|RCV000988743|RCV005055437|RCV002228009|RCV000122007|RCV003924810	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0021533,MedGen:C0349535,OMIM:114900|MedGen:C3661900|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:CN169374|	Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carcinoid tumor of intestine|not provided|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|not specified|SDHD-related disorder	germline;unknown	germline	GRCh38	NC_000011.10	11	112087953.0	112087953.0	11q23.1	criteria provided, multiple submitters, no conflicts	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016777,UniProtKB:O14521#VAR_017871,OMIM:602690.0019	3.0	6909.0	112087953.0	A	G	-	-	-	-	-	-	SCV000183872|SCV000261942|SCV000297095|SCV000367346|SCV000514602|SCV000574910|SCV000597000|SCV000605087|SCV000609650|SCV000698139|SCV000703621|SCV000888623|SCV001138593|SCV002527118|SCV004027251|SCV004362300|SCV005689605	-	-	149A>G 	His50Arg	NM_003002.4	2.0	2_Benign	0.00740724	6909.0	11	112087953.0	A	G	H	R	rs11214077	11	111958677.0	11	111463887.0	50.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.149A>G	p.His50Arg	c.149A>G	p.His50Arg	principal1	Y	1	YES	Select	+	CAC	2.0	0.0	A	./.	./.	./.	./.	0.065	0.91343	T	0.133	0.92967	T	0.985	0.61134	D	0.804	0.58344	P	0.63	0.78586	D	simple_aae	37.0	63.0	2.875	0.83215	M	-1.91	0.84629	N	0.533	0.69591	0.6916	0.93046	D	0.7712	0.92199	D	9.0	0.00989148	0.00218	T	.	.	.	0.681	0.88248	.	.	.	.	.	0.949941544596	0.94900	0.8321952904549407	0.83077	0.366577337986	0.37946	0.511648774147	0.40396	T	0.604841	0.87272	D	0.00267657	0.51703	T	0.244042	0.85234	D	0.0389905626794946	0.03481	T	0.876112	0.58713	D	0.17611195	0.38200	0.159546	0.37087	0.16287881	0.36096	0.17666198	0.40081	-3.62	0.18161	T	0.134	0.49161	B	0.893627502624236	0.75625	0.99399060	0.97449	0.427	0.66558	.	.	.	.	.	.	3.521592	0.49453	22.8	0.9961368203018628	0.75021	0.739987	0.68322	D	0.49081428387198	0.66377	4.96495	0.424179265049854	0.62877	4.534256	4.9	4.9	0.63598	.	.	2.521	0.45325	7.662000	0.64345	0.756	0.943	1.0	0.71675	1.0	0.68239	0.796	0.37596	635	0.64545	33	0.006589456869009584	0	0.0	17	0.016898608349900597	14	0.020172910662824207	0	0.0	2	0.002044989775051125	2054	264690	0.0077600214	segdup	699	109374	6.390920e-03	4	1314	208100	6.314270e-03	5	1570	236924	6.626600e-03	5	13	7164	1.814630e-03	0	126	17112	7.363250e-03	0	18	2320	7.758620e-03	0	0	9046	0.000000e+00	0	78	13360	5.838320e-03	0	408	42768	9.539840e-03	4	26	15690	1.657110e-03	0	408	42768	9.539840e-03	4	24	16218	1.479840e-03	0	212	30524	6.945350e-03	0	52	6212	8.370900e-03	0	0	13416	0.000000e+00	0	106	16700	6.347310e-03	0	811	89556	9.055790e-03	5	53	30608	1.731570e-03	0	811	89556	9.055790e-03	5	23	14902	1.543420e-03	0	251	34260	7.326330e-03	1	80	9572	8.357710e-03	0	0	17692	0.000000e+00	0	138	21598	6.389480e-03	0	961	102754	9.352430e-03	4	53	30526	1.736220e-03	0	961	102754	9.352430e-03	4	.	11829	1609602	7.349020e-03	54	15	912	1.644740e-02	1	135	74930	1.801680e-03	0	15	912	1.644740e-02	1	607	60020	1.011330e-02	2	260	29574	8.791510e-03	2	0	44866	0.000000e+00	0	430	63988	6.720010e-03	2	39	6058	6.437770e-03	0	9648	1175866	8.205020e-03	43	164	91004	1.802120e-03	3	1800	206608	0.008712150545961434	1	418	0.0023923444976076554	1	4578	2.1843599825251202E-4	21	11044	0.001901484969214053	9	1138	0.007908611599297012	9	1030	0.008737864077669903	1	1858	5.382131324004305E-4	0	326	0	154	20432	0.007537196554424432	22	11462	0.0019193857965451055	2	6436	3.1075201988812925E-4	1996	247432	0.008066862814833974	Benign/Likely_benign	Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Paragangliomas_1|not_specified|not_provided|Carcinoid_tumor_of_intestine|SDHD-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112087953A>G	ClinGen:CA016777|OMIM:602690.0019|UniProtKB:O14521#VAR_017871	C0031511|C0027672|CN166604|C1868633|C1847319|C3494181|CN169374|C3661900|C0349535	171300|606864|168000|114900	29072|140162|201|97286|29072	.	His	Arg	21948.0	single nucleotide variant	NM_003002.4(SDHD):c.149A>G (p.His50Arg)	6392.0	SDHD	HGNC:10683	Benign/Likely benign	0.0	Mar 04, 2025	11214077.0	-	RCV000023207|RCV000129149|RCV000238643|RCV000007318|RCV000034696|RCV000988743|RCV005055437|RCV002228009|RCV000122007|RCV003924810	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0021533,MedGen:C0349535,OMIM:114900|MedGen:C3661900|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:CN169374|	Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carcinoid tumor of intestine|not provided|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|not specified|SDHD-related disorder	germline;unknown	germline	GRCh38	NC_000011.10	11	112087953.0	112087953.0	11q23.1	criteria provided, multiple submitters, no conflicts	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016777,UniProtKB:O14521#VAR_017871,OMIM:602690.0019	3.0	6909.0	112087953.0	A	G	-	-	-	-	-	-	SCV000183872|SCV000261942|SCV000297095|SCV000367346|SCV000514602|SCV000574910|SCV000597000|SCV000605087|SCV000609650|SCV000698139|SCV000703621|SCV000888623|SCV001138593|SCV002527118|SCV004027251|SCV004362300|SCV005689605	-	-	149A>G 	His50Arg	NM_003002.4	2.0	2_Benign	76.82	0.9619565217391304	['171300', '168000', '114900', '606864', '171300', '606864']	autosomal dominant	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; CARCINOID TUMORS, INTESTINAL; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	76.82	0.9619565	$\geqslant$90	70-90						H	177			76.82	Positively-charged	Histidine												-3.2																		155									-68.9				106.7						C (loop/coil)	C (loop/coil)								Mitochondrion																																																												true	SDHDHis50Arg																																																																																																																																																																																																																																		
KRAS	KRAS_Phe156Ile	-1.3743464521347168	0.2117183578603233	4.60376764126087	0.0024731315942266253	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7595235386002198	0.4634384385549333	0.5880398122394583	0.6263327874286961	0.5154369071066711	0.5339240086725837	0.676551602508837	0.6553572596133344	0.46277101793242437	0.8187287129941277	0.49694980554075857	0.5761139723485552	0.5207223648655823	0.4641058591774421	0.7003183642063119	KRAS	-1.3743464521347168	0.2117183578603233	4.60376764126087	0.0024731315942266253	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7595235386002198	0.4634384385549333	0.5880398122394583	0.6263327874286961	0.5154369071066711	0.5339240086725837	0.676551602508837	0.6553572596133344	0.46277101793242437	0.8187287129941277	0.49694980554075857	0.5761139723485552	0.5207223648655823	0.4641058591774421	0.7003183642063119	KRAS	ENSG00000133703	3084	214496.0	CCSBVarC006102	ALE00006102	NC_000012.12:25209896:A:T	466T>A	Phe156Ile	CEGS2	CegsMutGDEh1042	D03	GDEhDisVCh_40061	C10	1.0	CegsMutGDDh1042	D03							1.0	6.0	1.0	1.0	0.0			0.0			0.0			12.0	25209896.0	A	T	12	N	Y	N	N	N	12-25209896-A-T	175711.0	single nucleotide variant	NM_004985.5(KRAS):c.466T>A (p.Phe156Ile)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Jan 05, 2022	397517042.0	-	RCV000150884|RCV000493013|RCV001813760	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:CN517202|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Noonan syndrome;Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome 3	germline	germline	GRCh38	NC_000012.12	12	25209896.0	25209896.0	12p12.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA273160	2.0	163758.0	25209896.0	A	T	-	-	-	-	-	-	SCV000198458|SCV000582867|SCV002061164	-	-	466T>A 	Phe156Ile	NM_004985.5	2.0	1_Pathogenic		163758.0	12	25209896.0	A	T	F	I	rs397517042	12	25362830.0	12	25254097.0	131.0	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.391T>A	p.Phe131Ile	.	Y	.	.	.	-	TTC	1.0	0.0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	.	0.90580	.	.	0.73823	.	.	0.95575	.	.	.	.	.	.	.	.	0.84554	.	.	0.86483	0.5739	0.91524	D	0.7138	0.90143	D	8.0	.	0.88974	.	0.39769	0.93315	D	.	0.97054	.	0.92541	.	.	.	.	0.98060	.	.	.	.	.	.	.	.	.	.	0.456603	0.92716	D	0.418102	0.92627	D	0.984689116477966	0.75739	D	.	0.88326	.	.	.	.	.	.	.	.	.	.	0.98607	.	.	0.95820	.	.	.	0.98468506	0.96023	0.937	0.96958	.	.	.	.	.	.	4.958659	0.82	27.7	0.9895182421540203	0.49243	0.871179	0.79169	D	0.741140742699006	0.82229	7.73527	0.744583996035912	0.85673	8.675262	5.43	5.43	0.78977	.	.	8.891	0.9215	11.233000	0.90185	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.999	0.91597	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Noonan_syndrome|Cardio-facio-cutaneous_syndrome|not_provided|Noonan_syndrome_3	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25209896A>T	ClinGen:CA273160	C0028326|C1275081|CN517202|C1860991	PS163950|PS115150|609942	648|1340|648	.	Phe	Ile	175711.0	single nucleotide variant	NM_004985.5(KRAS):c.466T>A (p.Phe156Ile)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Jan 05, 2022	397517042.0	-	RCV000150884|RCV000493013|RCV001813760	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:CN517202|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Noonan syndrome;Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome 3	germline	germline	GRCh38	NC_000012.12	12	25209896.0	25209896.0	12p12.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA273160	2.0	163758.0	25209896.0	A	T	-	-	-	-	-	-	SCV000198458|SCV000582867|SCV002061164	-	-	466T>A 	Phe156Ile	NM_004985.5	2.0	1_Pathogenic			['609942']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3			10-90	>90																																																																																																																																		true	KRASPhe156Ile																																																																																																																																																																																																																																		
BRCA1	BRCA1_Cys64Ser	-0.5198160846601582	0.619220375890755	-3.2780519643623762	0.013523323462305661	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7452379550737872	0.5581452944342807	0.7204550080489095	0.6277971469449901	0.6198776680144382	0.509193303597748	0.665192591066776	0.7189477005715086	0.4156154156519475	0.7746920340779846	0.7305620324311284	0.5904017028232041	0.7219623155263104	0.700675173216614	0.7157838760695898	BRCA1	-0.5198160846601582	0.619220375890755	-3.2780519643623762	0.013523323462305661	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7452379550737872	0.5581452944342807	0.7204550080489095	0.6277971469449901	0.6198776680144382	0.509193303597748	0.665192591066776	0.7189477005715086	0.4156154156519475	0.7746920340779846	0.7305620324311284	0.5904017028232041	0.7219623155263104	0.700675173216614	0.7157838760695898	BRCA1		14613		CCSBVarC011841		NC_000017.11:43106477:C:G	191G>C	Cys64Ser																												17.0	43106477.0	C	G	17						17-43106477-C-G	468251.0	single nucleotide variant	NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Nov 09, 2022	55851803.0	-	RCV000559047|RCV001076723	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43106477.0	43106477.0	17q21.31	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10601786	2.0	462571.0	43106477.0	C	G	-	-	-	-	-	-	SCV000635819	-	-	191G>C 	Cys64Ser	NM_007294.4	1.0	1_Pathogenic		462571.0	17	43106477.0	C	G	C	S	rs55851803	17	41258494.0	17	38512020.0	64.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.191G>C	p.Cys64Ser	c.191G>C	p.Cys64Ser	principal2	Y	1	YES	Select	-	TGT	2.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.99	0.68795	D	0.903	0.78943	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.99	0.96635	H	-1.45	0.98450	N	0.982	0.99346	0.9381	0.96208	D	0.9931	0.99838	D	10.0	0.9888865	0.99322	D	0.959083	0.99729	D	0.922	0.98039	0.968	0.99690	E9PFC7	C64S	Gain of disorder (P = 0.0079)| Loss of stability (P = 0.0171)| Gain of phosphorylation at C64 (P = 0.0837)| Gain of glycosylation at P62 (P = 0.1363)| Loss of methylation at K65 (P = 0.1443)	0.999450167335	0.99943	.	0.86148	.	0.40765	0.717033147812	0.69562	T	0.46945	0.92995	T	0.553376	0.95819	D	0.55711	0.95755	D	0.997346639633179	0.91262	D	.	0.80441	.	0.9870781	0.99591	0.88999635	0.94188	0.97642994	0.98806	0.88973695	0.94170	-12.832	0.92342	D	0.9961	0.97310	P	0.999399190328388	0.96461	0.99976617	0.99701	0.964	0.98523	.	.	.	.	.	.	5.090651	0.85032	28.5	0.9911084315967224	0.52805	0.851286	0.76729	D	0.91310061370465	0.92344	11.39386	0.783598264701654	0.88566	9.654935	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.0	0.68239	0.997	0.79771	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	criteria_provided,_single_submitter	NC_000017.11:g.43106477C>G	ClinGen:CA10601786	C2676676|C0677776	604370	145|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Ser	468251.0	single nucleotide variant	NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Nov 09, 2022	55851803.0	-	RCV000559047|RCV001076723	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43106477.0	43106477.0	17q21.31	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10601786	2.0	462571.0	43106477.0	C	G	-	-	-	-	-	-	SCV000635819	-	-	191G>C 	Cys64Ser	NM_007294.4	1.0	1_Pathogenic	88.77	0.3333333333333333	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	88.77	0.33333334	10-90	70-90																																																																																																																																		true	BRCA1Cys64Ser																																																																																																																																																																																																																																		
RAF1	RAF1_Ser427Gly	-5.857143473908194	0.08915991405016992	4.645910603471249	0.00992717572430983	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7714292756134752	0.7308256169591187	0.8491109426897272	0.8367656129433576	0.8135265518153487	0.7927766062981187	0.8314193235226529	0.8557426612183633	0.7318016857301761	0.8219138734955567	0.8342764973325788	0.8421119023640624	0.842479224161091	0.7298495481880614	0.7209446777313937	RAF1	-5.857143473908194	0.08915991405016992	4.645910603471249	0.00992717572430983	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7714292756134752	0.7308256169591187	0.8491109426897272	0.8367656129433576	0.8135265518153487	0.7927766062981187	0.8314193235226529	0.8557426612183633	0.7318016857301761	0.8219138734955567	0.8342764973325788	0.8421119023640624	0.842479224161091	0.7298495481880614	0.7209446777313937	RAF1		732		CCSBVarC008846		NC_000003.12:12618597:G:A	1279A>G	Ser427Gly																												3.0	12618597.0	G	A	3						3-12618597-G-A	289332.0	single nucleotide variant	NM_002880.4(RAF1):c.125C>T (p.Ala42Val)	5894.0	RAF1	HGNC:9829	Likely benign	0.0	Apr 18, 2017	11549992.0	-	RCV000290750|RCV000398939|RCV000521407|RCV001813467|RCV004544638|RCV000981698	MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733||MedGen:C3661900	LEOPARD syndrome 2|Noonan syndrome 5|RASopathy|Noonan syndrome and Noonan-related syndrome|RAF1-related disorder|not provided	germline	germline	GRCh38	NC_000003.12	3	12618597.0	12618597.0	3p25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA2259832	2.0	343103.0	12618597.0	G	A	-	-	-	-	-	-	SCV000616490	-	-	125C>T 	Ala42Val	NM_002880.4	3.0	2_Benign		343103.0	3	12618597.0	G	A	A	V	rs11549992	3	12660096.0	3	12635096.0	42.0	RAF1	ENSG00000132155	ENST00000685653	ENSP00000509968	P04049	RAF1_HUMAN	.	.	c.125C>T	p.Ala42Val	principal3	Y	.	.	.	-	GCA	2.0	0.0	G	G/G	G/G	G/G	G/G	.	0.43552	.	.	0.24339	.	0.44	0.35909	B	0.118	0.32091	B	.	0.63842	.	.	.	.	1.245	0.31258	L	.	0.26593	.	.	0.53299	-0.6482	0.62631	T	0.2338	0.59872	T	10.0	.	0.10650	.	0.030693	0.52764	D	.	0.54847	.	.	.	.	.	.	0.68373	.	0.47139	.	0.49126	0.562870502472	0.47606	T	0.461137	0.79651	T	-0.248036	0.14071	T	-0.277907	0.46682	T	0.0281786238071906	0.01706	T	0.980702	0.93698	D	0.14208941	0.32435	0.16238137	0.37602	0.15703622	0.35113	0.15447487	0.36141	-5.939	0.46894	T	.	0.39554	.	0.93421742321215	0.78789	0.34714562	0.78211	0.176	0.42719	.	.	.	.	.	.	4.404223	0.68134	25.2	0.9983696088703764	0.91806	0.777693	0.70936	D	0.159595556076659	0.49020	3.129022	0.329305395729113	0.57042	3.89199	6.17	5.3	0.74708	.	.	7.408	0.79314	11.846000	0.97942	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.998	0.85369	615	0.66487	.	.	.	.	.	.	.	.	.	.	.	.	70	264690	2.644603E-4	.	26	109408	2.376430e-04	0	67	208130	3.219140e-04	0	79	236948	3.334060e-04	0	0	7164	0.000000e+00	0	10	17112	5.843850e-04	0	3	2320	1.293100e-03	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	10	42768	2.338200e-04	0	1	15690	6.373490e-05	0	10	17112	5.843850e-04	0	0	16218	0.000000e+00	0	13	30524	4.258940e-04	0	16	6212	2.575660e-03	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	32	89554	3.573260e-04	0	2	30608	6.534240e-05	0	13	30524	4.258940e-04	0	0	14902	0.000000e+00	0	12	34260	3.502630e-04	0	22	9572	2.298370e-03	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	38	102746	3.698440e-04	0	2	30526	6.551790e-05	0	38	102746	3.698440e-04	0	.	350	1614154	2.168320e-04	0	47	29604	1.587620e-03	0	1	75032	1.332760e-05	0	0	910	0.000000e+00	0	18	60022	2.998900e-04	0	47	29604	1.587620e-03	0	0	44878	0.000000e+00	0	0	64030	0.000000e+00	0	9	6062	1.484660e-03	0	242	1180026	2.050800e-04	0	5	91090	5.489080e-05	0	19	42874	4.431590241171806E-4	0	306	0	0	112	0	1	8092	1.2357884330202668E-4	0	500	0	0	628	0	0	56	0	0	98	0	5	8486	5.892057506481263E-4	1	8398	1.1907597046915932E-4	0	168	0	25	61152	4.088173731030874E-4	Likely_benign	not_provided|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|Noonan_syndrome_5|LEOPARD_syndrome_2|RAF1-related_disorder	reviewed_by_expert_panel	NC_000003.12:g.12618597G>A	ClinGen:CA2259832	C3661900|C5681679|C5555857|C1969057|C1969056	611553|611554	98733|536391|648|500	.	Ala	Val	289332.0	single nucleotide variant	NM_002880.4(RAF1):c.125C>T (p.Ala42Val)	5894.0	RAF1	HGNC:9829	Likely benign	0.0	Apr 18, 2017	11549992.0	-	RCV000290750|RCV000398939|RCV000521407|RCV001813467|RCV004544638|RCV000981698	MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733||MedGen:C3661900	LEOPARD syndrome 2|Noonan syndrome 5|RASopathy|Noonan syndrome and Noonan-related syndrome|RAF1-related disorder|not provided	germline	germline	GRCh38	NC_000003.12	3	12618597.0	12618597.0	3p25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA2259832	2.0	343103.0	12618597.0	G	A	-	-	-	-	-	-	SCV000616490	-	-	125C>T 	Ala42Val	NM_002880.4	3.0	2_Benign	30.15	0.8584905660377359	['611554', '611553']	unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	LEOPARD SYNDROME 2; NOONAN SYNDROME 5	30.15	0.8584906	10-90	<=50						S	17			90.83	Polar/Neutral	Serine		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase	0.8539		-0.8				1 interaction				S427-L476; PAE: 1.0	5 interactions	S427-H432, S427-L476; PAE: 1.5, 1.0	8 interactions							105									-132.8		Pocket 1: Mean pLDDT: 90.5, Volume: 729.78 Å³, Druggability score: 0.85		172.7						B (undefined)	E (parallel sheets)																																																																				true	RAF1Ser427Gly																																																																																																																																																																																																																																		
RAD51D	RAD51D_Ile17Val	0.8297191536322671	0.4340774464288859	15.438748804892427	1.1544372823221078e-6	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9610843112174334	0.8211615965363215	0.9194796164079382	0.9034559086463199	0.8593047956991493	0.8462395722954139	0.9107998287096768	0.9061313570579054	0.8558146293961573	0.9677655186059482	0.8723700191028847	0.896111988582963	0.9328278757579709	0.7865085636764857	0.9544031038289187	RAD51D	0.8297191536322671	0.4340774464288859	15.438748804892427	1.1544372823221078e-6	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9610843112174334	0.8211615965363215	0.9194796164079382	0.9034559086463199	0.8593047956991493	0.8462395722954139	0.9107998287096768	0.9061313570579054	0.8558146293961573	0.9677655186059482	0.8723700191028847	0.896111988582963	0.9328278757579709	0.7865085636764857	0.9544031038289187	RAD51D		7201		CCSBVarC024709		NC_000017.11:35119565:T:C	49A>G	Ile17Val																												17.0	35119565.0	T	C	17						17-35119565-T-C	645822.0	single nucleotide variant	NM_002878.4(RAD51D):c.49A>G (p.Ile17Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Oct 09, 2024	1002032036.0	-	RCV000816764|RCV001816897|RCV000986016|RCV001183136	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35119565.0	35119565.0	17q12	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA290007271	2.0	659719.0	35119565.0	T	C	-	-	-	-	-	-	SCV000957288|SCV001134803|SCV001348793|SCV002066151|SCV002642374|SCV005054047|SCV005202652	-	-	49A>G 	Ile17Val	NM_002878.4	1.0	3_Conflicting		659719.0	17	35119565.0	T	C	I	V	rs1002032036	17	33446584.0	17	30470697.0	17.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.49A>G	p.Ile17Val	c.49A>G	p.Ile17Val	principal1	Y	5	.	.	-	ATC	1.0	0.0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.001	0.04348	B	0.17	0.40172	N	simple_aae	83.0	17.0	-0.695	0.01869	N	-0.03	0.07402	N	0.046	0.02082	-0.9952	0.31138	T	0.0324	0.13833	T	10.0	0.04814577	0.04229	T	0.024558	0.47336	T	0.028	0.06252	0.37	0.37869	O75771	I17V	Gain of helix (P = 0.0854)| Gain of MoRF binding (P = 0.2615)| Loss of loop (P = 0.3664)| Loss of catalytic residue at L19 (P = 0.4141)| Gain of disorder (P = 0.4367)	0.429666569261	0.42198	.	0.13960	.	0.07621	.	.	.	0.075739	0.34990	T	-0.308413	0.07683	T	-0.680791	0.06732	T	0.0592468314962335	0.06971	T	0.689731	0.29652	T	0.029664483	0.02476	0.046668846	0.06571	0.029664483	0.02476	0.046668846	0.06570	-2.791	0.17524	T	0.0821	0.22858	B	8.01046792450614e-05	0.02668	0.25106364	0.75187	0.018	0.02411	.	.	.	.	.	.	1.523251	0.19582	14.32	0.6845253055721503	0.08798	0.077523	0.15429	N	-0.963300152951958	0.09283	0.4445345	-0.761465596440251	0.15180	0.8120932	4.37	2.36	0.28182	1.23	0.31344	0.452	0.21585	1.583000	0.27571	-0.201	0.08901	0.997	0.40243	0.906	0.28131	0.792	0.37428	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	1612670	8.061170e-06	0	1	60000	1.666670e-05	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	1	60000	1.666670e-05	0	0	29600	0.000000e+00	0	0	44872	0.000000e+00	0	0	62816	0.000000e+00	0	0	6084	0.000000e+00	0	11	1179940	9.322510e-06	0	0	91086	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119565T>C	.	C3280345|C0027672|CN169374|C3661900	614291	145|140162	RAD51D, N-terminal domain	Ile	Val	645822.0	single nucleotide variant	NM_002878.4(RAD51D):c.49A>G (p.Ile17Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Oct 09, 2024	1002032036.0	-	RCV000816764|RCV001816897|RCV000986016|RCV001183136	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35119565.0	35119565.0	17q12	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA290007271	2.0	659719.0	35119565.0	T	C	-	-	-	-	-	-	SCV000957288|SCV001134803|SCV001348793|SCV002066151|SCV002642374|SCV005054047|SCV005202652	-	-	49A>G 	Ile17Val	NM_002878.4	1.0	3_Conflicting	90.86	0.0	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	90.86	0.0	<10	>90						I	0			90.86	Aliphatic	Isoleucine		DNA repair protein RAD51 homolog 4										4.5								I17-T13, I17-R21; PAE: 1.5, 1.0	5 interactions	I17-T13, I17-R21; PAE: 1.5, 1.0	7 interactions							131									-65.3				-41.2	preferentially binds ssDNA					H (helix)	H (α-helix)	Helix																																																																			true	RAD51DIle17Val																																																																																																																																																																																																																																		
RET	RET_Thr278Asn	-0.6907675516055969	0.5119595315860082	6.503086124471587	0.00033316518625512326	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8438653074473421	0.6540888817349044	0.7951639811161402	0.7473188108347992	0.683879205215141	0.8320212540974148	0.8256731724420541	0.8885259291901384	0.7689220201987548	0.8831043347292347	0.5357371563328672	0.6689644492275445	0.701802033042142	0.5392557432710541	0.8046262801654496	RET	-0.6907675516055969	0.5119595315860082	6.503086124471587	0.00033316518625512326	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8438653074473421	0.6540888817349044	0.7951639811161402	0.7473188108347992	0.683879205215141	0.8320212540974148	0.8256731724420541	0.8885259291901384	0.7689220201987548	0.8831043347292347	0.5357371563328672	0.6689644492275445	0.701802033042142	0.5392557432710541	0.8046262801654496	RET	ENSG00000165731	8858	202952.0	CCSBVarC006877	ALE00006875	NC_000010.11:43105159:C:A	833C>A	Thr278Asn	CEGS2	CegsMutGDEh1029	D06	GDEhDisVCh_40066	D06	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43105159.0	C	A	10	Y	N	N	N	N	10-43105159-C-A	50285.0	single nucleotide variant	NM_020975.6(RET):c.833C>A (p.Thr278Asn)	5979.0	RET	HGNC:9967	Benign/Likely benign	0.0	Mar 04, 2025	35118262.0	-	RCV000034778|RCV000121990|RCV000163444|RCV000490442|RCV000988341|RCV001104178|RCV001104180|RCV001104179|RCV001083124	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	not provided|not specified|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	germline;unknown	germline	GRCh38	NC_000010.11	10	43105159.0	43105159.0	10q11.21	criteria provided, multiple submitters, no conflicts	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009353,UniProtKB:P07949#VAR_041763	2.0	41846.0	43105159.0	C	A	-	-	-	-	-	-	SCV000213991|SCV000261217|SCV000267474|SCV000362270|SCV000540167|SCV000729739|SCV000807061|SCV001138021|SCV001261021|SCV001261022|SCV001261023|SCV002527928|SCV004127589|SCV004220048|SCV004243364|SCV004357223|SCV004564906	-	-	833C>A 	Thr278Asn	NM_020975.6	2.0	2_Benign	0.000677802	41846.0	10	43105159.0	C	A	T	N	rs35118262	10	43600607.0	10	42920613.0	278.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.833C>A	p.Thr278Asn	c.833C>A	p.Thr278Asn	principal4	Y	5	YES	Select	+	ACC	2.0	0.0	C	C/C	C/C	C/C	C/C	0.035	0.43867	D	0.194	0.28427	T	0.001	0.12194	B	0.004	0.16860	B	0.05	0.16373	N	simple_aae	95.0	5.0	2.595	0.75684	M	-1.04	0.27215	N	0.317	0.79815	-0.5698	0.65873	T	0.2726	0.64282	T	10.0	0.0058131814	0.00127	T	.	.	.	0.180	0.44851	.	.	.	.	.	0.764498015703	0.76048	0.8788456336718098	0.87776	0.869349038865	0.69149	0.447220146656	0.31525	T	0.476434	0.80560	T	-0.352383	0.0441	T	-0.258001	0.48694	T	0.0540457288643749	0.06132	T	0.865113	0.56224	D	0.48162338	0.65687	0.3053008	0.56338	0.48379323	0.65819	0.30986196	0.56777	-2.309	0.07193	T	0.1721	0.44951	B	0.723577208028241	0.67844	0.99777067	0.98500	0.561	0.75276	.	.	.	.	.	.	3.2057	0.43694	21.8	0.9710392157115023	0.32564	0.489384	0.52567	N	-0.160029608786539	0.34534	1.991452	-0.0125543226448844	0.38851	2.316717	4.73	3.82	0.43085	1.81	0.37505	3.421	0.52594	3.421000	0.38332	0.597	0.3436	0.996	0.3946	0.998	0.34068	0.997	0.79771	862	0.33096	20	0.003993610223642172	0	0.0	0	0.0	0	0.0	19	0.018849206349206348	1	0.0010224948875255625	328	264690	0.0012391855	.	268	108738	2.464640e-03	5	382	203268	1.879290e-03	6	541	233088	2.321010e-03	7	0	7086	0.000000e+00	0	0	17050	0.000000e+00	0	0	2308	0.000000e+00	0	255	8972	2.842180e-02	5	0	13120	0.000000e+00	0	2	42634	4.691090e-05	0	10	15664	6.384070e-04	0	255	8972	2.842180e-02	5	0	15770	0.000000e+00	0	1	30418	3.287530e-05	0	0	6120	0.000000e+00	0	353	13264	2.661340e-02	6	0	16456	0.000000e+00	0	7	85866	8.152240e-05	0	18	30570	5.888130e-04	0	353	13264	2.661340e-02	6	0	14546	0.000000e+00	0	2	34182	5.851030e-05	0	0	9522	0.000000e+00	0	509	17618	2.889090e-02	7	0	21196	0.000000e+00	0	10	99950	1.000500e-04	0	18	30494	5.902800e-04	0	509	17618	2.889090e-02	7	.	1119	1612876	6.937920e-04	14	938	44842	2.091790e-02	13	0	75052	0.000000e+00	0	0	912	0.000000e+00	0	4	60014	6.665110e-05	0	0	29582	0.000000e+00	0	938	44842	2.091790e-02	13	0	62980	0.000000e+00	0	1	6044	1.654530e-04	0	35	1179890	2.966380e-05	0	75	91072	8.235240e-04	1	7	170470	4.1062943626444535E-5	0	176	0	104	4426	0.02349751468594668	0	4788	0	0	794	0	0	968	0	31	1788	0.017337807606263984	0	280	0	48	15660	0.0030651340996168583	0	4964	0	135	6214	0.021725136787898294	190	199350	9.530975670930524E-4	Conflicting_classifications_of_pathogenicity	Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia_type_2A|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.43105159C>A	ClinGen:CA009353|UniProtKB:P07949#VAR_041763	C0027662|C3661900|C0031511|C1619700|C4048306|C0027672|C3888239|C0025268|CN169374	PS131100|171300|191830|142623|171400	276161|29072|411709|653|140162|388|247698|653	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Thr	Asn	50285.0	single nucleotide variant	NM_020975.6(RET):c.833C>A (p.Thr278Asn)	5979.0	RET	HGNC:9967	Benign/Likely benign	0.0	Mar 04, 2025	35118262.0	-	RCV000034778|RCV000121990|RCV000163444|RCV000490442|RCV000988341|RCV001104178|RCV001104180|RCV001104179|RCV001083124	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	not provided|not specified|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	germline;unknown	germline	GRCh38	NC_000010.11	10	43105159.0	43105159.0	10q11.21	criteria provided, multiple submitters, no conflicts	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009353,UniProtKB:P07949#VAR_041763	2.0	41846.0	43105159.0	C	A	-	-	-	-	-	-	SCV000213991|SCV000261217|SCV000267474|SCV000362270|SCV000540167|SCV000729739|SCV000807061|SCV001138021|SCV001261021|SCV001261022|SCV001261023|SCV002527928|SCV004127589|SCV004220048|SCV004243364|SCV004357223|SCV004564906	-	-	833C>A 	Thr278Asn	NM_020975.6	2.0	2_Benign	95.1	0.4084507042253521	['142623', '171400', '171300', '191830']	multiple	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; PHEOCHROMOCYTOMA; RENAL HYPODYSPLASIA/APLASIA 1	95.1	0.4084507	10-90	>90						T	58			95.1	Polar/Neutral	Threonine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-0.7									2 interactions		3 interactions							119									-123.6				129.0	Cadherin-like region 3 (CLD3)					B (undefined)	E (parallel sheets)							Extracellular																																																													true	RETThr278Asn																																																																																																																																																																																																																																		
BRCA1	BRCA1_Thr37Lys	-0.25728289233865603	0.80435939653231	4.81745560482641	0.0019270976461462812	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8935375560784924	0.8033209369588789	0.9167684511503182	0.8922364093851026	0.876967783201831	0.8174092776879838	0.9099221991247153	0.8792001815247644	0.6670508282803029	0.8751460309326402	0.9365262887156782	0.87455061964549	0.9543367207758721	0.9395910456374548	0.9119290812243445	BRCA1	-0.25728289233865603	0.80435939653231	4.81745560482641	0.0019270976461462812	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8935375560784924	0.8033209369588789	0.9167684511503182	0.8922364093851026	0.876967783201831	0.8174092776879838	0.9099221991247153	0.8792001815247644	0.6670508282803029	0.8751460309326402	0.9365262887156782	0.87455061964549	0.9543367207758721	0.9395910456374548	0.9119290812243445	BRCA1		14613		CCSBVarC011837		NC_000017.11:43115750:G:T	110C>A	Thr37Lys																												17.0	43115750.0	G	T	17						17-43115750-G-T	68798.0	single nucleotide variant	NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80356880.0	-	RCV000111781|RCV000763401|RCV001378528|RCV002433536	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115750.0	43115750.0	17q21.31	reviewed by expert panel	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00112,ClinGen:CA000742	2.0	54131.0	43115750.0	G	T	-	-	-	-	-	-	SCV000244295	-	-	110C>A 	Thr37Lys	NM_007294.4	3.0	1_Pathogenic		54131.0	17	43115750.0	G	T	T	K	rs80356880	17	41267767.0	17	38521293.0	37.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.110C>A	p.Thr37Lys	c.110C>A	p.Thr37Lys	principal2	Y	1	YES	Select	-	ACA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.979	0.90580	D	0.777	0.92348	P	0.99	0.99291	A	simple_aae	1.0	99.0	2.54	0.73893	M	-0.91	0.87019	N	0.909	0.91390	1.0434	0.97975	D	0.9155	0.97195	D	10.0	0.9803947	0.97988	D	0.597518	0.96439	D	0.823	0.94336	0.94	0.99178	E9PFC7	T37K	Gain of methylation at T37 (P = 0.0325)| Gain of disorder (P = 0.0355)| Gain of ubiquitination at T37 (P = 0.0369)| Loss of catalytic residue at T37 (P = 0.1105)| Loss of sheet (P = 0.1158)	0.980248173759	0.97984	.	0.87940	.	0.46547	0.74592012167	0.73798	T	0.4401	0.88719	T	0.478281	0.9359	D	0.449241	0.9351	D	0.992633044719696	0.83032	D	.	0.77715	.	0.9560325	0.96828	0.8919265	0.94327	0.96704304	0.97946	0.84243727	0.90882	-15.301	0.98159	D	0.9729	0.92484	P	0.992970792932514	0.89793	0.99969053	0.99611	0.962	0.98414	.	.	.	.	.	.	4.997611	0.82936	27.9	0.9930140367049056	0.58711	0.726971	0.67428	D	0.984277674482382	0.95215	13.43596	0.917667809072401	0.96277	14.52852	5.97	5.97	0.96929	.	.	4.401	0.59561	11.711000	0.94660	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.998	0.85369	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43115750G>T	BRCA1-HCI:BRCA1_00112|ClinGen:CA000742	C0677776|C0346153|C4554406|C2676676|C3280442|C0027672	114480|617883|604370|614320	145|227535|145|1333|140162	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Thr	Lys	68798.0	single nucleotide variant	NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80356880.0	-	RCV000111781|RCV000763401|RCV001378528|RCV002433536	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115750.0	43115750.0	17q21.31	reviewed by expert panel	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00112,ClinGen:CA000742	2.0	54131.0	43115750.0	G	T	-	-	-	-	-	-	SCV000244295	-	-	110C>A 	Thr37Lys	NM_007294.4	3.0	1_Pathogenic	88.99	0.028169014084507	['604370', '114480', '617883', '604370', '614320']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	88.99	0.028169014	<10	70-90																																																																																																																																		true	BRCA1Thr37Lys																																																																																																																																																																																																																																		
CTCF	CTCF_Ala697Thr	-1.1232772209850925	0.298362229751802	1.4887201352067425	0.18016786356357115	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5756301954847982	0.46108228326991146	0.5892073568358998	0.6086548922412327	0.488824612550828	0.427811937381813	0.5241640544122318	0.5020659078393217	0.45735774894400333	0.5867910532063902	0.549837287719843	0.6931457300702335	0.6763488058324778	0.4648068175958196	0.5644693377632063	CTCF	-1.1232772209850925	0.298362229751802	1.4887201352067425	0.18016786356357115	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5756301954847982	0.46108228326991146	0.5892073568358998	0.6086548922412327	0.488824612550828	0.427811937381813	0.5241640544122318	0.5020659078393217	0.45735774894400333	0.5867910532063902	0.549837287719843	0.6931457300702335	0.6763488058324778	0.4648068175958196	0.5644693377632063	CTCF		6173		CCSBVarC010818		NC_000016.10:67637777:G:A	2089G>A	Ala697Thr																												16.0	67637777.0	G	A	16						16-67637777-G-A	580362.0	single nucleotide variant	NM_006565.4(CTCF):c.2089G>A (p.Ala697Thr)	10664.0	CTCF	HGNC:13723	Conflicting classifications of pathogenicity	0.0	Aug 22, 2023	201916739.0	-	RCV002318105|RCV004535791|RCV003323701	MeSH:D030342,MedGen:C0950123||MedGen:CN169374	Inborn genetic diseases|CTCF-related disorder|not specified	germline	germline	GRCh38	NC_000016.10	16	67637777.0	67637777.0	16q22.1	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA8112854	2.0	589165.0	67637777.0	G	A	-	-	-	-	-	-	SCV000849791|SCV004029010|SCV004113932	-	-	2089G>A 	Ala697Thr	NM_006565.4	1.0	3_Conflicting		589165.0	16	67637777.0	G	A	A	T	rs201916739	16	67671680.0	16	66229181.0	697.0	CTCF	ENSG00000102974	ENST00000264010	ENSP00000264010	P49711	CTCF_HUMAN	c.2089G>A	p.Ala697Thr	c.2089G>A	p.Ala697Thr	principal4	Y	1	YES	Select	+	GCA	1.0	0.0	G	G/G	G/G	G/G	G/G	0.222	0.23840	T	0.358	0.23039	T	0.0	0.02950	B	0.0	0.01384	B	0.06	0.40172	N	simple_aae	94.0	6.0	0.345	0.11102	N	-0.8	0.23318	N	0.113	0.10018	-0.9502	0.40759	T	0.013	0.05035	T	10.0	0.074863106	0.11429	T	0.003775	0.08537	T	0.085	0.24571	0.089	0.00976	P49711	A697T	Gain of phosphorylation at A697 (P = 0.0106)| Gain of glycosylation at A697 (P = 0.0115)| Gain of loop (P = 0.0502)| Gain of solvent accessibility (P = 0.2291)| Gain of helix (P = 0.2684)	0.352914559346	0.34492	.	0.11959	0.580823813372	0.53620	0.28278157115	0.07880	T	0.353355	0.71894	T	-0.426293	0.01463	T	-0.680989	0.0672	T	0.068806566298008	0.08383	T	.	0.24416	.	0.019917462	0.00532	0.048129845	0.07099	0.02436098	0.01251	0.0497265	0.07671	-4.231	0.28985	T	.	0.04616	.	0.0183708095774007	0.28756	0.18858771	0.72542	0.025	0.04491	.	.	.	.	.	.	1.499315	0.19306	14.18	0.908832586711687	0.20385	0.269145	0.38347	N	-0.557516232399653	0.20004	1.066043	-0.41758376025414	0.24164	1.340807	5.92	2.91	0.3282	1.78	0.37175	3.992	0.56781	1.282000	0.25443	-0.108	0.15302	0.923	0.3214	0.001	0.17376	0.323	0.25089	50	0.97656	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	109398	9.140930e-06	0	3	208038	1.442040e-05	0	3	236742	1.267200e-05	0	0	7162	0.000000e+00	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15686	0.000000e+00	0	1	17112	5.843850e-05	0	0	16214	0.000000e+00	0	1	30522	3.276330e-05	0	0	6210	0.000000e+00	0	1	13416	7.453790e-05	0	0	16732	0.000000e+00	0	1	89478	1.117590e-05	0	0	30604	0.000000e+00	0	1	13416	7.453790e-05	0	0	14898	0.000000e+00	0	1	34256	2.919200e-05	0	0	9566	0.000000e+00	0	1	17690	5.652910e-05	0	0	21628	0.000000e+00	0	1	102564	9.750010e-06	0	0	30522	0.000000e+00	0	1	17690	5.652910e-05	0	.	36	1613310	2.231440e-05	0	3	44888	6.683300e-05	0	0	74890	0.000000e+00	0	0	912	0.000000e+00	0	1	59996	1.666780e-05	0	0	29602	0.000000e+00	0	3	44888	6.683300e-05	0	0	64024	0.000000e+00	0	0	5544	0.000000e+00	0	28	1180018	2.372850e-05	0	1	91036	1.098470e-05	0	9	163634	5.5000794455919916E-5	0	176	0	0	2710	0	0	4744	0	0	796	0	1	968	0.0010330578512396695	0	682	0	0	280	0	1	13700	7.299270072992701E-5	0	4920	0	0	3392	0	11	187690	5.860727795833555E-5	Conflicting_classifications_of_pathogenicity	not_specified|CTCF-related_disorder|Inborn_genetic_diseases	criteria_provided,_conflicting_classifications	NC_000016.10:g.67637777G>A	.	CN169374|C0950123	.	.	.	Ala	Thr	580362.0	single nucleotide variant	NM_006565.4(CTCF):c.2089G>A (p.Ala697Thr)	10664.0	CTCF	HGNC:13723	Conflicting classifications of pathogenicity	0.0	Aug 22, 2023	201916739.0	-	RCV002318105|RCV004535791|RCV003323701	MeSH:D030342,MedGen:C0950123||MedGen:CN169374	Inborn genetic diseases|CTCF-related disorder|not specified	germline	germline	GRCh38	NC_000016.10	16	67637777.0	67637777.0	16q22.1	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA8112854	2.0	589165.0	67637777.0	G	A	-	-	-	-	-	-	SCV000849791|SCV004029010|SCV004113932	-	-	2089G>A 	Ala697Thr	NM_006565.4	1.0	3_Conflicting	36.77	0.7924528301886793		unknown		0		36.77	0.7924528	10-90	<=50						A	84			36.77	Aliphatic	Alanine		Transcriptional repressor CTCF		Acidic residues								1.8																		89									-155.1				134.7	Disordered					C (loop/coil)	C (loop/coil)																																																																				true	CTCFAla697Thr																																																																																																																																																																																																																																		
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7383820860922137	0.7042052908979199	0.7976389948336224	0.7172295279337151	0.7592937766234651	0.6237540869814104	0.6095803779193913	0.6912579747611411	0.5958214472974044	0.6446597031932366	0.8948334662655197	0.8248786779480388	0.9040200149061038	0.8125891344984355	0.8321044689911908	F9	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7383820860922137	0.7042052908979199	0.7976389948336224	0.7172295279337151	0.7592937766234651	0.6237540869814104	0.6095803779193913	0.6912579747611411	0.5958214472974044	0.6446597031932366	0.8948334662655197	0.8248786779480388	0.9040200149061038	0.8125891344984355	0.8321044689911908	F9	ENSG00000101981	52861	204382.0	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561821.0	G	A	X	Y	N	N	N	N	X-139561821-G-A	25652.0	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Nov 21, 2024	137852259.0	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821.0	139561821.0	Xq27.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3.0	10613.0	139561821.0	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2.0	1_Pathogenic	9.1059e-7	10613.0	X	139561821.0	G	A	R	Q	rs137852259	X	138643980.0	X	138471646.0	379.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.8575	D	0.5944	0.85464	D	10.0	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.7876	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652.0	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Nov 21, 2024	137852259.0	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821.0	139561821.0	Xq27.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3.0	10613.0	139561821.0	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2.0	1_Pathogenic	92.81	0.4112903225806452	['306900', '306700', '300807', '306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA A; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	92.81	0.41129032	10-90	>90						R	102			92.81	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-4.5								R379-Y391, R379-I390, R379-L383; PAE: 2.0, 2.0, 1.0	5 interactions	R379-L383; PAE: 1.0	3 interactions							175									-62.8				-34.1				dbSNP: rs137852258; Variant type: LP/P; AA change: Arg379Gly; PTM type: Phosphorylation; PTM morphology: LVDR*AtCLRST; Var class: II&rs137852259		H (helix)	H (α-helix)	Helix																													1.205	1 mutation(s) (Arg379Glu: 1.342)	0.981		0.956		0.972		0.977																														true	F9Arg379Gln																																																																																																																																																																																																																																		
FH	FH_Leu303Ser	4.116431421416617	0.006241164929272879	-6.345032355574454	0.00038706498420756636	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8908919950531735	0.6570530961477011	0.8364508811737972	0.8398345773564726	0.7393071781128275	0.8505563411567993	0.859268928404852	0.9118880825508586	0.7094237006526922	0.8885463987713997	0.6280580150688557	0.8204002263080932	0.7610136797967357	0.60468249164271	0.8932375913349474	FH	4.116431421416617	0.006241164929272879	-6.345032355574454	0.00038706498420756636	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8908919950531735	0.6570530961477011	0.8364508811737972	0.8398345773564726	0.7393071781128275	0.8505563411567993	0.859268928404852	0.9118880825508586	0.7094237006526922	0.8885463987713997	0.6280580150688557	0.8204002263080932	0.7610136797967357	0.60468249164271	0.8932375913349474	FH	ENSG00000091483	3408	214596.0	CCSBVarC004051	ALE00004051	NC_000001.11:241504242:A:G	908T>C	Leu303Ser	CEGS2	CegsMutGDEh1040	C11	GDEhDisVCh_40065	F08	1.0	CegsMutGDDh1040	C11							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	241504242.0	A	G	1	Y	Y	N	N	N	1-241504242-A-G	50023.0	single nucleotide variant	NM_000143.4(FH):c.908T>C (p.Leu303Ser)	2271.0	FH	HGNC:3700	Conflicting classifications of pathogenicity	1.0	Jan 08, 2025	201502246.0	-	RCV000568576|RCV004767031|RCV000034486|RCV000471678	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not specified|not provided|Fumarase deficiency	germline	germline	GRCh38	NC_000001.11	1	241504242.0	241504242.0	1q43	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA215563	2.0	41584.0	241504242.0	A	G	-	-	-	-	-	-	SCV000544239|SCV000673377|SCV001986003|SCV002535579|SCV004224834|SCV005381789	-	-	908T>C 	Leu303Ser	NM_000143.4	1.0	3_Conflicting	0.0000437859	41584.0	1	241504242.0	A	G	L	S	rs201502246	1	241667542.0	1	239734165.0	303.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.908T>C	p.Leu303Ser	c.908T>C	p.Leu303Ser	principal1	Y	1	YES	Select	-	TTG	2.0	0.0	A	./.	./.	./.	./.	0.011	0.55689	D	0.023	0.57446	D	1.0	0.90580	D	0.987	0.77493	D	0.99	0.97926	D	simple_aae	1.0	99.0	3.44	0.92016	M	-4.68	0.79692	D	0.874	0.87133	0.967	0.96644	D	0.9919	0.99799	D	10.0	0.9618218	0.95552	D	0.846144	0.98810	D	0.946	0.98921	0.745	0.87592	P07954	L303S	Loss of stability (P = 0.0343)| Gain of glycosylation at L303 (P = 0.0808)| Gain of disorder (P = 0.2233)| Gain of phosphorylation at T301 (P = 0.2914)| Gain of MoRF binding (P = 0.2989)	0.993238567584	0.99308	0.9823634086207722	0.98220	0.74807911618	0.63377	0.741951107979	0.73213	T	0.984249	0.99894	D	0.547779	0.95628	D	0.564556	0.95967	D	0.981520354747772	0.73778	D	0.970103	0.89232	D	0.72908586	0.79431	0.67910284	0.80933	0.72908586	0.79432	0.67910284	0.80934	-11.157	0.80574	D	0.7218	0.73810	P	0.993515370856004	0.90091	0.94387890	0.93050	0.8	0.88939	.	.	.	.	.	.	4.874147	0.7991	27.2	0.9984616293695229	0.92581	0.938010	0.93635	D	1.02294957323601	0.96387	14.65791	0.942700215822651	0.97163	15.70981	5.73	5.73	0.89714	6.28	0.98834	8.711	0.91115	11.145000	0.87201	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.992	0.67791	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	0	109296	0.000000e+00	0	2	207286	9.648500e-06	0	1	235642	4.243730e-06	0	0	7160	0.000000e+00	0	0	17080	0.000000e+00	0	0	2318	0.000000e+00	0	0	9036	0.000000e+00	0	0	13390	0.000000e+00	0	0	42732	0.000000e+00	0	0	15672	0.000000e+00	0	.	.	.	.	0	15810	0.000000e+00	0	0	30442	0.000000e+00	0	0	6202	0.000000e+00	0	0	13406	0.000000e+00	0	0	16720	0.000000e+00	0	2	89310	2.239390e-05	0	0	30572	0.000000e+00	0	2	89310	2.239390e-05	0	0	14502	0.000000e+00	0	0	34174	0.000000e+00	0	0	9556	0.000000e+00	0	0	17666	0.000000e+00	0	0	21616	0.000000e+00	0	1	102080	9.796240e-06	0	0	30490	0.000000e+00	0	1	102080	9.796240e-06	0	.	65	1613904	4.027500e-05	0	65	1179950	5.508710e-05	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44900	0.000000e+00	0	0	64028	0.000000e+00	0	0	6030	0.000000e+00	0	65	1179950	5.508710e-05	0	0	91074	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Fumarase_deficiency	criteria_provided,_conflicting_classifications	NC_000001.11:g.241504242A>G	ClinGen:CA215563	C3661900|C0027672|C0342770	606812	140162|24	Fumarate lyase, N-terminal	Leu	Ser	50023.0	single nucleotide variant	NM_000143.4(FH):c.908T>C (p.Leu303Ser)	2271.0	FH	HGNC:3700	Conflicting classifications of pathogenicity	1.0	Jan 08, 2025	201502246.0	-	RCV000568576|RCV004767031|RCV000034486|RCV000471678	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not specified|not provided|Fumarase deficiency	germline	germline	GRCh38	NC_000001.11	1	241504242.0	241504242.0	1q43	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA215563	2.0	41584.0	241504242.0	A	G	-	-	-	-	-	-	SCV000544239|SCV000673377|SCV001986003|SCV002535579|SCV004224834|SCV005381789	-	-	908T>C 	Leu303Ser	NM_000143.4	1.0	3_Conflicting	98.71	0.1341463414634146	['606812']	autosomal recessive	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	FUMARASE DEFICIENCY	98.71	0.13414635	10-90	>90						L	22			98.71	Aliphatic	Leucine		Fumarate hydratase, mitochondrial										3.8										L303-A298; PAE: 1.0	4 interactions							131									-104.0				150.1						C (loop/coil)	S (bend)																																																																				true	FHLeu303Ser																																																																																																																																																																																																																																		
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5868320113459373	0.6199967558965909	0.5553684603556356	0.6232166183271743	0.6350559643172258	0.5792174404184528	0.568101870798119	0.49912756256391044	0.5720512359304173	0.5143703665717453	0.6908944882159987	0.6783313658562298	0.6116093581473607	0.6679422758627646	0.6592936561201292	F9	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5868320113459373	0.6199967558965909	0.5553684603556356	0.6232166183271743	0.6350559643172258	0.5792174404184528	0.568101870798119	0.49912756256391044	0.5720512359304173	0.5143703665717453	0.6908944882159987	0.6783313658562298	0.6116093581473607	0.6679422758627646	0.6592936561201292	F9	ENSG00000101981	52861	204388.0	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561917.0	G	T	X	Y	N	N	N	N	X-139561917-G-T	25688.0	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Mar 01, 1992	137852276.0	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917.0	139561917.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1.0	10649.0	139561917.0	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic		10649.0	X	139561917.0	G	T	S	I	rs137852276	X	138644076.0	X	138471742.0	411.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2.0	0.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10.0	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.9965291518965101	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688.0	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Mar 01, 1992	137852276.0	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917.0	139561917.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1.0	10649.0	139561917.0	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic	85.31	0.0538461538461538	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	85.31	0.053846154	<10	70-90						S	7		Charge relay system	85.31	Polar/Neutral	Serine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.8								S411-S430, S411-G253; PAE: 2.5, 2.0	5 interactions		5 interactions							105									-48.8				132.6						C (loop/coil)	T (turn)	Turn																													1.116		1.032		1.055		1.054	4 mutation(s) (Ser411Val: 1.109, Ser411Asp: 1.109, Ser411Ile: 1.110, Ser411Trp: 1.113)	1.055																														true	F9Ser411Ile																																																																																																																																																																																																																																		
KRAS	KRAS_Gly60Arg	-2.525125755633534	0.03951338958819366	5.200356910662419	0.0012525185362658572	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9034152534578637	0.441932224339954	0.8136102958588445	0.7753065669925034	0.5282116430999909	0.45365823166693264	0.7496155511033935	0.7991193309355495	0.43289043005965117	0.8984087278620452	0.6027650545330492	0.8009975828816134	0.8281012607821395	0.4509740186202568	0.908421779053682	KRAS	-2.525125755633534	0.03951338958819366	5.200356910662419	0.0012525185362658572	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9034152534578637	0.441932224339954	0.8136102958588445	0.7753065669925034	0.5282116430999909	0.45365823166693264	0.7496155511033935	0.7991193309355495	0.43289043005965117	0.8984087278620452	0.6027650545330492	0.8009975828816134	0.8281012607821395	0.4509740186202568	0.908421779053682	KRAS	ENSG00000133703	3084	214488.0	CCSBVarC006097	ALE00006097	NC_000012.12:25227346:C:G	178G>C	Gly60Arg	CEGS2	CegsMutGDEh1041	E01	GDEhDisVCh_40061	A10	1.0	CegsMutGDDh1041	E01							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25227346.0	C	G	12	Y	Y	N	N	N	12-25227346-C-G	27625.0	single nucleotide variant	NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894359.0	-	RCV000013416|RCV000157935|RCV000521390|RCV000254661|RCV001267316|RCV000844635|RCV003313917	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Cardiofaciocutaneous syndrome 2|RASopathy|Cardio-facio-cutaneous syndrome|not provided|Inborn genetic diseases|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 3	germline;unknown	germline	GRCh38	NC_000012.12	12	25227346.0	25227346.0	12p12.1	reviewed by expert panel	9.0	-	N	ClinGen:CA273416,UniProtKB:P01116#VAR_026112,OMIM:190070.0009	3.0	12586.0	25227346.0	C	G	-	-	-	-	-	-	SCV000616370	-	-	178G>C 	Gly60Arg	NM_004985.5	3.0	1_Pathogenic		12586.0	12	25227346.0	C	G	G	R	rs104894359	12	25380280.0	12	25271547.0	60.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.178G>C	p.Gly60Arg	c.178G>C	p.Gly60Arg	alternative1	Y	1	.	Plus_Clinical	-	GGT	1.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.17	0.97633	H	-7.76	0.95831	D	0.956	0.96546	1.0884	0.99174	D	0.9502	0.98375	D	9.0	0.96227115	0.95603	D	0.451783	0.94345	D	0.938	0.98634	0.802	0.92046	P01116	G60R	Gain of catalytic residue at L56 (P = 0.1064)| Gain of phosphorylation at T58 (P = 0.1068)| Loss of glycosylation at T58 (P = 0.123)| Gain of solvent accessibility (P = 0.1319)| Gain of loop (P = 0.2045)	0.995530386705	0.99541	0.9776364459571039	0.97742	2.98422368777	0.99182	0.947138845921	0.99682	D	0.960754	0.99490	D	0.541091	0.95437	D	0.539464	0.95369	D	0.999921560287476	0.9973	D	0.89791	0.64215	D	0.9893387	0.99724	0.98382205	0.99902	0.98968154	0.99743	0.9740602	0.99623	-12.016	0.88337	D	0.9998	0.99795	P	0.999979503899075	0.99427	0.99919980	0.99211	1	0.99985	.	.	.	.	.	.	5.208984	0.87425	29.2	0.9993620363978072	0.99621	0.908603	0.86363	D	1.15990254133055	0.99090	20.65427	1.0558655561841	0.99443	22.78603	5.77	5.77	0.91065	3.95	0.75212	7.892	0.85894	7.701000	0.66341	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|Inborn_genetic_diseases|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_3|not_provided|RASopathy|Noonan_syndrome	reviewed_by_expert_panel	NC_000012.12:g.25227346C>G	ClinGen:CA273416|OMIM:190070.0009|UniProtKB:P01116#VAR_026112	C3809005|C0950123|C1275081|C1860991|C3661900|C5555857|C0028326	615278|PS115150|609942|PS163950	1340|1340|648|536391|648	Small GTP-binding domain	Gly	Arg	27625.0	single nucleotide variant	NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894359.0	-	RCV000013416|RCV000157935|RCV000521390|RCV000254661|RCV001267316|RCV000844635|RCV003313917	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Cardiofaciocutaneous syndrome 2|RASopathy|Cardio-facio-cutaneous syndrome|not provided|Inborn genetic diseases|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 3	germline;unknown	germline	GRCh38	NC_000012.12	12	25227346.0	25227346.0	12p12.1	reviewed by expert panel	9.0	-	N	ClinGen:CA273416,UniProtKB:P01116#VAR_026112,OMIM:190070.0009	3.0	12586.0	25227346.0	C	G	-	-	-	-	-	-	SCV000616370	-	-	178G>C 	Gly60Arg	NM_004985.5	3.0	1_Pathogenic	82.99	0.1071428571428571	['615278', '609942']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2; NOONAN SYNDROME 3	82.99	0.10714286	10-90	70-90																																																																																																																																		true	KRASGly60Arg																																																																																																																																																																																																																																		
BRAF	BRAF_Phe468Ser	-5.287701209677223	0.0011384771237647243	2.961834070476631	0.021050194197223714	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6731107755301939	0.5512422908367552	0.6962555006181175	0.68962910251701	0.5859581265157354	0.5879989123605611	0.6842041802629649	0.6931227660608306	0.54522477106327	0.669575683879428	0.5839173406709097	0.695054024771055	0.6993882351754044	0.5572598106102404	0.67664586718096	BRAF	-5.287701209677223	0.0011384771237647243	2.961834070476631	0.021050194197223714	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6731107755301939	0.5512422908367552	0.6962555006181175	0.68962910251701	0.5859581265157354	0.5879989123605611	0.6842041802629649	0.6931227660608306	0.54522477106327	0.669575683879428	0.5839173406709097	0.695054024771055	0.6993882351754044	0.5572598106102404	0.67664586718096	BRAF	ENSG00000157764	71969	220599.0	CCSBVarC003159	ALE00003159	NC_000007.14:140781605:A:G	1403T>C	Phe468Ser	CEGS2	CegsMutGDEh1010	E05	GDEhDisVCh_40058	D02	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140781605.0	A	G	7	Y	N	N	N	N	7-140781605-A-G	48836.0	single nucleotide variant	NM_004333.6(BRAF):c.1403T>C (p.Phe468Ser)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Feb 24, 2023	397507473.0	-	RCV000033305|RCV000037917|RCV001813222|RCV001293860|RCV000797502|RCV003407389|RCV002251944	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||	not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1|RASopathy|BRAF-related disorder|See cases	de novo;germline	germline	GRCh38	NC_000007.14	7	140781605.0	140781605.0	7q34	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA280002,UniProtKB:P15056#VAR_035097	2.0	40366.0	140781605.0	A	G	-	-	-	-	-	-	SCV000057210|SCV000061579|SCV000937062|SCV001482525|SCV002060517|SCV002502773|SCV002523369|SCV004110177	-	-	1403T>C 	Phe468Ser	NM_004333.6	2.0	1_Pathogenic		40366.0	7	140781605.0	A	G	F	S	rs397507473	7	140481405.0	7	140127874.0	468.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1403T>C	p.Phe468Ser	c.1403T>C	p.Phe468Ser	principal4	Y	.	YES	Select	-	TTT	2.0	0.0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.474	0.36638	P	0.333	0.42166	B	.	0.99291	.	.	.	.	1.375	0.34130	L	.	.	.	.	.	0.2775	0.87139	D	0.6181	0.86478	D	10.0	0.9654888	0.95979	D	0.370597	0.92721	D	.	0.96308	0.907	0.98057	P15056	F468S	Gain of disorder (P = 0.003)| Gain of catalytic residue at F468 (P = 0.0093)| Gain of glycosylation at F468 (P = 0.0356)| Gain of methylation at K473 (P = 0.0485)| Gain of ubiquitination at K473 (P = 0.0682)	.	0.99561	.	0.93588	.	0.97063	0.896780073643	0.96070	D	0.8689	0.97127	D	0.433457	0.91644	D	0.384855	0.91542	D	0.996321439743042	0.89024	D	0.981002	0.93472	D	0.9767253	0.98831	0.96972746	0.99444	0.9715668	0.98378	0.95852166	0.98875	-13.116	0.89856	D	0.9997	0.99795	P	0.99997234991302	0.99427	0.99889910	0.99026	0.997	0.99892	.	.	.	.	.	.	5.459799	0.91162	32.0	0.9980132717354168	0.88648	0.883596	0.81195	D	0.395979229302215	0.61003	4.318368	0.517485622092491	0.68999	5.32187	5.62	5.62	0.85695	.	.	9.302	0.95273	11.190000	0.88645	0.691	0.84104	1.0	0.71675	1.0	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	1	109386	9.141940e-06	0	1	208098	4.805430e-06	0	1	236886	4.221440e-06	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13378	0.000000e+00	0	1	42766	2.338310e-05	0	0	15688	0.000000e+00	0	1	42766	2.338310e-05	0	0	16218	0.000000e+00	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16718	0.000000e+00	0	1	89544	1.116770e-05	0	0	30604	0.000000e+00	0	1	89544	1.116770e-05	0	0	14902	0.000000e+00	0	0	34254	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21616	0.000000e+00	0	1	102710	9.736150e-06	0	0	30522	0.000000e+00	0	1	102710	9.736150e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	83130	0	0	54	0	0	2596	0	0	1234	0	0	290	0	0	318	0	0	600	0	0	182	0	0	1566	0	0	1288	0	0	3196	0	0	89970	0	Pathogenic/Likely_pathogenic	Cardiofaciocutaneous_syndrome_1|not_provided|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|See_cases|RASopathy|BRAF-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781605A>G	ClinGen:CA280002|UniProtKB:P15056#VAR_035097	CN029449|C3661900|C1275081|C5681679|C5555857	115150|PS115150	1340|1340|98733|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Phe	Ser	48836.0	single nucleotide variant	NM_004333.6(BRAF):c.1403T>C (p.Phe468Ser)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Feb 24, 2023	397507473.0	-	RCV000033305|RCV000037917|RCV001813222|RCV001293860|RCV000797502|RCV003407389|RCV002251944	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||	not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1|RASopathy|BRAF-related disorder|See cases	de novo;germline	germline	GRCh38	NC_000007.14	7	140781605.0	140781605.0	7q34	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA280002,UniProtKB:P15056#VAR_035097	2.0	40366.0	140781605.0	A	G	-	-	-	-	-	-	SCV000057210|SCV000061579|SCV000937062|SCV001482525|SCV002060517|SCV002502773|SCV002523369|SCV004110177	-	-	1403T>C 	Phe468Ser	NM_004333.6	2.0	1_Pathogenic	64.72	0.0862944162436548	['115150']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	64.72	0.08629441	<10	50-70						F	17			64.72	Aromatic	Phenylalanine	ATP	Serine/threonine-protein kinase B-raf							Protein kinase	0.1384		2.8								F468-N486; PAE: 4.0	26 interactions	F468-N486; PAE: 4.0	36 interactions							165									-95.0		Pocket 3: Mean pLDDT: 56.91, Volume: 905.32 Å³, Druggability score: 0.14		-24.3				dbSNP: rs397507473; Variant type: LP/P; AA change: Phe468Ser; PTM type: Ubiquitylation; PTM morphology: F*GtVYkGkWHG; Var class: II&rs397507473		C (loop/coil)	T (turn)																																																																				true	BRAFPhe468Ser																																																																																																																																																																																																																																		
RAD51D	RAD51D_Gly289Ser	7.092665294834583	0.00019491549970907673	4.424250910670517	0.0030654811896686845	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.9089434977704189	0.8769361257530477	0.916941184193312	0.9129257782376837	0.9401315062354583	0.9505417159707916	0.8848897946836229	0.8825882918074114	0.9324648798930826	0.8829042769396422	0.9297212965001249	0.9409617617917445	0.9512940765792127	0.8214073716130127	0.9349827186011955	RAD51D	7.092665294834583	0.00019491549970907673	4.424250910670517	0.0030654811896686845	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.9089434977704189	0.8769361257530477	0.916941184193312	0.9129257782376837	0.9401315062354583	0.9505417159707916	0.8848897946836229	0.8825882918074114	0.9324648798930826	0.8829042769396422	0.9297212965001249	0.9409617617917445	0.9512940765792127	0.8214073716130127	0.9349827186011955	RAD51D		7201		CCSBVarC024877		NC_000017.11:35101239:C:T	865G>A	Gly289Ser																												17.0	35101239.0	C	T	17						17-35101239-C-T	151659.0	single nucleotide variant	NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Nov 29, 2024	587782129.0	-	RCV000130672|RCV000462688|RCV000480701|RCV001194378	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	germline	germline	GRCh38	NC_000017.11	17	35101239.0	35101239.0	17q12	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA166871	2.0	141945.0	35101239.0	C	T	-	-	-	-	-	-	SCV000185558|SCV000551343|SCV000569950|SCV000908946|SCV001363870	-	-	865G>A 	Gly289Ser	NM_002878.4	1.0	3_Conflicting		141945.0	17	35101239.0	C	T	G	S	rs587782129	17	33428258.0	17	30452371.0	289.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.865G>A	p.Gly289Ser	c.865G>A	p.Gly289Ser	principal1	Y	5	.	.	-	GGC	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.00968	.	1.0	0.10481	T	0.008	0.20016	B	0.008	0.16009	B	0.06	0.18971	N	simple_aae	94.0	6.0	-0.395	0.03015	N	.	0.02351	.	0.225	0.25080	-1.0152	0.25206	T	0.1048	0.3818	T	10.0	0.047472775	0.04072	T	0.015582	0.36140	T	0.030	0.06938	0.393	0.41625	O75771	G289S	Gain of phosphorylation at G289 (P = 0.0191)| Gain of glycosylation at G289 (P = 0.0564)| Loss of methylation at R290 (P = 0.0588)| Gain of disorder (P = 0.0724)| Gain of MoRF binding (P = 0.1175)	0.0762999501168	0.06748	.	0.22253	.	0.36811	.	.	.	0.105892	0.41382	T	-0.28641	0.0977	T	-0.55233	0.16804	T	0.0316729542490267	0.02239	T	0.675032	0.28091	T	0.018450681	0.00366	0.023860626	0.00404	0.018450681	0.00366	0.023860626	0.00404	-2.752	0.11831	T	0.0718	0.06786	B	2.70558370001736e-05	0.01340	0.14648667	0.70195	0.008	0.00393	.	.	.	.	.	.	-0.012147	0.0421	1.022	0.7448272239278378	0.10886	0.042395	0.06461	N	-1.33388171991115	0.03260	0.1469401	-1.31009436204477	0.04234	0.2024671	4.86	0.314	0.1505	-1.35	0.14151	0.155	0.16235	-0.662000	0.08011	-0.181	0.10317	0.037	0.20898	0.0	0.08389	0.001	0.02614	912	0.21478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	2	208106	9.610490e-06	0	3	236918	1.266260e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	1	15690	6.373490e-05	0	0	16214	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	1	89538	1.116840e-05	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	1	102720	9.735200e-06	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	11	1614202	6.814510e-06	0	1	91088	1.097840e-05	0	0	75044	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29604	0.000000e+00	0	0	44874	0.000000e+00	0	0	64048	0.000000e+00	0	0	6062	0.000000e+00	0	9	1180036	7.626890e-06	0	1	91088	1.097840e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_specified	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101239C>T	ClinGen:CA166871	C3661900|C0027672|C3280345|CN169374	614291	140162|145	DNA repair protein RAD51 homolog 4, C-terminal	Gly	Ser	151659.0	single nucleotide variant	NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Nov 29, 2024	587782129.0	-	RCV000130672|RCV000462688|RCV000480701|RCV001194378	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	germline	germline	GRCh38	NC_000017.11	17	35101239.0	35101239.0	17q12	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA166871	2.0	141945.0	35101239.0	C	T	-	-	-	-	-	-	SCV000185558|SCV000551343|SCV000569950|SCV000908946|SCV001363870	-	-	865G>A 	Gly289Ser	NM_002878.4	1.0	3_Conflicting	76.22	0.2023809523809523	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	76.22	0.20238096	10-90	70-90						G	17			76.22	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		DNA repair protein RAD51 homolog 4										-0.4								G289-I311; PAE: 4.0	2 interactions	G289-I311, G289-G312; PAE: 4.0, 5.5	5 interactions							75									-66.1				-15.7						C (loop/coil)	C (loop/coil)																																																																				true	RAD51DGly289Ser																																																																																																																																																																																																																																		
ABCD1	ABCD1_Arg389Gly	7.214936905963234	0.00017516911910830517	1.7323208335459606	0.12682045577777387	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7282115376274452	0.6416306187719074	0.7746603470670775	0.7208348194902399	0.7159524873394272	0.557767958912841	0.6887665001171852	0.6603323432592614	0.543234493297224	0.727044639701077	0.8741370157660132	0.7529031388632945	0.8889883508748937	0.7400267442465908	0.7293784355538133	ABCD1	7.214936905963234	0.00017516911910830517	1.7323208335459606	0.12682045577777387	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7282115376274452	0.6416306187719074	0.7746603470670775	0.7208348194902399	0.7159524873394272	0.557767958912841	0.6887665001171852	0.6603323432592614	0.543234493297224	0.727044639701077	0.8741370157660132	0.7529031388632945	0.8889883508748937	0.7400267442465908	0.7293784355538133	ABCD1	ENSG00000101986	100008637	209127.0	CCSBVarC007023	ALE00007021	NC_000023.11:153736195:C:G	1165C>G	Arg389Gly	CEGS2	CegsMutGDEh1023	H04	GDEhDisVCh_40030	G07	2.0									1.0	5.0	0.0		0.0			0.0			0.0			23.0	153736195.0	C	G	X	N	N	N	N	N	X-153736195-C-G	26335.0	single nucleotide variant	NM_000033.4(ABCD1):c.1165C>G (p.Arg389Gly)	215.0	ABCD1	HGNC:61	Pathogenic	1.0	May 29, 2023	128624215.0	-	RCV000012048|RCV003488335	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900	Adrenoleukodystrophy|not provided	germline	germline	GRCh38	NC_000023.11	X	153736195.0	153736195.0	Xq28	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA278102,UniProtKB:P33897#VAR_000062,OMIM:300371.0005	3.0	11296.0	153736195.0	C	G	-	-	-	-	-	-	SCV000932772|SCV004238662	-	-	1165C>G 	Arg389Gly	NM_000033.4	2.0	1_Pathogenic		11296.0	X	153736195.0	C	G	R	G	rs128624215	X	153001649.0	X	152654843.0	389.0	ABCD1	ENSG00000101986	ENST00000218104	ENSP00000218104	P33897	ABCD1_HUMAN	c.1165C>G	p.Arg389Gly	c.1165C>G	p.Arg389Gly	principal1	Y	1	YES	Select	+	CGC	1.0	0.0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	0.999	0.77914	D	0.975	0.73364	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.46	0.71273	M	-5.91	0.88932	D	0.854	0.84989	0.7399	0.93647	D	0.8189	0.93891	D	9.0	0.97479206	0.97172	D	0.361811	0.92514	D	0.876	0.96308	0.848	0.95057	P33897	R389G	Loss of helix (P = 3e-04)| Gain of loop (P = 0.002)| Gain of sheet (P = 0.0036)| Loss of MoRF binding (P = 0.0526)| Loss of stability (P = 0.0594)	0.999475327291	0.99945	0.9960308022787095	0.99601	1.06563260916	0.76482	0.685714960098	0.65032	T	0.896327	0.97912	D	0.570331	0.96581	D	0.581464	0.96524	D	0.994085788726807	0.85058	D	0.963104	0.86253	D	0.7260219	0.79256	0.6468293	0.79120	0.7260219	0.79257	0.6468293	0.79121	-8.866	0.66907	D	0.8374	0.79060	P	0.999806454133949	0.98063	0.99975282	0.99678	0.926	0.96292	.	.	.	.	.	.	4.162932	0.62608	24.5	0.9974844639321528	0.84091	.	.	.	.	.	.	.	.	.	4.85	4.85	0.62327	.	.	2.238	0.42822	.	.	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.99	0.65338	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Adrenoleukodystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.153736195C>G	ClinGen:CA278102|OMIM:300371.0005|UniProtKB:P33897#VAR_000062	C3661900|C0162309	300100	43	.	Arg	Gly	26335.0	single nucleotide variant	NM_000033.4(ABCD1):c.1165C>G (p.Arg389Gly)	215.0	ABCD1	HGNC:61	Pathogenic	1.0	May 29, 2023	128624215.0	-	RCV000012048|RCV003488335	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900	Adrenoleukodystrophy|not provided	germline	germline	GRCh38	NC_000023.11	X	153736195.0	153736195.0	Xq28	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA278102,UniProtKB:P33897#VAR_000062,OMIM:300371.0005	3.0	11296.0	153736195.0	C	G	-	-	-	-	-	-	SCV000932772|SCV004238662	-	-	1165C>G 	Arg389Gly	NM_000033.4	2.0	1_Pathogenic	83.03	0.4556451612903225	['300100']	x-linked recessive	Rare genetic developmental defect during embryogenesis; Rare genetic hepatic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Genetic infertility	6	ADRENOLEUKODYSTROPHY	83.03	0.45564517	10-90	70-90						R	113			83.03	Positively-charged	Arginine		ATP-binding cassette sub-family D member 1										-4.5			2 interactions		2 interactions			R389-F385, R389-T393; PAE: 1.0, 1.0	8 interactions	R389-F385, R389-T393; PAE: 1.0, 1.0	8 interactions							175									-61.7				-54.0						H (helix)	H (α-helix)	Turn																																																																			true	ABCD1Arg389Gly																																																																																																																																																																																																																																		
BAP1	BAP1_Pro12Thr	1.2327266947006599	0.2574688649083334	-4.423763667701538	0.0030672880820356166	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7078250921699138	0.6299497786322784	0.6394755763891051	0.598572921579564	0.600122165829045	0.5225870430891271	0.6416290286580817	0.6437854650790235	0.5746693073816628	0.7147171308588358	0.6776572885689629	0.5555168145010463	0.6351656876991867	0.685230249882894	0.7009330534809918	BAP1	1.2327266947006599	0.2574688649083334	-4.423763667701538	0.0030672880820356166	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7078250921699138	0.6299497786322784	0.6394755763891051	0.598572921579564	0.600122165829045	0.5225870430891271	0.6416290286580817	0.6437854650790235	0.5746693073816628	0.7147171308588358	0.6776572885689629	0.5555168145010463	0.6351656876991867	0.685230249882894	0.7009330534809918	BAP1		3760		CCSBVarC009495		NC_000003.12:52409845:G:T	34C>A	Pro12Thr																												3.0	52409845.0	G	T	3						3-52409845-G-T	1053076.0	single nucleotide variant	NM_004656.4(BAP1):c.34C>A (p.Pro12Thr)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Feb 24, 2022	2153228682.0	-	RCV001374940|RCV001839042	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0859230,MedGen:C5676925,OMIM:619762	Neurodevelopmental disorder|Kury-Isidor syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52409845.0	52409845.0	3p21.1	no assertion criteria provided	2.0	-	N	OMIM:603089.0011,ClinGen:CA353115049	3.0	1064792.0	52409845.0	G	T	-	-	-	-	-	-	SCV001572228|SCV002098941	-	-	34C>A 	Pro12Thr	NM_004656.4		1_Pathogenic		1064792.0	3	52409845.0	G	T	P	T	rs2153228682	3	52443861.0	3	52418901.0	12.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.34C>A	p.Pro12Thr	c.34C>A	p.Pro12Thr	principal1	Y	1	YES	Select	-	CCA	1.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	0.994	0.66535	D	0.943	0.67917	D	.	.	.	.	.	.	3.34	0.90844	M	-7.52	0.95806	D	0.717	0.76196	0.5791	0.91592	D	0.6438	0.8752	D	10.0	0.9533975	0.94626	D	0.613498	0.96627	D	0.834	0.94750	0.826	0.93687	Q92560	P12T	Gain of catalytic residue at F15 (P = 0.1611)| Loss of stability (P = 0.1989)| Loss of disorder (P = 0.2123)| Loss of glycosylation at P12 (P = 0.257)| Gain of phosphorylation at S10 (P = 0.4485)	0.910963055978	0.90939	0.932184403075094	0.93154	2.47156410767	0.97481	0.78230202198	0.79237	T	0.587622	0.86468	D	0.322782	0.84559	D	0.225878	0.84358	D	0.99904853105545	0.95954	D	0.89941	0.64684	D	0.9520596	0.96419	0.9296314	0.97027	0.9520596	0.96420	0.9296314	0.97028	-13.412	0.91007	D	0.9986	0.97942	P	0.938734357228053	0.79228	0.99978024	0.99714	0.862	0.92474	.	.	.	.	.	.	5.259026	0.88323	29.5	0.9975871830702311	0.84864	0.875323	0.79793	D	0.957361183823445	0.94241	12.63146	0.862850773711547	0.93709	12.2498	4.93	4.93	0.64349	2.88	0.52655	6.576	0.73975	11.420000	0.92722	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.974	0.5568	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Kury-Isidor_syndrome|Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52409845G>T	OMIM:603089.0011	C5676925|C1535926	619762	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Pro	Thr	1053076.0	single nucleotide variant	NM_004656.4(BAP1):c.34C>A (p.Pro12Thr)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Feb 24, 2022	2153228682.0	-	RCV001374940|RCV001839042	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0859230,MedGen:C5676925,OMIM:619762	Neurodevelopmental disorder|Kury-Isidor syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52409845.0	52409845.0	3p21.1	no assertion criteria provided	2.0	-	N	OMIM:603089.0011,ClinGen:CA353115049	3.0	1064792.0	52409845.0	G	T	-	-	-	-	-	-	SCV001572228|SCV002098941	-	-	34C>A 	Pro12Thr	NM_004656.4		1_Pathogenic	95.22	0.1102941176470588	['619762']	unknown		0	KURY-ISIDOR SYNDROME	95.22	0.11029412	10-90	>90						P	15			95.22	Special, No backbone hydrogen	Proline		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			1.6								P12-T16; PAE: 1.0	1 interaction	P12-T16; PAE: 1.0	4 interactions							115									-61.1				-25.5						H (helix)	H (α-helix)	Helix																																																																			true	BAP1Pro12Thr																																																																																																																																																																																																																																		
FH	FH_Ser334Arg	0.5356287401458311	0.6114778201904933	-5.513451391166578	0.0008937233895488164	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9123497418664415	0.7552502164094068	0.9060419253464205	0.8486517173913317	0.8020219242904904	0.8007347478615932	0.8589931606726063	0.9153387714918513	0.7111055567943652	0.8978571531593534	0.8033091007193875	0.838310274110057	0.8967450792009897	0.7993948760244484	0.9268423305735295	FH	0.5356287401458311	0.6114778201904933	-5.513451391166578	0.0008937233895488164	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9123497418664415	0.7552502164094068	0.9060419253464205	0.8486517173913317	0.8020219242904904	0.8007347478615932	0.8589931606726063	0.9153387714918513	0.7111055567943652	0.8978571531593534	0.8033091007193875	0.838310274110057	0.8967450792009897	0.7993948760244484	0.9268423305735295	FH	ENSG00000091483	3408	214599.0	CCSBVarC004053	ALE00004053	NC_000001.11:241504148:A:C	1002T>G	Ser334Arg	CEGS2	CegsMutGDEh1041	C09	GDEhDisVCh_40065	H08	1.0	CegsMutGDDh1041	C09							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	241504148.0	A	C	1	Y	Y	N	N	N	1-241504148-A-C	1314676.0	single nucleotide variant	NM_000143.4(FH):c.1002T>G (p.Ser334Arg)	2271.0	FH	HGNC:3700	Likely pathogenic	1.0	May 22, 2023	2147916185.0	-	RCV003236374	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary leiomyomatosis and renal cell cancer	germline	germline	GRCh38	NC_000001.11	1	241504148.0	241504148.0	1q43	criteria provided, single submitter	1.0	-	N	ClinGen:CA345438245	2.0	2506143.0	241504148.0	A	C	-	-	-	-	-	-	SCV003934314	-	-	1002T>G 	Ser334Arg	NM_000143.4	1.0	1_Pathogenic		2506143.0	1	241504148.0	A	C	S	R	rs2147916185	1	241667448.0	1	239734071.0	334.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1002T>G	p.Ser334Arg	c.1002T>G	p.Ser334Arg	principal1	Y	1	YES	Select	-	AGT	3.0	2.0	A	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	D	simple_aae	3.0	97.0	3.55	0.93172	H	-4.9	0.81545	D	0.983	0.99270	1.0955	0.99468	D	0.9817	0.99438	D	10.0	0.96632713	0.96080	D	0.928795	0.99481	D	0.902	0.97281	0.765	0.89238	P07954	S334R	Gain of MoRF binding (P = 0.012)| Gain of methylation at S334 (P = 0.1999)| Gain of catalytic residue at S334 (P = 0.2478)| Gain of ubiquitination at K337 (P = 0.2694)| Loss of helix (P = 0.3949)	0.986805441107	0.98651	0.991474710610662	0.99141	1.03551510566	0.75429	0.77938503027	0.78796	T	0.968915	0.99646	D	0.540935	0.95434	D	0.539239	0.95366	D	0.996222853660583	0.8882	D	0.991801	0.97448	D	0.988074	0.99652	0.94546735	0.98092	0.988074	0.99652	0.94546735	0.98092	-15.188	0.96286	D	0.9943	0.95185	P	0.999937025252751	0.98982	0.96908960	0.94587	0.973	0.98982	.	.	.	.	.	.	3.81089	0.55043	23.6	0.9982587952017133	0.90858	0.530379	0.54952	D	0.60202261948517	0.73159	5.94406	0.506605376223128	0.68262	5.219445	5.73	3.45	0.3853	2.53	0.46530	1.348	0.33697	1.133000	0.24427	0.756	0.943	1.0	0.71675	0.994000	0.32271	0.999	0.91597	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_single_submitter	NC_000001.11:g.241504148A>C	.	C1708350	150800	523	Fumarate lyase, N-terminal	Ser	Arg	1314676.0	single nucleotide variant	NM_000143.4(FH):c.1002T>G (p.Ser334Arg)	2271.0	FH	HGNC:3700	Likely pathogenic	1.0	May 22, 2023	2147916185.0	-	RCV003236374	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary leiomyomatosis and renal cell cancer	germline	germline	GRCh38	NC_000001.11	1	241504148.0	241504148.0	1q43	criteria provided, single submitter	1.0	-	N	ClinGen:CA345438245	2.0	2506143.0	241504148.0	A	C	-	-	-	-	-	-	SCV003934314	-	-	1002T>G 	Ser334Arg	NM_000143.4	1.0	1_Pathogenic	98.88	0.0846153846153846	['150800']	autosomal dominant	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	98.88	0.08461539	<10	>90						S	11			98.88	Polar/Neutral	Serine		Fumarate hydratase, mitochondrial										-0.8			4 interactions	3 interactions				S334-I338, S334-T330; PAE: 1.0, 1.0	6 interactions	S334-I338, S334-T330, S334-Q254; PAE: 1.0, 1.0, 1.0	6 interactions							105									-66.5				-48.8						H (helix)	H (α-helix)	Helix																																																																			true	FHSer334Arg																																																																																																																																																																																																																																		
BRCA1	BRCA1_Ser611Arg	0.9435653387772786	1.0	3.4350690406883606	0.022021464779879492	2025_01_Batch_13-14	false	true	true	true	true	false	true	false	false	true	0.9149624939246632	0.8866295495753775	0.964237657516539	0.945209057336527	0.9681934372563926	0.9553935623214185	0.9507932560196941	0.949490270032494	0.883887929907112	0.9084188437682514	0.9809933121913668	0.9396248586533601	0.9789850450005839	0.889371169243643	0.9215061440810749	BRCA1	0.9435653387772786	1.0	3.4350690406883606	0.022021464779879492	2025_01_Batch_13-14	false	true	true	true	true	false	true	false	false	true	0.9149624939246632	0.8866295495753775	0.964237657516539	0.945209057336527	0.9681934372563926	0.9553935623214185	0.9507932560196941	0.949490270032494	0.883887929907112	0.9084188437682514	0.9809933121913668	0.9396248586533601	0.9789850450005839	0.889371169243643	0.9215061440810749	BRCA1		14613		CCSBVarC011835		NC_000017.11:43063881:G:C	1833C>G	Ser611Arg																												17.0	43063881.0	G	C	17						17-43063881-G-C	70085.0	single nucleotide variant	NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg)	672.0	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1.0	Oct 16, 2024	80357094.0	-	RCV000112509|RCV002336193|RCV005089439	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063881.0	43063881.0	17q21.31	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003268,UniProtKB:P38398#VAR_063906	2.0	55418.0	43063881.0	G	C	-	-	-	-	-	-	SCV000326168|SCV002645244|SCV005058237|SCV005812863	-	-	5145C>G 	Ser1715Arg	NM_007294.4	2.0	1_Pathogenic		55418.0	17	43063881.0	G	C	S	R	rs80357094	17	41215898.0	17	38469424.0	1715.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5145C>G	p.Ser1715Arg	principal2	Y	1	.	.	-	AGC	3.0	2.0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.064	0.90580	B	0.031	0.92348	B	.	0.99291	.	.	.	.	3.09	0.87301	M	.	0.74220	.	.	0.93850	0.3749	0.88675	D	0.661	0.88183	D	10.0	.	0.79960	.	0.483874	0.94878	D	.	0.88582	.	.	.	.	.	.	0.91515	.	0.92636	.	0.45682	0.678713917732	0.64025	T	0.249441	0.61729	T	0.397653	0.89708	D	0.333424	0.89578	D	0.98091846704483	0.73434	D	.	0.85294	.	0.9707088	0.98298	0.7604528	0.85672	0.97296304	0.98504	0.7653877	0.85971	-15.775	0.97410	D	.	0.96584	.	0.998593400129946	0.94714	0.99986792	0.99835	0.992	0.99727	.	.	.	.	.	.	3.655532	0.51985	23.2	0.9983873013318059	0.91978	0.429032	0.49057	N	0.670045961903725	0.77549	6.719747	0.654600882003088	0.78837	6.981316	6.04	4.89	0.63341	4.33	0.81833	2.013	0.40665	4.969000	0.46465	0.596	0.33565	1.0	0.71675	1.0	0.68239	0.998	0.85369	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43063881G>C	ClinGen:CA003268|UniProtKB:P38398#VAR_063906	C0027672|C2676676	604370	140162|145	BRCT domain|BRCT domain|BRCT domain	Ser	Arg	70085.0	single nucleotide variant	NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg)	672.0	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1.0	Oct 16, 2024	80357094.0	-	RCV000112509|RCV002336193|RCV005089439	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063881.0	43063881.0	17q21.31	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003268,UniProtKB:P38398#VAR_063906	2.0	55418.0	43063881.0	G	C	-	-	-	-	-	-	SCV000326168|SCV002645244|SCV005058237|SCV005812863	-	-	5145C>G 	Ser1715Arg	NM_007294.4	2.0	1_Pathogenic	97.51	0.0	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	97.51	0.0	<10	>90																																																																																																																																		true	BRCA1Ser611Arg																																																																																																																																																																																																																																		
LMNA	LMNA_Ala43Thr	2.826701345748407	0.02552666596388305	-4.1903998369062005	0.004084025769311878	2025_01_Batch_13-14	false	true	false	true	true	false	false	false	false	false	0.8848123356677271	0.8824246553003272	0.8566616563186553	0.9265105990690066	0.9366122182698651	0.9215057423653834	0.9396516603326881	0.7509784047159569	0.9010626710007219	0.8710391824484176	0.9517186941743468	0.9133695378053251	0.9623449079213537	0.8637866395999324	0.8985854888870367	LMNA	2.826701345748407	0.02552666596388305	-4.1903998369062005	0.004084025769311878	2025_01_Batch_13-14	false	true	false	true	true	false	false	false	false	false	0.8848123356677271	0.8824246553003272	0.8566616563186553	0.9265105990690066	0.9366122182698651	0.9215057423653834	0.9396516603326881	0.7509784047159569	0.9010626710007219	0.8710391824484176	0.9517186941743468	0.9133695378053251	0.9623449079213537	0.8637866395999324	0.8985854888870367	LMNA	ENSG00000160789	3903	201283.0	CCSBVarC003606	ALE00003606	NC_000001.11:156115045:G:A	127G>A	Ala43Thr	CEGS2	CegsMutGDEh1035	C03	GDEhDisVCh_40057	F08	1.0	CegsMutGDDh1035	C03							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	156115045.0	G	A	1	Y	Y	N	N	N	1-156115045-G-A	77696.0	single nucleotide variant	NM_170707.4(LMNA):c.127G>A (p.Ala43Thr)	4000.0	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1.0	Feb 26, 2024	60446065.0	-	RCV000057262|RCV001225020	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746	not provided|Charcot-Marie-Tooth disease type 2	germline	germline	GRCh38	NC_000001.11	1	156115045.0	156115045.0	1q22	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016942,UniProtKB:P02545#VAR_039753	2.0	66799.0	156115045.0	G	A	-	-	-	-	-	-	SCV000293392|SCV000339872|SCV001397255	-	-	127G>A 	Ala43Thr	NM_170707.4	1.0	3_Conflicting	6.92112e-7	66799.0	1	156115045.0	G	A	A	T	rs60446065	1	156084836.0	1	154351460.0	43.0	LMNA	ENSG00000160789	ENST00000675939	ENSP00000502256	P02545	LMNA_HUMAN	.	.	c.127G>A	p.Ala43Thr	principal1	Y	.	.	.	+	GCG	1.0	0.0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.60671	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	4.8	0.99640	H	.	0.67623	.	.	0.97975	1.0724	0.98653	D	0.9299	0.97681	D	10.0	.	0.99375	.	0.712602	0.97660	D	.	0.99545	0.924	0.98699	P02545	A43T	Gain of phosphorylation at A43 (P = 0.0767)| Gain of disorder (P = 0.0918)| Gain of MoRF binding (P = 0.1749)| Loss of stability (P = 0.302)| Gain of solvent accessibility (P = 0.3819)	.	0.98919	.	0.99215	.	0.94644	0.757743537426	0.75550	T	0.975701	0.99763	D	0.565194	0.96303	D	0.574085	0.96243	D	0.999742329120636	0.98769	D	.	0.97858	.	0.85589856	0.87609	0.7691078	0.86196	0.819483	0.84994	0.751655	0.85142	-10.307	0.75805	D	.	0.95185	.	0.999479217996385	0.96705	0.99996510	0.99965	0.984	0.99450	.	.	.	.	.	.	5.634268	0.92707	32.0	0.9990120507988541	0.97276	0.964074	0.98608	D	0.98056132522041	0.95089	13.32298	0.888889835448083	0.95043	13.28456	4.77	4.77	0.60376	.	.	9.953	0.98981	11.667000	0.94064	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.999	0.91597	420	0.81453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1597190	6.261000e-07	0	1	1171998	8.532440e-07	0	0	74668	0.000000e+00	0	0	912	0.000000e+00	0	0	57712	0.000000e+00	0	0	29200	0.000000e+00	0	0	43966	0.000000e+00	0	0	62534	0.000000e+00	0	0	6040	0.000000e+00	0	1	1171998	8.532440e-07	0	0	88354	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Charcot-Marie-Tooth_disease_type_2|not_provided	criteria_provided,_conflicting_classifications	NC_000001.11:g.156115045G>A	ClinGen:CA016942|UniProtKB:P02545#VAR_039753	C0270914|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Thr	77696.0	single nucleotide variant	NM_170707.4(LMNA):c.127G>A (p.Ala43Thr)	4000.0	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1.0	Feb 26, 2024	60446065.0	-	RCV000057262|RCV001225020	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746	not provided|Charcot-Marie-Tooth disease type 2	germline	germline	GRCh38	NC_000001.11	1	156115045.0	156115045.0	1q22	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016942,UniProtKB:P02545#VAR_039753	2.0	66799.0	156115045.0	G	A	-	-	-	-	-	-	SCV000293392|SCV000339872|SCV001397255	-	-	127G>A 	Ala43Thr	NM_170707.4	1.0	3_Conflicting	89.32	0.4245283018867924		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		89.32	0.4245283	10-90	70-90						A	45			89.32	Aliphatic	Alanine		Prelamin-A/C; Lamin-A/C							IF rod			1.8								A43-D47, A43-N39; PAE: 2.5, 4.5	2 interactions	A43-D47, A43-N39; PAE: 2.5, 4.5	2 interactions							89									-66.3				-47.9	Interaction with MLIP; Coil 1A			dbSNP: rs60446065; Variant type: LP/P; AA change: Ala43Thr; PTM type: Phosphorylation; PTM morphology: DrLA*VyIDrVR; Var class: II		H (helix)	H (α-helix)	Helix																																																																			true	LMNAAla43Thr																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Arg18Lys	-6.340999360000492	0.00038856290197054536	7.618121131716513	0.00012439311242996078	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9712566068215894	0.6932241667406536	0.9191830659065093	0.9289401104767521	0.7052544043533227	0.7503559799668514	0.9185601696203177	0.9064220148723456	0.7522493313481461	0.963587118979357	0.6601528287397938	0.9393200513331863	0.931944116940673	0.6341990021331609	0.9789260946638219	ZC4H2	-6.340999360000492	0.00038856290197054536	7.618121131716513	0.00012439311242996078	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9712566068215894	0.6932241667406536	0.9191830659065093	0.9289401104767521	0.7052544043533227	0.7503559799668514	0.9185601696203177	0.9064220148723456	0.7522493313481461	0.963587118979357	0.6601528287397938	0.9393200513331863	0.931944116940673	0.6341990021331609	0.9789260946638219	ZC4H2		4320		CCSBVarC009194		NC_000023.11:64976325:C:T	53G>A	Arg18Lys																												23.0	64976325.0	C	T	X						X-64976325-C-T	380137.0	single nucleotide variant	NM_018684.4(ZC4H2):c.53G>A (p.Arg18Lys)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 02, 2017	1057520299.0	-	RCV000426615	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64976325.0	64976325.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA16609222,OMIM:300897.0007	1.0	378045.0	64976325.0	C	T	-	-	-	-	-	-	SCV000513398	-	-	53G>A 	Arg18Lys	NM_018684.4		1_Pathogenic		378045.0	X	64976325.0	C	T	R	K	rs1057520299	X	64196205.0	X	64112930.0	18.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.53G>A	p.Arg18Lys	c.53G>A	p.Arg18Lys	principal1	Y	1	YES	Select	-	AGG	2.0	0.0	C	C/C	C/C	C/C	C/C	0.162	0.24024	T	0.428	0.54507	T	0.979	0.59057	D	0.973	0.72925	D	0.39	0.63057	A	simple_aae	61.0	39.0	1.61	0.40979	L	-1.74	0.52471	N	0.866	0.86268	-0.6422	0.62892	T	0.2792	0.64962	T	8.0	0.76925564	0.76724	D	0.017247	0.38628	T	0.231	0.52992	0.607	0.73845	Q9NQZ6	R18K	Gain of methylation at R18 (P = 0.0377)| Gain of ubiquitination at K15 (P = 0.0632)| Loss of MoRF binding (P = 0.0922)| Loss of phosphorylation at T21 (P = 0.1157)| Loss of glycosylation at K15 (P = 0.2)	0.622178612725	0.61618	0.901597971559674	0.90069	1.62403551474	0.89065	0.773836612701	0.77960	T	0.486907	0.81174	T	0.0608247	0.59433	T	-0.150406	0.58921	T	0.973198473453522	0.69797	D	0.89491	0.63411	D	0.6772347	0.76559	0.5044407	0.71097	0.6783023	0.76618	0.41600963	0.65445	-4.683	0.36534	T	0.7363	0.75522	P	0.99398228578285	0.90367	0.99041635	0.96797	0.321	0.58615	.	.	.	.	.	.	5.580871	0.92311	32.0	0.9959977395401752	0.74191	.	.	.	.	.	.	.	.	.	4.73	4.73	0.59435	4.0	0.76287	5.226	0.65208	7.412000	0.58717	0.549	0.27038	1.0	0.71675	1.0	0.68239	0.967	0.53449	45	0.97779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1209679	8.266660e-07	0	1	45815	2.182690e-05	0	0	57101	0.000000e+00	0	0	687	0.000000e+00	0	1	45815	2.182690e-05	0	0	22031	0.000000e+00	0	0	33732	0.000000e+00	0	0	46659	0.000000e+00	0	0	4372	0.000000e+00	0	0	894933	0.000000e+00	0	0	56759	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64976325C>T	ClinGen:CA16609222|OMIM:300897.0007	C0796200	314580	3454|85283	.	Arg	Lys	380137.0	single nucleotide variant	NM_018684.4(ZC4H2):c.53G>A (p.Arg18Lys)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 02, 2017	1057520299.0	-	RCV000426615	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64976325.0	64976325.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA16609222,OMIM:300897.0007	1.0	378045.0	64976325.0	C	T	-	-	-	-	-	-	SCV000513398	-	-	53G>A 	Arg18Lys	NM_018684.4		1_Pathogenic	97.95	0.7056451612903226	['314580']	unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	97.95	0.70564514	10-90	>90						R	175			97.95	Positively-charged	Arginine		Zinc finger C4H2 domain-containing protein	Coiled coil									-4.5								R18-L22, R18-I14; PAE: 1.0, 1.0		R18-L22, R18-I14; PAE: 1.0, 1.0								175									-56.7				-46.0				dbSNP: rs1057520299; Variant type: LP/P; AA change: Arg18Lys; PTM type: Acetylation; PTM morphology: KLESIkEIR*Nk; Var class: II		H (helix)	H (α-helix)																																																																				true	ZC4H2Arg18Lys																																																																																																																																																																																																																																		
RAF1	RAF1_Cys95Trp	2.1174108905084634	0.25563446626635816	-1.491000957661587	0.23274383192261294	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7599635836107428	0.7118346818786421	0.8118655163109387	0.826065134458348	0.7836407261209146	0.6617335274570855	0.805767475717292	0.7165035141792934	0.6139034617369616	0.7057777209753036	0.9055479247847438	0.8463627931994039	0.9072275184425841	0.8097659020203224	0.8141494462461819	RAF1	2.1174108905084634	0.25563446626635816	-1.491000957661587	0.23274383192261294	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7599635836107428	0.7118346818786421	0.8118655163109387	0.826065134458348	0.7836407261209146	0.6617335274570855	0.805767475717292	0.7165035141792934	0.6139034617369616	0.7057777209753036	0.9055479247847438	0.8463627931994039	0.9072275184425841	0.8097659020203224	0.8141494462461819	RAF1		732		CCSBVarC008910		NC_000003.12:12611985:G:C	285C>G	Cys95Trp																												3.0	12611985.0	G	C	3						3-12611985-G-C	173887.0	single nucleotide variant	NM_002880.4(RAF1):c.285C>G (p.Cys95Trp)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Aug 11, 2014	727503384.0	-	RCV000151719	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	germline	germline	GRCh38	NC_000003.12	3	12611985.0	12611985.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA273221	2.0	165011.0	12611985.0	G	C	-	-	-	-	-	-	SCV000200051	-	-	285C>G 	Cys95Trp	NM_002880.4	1.0	1_Pathogenic		165011.0	3	12611985.0	G	C	C	W	rs727503384	3	12653484.0	3	12628484.0	95.0	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.285C>G	p.Cys95Trp	principal3	Y	.	.	.	-	TGC	3.0	2.0	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.38356	.	1.0	0.90580	D	0.996	0.84488	D	.	0.94956	.	.	.	.	2.485	0.72164	M	.	0.79947	.	.	0.79136	0.1432	0.84874	D	0.5496	0.83427	D	10.0	.	0.89682	.	0.141331	0.82326	D	.	0.91849	0.754	0.88343	P04049	C95W	Gain of MoRF binding (P = 0.0301)| Gain of sheet (P = 0.0827)| Gain of catalytic residue at C96 (P = 0.2212)| Loss of loop (P = 0.2897)| Loss of stability (P = 0.5099)	.	0.87322	.	0.85122	.	0.87009	0.869541406631	0.92491	D	0.903854	0.98115	D	0.365418	0.8757	D	0.287121	0.8741	D	0.994695365428925	0.86028	D	.	0.92203	.	0.87996113	0.89519	0.8072368	0.88581	0.8894862	0.90329	0.8686348	0.92675	-10.122	0.74995	D	.	0.94636	.	0.999741413090409	0.97751	0.95872940	0.93882	0.627	0.79193	.	.	.	.	.	.	4.838956	0.79021	27.0	0.9928224962569261	0.58002	0.756013	0.69429	D	0.698857312374925	0.79444	7.102922	0.676399396255758	0.80484	7.33289	5.77	4.71	0.58959	3.37	0.61085	3.451	0.52821	6.510000	0.55873	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Noonan_syndrome	criteria_provided,_single_submitter	NC_000003.12:g.12611985G>C	ClinGen:CA273221	C0028326	PS163950	648	Raf-like Ras-binding|Raf-like Ras-binding|Raf-like Ras-binding	Cys	Trp	173887.0	single nucleotide variant	NM_002880.4(RAF1):c.285C>G (p.Cys95Trp)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Aug 11, 2014	727503384.0	-	RCV000151719	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	germline	germline	GRCh38	NC_000003.12	3	12611985.0	12611985.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA273221	2.0	165011.0	12611985.0	G	C	-	-	-	-	-	-	SCV000200051	-	-	285C>G 	Cys95Trp	NM_002880.4	1.0	1_Pathogenic	71.64	0.037037037037037		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		71.64	0.037037037	<10	70-90						C	5			71.64	Special, a very reactive sulfhydryl group	Cysteine		RAF proto-oncogene serine/threonine-protein kinase							RBD			2.5								C95-L131; PAE: 2.5	7 interactions	C95-L131; PAE: 2.5	16 interactions							121									-87.1				-4.0						H (helix)	G (3₁₀-helix)	Helix																																																									-0.11	1 mutation(s) (Cys95Glu: 0.374)									true	RAF1Cys95Trp																																																																																																																																																																																																																																		
BRAF	BRAF_Gly596Val	2.2257131093137597	0.06135777408658752	-3.8089973889178856	0.006636562833595199	2025_01_Batch_13-14	false	true	true	true	true	false	false	false	true	true	0.9642639949594443	0.8741998481419343	0.9752659064212066	0.9738633061882711	0.9532177126836002	0.9381108039505246	0.9650002822404748	0.9621695175747484	0.8710569467787093	0.9443067789577735	0.9683246214166759	0.9827263301360674	0.9883622952676646	0.8773427495051593	0.984221210961115	BRAF	2.2257131093137597	0.06135777408658752	-3.8089973889178856	0.006636562833595199	2025_01_Batch_13-14	false	true	true	true	true	false	false	false	true	true	0.9642639949594443	0.8741998481419343	0.9752659064212066	0.9738633061882711	0.9532177126836002	0.9381108039505246	0.9650002822404748	0.9621695175747484	0.8710569467787093	0.9443067789577735	0.9683246214166759	0.9827263301360674	0.9883622952676646	0.8773427495051593	0.984221210961115	BRAF	ENSG00000157764	71969	220614.0	CCSBVarC003171	ALE00003171	NC_000007.14:140753348:C:A	1787G>T	Gly596Val	CEGS2	CegsMutGDEh1020	G07	GDEhDisVCh_40058	F08	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140753348.0	C	A	7	Y	N	N	N	N	7-140753348-C-A	48857.0	single nucleotide variant	NM_004333.6(BRAF):c.1787G>T (p.Gly596Val)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Apr 03, 2017	397507483.0	-	RCV000033332|RCV000208758|RCV000844615|RCV000856749|RCV000077865|RCV001265809	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	RASopathy|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000007.14	7	140753348.0	140753348.0	7q34	reviewed by expert panel	12.0	-	N	ClinGen:CA220161,UniProtKB:P15056#VAR_035098	3.0	40387.0	140753348.0	C	A	-	-	-	-	-	-	SCV000616388	-	-	1787G>T 	Gly596Val	NM_004333.6	3.0	1_Pathogenic		40387.0	7	140753348.0	C	A	G	V	rs397507483	7	140453148.0	7	140099617.0	596.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1787G>T	p.Gly596Val	c.1787G>T	p.Gly596Val	principal4	Y	.	YES	Select	-	GGT	2.0	0.0	C	./.	./.	./.	./.	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97926	.	.	.	.	3.295	0.90281	M	.	.	.	.	.	0.6405	0.92395	D	0.6951	0.89454	D	10.0	0.99041414	0.99538	D	0.395627	0.93272	D	.	0.99969	0.986	0.99859	P15056	G596V	Loss of sheet (P = 0.0817)| Loss of ubiquitination at K601 (P = 0.0992)| Loss of disorder (P = 0.1248)| Gain of methylation at K591 (P = 0.1331)| Loss of catalytic residue at G596 (P = 0.1549)	.	0.98509	.	0.98578	.	0.96552	0.919968366623	0.98320	D	0.963797	0.99550	D	0.575047	0.96883	D	0.588239	0.96832	D	0.999177873134613	0.96398	D	0.99514	0.98365	D	0.99520737	0.99966	0.98436314	0.99912	0.9940386	0.99934	0.98400426	0.99906	-12.721	0.88207	D	0.9996	0.99584	P	0.999992243767439	0.99831	0.99971479	0.99632	1	0.99985	.	.	.	.	.	.	5.562398	0.92161	32.0	0.9979890824652086	0.88381	0.917943	0.88587	D	0.742007177940642	0.82286	7.749107	0.747081129508623	0.85861	8.732487	5.65	5.65	0.86862	.	.	7.831	0.84961	7.673000	0.64945	0.595	0.32887	1.0	0.71675	1.0	0.68239	0.999	0.91597	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Transitional_cell_carcinoma_of_the_bladder|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|Inborn_genetic_diseases|Glioblastoma|not_provided|RASopathy|Multiple_myeloma|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1	reviewed_by_expert_panel	NC_000007.14:g.140753348C>A	ClinGen:CA220161|UniProtKB:P15056#VAR_035098	C0279680|C1275081|C0028326|C0950123|C0017636|C3661900|C5555857|C0026764|C0152013|CN029449	PS115150|PS163950|254500|115150	1340|648|360|536391|29073|85443|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Gly	Val	48857.0	single nucleotide variant	NM_004333.6(BRAF):c.1787G>T (p.Gly596Val)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Apr 03, 2017	397507483.0	-	RCV000033332|RCV000208758|RCV000844615|RCV000856749|RCV000077865|RCV001265809	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	RASopathy|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000007.14	7	140753348.0	140753348.0	7q34	reviewed by expert panel	12.0	-	N	ClinGen:CA220161,UniProtKB:P15056#VAR_035098	3.0	40387.0	140753348.0	C	A	-	-	-	-	-	-	SCV000616388	-	-	1787G>T 	Gly596Val	NM_004333.6	3.0	1_Pathogenic	56.55	0.1071428571428571	['115150']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	56.55	0.10714286	10-90	50-70						G	9			56.55	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Serine/threonine-protein kinase B-raf							Protein kinase			-0.4									24 interactions		47 interactions							75									79.2				-45.2				dbSNP: rs121913361; Variant type: US; AA change: Gly596Arg; PTM type: Ubiquitylation; PTM morphology: G*LAtVksRWsG; Var class: II&rs397507483		C (loop/coil)	S (bend)																																																																				true	BRAFGly596Val																																																																																																																																																																																																																																		
FANCC	FANCC_Leu554Pro	-0.3335628604146983	0.7484786135159357	-4.383117084986827	0.0032222333592398064	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.9559856145312168	0.9067946345079881	0.9523900998771666	0.9377478370295699	0.8214485122369959	0.682887537830733	0.9185174287367518	0.9271406611938001	0.8591763545189698	0.9441415721015707	0.9600094866432589	0.956978245322388	0.977639538560533	0.9544129144970065	0.9678296569608629	FANCC	-0.3335628604146983	0.7484786135159357	-4.383117084986827	0.0032222333592398064	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.9559856145312168	0.9067946345079881	0.9523900998771666	0.9377478370295699	0.8214485122369959	0.682887537830733	0.9185174287367518	0.9271406611938001	0.8591763545189698	0.9441415721015707	0.9600094866432589	0.956978245322388	0.977639538560533	0.9544129144970065	0.9678296569608629	FANCC	ENSG00000158169	7699	13991.0	CCSBVarC001231	ALE00001231	NC_000009.12:95101723:A:G	1661T>C	Leu554Pro	RC4	RC4_Mut_GDEh1009	D09	GDEhDisVCh_40044	G07	2.0	RC4_Mut_GDDh1009	D09							1.0	1.0	1.0	1.0	0.0			0.0			0.0			9.0	95101723.0	A	G	9	Y	Y	N	N	N	9-95101723-A-G	27082.0	single nucleotide variant	NM_000136.3(FANCC):c.1661T>C (p.Leu554Pro)	2176.0	FANCC	HGNC:3584	Pathogenic/Likely pathogenic	1.0	Nov 18, 2024	104886458.0	-	RCV000058925|RCV000012823|RCV002399319|RCV001221431|RCV003421917	MedGen:C3661900|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|	not provided|Fanconi anemia complementation group C|Hereditary cancer-predisposing syndrome|Fanconi anemia|FANCC-related disorder	germline;unknown	germline	GRCh38	NC_000009.12	9	95101723.0	95101723.0	9q22.32	criteria provided, multiple submitters, no conflicts	15.0	-	N	ClinGen:CA284829,UniProtKB:Q00597#VAR_005233,OMIM:613899.0001	3.0	12043.0	95101723.0	A	G	-	-	-	-	-	-	SCV000512973|SCV001163619|SCV001363461|SCV001393476|SCV002022325|SCV002707544|SCV002776573|SCV004108354|SCV005625570	-	-	1661T>C 	Leu554Pro	NM_000136.3	2.0	1_Pathogenic	0.000014366	12043.0	9	95101723.0	A	G	L	P	rs104886458	9	97864005.0	9	96903826.0	554.0	FANCC	ENSG00000158169	ENST00000289081	ENSP00000289081	Q00597	FANCC_HUMAN	c.1661T>C	p.Leu554Pro	c.1661T>C	p.Leu554Pro	principal1	Y	1	YES	Select	-	CTG	2.0	0.0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.3	0.55288	A	simple_aae	70.0	30.0	2.215	0.62356	M	-3.85	0.72390	D	0.896	0.89567	-0.0283	0.81584	T	0.388	0.74183	T	9.0	0.9469856	0.93958	D	0.055743	0.66224	D	0.617	0.85019	.	.	.	.	.	0.900282806353	0.89853	0.8253407305087601	0.82387	0.413463600646	0.41766	0.590069651604	0.51437	T	0.473774	0.80403	T	0.271784	0.80457	D	0.216268	0.83872	D	0.949487268924713	0.62897	D	.	0.12239	.	0.90733176	0.91931	0.87151235	0.92876	0.87194806	0.88866	0.8482753	0.91276	-7.71	0.59149	D	0.6917	0.72637	LP	0.921516655278869	0.77669	0.95718740	0.93787	0.731	0.85095	.	.	.	.	.	.	4.178114	0.62948	24.5	0.9983982519949924	0.92063	0.586505	0.58304	D	0.440542923641051	0.63480	4.605117	0.331677567903355	0.57182	3.906634	4.76	4.76	0.60139	.	.	4.529	0.60386	10.861000	0.84000	0.756	0.943	0.99	0.37076	1.0	0.68239	0.016	0.10745	167	0.93511	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	2	109336	1.829220e-05	0	2	207912	9.619450e-06	0	3	236760	1.267110e-05	0	0	7156	0.000000e+00	0	0	17096	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13380	0.000000e+00	0	2	42740	4.679460e-05	0	0	15684	0.000000e+00	0	2	42740	4.679460e-05	0	0	16190	0.000000e+00	0	0	30492	0.000000e+00	0	0	6200	0.000000e+00	0	0	13412	0.000000e+00	0	0	16720	0.000000e+00	0	2	89440	2.236140e-05	0	0	30596	0.000000e+00	0	2	89440	2.236140e-05	0	0	14880	0.000000e+00	0	0	34228	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21610	0.000000e+00	0	3	102652	2.922500e-05	0	0	30514	0.000000e+00	0	3	102652	2.922500e-05	0	.	24	1613908	1.487070e-05	0	24	1180000	2.033900e-05	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29608	0.000000e+00	0	0	44874	0.000000e+00	0	0	63982	0.000000e+00	0	0	6074	0.000000e+00	0	24	1180000	2.033900e-05	0	0	91068	0.000000e+00	0	4	92818	4.3095089314572604E-5	0	168	0	0	2680	0	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	0	4188	0	0	3306	0	4	104018	3.845488280874464E-5	Pathogenic/Likely_pathogenic	Fanconi_anemia_complementation_group_C|not_provided|Hereditary_cancer-predisposing_syndrome|Fanconi_anemia|FANCC-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.95101723A>G	ClinGen:CA284829|Genetic_Testing_Registry_(GTR):GTR000603994|OMIM:613899.0001|UniProtKB:Q00597#VAR_005233	C3468041|C3661900|C0027672|C0015625	227645|PS227650	84|140162|84	.	Leu	Pro	27082.0	single nucleotide variant	NM_000136.3(FANCC):c.1661T>C (p.Leu554Pro)	2176.0	FANCC	HGNC:3584	Pathogenic/Likely pathogenic	1.0	Nov 18, 2024	104886458.0	-	RCV000058925|RCV000012823|RCV002399319|RCV001221431|RCV003421917	MedGen:C3661900|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|	not provided|Fanconi anemia complementation group C|Hereditary cancer-predisposing syndrome|Fanconi anemia|FANCC-related disorder	germline;unknown	germline	GRCh38	NC_000009.12	9	95101723.0	95101723.0	9q22.32	criteria provided, multiple submitters, no conflicts	15.0	-	N	ClinGen:CA284829,UniProtKB:Q00597#VAR_005233,OMIM:613899.0001	3.0	12043.0	95101723.0	A	G	-	-	-	-	-	-	SCV000512973|SCV001163619|SCV001363461|SCV001393476|SCV002022325|SCV002707544|SCV002776573|SCV004108354|SCV005625570	-	-	1661T>C 	Leu554Pro	NM_000136.3	2.0	1_Pathogenic	88.01	0.0182926829268292	['227645']	autosomal recessive	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Inherited cancer-predisposing syndrome	6	FANCONI ANEMIA, COMPLEMENTATION GROUP C	88.01	0.018292682	<10	70-90						L	3			88.01	Aliphatic	Leucine		Fanconi anemia group C protein										3.8								L554-L550; PAE: 1.0		L554-L550, L554-V558; PAE: 1.0, 2.5								131									-67.3				-34.1						H (helix)	H (α-helix)																																																																				true	FANCCLeu554Pro																																																																																																																																																																																																																																		
BRCA1	BRCA1_Thr581Ala	0.0497091547769512	0.9617428060924307	4.326359069964326	0.003453197422548223	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8813278351256801	0.7791793757527026	0.9367916193654093	0.8775274798248345	0.9002714608523378	0.9167490291041218	0.9030116271717452	0.9247672489714605	0.8009118765693297	0.903340193991352	0.8837938926005537	0.8520433324779236	0.9488159897593582	0.7574468749360753	0.8593154762600081	BRCA1	0.0497091547769512	0.9617428060924307	4.326359069964326	0.003453197422548223	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8813278351256801	0.7791793757527026	0.9367916193654093	0.8775274798248345	0.9002714608523378	0.9167490291041218	0.9030116271717452	0.9247672489714605	0.8009118765693297	0.903340193991352	0.8837938926005537	0.8520433324779236	0.9488159897593582	0.7574468749360753	0.8593154762600081	BRCA1		14613		CCSBVarC011843		NC_000017.11:43067629:T:C	1741A>G	Thr581Ala																												17.0	43067629.0	T	C	17						17-43067629-T-C	70031.0	single nucleotide variant	NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80356890.0	-	RCV000048749|RCV000112475|RCV000163024|RCV000212192	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067629.0	43067629.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00042,ClinGen:CA003174,UniProtKB:P38398#VAR_063902	2.0	55364.0	43067629.0	T	C	-	-	-	-	-	-	SCV000244379	-	-	5053A>G 	Thr1685Ala	NM_007294.4	3.0	1_Pathogenic		55364.0	17	43067629.0	T	C	T	A	rs80356890	17	41219646.0	17	38473172.0	1685.0	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.5053A>G	p.Thr1685Ala	c.5053A>G	p.Thr1685Ala	principal2	Y	1	YES	Select	-	ACT	1.0	0.0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.53	0.77914	P	0.183	0.88579	B	0.91	0.99291	A	simple_aae	9.0	91.0	3.31	0.90471	M	-0.82	0.74769	N	0.875	0.91505	0.7304	0.9353	D	0.7785	0.92454	D	10.0	0.8680128	0.85903	D	0.754689	0.98044	D	0.882	0.96531	.	.	.	.	.	0.952919659821	0.95202	.	0.86482	.	0.09116	0.670587182045	0.62862	T	0.403358	0.81781	T	0.418536	0.90878	D	0.363421	0.90764	D	0.970580279827118	0.68797	D	.	0.76208	.	0.96085334	0.97324	0.6886691	0.81474	0.9444927	0.95639	0.6872717	0.81396	-14.503	0.94593	D	0.523	0.76577	A	0.979632873704045	0.85227	0.99986613	0.99835	0.966	0.98629	.	.	.	.	.	.	3.78294	0.54478	23.5	0.9977773104973581	0.86531	0.717269	0.66764	D	0.641941303045784	0.75718	6.379083	0.607013709110586	0.75311	6.31232	5.24	5.24	0.72825	3.42	0.61925	4.786	0.62201	7.873000	0.72109	0.56	0.28431	1.0	0.71675	1.0	0.68239	0.983	0.59808	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067629T>C	BRCA1-HCI:BRCA1_00042|ClinGen:CA003174|UniProtKB:P38398#VAR_063902	C3661900|C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ala	70031.0	single nucleotide variant	NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80356890.0	-	RCV000048749|RCV000112475|RCV000163024|RCV000212192	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067629.0	43067629.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00042,ClinGen:CA003174,UniProtKB:P38398#VAR_063902	2.0	55364.0	43067629.0	T	C	-	-	-	-	-	-	SCV000244379	-	-	5053A>G 	Thr1685Ala	NM_007294.4	3.0	1_Pathogenic	94.85	0.352112676056338	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	94.85	0.35211268	10-90	>90																																																																																																																																		true	BRCA1Thr581Ala																																																																																																																																																																																																																																		
BRCA1	BRCA1_Cys61Gly	0.9686368160707995	0.36499496144588084	4.370983692104869	0.003270140985358988	2025_01_Batch_13-14	false	true	true	false	true	false	true	false	false	false	0.9156933741802082	0.8972719874213329	0.955213978242027	0.8860689576449626	0.9657271784118282	0.9816626134163466	0.9382680897369753	0.9675114203479335	0.8882441185541432	0.9381794369642189	0.9497917434073099	0.83386982555295	0.9429165361361207	0.9062998562885225	0.8932073113961976	BRCA1	0.9686368160707995	0.36499496144588084	4.370983692104869	0.003270140985358988	2025_01_Batch_13-14	false	true	true	false	true	false	true	false	false	false	0.9156933741802082	0.8972719874213329	0.955213978242027	0.8860689576449626	0.9657271784118282	0.9816626134163466	0.9382680897369753	0.9675114203479335	0.8882441185541432	0.9381794369642189	0.9497917434073099	0.83386982555295	0.9429165361361207	0.9062998562885225	0.8932073113961976	BRCA1		14613		CCSBVarC011874		NC_000017.11:43106487:A:C	181T>G	Cys61Gly																												17.0	43106487.0	A	C	17						17-43106487-A-C	32700.0	single nucleotide variant	NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	28897672.0	-	RCV000019229|RCV000415051|RCV000159935|RCV000239114|RCV000047597|RCV000131902|RCV000412714|RCV001270967|RCV000785199|RCV005003390|RCV004802937	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	Breast-ovarian cancer, familial, susceptibility to, 1|Breast carcinoma|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast and/or ovarian cancer|Ovarian neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	germline;not applicable;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	43106487.0	43106487.0	17q21.31	reviewed by expert panel	59.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	OMIM:113705.0002,BRCA1-HCI:BRCA1_00099,ClinGen:CA001182,UniProtKB:P38398#VAR_007757	3.0	17661.0	43106487.0	A	C	-	-	-	-	-	-	SCV000244308	-	-	181T>G 	Cys61Gly	NM_007294.4	3.0	1_Pathogenic		17661.0	17	43106487.0	A	C	C	G	rs28897672	17	41258504.0	17	38512030.0	61.0	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.181T>G	p.Cys61Gly	c.181T>G	p.Cys61Gly	principal2	Y	1	.	.	-	TGT	1.0	0.0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.116	0.77914	B	0.026	0.82066	B	.	0.99291	.	.	.	.	4.355	0.98454	H	-2.81	0.99397	D	.	0.99781	0.9506	0.96392	D	0.9929	0.99832	D	10.0	0.99176705	0.99706	D	0.963103	0.99761	D	0.948	0.98989	0.995	0.99946	E9PFC7	C61G	Gain of disorder (P = 0.0488)| Loss of stability (P = 0.105)| Gain of phosphorylation at S59 (P = 0.1362)| Loss of methylation at K56 (P = 0.1519)| Gain of glycosylation at P62 (P = 0.1609)	0.998499671764	0.99845	.	0.90513	.	0.44456	0.648884236813	0.59765	T	0.479885	0.92979	T	0.433365	0.91638	D	0.565018	0.95972	D	0.983885645866394	0.75212	D	.	0.85963	.	0.9937476	0.99925	0.9444327	0.98025	0.98292416	0.99313	0.9264142	0.96801	-14.65	0.98194	D	0.9865	0.94756	LP	0.998778029465221	0.95035	0.99978560	0.99726	0.984	0.99450	.	.	.	.	.	.	4.174515	0.62863	24.5	0.9851817078882297	0.42557	0.869181	0.78883	D	0.838128507262834	0.88357	9.572342	0.742507123425794	0.85517	8.62807	5.17	5.17	0.70808	5.61	0.95042	5.098	0.64462	11.169000	0.87924	0.667	0.69024	1.0	0.71675	1.0	0.68239	0.995	0.73271	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	4	109170	3.664010e-05	0	7	207470	3.373980e-05	0	6	236276	2.539400e-05	0	0	7152	0.000000e+00	0	0	17022	0.000000e+00	0	0	2310	0.000000e+00	0	0	9042	0.000000e+00	0	1	13390	7.468260e-05	0	3	42724	7.021810e-05	0	0	15618	0.000000e+00	0	3	42724	7.021810e-05	0	0	16132	0.000000e+00	0	0	30412	0.000000e+00	0	0	6194	0.000000e+00	0	0	13404	0.000000e+00	0	1	16718	5.981580e-05	0	6	89312	6.718020e-05	0	0	30448	0.000000e+00	0	6	89312	6.718020e-05	0	0	14822	0.000000e+00	0	0	34140	0.000000e+00	0	0	9556	0.000000e+00	0	0	17674	0.000000e+00	0	1	21614	4.626630e-05	0	5	102510	4.877570e-05	0	0	30366	0.000000e+00	0	5	102510	4.877570e-05	0	.	30	1604818	1.869370e-05	0	28	1172588	2.387880e-05	0	0	74730	0.000000e+00	0	0	912	0.000000e+00	0	0	59940	0.000000e+00	0	0	29524	0.000000e+00	0	0	44766	0.000000e+00	0	1	63978	1.563040e-05	0	0	5856	0.000000e+00	0	28	1172588	2.387880e-05	0	0	90418	0.000000e+00	0	0	10344	0	0	144	0	0	88	0	0	4314	0	0	154	0	0	616	0	0	28	0	0	98	0	0	860	0	0	4458	0	0	116	0	0	16646	0	Pathogenic	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_carcinoma|Breast_neoplasm|Ovarian_neoplasm	reviewed_by_expert_panel	NC_000017.11:g.43106487A>C	BRCA1-HCI:BRCA1_00099|ClinGen:CA001182|OMIM:113705.0002|UniProtKB:P38398#VAR_007757	C2676676|C0346153|C0027672|CN221562|C3661900|C3280442|C4554406|C0677776|C0678222|C1458155|C0919267	604370|114480|614320|617883	145|227535|140162|1333|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Gly	32700.0	single nucleotide variant	NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	28897672.0	-	RCV000019229|RCV000415051|RCV000159935|RCV000239114|RCV000047597|RCV000131902|RCV000412714|RCV001270967|RCV000785199|RCV005003390|RCV004802937	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	Breast-ovarian cancer, familial, susceptibility to, 1|Breast carcinoma|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast and/or ovarian cancer|Ovarian neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	germline;not applicable;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	43106487.0	43106487.0	17q21.31	reviewed by expert panel	59.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	OMIM:113705.0002,BRCA1-HCI:BRCA1_00099,ClinGen:CA001182,UniProtKB:P38398#VAR_007757	3.0	17661.0	43106487.0	A	C	-	-	-	-	-	-	SCV000244308	-	-	181T>G 	Cys61Gly	NM_007294.4	3.0	1_Pathogenic	86.97	0.0148148148148148	['604370', '114480', '604370', '617883', '614320']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	86.97	0.014814815	<10	70-90																																																																																																																																		true	BRCA1Cys61Gly																																																																																																																																																																																																																																		
CTCF	CTCF_Arg567Trp	-2.2467893963047323	0.05947914658227662	4.260796641789189	0.0037429098147742346	2025_01_Batch_13-14	true	true	true	false	false	true	true	false	false	false	0.9945517422062444	0.9688849199257413	0.9832958291931133	0.9305858518043898	0.8513823363851716	0.8450624249097829	0.9353934882605206	0.98291111648267	0.958814571357891	0.9929235469435809	0.8577022478605603	0.925778215348259	0.9836805419035566	0.9789552684935916	0.9961799374689079	CTCF	-2.2467893963047323	0.05947914658227662	4.260796641789189	0.0037429098147742346	2025_01_Batch_13-14	true	true	true	false	false	true	true	false	false	false	0.9945517422062444	0.9688849199257413	0.9832958291931133	0.9305858518043898	0.8513823363851716	0.8450624249097829	0.9353934882605206	0.98291111648267	0.958814571357891	0.9929235469435809	0.8577022478605603	0.925778215348259	0.9836805419035566	0.9789552684935916	0.9961799374689079	CTCF		6173		CCSBVarC010838		NC_000016.10:67628550:C:T	1699C>T	Arg567Trp																												16.0	67628550.0	C	T	16						16-67628550-C-T	94227.0	single nucleotide variant	NM_006565.4(CTCF):c.1699C>T (p.Arg567Trp)	10664.0	CTCF	HGNC:13723	Pathogenic/Likely pathogenic	1.0	Oct 04, 2024	879255516.0	-	RCV000074335|RCV000413282|RCV002260512|RCV002399425|RCV004798770	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900||MeSH:D030342,MedGen:C0950123|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided|CTCF-related syndromic intellectual disability|Inborn genetic diseases|Intellectual disability	de novo;germline;unknown	germline	GRCh38	NC_000016.10	16	67628550.0	67628550.0	16q22.1	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA10575614,UniProtKB:P49711#VAR_070776,OMIM:604167.0003	3.0	88638.0	67628550.0	C	T	-	-	-	-	-	-	SCV000491326|SCV001140119|SCV001763559|SCV002026307|SCV002540226|SCV002712444|SCV004012893|SCV005418082|SCV005420471	-	-	1699C>T 	Arg567Trp	NM_006565.4	2.0	1_Pathogenic		88638.0	16	67628550.0	C	T	R	W	rs879255516	16	67662453.0	16	66219954.0	567.0	CTCF	ENSG00000102974	ENST00000264010	ENSP00000264010	P49711	CTCF_HUMAN	c.1699C>T	p.Arg567Trp	c.1699C>T	p.Arg567Trp	principal4	Y	1	YES	Select	+	CGG	1.0	2.0	C	C/C	C/C	C/C	C/C	0.272	0.16020	T	0.032	0.53775	D	1.0	0.90580	D	0.996	0.84488	D	0.9	0.92286	A	simple_aae	10.0	90.0	0.975	0.24371	L	3.81	0.00067	N	0.871	0.86807	-0.191	0.77803	T	0.463	0.79128	T	10.0	0.45562387	0.58637	D	0.259847	0.89437	D	0.467	0.76095	0.505	0.59796	P49711	R567W	Loss of disorder (P = 0.0022)| Gain of catalytic residue at M570 (P = 0.0054)| Loss of ubiquitination at K562 (P = 0.0595)| Loss of glycosylation at T565 (P = 0.062)| Gain of MoRF binding (P = 0.0672)	0.924862249397	0.92352	.	0.85423	1.77042804158	0.91237	0.938079476357	0.99381	D	0.337032	0.70472	T	0.299086	0.82769	D	0.19184	0.82547	D	0.758090436458588	0.43448	D	.	0.72299	.	0.34531498	0.56370	0.20212594	0.44068	0.21461935	0.43549	0.19353762	0.42778	-8.437	0.81389	D	.	0.88398	.	0.977421928894321	0.84724	0.93024755	0.92403	0.348	0.60781	.	.	.	.	.	.	5.827689	0.93734	33.0	0.9991287887003651	0.98168	0.650883	0.62348	D	0.233022080859582	0.52570	3.452482	0.364610182935106	0.59176	4.116707	5.72	5.72	0.89363	2.48	0.45773	3.487	0.53079	3.253000	0.37120	0.599	0.40292	0.997	0.40243	0.999	0.35501	0.998	0.85369	53	0.97599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Inborn_genetic_diseases|CTCF-related_syndromic_intellectual_disability|not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67628550C>T	ClinGen:CA10575614|OMIM:604167.0003|UniProtKB:P49711#VAR_070776	C0950123|C3661900|C3809686	615502	363611	.	Arg	Trp	94227.0	single nucleotide variant	NM_006565.4(CTCF):c.1699C>T (p.Arg567Trp)	10664.0	CTCF	HGNC:13723	Pathogenic/Likely pathogenic	1.0	Oct 04, 2024	879255516.0	-	RCV000074335|RCV000413282|RCV002260512|RCV002399425|RCV004798770	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900||MeSH:D030342,MedGen:C0950123|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided|CTCF-related syndromic intellectual disability|Inborn genetic diseases|Intellectual disability	de novo;germline;unknown	germline	GRCh38	NC_000016.10	16	67628550.0	67628550.0	16q22.1	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA10575614,UniProtKB:P49711#VAR_070776,OMIM:604167.0003	3.0	88638.0	67628550.0	C	T	-	-	-	-	-	-	SCV000491326|SCV001140119|SCV001763559|SCV002026307|SCV002540226|SCV002712444|SCV004012893|SCV005418082|SCV005420471	-	-	1699C>T 	Arg567Trp	NM_006565.4	2.0	1_Pathogenic	82.48	0.6693548387096774	['615502']	unknown		0	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	82.48	0.66935486	10-90	70-90						R	166			82.48	Positively-charged	Arginine		Transcriptional repressor CTCF										-4.5								R567-A571; PAE: 1.5	4 interactions	R567-F555, R567-A571; PAE: 3.0, 1.5	6 interactions							175									-55.5				-43.1				dbSNP: rs879255516; Variant type: LP/P; AA change: Arg567Trp; PTM type: Phosphorylation; PTM morphology: CGKTFtRR*NTM; Var class: II&rs879255516		H (helix)	H (α-helix)	Helix										C2H2-type 11; atypical																																																									true	CTCFArg567Trp																																																																																																																																																																																																																																		
LMNA	LMNA_Leu162Pro	-3.3189154883621836	0.012784044679513561	-3.875594822687866	0.006087518771187429	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9327170629756176	0.7980878497009543	0.9032841792924695	0.878519885397369	0.8432772981546591	0.8736470722150931	0.8836403304174143	0.88339887378602	0.8122503904346556	0.9295726105636404	0.8129075240942252	0.8733994403773238	0.9231694847989189	0.7839253089672528	0.935861515387595	LMNA	-3.3189154883621836	0.012784044679513561	-3.875594822687866	0.006087518771187429	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9327170629756176	0.7980878497009543	0.9032841792924695	0.878519885397369	0.8432772981546591	0.8736470722150931	0.8836403304174143	0.88339887378602	0.8122503904346556	0.9295726105636404	0.8129075240942252	0.8733994403773238	0.9231694847989189	0.7839253089672528	0.935861515387595	LMNA	ENSG00000160789	3903	7240.0	CCSBVarC000579	ALE00000579	NC_000001.11:156130745:T:C	485T>C	Leu162Pro	RC4	RC4_Mut_GDEh1027	A01	GDEhDisVCh_40057	E12	1.0	RC4_Mut_GDDh1027	A01							1.0	2.0	1.0	7.0	0.0			0.0			0.0			1.0	156130745.0	T	C	1	Y	Y	N	N	N	1-156130745-T-C	57232.0	single nucleotide variant	NM_170707.4(LMNA):c.485T>C (p.Leu162Pro)	4000.0	LMNA	HGNC:6636	Likely pathogenic	1.0	Apr 02, 2009	267607594.0	-	RCV000041352|RCV000057410	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900	Primary dilated cardiomyopathy|not provided	germline	germline	GRCh38	NC_000001.11	1	156130745.0	156130745.0	1q22	no assertion criteria provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018144	2.0	48068.0	156130745.0	T	C	-	-	-	-	-	-	SCV000065045	-	-	485T>C 	Leu162Pro	NM_170707.4		1_Pathogenic		48068.0	1	156130745.0	T	C	L	P	rs267607594	1	156100536.0	1	154367160.0	162.0	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.485T>C	p.Leu162Pro	c.485T>C	p.Leu162Pro	principal1	Y	1	YES	Select	+	CTG	2.0	0.0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.033	0.70891	D	0.899	0.66535	P	0.701	0.71005	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.525	0.92921	H	-4.21	0.78753	D	0.649	0.88009	0.9396	0.9623	D	0.8568	0.95221	D	10.0	0.98645115	0.98945	D	0.700292	0.97542	D	0.855	0.95533	0.872	0.96404	P02545	L162P	Loss of stability (P = 0.0302)| Loss of catalytic residue at L162 (P = 0.1798)| Loss of MoRF binding (P = 0.2541)| Gain of methylation at R166 (P = 0.2594)| Gain of glycosylation at L162 (P = 0.618)	0.97668052646	0.97620	0.9799140373469903	0.97973	2.28727837	0.96349	0.738907754421	0.72764	T	0.97322	0.99722	D	0.467231	0.93175	D	0.433368	0.9309	D	0.994527041912079	0.8575	D	0.922208	0.75543	D	0.91780204	0.92932	0.88798314	0.94044	0.89284736	0.90622	0.90807116	0.95490	-16.821	0.98755	D	0.9901	0.93613	P	0.996923279603381	0.92597	0.99995673	0.99965	0.965	0.98576	.	.	.	.	.	.	4.84313	0.79131	27.0	0.9990229769305947	0.97352	0.974602	0.99567	D	0.755506102375548	0.83173	7.971851	0.697166544701107	0.82066	7.699593	5.59	5.59	0.84656	5.37	0.93424	6.268	0.72593	7.897000	0.73388	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.286	0.24211	447	0.79601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Primary_dilated_cardiomyopathy	no_assertion_criteria_provided	NC_000001.11:g.156130745T>C	ClinGen:CA018144	C3661900|C0007193	.	217604	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	57232.0	single nucleotide variant	NM_170707.4(LMNA):c.485T>C (p.Leu162Pro)	4000.0	LMNA	HGNC:6636	Likely pathogenic	1.0	Apr 02, 2009	267607594.0	-	RCV000041352|RCV000057410	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900	Primary dilated cardiomyopathy|not provided	germline	germline	GRCh38	NC_000001.11	1	156130745.0	156130745.0	1q22	no assertion criteria provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018144	2.0	48068.0	156130745.0	T	C	-	-	-	-	-	-	SCV000065045	-	-	485T>C 	Leu162Pro	NM_170707.4		1_Pathogenic	96.21	0.5792682926829268		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		96.21	0.5792683	10-90	>90						L	95			96.21	Aliphatic	Leucine		Prelamin-A/C; Lamin-A/C							IF rod			3.8								L162-L158, L162-R166; PAE: 1.0, 1.0	3 interactions	L162-L158, L162-R166; PAE: 1.0, 1.0	3 interactions							131									-63.2				-38.1	Coil 1B					H (helix)	H (α-helix)	Helix																																																																			true	LMNALeu162Pro																																																																																																																																																																																																																																		
FARS2	FARS2_Tyr144Cys	-0.31983357585618055	1.0	-0.9424771139167271	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6540403889373589	0.564559876833752	0.7629310530059639	0.6866797497826191	0.6967186925767608	0.6419072422105627	0.7236909392375388	0.7433070910902596	0.4927485261018876	0.6679936181015709	0.7515301429429588	0.6496685603276995	0.782555014921668	0.6363712275656164	0.6400871597731469	FARS2	-0.31983357585618055	1.0	-0.9424771139167271	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6540403889373589	0.564559876833752	0.7629310530059639	0.6866797497826191	0.6967186925767608	0.6419072422105627	0.7236909392375388	0.7433070910902596	0.4927485261018876	0.6679936181015709	0.7515301429429588	0.6496685603276995	0.782555014921668	0.6363712275656164	0.6400871597731469	FARS2		12653		CCSBVarC011920		NC_000006.12:5369001:A:G	431A>G	Tyr144Cys																												6.0	5369001.0	A	G	6						6-5369001-A-G	48423.0	single nucleotide variant	NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Mar 25, 2024	397514610.0	-	RCV000033044|RCV000497519|RCV000162158	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900|Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,Human Phenotype Ontology:HP:0025356,MedGen:C0557874;MONDO:MONDO:0004675,MedGen:C0162666	Combined oxidative phosphorylation defect type 14|not provided|Global developmental delay;Mitochondrial encephalomyopathy	germline;inherited	germline	GRCh38	NC_000006.12	6	5369001.0	5369001.0	6p25.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA130596,UniProtKB:O95363#VAR_069487,OMIM:611592.0001	3.0	39824.0	5369001.0	A	G	-	-	-	-	-	-	SCV000589666|SCV000845708|SCV001389842|SCV005038812	-	-	431A>G 	Tyr144Cys	NM_006567.5	2.0	1_Pathogenic		39824.0	6	5369001.0	A	G	Y	C	rs397514610	6	5369234.0	6	5314233.0	144.0	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.431A>G	p.Tyr144Cys	c.431A>G	p.Tyr144Cys	principal1	Y	1	.	.	+	TAT	2.0	0.0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.145	0.97505	H	-8.24	0.96895	D	0.886	0.88450	0.1109	0.84306	D	0.465	0.79239	T	10.0	0.94212466	0.93464	D	0.137269	0.81925	D	0.703	0.89285	0.815	0.92954	O95363	Y144C	Loss of phosphorylation at Y144 (P = 0.0287)| Loss of methylation at K140 (P = 0.0513)| Loss of disorder (P = 0.0822)| Loss of ubiquitination at K140 (P = 0.0949)| Loss of stability (P = 0.1997)	0.912760158171	0.91122	0.8535715990371623	0.85230	0.75116851782	0.63550	0.795505642891	0.81246	T	0.548925	0.84551	D	0.377045	0.88436	D	0.303823	0.8829	D	0.999801814556122	0.99082	D	.	0.88094	.	0.9363221	0.94794	0.7782626	0.86759	0.9463944	0.95835	0.72315854	0.83457	-11.22	0.80911	D	0.5541	0.66907	A	0.999742363997179	0.97751	0.96441020	0.94252	1	0.99985	.	.	.	.	.	.	4.621909	0.73447	26.0	0.9984046209812032	0.92063	0.879351	0.80452	D	0.824854143750858	0.87566	9.286241	0.715026058591333	0.83429	8.04306	5.38	4.2	0.48755	2.35	0.43917	7.079	0.76566	7.903000	0.73696	0.756	0.943	1.0	0.71675	0.999	0.35501	0.995	0.73271	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	1614150	4.336650e-06	0	1	6062	1.649620e-04	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29606	0.000000e+00	0	2	44878	4.456530e-05	0	0	64024	0.000000e+00	0	1	6062	1.649620e-04	0	1	1180020	8.474430e-07	0	2	91080	2.195870e-05	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic/Likely_pathogenic	Global_developmental_delay|Mitochondrial_encephalomyopathy|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5369001A>G	ClinGen:CA130596|OMIM:611592.0001|UniProtKB:O95363#VAR_069487	C0557874|C0162666|C3661900|C4755312	614946	319519	Phenylalanyl-tRNA synthetase	Tyr	Cys	48423.0	single nucleotide variant	NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Mar 25, 2024	397514610.0	-	RCV000033044|RCV000497519|RCV000162158	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900|Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,Human Phenotype Ontology:HP:0025356,MedGen:C0557874;MONDO:MONDO:0004675,MedGen:C0162666	Combined oxidative phosphorylation defect type 14|not provided|Global developmental delay;Mitochondrial encephalomyopathy	germline;inherited	germline	GRCh38	NC_000006.12	6	5369001.0	5369001.0	6p25.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA130596,UniProtKB:O95363#VAR_069487,OMIM:611592.0001	3.0	39824.0	5369001.0	A	G	-	-	-	-	-	-	SCV000589666|SCV000845708|SCV001389842|SCV005038812	-	-	431A>G 	Tyr144Cys	NM_006567.5	2.0	1_Pathogenic	98.45	0.0135135135135135	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	98.45	0.013513514	<10	>90						Y	3			98.45	Aromatic	Tyrosine												-1.3								Y144-D383, Y144-L152; PAE: 1.5, 1.0	10 interactions	Y144-L152, Y144-R179, Y144-R180; PAE: 1.0, 1.0, 1.0	15 interactions							181									-92.9				94.7						C (loop/coil)	C (loop/coil)																																																																				true	FARS2Tyr144Cys																																																																																																																																																																																																																																		
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9647820375065654	0.7933671429751604	0.8891697926871742	0.862934201513075	0.7257446508839096	0.7565656990470252	0.8617514493114371	0.9085594111787956	0.8213537820014284	0.962275331505049	0.694923602720794	0.8641169537147129	0.869780174195553	0.7653805039488925	0.9672887435080819	F9	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9647820375065654	0.7933671429751604	0.8891697926871742	0.862934201513075	0.7257446508839096	0.7565656990470252	0.8617514493114371	0.9085594111787956	0.8213537820014284	0.962275331505049	0.694923602720794	0.8641169537147129	0.869780174195553	0.7653805039488925	0.9672887435080819	F9	ENSG00000101981	52861	204371.0	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561566.0	G	A	X	Y	N	N	N	N	X-139561566-G-A	25641.0	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Nov 01, 2024	137852249.0	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566.0	139561566.0	Xq27.1	reviewed by expert panel	11.0	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3.0	10602.0	139561566.0	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3.0	1_Pathogenic	1.82809e-6	10602.0	X	139561566.0	G	A	R	Q	rs137852249	X	138643725.0	X	138471391.0	294.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.32	0.87825	D	0.8304	0.943	D	10.0	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.9993707844163529	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.0	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641.0	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Nov 01, 2024	137852249.0	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566.0	139561566.0	Xq27.1	reviewed by expert panel	11.0	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3.0	10602.0	139561566.0	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3.0	1_Pathogenic	97.66	0.1290322580645161	['306900', '300807', '306900', '306700']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; HEMOPHILIA A	97.66	0.12903225	10-90	>90						R	32			97.66	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-4.5								R294-P324, R294-V277; PAE: 1.0, 1.0	5 interactions	R294-V277; PAE: 1.0	7 interactions							175									-139.5				136.9						B (undefined)	E (parallel sheets)	Beta strand																													0.178		0.112		0.14		0.114		0.106																														true	F9Arg294Gln																																																																																																																																																																																																																																		
F9	F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.59988145327602	0.4869292389792154	0.6405399452709002	0.5904111027576255	0.5423774158894656	0.6558178130219405	0.6025004035799757	0.6591622700607214	0.5756913680537931	0.5698035918988065	0.42893701875699064	0.5783218019352754	0.6219176204810789	0.3981671099046378	0.6299593146532336	F9	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.59988145327602	0.4869292389792154	0.6405399452709002	0.5904111027576255	0.5423774158894656	0.6558178130219405	0.6025004035799757	0.6591622700607214	0.5756913680537931	0.5698035918988065	0.42893701875699064	0.5783218019352754	0.6219176204810789	0.3981671099046378	0.6299593146532336	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A	679G>A	Val227Ile																												23.0	139551220.0	G	A	X						X-139551220-G-A	1602531.0	single nucleotide variant	NM_000133.4(F9):c.679G>A (p.Val227Ile)	2158.0	F9	HGNC:3551	Benign	0.0	Nov 02, 2020	137852242.0	-	RCV002127085	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551220.0	139551220.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10529819	2.0	1596936.0	139551220.0	G	A	-	-	-	-	-	-	SCV002408526	-	-	679G>A 	Val227Ile	NM_000133.4	1.0	2_Benign		1596936.0	X	139551220.0	G	A	V	I	rs137852242	X	138633379.0	X	138461045.0	227.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.679G>A	p.Val227Ile	c.679G>A	p.Val227Ile	principal1	Y	1	YES	Select	+	GTT	1.0	0.0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.002	0.06938	B	0.05	0.16373	N	simple_aae	95.0	5.0	-0.745	0.01745	N	0.55	0.02974	N	0.111	0.10159	-0.7209	0.59247	T	0.2776	0.64798	T	10.0	0.39294234	0.54669	D	0.621022	0.96713	D	0.260	0.57011	0.63	0.76495	P00740	V227I	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.643927873118	0.63820	0.9149323540622197	0.91414	0.556390487147	0.52008	0.328283965588	0.14662	T	0.268576	0.63869	T	-0.334459	0.05599	T	-0.469894	0.25179	T	0.0151561946545469	0.00329	T	0.725427	0.40678	T	0.15264371	0.34352	0.11417206	0.27496	0.15264371	0.34352	0.11417206	0.27495	-1.977	0.03887	T	0.0705	0.07209	B	0.115496154533624	0.44646	0.99916210	0.99185	0.219	0.48537	.	.	.	.	.	.	-0.434396	0.02094	0.194	0.24669674744976147	0.01097	.	.	.	.	.	.	.	.	.	5.31	0.512	0.16159	0.0673	0.22013	-0.416	0.07178	-0.575000	0.08443	0.676	0.76753	0.012	0.18747	0.0	0.08389	0.969	0.5403	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	5	80344	6.223240e-05	0	9	151854	5.926750e-05	0	12	172253	6.966500e-05	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	5	30956	1.615200e-04	0	0	9951	0.000000e+00	0	5	30956	1.615200e-04	0	0	13134	0.000000e+00	0	0	24393	0.000000e+00	0	0	4649	0.000000e+00	0	0	10127	0.000000e+00	0	0	12192	0.000000e+00	0	9	64659	1.391920e-04	0	0	19074	0.000000e+00	0	9	64659	1.391920e-04	0	0	12064	0.000000e+00	0	0	27171	0.000000e+00	0	0	7083	0.000000e+00	0	0	13318	0.000000e+00	0	0	15997	0.000000e+00	0	12	73464	1.633450e-04	0	0	19009	0.000000e+00	0	12	73464	1.633450e-04	0	.	15	1211372	1.238270e-05	0	14	895405	1.563540e-05	0	0	57663	0.000000e+00	0	0	687	0.000000e+00	0	0	45983	0.000000e+00	0	0	22042	0.000000e+00	0	0	33840	0.000000e+00	0	0	46797	0.000000e+00	0	0	4355	0.000000e+00	0	14	895405	1.563540e-05	0	0	56953	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551220G>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	1602531.0	single nucleotide variant	NM_000133.4(F9):c.679G>A (p.Val227Ile)	2158.0	F9	HGNC:3551	Benign	0.0	Nov 02, 2020	137852242.0	-	RCV002127085	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551220.0	139551220.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10529819	2.0	1596936.0	139551220.0	G	A	-	-	-	-	-	-	SCV002408526	-	-	679G>A 	Val227Ile	NM_000133.4	1.0	2_Benign	47.5	0.0845070422535211	['306900', '300807']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	47.5	0.08450704	<10	<=50						V	12			47.5	Aliphatic	Valine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			4.2									2 interactions		6 interactions							117									-124.5				159.0						B (undefined)	B (beta bridge)					Cleavage; by factor XIa																									1.008		1.01		1.006		1.006		1.001																														true	F9Val227Ile																																																																																																																																																																																																																																		
RAD51D	RAD51D_Arg165Gln	0.47586595548630994	1.0	3.8063421461726854	0.4404648365303642	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9415987379931244	0.8392059140560219	0.8973812732443798	0.8646914671029955	0.8741681374898789	0.8167428149144145	0.8087444747462854	0.8498909586148119	0.8059725835278194	0.9222728431096141	0.9315934600653433	0.9206384594597057	0.9448715878739475	0.8724392445842243	0.9609246328766348	RAD51D	0.47586595548630994	1.0	3.8063421461726854	0.4404648365303642	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9415987379931244	0.8392059140560219	0.8973812732443798	0.8646914671029955	0.8741681374898789	0.8167428149144145	0.8087444747462854	0.8498909586148119	0.8059725835278194	0.9222728431096141	0.9315934600653433	0.9206384594597057	0.9448715878739475	0.8724392445842243	0.9609246328766348	RAD51D	ENSG00000185379	7201	900197.0	CCSBVarC002917	ALE00002917	NC_000017.11:35106468:C:T	494G>A	Arg165Gln	RC4	NatVar_GDE_001	F05	GDEhDisVCh_40046	E03	2.0					VUSMutpDEST2_06	G01	VUSmut_GDEh12	E02	1.0	1.0	0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	17.0	35106468.0	C	T	17	Y	N	N	Y	Y	17-35106468-C-T	151873.0	single nucleotide variant	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	5892.0	RAD51D	HGNC:9823	Benign	0.0	Feb 04, 2025	4796033.0	-	RCV000131069|RCV000245575|RCV000409134|RCV001705932	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35106468.0	35106468.0	17q12	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	2.0	142159.0	35106468.0	C	T	-	-	-	-	-	-	SCV000185999|SCV000292088|SCV000309255|SCV000488799|SCV000884439|SCV001440195|SCV001717669|SCV001841070|SCV004044159|SCV005253873	-	-	494G>A 	Arg165Gln	NM_002878.4	2.0	2_Benign	0.14061	142159.0	17	35106468.0	C	T	R	Q	rs4796033	17	33433487.0	17	30457600.0	165.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.494G>A	p.Arg165Gln	c.494G>A	p.Arg165Gln	principal1	Y	5	.	.	-	CGG	2.0	0.0	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	1.0	0.01173	T	0.0	0.14667	B	0.001	0.04348	B	0.01	0.13669	P	simple_aae	99.0	1.0	-1.43	0.00575	N	-3.12	0.63808	D	0.019	0.15800	-1.0318	0.19845	T	0.0001	0.00038	T	9.0	0.0022848845	0.00033	T	.	.	.	0.127	0.34681	.	.	.	.	.	.	.	.	0.04975	.	0.41278	.	.	.	0.074496	0.34695	T	-0.647874	0.00072	T	-0.559582	0.16122	T	0.0074258539368577	0.00085	T	0.740726	0.35767	T	0.029415702	0.02411	0.048267353	0.07149	0.029415702	0.02411	0.048267353	0.07148	3.206	0.12431	T	0.057	0.00818	B	2.61638337411342e-05	0.01340	0.02316738	0.51051	0.078	0.22017	.	.	.	.	.	.	1.452401	0.18765	13.9	0.9147050559477902	0.20995	0.077101	0.15335	N	-1.06674822980265	0.07176	0.3368571	-0.830017416971714	0.13532	0.7160679	4.96	0.253	0.14768	1.12	0.30289	1.179	0.31705	0.032000	0.13801	-0.169	0.1135	1.0	0.71675	0.963	0.29478	0.96	0.51684	917	0.20141	476	0.0950479233226837	18	0.01361573373676248	130	0.12922465208747516	153	0.22046109510086456	41	0.040674603174603176	134	0.13701431492842536	31713	264690	0.119811855	.	17045	107270	1.588980e-01	1699	31945	204674	1.560770e-01	3152	36543	232850	1.569380e-01	3557	180	6652	2.705950e-02	1	5012	16850	2.974480e-01	784	395	2196	1.798720e-01	42	413	9024	4.576680e-02	8	2281	13332	1.710920e-01	204	6003	41956	1.430780e-01	432	2481	15384	1.612710e-01	210	5012	16850	2.974480e-01	784	458	15532	2.948750e-02	12	9035	30024	3.009260e-01	1451	1134	6024	1.882470e-01	111	564	13384	4.213990e-02	6	2827	16654	1.697490e-01	255	12341	88222	1.398860e-01	860	4896	30022	1.630800e-01	411	9035	30024	3.009260e-01	1451	409	14258	2.868570e-02	9	9971	33746	2.954720e-01	1567	1778	9368	1.897950e-01	174	815	17666	4.613380e-02	15	3630	21494	1.688840e-01	330	14237	100834	1.411920e-01	990	4879	29942	1.629480e-01	407	9971	33746	2.954720e-01	1567	.	223574	1611192	1.387630e-01	17336	15964	59646	2.676460e-01	2333	2280	74974	3.041050e-02	55	100	912	1.096490e-01	6	15964	59646	2.676460e-01	2333	5762	29446	1.956800e-01	582	1940	44876	4.323020e-02	36	10732	63890	1.679760e-01	897	779	6052	1.287180e-01	57	162928	1178350	1.382680e-01	11455	14721	90614	1.624580e-01	1305	47230	333254	0.14172373024779897	6	594	0.010101010101010102	215	5014	0.04287993617869964	636	15964	0.03983963918817339	182	1488	0.12231182795698925	1955	7246	0.2698040298095501	99	1968	0.05030487804878049	864	5226	0.1653272101033295	3257	24004	0.13568571904682553	642	16558	0.03877279864717961	314	6982	0.04497278716700086	54444	394758	0.1379174076269512	Benign	not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35106468C>T	ClinGen:CA167606|UniProtKB:O75771#VAR_020561	CN169374|C3661900|C3280345|C0027672	614291	145|140162	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Arg	Gln	151873.0	single nucleotide variant	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	5892.0	RAD51D	HGNC:9823	Benign	0.0	Feb 04, 2025	4796033.0	-	RCV000131069|RCV000245575|RCV000409134|RCV001705932	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35106468.0	35106468.0	17q12	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	2.0	142159.0	35106468.0	C	T	-	-	-	-	-	-	SCV000185999|SCV000292088|SCV000309255|SCV000488799|SCV000884439|SCV001440195|SCV001717669|SCV001841070|SCV004044159|SCV005253873	-	-	494G>A 	Arg165Gln	NM_002878.4	2.0	2_Benign	95.74	0.7298387096774194	['614291']	autosomal dominant	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	95.74	0.7298387	10-90	>90	1.7229351826167216	Uncertain	Increase			R	181			95.74	Positively-charged	Arginine		DNA repair protein RAD51 homolog 4										-4.5				5 interactions				R165-A161; PAE: 1.0	3 interactions	R165-A161; PAE: 1.0	4 interactions							175									-62.8				-29.4						H (helix)	H (α-helix)	Helix																																																																			true	RAD51DArg165Gln																																																																																																																																																																																																																																		
FARS2	FARS2_Arg419Cys	1.6552138932581775	1.0	-1.28234935661335	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7382035880743057	0.5561344521855118	0.7125868053900762	0.7076254559815107	0.6884941478045885	0.7332088438429117	0.67991349779559	0.6559214897792586	0.6525787544082512	0.6942451587201367	0.6437794517662652	0.7353374141674315	0.7692521210008939	0.45969014996277247	0.7821620174284748	FARS2	1.6552138932581775	1.0	-1.28234935661335	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7382035880743057	0.5561344521855118	0.7125868053900762	0.7076254559815107	0.6884941478045885	0.7332088438429117	0.67991349779559	0.6559214897792586	0.6525787544082512	0.6942451587201367	0.6437794517662652	0.7353374141674315	0.7692521210008939	0.45969014996277247	0.7821620174284748	FARS2		12653		CCSBVarC011932		NC_000006.12:5771328:C:T	1255C>T	Arg419Cys																												6.0	5771328.0	C	T	6						6-5771328-C-T	211261.0	single nucleotide variant	NM_006567.5(FARS2):c.1255C>T (p.Arg419Cys)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Jan 29, 2025	775690041.0	-	RCV000197201|RCV000578139|RCV001378476	MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5771328.0	5771328.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA321645,OMIM:611592.0006	3.0	214336.0	5771328.0	C	T	-	-	-	-	-	-	SCV000251376|SCV000845719|SCV001576048	-	-	1255C>T 	Arg419Cys	NM_006567.5	2.0	1_Pathogenic		214336.0	6	5771328.0	C	T	R	C	rs775690041	6	5771561.0	6	5716560.0	419.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1255C>T	p.Arg419Cys	c.1255C>T	p.Arg419Cys	principal1	Y	1	YES	Select	+	CGC	1.0	0.0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.995	0.83178	D	0.94	0.94378	A	simple_aae	6.0	94.0	3.715	0.94651	H	-7.26	0.94393	D	0.932	0.99026	0.6632	0.92683	D	0.7452	0.91281	D	10.0	0.928861	0.92141	D	0.349699	0.92219	D	0.945	0.98886	0.723	0.85693	O95363	R419C	Loss of MoRF binding (P = 5e-04)| Loss of disorder (P = 0.0261)| Gain of catalytic residue at E422 (P = 0.0714)| Gain of sheet (P = 0.0827)| Loss of phosphorylation at T417 (P = 0.1046)	0.955839850528	0.95499	.	0.77993	.	0.65239	0.68183016777	0.64473	T	0.810547	0.95222	D	0.348511	0.86306	D	0.35969	0.90625	D	0.998910188674927	0.95528	D	0.995867	0.98584	D	0.9438368	0.95571	0.897082	0.94697	0.92678815	0.93825	0.8879299	0.94041	-10.535	0.77122	D	0.2542	0.50506	B	0.98820251721525	0.87710	0.97777240	0.95306	0.994	0.99793	.	.	.	.	.	.	5.901953	0.94011	33.0	0.9993755186479938	0.99661	0.856660	0.77309	D	0.97565369231617	0.94917	13.17435	0.915579723915553	0.96194	14.4338	5.81	5.81	0.92402	.	.	6.805	0.75041	7.527000	0.59919	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.964	0.52647	964	0.07711	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	2	109402	1.828120e-05	0	2	207842	9.622690e-06	0	3	236614	1.267890e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	1	15690	6.373490e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6208	0.000000e+00	0	0	13414	0.000000e+00	0	0	16730	0.000000e+00	0	1	89280	1.120070e-05	0	1	30606	3.267330e-05	0	1	30606	3.267330e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	2	102430	1.952550e-05	0	1	30524	3.276110e-05	0	1	30524	3.276110e-05	0	.	33	1614088	2.044500e-05	0	28	1180044	2.372790e-05	0	1	74938	1.334440e-05	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29604	0.000000e+00	0	0	44888	0.000000e+00	0	0	64038	0.000000e+00	0	0	6084	0.000000e+00	0	28	1180044	2.372790e-05	0	2	91084	2.195780e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic/Likely_pathogenic	Hereditary_spastic_paraplegia_77|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5771328C>T	ClinGen:CA321645|OMIM:611592.0006	C5569007|C3661900|C4755312	617046|614946	466722|319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Arg	Cys	211261.0	single nucleotide variant	NM_006567.5(FARS2):c.1255C>T (p.Arg419Cys)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Jan 29, 2025	775690041.0	-	RCV000197201|RCV000578139|RCV001378476	MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5771328.0	5771328.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA321645,OMIM:611592.0006	3.0	214336.0	5771328.0	C	T	-	-	-	-	-	-	SCV000251376|SCV000845719|SCV001576048	-	-	1255C>T 	Arg419Cys	NM_006567.5	2.0	1_Pathogenic	96.95	0.1612903225806451	['617046', '614946']	unknown		0	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	96.95	0.16129032	10-90	>90						R	40			96.95	Positively-charged	Arginine									FDX-ACB	0.1701		-4.5								R419-R330, R419-L392, R419-Y360, R419-E394; PAE: 1.5, 1.0, 1.5, 1.0	13 interactions	R419-A362, R419-Y360, R419-L392, R419-E394; PAE: 1.0, 1.5, 1.0, 1.0	17 interactions	R419-E394; PAE: 1.0	8 interactions					175									-150.5		Pocket 4: Mean pLDDT: 91.52, Volume: 344.54 Å³, Druggability score: 0.17		119.6						C (loop/coil)	C (loop/coil)																																																																				true	FARS2Arg419Cys																																																																																																																																																																																																																																		
BRAF	BRAF_Gln257Arg	-4.0967768173781565	0.004591621866850185	-0.4372464292354162	0.6751046251185971	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7957457357363789	0.6507074338689429	0.7174565404494718	0.7345770876640116	0.7080085259563943	0.7356388350237879	0.7482928419550411	0.7098961831331446	0.614278519703086	0.8074035000113406	0.6803782168890007	0.7208613333729822	0.725016897765799	0.6871363480348	0.784087971461417	BRAF	-4.0967768173781565	0.004591621866850185	-0.4372464292354162	0.6751046251185971	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7957457357363789	0.6507074338689429	0.7174565404494718	0.7345770876640116	0.7080085259563943	0.7356388350237879	0.7482928419550411	0.7098961831331446	0.614278519703086	0.8074035000113406	0.6803782168890007	0.7208613333729822	0.725016897765799	0.6871363480348	0.784087971461417	BRAF	ENSG00000157764	71969	220590.0	CCSBVarC003156	ALE00003156	NC_000007.14:140801502:T:C	770A>G	Gln257Arg	CEGS2	CegsMutGDEh1027	G07	GDEhDisVCh_40058	D10	2.0									1.0	2.0	0.0		0.0			0.0			0.0			7.0	140801502.0	T	C	7	Y	N	N	N	N	7-140801502-T-C	29012.0	single nucleotide variant	NM_004333.6(BRAF):c.770A>G (p.Gln257Arg)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Apr 03, 2017	180177035.0	-	RCV000015007|RCV000033289|RCV000080904|RCV000208766|RCV001027771|RCV001261967|RCV001329219|RCV001813208|RCV001813744|RCV004752707|RCV004018628|RCV003224098	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500;MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648;MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648||MedGen:CN230736|6 conditions	Cardiofaciocutaneous syndrome 1|RASopathy|not provided|Cardio-facio-cutaneous syndrome|LEOPARD syndrome 3;Noonan syndrome 7;Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1|BRAF-related disorder|Cardiovascular phenotype|6 conditions	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801502.0	140801502.0	7q34	reviewed by expert panel	33.0	-	N	ClinGen:CA222583,UniProtKB:P15056#VAR_026114,OMIM:164757.0013	3.0	13973.0	140801502.0	T	C	-	-	-	-	-	-	SCV000616360	-	-	770A>G 	Gln257Arg	NM_004333.6	3.0	1_Pathogenic	6.84148e-7	13973.0	7	140801502.0	T	C	Q	R	rs180177035	7	140501302.0	7	140147771.0	257.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.770A>G	p.Gln257Arg	c.770A>G	p.Gln257Arg	principal4	Y	.	YES	Select	-	CAG	2.0	0.0	T	./.	./.	./.	./.	.	0.48802	.	.	0.24199	.	0.959	0.55150	D	0.626	0.51596	P	.	0.94956	.	.	.	.	3.07	0.86962	M	.	0.25939	.	.	0.91737	1.0162	0.97459	D	0.8814	0.96054	D	9.0	0.962993	0.95685	D	0.23991	0.88624	D	.	0.94900	0.914	0.98337	P15056	Q257R	Gain of MoRF binding (P = 0.0136)| Loss of helix (P = 0.0376)| Loss of sheet (P = 0.0457)| Gain of loop (P = 0.0502)| Loss of ubiquitination at K253 (P = 0.0525)	.	0.99132	.	0.99541	.	0.81887	0.876263439655	0.93441	D	0.758931	0.93394	D	0.497157	0.94149	D	0.476355	0.94072	D	0.946888327598572	0.62335	D	0.937906	0.77715	D	0.8394073	0.86387	0.6523551	0.79429	0.8253214	0.85393	0.65886503	0.79796	-13.31	0.90620	D	0.9831	0.93940	P	0.984355110891765	0.86463	0.99508744	0.97698	0.646	0.80291	.	.	.	.	.	.	4.989844	0.82746	27.9	0.9982895054652174	0.91119	0.858490	0.77519	D	0.801626318931521	0.86133	8.812097	0.761899469924724	0.86971	9.087886	5.43	5.43	0.78977	.	.	7.971	0.87647	7.808000	0.69392	0.661	0.55789	1.0	0.71675	1.0	0.68239	0.997	0.79771	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Cardiofaciocutaneous_syndrome_1|Noonan_syndrome_7|LEOPARD_syndrome_3|Cardio-facio-cutaneous_syndrome|Lung_cancer|Colorectal_cancer|Melanoma,_cutaneous_malignant,_susceptibility_to,_1|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype|RASopathy|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140801502T>C	ClinGen:CA222583|OMIM:164757.0013|UniProtKB:P15056#VAR_026114	CN029449|C3150970|C3150971|C1275081|C0242379|C0346629|C1835047|C4551602|C5681679|CN230736|C5555857|C3661900	115150|613706|613707|PS115150|211980|114500|155600|163950	1340|648|500|1340|618|648|98733|536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Gln	Arg	29012.0	single nucleotide variant	NM_004333.6(BRAF):c.770A>G (p.Gln257Arg)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Apr 03, 2017	180177035.0	-	RCV000015007|RCV000033289|RCV000080904|RCV000208766|RCV001027771|RCV001261967|RCV001329219|RCV001813208|RCV001813744|RCV004752707|RCV004018628|RCV003224098	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500;MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648;MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648||MedGen:CN230736|6 conditions	Cardiofaciocutaneous syndrome 1|RASopathy|not provided|Cardio-facio-cutaneous syndrome|LEOPARD syndrome 3;Noonan syndrome 7;Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1|BRAF-related disorder|Cardiovascular phenotype|6 conditions	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801502.0	140801502.0	7q34	reviewed by expert panel	33.0	-	N	ClinGen:CA222583,UniProtKB:P15056#VAR_026114,OMIM:164757.0013	3.0	13973.0	140801502.0	T	C	-	-	-	-	-	-	SCV000616360	-	-	770A>G 	Gln257Arg	NM_004333.6	3.0	1_Pathogenic	88.5	0.5858585858585859	['115150', '613707', '613706', '115150', '613706', '613707', '163950']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1; LEOPARD SYNDROME 3; NOONAN SYNDROME 7; CARDIOFACIOCUTANEOUS SYNDROME 1; NOONAN SYNDROME 7; LEOPARD SYNDROME 3; NOONAN SYNDROME 1	88.5	0.5858586	10-90	70-90						Q	116			88.5	Polar/Neutral	Glutamine		Serine/threonine-protein kinase B-raf										-3.5			2 interactions	2 interactions							4 interactions							146									-138.4				139.5				dbSNP: rs180177035; Variant type: LP/P; AA change: Gln257Arg; PTM type: Acetylation; PTM morphology: CDFCRkLLFQ*G; Var class: II		B (undefined)	E (parallel sheets)											Phorbol-ester/DAG-type																																																									true	BRAFGln257Arg																																																																																																																																																																																																																																		
FH	FH_His318Tyr	3.1703971636548824	0.019309050557584827	-8.740897838119132	0.000051562458963120044	2025_01_Batch_13-14	false	true	false	false	false	false	true	false	false	false	0.9510331941400851	0.9089232014113003	0.9191926076945791	0.8877453378939116	0.7187393912164326	0.7185095770613064	0.9010962748991456	0.9152637329177788	0.8993966433284734	0.9437543763498761	0.718969205371559	0.8743944008886777	0.9231214824713794	0.9184497594941273	0.9583120119302941	FH	3.1703971636548824	0.019309050557584827	-8.740897838119132	0.000051562458963120044	2025_01_Batch_13-14	false	true	false	false	false	false	true	false	false	false	0.9510331941400851	0.9089232014113003	0.9191926076945791	0.8877453378939116	0.7187393912164326	0.7185095770613064	0.9010962748991456	0.9152637329177788	0.8993966433284734	0.9437543763498761	0.718969205371559	0.8743944008886777	0.9231214824713794	0.9184497594941273	0.9583120119302941	FH	ENSG00000091483	3408	214597.0	CCSBVarC004052	ALE00004052	NC_000001.11:241504198:G:A	952C>T	His318Tyr	CEGS2	CegsMutGDEh1041	E03	GDEhDisVCh_40065	G08	1.0	CegsMutGDDh1041	E03							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	241504198.0	G	A	1	Y	Y	N	N	N	1-241504198-G-A	98367.0	single nucleotide variant	NM_000143.4(FH):c.952C>T (p.His318Tyr)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Mar 04, 2025	398123168.0	-	RCV000078152|RCV000445608|RCV000762893|RCV003460742|RCV002371923	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241504198.0	241504198.0	1q43	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA285329	2.0	92458.0	241504198.0	G	A	-	-	-	-	-	-	SCV000109990|SCV000251474|SCV000537249|SCV000756697|SCV000893293|SCV002580555|SCV002688460|SCV004187986|SCV004197372|SCV005090906|SCV005394266|SCV005625606	-	-	952C>T 	His318Tyr	NM_000143.4	2.0	1_Pathogenic	6.84061e-7	92458.0	1	241504198.0	G	A	H	Y	rs398123168	1	241667498.0	1	239734121.0	318.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.952C>T	p.His318Tyr	c.952C>T	p.His318Tyr	principal1	Y	1	YES	Select	-	CAT	1.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.79703	D	0.998	0.73231	D	0.967	0.71532	D	0.51	0.71237	A	simple_aae	49.0	51.0	4.24	0.97965	H	-5.19	0.83652	D	0.855	0.85095	1.0075	0.97307	D	0.9896	0.99711	D	10.0	0.96449435	0.95861	D	0.783796	0.98295	D	0.981	0.99874	0.748	0.87844	P07954	H318Y	Gain of phosphorylation at H318 (P = 0.111)| Loss of catalytic residue at D319 (P = 0.1709)| Loss of disorder (P = 0.2552)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)	0.970197299285	0.96959	0.9644412197578099	0.96411	1.04814267846	0.75889	0.870154500008	0.92578	D	0.96242	0.99523	D	0.580039	0.96967	D	0.595409	0.96917	D	0.998691618442535	0.94843	D	0.990021	0.96938	D	0.95636344	0.96862	0.92381674	0.96618	0.95636344	0.96862	0.92381674	0.96619	-11.478	0.82269	D	0.8651	0.80553	P	0.999672043470544	0.97434	0.96164210	0.94067	0.997	0.99892	.	.	.	.	.	.	4.864406	0.79665	27.1	0.9984337095152432	0.92321	0.934609	0.92797	D	1.05284626535223	0.97140	15.67457	0.99436337600402	0.98507	18.50119	5.73	5.73	0.89714	6.28	0.98834	9.346	0.96466	9.909000	0.82440	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.976	0.56441	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614178	6.195100e-07	0	1	1180018	8.474450e-07	0	0	75048	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180018	8.474450e-07	0	0	91080	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_leiomyomatosis_and_renal_cell_cancer|Fumarase_deficiency|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241504198G>A	ClinGen:CA285329	C1708350|C0342770|C3661900|C0027672	150800|606812	523|24|140162	Fumarate lyase, N-terminal	His	Tyr	98367.0	single nucleotide variant	NM_000143.4(FH):c.952C>T (p.His318Tyr)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Mar 04, 2025	398123168.0	-	RCV000078152|RCV000445608|RCV000762893|RCV003460742|RCV002371923	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241504198.0	241504198.0	1q43	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA285329	2.0	92458.0	241504198.0	G	A	-	-	-	-	-	-	SCV000109990|SCV000251474|SCV000537249|SCV000756697|SCV000893293|SCV002580555|SCV002688460|SCV004187986|SCV004197372|SCV005090906|SCV005394266|SCV005625606	-	-	952C>T 	His318Tyr	NM_000143.4	2.0	1_Pathogenic	98.8	0.0271739130434782	['150800', '606812', '150800', '606812']	multiple	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; FUMARASE DEFICIENCY; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; FUMARASE DEFICIENCY	98.8	0.027173912	<10	>90						H	5			98.8	Positively-charged	Histidine		Fumarate hydratase, mitochondrial										-3.2								H318-K409, H318-V322; PAE: 1.0, 1.0	6 interactions	H318-K409, H318-V322; PAE: 1.0, 1.0	7 interactions							155									-137.4				45.9						C (loop/coil)	C (loop/coil)																																																																				true	FHHis318Tyr																																																																																																																																																																																																																																		
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.9418368703188513	0.8417720713336102	0.8910937975594257	0.8213691256486676	0.7910479072545488	0.8892735093039861	0.7561848273421976	0.8641364563942026	0.8233886404938451	0.9070192044711107	0.6928223052051115	0.8865534239551376	0.9180511387246488	0.8601555021733753	0.9766545361665918	F9	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.9418368703188513	0.8417720713336102	0.8910937975594257	0.8213691256486676	0.7910479072545488	0.8892735093039861	0.7561848273421976	0.8641364563942026	0.8233886404938451	0.9070192044711107	0.6928223052051115	0.8865534239551376	0.9180511387246488	0.8601555021733753	0.9766545361665918	F9	ENSG00000101981	52861	24671.0	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2.0	RC4_Mut_GDDh1022	D11							1.0	1.0	1.0	1.0	0.0			0.0			0.0			23.0	139548480.0	G	A	X	Y	Y	N	N	N	X-139548480-G-A	800231.0	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 28, 2019	1603265500.0	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480.0	139548480.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414439424	2.0	811517.0	139548480.0	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1.0	1_Pathogenic		811517.0	X	139548480.0	G	A	C	Y	rs1603265500	X	138630639.0	X	138458305.0	170.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9.0	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.9973	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.9942554889537664	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.0	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231.0	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 28, 2019	1603265500.0	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480.0	139548480.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414439424	2.0	811517.0	139548480.0	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1.0	1_Pathogenic	95.58	0.0444444444444444		unknown	Rare genetic hematologic disease	1		95.58	0.044444446	<10	>90						C	6			95.58	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa light chain						Disulfide bond 157-170	EGF-like 2			2.5								C170-E142; PAE: 1.5	11 interactions	C170-E142; PAE: 1.5	12 interactions							121									-115.1				105.3						B (undefined)	E (parallel sheets)	Beta strand																													0.134	1 mutation(s) (Cys170Thr: 0.006)	0.085	1 mutation(s) (Cys170Tyr: -0.003)	0.084		0.076		0.085	2 mutation(s) (Cys170Met: -0.007, Cys170Tyr: -0.002)																													true	F9Cys170Tyr																																																																																																																																																																																																																																		
BRCA1	BRCA1_Met548Ile	0.2873204807817469	0.7821863607221871	4.279146156570467	0.003659222814302877	2025_01_Batch_13-14	false	true	true	true	true	false	true	false	false	true	0.9377020902829282	0.9271290324091443	0.9719792556640614	0.9461387476154925	0.9838171753239306	0.9785719900798429	0.9429073217627154	0.9557560006145543	0.8910223522970666	0.924181783445701	0.9890623605680184	0.9493701734682697	0.9882025107135686	0.9632357125212221	0.9512223971201553	BRCA1	0.2873204807817469	0.7821863607221871	4.279146156570467	0.003659222814302877	2025_01_Batch_13-14	false	true	true	true	true	false	true	false	false	true	0.9377020902829282	0.9271290324091443	0.9719792556640614	0.9461387476154925	0.9838171753239306	0.9785719900798429	0.9429073217627154	0.9557560006145543	0.8910223522970666	0.924181783445701	0.9890623605680184	0.9493701734682697	0.9882025107135686	0.9632357125212221	0.9512223971201553	BRCA1		14613		CCSBVarC013069		NC_000017.11:43070958:C:T	1644G>A	Met548Ile																												17.0	43070958.0	C	T	17						17-43070958-C-T	50269.0	single nucleotide variant	NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	1799967.0	-	RCV000034756|RCV000128916|RCV000048709|RCV000112434|RCV000120261|RCV000476093|RCV001270155|RCV004803120	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43070958.0	43070958.0	17q21.31	reviewed by expert panel	46.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00107,ClinGen:CA003103,UniProtKB:P38398#VAR_007795	2.0	41830.0	43070958.0	C	T	-	-	-	-	-	-	SCV000244374	-	-	4956G>A 	Met1652Ile	NM_007294.4	3.0	2_Benign		41830.0	17	43070958.0	C	T	M	I	rs1799967	17	41222975.0	17	38476501.0	1652.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4956G>A	p.Met1652Ile	principal2	Y	1	.	.	-	ATG	3.0	0.0	C	C/C	C/C	C/C	C/C	.	0.33898	.	.	0.36968	.	0.0	0.28566	B	0.004	0.29523	B	.	0.16373	.	.	.	.	0.175	0.08964	N	.	0.38141	.	.	0.33676	-0.8538	0.51511	T	0.1432	0.46308	T	10.0	.	0.00157	.	.	.	.	.	0.73230	.	.	.	.	.	.	.	.	0.30010	.	0.10046	0.360434174538	0.19429	T	0.099528	0.40156	T	-0.195766	0.21097	T	-0.0261181	0.68398	D	0.0072100418028408	0.00082	T	.	0.64025	.	0.19599688	0.41094	0.13775083	0.32824	0.25679418	0.48390	0.11591255	0.27917	-4.756	0.35788	T	.	0.64691	.	0.164986458329954	0.48018	0.95295440	0.93539	0.216	0.48172	.	.	.	.	.	.	2.32095	0.29778	18.21	0.9664442683677605	0.30766	0.454853	0.50568	N	-0.274289964374125	0.29865	1.678113	-0.0674097859341404	0.36444	2.142461	4.82	3.78	0.42561	3.78	0.69545	1.313	0.33295	2.710000	0.34310	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.99	0.65338	544	0.72706	56	0.011182108626198083	0	0.0	16	0.015904572564612324	3	0.004322766570605188	0	0.0	37	0.03783231083844581	2323	264690	0.008776304	.	2157	109398	1.971700e-02	48	3761	207690	1.810870e-02	80	4287	236388	1.813540e-02	88	10	7164	1.395870e-03	0	64	17110	3.740500e-03	0	67	2320	2.887930e-02	0	1	9046	1.105460e-04	0	723	13386	5.401170e-02	25	632	42768	1.477740e-02	3	626	15690	3.989800e-02	20	626	15690	3.989800e-02	20	30	16216	1.850020e-03	0	114	30522	3.735010e-03	0	157	6210	2.528180e-02	1	2	13416	1.490760e-04	0	890	16726	5.321060e-02	31	1317	89130	1.477620e-02	11	1163	30608	3.799660e-02	37	1163	30608	3.799660e-02	37	27	14902	1.811840e-03	0	144	34258	4.203400e-03	0	225	9568	2.351590e-02	2	2	17692	1.130450e-04	0	1113	21624	5.147060e-02	37	1517	102208	1.484230e-02	12	1159	30526	3.796760e-02	37	1159	30526	3.796760e-02	37	.	23606	1614160	1.462430e-02	338	3175	64006	4.960470e-02	99	143	75032	1.905850e-03	0	7	910	7.692310e-03	0	271	60024	4.514860e-03	0	679	29608	2.293300e-02	8	5	44892	1.113780e-04	0	3175	64006	4.960470e-02	99	143	6062	2.358960e-02	3	15052	1180032	1.275560e-02	119	3269	91088	3.588840e-02	99	3242	204736	0.015835026570803375	1	394	0.0025380710659898475	0	4556	0	31	10580	0.0029300567107750472	8	818	0.009779951100244499	9	1028	0.008754863813229572	0	1850	0	6	280	0.02142857142857143	228	18068	0.012618994908124861	32	10974	0.00291598323309641	0	6406	0	3525	242310	0.014547480500185712	Benign	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Malignant_tumor_of_breast	reviewed_by_expert_panel	NC_000017.11:g.43070958C>T	BRCA1-HCI:BRCA1_00107|ClinGen:CA003103|UniProtKB:P38398#VAR_007795	C3661900|C0677776|C0027672|CN169374|C2676676|C0346153|C0006142	604370|114480	145|140162|145|227535	BRCT domain|BRCT domain|BRCT domain	Met	Ile	50269.0	single nucleotide variant	NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	1799967.0	-	RCV000034756|RCV000128916|RCV000048709|RCV000112434|RCV000120261|RCV000476093|RCV001270155|RCV004803120	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43070958.0	43070958.0	17q21.31	reviewed by expert panel	46.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00107,ClinGen:CA003103,UniProtKB:P38398#VAR_007795	2.0	41830.0	43070958.0	C	T	-	-	-	-	-	-	SCV000244374	-	-	4956G>A 	Met1652Ile	NM_007294.4	3.0	2_Benign	96.01	0.0	['604370', '114480']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER	96.01	0.0	<10	>90																																																																																																																																		true	BRCA1Met548Ile																																																																																																																																																																																																																																		
BAP1	BAP1_Arg59Pro	-2.590423379221777	0.037552604621238606	-6.724527061687107	0.0006642771727354712	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8958025348137719	0.5814879009667274	0.872738126814029	0.8314031706307383	0.6535041734304495	0.5309453839443148	0.7984598136944672	0.8386750927350094	0.5029391190634009	0.8843641487311844	0.7760629629165843	0.8643465275670094	0.9068011608930485	0.6600366828700539	0.9072409208963593	BAP1	-2.590423379221777	0.037552604621238606	-6.724527061687107	0.0006642771727354712	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8958025348137719	0.5814879009667274	0.872738126814029	0.8314031706307383	0.6535041734304495	0.5309453839443148	0.7984598136944672	0.8386750927350094	0.5029391190634009	0.8843641487311844	0.7760629629165843	0.8643465275670094	0.9068011608930485	0.6600366828700539	0.9072409208963593	BAP1		3760		CCSBVarC009502		NC_000003.12:52408553:C:G	176G>C	Arg59Pro																												3.0	52408553.0	C	G	3						3-52408553-C-G	1162265.0	single nucleotide variant	NM_004656.4(BAP1):c.176G>C (p.Arg59Pro)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Jun 22, 2021	1298276806.0	-	RCV001797186	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Neurodevelopmental disorder	de novo	germline	GRCh38	NC_000003.12	3	52408553.0	52408553.0	3p21.1	no assertion criteria provided	1.0	-	N	ClinGen:CA353113466	2.0	1173080.0	52408553.0	C	G	-	-	-	-	-	-	SCV001738371	-	-	176G>C 	Arg59Pro	NM_004656.4		1_Pathogenic		1173080.0	3	52408553.0	C	G	R	P	rs1298276806	3	52442569.0	3	52417609.0	59.0	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.176G>C	p.Arg59Pro	c.176G>C	p.Arg59Pro	principal1	Y	1	YES	Select	-	CGG	2.0	0.0	C	C/C	C/C	C/C	C/C	0.033	0.44516	D	0.019	0.69466	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	2.33	0.66629	M	-6.28	0.91119	D	0.734	0.73344	-0.462	0.69867	T	0.3193	0.68734	T	10.0	0.73717695	0.74462	D	0.080609	0.73409	D	0.516	0.79231	0.438	0.49015	Q92560	R59P	Gain of glycosylation at S58 (P = 0.0035)| Loss of MoRF binding (P = 0.0099)| Gain of relative solvent accessibility (P = 0.0166)| Gain of loop (P = 0.0435)| Gain of ubiquitination at K61 (P = 0.0519)	0.836624110132	0.83377	0.8990698988239344	0.89814	3.06138964259	0.99302	0.848732292652	0.89405	D	0.266761	0.63670	T	0.213371	0.74962	D	0.0687164	0.74637	D	0.978495126974096	0.72163	D	0.983202	0.94307	D	0.9713552	0.98358	0.9540301	0.98616	0.9713552	0.98358	0.9540301	0.98617	-16.228	0.98086	D	0.9967	0.96455	P	0.99866373685461	0.94835	0.99953306	0.99461	0.706	0.83697	.	.	.	.	.	.	5.519378	0.91776	32.0	0.9981755105392318	0.90069	0.969708	0.99205	D	0.78803106441148	0.85268	8.550095	0.78537237783733	0.88696	9.704019	5.43	5.43	0.78977	.	.	7.867	0.85526	7.674000	0.64997	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.98	0.58201	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52408553C>G	.	C1535926	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Arg	Pro	1162265.0	single nucleotide variant	NM_004656.4(BAP1):c.176G>C (p.Arg59Pro)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Jun 22, 2021	1298276806.0	-	RCV001797186	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Neurodevelopmental disorder	de novo	germline	GRCh38	NC_000003.12	3	52408553.0	52408553.0	3p21.1	no assertion criteria provided	1.0	-	N	ClinGen:CA353113466	2.0	1173080.0	52408553.0	C	G	-	-	-	-	-	-	SCV001738371	-	-	176G>C 	Arg59Pro	NM_004656.4		1_Pathogenic	48.83	0.782258064516129		unknown		0		48.83	0.7822581	10-90	<=50						R	194			48.83	Positively-charged	Arginine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			-4.5			1 interaction		1 interaction			R59-E55; PAE: 5.5		R59-E55; PAE: 5.5		R59-E55; PAE: 5.5						175	Arg-finger motif	Mutation: RRSRR -> AASAA. Probably disrupts interaction with the histone H2A-H2B acidic patch. Severely attenuates deubiquitination of histone H2AK119ub1 substrates in the context of the nucleosome but does not disrupt nucleosome interaction.; Mutation: R -> W. Reduces deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome.							-77.2				-35.5						H (helix)	H (α-helix)	Helix																																																																			true	BAP1Arg59Pro																																																																																																																																																																																																																																		
SDHD	SDHD_Val111Ile	7.7451222208037676	0.00011337695822120214	-1.6891303326515865	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8063896561713839	0.6688405935235522	0.8014306768180487	0.8323696060367665	0.7584557831408983	0.6806283428302172	0.7903913226120411	0.7197309821074369	0.6622642931221312	0.7415580184685204	0.8362832234515795	0.8743478894614917	0.8831303715286605	0.6754168939249733	0.8712212938742474	SDHD	7.7451222208037676	0.00011337695822120214	-1.6891303326515865	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8063896561713839	0.6688405935235522	0.8014306768180487	0.8323696060367665	0.7584557831408983	0.6806283428302172	0.7903913226120411	0.7197309821074369	0.6622642931221312	0.7415580184685204	0.8362832234515795	0.8743478894614917	0.8831303715286605	0.6754168939249733	0.8712212938742474	SDHD		6363		CCSBVarC023342		NC_000011.10:112094821:G:A	331G>A	Val111Ile																												11.0	112094821.0	G	A	11						11-112094821-G-A	398070.0	single nucleotide variant	NM_003002.4(SDHD):c.331G>A (p.Val111Ile)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Jan 21, 2025	201869798.0	-	RCV002230665|RCV003325203|RCV003476144|RCV000565076|RCV001591105	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1|Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary cancer-predisposing syndrome|not provided	germline;unknown	germline	GRCh38	NC_000011.10	11	112094821.0	112094821.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA071246	2.0	412515.0	112094821.0	G	A	-	-	-	-	-	-	SCV000554067|SCV000675110|SCV001825380|SCV004031142|SCV004203107	-	-	331G>A 	Val111Ile	NM_003002.4	1.0	3_Conflicting		412515.0	11	112094821.0	G	A	V	I	rs201869798	11	111965545.0	11	111470755.0	111.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.331G>A	p.Val111Ile	c.331G>A	p.Val111Ile	principal1	Y	1	YES	Select	+	GTT	1.0	0.0	G	./.	./.	./.	./.	0.26	0.16832	T	0.779	0.15871	T	0.104	0.25957	B	0.055	0.25997	B	0.9	0.92786	D	simple_aae	10.0	90.0	.	.	.	-0.14	0.09078	N	0.052	0.11434	0.4711	0.90098	D	0.7829	0.92608	D	10.0	0.2911021	0.46306	D	0.050089	0.63956	D	0.572	0.82541	0.872	0.96404	O14521	V111I	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Gain of phosphorylation at Y114 (P = 0.2011)| Gain of catalytic residue at V111 (P = 0.4375)| Loss of disorder (P = 0.6326)	0.97911266155	0.97867	0.7076145117288314	0.70553	0.181760226822	0.20157	0.386111408472	0.23094	T	0.505437	0.82256	D	0.180199	0.71854	D	0.246769	0.85364	D	0.826030075550079	0.47946	D	0.852415	0.53609	D	0.023600794	0.01108	0.059936233	0.11338	0.027904507	0.02032	0.051471613	0.08303	-2.495	0.10596	T	0.081	0.08359	B	0.0132951746215333	0.26155	0.98876506	0.96548	0.232	0.50061	.	.	.	.	.	.	2.179907	0.27837	17.58	0.9737382641385139	0.33813	0.151882	0.27431	N	-0.212263563345696	0.32351	1.842281	-0.0625121141246808	0.36653	2.157289	4.85	2.83	0.32068	.	.	1.908	0.39642	3.805000	0.39965	0.672	0.70176	1.0	0.71675	1.0	0.68239	1.0	0.97202	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	segdup	1	109400	9.140770e-06	0	3	207800	1.443700e-05	0	3	236248	1.269850e-05	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9046	1.105460e-04	0	0	16100	0.000000e+00	0	1	30508	3.277830e-05	0	0	6206	0.000000e+00	0	2	13416	1.490760e-04	0	0	16734	0.000000e+00	0	0	89376	0.000000e+00	0	0	30606	0.000000e+00	0	2	13416	1.490760e-04	0	0	14784	0.000000e+00	0	1	34244	2.920220e-05	0	0	9566	0.000000e+00	0	2	17692	1.130450e-04	0	0	21630	0.000000e+00	0	0	102210	0.000000e+00	0	0	30524	0.000000e+00	0	2	17692	1.130450e-04	0	.	111	1611796	6.886730e-05	0	109	44898	2.427730e-03	0	0	74848	0.000000e+00	0	0	912	0.000000e+00	0	2	59980	3.334440e-05	0	0	29602	0.000000e+00	0	109	44898	2.427730e-03	0	0	64020	0.000000e+00	0	0	4452	0.000000e+00	0	0	1179800	0.000000e+00	0	0	90990	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|Paragangliomas_1	criteria_provided,_conflicting_classifications	NC_000011.10:g.112094821G>A	ClinGen:CA071246	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|C5436934|C3494181	606864|171300|619167|168000	140162|97286|29072|201|29072	.	Val	Ile	398070.0	single nucleotide variant	NM_003002.4(SDHD):c.331G>A (p.Val111Ile)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Jan 21, 2025	201869798.0	-	RCV002230665|RCV003325203|RCV003476144|RCV000565076|RCV001591105	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1|Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary cancer-predisposing syndrome|not provided	germline;unknown	germline	GRCh38	NC_000011.10	11	112094821.0	112094821.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA071246	2.0	412515.0	112094821.0	G	A	-	-	-	-	-	-	SCV000554067|SCV000675110|SCV001825380|SCV004031142|SCV004203107	-	-	331G>A 	Val111Ile	NM_003002.4	1.0	3_Conflicting	98.59	0.1408450704225352	['171300', '606864', '168000', '619167']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3	98.59	0.14084508	10-90	>90						V	20			98.59	Aliphatic	Valine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										4.2								V111-L107, V111-V115; PAE: 1.0, 1.0	2 interactions	V111-L107, V111-V115; PAE: 1.0, 1.0	2 interactions							117									-62.7				-43.3						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDVal111Ile																																																																																																																																																																																																																																		
BRAF	BRAF_Val471Phe	2.3797904528016036	0.04889717181123469	-3.0812311870095046	0.01778459894246216	2025_01_Batch_13-14	false	true	true	true	true	false	false	false	false	true	0.9359043947138972	0.898648495753396	0.9720264399685471	0.9655236961679623	0.9728050624774222	0.9613681814926571	0.9661325211342289	0.9590310998708382	0.8605722800791198	0.8996643083809368	0.9842419434621872	0.9649148712016956	0.985021780066256	0.9367247114276722	0.9721444810468575	BRAF	2.3797904528016036	0.04889717181123469	-3.0812311870095046	0.01778459894246216	2025_01_Batch_13-14	false	true	true	true	true	false	false	false	false	true	0.9359043947138972	0.898648495753396	0.9720264399685471	0.9655236961679623	0.9728050624774222	0.9613681814926571	0.9661325211342289	0.9590310998708382	0.8605722800791198	0.8996643083809368	0.9842419434621872	0.9649148712016956	0.985021780066256	0.9367247114276722	0.9721444810468575	BRAF	ENSG00000157764	71969	220601.0	CCSBVarC003161	ALE00003161	NC_000007.14:140781597:C:A	1411G>T	Val471Phe	CEGS2	CegsMutGDEh1018	F01	GDEhDisVCh_40058	C06	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140781597.0	C	A	7	Y	N	N	N	N	7-140781597-C-A	48837.0	single nucleotide variant	NM_004333.6(BRAF):c.1411G>T (p.Val471Phe)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	May 17, 2024	121913376.0	-	RCV000033308|RCV002051798|RCV000654957	MedGen:C3661900|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Ataxia-telangiectasia syndrome|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140781597.0	140781597.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA281968	2.0	40367.0	140781597.0	C	A	-	-	-	-	-	-	SCV000057213|SCV000776865|SCV002318959	-	-	1411G>T 	Val471Phe	NM_004333.6	2.0	1_Pathogenic		40367.0	7	140781597.0	C	A	V	F	rs121913376	7	140481397.0	7	140127866.0	471.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1411G>T	p.Val471Phe	c.1411G>T	p.Val471Phe	principal4	Y	.	YES	Select	-	GTC	1.0	0.0	C	./.	./.	./.	./.	.	0.78662	.	.	.	.	0.999	0.77914	D	0.978	0.74106	D	.	0.93300	.	.	.	.	3.085	0.87210	M	.	0.75724	.	.	.	0.9449	0.96308	D	0.994	0.99862	D	10.0	0.98959863	0.99425	D	0.776752	0.98235	D	.	0.99762	0.928	0.98831	P15056	V471F	Loss of MoRF binding (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of methylation at K473 (P = 0.132)| Gain of ubiquitination at K473 (P = 0.2122)| Gain of phosphorylation at T470 (P = 0.2345)	.	0.99319	.	0.97785	.	0.94779	0.875435829163	0.93326	D	0.969342	0.99654	D	0.565576	0.9631	D	0.574634	0.9625	D	0.997305870056152	0.91167	D	0.994967	0.98313	D	0.97874874	0.98996	0.9485988	0.98289	0.98134124	0.99197	0.94787174	0.98244	-16.156	0.97989	D	0.9991	0.99217	P	0.999981316373626	0.99579	0.99920601	0.99218	0.997	0.99892	.	.	.	.	.	.	5.405591	0.9052	31.0	0.997099755889649	0.81301	0.888659	0.82134	D	1.04820146480743	0.97030	15.51097	0.96315625170976	0.97767	16.74944	5.62	5.62	0.85695	.	.	7.886	0.85829	7.654000	0.63915	0.549	0.27038	1.0	0.71675	1.0	0.68239	0.994	0.71086	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	RASopathy|Ataxia-telangiectasia_syndrome|Melanoma|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781597C>A	ClinGen:CA281968	C5555857|C0004135|C0025202|C3661900	208900	536391|100	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Val	Phe	48837.0	single nucleotide variant	NM_004333.6(BRAF):c.1411G>T (p.Val471Phe)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	May 17, 2024	121913376.0	-	RCV000033308|RCV002051798|RCV000654957	MedGen:C3661900|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Ataxia-telangiectasia syndrome|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140781597.0	140781597.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA281968	2.0	40367.0	140781597.0	C	A	-	-	-	-	-	-	SCV000057213|SCV000776865|SCV002318959	-	-	1411G>T 	Val471Phe	NM_004333.6	2.0	1_Pathogenic	89.55	0.1056338028169014	['208900']	autosomal recessive	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	ATAXIA-TELANGIECTASIA	89.55	0.1056338	10-90	70-90						V	15			89.55	Aliphatic	Valine	ATP	Serine/threonine-protein kinase B-raf							Protein kinase	0.5186		4.2								V471-G464, V471-I463; PAE: 1.0, 1.0	68 interactions	V471-G464; PAE: 1.0	69 interactions							117									-97.8		Pocket 1: Mean pLDDT: 73.28, Volume: 405.11 Å³, Druggability score: 0.52		140.9						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	BRAFVal471Phe																																																																																																																																																																																																																																		
BRCA1	BRCA1_Ala102Gly	-1.4050219512461604	0.20280504742642533	-6.386066195669308	0.00037218712893209255	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9673664321220692	0.785918645613632	0.9410854177542289	0.85447648911337	0.7985497170044982	0.87910947777377	0.9080614217344603	0.9649037055693481	0.8255454760853147	0.9790875484839284	0.7179899562352263	0.8008915564922798	0.9172671299391097	0.7462918151419493	0.9556453157602098	BRCA1	-1.4050219512461604	0.20280504742642533	-6.386066195669308	0.00037218712893209255	2025_01_Batch_13-14	true	false	false	false	false	false	false	false	false	false	0.9673664321220692	0.785918645613632	0.9410854177542289	0.85447648911337	0.7985497170044982	0.87910947777377	0.9080614217344603	0.9649037055693481	0.8255454760853147	0.9790875484839284	0.7179899562352263	0.8008915564922798	0.9172671299391097	0.7462918151419493	0.9556453157602098	BRCA1		14613		CCSBVarC013080		NC_000017.11:43104258:G:C	305C>G	Ala102Gly																												17.0	43104258.0	G	C	17						17-43104258-G-C	46061.0	single nucleotide variant	NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 11, 2024	80357190.0	-	RCV004566761|RCV001353922|RCV000166160|RCV000203639|RCV000031086|RCV000048062	MONDO:MONDO:0700268,MedGen:CN377757|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374	BRCA1-related cancer predisposition|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	43104258.0	43104258.0	17q21.31	reviewed by expert panel	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002009	2.0	37505.0	43104258.0	G	C	-	-	-	-	-	-	SCV004101421	-	-	305C>G 	Ala102Gly	NM_007294.4	3.0	2_Benign		37505.0	17	43104258.0	G	C	A	G	rs80357190	17	41256275.0	17	38509801.0	102.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	c.305C>G	p.Ala102Gly	c.305C>G	p.Ala102Gly	principal2	Y	1	.	.	-	GCA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.006	0.68399	D	0.065	0.48945	T	0.057	0.44237	B	0.023	0.42592	B	.	0.61445	.	.	.	.	2.24	0.63167	M	-0.52	0.48535	N	.	0.53827	-0.8845	0.492	T	0.1938	0.54543	T	10.0	0.33566126	0.50348	D	0.118185	0.79755	D	0.606	0.84430	0.48	0.55849	E9PFC7	A102G	Loss of stability (P = 0.0442)| Gain of relative solvent accessibility (P = 0.0999)| Gain of disorder (P = 0.157)| Gain of catalytic residue at S104 (P = 0.1636)| Loss of phosphorylation at Y101 (P = 0.2814)	0.947690629548	0.94671	.	0.33795	.	0.20076	0.312466681004	0.12270	T	0.212967	0.57203	T	0.262764	0.79636	D	0.139666	0.79372	D	0.518966853618622	0.33015	D	.	0.80632	.	0.12579814	0.29224	0.06543072	0.13260	0.12579814	0.29224	0.06543072	0.13260	-4.128	0.40366	T	0.1268	0.35034	LB	0.485608964919914	0.60346	0.99054370	0.96816	0.105	0.29145	.	.	.	.	.	.	2.791559	0.36769	20.3	0.9935652498726523	0.60877	0.328409	0.42717	N	0.0961423372559193	0.46027	2.871031	0.125822333913209	0.45602	2.842934	5.32	3.24	0.3618	4.41	0.82967	1.516	0.35569	6.237000	0.55333	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.968	0.53734	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	1609246	2.485640e-06	0	1	74900	1.335110e-05	0	1	74900	1.335110e-05	0	0	912	0.000000e+00	0	0	59924	0.000000e+00	0	0	29582	0.000000e+00	0	0	44828	0.000000e+00	0	0	63826	0.000000e+00	0	0	6050	0.000000e+00	0	0	1176114	0.000000e+00	0	0	90756	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	1	24	0.041666666666666664	0	94	0	0	466	0	0	2294	0	1	108	0.009259259259259259	1	10680	9.363295880149813E-5	Benign	not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43104258G>C	ClinGen:CA002009	CN169374|C0677776|C3661900|C2676676|CN377757|C0027672	604370	145|145|140162	.	Ala	Gly	46061.0	single nucleotide variant	NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 11, 2024	80357190.0	-	RCV004566761|RCV001353922|RCV000166160|RCV000203639|RCV000031086|RCV000048062	MONDO:MONDO:0700268,MedGen:CN377757|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374	BRCA1-related cancer predisposition|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	43104258.0	43104258.0	17q21.31	reviewed by expert panel	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002009	2.0	37505.0	43104258.0	G	C	-	-	-	-	-	-	SCV004101421	-	-	305C>G 	Ala102Gly	NM_007294.4	3.0	2_Benign	57.52	0.7924528301886793	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	57.52	0.7924528	10-90	50-70																																																																																																																																		true	BRCA1Ala102Gly																																																																																																																																																																																																																																		
SHOC2	SHOC2_Ser2Gly	-3.1962184734631762	0.015145173112769224	10.615593920721482	0.000014410874200003568	2025_01_Batch_13-14	true	false	false	true	true	false	false	false	false	false	0.9778620886638342	0.777721700702442	0.9103892689734077	0.9445404273697964	0.8812307260582745	0.8812307260582745	0.9445404273697964	0.9103892689734077	0.777721700702442	0.9778620886638342						SHOC2	-3.1962184734631762	0.015145173112769224	10.615593920721482	0.000014410874200003568	2025_01_Batch_13-14	true	false	false	true	true	false	false	false	false	false	0.9778620886638342	0.777721700702442	0.9103892689734077	0.9445404273697964	0.8812307260582745	0.8812307260582745	0.9445404273697964	0.9103892689734077	0.777721700702442	0.9778620886638342						SHOC2	ENSG00000108061	11602	203498.0	CCSBVarC003572	ALE00003572	NC_000010.11:110964362:A:G	4A>G	Ser2Gly	CEGS2	CegsMutGDEh1003	E02	GDEhDisVCh_40089	E02	1.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	110964362.0	A	G	10	Y	N	N	N	N	10-110964362-A-G	21860.0	single nucleotide variant	NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly)	8036.0	SHOC2	HGNC:15454	Pathogenic	1.0	Apr 03, 2017	267607048.0	-	RCV000213000|RCV000624656|RCV000007223|RCV000208379|RCV002221469|RCV004752691|RCV001813181|RCV003330311|RCV000149834|RCV000853278	MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0033004,MedGen:C4540575,OMIM:263200||MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701;Human Phenotype Ontology:HP:0000767,Human Phenotype Ontology:HP:0006613,Human Phenotype Ontology:HP:0006617,MONDO:MONDO:0008213,MedGen:C2051831,OMIM:169300|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701	not provided|Inborn genetic diseases|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome|Polycystic kidney disease 4|SHOC2-related disorder|Noonan syndrome and Noonan-related syndrome|Noonan syndrome-like disorder with loose anagen hair 1;Pectus excavatum|RASopathy|Noonan syndrome-like disorder with loose anagen hair	de novo;germline;unknown	germline	GRCh38	NC_000010.11	10	110964362.0	110964362.0	10q25.2	reviewed by expert panel	45.0	-	N	ClinGen:CA118524,UniProtKB:Q9UQ13#VAR_060199,OMIM:602775.0001	3.0	6821.0	110964362.0	A	G	-	-	-	-	-	-	SCV000616382	-	-	4A>G 	Ser2Gly	NM_007373.4	3.0	1_Pathogenic	3.42269e-6	6821.0	10	110964362.0	A	G	S	G	rs267607048	10	112724120.0	10	112714110.0	2.0	SHOC2	ENSG00000108061	ENST00000689118	ENSP00000510554	Q9UQ13	SHOC2_HUMAN	.	.	c.4A>G	p.Ser2Gly	principal1	Y	.	.	.	+	AGT	1.0	0.0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.08048	.	0.924	0.54410	P	0.827	0.65195	P	.	0.90832	.	.	.	.	1.95	0.52299	M	.	0.18812	.	.	0.79136	-0.871	0.50259	T	0.1062	0.38523	T	10.0	.	0.84179	.	0.02323	0.45962	T	.	0.70445	0.737	0.86913	Q9UQ13	S2G	Loss of phosphorylation at S2 (P = 0.0013)| Gain of sheet (P = 0.0028)| Loss of loop (P = 0.0112)| Gain of ubiquitination at K7 (P = 0.0913)| Loss of methylation at K7 (P = 0.0917)	.	0.50012	.	0.01588	.	0.81400	0.709850311279	0.68519	T	0.168512	0.51307	T	0.158547	0.69846	D	-0.0100348	0.69461	D	0.952564656734467	0.63597	D	0.756024	0.37697	T	0.43829516	0.62973	0.3389099	0.59430	0.3963055	0.60151	0.3356854	0.59147	-3.508	0.17366	T	.	0.20926	.	0.949115075084258	0.80343	0.03609608	0.55985	0.27	0.54055	.	.	.	.	.	.	4.350761	0.66885	25.0	0.9969381354100902	0.80133	0.926990	0.90862	D	0.506295370116211	0.67289	5.084776	0.576779642148786	0.73134	5.944563	5.22	5.22	0.72246	.	.	8.492	0.90332	10.555000	0.83455	0.751	0.87726	1.0	0.71675	1.0	0.68239	1.0	0.97202	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613004	3.719770e-06	0	1	29596	3.378830e-05	0	0	74876	0.000000e+00	0	0	912	0.000000e+00	0	0	59750	0.000000e+00	0	1	29596	3.378830e-05	0	0	44884	0.000000e+00	0	0	63960	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179528	4.238980e-06	0	0	90972	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Noonan_syndrome_and_Noonan-related_syndrome|Noonan_syndrome|Noonan_syndrome-like_disorder_with_loose_anagen_hair|RASopathy|Polycystic_kidney_disease_4|Inborn_genetic_diseases|not_provided|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|Pectus_excavatum	reviewed_by_expert_panel	NC_000010.11:g.110964362A>G	ClinGen:CA118524|OMIM:602775.0001|UniProtKB:Q9UQ13#VAR_060199	C5681679|C0028326|C1843181|C5555857|C4540575|C0950123|C3661900|C4478716|C2051831	PS163950|PS607721|263200|607721|169300	98733|648|2701|536391|2701	.	Ser	Gly	21860.0	single nucleotide variant	NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly)	8036.0	SHOC2	HGNC:15454	Pathogenic	1.0	Apr 03, 2017	267607048.0	-	RCV000213000|RCV000624656|RCV000007223|RCV000208379|RCV002221469|RCV004752691|RCV001813181|RCV003330311|RCV000149834|RCV000853278	MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0033004,MedGen:C4540575,OMIM:263200||MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701;Human Phenotype Ontology:HP:0000767,Human Phenotype Ontology:HP:0006613,Human Phenotype Ontology:HP:0006617,MONDO:MONDO:0008213,MedGen:C2051831,OMIM:169300|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701	not provided|Inborn genetic diseases|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome|Polycystic kidney disease 4|SHOC2-related disorder|Noonan syndrome and Noonan-related syndrome|Noonan syndrome-like disorder with loose anagen hair 1;Pectus excavatum|RASopathy|Noonan syndrome-like disorder with loose anagen hair	de novo;germline;unknown	germline	GRCh38	NC_000010.11	10	110964362.0	110964362.0	10q25.2	reviewed by expert panel	45.0	-	N	ClinGen:CA118524,UniProtKB:Q9UQ13#VAR_060199,OMIM:602775.0001	3.0	6821.0	110964362.0	A	G	-	-	-	-	-	-	SCV000616382	-	-	4A>G 	Ser2Gly	NM_007373.4	3.0	1_Pathogenic	36.92	0.8692307692307693	['607721', '263200', '607721', '169300']	multiple	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; PECTUS EXCAVATUM	36.92	0.86923075	10-90	<=50						S	113			36.92	Polar/Neutral	Serine		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-0.8																		105									29.4				117.1	Disordered					C (loop/coil)	C (loop/coil)																																																																				true	SHOC2Ser2Gly																																																																																																																																																																																																																																		
F9	F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9596294108315151	0.6202202792689997	0.8301266795417084	0.8235058813286767	0.5271070619127192	0.5508116033443167	0.7741940432245226	0.792682624193488	0.59657621055612	0.9402112969107692	0.5034025204811217	0.8728177194328309	0.8675707348899288	0.6438643479818795	0.979047524752261	F9	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9596294108315151	0.6202202792689997	0.8301266795417084	0.8235058813286767	0.5271070619127192	0.5508116033443167	0.7741940432245226	0.792682624193488	0.59657621055612	0.9402112969107692	0.5034025204811217	0.8728177194328309	0.8675707348899288	0.6438643479818795	0.979047524752261	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G	1005C>G	Cys335Trp																												23.0	139561690.0	C	G	X						X-139561690-C-G	962089.0	single nucleotide variant	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Jun 01, 2019	1928110579.0	-	RCV001265097	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561690.0	139561690.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA414445330	2.0	973811.0	139561690.0	C	G	-	-	-	-	-	-	SCV001424890	-	-	1005C>G 	Cys335Trp	NM_000133.4		1_Pathogenic		973811.0	X	139561690.0	C	G	C	W	rs1928110579	X	138643849.0	X	138471515.0	335.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1005C>G	p.Cys335Trp	c.1005C>G	p.Cys335Trp	principal1	Y	1	YES	Select	+	TGC	3.0	2.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	4.345	0.98414	H	-10.94	0.99269	D	0.867	0.94798	0.9106	0.9581	D	0.9301	0.97688	D	10.0	0.99144864	0.99668	D	0.785421	0.98309	D	0.874	0.96234	0.927	0.98799	P00740	C335W	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.998771782893	0.99874	0.9999734769876236	0.99997	1.9161241583	0.92915	0.691920042038	0.65925	T	0.970652	0.99678	D	0.619316	0.98093	D	0.651828	0.98062	D	0.99990177154541	0.99626	D	0.90321	0.66020	D	0.99243474	0.99876	0.9700131	0.99457	0.99243474	0.99876	0.9700131	0.99457	-13.176	0.90095	D	0.9894	0.93397	P	0.999969305192545	0.99297	0.99999310	0.99996	0.978	0.99209	.	.	.	.	.	.	3.435492	0.47852	22.5	0.9936490082355044	0.61211	.	.	.	.	.	.	.	.	.	5.66	1.89	0.24633	1.11	0.30197	1.625	0.36745	-0.017000	0.13030	-0.202	0.08747	0.857	0.30652	0.001	0.17376	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561690C>G	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	962089.0	single nucleotide variant	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Jun 01, 2019	1928110579.0	-	RCV001265097	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561690.0	139561690.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA414445330	2.0	973811.0	139561690.0	C	G	-	-	-	-	-	-	SCV001424890	-	-	1005C>G 	Cys335Trp	NM_000133.4		1_Pathogenic	96.87	0.0074074074074074	['306900']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B	96.87	0.0074074073	<10	>90						C	1			96.87	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa heavy chain						Disulfide bond 178-335	Peptidase S1			2.5				4 interactions				C335-L425, C335-S423; PAE: 1.0, 1.0	3 interactions	C335-G179, C335-L425, C335-C178; PAE: 1.5, 1.0, 1.5	6 interactions							121									-73.1				140.5						B (undefined)	B (beta bridge)																														0.169	1 mutation(s) (Cys335Leu: -0.045)	0.101		0.083	1 mutation(s) (Cys335Ile: -0.004)	0.083	3 mutation(s) (Cys335Phe: -0.014, Cys335Leu: -0.009, Cys335Ala: -0.006)	0.096	1 mutation(s) (Cys335Trp: -0.002)																													true	F9Cys335Trp																																																																																																																																																																																																																																		
BRCA1	BRCA1_Met1Ile	6.765004300970164	0.0002614050448425321	-8.007642466557488	0.00009059512375294578	2025_01_Batch_13-14	true	true	true	true	true	true	true	false	false	false	0.9878947833086833	0.9065082197137221	0.9866367487583159	0.941839900903998	0.95398490495553	0.965432133065669	0.9708351231137582	0.9890790736252655	0.9369278802773922	0.9923100505613676	0.942537676845391	0.9128446786942379	0.9841944238913661	0.876088559150052	0.9834795160559991	BRCA1	6.765004300970164	0.0002614050448425321	-8.007642466557488	0.00009059512375294578	2025_01_Batch_13-14	true	true	true	true	true	true	true	false	false	false	0.9878947833086833	0.9065082197137221	0.9866367487583159	0.941839900903998	0.95398490495553	0.965432133065669	0.9708351231137582	0.9890790736252655	0.9369278802773922	0.9923100505613676	0.942537676845391	0.9128446786942379	0.9841944238913661	0.876088559150052	0.9834795160559991	BRCA1	ENSG00000012048	14613	218379.0	CCSBVarC003295	ALE00003295	NC_000017.11:43124094:C:A	3G>T	Met1Ile	CEGS2	CegsMutGDEh1009	D10	GDEhDisVCh_40059	B03	1.0									1.0	4.0	0.0		0.0			0.0			0.0			17.0	43124094.0	C	A	17	N	N	N	N	N	17-43124094-C-A	69739.0	single nucleotide variant	NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80357475.0	-	RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124094.0	43124094.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002562	2.0	55072.0	43124094.0	C	A	-	-	-	-	-	-	SCV001161632	-	-	3G>T 	Met1Ile	NM_007294.4	3.0	1_Pathogenic	6.84988e-7	55072.0	17	43124094.0	C	A	M	I	rs80357475	17	41276111.0	17	38529637.0	1.0	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	c.3G>T	p.Met1?	c.3G>T	p.Met1?	principal2	Y	1	.	.	-	ATG	3.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.009	0.92967	D	0.924	0.51298	P	0.878	0.62305	P	.	0.99291	.	.	.	.	.	.	.	-0.56	0.54406	N	.	0.93850	0.5223	0.90822	D	0.7099	0.9	D	9.0	0.9873682	0.99089	D	0.932498	0.99511	D	0.696	0.88959	0.996	0.99957	E9PFC7	M1I	Gain of catalytic residue at M1 (P = 0.0314)| Loss of disorder (P = 0.1193)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2684)| Loss of phosphorylation at S4 (P = 0.3332)	0.887736870969	0.88576	.	0.24402	.	.	.	.	.	0.280176	0.65093	T	0.398321	0.89744	D	0.334384	0.89616	D	0.996361911296844	0.89105	D	.	0.64967	.	0.90739095	0.91937	0.707353	0.82542	0.9052275	0.91737	0.64797	0.79185	-12.231	0.90483	D	.	.	.	0.999999926062728	0.99831	0.99954283	0.99470	.	.	.	.	.	.	.	.	4.144486	0.62186	24.4	0.9963500389217754	0.76291	0.062568	0.11864	N	0.34664899273018	0.58348	4.029269	0.312639291828477	0.56049	3.791295	3.83	3.83	0.43219	.	.	3.426	0.52638	3.191000	0.36784	-0.284	0.0639	1.0	0.71675	1.0	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612162	6.202850e-07	0	1	1178330	8.486590e-07	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29594	0.000000e+00	0	0	44826	0.000000e+00	0	0	64006	0.000000e+00	0	0	6024	0.000000e+00	0	1	1178330	8.486590e-07	0	0	91032	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43124094C>A	ClinGen:CA002562	C0027672|C3661900|C0346153|C4554406|C2676676|C3280442|C0677776	114480|617883|604370|614320	140162|227535|145|1333|145	.	Met	Ile	69739.0	single nucleotide variant	NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80357475.0	-	RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124094.0	43124094.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002562	2.0	55072.0	43124094.0	C	A	-	-	-	-	-	-	SCV001161632	-	-	3G>T 	Met1Ile	NM_007294.4	3.0	1_Pathogenic	41.59	1.0	['604370', '114480', '617883', '604370', '614320']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	41.59	1.0	$\geqslant$90	<=50																																																																																																																																		true	BRCA1Met1Ile																																																																																																																																																																																																																																		
FARS2	FARS2_Leu371Phe	0.24590492354475124	1.0	-2.718592944820779	0.04215074661217547	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7858540681027969	0.5604473559096629	0.8161826541326183	0.7674272954442991	0.6975368959158603	0.6725393516295189	0.7424490977972589	0.7909852528347302	0.5574119026468386	0.7699201139117763	0.7225344402022017	0.7924054930913393	0.8413800554305063	0.5634828091724872	0.8017880222938175	FARS2	0.24590492354475124	1.0	-2.718592944820779	0.04215074661217547	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7858540681027969	0.5604473559096629	0.8161826541326183	0.7674272954442991	0.6975368959158603	0.6725393516295189	0.7424490977972589	0.7909852528347302	0.5574119026468386	0.7699201139117763	0.7225344402022017	0.7924054930913393	0.8413800554305063	0.5634828091724872	0.8017880222938175	FARS2		12653		CCSBVarC011882		NC_000006.12:5613216:G:T	1113G>T	Leu371Phe																												6.0	5613216.0	G	T	6						6-5613216-G-T	962037.0	single nucleotide variant	NM_006567.5(FARS2):c.1113G>T (p.Leu371Phe)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Dec 12, 2019	1204079767.0	-	RCV001250395	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5613216.0	5613216.0	6p25.1	no assertion criteria provided	1.0	-	N	ClinGen:CA362736853	2.0	973745.0	5613216.0	G	T	-	-	-	-	-	-	SCV001424746	-	-	1113G>T 	Leu371Phe	NM_006567.5		1_Pathogenic		973745.0	6	5613216.0	G	T	L	F	rs1204079767	6	5613449.0	6	5558448.0	371.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1113G>T	p.Leu371Phe	c.1113G>T	p.Leu371Phe	principal1	Y	1	YES	Select	+	TTG	3.0	2.0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.005	0.72530	D	0.984	0.60748	D	0.905	0.64254	P	0.98	0.97016	A	simple_aae	2.0	98.0	3.49	0.92559	M	-3.3	0.65888	D	0.828	0.82302	0.0185	0.82548	D	0.5146	0.81736	D	10.0	0.87487864	0.86629	D	0.114229	0.79238	D	0.721	0.90105	0.653	0.78980	O95363	L371F	Loss of catalytic residue at L371 (P = 0.134)| Gain of sheet (P = 0.1451)| Loss of stability (P = 0.1495)| Gain of loop (P = 0.3485)| Gain of disorder (P = 0.4546)	0.934491293691	0.93330	.	0.75719	.	0.59072	0.566125333309	0.48064	T	0.632922	0.88531	D	0.282506	0.81394	D	0.168024	0.81155	D	0.98774379491806	0.78021	D	0.949505	0.80529	D	0.6913538	0.77328	0.57329565	0.75036	0.6913538	0.77329	0.57329565	0.75036	-9.639	0.71800	D	0.4567	0.62580	A	0.937195805839724	0.79075	0.94634580	0.93179	0.82	0.90063	.	.	.	.	.	.	2.807945	0.37026	20.4	0.9985470103499772	0.93373	0.344351	0.43798	N	0.383302004000591	0.60314	4.241475	0.254276606892227	0.52647	3.461171	5.53	0.378	0.15396	0.251	0.23301	0.161	0.16353	0.741000	0.21243	0.676	0.76753	0.99	0.37076	0.997	0.33331	0.996	0.76032	976	0.04721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Combined_oxidative_phosphorylation_defect_type_14	no_assertion_criteria_provided	NC_000006.12:g.5613216G>T	.	C4755312	614946	319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Leu	Phe	962037.0	single nucleotide variant	NM_006567.5(FARS2):c.1113G>T (p.Leu371Phe)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Dec 12, 2019	1204079767.0	-	RCV001250395	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5613216.0	5613216.0	6p25.1	no assertion criteria provided	1.0	-	N	ClinGen:CA362736853	2.0	973745.0	5613216.0	G	T	-	-	-	-	-	-	SCV001424746	-	-	1113G>T 	Leu371Phe	NM_006567.5		1_Pathogenic	96.82	0.1768292682926829	['614946']	unknown		0	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	96.82	0.17682926	10-90	>90						L	29			96.82	Aliphatic	Leucine									FDX-ACB			3.8								L371-T410; PAE: 1.0	9 interactions	L371-H412; PAE: 1.0	11 interactions							131									-72.3				150.5						H (helix)	P (polyproline helix)																																																																				true	FARS2Leu371Phe																																																																																																																																																																																																																																		
F9	F9_Glu27Lys	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6514881755093695	0.7011830196326599	0.702294841167481	0.6005833479958536	0.7659905117648657	0.8211449773890915	0.6077626066331344	0.733824328613967	0.7978611430742861	0.6538387561093866	0.7108360461406398	0.5934040893585728	0.670765353720995	0.6045048961910338	0.6491375949093524	F9	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6514881755093695	0.7011830196326599	0.702294841167481	0.6005833479958536	0.7659905117648657	0.8211449773890915	0.6077626066331344	0.733824328613967	0.7978611430742861	0.6538387561093866	0.7108360461406398	0.5934040893585728	0.670765353720995	0.6045048961910338	0.6491375949093524	F9		52861					217G>A	Glu27Lys																																																																																				5_Others																																																																																																																																																																																																																																																																																																																																																																																																																																																	unknown	Rare genetic hematologic disease	1				10-90	>90						E	169			59.64	Negatively-charged	Glutamic Acid												-3.5																		146									-67.1				85.8						C (loop/coil)	C (loop/coil)				Signal																										0.627		0.64		0.709		0.738		0.663																														true	F9Glu27Lys																																																																																																																																																																																																																																		
SDHD	SDHD_Ser68Gly	6.045343083600106	0.0007737129719721013	0.011366001524099056	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8168240983673386	0.7264908519888521	0.8649791558054976	0.8493601987112902	0.7969020749731797	0.81903851669005	0.8837958005716589	0.8905435213901371	0.7668257119115635	0.8233262997117662	0.7747656332563092	0.8149245968509216	0.839414790220858	0.6861559920661408	0.810321897022911	SDHD	6.045343083600106	0.0007737129719721013	0.011366001524099056	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8168240983673386	0.7264908519888521	0.8649791558054976	0.8493601987112902	0.7969020749731797	0.81903851669005	0.8837958005716589	0.8905435213901371	0.7668257119115635	0.8233262997117662	0.7747656332563092	0.8149245968509216	0.839414790220858	0.6861559920661408	0.810321897022911	SDHD		6363		CCSBVarC023282		NC_000011.10:112088899:A:G	202A>G	Ser68Gly																												11.0	112088899.0	A	G	11						11-112088899-A-G	1685180.0	single nucleotide variant	NM_003002.4(SDHD):c.202A>G (p.Ser68Gly)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Apr 16, 2024	2135269276.0	-	RCV002257333|RCV004804413	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112088899.0	112088899.0	11q23.1	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617218	2.0	1692740.0	112088899.0	A	G	-	-	-	-	-	-	SCV002527119|SCV004051962|SCV005424122	-	-	202A>G 	Ser68Gly	NM_003002.4	1.0	3_Conflicting		1692740.0	11	112088899.0	A	G	S	G	rs2135269276	11	111959623.0	11	111464833.0	68.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.202A>G	p.Ser68Gly	c.202A>G	p.Ser68Gly	principal1	Y	1	YES	Select	+	AGC	1.0	0.0	A	./.	./.	./.	./.	0.976	0.05990	T	0.707	0.07740	T	0.001	0.07480	B	0.001	0.04348	B	0.13	0.33788	N	simple_aae	87.0	13.0	0.415	0.12397	N	-1.06	0.30311	N	0.309	0.34641	0.13	0.84642	D	0.6363	0.87225	D	10.0	0.27792534	0.44975	D	0.027744	0.50323	D	0.589	0.83500	0.323	0.30252	O14521	S68G	Loss of disorder (P = 0.1141)| Loss of stability (P = 0.2528)| Loss of phosphorylation at S68 (P = 0.2631)| Gain of catalytic residue at T67 (P = 0.2736)| Loss of loop (P = 0.2897)	0.983747050717	0.98339	0.6418887932230426	0.63954	0.171667858329	0.19059	0.347676306963	0.17562	T	0.705796	0.91487	D	0.153806	0.69403	D	-0.016845	0.69011	D	0.118915073573589	0.14142	T	0.819918	0.49610	T	0.04305329	0.06580	0.04685765	0.06638	0.04305329	0.06580	0.04685765	0.06637	-1.587	0.38256	T	0.0495	0.00860	B	0.109295900523767	0.44137	0.97679627	0.95218	0.145	0.37545	.	.	.	.	.	.	1.080037	0.1465	11.19	0.7301846841849414	0.10342	0.321938	0.42266	N	-0.922609032286981	0.10190	0.4922996	-0.794832955240867	0.14373	0.7649354	5.04	-5.0	0.0278	.	.	0.898	0.2813	1.446000	0.26652	0.691	0.84104	0.885	0.31181	0.972	0.29889	0.998	0.85369	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612668	6.200900e-07	0	1	91012	1.098760e-05	0	0	74984	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29606	0.000000e+00	0	0	44870	0.000000e+00	0	0	64046	0.000000e+00	0	0	4916	0.000000e+00	0	0	1179934	0.000000e+00	0	1	91012	1.098760e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088899A>G	.	C0027672	.	140162	.	Ser	Gly	1685180.0	single nucleotide variant	NM_003002.4(SDHD):c.202A>G (p.Ser68Gly)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Apr 16, 2024	2135269276.0	-	RCV002257333|RCV004804413	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112088899.0	112088899.0	11q23.1	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617218	2.0	1692740.0	112088899.0	A	G	-	-	-	-	-	-	SCV002527119|SCV004051962|SCV005424122	-	-	202A>G 	Ser68Gly	NM_003002.4	1.0	3_Conflicting	98.25	0.3846153846153846		unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7		98.25	0.3846154	10-90	>90						S	50			98.25	Polar/Neutral	Serine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										-0.8								S68-L64, S68-V72; PAE: 1.0, 1.0	2 interactions	S68-L64, S68-V72; PAE: 1.0, 1.0	2 interactions							105									-60.1				-41.2						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDSer68Gly																																																																																																																																																																																																																																		
RAF1	RAF1_Asp486Asn	0.45327533329345343	1.0	-3.177824308148034	0.02572498582917983	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8958750774858364	0.7362641564325991	0.9066051923018755	0.8884150740705622	0.8302164226748101	0.8739391265851167	0.9053125702290953	0.9293565178076245	0.7916608191821694	0.9058966866448821	0.7864937187645036	0.8715175779120291	0.8838538667961265	0.6808674936830288	0.8858534683267907	RAF1	0.45327533329345343	1.0	-3.177824308148034	0.02572498582917983	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8958750774858364	0.7362641564325991	0.9066051923018755	0.8884150740705622	0.8302164226748101	0.8739391265851167	0.9053125702290953	0.9293565178076245	0.7916608191821694	0.9058966866448821	0.7864937187645036	0.8715175779120291	0.8838538667961265	0.6808674936830288	0.8858534683267907	RAF1	ENSG00000132155	732	213824.0	CCSBVarC003426	ALE00003426	NC_000003.12:12585761:C:T	1456G>A	Asp486Asn	CEGS2	CegsMutGDEh1014	G11	GDEhDisVCh_40029	D08	1.0									1.0	1.0	0.0		0.0			0.0			0.0			3.0	12585761.0	C	T	3	Y	N	N	N	N	3-12585761-C-T	34193.0	single nucleotide variant	NM_002880.4(RAF1):c.1456G>A (p.Asp486Asn)	5894.0	RAF1	HGNC:9829	not provided	0.0	-	80338798.0	-	RCV000020506	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500	Noonan syndrome with multiple lentigines	unknown	unknown	GRCh38	NC_000003.12	3	12585761.0	12585761.0	3p25.2	no classification provided	1.0	-	N	ClinGen:CA341928,UniProtKB:P04049#VAR_037817	1.0	21341.0	12585761.0	C	T	-	-	-	-	-	-	SCV000040957	-	-	1456G>A 	Asp486Asn	NM_002880.4		5_Others		21341.0	3	12585761.0	C	T	D	N	rs80338798	3	12627260.0	3	12602260.0	486.0	RAF1	ENSG00000132155	ENST00000685653	ENSP00000509968	P04049	RAF1_HUMAN	.	.	c.1456G>A	p.Asp486Asn	principal3	Y	.	.	.	-	GAT	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	0.998	0.88579	D	.	0.92286	.	.	.	.	2.89	0.83536	M	.	0.78079	.	.	0.99419	0.942	0.96265	D	0.9946	0.99877	D	9.0	.	0.99202	.	0.825636	0.98643	D	.	0.97963	0.968	0.99690	P04049	D486N	Gain of MoRF binding (P = 0.0343)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K483 (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K483 (P = 0.1041)	.	0.95330	.	0.98776	.	0.97323	0.879874408245	0.93935	D	0.949346	0.99250	D	0.270705	0.80361	D	0.151072	0.80106	D	0.998047471046448	0.93025	D	0.9975	0.98985	D	0.94164735	0.95344	0.889279	0.94137	0.94205755	0.95387	0.8781777	0.93345	-14.009	0.93099	D	.	0.98152	.	0.99999342572825	0.99831	0.99668110	0.98129	0.995	0.99826	.	.	.	.	.	.	5.650199	0.92811	33.0	0.9992180874276057	0.98788	0.892841	0.82954	D	1.01881719419438	0.96274	14.52467	0.933976822940601	0.96872	15.28689	5.26	5.26	0.73443	5.35	0.93259	7.9	0.86061	7.684000	0.65502	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.998	0.85369	692.0	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Noonan_syndrome_with_multiple_lentigines	no_classification_provided	NC_000003.12:g.12585761C>T	ClinGen:CA341928|UniProtKB:P04049#VAR_037817	C0175704	PS151100	500	Protein kinase domain|Protein kinase domain|Protein kinase domain	Asp	Asn	34193.0	single nucleotide variant	NM_002880.4(RAF1):c.1456G>A (p.Asp486Asn)	5894.0	RAF1	HGNC:9829	not provided	0.0	-	80338798.0	-	RCV000020506	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500	Noonan syndrome with multiple lentigines	unknown	unknown	GRCh38	NC_000003.12	3	12585761.0	12585761.0	3p25.2	no classification provided	1.0	-	N	ClinGen:CA341928,UniProtKB:P04049#VAR_037817	1.0	21341.0	12585761.0	C	T	-	-	-	-	-	-	SCV000040957	-	-	1456G>A 	Asp486Asn	NM_002880.4		5_Others	81.82	0.3680981595092024		unknown	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		81.82	0.36809817	10-90	70-90						D	60			81.82	Negatively-charged	Aspartic Acid		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase	0.8539		-3.5			2 interactions	4 interactions	1 interaction			D486-K375; PAE: 4.0	4 interactions		5 interactions							132									54.8		Pocket 1: Mean pLDDT: 90.5, Volume: 729.78 Å³, Druggability score: 0.85		24.6				dbSNP: rs397516815; Variant type: LP/P; AA change: Asp486Gly; PTM type: Phosphorylation; PTM morphology: LHEGLtVKIGD*; Var class: II&rs80338798		C (loop/coil)	S (bend)																																																																				true	RAF1Asp486Asn																																																																																																																																																																																																																																		
F9	F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6606398915821818	0.48556902667723223	0.70813704438078	0.6355392714821195	0.585427423605482	0.6355069577937184	0.6587303270483099	0.6876251281328446	0.5374405565953059	0.6652840299340169	0.5353478894172454	0.612348215915929	0.7286489606287152	0.43369749675915864	0.6559957532303466	F9	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6606398915821818	0.48556902667723223	0.70813704438078	0.6355392714821195	0.585427423605482	0.6355069577937184	0.6587303270483099	0.6876251281328446	0.5374405565953059	0.6652840299340169	0.5353478894172454	0.612348215915929	0.7286489606287152	0.43369749675915864	0.6559957532303466	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A	769G>A	Val257Ile																												23.0	139560786.0	G	A	X						X-139560786-G-A	227419.0	single nucleotide variant	NM_000133.4(F9):c.769G>A (p.Val257Ile)	2158.0	F9	HGNC:3551	Conflicting classifications of pathogenicity	0.0	Aug 18, 2024	200608775.0	-	RCV000862519|RCV000490374|RCV003917862	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline	germline	GRCh38	NC_000023.11	X	139560786.0	139560786.0	Xq27.1	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA10529834	2.0	225354.0	139560786.0	G	A	-	-	-	-	-	-	SCV000267310|SCV000481885|SCV001003033	-	-	769G>A 	Val257Ile	NM_000133.4	1.0	3_Conflicting		225354.0	X	139560786.0	G	A	V	I	rs200608775	X	138642945.0	X	138470611.0	257.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.769G>A	p.Val257Ile	c.769G>A	p.Val257Ile	principal1	Y	1	YES	Select	+	GTT	1.0	0.0	G	G/G	G/G	G/G	G/G	0.488	0.08092	T	0.41	0.14754	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.21442	N	simple_aae	93.0	7.0	-1.135	0.00932	N	0.81	0.01825	N	0.396	0.66533	-0.855	0.51428	T	0.2284	0.59203	T	10.0	0.025891602	0.00768	T	0.068982	0.70500	D	0.483	0.77150	.	.	.	.	.	0.975202009541	0.97469	0.8969268504407544	0.89598	0.51541283519	0.49159	0.24926649034	0.03692	T	0.385448	0.74512	T	-0.276942	0.10755	T	-0.195212	0.54792	T	0.0201428491067639	0.00712	T	0.808919	0.50832	T	0.050574146	0.09073	0.1163571	0.28024	0.07762356	0.17469	0.10740013	0.25799	-0.934	0.01014	T	0.0601	0.01289	B	0.0165363210494945	0.27901	0.99979204	0.99726	0.068	0.19020	.	.	.	.	.	.	-1.717606	0.00187	0.003	0.6103820101949828	0.06705	.	.	.	.	.	.	.	.	.	5.84	-5.82	0.02145	-10.4	0.00170	-0.992	0.03838	-0.886000	0.07077	-0.272	0.06718	0.0	0.06393	0.0	0.08389	0.82	0.3867	924	0.18019	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	28	264690	1.0578412E-4	.	8	80322	9.959910e-05	0	22	151849	1.448810e-04	0	23	172240	1.335350e-04	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	8	6916	1.156740e-03	0	0	9912	0.000000e+00	0	0	30957	0.000000e+00	0	0	9952	0.000000e+00	0	8	6916	1.156740e-03	0	0	13134	0.000000e+00	0	1	24390	4.100040e-05	0	0	4649	0.000000e+00	0	20	10127	1.974920e-03	0	1	12170	8.216930e-05	0	0	64682	0.000000e+00	0	0	19072	0.000000e+00	0	20	10127	1.974920e-03	0	0	12064	0.000000e+00	0	1	27168	3.680800e-05	0	0	7083	0.000000e+00	0	21	13318	1.576810e-03	0	1	15975	6.259780e-05	0	0	73479	0.000000e+00	0	0	19007	0.000000e+00	0	21	13318	1.576810e-03	0	.	231	1209089	1.910530e-04	1	203	33751	6.014640e-03	1	7	57201	1.223750e-04	0	0	684	0.000000e+00	0	2	45735	4.373020e-05	0	0	22020	0.000000e+00	0	203	33751	6.014640e-03	1	4	46494	8.603260e-05	0	1	4350	2.298850e-04	0	8	894497	8.943570e-06	0	0	56760	0.000000e+00	0	1	92828	1.0772611711983453E-5	1	168	0.005952380952380952	17	2680	0.006343283582089552	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	1	4188	2.387774594078319E-4	17	3306	0.00514216575922565	19	104028	1.8264313454070057E-4	Conflicting_classifications_of_pathogenicity	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_conflicting_classifications	NC_000023.11:g.139560786G>A	ClinGen:CA10529834	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	227419.0	single nucleotide variant	NM_000133.4(F9):c.769G>A (p.Val257Ile)	2158.0	F9	HGNC:3551	Conflicting classifications of pathogenicity	0.0	Aug 18, 2024	200608775.0	-	RCV000862519|RCV000490374|RCV003917862	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline	germline	GRCh38	NC_000023.11	X	139560786.0	139560786.0	Xq27.1	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA10529834	2.0	225354.0	139560786.0	G	A	-	-	-	-	-	-	SCV000267310|SCV000481885|SCV001003033	-	-	769G>A 	Val257Ile	NM_000133.4	1.0	3_Conflicting	97.45	0.028169014084507	['300807', '306900', '306900']	unknown	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; HEMOPHILIA B	97.45	0.028169014	<10	>90						V	4			97.45	Aliphatic	Valine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1	0.2107		4.2								V257-W261; PAE: 1.0	3 interactions	V257-V263; PAE: 1.0	6 interactions							117									-89.4		Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21		-42.5						C (loop/coil)	C (loop/coil)	Beta strand																													0.251		0.193	2 mutation(s) (Val257Pro: -0.019, Val257Asn: -0.002)	0.189	2 mutation(s) (Val257Pro: -0.010, Val257His: -0.006)	0.172	2 mutation(s) (Val257Pro: -0.009, Val257His: -0.005)	0.168	1 mutation(s) (Val257His: -0.012)																													true	F9Val257Ile																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Arg198Gln	-4.669579694535985	0.0022886216209041625	7.053550426742774	0.0002017525172681343	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9131549147764659	0.5824338474841486	0.8526514977801717	0.846311357539621	0.7063604692120679	0.6162865094081145	0.8397023423212076	0.7860623351426326	0.5328589394680393	0.8895967094541701	0.7964344290160212	0.8529203727580343	0.9192406604177108	0.632008755500258	0.9367131200987617	ZC4H2	-4.669579694535985	0.0022886216209041625	7.053550426742774	0.0002017525172681343	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9131549147764659	0.5824338474841486	0.8526514977801717	0.846311357539621	0.7063604692120679	0.6162865094081145	0.8397023423212076	0.7860623351426326	0.5328589394680393	0.8895967094541701	0.7964344290160212	0.8529203727580343	0.9192406604177108	0.632008755500258	0.9367131200987617	ZC4H2		4320		CCSBVarC009191		NC_000023.11:64917865:C:T	593G>A	Arg198Gln																												23.0	64917865.0	C	T	X						X-64917865-C-T	65652.0	single nucleotide variant	NM_018684.4(ZC4H2):c.593G>A (p.Arg198Gln)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	May 27, 2023	879255235.0	-	RCV000043677|RCV000498696|RCV001770066	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MedGen:C3661900|MONDO:MONDO:0026762,MedGen:C5393303,OMIM:301041	Wieacker-Wolff syndrome|not provided|Wieacker-Wolff syndrome, female-restricted	germline;unknown	germline	GRCh38	NC_000023.11	X	64917865.0	64917865.0	Xq11.2	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA10575580,UniProtKB:Q9NQZ6#VAR_069622,OMIM:300897.0002	3.0	50981.0	64917865.0	C	T	-	-	-	-	-	-	SCV000589376|SCV002011544|SCV002512603|SCV002521347|SCV004040963	-	-	593G>A 	Arg198Gln	NM_018684.4	2.0	1_Pathogenic		50981.0	X	64917865.0	C	T	R	Q	rs879255235	X	64137745.0	X	64054470.0	198.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.593G>A	p.Arg198Gln	c.593G>A	p.Arg198Gln	principal1	Y	1	YES	Select	-	CGG	2.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.009	0.67073	D	0.998	0.73231	D	0.988	0.77983	D	0.93	0.94378	A	simple_aae	7.0	93.0	.	.	.	-3.56	0.68915	D	0.865	0.89118	-0.0594	0.8092	T	0.4448	0.78059	T	8.0	0.91766816	0.91026	D	0.931883	0.99506	D	0.540	0.80683	0.558	0.67570	Q9NQZ6	R198Q	Loss of MoRF binding (P = 0.0352)| Loss of helix (P = 0.1299)| Gain of relative solvent accessibility (P = 0.1684)| Gain of catalytic residue at R198 (P = 0.2542)| Gain of loop (P = 0.3485)	0.896646558922	0.89483	0.6985962743898447	0.69647	3.04366087562	0.99279	0.863531589508	0.91618	D	0.861236	0.96898	D	0.619807	0.98328	D	0.652534	0.983	D	0.998395621776581	0.93976	D	0.974003	0.91550	D	0.8665144	0.88431	0.84589994	0.91114	0.8701332	0.88719	0.84851253	0.91292	-14.555	0.95182	D	0.9999	0.99795	P	0.999345122363188	0.96318	0.99758303	0.98429	0.99	0.99661	.	.	.	.	.	.	5.374841	0.90114	31.0	0.9995493317875814	0.99969	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.301	0.78228	7.539000	0.60115	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.995	0.73271	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Wieacker-Wolff_syndrome,_female-restricted|Wieacker-Wolff_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917865C>T	ClinGen:CA10575580|OMIM:300897.0002|UniProtKB:Q9NQZ6#VAR_069622	CN517202|C5393303|C0796200	301041|314580	3454|85283	Zinc finger C4H2-type	Arg	Gln	65652.0	single nucleotide variant	NM_018684.4(ZC4H2):c.593G>A (p.Arg198Gln)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	May 27, 2023	879255235.0	-	RCV000043677|RCV000498696|RCV001770066	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MedGen:C3661900|MONDO:MONDO:0026762,MedGen:C5393303,OMIM:301041	Wieacker-Wolff syndrome|not provided|Wieacker-Wolff syndrome, female-restricted	germline;unknown	germline	GRCh38	NC_000023.11	X	64917865.0	64917865.0	Xq11.2	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA10575580,UniProtKB:Q9NQZ6#VAR_069622,OMIM:300897.0002	3.0	50981.0	64917865.0	C	T	-	-	-	-	-	-	SCV000589376|SCV002011544|SCV002512603|SCV002521347|SCV004040963	-	-	593G>A 	Arg198Gln	NM_018684.4	2.0	1_Pathogenic	88.17	0.4435483870967742	['314580', '301041']	unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME; WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED	88.17	0.44354838	10-90	70-90						R	110			88.17	Positively-charged	Arginine		Zinc finger C4H2 domain-containing protein										-4.5								R198-K187, R198-P185; PAE: 2.0, 3.5		R198-P185; PAE: 3.5								175									-53.7				-30.5						C (loop/coil)	T (turn)											C4H2-type																																																									true	ZC4H2Arg198Gln																																																																																																																																																																																																																																		
SDHD	SDHD_Ala90Val	3.9356948777612146	0.00674516202223278	1.0316194490045099	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7513748763178676	0.6751442894604585	0.7201777095126854	0.7556810559565751	0.7039158792957778	0.7664720793721204	0.7787970486630793	0.726195561365361	0.7396530881799547	0.7485959972249652	0.6413596792194352	0.7325650632500709	0.7141598576600099	0.6106354907409622	0.75415375541077	SDHD	3.9356948777612146	0.00674516202223278	1.0316194490045099	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7513748763178676	0.6751442894604585	0.7201777095126854	0.7556810559565751	0.7039158792957778	0.7664720793721204	0.7787970486630793	0.726195561365361	0.7396530881799547	0.7485959972249652	0.6413596792194352	0.7325650632500709	0.7141598576600099	0.6106354907409622	0.75415375541077	SDHD		6363		CCSBVarC023308		NC_000011.10:112088966:C:T	269C>T	Ala90Val																												11.0	112088966.0	C	T	11						11-112088966-C-T	398394.0	single nucleotide variant	NM_003002.4(SDHD):c.269C>T (p.Ala90Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Nov 06, 2024	200255724.0	-	RCV000562410|RCV001584171|RCV001821298|RCV002230663	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Hereditary cancer-predisposing syndrome|not provided|not specified|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3	germline;unknown	germline	GRCh38	NC_000011.10	11	112088966.0	112088966.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA070974	2.0	412511.0	112088966.0	C	T	-	-	-	-	-	-	SCV000554063|SCV000675115|SCV001811695|SCV002065336|SCV002774237	-	-	269C>T 	Ala90Val	NM_003002.4	1.0	3_Conflicting		412511.0	11	112088966.0	C	T	A	V	rs200255724	11	111959690.0	11	111464900.0	90.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.269C>T	p.Ala90Val	c.269C>T	p.Ala90Val	principal1	Y	1	YES	Select	+	GCG	2.0	0.0	C	./.	./.	./.	./.	0.458	0.15912	T	1.0	0.17298	T	0.006	0.13655	B	0.002	0.06938	B	0.13	0.45549	N	simple_aae	87.0	13.0	-0.4	0.02998	N	-0.49	0.18604	N	0.325	0.37474	-0.0242	0.8167	T	0.7223	0.90456	D	10.0	0.033454627	0.01525	T	0.039239	0.58532	D	0.538	0.80564	0.554	0.67018	O14521	A90V	Gain of catalytic residue at A90 (P = 0.0619)| Loss of glycosylation at S94 (P = 0.2021)| Loss of helix (P = 0.3949)| Gain of solvent accessibility (P = 0.4304)| Loss of sheet (P = 0.5184)	0.97841390163	0.97797	0.6562659735392878	0.65397	0.186988364634	0.20745	0.404172539711	0.25620	T	0.612815	0.87639	D	-0.096085	0.36716	T	0.0203817	0.71444	D	0.0642470002855991	0.0773	T	0.778722	0.41636	T	0.025199682	0.01422	0.04753903	0.06884	0.025199682	0.01422	0.04753903	0.06884	-3.974	0.23434	T	0.063	0.13138	B	0.0286794542137332	0.32439	0.96888520	0.94571	0.063	0.17447	.	.	.	.	.	.	1.598506	0.20471	14.75	0.9692504179838964	0.31823	0.374914	0.45781	N	-0.764187358777515	0.14078	0.7083525	-0.647685205617222	0.17985	0.9755563	5.04	1.52	0.22101	.	.	0.348	0.19856	-0.210000	0.10908	0.549	0.27038	0.03	0.20497	0.0	0.08389	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	17	109406	1.553850e-04	0	32	208128	1.537520e-04	0	31	236928	1.308410e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	17	15690	1.083490e-03	0	17	15690	1.083490e-03	0	0	16218	0.000000e+00	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	0	16734	0.000000e+00	0	2	89554	2.233290e-05	0	28	30608	9.147940e-04	0	28	30608	9.147940e-04	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21632	0.000000e+00	0	2	102728	1.946890e-05	0	28	30526	9.172510e-04	0	28	30526	9.172510e-04	0	.	119	1614014	7.372920e-05	1	101	91090	1.108790e-03	1	0	74936	0.000000e+00	0	0	912	0.000000e+00	0	2	60008	3.332890e-05	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64032	0.000000e+00	0	0	6060	0.000000e+00	0	15	1179998	1.271190e-05	0	101	91090	1.108790e-03	1	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|not_specified	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088966C>T	ClinGen:CA070974	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|CN169374	606864|171300	140162|97286|29072|201	.	Ala	Val	398394.0	single nucleotide variant	NM_003002.4(SDHD):c.269C>T (p.Ala90Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Nov 06, 2024	200255724.0	-	RCV000562410|RCV001584171|RCV001821298|RCV002230663	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Hereditary cancer-predisposing syndrome|not provided|not specified|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3	germline;unknown	germline	GRCh38	NC_000011.10	11	112088966.0	112088966.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA070974	2.0	412511.0	112088966.0	C	T	-	-	-	-	-	-	SCV000554063|SCV000675115|SCV001811695|SCV002065336|SCV002774237	-	-	269C>T 	Ala90Val	NM_003002.4	1.0	3_Conflicting	98.3	0.6320754716981132	['171300', '606864']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	98.3	0.6320755	10-90	>90						A	67			98.3	Aliphatic	Alanine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										1.8								A90-S94; PAE: 1.0	1 interaction	A90-S94; PAE: 1.0	1 interaction							89									-61.7				-36.6						H (helix)	H (α-helix)	Helix						Mitochondrial intermembrane																																																													true	SDHDAla90Val																																																																																																																																																																																																																																		
F9	F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8753492471914457	0.6586565610878954	0.8529502163528302	0.7592628211426117	0.649607362703761	0.78191504566733	0.7122875845034075	0.8195747191013218	0.6111011003177287	0.8207417031739346	0.5172996797401919	0.8062380577818159	0.8863257136043384	0.7062120218580621	0.9299567912089567	F9	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8753492471914457	0.6586565610878954	0.8529502163528302	0.7592628211426117	0.649607362703761	0.78191504566733	0.7122875845034075	0.8195747191013218	0.6111011003177287	0.8207417031739346	0.5172996797401919	0.8062380577818159	0.8863257136043384	0.7062120218580621	0.9299567912089567	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A	1183T>A	Phe395Ile																												23.0	139561868.0	T	A	X						X-139561868-T-A	1386208.0	single nucleotide variant	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 18, 2021	1175050951.0	-	RCV001905309	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561868.0	139561868.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414446355	2.0	1364269.0	139561868.0	T	A	-	-	-	-	-	-	SCV002132959	-	-	1183T>A 	Phe395Ile	NM_000133.4	1.0	1_Pathogenic		1364269.0	X	139561868.0	T	A	F	I	rs1175050951	X	138644027.0	X	138471693.0	395.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1183T>A	p.Phe395Ile	c.1183T>A	p.Phe395Ile	principal1	Y	1	YES	Select	+	TTC	1.0	0.0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.98	0.74847	D	1.0	0.99291	D	simple_aae	0.0	100.0	0.935	0.23470	L	-5.97	0.89297	D	0.694	0.95387	0.3983	0.89027	D	0.6139	0.86302	D	10.0	0.98510087	0.98730	D	0.874725	0.99041	D	0.891	0.96866	0.903	0.97889	P00740	F395I	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.999082510293	0.99905	0.9980519219227515	0.99804	1.94421044628	0.93244	0.69013696909	0.65668	T	0.860248	0.96868	D	0.52535	0.94991	D	0.516853	0.94917	D	0.99892920255661	0.95561	D	0.906209	0.66886	D	0.9748932	0.98675	0.9731375	0.99587	0.9870631	0.99591	0.9672711	0.99332	-7.756	0.63197	D	0.6552	0.73049	P	0.999904283247364	0.98723	0.99998820	0.99996	0.995	0.99826	.	.	.	.	.	.	4.455722	0.69364	25.4	0.9920560539460055	0.55483	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.991	0.87929	7.926000	0.74810	0.665	0.62996	1.0	0.71675	1.0	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139561868T>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Phe	Ile	1386208.0	single nucleotide variant	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 18, 2021	1175050951.0	-	RCV001905309	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561868.0	139561868.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414446355	2.0	1364269.0	139561868.0	T	A	-	-	-	-	-	-	SCV002132959	-	-	1183T>A 	Phe395Ile	NM_000133.4	1.0	1_Pathogenic	95.32	0.0761421319796954	['306900', '300807']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	95.32	0.07614213	<10	>90						F	15			95.32	Aromatic	Phenylalanine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			2.8								F395-Y444; PAE: 1.0	3 interactions	F395-Y444; PAE: 1.0	6 interactions							165									-141.1				160.4						B (undefined)	E (parallel sheets)	Beta strand																													0.275		0.118		0.102		0.097		0.092																														true	F9Phe395Ile																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Ala200Thr	-5.682062973976312	0.0007491281331314925	7.059848916684998	0.00020063357271856742	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9196991459272627	0.7304535969529005	0.8990424016466309	0.8704081218100768	0.7398127866703845	0.6924139725116503	0.8069410503271048	0.8467151459798945	0.6814470523169307	0.8641759199854547	0.7872116008291187	0.9338751932930486	0.9513696573133672	0.7794601415888701	0.9752223718690706	ZC4H2	-5.682062973976312	0.0007491281331314925	7.059848916684998	0.00020063357271856742	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9196991459272627	0.7304535969529005	0.8990424016466309	0.8704081218100768	0.7398127866703845	0.6924139725116503	0.8069410503271048	0.8467151459798945	0.6814470523169307	0.8641759199854547	0.7872116008291187	0.9338751932930486	0.9513696573133672	0.7794601415888701	0.9752223718690706	ZC4H2		4320		CCSBVarC009163		NC_000023.11:64917860:C:T	598G>A	Ala200Thr																												23.0	64917860.0	C	T	X						X-64917860-C-T	920050.0	single nucleotide variant	NM_018684.4(ZC4H2):c.598G>A (p.Ala200Thr)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 23, 2020	1929006117.0	-	RCV001197017	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	unknown	unknown	GRCh38	NC_000023.11	X	64917860.0	64917860.0	Xq11.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA413411194	2.0	930963.0	64917860.0	C	T	-	-	-	-	-	-	SCV001367652	-	-	598G>A 	Ala200Thr	NM_018684.4	1.0	1_Pathogenic		930963.0	X	64917860.0	C	T	A	T	rs1929006117	X	64137740.0	X	64054465.0	200.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.598G>A	p.Ala200Thr	c.598G>A	p.Ala200Thr	principal1	Y	1	YES	Select	-	GCA	1.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.997	0.70687	D	0.994	0.82066	D	0.97	0.96253	A	simple_aae	3.0	97.0	.	.	.	-3.52	0.68446	D	0.866	0.87678	-0.8962	0.4817	T	0.1833	0.52977	T	8.0	0.8993199	0.89172	D	0.645518	0.96983	D	0.493	0.77793	0.541	0.65184	Q9NQZ6	A200T	Gain of phosphorylation at A200 (P = 0.0325)| Loss of MoRF binding (P = 0.1211)| Loss of helix (P = 0.1299)| Loss of catalytic residue at A200 (P = 0.3072)| Loss of stability (P = 0.3362)	0.883420790715	0.88137	0.8527665168203684	0.85148	3.0674637903	0.99314	0.833977639675	0.87150	D	0.861348	0.96901	D	0.478681	0.93601	D	0.449816	0.93521	D	0.997183978557587	0.90886	D	0.958704	0.85578	D	0.8956946	0.90872	0.8811168	0.93554	0.8956946	0.90873	0.8811168	0.93554	-11.278	0.81389	D	0.9998	0.99584	P	0.992700566218043	0.89650	0.99633140	0.98026	0.997	0.99892	.	.	.	.	.	.	5.023812	0.83539	28.1	0.9994258080004339	0.99824	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.301	0.78228	7.539000	0.60115	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.997	0.79771	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	criteria_provided,_single_submitter	NC_000023.11:g.64917860C>T	.	C0796200	314580	3454|85283	Zinc finger C4H2-type	Ala	Thr	920050.0	single nucleotide variant	NM_018684.4(ZC4H2):c.598G>A (p.Ala200Thr)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 23, 2020	1929006117.0	-	RCV001197017	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	unknown	unknown	GRCh38	NC_000023.11	X	64917860.0	64917860.0	Xq11.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA413411194	2.0	930963.0	64917860.0	C	T	-	-	-	-	-	-	SCV001367652	-	-	598G>A 	Ala200Thr	NM_018684.4	1.0	1_Pathogenic	86.6	0.1792452830188679	['314580']	unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	86.6	0.17924528	10-90	70-90						A	19			86.6	Aliphatic	Alanine		Zinc finger C4H2 domain-containing protein								0.1134		1.8								A200-K187; PAE: 2.0		A200-S210; PAE: 4.5								89									-60.6		Pocket 1: Mean pLDDT: 78.68, Volume: 1167.67 Å³, Druggability score: 0.11		125.7						C (loop/coil)	C (loop/coil)											C4H2-type																																																									true	ZC4H2Ala200Thr																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Arg211Trp	-11.187153169578217	0.00001016631686776567	7.731852774534217	0.00011324258461463719	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9594074709833893	0.783491769352343	0.9264719153717538	0.8980883632668015	0.7850744938943852	0.7362756564933739	0.8753523082842992	0.9020731924419153	0.7336457636726176	0.9440339686968097	0.8338733312953966	0.9208244182493037	0.9508706383015921	0.8333377750320684	0.9747809732699688	ZC4H2	-11.187153169578217	0.00001016631686776567	7.731852774534217	0.00011324258461463719	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9594074709833893	0.783491769352343	0.9264719153717538	0.8980883632668015	0.7850744938943852	0.7362756564933739	0.8753523082842992	0.9020731924419153	0.7336457636726176	0.9440339686968097	0.8338733312953966	0.9208244182493037	0.9508706383015921	0.8333377750320684	0.9747809732699688	ZC4H2		4320		CCSBVarC009207		NC_000023.11:64917827:G:A	631C>T	Arg211Trp																												23.0	64917827.0	G	A	X						X-64917827-G-A	446729.0	single nucleotide variant	NM_018684.4(ZC4H2):c.631C>T (p.Arg211Trp)	55906.0	ZC4H2	HGNC:24931	Likely pathogenic	1.0	Feb 27, 2024	1555933616.0	-	RCV000521213|RCV004758699|RCV001375995	MedGen:C3661900||Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	not provided|ZC4H2-related disorder|Wieacker-Wolff syndrome	germline;maternal	germline	GRCh38	NC_000023.11	X	64917827.0	64917827.0	Xq11.2	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA413411099	2.0	451159.0	64917827.0	G	A	-	-	-	-	-	-	SCV000619821|SCV001572998|SCV002581693|SCV005880170	-	-	631C>T 	Arg211Trp	NM_018684.4	2.0	1_Pathogenic		451159.0	X	64917827.0	G	A	R	W	rs1555933616	X	64137707.0	X	64054432.0	211.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.631C>T	p.Arg211Trp	c.631C>T	p.Arg211Trp	principal1	Y	1	YES	Select	-	CGG	1.0	2.0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.993	0.81117	D	0.86	0.90832	A	simple_aae	14.0	86.0	.	.	.	-7.09	0.93964	D	0.739	0.76009	-0.0594	0.8092	T	0.4448	0.78059	T	8.0	0.9010761	0.89353	D	0.951091	0.99664	D	0.659	0.87175	0.543	0.65470	Q9NQZ6	R211W	Gain of glycosylation at K207 (P = 0.1309)| Gain of methylation at K209 (P = 0.1951)| Loss of MoRF binding (P = 0.2024)| Loss of helix (P = 0.2662)| Loss of solvent accessibility (P = 0.2668)	0.962268395915	0.96153	0.7471255375488876	0.74521	3.13339230401	0.99404	0.906362950802	0.97112	D	0.864508	0.96996	D	0.550822	0.95775	D	0.553441	0.95711	D	0.99964702129364	0.98285	D	0.950905	0.82300	D	0.9233236	0.93476	0.92333007	0.96584	0.92091435	0.93238	0.9177878	0.96190	-14.699	0.95317	D	0.9995	0.99217	P	0.998500480413866	0.94564	0.99873880	0.98937	0.997	0.99892	.	.	.	.	.	.	5.163537	0.86543	28.9	0.9992038374274536	0.98722	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.42	0.61925	7.402	0.79258	6.482000	0.55808	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.997	0.79771	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Wieacker-Wolff_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917827G>A	ClinGen:CA413411099	C3661900|C0796200	314580	3454|85283	Zinc finger C4H2-type	Arg	Trp	446729.0	single nucleotide variant	NM_018684.4(ZC4H2):c.631C>T (p.Arg211Trp)	55906.0	ZC4H2	HGNC:24931	Likely pathogenic	1.0	Feb 27, 2024	1555933616.0	-	RCV000521213|RCV004758699|RCV001375995	MedGen:C3661900||Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	not provided|ZC4H2-related disorder|Wieacker-Wolff syndrome	germline;maternal	germline	GRCh38	NC_000023.11	X	64917827.0	64917827.0	Xq11.2	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA413411099	2.0	451159.0	64917827.0	G	A	-	-	-	-	-	-	SCV000619821|SCV001572998|SCV002581693|SCV005880170	-	-	631C>T 	Arg211Trp	NM_018684.4	2.0	1_Pathogenic	78.85	0.8064516129032258	['314580']	unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	78.85	0.8064516	10-90	70-90						R	200			78.85	Positively-charged	Arginine		Zinc finger C4H2 domain-containing protein										-4.5																		175									-115.1				133.9						C (loop/coil)	C (loop/coil)																																																																				true	ZC4H2Arg211Trp																																																																																																																																																																																																																																		
FANCC	FANCC_Leu496Arg	-1.549280011711085	0.1652455454136042	-6.82618618656796	0.0002472608798740025	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9312944150106531	0.8392744035218858	0.8892406685088661	0.8792753045263234	0.6952172565939935	0.6463386509857353	0.8060808157714119	0.8497309349742465	0.8065596656809763	0.8949602032890903	0.7440958622022517	0.9524697932812349	0.9287504020434858	0.8719891413627952	0.967628626732216	FANCC	-1.549280011711085	0.1652455454136042	-6.82618618656796	0.0002472608798740025	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9312944150106531	0.8392744035218858	0.8892406685088661	0.8792753045263234	0.6952172565939935	0.6463386509857353	0.8060808157714119	0.8497309349742465	0.8065596656809763	0.8949602032890903	0.7440958622022517	0.9524697932812349	0.9287504020434858	0.8719891413627952	0.967628626732216	FANCC	ENSG00000158169	7699	13989.0	CCSBVarC001230	ALE00001230	NC_000009.12:95107112:A:C	1487T>G	Leu496Arg	RC4	RC4_Mut_GDEh1009	C09	GDEhDisVCh_40044	F07	2.0	RC4_Mut_GDDh1009	C09							1.0	1.0	1.0	1.0	0.0			0.0			0.0			9.0	95107112.0	A	C	9	Y	Y	N	N	N	9-95107112-A-C	27089.0	single nucleotide variant	NM_000136.3(FANCC):c.1487T>G (p.Leu496Arg)	2176.0	FANCC	HGNC:3584	Pathogenic	1.0	Aug 01, 1999	121917785.0	-	RCV000012830	MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84	Fanconi anemia complementation group C	germline	germline	GRCh38	NC_000009.12	9	95107112.0	95107112.0	9q22.32	no assertion criteria provided	1.0	-	N	ClinGen:CA256207,UniProtKB:Q00597#VAR_005232,OMIM:613899.0008	1.0	12050.0	95107112.0	A	C	-	-	-	-	-	-	SCV000033070	-	-	1487T>G 	Leu496Arg	NM_000136.3		1_Pathogenic		12050.0	9	95107112.0	A	C	L	R	rs121917785	9	97869394.0	9	96909215.0	496.0	FANCC	ENSG00000158169	ENST00000289081	ENSP00000289081	Q00597	FANCC_HUMAN	c.1487T>G	p.Leu496Arg	c.1487T>G	p.Leu496Arg	principal1	Y	1	YES	Select	-	CTC	2.0	0.0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.99	0.78943	D	0.74	0.84487	A	simple_aae	26.0	74.0	2.395	0.69015	M	-5.08	0.82920	D	0.944	0.95151	-0.0954	0.80115	T	0.3623	0.72245	T	9.0	0.9910704	0.99622	D	0.041256	0.59673	D	0.522	0.79598	0.932	0.98955	Q00597	L496R	Gain of MoRF binding (P = 0.0166)| Gain of methylation at L496 (P = 0.0294)| Gain of solvent accessibility (P = 0.0584)| Gain of relative solvent accessibility (P = 0.09)| Loss of stability (P = 0.101)	0.91854953846	0.91711	0.7235648123959582	0.72155	0.400379318551	0.40752	0.527930855751	0.42681	T	0.502392	0.82079	D	0.30647	0.83356	D	0.202447	0.83141	D	0.990214049816132	0.80281	D	.	0.39699	.	0.87331074	0.88974	0.7835274	0.87085	0.8566318	0.87667	0.77439195	0.86521	-6.134	0.47446	T	0.5133	0.65167	A	0.939888730715306	0.79344	0.95983505	0.93950	0.809	0.89444	.	.	.	.	.	.	3.643055	0.51746	23.1	0.9973758894049084	0.8328	0.455600	0.50611	N	0.551271328372298	0.70000	5.460852	0.462495863549082	0.65336	4.834584	4.94	4.94	0.646	5.03	0.90264	5.392	0.66097	11.055000	0.85376	0.756	0.943	1.0	0.71675	1.0	0.68239	0.023	0.12113	167	0.93511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Fanconi_anemia_complementation_group_C	no_assertion_criteria_provided	NC_000009.12:g.95107112A>C	ClinGen:CA256207|OMIM:613899.0008|UniProtKB:Q00597#VAR_005232	C3468041	227645	84	.	Leu	Arg	27089.0	single nucleotide variant	NM_000136.3(FANCC):c.1487T>G (p.Leu496Arg)	2176.0	FANCC	HGNC:3584	Pathogenic	1.0	Aug 01, 1999	121917785.0	-	RCV000012830	MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84	Fanconi anemia complementation group C	germline	germline	GRCh38	NC_000009.12	9	95107112.0	95107112.0	9q22.32	no assertion criteria provided	1.0	-	N	ClinGen:CA256207,UniProtKB:Q00597#VAR_005232,OMIM:613899.0008	1.0	12050.0	95107112.0	A	C	-	-	-	-	-	-	SCV000033070	-	-	1487T>G 	Leu496Arg	NM_000136.3		1_Pathogenic	88.47	0.0121951219512195	['227645']	autosomal recessive	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Inherited cancer-predisposing syndrome	6	FANCONI ANEMIA, COMPLEMENTATION GROUP C	88.47	0.0121951215	<10	70-90						L	2			88.47	Aliphatic	Leucine		Fanconi anemia group C protein										3.8								L496-H502, L496-S543, L496-L492; PAE: 2.0, 3.0, 1.0		L496-H502, L496-S543, L496-L492; PAE: 2.0, 3.0, 1.0								131									-84.2				-26.7						H (helix)	H (α-helix)																																																																				true	FANCCLeu496Arg																																																																																																																																																																																																																																		
CTCF	CTCF_Arg342Gly	6.0220837101592055	0.0005304623673855454	1.3306764800790363	0.22500413846281694	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9282483217528718	0.747863898413595	0.815795065936776	0.8033904919524901	0.6410643683227852	0.6738743571694993	0.8386015774173865	0.823922261253352	0.7704360005544952	0.9362891247658401	0.6082543794760712	0.7681794064875938	0.8076678706202	0.7252917962726947	0.9202075187399034	CTCF	6.0220837101592055	0.0005304623673855454	1.3306764800790363	0.22500413846281694	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9282483217528718	0.747863898413595	0.815795065936776	0.8033904919524901	0.6410643683227852	0.6738743571694993	0.8386015774173865	0.823922261253352	0.7704360005544952	0.9362891247658401	0.6082543794760712	0.7681794064875938	0.8076678706202	0.7252917962726947	0.9202075187399034	CTCF		6173		CCSBVarC010867		NC_000016.10:67616816:C:G	1024C>G	Arg342Gly																												16.0	67616816.0	C	G	16						16-67616816-C-G	1166187.0	single nucleotide variant	NM_006565.4(CTCF):c.1024C>G (p.Arg342Gly)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Feb 01, 2021	1131691283.0	-	RCV001532325	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000016.10	16	67616816.0	67616816.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA396312242	2.0	1176667.0	67616816.0	C	G	-	-	-	-	-	-	SCV001747837	-	-	1024C>G 	Arg342Gly	NM_006565.4	1.0	1_Pathogenic		1176667.0	16	67616816.0	C	G	R	G	rs1131691283	16	67650719.0	16	66208220.0	342.0	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.1024C>G	p.Arg342Gly	c.1024C>G	p.Arg342Gly	principal4	Y	.	.	.	+	CGT	1.0	0.0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.79703	.	0.997	0.70687	D	0.993	0.81117	D	.	0.93829	.	.	.	.	2.485	0.72164	M	.	0.91330	.	.	0.79815	-0.8813	0.4946	T	0.1541	0.48246	T	10.0	0.8994916	0.89190	D	0.046837	0.62502	D	.	0.85178	0.787	0.90945	P49711	R342G	Loss of stability (P = 0.0064)| Loss of MoRF binding (P = 0.0492)| Gain of methylation at K344 (P = 0.0961)| Gain of phosphorylation at Y343 (P = 0.1164)| Loss of disorder (P = 0.1303)	.	0.90579	.	0.96335	.	0.99365	0.949047386646	0.99729	D	0.857179	0.96774	D	0.260551	0.79429	D	0.136487	0.79163	D	0.986837384407801	0.77291	D	.	0.80202	.	0.9000301	0.91262	0.84071624	0.90766	0.9000301	0.91263	0.84071624	0.90766	-15.136	0.96171	D	.	0.97655	.	0.999648397760086	0.97310	0.96604900	0.94367	0.857	0.92182	.	.	.	.	.	.	4.995947	0.82886	27.9	0.9969336090574403	0.80133	0.947897	0.95882	D	0.75661128044812	0.83245	7.990627	0.730908088587966	0.84641	8.37291	4.89	4.89	0.63341	.	.	7.701	0.83585	7.609000	0.61899	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.995	0.73271	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67616816C>G	.	C3661900	.	.	.	Arg	Gly	1166187.0	single nucleotide variant	NM_006565.4(CTCF):c.1024C>G (p.Arg342Gly)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Feb 01, 2021	1131691283.0	-	RCV001532325	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000016.10	16	67616816.0	67616816.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA396312242	2.0	1176667.0	67616816.0	C	G	-	-	-	-	-	-	SCV001747837	-	-	1024C>G 	Arg342Gly	NM_006565.4	1.0	1_Pathogenic	86.65	0.407258064516129		unknown		0		86.65	0.40725806	10-90	70-90						R	101			86.65	Positively-charged	Arginine		Transcriptional repressor CTCF										-4.5								R342-V338; PAE: 1.0	9 interactions	R342-H347, R342-E348, R342-V338, R342-T346; PAE: 3.0, 4.5, 1.0, 3.0	12 interactions							175									-65.5				-35.5				dbSNP: -; Variant type: US; AA change: Arg342His; PTM type: Phosphorylation; PTM morphology: VRHRR*yKHtHE; Var class: II&-		H (helix)	H (α-helix)	Helix										C2H2-type 3																																																									true	CTCFArg342Gly																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Ile7Val	-1.3973623365001806	0.20499887214456444	6.065888508703813	0.0005079045702971349	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9214858818341379	0.6908215531847735	0.8665145971630663	0.9152600307719636	0.7472634267187199	0.7632383538736797	0.8936149046548247	0.8389151966396824	0.6777458244127534	0.8807897003645184	0.7312884995637603	0.9369051568891026	0.8941139976864503	0.7038972819567935	0.9621820633037574	ZC4H2	-1.3973623365001806	0.20499887214456444	6.065888508703813	0.0005079045702971349	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9214858818341379	0.6908215531847735	0.8665145971630663	0.9152600307719636	0.7472634267187199	0.7632383538736797	0.8936149046548247	0.8389151966396824	0.6777458244127534	0.8807897003645184	0.7312884995637603	0.9369051568891026	0.8941139976864503	0.7038972819567935	0.9621820633037574	ZC4H2		4320		CCSBVarC009155		NC_000023.11:64976359:T:C	19A>G	Ile7Val																												23.0	64976359.0	T	C	X						X-64976359-T-C	1195793.0	single nucleotide variant	NM_018684.4(ZC4H2):c.19A>G (p.Ile7Val)	55906.0	ZC4H2	HGNC:24931	Benign/Likely benign	0.0	May 31, 2024	199516840.0	-	RCV001570468|RCV002570776	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64976359.0	64976359.0	Xq11.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA10433516	2.0	1204188.0	64976359.0	T	C	-	-	-	-	-	-	SCV001794764|SCV003484470|SCV003707394	-	-	19A>G 	Ile7Val	NM_018684.4	2.0	2_Benign		1204188.0	X	64976359.0	T	C	I	V	rs199516840	X	64196239.0	X	64112964.0	7.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.19A>G	p.Ile7Val	c.19A>G	p.Ile7Val	principal1	Y	1	YES	Select	-	ATC	1.0	0.0	T	T/T	T/T	T/T	T/T	0.351	0.16776	T	0.678	0.12680	T	0.002	0.09864	B	0.001	0.04348	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.32	0.32853	L	-0.26	0.11844	N	0.31	0.34747	-0.9875	0.33106	T	0.132	0.44177	T	9.0	0.07205117	0.10648	T	0.006027	0.15489	T	0.095	0.27216	.	.	.	.	.	0.334371577756	0.32629	0.5398168254113483	0.53715	0.722628895279	0.62047	0.768219232559	0.77118	T	0.032331	0.22195	T	-0.305108	0.07976	T	-0.359887	0.3771	T	0.0683943516306379	0.08326	T	0.849515	0.53108	T	0.18977433	0.40220	0.13270241	0.31751	0.18977433	0.40220	0.13270241	0.31750	-3.754	0.20389	T	0.1285	0.50035	B	0.474340545313315	0.60002	0.85911566	0.89902	0.185	0.44051	.	.	.	.	.	.	2.686521	0.35125	19.8	0.9631228105474665	0.29591	.	.	.	.	.	.	.	.	.	4.94	4.94	0.646	4.0	0.76287	5.297	0.65577	7.617000	0.62206	0.609	0.47831	1.0	0.71675	1.0	0.68239	1.0	0.97202	45	0.97779	.	.	.	.	.	.	.	.	.	.	.	.	46	264690	1.7378821E-4	.	13	80322	1.618490e-04	0	23	151839	1.514760e-04	0	27	172229	1.567680e-04	0	0	5702	0.000000e+00	0	0	13663	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9917	0.000000e+00	0	13	30957	4.199370e-04	0	0	9952	0.000000e+00	0	13	30957	4.199370e-04	0	0	13134	0.000000e+00	0	0	24382	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12175	0.000000e+00	0	22	64678	3.401470e-04	0	0	19070	0.000000e+00	0	22	64678	3.401470e-04	0	0	12064	0.000000e+00	0	0	27160	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15980	0.000000e+00	0	26	73474	3.538670e-04	0	0	19005	0.000000e+00	0	26	73474	3.538670e-04	0	.	657	1210216	5.428780e-04	1	630	895221	7.037370e-04	1	5	57198	8.741560e-05	0	0	685	0.000000e+00	0	0	45866	0.000000e+00	0	0	22034	0.000000e+00	0	0	33739	0.000000e+00	0	0	46687	0.000000e+00	0	0	4373	0.000000e+00	0	630	895221	7.037370e-04	1	0	56809	0.000000e+00	0	161	146822	0.001096565909741047	0	168	0	0	2686	0	0	4124	0	0	442	0	0	950	0	0	652	0	0	280	0	4	7604	5.260389268805891E-4	0	4292	0	0	3338	0	165	163728	0.0010077689827030197	Benign/Likely_benign	Inborn_genetic_diseases|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64976359T>C	.	C0950123|C3661900	.	.	.	Ile	Val	1195793.0	single nucleotide variant	NM_018684.4(ZC4H2):c.19A>G (p.Ile7Val)	55906.0	ZC4H2	HGNC:24931	Benign/Likely benign	0.0	May 31, 2024	199516840.0	-	RCV001570468|RCV002570776	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64976359.0	64976359.0	Xq11.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA10433516	2.0	1204188.0	64976359.0	T	C	-	-	-	-	-	-	SCV001794764|SCV003484470|SCV003707394	-	-	19A>G 	Ile7Val	NM_018684.4	2.0	2_Benign	94.16	0.4556213017751479		unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		94.16	0.4556213	10-90	>90						I	77			94.16	Aliphatic	Isoleucine		Zinc finger C4H2 domain-containing protein										4.5								I7-L11, I7-D3; PAE: 1.0, 3.0		I7-L11, I7-D3; PAE: 1.0, 3.0								131									-60.2				-45.0						H (helix)	H (α-helix)																																																																				true	ZC4H2Ile7Val																																																																																																																																																																																																																																		
SDHD	SDHD_His102Arg	4.23284378127999	0.003902401439764406	-4.099256799150142	0.05237100831983184	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7730988140953278	0.7094170513789073	0.7645745104190336	0.8017146116020568	0.7292861333430671	0.7646330805473626	0.8300745460760569	0.8447132748304026	0.731416119505325	0.7906816420510188	0.6939391861387718	0.7733546771280568	0.6844357460076645	0.6874179832524896	0.7555159861396368	SDHD	4.23284378127999	0.003902401439764406	-4.099256799150142	0.05237100831983184	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7730988140953278	0.7094170513789073	0.7645745104190336	0.8017146116020568	0.7292861333430671	0.7646330805473626	0.8300745460760569	0.8447132748304026	0.731416119505325	0.7906816420510188	0.6939391861387718	0.7733546771280568	0.6844357460076645	0.6874179832524896	0.7555159861396368	SDHD		6363		CCSBVarC023323		NC_000011.10:112089002:A:G	305A>G	His102Arg																												11.0	112089002.0	A	G	11						11-112089002-A-G	639710.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>G (p.His102Arg)	6392.0	SDHD	HGNC:10683	Pathogenic/Likely pathogenic	1.0	Dec 02, 2024	104894302.0	-	RCV001018360|RCV002538159|RCV004028788	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072	Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1	germline;unknown	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA071040	2.0	656860.0	112089002.0	A	G	-	-	-	-	-	-	SCV000953725|SCV001179586|SCV004933595	-	-	305A>G 	His102Arg	NM_003002.4	2.0	1_Pathogenic	3.42028e-6	656860.0	11	112089002.0	A	G	H	R	rs104894302	11	111959726.0	11	111464936.0	102.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>G	p.His102Arg	c.305A>G	p.His102Arg	principal1	Y	1	YES	Select	+	CAT	2.0	0.0	A	./.	./.	./.	./.	0.002	0.91343	D	0.005	0.92967	D	0.999	0.77914	D	0.96	0.70309	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.58	0.93458	H	-7.95	0.96333	D	0.981	0.99987	0.8464	0.94968	D	0.9986	0.99961	D	10.0	0.9932964	0.99869	D	0.668847	0.97228	D	0.925	0.98152	0.96	0.99581	O14521	H102R	Gain of relative solvent accessibility (P = 0.1259)| Gain of solvent accessibility (P = 0.1319)| Loss of catalytic residue at L101 (P = 0.168)| Gain of loop (P = 0.2045)| Gain of MoRF binding (P = 0.3566)	0.99569366784	0.99559	0.9941230044772663	0.99408	0.822716399301	0.67041	0.615795195103	0.55067	T	0.978249	0.99805	D	0.565929	0.96317	D	0.575142	0.96257	D	0.995160043239594	0.86836	D	0.931507	0.74447	D	0.95057625	0.96266	0.9087782	0.95540	0.93406326	0.94564	0.9051902	0.95282	-9.682	0.83515	D	0.8694	0.80800	P	0.9963025324275	0.92025	0.99930870	0.99288	0.993	0.99760	.	.	.	.	.	.	4.730387	0.76234	26.5	0.995954364998685	0.73897	0.960222	0.98087	D	0.663599630439143	0.77127	6.639008	0.502772132901211	0.68002	5.184201	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.0	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	0	109408	0.000000e+00	0	1	208128	4.804740e-06	0	1	236948	4.220340e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	1	89552	1.116670e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102746	9.732740e-06	0	0	30526	0.000000e+00	0	1	102746	9.732740e-06	0	.	5	1614116	3.097670e-06	0	5	1180006	4.237270e-06	0	0	75020	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29608	0.000000e+00	0	0	44878	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	5	1180006	4.237270e-06	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112089002A>G	.	C0027672|C3494181|C1847319|CN166604|C0031511|C1868633	168000|606864|171300	140162|29072|97286|201|29072	.	His	Arg	639710.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>G (p.His102Arg)	6392.0	SDHD	HGNC:10683	Pathogenic/Likely pathogenic	1.0	Dec 02, 2024	104894302.0	-	RCV001018360|RCV002538159|RCV004028788	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072	Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1	germline;unknown	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA071040	2.0	656860.0	112089002.0	A	G	-	-	-	-	-	-	SCV000953725|SCV001179586|SCV004933595	-	-	305A>G 	His102Arg	NM_003002.4	2.0	1_Pathogenic	98.8	0.3858695652173913	['171300', '606864', '168000']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1	98.8	0.38586956	10-90	>90						H	71			98.8	Positively-charged	Histidine	heme b	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-3.2								H102-G106, H102-A98; PAE: 1.0, 1.0	2 interactions	H102-S73, H102-G106, H102-A98; PAE: 1.0, 1.0, 1.0	4 interactions							155									-59.3		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-46.5						H (helix)	H (α-helix)	Helix								Helical																																																											true	SDHDHis102Arg																																																																																																																																																																																																																																		
KRAS	KRAS_Gly12Val	-5.955690773263131	0.0005668221876575696	7.386569839087916	0.00015114042618877112	2025_01_Batch_13-14	false	false	false	true	true	false	false	false	false	false	0.927226337695236	0.7652577903601956	0.9131845482648582	0.9507396598796823	0.9470796834800488	0.9194774110318478	0.9556724593463344	0.8482163409955505	0.5948166390174948	0.9016831345899275	0.9746819559282497	0.9458068604130303	0.9781527555341658	0.9356989417028965	0.9527695408005444	KRAS	-5.955690773263131	0.0005668221876575696	7.386569839087916	0.00015114042618877112	2025_01_Batch_13-14	false	false	false	true	true	false	false	false	false	false	0.927226337695236	0.7652577903601956	0.9131845482648582	0.9507396598796823	0.9470796834800488	0.9194774110318478	0.9556724593463344	0.8482163409955505	0.5948166390174948	0.9016831345899275	0.9746819559282497	0.9458068604130303	0.9781527555341658	0.9356989417028965	0.9527695408005444	KRAS	ENSG00000133703	3084	214485.0	CCSBVarC006089	ALE00006089	NC_000012.12:25245350:C:A	35G>T	Gly12Val	CEGS2	CegsMutGDEh1035	A04	GDEhDisVCh_40061	G08	1.0	CegsMutGDDh1035	A04							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25245350.0	C	A	12	Y	Y	N	N	N	12-25245350-C-A	27622.0	single nucleotide variant	NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Oct 13, 2023	121913529.0	-	RCV000013413|RCV000157944|RCV000585801|RCV003322589|RCV003539760|RCV000029216|RCV003455987|RCV000150895|RCV000154262|RCV004668725|RCV002291496	MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C3661900|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724|MONDO:MONDO:0006279,MedGen:C1708781|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0005506,Human Phenotype Ontology:HP:0005544,MONDO:MONDO:0011996,MeSH:D015464,MedGen:C0279543,OMIM:608232,Orphanet:521	Carcinoma of pancreas|not provided|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|RASopathy|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|Neoplasm|Chronic myelogenous leukemia, BCR-ABL1 positive	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350.0	25245350.0	12p12.1	criteria provided, multiple submitters, no conflicts	12.0	-	N	COSMIC:520,ClinGen:CA122540,UniProtKB:P01116#VAR_006840,OMIM:190070.0006,OMIM:190070.0026	3.0	12583.0	25245350.0	C	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000198477|SCV000203917|SCV000207879|SCV001746133|SCV004176921|SCV004295856	-	SCV005094259	35G>T 	Gly12Val	NM_004985.5	2.0	1_Pathogenic	6.84666e-7	12583.0	12	25245350.0	C	A	G	V	rs121913529	12	25398284.0	12	25289551.0	12.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.35G>T	p.Gly12Val	c.35G>T	p.Gly12Val	alternative1	Y	1	.	Plus_Clinical	-	GGT	2.0	0.0	C	./.	./.	./.	./.	0.008	0.60085	D	0.001	0.83643	D	0.999	0.77914	D	0.978	0.74106	D	1.0	0.99291	A	simple_aae	0.0	100.0	1.84	0.48108	L	-7.11	0.97229	D	0.939	0.94561	0.5429	0.91106	D	0.6987	0.89587	D	10.0	0.9236257	0.91620	D	0.181073	0.85494	D	0.910	0.97583	0.767	0.89397	P01116	G12V	Gain of catalytic residue at V14 (P = 0)| Loss of ubiquitination at K16 (P = 0.1037)| Loss of methylation at K16 (P = 0.1785)| Loss of disorder (P = 0.1841)| Loss of sheet (P = 0.302)	0.988619423247	0.98836	0.9781072363123009	0.97790	2.35052041495	0.96801	0.898488461971	0.96267	D	0.843047	0.96328	D	0.385769	0.88997	D	0.316354	0.88859	D	0.990357935428619	0.80423	D	0.366763	0.56662	T	0.96866757	0.98104	0.9503655	0.98397	0.9776439	0.98906	0.9436424	0.97974	-15.17	0.98083	D	0.9949	0.96393	P	0.999985518475673	0.99579	0.99924910	0.99245	0.997	0.99892	.	.	.	.	.	.	4.859019	0.79528	27.1	0.9979254245871839	0.87849	0.919073	0.88866	D	0.947784823501693	0.93861	12.35383	0.901530992395951	0.95614	13.81752	5.68	5.68	0.88004	.	.	7.892	0.85894	7.698000	0.66189	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612866	6.200140e-07	0	1	1179302	8.479590e-07	0	0	75026	0.000000e+00	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29524	0.000000e+00	0	0	44856	0.000000e+00	0	0	63988	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179302	8.479590e-07	0	0	90794	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Linear_nevus_sebaceous_syndrome|Nevus_sebaceous|not_provided|Non-small_cell_lung_carcinoma|Chronic_myelogenous_leukemia,_BCR-ABL1_positive|Carcinoma_of_pancreas|Lung_sarcomatoid_carcinoma|Acute_myeloid_leukemia|Juvenile_myelomonocytic_leukemia|Cerebral_arteriovenous_malformation|Thyroid_tumor|Ovarian_neoplasm|RASopathy|Neoplasm_of_the_large_intestine	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245350C>A	COSMIC:520|ClinGen:CA122540|OMIM:190070.0006|OMIM:190070.0026|UniProtKB:P01116#VAR_006840	C4552097|C3854181|C3661900|C0007131|C0279543|C0235974|C1708781|C0023467|C0349639|C0917804|C0040136|C0919267|C5555857|C0009404	163200|608232|601626|607785|108010	2612|521|1333|217074|519|86834|46724|100087|536391	Small GTP-binding domain	Gly	Val	27622.0	single nucleotide variant	NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Oct 13, 2023	121913529.0	-	RCV000013413|RCV000157944|RCV000585801|RCV003322589|RCV003539760|RCV000029216|RCV003455987|RCV000150895|RCV000154262|RCV004668725|RCV002291496	MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C3661900|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724|MONDO:MONDO:0006279,MedGen:C1708781|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0005506,Human Phenotype Ontology:HP:0005544,MONDO:MONDO:0011996,MeSH:D015464,MedGen:C0279543,OMIM:608232,Orphanet:521	Carcinoma of pancreas|not provided|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|RASopathy|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|Neoplasm|Chronic myelogenous leukemia, BCR-ABL1 positive	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350.0	25245350.0	12p12.1	criteria provided, multiple submitters, no conflicts	12.0	-	N	COSMIC:520,ClinGen:CA122540,UniProtKB:P01116#VAR_006840,OMIM:190070.0006,OMIM:190070.0026	3.0	12583.0	25245350.0	C	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000198477|SCV000203917|SCV000207879|SCV001746133|SCV004176921|SCV004295856	-	SCV005094259	35G>T 	Gly12Val	NM_004985.5	2.0	1_Pathogenic	94.86	0.2261904761904762	['108010', '163200', '607785', '608232']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN; SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKEMIA, CHRONIC MYELOID	94.86	0.22619048	10-90	>90																																																																																																																																		true	KRASGly12Val																																																																																																																																																																																																																																		
F9	F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8083708964952888	0.7153298233355938	0.8396586384905589	0.7697955729293582	0.8276646758994048	0.8092956455580312	0.7482211894547589	0.8421319766343551	0.6359506216068829	0.8647586304094397	0.8460337062407786	0.7913699564039575	0.8371853003467626	0.7947090250643046	0.751983162581138	F9	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8083708964952888	0.7153298233355938	0.8396586384905589	0.7697955729293582	0.8276646758994048	0.8092956455580312	0.7482211894547589	0.8421319766343551	0.6359506216068829	0.8647586304094397	0.8460337062407786	0.7913699564039575	0.8371853003467626	0.7947090250643046	0.751983162581138	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G	845A>G	His282Arg																												23.0	139561530.0	A	G	X						X-139561530-A-G	615669.0	single nucleotide variant	NM_000133.4(F9):c.845A>G (p.His282Arg)	2158.0	F9	HGNC:3551	Conflicting classifications of pathogenicity	1.0	Feb 14, 2024	753654616.0	-	RCV000851898|RCV004588168	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561530.0	139561530.0	Xq27.1	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA336143030	2.0	627146.0	139561530.0	A	G	-	-	-	-	-	-	SCV000899963|SCV005079373|SCV005413446	-	-	845A>G 	His282Arg	NM_000133.4	1.0	3_Conflicting		627146.0	X	139561530.0	A	G	H	R	rs753654616	X	138643689.0	X	138471355.0	282.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.845A>G	p.His282Arg	c.845A>G	p.His282Arg	principal1	Y	1	YES	Select	+	CAT	2.0	0.0	A	A/A	A/A	A/A	A/A	0.601	0.06521	T	0.379	0.17349	T	0.046	0.21889	B	0.113	0.31692	B	0.83	0.90832	A	simple_aae	17.0	83.0	2.315	0.66058	M	-3.71	0.70711	D	0.405	0.78847	0.4026	0.89093	D	0.7468	0.91338	D	10.0	0.9492965	0.94197	D	0.669559	0.97236	D	0.707	0.89469	0.938	0.99125	P00740	H282R	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.999137776672	0.99911	0.9970016739794073	0.99698	1.73630748658	0.90767	0.379394561052	0.22147	T	0.866353	0.97052	D	0.370769	0.88019	D	0.294808	0.87868	D	0.900605976581573	0.55065	D	0.852415	0.53609	D	0.84553546	0.86834	0.8327217	0.90237	0.8688038	0.88613	0.81526446	0.89097	-6.135	0.50934	T	0.1387	0.45138	B	0.98658244579304	0.87152	0.99998010	0.99989	0.775	0.87544	.	.	.	.	.	.	2.423931	0.31233	18.66	0.9246492010866614	0.22143	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	4.839	0.62586	9.394000	0.80629	0.691	0.84104	0.856	0.30635	0.999	0.35501	0.629	0.32173	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	33	1204562	2.739590e-05	0	32	890491	3.593520e-05	0	0	57696	0.000000e+00	0	0	689	0.000000e+00	0	0	45620	0.000000e+00	0	0	21828	0.000000e+00	0	0	33803	0.000000e+00	0	0	46844	0.000000e+00	0	0	4331	0.000000e+00	0	32	890491	3.593520e-05	0	0	55876	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Hereditary_factor_VIII_deficiency_disease|not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.139561530A>G	.	C0019069|C3661900	134500|306700	98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Arg	615669.0	single nucleotide variant	NM_000133.4(F9):c.845A>G (p.His282Arg)	2158.0	F9	HGNC:3551	Conflicting classifications of pathogenicity	1.0	Feb 14, 2024	753654616.0	-	RCV000851898|RCV004588168	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561530.0	139561530.0	Xq27.1	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA336143030	2.0	627146.0	139561530.0	A	G	-	-	-	-	-	-	SCV000899963|SCV005079373|SCV005413446	-	-	845A>G 	His282Arg	NM_000133.4	1.0	3_Conflicting	93.76	0.1304347826086956	['306700']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA A	93.76	0.13043478	10-90	>90						H	24			93.76	Positively-charged	Histidine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-3.2								H282-W356, H282-E288, H282-L369; PAE: 1.5, 3.0, 1.0	4 interactions	H282-P235, H282-L369; PAE: 1.0, 1.0	7 interactions							155									-128.8				-44.1						C (loop/coil)	S (bend)	Beta strand																													0.941		0.888		0.9		0.877		0.878																														true	F9His282Arg																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Lys217Arg	-4.109348315318837	0.004519611248172494	-0.4673650531179406	0.6544384299817575	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.94119445414044	0.8503183369868518	0.9051466129727719	0.8796778609921344	0.47267235248003736	0.5219040011392475	0.8915689837768885	0.9120649636540208	0.863185593859517	0.9502369389311607	0.4234407038208272	0.8677867382073803	0.8982282622915231	0.8374510801141866	0.9321519693497194	ZC4H2	-4.109348315318837	0.004519611248172494	-0.4673650531179406	0.6544384299817575	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	0.94119445414044	0.8503183369868518	0.9051466129727719	0.8796778609921344	0.47267235248003736	0.5219040011392475	0.8915689837768885	0.9120649636540208	0.863185593859517	0.9502369389311607	0.4234407038208272	0.8677867382073803	0.8982282622915231	0.8374510801141866	0.9321519693497194	ZC4H2		4320		CCSBVarC009181		NC_000023.11:64917808:T:C	650A>G	Lys217Arg																												23.0	64917808.0	T	C	X						X-64917808-T-C	822347.0	single nucleotide variant	NM_018684.4(ZC4H2):c.650A>G (p.Lys217Arg)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Apr 09, 2020	1929002470.0	-	RCV001034718	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64917808.0	64917808.0	Xq11.2	no assertion criteria provided	1.0	-	N	OMIM:300897.0011,ClinGen:CA413411045	1.0	834097.0	64917808.0	T	C	-	-	-	-	-	-	SCV001198008	-	-	650A>G 	Lys217Arg	NM_018684.4		1_Pathogenic		834097.0	X	64917808.0	T	C	K	R	rs1929002470	X	64137688.0	X	64054413.0	217.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.650A>G	p.Lys217Arg	c.650A>G	p.Lys217Arg	principal1	Y	1	YES	Select	-	AAG	2.0	0.0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.941	0.52895	P	0.973	0.72925	D	0.97	0.96253	A	simple_aae	3.0	97.0	.	.	.	-2.44	0.53442	N	0.465	0.51703	-0.9665	0.37756	T	0.1423	0.46144	T	8.0	0.3894233	0.54427	D	0.189364	0.86022	D	0.333	0.65341	0.44	0.49343	Q9NQZ6	K217R	Loss of methylation at K217 (P = 0.007)| Loss of glycosylation at K217 (P = 0.0664)| Gain of helix (P = 0.1736)| Loss of ubiquitination at K217 (P = 0.2936)| Loss of solvent accessibility (P = 0.322)	0.814197371498	0.81098	0.5036670474541309	0.50093	2.6112261011	0.98235	0.826741635799	0.86039	D	0.521062	0.83103	D	0.142269	0.68312	D	-0.033417	0.67911	D	0.994114935398102	0.85104	D	0.967303	0.88633	D	0.75298744	0.80812	0.7599174	0.85640	0.75298744	0.80813	0.7599174	0.85641	-6.96	0.53810	T	0.2619	0.49675	B	0.965892135885726	0.82597	0.99151430	0.96976	0.921	0.95990	.	.	.	.	.	.	4.467578	0.69648	25.4	0.9988496640312855	0.96051	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.404	0.79277	7.742000	0.68069	0.665	0.62996	1.0	0.71675	1.0	0.68239	1.0	0.97202	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64917808T>C	OMIM:300897.0011	C0796200	314580	3454|85283	Zinc finger C4H2-type	Lys	Arg	822347.0	single nucleotide variant	NM_018684.4(ZC4H2):c.650A>G (p.Lys217Arg)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Apr 09, 2020	1929002470.0	-	RCV001034718	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64917808.0	64917808.0	Xq11.2	no assertion criteria provided	1.0	-	N	OMIM:300897.0011,ClinGen:CA413411045	1.0	834097.0	64917808.0	T	C	-	-	-	-	-	-	SCV001198008	-	-	650A>G 	Lys217Arg	NM_018684.4		1_Pathogenic	67.1	0.946341463414634	['314580']	unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	67.1	0.94634145	$\geqslant$90	50-70						K	194			67.1	Positively-charged	Lysine		Zinc finger C4H2 domain-containing protein										-3.9																		147									-55.1				128.3						H (helix)	P (polyproline helix)																																																																				true	ZC4H2Lys217Arg																																																																																																																																																																																																																																		
F9	F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14	true	true	false	true	false	false	true	false	false	false	0.9750516487562308	0.8754010822333609	0.9037037095107087	0.9175078848884123	0.8380546549952954						0.8380546549952954	0.9175078848884123	0.9037037095107087	0.8754010822333609	0.9750516487562308	F9	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14	true	true	false	true	false	false	true	false	false	false	0.9750516487562308	0.8754010822333609	0.9037037095107087	0.9175078848884123	0.8380546549952954						0.8380546549952954	0.9175078848884123	0.9037037095107087	0.8754010822333609	0.9750516487562308	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C	947T>C	Ile316Thr																												23.0	139561632.0	T	C	X						X-139561632-T-C	800240.0	single nucleotide variant	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Nov 13, 2023	1603267344.0	-	RCV001001414|RCV003769385|RCV004792605	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	germline	germline	GRCh38	NC_000023.11	X	139561632.0	139561632.0	Xq27.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA414444900	2.0	811502.0	139561632.0	T	C	-	-	-	-	-	-	SCV001158649|SCV004571525|SCV005413449	-	-	947T>C 	Ile316Thr	NM_000133.4	2.0	1_Pathogenic		811502.0	X	139561632.0	T	C	I	T	rs1603267344	X	138643791.0	X	138471457.0	316.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.947T>C	p.Ile316Thr	c.947T>C	p.Ile316Thr	principal1	Y	1	YES	Select	+	ATT	2.0	0.0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	0.9	0.92786	A	simple_aae	10.0	90.0	3.94	0.96320	H	-4.77	0.80975	D	0.884	0.98575	1.0921	0.99323	D	0.9553	0.98549	D	10.0	0.99409103	0.99921	D	0.969256	0.99811	D	0.976	0.99783	0.964	0.99639	P00740	I316T	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.999203327797	0.99918	0.9996498989908393	0.99964	1.84500378867	0.92182	0.573964655399	0.49171	T	0.972778	0.99714	D	0.694692	0.99926	D	0.7601	0.99925	D	0.998964428901672	0.9569	D	0.935206	0.78054	D	0.9802627	0.99114	0.9668009	0.99308	0.98325217	0.99336	0.9520444	0.98499	-12.147	0.85599	D	0.5673	0.75544	P	0.999656738398078	0.97351	0.99999190	0.99996	0.981	0.99334	.	.	.	.	.	.	4.529531	0.71151	25.6	0.998596801767716	0.93824	.	.	.	.	.	.	.	.	.	5.57	5.57	0.83999	4.99	0.89858	7.647	0.82668	7.922000	0.74613	0.609	0.47831	1.0	0.71675	1.0	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561632T>C	.	CN169374|C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	800240.0	single nucleotide variant	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Nov 13, 2023	1603267344.0	-	RCV001001414|RCV003769385|RCV004792605	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	germline	germline	GRCh38	NC_000023.11	X	139561632.0	139561632.0	Xq27.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA414444900	2.0	811502.0	139561632.0	T	C	-	-	-	-	-	-	SCV001158649|SCV004571525|SCV005413449	-	-	947T>C 	Ile316Thr	NM_000133.4	2.0	1_Pathogenic	97.7	0.0	['306900', '300807']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	97.7	0.0	<10	>90						I	0			97.7	Aliphatic	Isoleucine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			4.5								I316-H302; PAE: 1.0	2 interactions	I316-A266; PAE: 1.0	6 interactions							131									-149.7				136.6						C (loop/coil)	C (loop/coil)																														0.228		0.195		0.174		0.165	1 mutation(s) (Ile316Glu: -0.007)	0.176																														true	F9Ile316Thr																																																																																																																																																																																																																																		
F9	F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6488131291938873	0.562341500662288	0.6881624489624669	0.6433785874884863	0.6811578759957931	0.7029388431329562	0.6639941960024667	0.7148120661176882	0.44746059654442905	0.6414383780251568	0.6593769088586301	0.622762978974506	0.6615128318072457	0.6772224047801471	0.6561878803626179	F9	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6488131291938873	0.562341500662288	0.6881624489624669	0.6433785874884863	0.6811578759957931	0.7029388431329562	0.6639941960024667	0.7148120661176882	0.44746059654442905	0.6414383780251568	0.6593769088586301	0.622762978974506	0.6615128318072457	0.6772224047801471	0.6561878803626179	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G	584T>G	Val195Gly																												23.0	139551125.0	T	G	X						X-139551125-T-G	1921180.0	single nucleotide variant	NM_000133.4(F9):c.584T>G (p.Val195Gly)	2158.0	F9	HGNC:3551	Likely benign	0.0	Aug 23, 2023	-1.0	-	RCV002632292	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551125.0	139551125.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA336137420	2.0	2184672.0	139551125.0	T	G	-	-	-	-	-	-	SCV003501528	-	-	584T>G 	Val195Gly	NM_000133.4	1.0	2_Benign		2184672.0	X	139551125.0	T	G	V	G	rs374674030	X	138633284.0	X	138460950.0	195.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.584T>G	p.Val195Gly	c.584T>G	p.Val195Gly	principal1	Y	1	YES	Select	+	GTT	2.0	0.0	T	T/T	T/T	T/T	T/T	0.349	0.12418	T	0.376	0.16408	T	0.0	0.02950	B	0.002	0.06938	B	0.15	0.45549	N	simple_aae	85.0	15.0	0	0.06502	N	-1.61	0.38726	N	0.132	0.17857	-0.1972	0.77642	T	0.6775	0.88803	D	10.0	0.1398688	0.26271	T	0.063227	0.68789	D	0.301	0.61985	.	.	.	.	.	0.941715556567	0.94064	0.9536002345262253	0.95316	0.852731849783	0.68423	0.307745546103	0.11558	T	0.471326	0.80258	T	-0.0125828	0.49576	T	-0.14336	0.59542	T	0.0311624814342412	0.02159	T	0.483452	0.15897	T	0.23625271	0.46144	0.14323859	0.33951	0.23625271	0.46144	0.14323859	0.33950	-4.071	0.26473	T	0.0972	0.21572	B	0.962737860313214	0.82113	0.99982518	0.99765	0.329	0.59271	.	.	.	.	.	.	0.903261	0.12793	9.29	0.41800775336298984	0.03062	.	.	.	.	.	.	.	.	.	4.94	4.94	0.646	3.33	0.60393	1.842	0.38995	2.316000	0.32189	0.665	0.62996	0.186	0.24222	0.258	0.24039	0.062	0.16152	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	80340	1.244710e-05	0	1	151858	6.585100e-06	0	1	172272	5.804770e-06	0	0	5701	0.000000e+00	0	1	13666	7.317430e-05	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9932	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	1	13666	7.317430e-05	0	0	13132	0.000000e+00	0	1	24389	4.100210e-05	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12189	0.000000e+00	0	0	64675	0.000000e+00	0	0	19071	0.000000e+00	0	1	24389	4.100210e-05	0	0	12062	0.000000e+00	0	1	27167	3.680940e-05	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15994	0.000000e+00	0	0	73497	0.000000e+00	0	0	19006	0.000000e+00	0	1	27167	3.680940e-05	0	.	4	1209607	3.306860e-06	0	3	57267	5.238620e-05	0	3	57267	5.238620e-05	0	0	685	0.000000e+00	0	1	45773	2.184690e-05	0	0	22036	0.000000e+00	0	0	33786	0.000000e+00	0	0	46636	0.000000e+00	0	0	4374	0.000000e+00	0	0	894681	0.000000e+00	0	0	56793	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551125T>G	.	C0008533|C2749016	306900|300807	98879	.	Val	Gly	1921180.0	single nucleotide variant	NM_000133.4(F9):c.584T>G (p.Val195Gly)	2158.0	F9	HGNC:3551	Likely benign	0.0	Aug 23, 2023	-1.0	-	RCV002632292	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551125.0	139551125.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA336137420	2.0	2184672.0	139551125.0	T	G	-	-	-	-	-	-	SCV003501528	-	-	584T>G 	Val195Gly	NM_000133.4	1.0	2_Benign	34.93	0.9295774647887324	['300807', '306900']	unknown	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	34.93	0.92957747	$\geqslant$90	<=50						V	132			34.93	Aliphatic	Valine		Coagulation factor IX										4.2																		117									-66.7			Activation peptide	107.7						C (loop/coil)	C (loop/coil)																														0.972		0.989		1.025		1.0		0.998																														true	F9Val195Gly																																																																																																																																																																																																																																		
FANCC	FANCC_Asp195Val	1.2566203609821562	0.24919974099408038	-11.6293475965227	7.846369178135278e-6	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.931713104822269	0.8048927562759389	0.8917414242938345	0.8758175654644216	0.5600202052352192	0.6351832855990385	0.8836968194865118	0.8959693048993332	0.8450017977379654	0.92331818841267	0.48485712487139987	0.8679383114423312	0.8875135436883358	0.7647837148139124	0.940108021231868	FANCC	1.2566203609821562	0.24919974099408038	-11.6293475965227	7.846369178135278e-6	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.931713104822269	0.8048927562759389	0.8917414242938345	0.8758175654644216	0.5600202052352192	0.6351832855990385	0.8836968194865118	0.8959693048993332	0.8450017977379654	0.92331818841267	0.48485712487139987	0.8679383114423312	0.8875135436883358	0.7647837148139124	0.940108021231868	FANCC	ENSG00000158169	7699	13987.0	CCSBVarC001229	ALE00001229	NC_000009.12:95150025:T:A	584A>T	Asp195Val	RC4	RC4_Mut_GDEh1009	B09	GDEhDisVCh_40044	E07	2.0	RC4_Mut_GDDh1009	B09							1.0	1.0	1.0	1.0	0.0			0.0			0.0			9.0	95150025.0	T	A	9	Y	Y	N	N	N	9-95150025-T-A	138044.0	single nucleotide variant	NM_000136.3(FANCC):c.584A>T (p.Asp195Val)	2176.0	FANCC	HGNC:3584	Conflicting classifications of pathogenicity	0.0	Jan 29, 2025	1800365.0	-	RCV000124962|RCV000120978|RCV000179716|RCV001083500|RCV000667368|RCV000988215|RCV001356570	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0007254,MedGen:C0006142	Hereditary cancer-predisposing syndrome|not specified|not provided|Fanconi anemia|Fanconi anemia complementation group C|Fanconi anemia complementation group A|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000009.12	9	95150025.0	95150025.0	9q22.32	criteria provided, conflicting classifications	27.0	-	N	UniProtKB:Q00597#VAR_005228,ClinGen:CA247025	2.0	134305.0	95150025.0	T	A	-	-	-	-	-	-	SCV000168402|SCV000232007|SCV000261219|SCV000267037|SCV000281279|SCV000302521|SCV000539136|SCV000594678|SCV000673285|SCV000791802|SCV000892896|SCV001137852|SCV001329919|SCV001522905|SCV001653385|SCV002010154|SCV002047091|SCV002535110|SCV005875402	-	-	584A>T 	Asp195Val	NM_000136.3	1.0	3_Conflicting	0.00405785	134305.0	9	95150025.0	T	A	D	V	rs1800365	9	97912307.0	9	96952128.0	195.0	FANCC	ENSG00000158169	ENST00000375305	ENSP00000364454	Q00597	FANCC_HUMAN	c.584A>T	p.Asp195Val	c.584A>T	p.Asp195Val	principal1	Y	1	.	.	-	GAT	2.0	0.0	T	T/T	T/T	T/T	T/T	0.004	0.65576	D	0.002	0.79703	D	0.992	0.64752	D	0.971	0.72446	D	0.04	0.13669	N	simple_aae	96.0	4.0	2.395	0.69015	M	-5.58	0.86481	D	0.83	0.82505	-0.5256	0.67564	T	0.2312	0.59552	T	10.0	0.027212769	0.00870	T	.	.	.	0.417	0.72559	.	.	.	.	.	0.869862672899	0.86759	.	0.49056	.	0.40953	0.38103300333	0.22378	T	0.508738	0.82439	D	-0.186631	0.22426	T	-0.0371334	0.67662	D	0.028442771770713	0.01743	T	0.893711	0.71646	D	0.4535079	0.63947	0.3693059	0.61960	0.43107343	0.62503	0.41695112	0.65510	-4.396	0.29534	T	0.2603	0.50323	B	0.427087705106892	0.58537	0.48957047	0.81662	0.506	0.71835	.	.	.	.	.	.	3.822049	0.55272	23.6	0.9932851719681968	0.5972	0.471210	0.51517	N	0.491382671950936	0.66409	4.969212	0.405209269013319	0.61683	4.395473	4.77	4.77	0.60376	.	.	4.533	0.60413	5.887000	0.50787	0.665	0.62996	0.999	0.42732	1.0	0.68239	0.174	0.21152	167	0.93511	13	0.002595846645367412	1	7.564296520423601E-4	12	0.011928429423459244	0	0.0	0	0.0	0	0.0	840	264690	0.0031735238	.	319	109386	2.916280e-03	2	661	208056	3.177030e-03	4	722	236802	3.048960e-03	4	4	7162	5.585030e-04	0	47	17110	2.746930e-03	0	5	2320	2.155170e-03	0	0	9044	0.000000e+00	0	3	13394	2.239810e-04	0	204	42762	4.770590e-03	2	49	15684	3.124200e-03	0	204	42762	4.770590e-03	2	6	16212	3.700960e-04	0	82	30508	2.687820e-03	1	18	6210	2.898550e-03	0	0	13414	0.000000e+00	0	5	16734	2.987930e-04	0	434	89528	4.847650e-03	3	102	30592	3.334210e-03	0	434	89528	4.847650e-03	3	5	14900	3.355700e-04	0	89	34242	2.599150e-03	1	37	9566	3.867870e-03	0	0	17690	0.000000e+00	0	7	21632	3.235950e-04	0	466	102654	4.539520e-03	3	102	30510	3.343170e-03	0	466	102654	4.539520e-03	3	.	6367	1614040	3.944760e-03	26	31	6060	5.115510e-03	0	52	75002	6.933150e-04	0	0	912	0.000000e+00	0	174	60004	2.899810e-03	1	94	29606	3.175030e-03	0	1	44868	2.228760e-05	0	37	64010	5.780350e-04	0	31	6060	5.115510e-03	0	5355	1180010	4.538100e-03	18	308	91058	3.382460e-03	4	442	92472	0.004779825244398304	0	174	0	0	2674	0	6	4186	0.001433349259436216	8	790	0.010126582278481013	2	946	0.0021141649048625794	0	656	0	1	274	0.0036496350364963502	41	8036	0.00510204081632653	6	4360	0.0013761467889908258	0	3330	0	500	110208	0.004536875725900116	Conflicting_classifications_of_pathogenicity	Fanconi_anemia_complementation_group_A|Fanconi_anemia|Malignant_tumor_of_breast|Fanconi_anemia_complementation_group_C|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000009.12:g.95150025T>A	ClinGen:CA247025|UniProtKB:Q00597#VAR_005228	C3469521|C0015625|C0006142|C3468041|C3661900|CN169374|C0027672	227650|PS227650|227645	84|84|84|140162	.	Asp	Val	138044.0	single nucleotide variant	NM_000136.3(FANCC):c.584A>T (p.Asp195Val)	2176.0	FANCC	HGNC:3584	Conflicting classifications of pathogenicity	0.0	Jan 29, 2025	1800365.0	-	RCV000124962|RCV000120978|RCV000179716|RCV001083500|RCV000667368|RCV000988215|RCV001356570	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0007254,MedGen:C0006142	Hereditary cancer-predisposing syndrome|not specified|not provided|Fanconi anemia|Fanconi anemia complementation group C|Fanconi anemia complementation group A|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000009.12	9	95150025.0	95150025.0	9q22.32	criteria provided, conflicting classifications	27.0	-	N	UniProtKB:Q00597#VAR_005228,ClinGen:CA247025	2.0	134305.0	95150025.0	T	A	-	-	-	-	-	-	SCV000168402|SCV000232007|SCV000261219|SCV000267037|SCV000281279|SCV000302521|SCV000539136|SCV000594678|SCV000673285|SCV000791802|SCV000892896|SCV001137852|SCV001329919|SCV001522905|SCV001653385|SCV002010154|SCV002047091|SCV002535110|SCV005875402	-	-	584A>T 	Asp195Val	NM_000136.3	1.0	3_Conflicting	79.61	0.3926380368098159	['227645', '227650']	autosomal recessive	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Inherited cancer-predisposing syndrome	6	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCONI ANEMIA, COMPLEMENTATION GROUP A	79.61	0.39263803	10-90	70-90						D	64			79.61	Negatively-charged	Aspartic Acid		Fanconi anemia group C protein										-3.5																		132									-68.4				-18.3						C (loop/coil)	T (turn)																																																																				true	FANCCAsp195Val																																																																																																																																																																																																																																		
BRIP1	BRIP1_Ser520Thr	0.37199351651584694	0.7214710962483611	0.7464293414885846	0.5681293449170274	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6892459605616326	0.6846234631578623	0.6760151722153082	0.718035912963571	0.7383581047885714	0.7296687083203656	0.6929974826337902	0.6362999541312206	0.688999708379693	0.6576451968220566	0.7470475012567772	0.7430743432933519	0.7157303902993957	0.6802472179360314	0.7208467243012086	BRIP1	0.37199351651584694	0.7214710962483611	0.7464293414885846	0.5681293449170274	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6892459605616326	0.6846234631578623	0.6760151722153082	0.718035912963571	0.7383581047885714	0.7296687083203656	0.6929974826337902	0.6362999541312206	0.688999708379693	0.6576451968220566	0.7470475012567772	0.7430743432933519	0.7157303902993957	0.6802472179360314	0.7208467243012086	BRIP1		55128		CCSBVarC031368		NC_000017.11:61784339:C:G	1559G>C	Ser520Thr																												17.0	61784339.0	C	G	17						17-61784339-C-G	1670804.0	single nucleotide variant	NM_032043.3(BRIP1):c.1559G>C (p.Ser520Thr)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0.0	Jan 20, 2025	757629526.0	-	RCV002226323|RCV005225570	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	Hereditary breast ovarian cancer syndrome|Familial cancer of breast;Fanconi anemia complementation group J	germline	germline	GRCh38	NC_000017.11	17	61784339.0	61784339.0	17q23.2	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA8690715	2.0	1679010.0	61784339.0	C	G	-	-	-	-	-	-	SCV002505035|SCV005863038	-	-	1559G>C 	Ser520Thr	NM_032043.3	1.0	3_Conflicting		1679010.0	17	61784339.0	C	G	S	T	rs757629526	17	59861700.0	17	57216482.0	520.0	BRIP1	ENSG00000136492	ENST00000682453	ENSP00000506943	Q9BX63	FANCJ_HUMAN	.	.	c.1559G>C	p.Ser520Thr	principal2	Y	.	.	.	-	AGT	2.0	0.0	C	C/C	C/C	C/C	C/C	.	0.35312	.	.	0.25277	.	0.997	0.70687	D	0.985	0.76461	D	.	.	.	.	.	.	2.77	0.80725	M	.	0.47017	.	.	0.33568	0.215	0.86105	D	0.5977	0.85609	D	9.0	.	0.52780	.	0.242835	0.88750	D	.	0.70117	0.37	0.37869	Q9BX63	S520T	Gain of loop (P = 0.0435)| Loss of helix (P = 0.079)| Gain of relative solvent accessibility (P = 0.09)| Loss of disorder (P = 0.099)| Gain of glycosylation at S520 (P = 0.1371)	.	0.88833	.	0.68862	.	0.43011	0.593239068985	0.51884	T	0.189817	0.54192	T	-0.00666905	0.50407	T	-0.150502	0.58913	T	0.951732993125916	0.63403	D	0.758424	0.38019	T	0.33792168	0.55782	0.27921516	0.53680	0.33792168	0.55782	0.27921516	0.53679	-8.391	0.63781	D	.	0.17342	.	0.273335049405932	0.53188	0.92831135	0.92318	0.238	0.50735	.	.	.	.	.	.	3.879663	0.56457	23.7	0.9960558309288255	0.74486	0.663288	0.63154	D	0.718735528270629	0.80755	7.388994	0.687325371777153	0.81314	7.521477	5.37	5.37	0.76916	.	.	4.902	0.63037	4.818000	0.45172	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.996	0.76032	49	0.97674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109392	0.000000e+00	0	1	208056	4.806400e-06	0	1	236844	4.222190e-06	0	0	7160	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30508	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89510	0.000000e+00	0	1	30600	3.267970e-05	0	1	30600	3.267970e-05	0	0	14898	0.000000e+00	0	0	34244	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102680	0.000000e+00	0	1	30518	3.276750e-05	0	1	30518	3.276750e-05	0	.	1	1613166	6.198990e-07	0	1	91054	1.098250e-05	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29600	0.000000e+00	0	0	44820	0.000000e+00	0	0	64020	0.000000e+00	0	0	6032	0.000000e+00	0	0	1179258	0.000000e+00	0	1	91054	1.098250e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Hereditary_breast_ovarian_cancer_syndrome	criteria_provided,_single_submitter	NC_000017.11:g.61784339C>G	.	C0677776	.	145	.	Ser	Thr	1670804.0	single nucleotide variant	NM_032043.3(BRIP1):c.1559G>C (p.Ser520Thr)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0.0	Jan 20, 2025	757629526.0	-	RCV002226323|RCV005225570	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	Hereditary breast ovarian cancer syndrome|Familial cancer of breast;Fanconi anemia complementation group J	germline	germline	GRCh38	NC_000017.11	17	61784339.0	61784339.0	17q23.2	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA8690715	2.0	1679010.0	61784339.0	C	G	-	-	-	-	-	-	SCV002505035|SCV005863038	-	-	1559G>C 	Ser520Thr	NM_032043.3	1.0	3_Conflicting	86.39	0.2538461538461538	['114480', '609054']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP J	86.39	0.25384617	10-90	70-90						S	33			86.39	Polar/Neutral	Serine		Fanconi anemia group J protein										-0.8								S520-E421, S520-Q524; PAE: 3.0, 1.0		S520-Q524; PAE: 1.0								105									-55.9				148.8						C (loop/coil)	C (loop/coil)																																																																				true	BRIP1Ser520Thr																																																																																																																																																																																																																																		
RET	RET_Pro64Leu	-1.201347931595469	0.2686812116504655	8.469985626960886	0.00006319510150519935	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8946365929306797	0.7825358120987007	0.8678592099540405	0.8948256765341512	0.8196083026347166	0.9804880815822492	0.9530161642274781	0.9760410272134588	0.9326239165240031	0.9435651694351904	0.658728523687184	0.8366351888408243	0.7596773926946224	0.6324477076733983	0.8457080164261688	RET	-1.201347931595469	0.2686812116504655	8.469985626960886	0.00006319510150519935	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8946365929306797	0.7825358120987007	0.8678592099540405	0.8948256765341512	0.8196083026347166	0.9804880815822492	0.9530161642274781	0.9760410272134588	0.9326239165240031	0.9435651694351904	0.658728523687184	0.8366351888408243	0.7596773926946224	0.6324477076733983	0.8457080164261688	RET	ENSG00000165731	8858	202947.0	CCSBVarC006874	ALE00006872	NC_000010.11:43100576:C:T	191C>T	Pro64Leu	CEGS2	CegsMutGDEh1028	E01	GDEhDisVCh_40066	A06	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43100576.0	C	T	10	Y	N	N	N	N	10-43100576-C-T	28963.0	single nucleotide variant	NM_020975.6(RET):c.191C>T (p.Pro64Leu)	5979.0	RET	HGNC:9967	Uncertain significance	0.0	Apr 09, 2024	77596424.0	-	RCV000014949|RCV003531901	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43100576.0	43100576.0	10q11.21	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008426,UniProtKB:P07949#VAR_006296,OMIM:164761.0019	3.0	13924.0	43100576.0	C	T	-	-	-	-	-	-	SCV004294349|SCV004831371	-	-	191C>T 	Pro64Leu	NM_020975.6	2.0	4_VUS		13924.0	10	43100576.0	C	T	P	L	rs77596424	10	43596024.0	10	42916030.0	64.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.191C>T	p.Pro64Leu	c.191C>T	p.Pro64Leu	principal4	Y	5	YES	Select	+	CCC	2.0	0.0	C	C/C	C/C	C/C	C/C	0.004	0.65576	D	0.004	0.74454	D	0.959	0.58322	D	0.411	0.51228	B	0.76	0.87470	D	simple_aae	24.0	76.0	2.67	0.77975	M	-3.22	0.64967	D	0.536	0.85733	0.0771	0.83683	D	0.5121	0.81614	D	10.0	0.89362335	0.88586	D	0.118491	0.79794	D	0.672	0.87814	0.818	0.93158	P07949	P64L	Loss of disorder (P = 0.0168)| Gain of sheet (P = 0.0266)| Loss of loop (P = 0.0374)| Loss of catalytic residue at P64 (P = 0.301)| Gain of stability (P = 0.3098)	0.926320950286	0.92500	0.9054588325528415	0.90458	0.905716289001	0.70658	0.415368586779	0.27167	T	0.721132	0.92046	D	0.22536	0.76106	D	0.0859375	0.75795	D	0.963108539581299	0.66346	D	0.863614	0.55862	D	0.24177787	0.46769	0.1777569	0.40264	0.2933445	0.51970	0.190038	0.42237	-3.563	0.17366	T	0.2	0.49988	B	0.356992193338291	0.56253	0.99964368	0.99561	0.512	0.72220	.	.	.	.	.	.	3.585512	0.50649	23.0	0.9987780691631992	0.95413	0.312706	0.41613	N	0.524681360864973	0.68387	5.233171	0.540917518592382	0.70609	5.553941	5.51	5.51	0.81744	3.8	0.70283	2.831	0.47943	4.843000	0.45380	0.599	0.40292	1.0	0.71675	0.996	0.32869	0.839	0.39622	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia,_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43100576C>T	ClinGen:CA008426|OMIM:164761.0019|UniProtKB:P07949#VAR_006296	C3888239|C4048306	142623	388|653	Ret, cadherin like domain 1	Pro	Leu	28963.0	single nucleotide variant	NM_020975.6(RET):c.191C>T (p.Pro64Leu)	5979.0	RET	HGNC:9967	Uncertain significance	0.0	Apr 09, 2024	77596424.0	-	RCV000014949|RCV003531901	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43100576.0	43100576.0	10q11.21	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008426,UniProtKB:P07949#VAR_006296,OMIM:164761.0019	3.0	13924.0	43100576.0	C	T	-	-	-	-	-	-	SCV004294349|SCV004831371	-	-	191C>T 	Pro64Leu	NM_020975.6	2.0	4_VUS	87.13	0.2647058823529412	['142623']	autosomal dominant	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	87.13	0.2647059	10-90	70-90						P	36			87.13	Special, No backbone hydrogen	Proline		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										1.6																		115									-67.3				135.7	Cadherin-like region 1 (CLD1)			dbSNP: rs77596424; Variant type: LP/P; AA change: Pro64Leu; PTM type: Phosphorylation; PTM morphology: PEEVP*sFRLGQ; Var class: II		C (loop/coil)	C (loop/coil)							Extracellular																																																													true	RETPro64Leu																																																																																																																																																																																																																																		
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8916138476481084	0.7980533896760693	0.9295069257770723	0.8592978211753017	0.9162840818084527	0.8868635815796786	0.8405685454044737	0.9218056487360786	0.6794363061150756	0.8735975253877695	0.9457045820372267	0.8780270969461299	0.937208202818066	0.916670473237063	0.9096301699084473	F9	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8916138476481084	0.7980533896760693	0.9295069257770723	0.8592978211753017	0.9162840818084527	0.8868635815796786	0.8405685454044737	0.9218056487360786	0.6794363061150756	0.8735975253877695	0.9457045820372267	0.8780270969461299	0.937208202818066	0.916670473237063	0.9096301699084473	F9	ENSG00000101981	52861	204386.0	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561902.0	C	T	X	Y	N	N	N	N	X-139561902-C-T	25656.0	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852263.0	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902.0	139561902.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255405,OMIM:300746.0061	1.0	10617.0	139561902.0	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic		10617.0	X	139561902.0	C	T	S	L	rs137852263	X	138644061.0	X	138471727.0	406.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2.0	0.0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.928	0.96061	D	0.8695	0.95652	D	10.0	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.9990084657283724	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656.0	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852263.0	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902.0	139561902.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255405,OMIM:300746.0061	1.0	10617.0	139561902.0	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic	60.89	0.1153846153846153	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	60.89	0.115384616	10-90	50-70						S	15			60.89	Polar/Neutral	Serine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.8								S406-Y444; PAE: 7.5	2 interactions		3 interactions							105									-67.6				141.3						C (loop/coil)	C (loop/coil)																														1.075		1.038		1.037		1.022	1 mutation(s) (Ser406Glu: 1.118)	1.047																														true	F9Ser406Leu																																																																																																																																																																																																																																		
RAD51D	RAD51D_Cys9Ser	-0.430044793701963	0.6800918575546037	5.444910176636157	0.0009611984439907118	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9077212825295029	0.7661016972976566	0.8740246636756364	0.8369092492667753	0.7663758588209051	0.6324635710169321	0.8021323314471392	0.818850060236358	0.6706305219371522	0.887076778154518	0.9002881466248781	0.8716861670864113	0.9291992671149147	0.8615728726581611	0.9283657869044879	RAD51D	-0.430044793701963	0.6800918575546037	5.444910176636157	0.0009611984439907118	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9077212825295029	0.7661016972976566	0.8740246636756364	0.8369092492667753	0.7663758588209051	0.6324635710169321	0.8021323314471392	0.818850060236358	0.6706305219371522	0.887076778154518	0.9002881466248781	0.8716861670864113	0.9291992671149147	0.8615728726581611	0.9283657869044879	RAD51D		7201		CCSBVarC024707		NC_000017.11:35119588:C:G	26G>C	Cys9Ser																												17.0	35119588.0	C	G	17						17-35119588-C-G	133343.0	single nucleotide variant	NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	140825795.0	-	RCV000115812|RCV000231466|RCV000587404|RCV001175378|RCV001357793|RCV003492494|RCV001798342|RCV003389691	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C1333600|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified|Malignant tumor of breast|Hereditary cancer|Breast and/or ovarian cancer|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35119588.0	35119588.0	17q12	criteria provided, conflicting classifications	20.0	-	N	ClinGen:CA287968	2.0	127886.0	35119588.0	C	G	-	-	-	-	-	-	SCV000149721|SCV000185831|SCV000287702|SCV000488471|SCV000537513|SCV000602155|SCV000698094|SCV000839205|SCV000861249|SCV001434312|SCV002010056|SCV002043216|SCV002071956|SCV002534788|SCV003799801|SCV004009783|SCV004017720|SCV004242788	-	-	26G>C 	Cys9Ser	NM_002878.4	1.0	3_Conflicting		127886.0	17	35119588.0	C	G	C	S	rs140825795	17	33446607.0	17	30470720.0	9.0	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.26G>C	p.Cys9Ser	c.26G>C	p.Cys9Ser	principal1	Y	5	.	.	-	TGC	2.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.005	0.79703	D	0.948	0.77914	P	0.539	0.82066	P	0.0	0.33788	N	simple_aae	100.0	0.0	2.37	0.68084	M	-5.89	0.91889	D	0.767	0.76382	-0.5618	0.66187	T	0.3025	0.67215	T	10.0	0.23021111	0.39578	T	0.269442	0.89798	D	0.218	0.51046	0.75	0.88011	O75771	C9S	Gain of disorder (P = 0.0024)| Gain of phosphorylation at C9 (P = 0.0829)| Gain of methylation at R5 (P = 0.2031)| Gain of helix (P = 0.2294)| Gain of catalytic residue at G7 (P = 0.288)	0.89673440463	0.89492	.	0.75662	.	0.38233	.	.	.	0.542336	0.84209	D	-0.0621782	0.4222	T	0.0874681	0.75898	D	0.123274603139513	0.1456	T	0.89681	0.63880	D	0.90909326	0.92096	0.91432685	0.95940	0.9053122	0.91745	0.9265354	0.96810	-13.828	0.92500	D	0.7562	0.75474	P	0.0197165020029777	0.29331	0.98283120	0.95814	0.694	0.83023	.	.	.	.	.	.	4.809918	0.78275	26.9	0.9905536926479037	0.51428	0.811646	0.73360	D	0.419960104252545	0.62325	4.469254	0.393835298150661	0.60976	4.315044	4.5	4.5	0.54328	.	.	3.449	0.52806	7.405000	0.58667	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.842	0.39783	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	112	264690	4.231365E-4	.	27	108026	2.499400e-04	1	83	204386	4.060940e-04	1	81	233462	3.469520e-04	1	0	7118	0.000000e+00	0	6	17088	3.511240e-04	1	0	2320	0.000000e+00	0	0	9008	0.000000e+00	0	1	12198	8.198070e-05	0	20	42712	4.682520e-04	0	0	15682	0.000000e+00	0	20	42712	4.682520e-04	0	1	16132	6.198860e-05	0	12	30494	3.935200e-04	1	0	6188	0.000000e+00	0	0	13354	0.000000e+00	0	1	15538	6.435830e-05	0	68	87248	7.793870e-04	0	0	30600	0.000000e+00	0	68	87248	7.793870e-04	0	1	14856	6.731290e-05	0	13	34236	3.797170e-04	1	0	9562	0.000000e+00	0	0	17654	0.000000e+00	0	1	20436	4.893330e-05	0	64	100606	6.361450e-04	0	0	30518	0.000000e+00	0	64	100606	6.361450e-04	0	.	1058	1612440	6.561480e-04	1	980	1179946	8.305460e-04	0	12	75044	1.599060e-04	0	0	912	0.000000e+00	0	15	60030	2.498750e-04	1	0	29602	0.000000e+00	0	0	44872	0.000000e+00	0	2	62412	3.204510e-05	0	0	6062	0.000000e+00	0	980	1179946	8.305460e-04	0	0	91086	0.000000e+00	0	56	93168	6.010647432594882E-4	0	174	0	0	2674	0	0	4182	0	1	772	0.0012953367875647669	0	946	0	0	656	0	0	274	0	3	7122	4.2122999157540015E-4	0	4356	0	0	3330	0	60	109968	5.456132693147098E-4	Conflicting_classifications_of_pathogenicity	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|RAD51D-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119588C>G	ClinGen:CA287968	C0006142|CN221562|C3280345|C1333600|CN169374|C0027672|C3661900	614291	145|140162	RAD51D, N-terminal domain	Cys	Ser	133343.0	single nucleotide variant	NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	140825795.0	-	RCV000115812|RCV000231466|RCV000587404|RCV001175378|RCV001357793|RCV003492494|RCV001798342|RCV003389691	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C1333600|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified|Malignant tumor of breast|Hereditary cancer|Breast and/or ovarian cancer|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35119588.0	35119588.0	17q12	criteria provided, conflicting classifications	20.0	-	N	ClinGen:CA287968	2.0	127886.0	35119588.0	C	G	-	-	-	-	-	-	SCV000149721|SCV000185831|SCV000287702|SCV000488471|SCV000537513|SCV000602155|SCV000698094|SCV000839205|SCV000861249|SCV001434312|SCV002010056|SCV002043216|SCV002071956|SCV002534788|SCV003799801|SCV004009783|SCV004017720|SCV004242788	-	-	26G>C 	Cys9Ser	NM_002878.4	1.0	3_Conflicting	80.18	0.0518518518518518	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	80.18	0.05185185	<10	70-90						C	7			80.18	Special, a very reactive sulfhydryl group	Cysteine		DNA repair protein RAD51 homolog 4										2.5									1 interaction		4 interactions							121									-149.0				157.1	preferentially binds ssDNA					C (loop/coil)	S (bend)																																																																				true	RAD51DCys9Ser																																																																																																																																																																																																																																		
ZC4H2	ZC4H2_Leu66His	-6.503081082564646	0.0003331667654269905	5.090199097323906	0.0014148589207405259	2025_01_Batch_13-14	true	true	true	true	false	false	true	false	false	false	0.9819447714602738	0.9695243331978212	0.9818317123781239	0.9662020735616346	0.9032734358186609	0.8522655514090401	0.9633536275335962	0.9752995486173831	0.9748941121269308	0.9804984863300853	0.9542813202282818	0.9690505195896728	0.9883638761388648	0.9641545542687115	0.9833910565904622	ZC4H2	-6.503081082564646	0.0003331667654269905	5.090199097323906	0.0014148589207405259	2025_01_Batch_13-14	true	true	true	true	false	false	true	false	false	false	0.9819447714602738	0.9695243331978212	0.9818317123781239	0.9662020735616346	0.9032734358186609	0.8522655514090401	0.9633536275335962	0.9752995486173831	0.9748941121269308	0.9804984863300853	0.9542813202282818	0.9690505195896728	0.9883638761388648	0.9641545542687115	0.9833910565904622	ZC4H2		4320		CCSBVarC009188		NC_000023.11:64921845:A:T	197T>A	Leu66His																												23.0	64921845.0	A	T	X						X-64921845-A-T	380135.0	single nucleotide variant	NM_018684.4(ZC4H2):c.197T>A (p.Leu66His)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 02, 2017	1057520297.0	-	RCV000425925	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921845.0	64921845.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA16609220,OMIM:300897.0005	1.0	378042.0	64921845.0	A	T	-	-	-	-	-	-	SCV000513395	-	-	197T>A 	Leu66His	NM_018684.4		1_Pathogenic		378042.0	X	64921845.0	A	T	L	H	rs1057520297	X	64141725.0	X	64058450.0	66.0	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.197T>A	p.Leu66His	c.197T>A	p.Leu66His	principal1	Y	1	YES	Select	-	CTC	2.0	0.0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.94	0.94378	A	simple_aae	6.0	94.0	2.58	0.75182	M	-6.17	0.90790	D	0.966	0.97658	-0.413	0.71488	T	0.3407	0.70541	T	9.0	0.91775376	0.91035	D	0.110217	0.78686	D	0.673	0.87862	0.827	0.93752	Q9NQZ6	L66H	Loss of stability (P = 0.0086)| Gain of disorder (P = 0.0553)| Loss of helix (P = 0.079)| Gain of catalytic residue at L68 (P = 0.0857)| Loss of MoRF binding (P = 0.5018)	0.958049427582	0.95723	0.9684491553990456	0.96815	2.23748090164	0.95976	0.934989273548	0.99245	D	0.857357	0.96779	D	0.55841	0.96027	D	0.564341	0.95964	D	0.997178673744202	0.90862	D	0.950605	0.87028	D	0.9276844	0.93915	0.8559096	0.91794	0.9275634	0.93903	0.858151	0.91947	-11.957	0.85475	D	1.0	0.99952	P	0.99974676713688	0.97751	0.99785450	0.98531	0.994	0.99793	.	.	.	.	.	.	4.36859	0.67299	25.1	0.9834854610322283	0.4065	.	.	.	.	.	.	.	.	.	5.7	4.54	0.55168	.	.	9.008	0.9315	11.114000	0.86409	0.756	0.943	1.0	0.71675	1.0	0.68239	0.995	0.73271	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64921845A>T	ClinGen:CA16609220|OMIM:300897.0005	C0796200	314580	3454|85283	.	Leu	His	380135.0	single nucleotide variant	NM_018684.4(ZC4H2):c.197T>A (p.Leu66His)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 02, 2017	1057520297.0	-	RCV000425925	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921845.0	64921845.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA16609220,OMIM:300897.0005	1.0	378042.0	64921845.0	A	T	-	-	-	-	-	-	SCV000513395	-	-	197T>A 	Leu66His	NM_018684.4		1_Pathogenic	93.3	0.5	['314580']	unknown	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	93.3	0.5	10-90	>90						L	82			93.3	Aliphatic	Leucine		Zinc finger C4H2 domain-containing protein	Coiled coil							0.0136		3.8								L66-H62, L66-H70; PAE: 1.0, 1.0		L66-H62, L66-H70; PAE: 1.0, 1.0								131									-61.8		Pocket 3: Mean pLDDT: 80.71, Volume: 332.58 Å³, Druggability score: 0.01		-37.9						H (helix)	H (α-helix)																																																																				true	ZC4H2Leu66His																																																																																																																																																																																																																																		
BRIP1	BRIP1_Leu195Pro	1.2668702182308096	0.2718645879814718	-1.8989442577783242	0.3193129417034555	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6814497901870833	0.6633747124171891	0.703444152328791	0.6858508588870511	0.7008058306509546	0.7376117184704061	0.6595460545978806	0.6998852237962895	0.6857644396183068	0.6706831149265664	0.663999942831503	0.7121556631762217	0.7070030808612925	0.6409849852160716	0.6922164654476003	BRIP1	1.2668702182308096	0.2718645879814718	-1.8989442577783242	0.3193129417034555	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.6814497901870833	0.6633747124171891	0.703444152328791	0.6858508588870511	0.7008058306509546	0.7376117184704061	0.6595460545978806	0.6998852237962895	0.6857644396183068	0.6706831149265664	0.663999942831503	0.7121556631762217	0.7070030808612925	0.6409849852160716	0.6922164654476003	BRIP1	ENSG00000136492	55128	28906.0	CCSBVarC002407	ALE00002407	NC_000017.11:61847144:A:G	584T>C	Leu195Pro	RC4	RC4_Mut_GDEh1031	G07	GDEhDisVCh_40040	B12	2.0	RC4_Mut_GDDh1031	G07							1.0	1.0	1.0	1.0	0.0			0.0			0.0			17.0	61847144.0	A	G	17	Y	Y	N	N	N	17-61847144-A-G	133650.0	single nucleotide variant	NM_032043.3(BRIP1):c.584T>C (p.Leu195Pro)	83990.0	BRIP1	HGNC:20473	Benign/Likely benign	0.0	Mar 04, 2025	4988347.0	-	RCV000120407|RCV000116162|RCV000410203|RCV000411259|RCV000990029|RCV000589840|RCV001798361|RCV004528812|RCV001082551	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:C3661900|MedGen:CN221562|MedGen:CN239206|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J|Ovarian neoplasm|Familial cancer of breast|not provided|Breast and/or ovarian cancer|BRIP1-related disorder|Fanconi anemia complementation group J;Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61847144.0	61847144.0	17q23.2	criteria provided, multiple submitters, no conflicts	25.0	-	N	ClinGen:CA157725	2.0	128193.0	61847144.0	A	G	-	-	-	-	-	-	SCV000150071|SCV000166684|SCV000172953|SCV000489853|SCV000489854|SCV000699730|SCV000889221|SCV000910543|SCV001140793|SCV001157291|SCV001287318|SCV002043640|SCV002066143|SCV002533721|SCV002551206|SCV002819151|SCV004016923|SCV004145821|SCV005404126	-	-	584T>C 	Leu195Pro	NM_032043.3	2.0	2_Benign	0.00227726	128193.0	17	61847144.0	A	G	L	P	rs4988347	17	59924505.0	17	57279287.0	195.0	BRIP1	ENSG00000136492	ENST00000683039	ENSP00000508303	Q9BX63	FANCJ_HUMAN	.	.	c.584T>C	p.Leu195Pro	principal2	Y	.	.	.	-	CTC	2.0	0.0	A	A/A	A/A	A/A	A/A	.	0.13823	.	.	0.15573	.	0.0	0.02950	B	0.001	0.04348	B	.	0.37131	.	.	.	.	0.75	0.18917	N	.	0.08443	.	.	0.14123	-0.9191	0.45481	T	0.1553	0.48453	T	9.0	.	0.00085	.	0.03251	0.54133	D	.	0.29213	.	.	.	.	.	.	0.39799	.	0.47148	.	0.28563	0.3499096632	0.17890	T	0.06698	0.32835	T	-0.505713	0.00508	T	-0.505056	0.21493	T	0.00119638136319552	0.00012	T	.	0.13035	.	0.031770874	0.03049	0.031210301	0.01687	0.029862495	0.02528	0.03966814	0.04125	-4.048	0.24602	T	.	0.00668	.	0.00173275598557616	0.12269	0.23876125	0.74722	0.019	0.02684	.	.	.	.	.	.	0.472332	0.08447	5.175	0.2264141844658854	0.00915	0.039188	0.05557	N	-1.11276007648918	0.06339	0.2952269	-1.00712536356647	0.09467	0.4800915	5.26	-0.0114	0.1328	-1.01	0.15704	0.364	0.20126	3.456000	0.38560	-0.592	0.0465	0.393	0.262	0.999000	0.35501	0.001	0.02614	45	0.97779	4	7.987220447284345E-4	0	0.0	1	9.940357852882703E-4	1	0.001440922190201729	0	0.0	2	0.002044989775051125	318	264690	0.0012014054	.	270	109370	2.468680e-03	1	407	208056	1.956200e-03	2	467	236808	1.972060e-03	2	2	7160	2.793300e-04	0	11	17112	6.428240e-04	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	149	13378	1.113770e-02	1	94	42762	2.198210e-03	0	8	15688	5.099440e-04	0	94	42762	2.198210e-03	0	8	16212	4.934620e-04	0	21	30524	6.879830e-04	1	0	6208	0.000000e+00	0	0	13404	0.000000e+00	0	175	16718	1.046780e-02	1	178	89524	1.988290e-03	0	13	30604	4.247810e-04	0	178	89524	1.988290e-03	0	8	14896	5.370570e-04	0	25	34260	7.297140e-04	1	0	9568	0.000000e+00	0	0	17680	0.000000e+00	0	197	21616	9.113620e-03	1	211	102658	2.055370e-03	0	13	30522	4.259220e-04	0	211	102658	2.055370e-03	0	.	3615	1613712	2.240180e-03	7	525	64018	8.200820e-03	0	32	75020	4.265530e-04	0	0	912	0.000000e+00	0	56	60024	9.329600e-04	1	0	29594	0.000000e+00	0	0	44838	0.000000e+00	0	525	64018	8.200820e-03	0	0	6056	0.000000e+00	0	2836	1179684	2.404030e-03	5	39	91082	4.281860e-04	1	322	198354	0.001623360254897809	0	360	0	0	2728	0	5	9426	5.304476978569913E-4	0	794	0	0	964	0	0	672	0	0	276	0	28	15672	0.0017866258295048494	5	9786	5.109339873288372E-4	0	3400	0	355	229246	0.0015485548275651483	Benign/Likely_benign	BRIP1-related_disorder|Breast_and/or_ovarian_cancer|Fanconi_anemia_complementation_group_J|not_specified|Ovarian_neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.61847144A>G	ClinGen:CA157725	CN239206|CN221562|C1836860|CN169374|C0919267|C0027672|C0346153|C3661900	609054|114480	84|140162|227535	.	Leu	Pro	133650.0	single nucleotide variant	NM_032043.3(BRIP1):c.584T>C (p.Leu195Pro)	83990.0	BRIP1	HGNC:20473	Benign/Likely benign	0.0	Mar 04, 2025	4988347.0	-	RCV000120407|RCV000116162|RCV000410203|RCV000411259|RCV000990029|RCV000589840|RCV001798361|RCV004528812|RCV001082551	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:C3661900|MedGen:CN221562|MedGen:CN239206|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J|Ovarian neoplasm|Familial cancer of breast|not provided|Breast and/or ovarian cancer|BRIP1-related disorder|Fanconi anemia complementation group J;Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61847144.0	61847144.0	17q23.2	criteria provided, multiple submitters, no conflicts	25.0	-	N	ClinGen:CA157725	2.0	128193.0	61847144.0	A	G	-	-	-	-	-	-	SCV000150071|SCV000166684|SCV000172953|SCV000489853|SCV000489854|SCV000699730|SCV000889221|SCV000910543|SCV001140793|SCV001157291|SCV001287318|SCV002043640|SCV002066143|SCV002533721|SCV002551206|SCV002819151|SCV004016923|SCV004145821|SCV005404126	-	-	584T>C 	Leu195Pro	NM_032043.3	2.0	2_Benign	27.47	0.823170731707317	['609054', '114480', '609054', '114480']	autosomal dominant	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	FANCONI ANEMIA, COMPLEMENTATION GROUP J; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP J; BREAST CANCER	27.47	0.8231707	10-90	<=50						L	135			27.47	Aliphatic	Leucine		Fanconi anemia group J protein							Helicase ATP-binding			3.8																		131									79.8				131.5				dbSNP: rs4988347; Variant type: LB/B; AA change: Leu195Pro; PTM type: Acetylation; PTM morphology: kVDSGkTVKL*N; Var class: II&rs4988347		C (loop/coil)	C (loop/coil)																																																																				true	BRIP1Leu195Pro																																																																																																																																																																																																																																		
RET	RET_Thr338Ile	-1.424602819963752	0.19729169514798545	2.2743462514220494	0.05711032904998553	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.7512619144710555	0.8640284405394438	0.7566165842487134	0.806650231702349	0.9190116567427862	0.9174918166052234	0.7105123566417155	0.5926499598947482	0.8981003866469992	0.6594978765357586	0.9205314968803489	0.9027881067629824	0.9205832086026784	0.8299564944318886	0.8430259524063524	RET	-1.424602819963752	0.19729169514798545	2.2743462514220494	0.05711032904998553	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	0.7512619144710555	0.8640284405394438	0.7566165842487134	0.806650231702349	0.9190116567427862	0.9174918166052234	0.7105123566417155	0.5926499598947482	0.8981003866469992	0.6594978765357586	0.9205314968803489	0.9027881067629824	0.9205832086026784	0.8299564944318886	0.8430259524063524	RET	ENSG00000165731	8858	202954.0	CCSBVarC006878	ALE00006876	NC_000010.11:43106521:C:T	1013C>T	Thr338Ile	CEGS2	CegsMutGDEh1025	A12	GDEhDisVCh_40066	C05	2.0									1.0	1.0	0.0		0.0			0.0			0.0			10.0	43106521.0	C	T	10	Y	N	N	N	N	10-43106521-C-T	47198.0	single nucleotide variant	NM_020975.6(RET):c.1013C>T (p.Thr338Ile)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Jan 28, 2025	377767433.0	-	RCV000709106|RCV000570795|RCV001046577|RCV001262456|RCV005042101|RCV004566792|RCV004700294	MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Pheochromocytoma;Familial medullary thyroid carcinoma;Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106521.0	43106521.0	10q11.21	criteria provided, conflicting classifications	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007399	2.0	38594.0	43106521.0	C	T	-	-	-	-	-	-	SCV000664515|SCV000838375|SCV001210484|SCV001440343|SCV005054176|SCV005201970|SCV005666584	-	-	1013C>T 	Thr338Ile	NM_020975.6	1.0	3_Conflicting	0.000018474	38594.0	10	43106521.0	C	T	T	I	rs377767433	10	43601969.0	10	42921975.0	338.0	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.1013C>T	p.Thr338Ile	c.1013C>T	p.Thr338Ile	principal4	Y	5	YES	Select	+	ACC	2.0	0.0	C	C/C	C/C	C/C	C/C	0.478	0.08337	T	0.239	0.24837	T	0.017	0.24484	B	0.007	0.19965	B	0.91	0.92786	D	simple_aae	9.0	91.0	2.135	0.59336	M	-0.16	0.09401	N	0.235	0.30814	-0.8203	0.53729	T	0.2905	0.66078	T	10.0	0.2821769	0.45410	D	0.028251	0.50756	D	0.410	0.72027	0.755	0.88426	P07949	T338I	Loss of disorder (P = 0.0525)| Gain of catalytic residue at A342 (P = 0.1324)| Gain of sheet (P = 0.1945)| Gain of MoRF binding (P = 0.2848)| Loss of loop (P = 0.2897)	0.981789031089	0.98140	0.6790319585223052	0.67683	0.218286694533	0.24083	0.481091409922	0.36160	T	0.376246	0.73794	T	0.151122	0.69149	D	0.135665	0.79109	D	0.17234893143177	0.18506	T	0.726327	0.33844	T	0.14303645	0.32613	0.08598992	0.19866	0.099525385	0.23277	0.08741958	0.20292	-7.255	0.55945	T	0.3018	0.55809	B	0.094241815648635	0.42787	0.99947983	0.99419	0.065	0.18082	.	.	.	.	.	.	2.501402	0.32347	19.0	0.9880509143872653	0.46629	0.155931	0.27906	N	-0.117237538328119	0.36368	2.120756	0.048901495971743	0.41733	2.534287	5.32	5.32	0.75341	4.24	0.80495	1.993	0.40471	4.824000	0.45219	0.599	0.40292	0.974	0.34718	1.0	0.68239	0.734	0.35269	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	6	109044	5.502370e-05	0	4	206970	1.932650e-05	0	8	235572	3.395990e-05	0	0	7096	0.000000e+00	0	0	17042	0.000000e+00	0	0	2312	0.000000e+00	0	0	9024	0.000000e+00	0	0	13372	0.000000e+00	0	6	42620	1.407790e-04	0	0	15670	0.000000e+00	0	6	42620	1.407790e-04	0	0	16044	0.000000e+00	0	0	30424	0.000000e+00	0	0	6182	0.000000e+00	0	0	13366	0.000000e+00	0	0	16712	0.000000e+00	0	4	88828	4.503080e-05	0	0	30574	0.000000e+00	0	4	88828	4.503080e-05	0	0	14776	0.000000e+00	0	0	34164	0.000000e+00	0	0	9550	0.000000e+00	0	0	17668	0.000000e+00	0	0	21236	0.000000e+00	0	8	102092	7.836070e-05	0	0	30494	0.000000e+00	0	8	102092	7.836070e-05	0	.	31	1613700	1.921050e-05	0	2	6078	3.290560e-04	0	0	74914	0.000000e+00	0	0	912	0.000000e+00	0	0	59994	0.000000e+00	0	0	29596	0.000000e+00	0	0	44888	0.000000e+00	0	0	63946	0.000000e+00	0	2	6078	3.290560e-04	0	28	1179836	2.373210e-05	0	1	91072	1.098030e-05	0	0	26588	0	0	114	0	0	86	0	0	3230	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4640	2.1551724137931034E-4	0	3344	0	0	112	0	1	35910	2.78473962684489E-5	Conflicting_classifications_of_pathogenicity	Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hirschsprung_disease,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106521C>T	ClinGen:CA007399	C4048306|C0027672|C0025268|C0025269|C3888239	171400|162300|142623	653|140162|247698|653|247709|653|388	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Thr	Ile	47198.0	single nucleotide variant	NM_020975.6(RET):c.1013C>T (p.Thr338Ile)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Jan 28, 2025	377767433.0	-	RCV000709106|RCV000570795|RCV001046577|RCV001262456|RCV005042101|RCV004566792|RCV004700294	MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Pheochromocytoma;Familial medullary thyroid carcinoma;Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106521.0	43106521.0	10q11.21	criteria provided, conflicting classifications	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007399	2.0	38594.0	43106521.0	C	T	-	-	-	-	-	-	SCV000664515|SCV000838375|SCV001210484|SCV001440343|SCV005054176|SCV005201970|SCV005666584	-	-	1013C>T 	Thr338Ile	NM_020975.6	1.0	3_Conflicting	87.78	0.3450704225352112	['171400', '162300', '142623', '171400', '171300', '155240', '162300', '142623']	autosomal dominant	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; PHEOCHROMOCYTOMA; THYROID CARCINOMA, FAMILIAL MEDULLARY; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	87.78	0.34507042	10-90	70-90						T	49			87.78	Polar/Neutral	Threonine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-0.7								T338-A349; PAE: 1.0	6 interactions	T338-A349; PAE: 1.0	6 interactions							119									-133.9				154.0	Cadherin-like region 3 (CLD3)					B (undefined)	E (parallel sheets)							Extracellular																																																													true	RETThr338Ile																																																																																																																																																																																																																																		
CTCF	CTCF_His455Gln	3.8257806455949326	0.006493290691325369	-3.9544631677107454	0.00550049482130096	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8131409219678946	0.8148728261507332	0.8388991702776349	0.9152160738046102	0.9057477566854892	0.9144240132292991	0.9697413493209072	0.8540200173951931	0.8175221726722572	0.8484144726341254	0.8970715001416795	0.8606907982883133	0.8237783231600767	0.8122234796292092	0.7778673713016637	CTCF	3.8257806455949326	0.006493290691325369	-3.9544631677107454	0.00550049482130096	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.8131409219678946	0.8148728261507332	0.8388991702776349	0.9152160738046102	0.9057477566854892	0.9144240132292991	0.9697413493209072	0.8540200173951931	0.8175221726722572	0.8484144726341254	0.8970715001416795	0.8606907982883133	0.8237783231600767	0.8122234796292092	0.7778673713016637	CTCF		6173		CCSBVarC010858		NC_000016.10:67626562:C:G	1365C>G	His455Gln																												16.0	67626562.0	C	G	16						16-67626562-C-G	799962.0	single nucleotide variant	NM_006565.4(CTCF):c.1365C>G (p.His455Gln)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Jun 10, 2019	1597725291.0	-	RCV001002552	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome	germline	germline	GRCh38	NC_000016.10	16	67626562.0	67626562.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA396317165	2.0	812003.0	67626562.0	C	G	-	-	-	-	-	-	SCV001160523	-	-	1365C>G 	His455Gln	NM_006565.4	1.0	1_Pathogenic		812003.0	16	67626562.0	C	G	H	Q	rs1597725291	16	67660465.0	16	66217966.0	455.0	CTCF	ENSG00000102974	ENST00000264010	ENSP00000264010	P49711	CTCF_HUMAN	c.1365C>G	p.His455Gln	c.1365C>G	p.His455Gln	principal4	Y	1	YES	Select	+	CAC	3.0	2.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.997	0.70687	D	0.992	0.80453	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.485	0.98910	H	-7.51	0.95091	D	0.92	0.92320	-0.2605	0.75966	T	0.3925	0.74513	T	10.0	0.8887602	0.88083	D	0.149609	0.83093	D	0.579	0.82939	0.748	0.87844	P49711	H455Q	Gain of MoRF binding (P = 0.0878)| Loss of helix (P = 0.1706)| Gain of disorder (P = 0.19)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2629)	0.949006423897	0.94804	.	0.97634	3.03790854674	0.99266	0.889497578144	0.95192	D	0.917886	0.98488	D	0.309664	0.83603	D	0.207035	0.83391	D	0.989961684048839	0.8003	D	.	0.80399	.	0.969477	0.98182	0.83204865	0.90192	0.969477	0.98182	0.83204865	0.90192	-13.14	0.89952	D	.	0.99795	.	0.99981684735099	0.98120	0.98982334	0.96704	0.864	0.92591	.	.	.	.	.	.	3.86468	0.56146	23.7	0.9914363129715645	0.53677	0.530946	0.54986	D	0.449511622968474	0.63986	4.666273	0.33042528030055	0.57107	3.898847	5.48	1.99	0.25354	2.62	0.47948	2.183	0.42298	0.800000	0.21732	-0.182	0.10118	1.0	0.71675	0.999	0.35501	0.99	0.65338	53	0.97599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	criteria_provided,_single_submitter	NC_000016.10:g.67626562C>G	.	C3809686	615502	363611	.	His	Gln	799962.0	single nucleotide variant	NM_006565.4(CTCF):c.1365C>G (p.His455Gln)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Jun 10, 2019	1597725291.0	-	RCV001002552	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome	germline	germline	GRCh38	NC_000016.10	16	67626562.0	67626562.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA396317165	2.0	812003.0	67626562.0	C	G	-	-	-	-	-	-	SCV001160523	-	-	1365C>G 	His455Gln	NM_006565.4	1.0	1_Pathogenic	85.99	0.1684782608695652	['615502']	unknown		0	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	85.99	0.16847827	10-90	70-90						H	31			85.99	Positively-charged	Histidine		Transcriptional repressor CTCF										-3.2								H455-Q459, H455-H460, H455-D451, H455-C442, H455-C439; PAE: 1.0, 2.0, 1.0, 2.5, 2.0	19 interactions	H455-H460, H455-D451, H455-Q459; PAE: 2.0, 1.0, 1.0	20 interactions							155									-63.8				-53.6						H (helix)	H (α-helix)	Helix										C2H2-type 7																																																									true	CTCFHis455Gln																																																																																																																																																																																																																																		
SDHD	SDHD_Tyr114Cys	4.506251060822262	0.004604751431917464	-8.333215389049078	0.004201518252758375	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8100749365893497	0.7601074150453182	0.7603530340294904	0.8557839577683707	0.8267088282373268	0.8682120279262552	0.8812581055560494	0.7870337879673006	0.788748895242953	0.8449747493825295	0.7852056285483985	0.8303098099806919	0.7336722800916803	0.7314659348476833	0.7751751237961699	SDHD	4.506251060822262	0.004604751431917464	-8.333215389049078	0.004201518252758375	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8100749365893497	0.7601074150453182	0.7603530340294904	0.8557839577683707	0.8267088282373268	0.8682120279262552	0.8812581055560494	0.7870337879673006	0.788748895242953	0.8449747493825295	0.7852056285483985	0.8303098099806919	0.7336722800916803	0.7314659348476833	0.7751751237961699	SDHD	ENSG00000204370	5678	201959.0	CCSBVarC006161	ALE00006161	NC_000011.10:112094831:A:G	341A>G	Tyr114Cys	CEGS2	CegsMutGDEh1008	F02	GDEhDisVCh_40066	D01	2.0									1.0	1.0	0.0		0.0			0.0			0.0			11.0	112094831.0	A	G	11	Y	N	N	N	N	11-112094831-A-G	21939.0	single nucleotide variant	NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	Mar 04, 2025	104894304.0	-	RCV000007309|RCV001810833|RCV000155750|RCV000221353|RCV002228004	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112094831.0	112094831.0	11q23.1	criteria provided, multiple submitters, no conflicts	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	OMIM:602690.0007,ClinGen:CA016797,UniProtKB:O14521#VAR_017872	3.0	6900.0	112094831.0	A	G	-	-	-	-	-	-	SCV000205461|SCV000275206|SCV000823357|SCV001477811|SCV002527126|SCV002599968|SCV004814332|SCV005689607|SCV005872649	-	-	341A>G 	Tyr114Cys	NM_003002.4	2.0	1_Pathogenic		6900.0	11	112094831.0	A	G	Y	C	rs104894304	11	111965555.0	11	111470765.0	114.0	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.341A>G	p.Tyr114Cys	c.341A>G	p.Tyr114Cys	principal1	Y	1	YES	Select	+	TAT	2.0	0.0	A	./.	./.	./.	./.	0.018	0.50835	D	0.065	0.45051	T	0.964	0.55869	D	0.844	0.60367	P	0.87	0.93829	A	simple_aae	13.0	87.0	.	.	.	-7.31	0.94609	D	0.976	0.98669	1.0006	0.9719	D	0.9867	0.99604	D	9.0	0.9957507	0.99992	D	0.633257	0.96850	D	0.943	0.98815	0.983	0.99835	O14521	Y114C	Loss of phosphorylation at Y114 (P = 0.1741)| Loss of disorder (P = 0.1918)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2363)| Loss of helix (P = 0.2662)	0.936232506373	0.93507	0.976168329744005	0.97594	0.746907957965	0.63330	0.698327541351	0.66847	T	0.978102	0.99803	D	0.331545	0.85161	D	0.238465	0.84966	D	0.993272423744202	0.8388	D	0.867413	0.57053	D	0.6309356	0.74072	0.5530032	0.73898	0.56750697	0.70631	0.64086455	0.78789	-10.9	0.82441	D	0.6697	0.73951	P	0.99848854137229	0.94531	0.99825233	0.98698	0.801	0.88995	.	.	.	.	.	.	4.453053	0.69299	25.3	0.9505350091819748	0.26304	0.957666	0.97690	D	0.756609150763795	0.83245	7.990596	0.715173977717976	0.83441	8.04602	4.85	4.85	0.62327	.	.	8.931	0.92428	9.292000	0.79831	0.751	0.87726	1.0	0.71675	1.0	0.68239	0.992	0.67791	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|not_provided|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112094831A>G	ClinGen:CA016797|OMIM:602690.0007|UniProtKB:O14521#VAR_017872	CN166604|C1868633|C0031511|C1847319|C0027672|C3494181|C3661900|C1708353	171300|606864|168000	201|29072|97286|140162|29072|29072	.	Tyr	Cys	21939.0	single nucleotide variant	NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	Mar 04, 2025	104894304.0	-	RCV000007309|RCV001810833|RCV000155750|RCV000221353|RCV002228004	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112094831.0	112094831.0	11q23.1	criteria provided, multiple submitters, no conflicts	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	OMIM:602690.0007,ClinGen:CA016797,UniProtKB:O14521#VAR_017872	3.0	6900.0	112094831.0	A	G	-	-	-	-	-	-	SCV000205461|SCV000275206|SCV000823357|SCV001477811|SCV002527126|SCV002599968|SCV004814332|SCV005689607|SCV005872649	-	-	341A>G 	Tyr114Cys	NM_003002.4	2.0	1_Pathogenic	98.58	0.7522522522522522	['168000', '171300', '606864']	autosomal dominant	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	98.58	0.7522523	10-90	>90						Y	167			98.58	Aromatic	Tyrosine	a ubiquinone	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										-1.3				1 interaction				Y114-V110; PAE: 1.0	1 interaction	Y114-V110; PAE: 1.0	1 interaction							181									-120.4				-20.6						H (helix)	H (α-helix)	Helix						Mitochondrial matrix																																																													true	SDHDTyr114Cys																																																																																																																																																																																																																																		
BRAF	BRAF_Gly464Val	-4.383115862384623	0.003222238147491784	2.1555502654060805	0.06805360380374736	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.836866009281579	0.6141787461590097	0.8033189136484684	0.8208140248161175	0.7314311220683629	0.748407048873009	0.8220743875740791	0.8736790115577736	0.6191896953787797	0.8607412739439905	0.7144551952637169	0.819553662058156	0.7329588157391633	0.6091677969392397	0.8129907446191675	BRAF	-4.383115862384623	0.003222238147491784	2.1555502654060805	0.06805360380374736	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.836866009281579	0.6141787461590097	0.8033189136484684	0.8208140248161175	0.7314311220683629	0.748407048873009	0.8220743875740791	0.8736790115577736	0.6191896953787797	0.8607412739439905	0.7144551952637169	0.819553662058156	0.7329588157391633	0.6091677969392397	0.8129907446191675	BRAF	ENSG00000157764	71969	220600.0	CCSBVarC003158	ALE00003158	NC_000007.14:140781617:C:A	1391G>T	Gly464Val	CEGS2	CegsMutGDEh1009	F10	GDEhDisVCh_40058	G01	2.0									1.0	1.0	0.0		0.0			0.0			0.0			7.0	140781617.0	C	A	7	Y	N	N	N	N	7-140781617-C-A	48834.0	single nucleotide variant	NM_004333.6(BRAF):c.1391G>T (p.Gly464Val)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 16, 2023	121913348.0	-	RCV000033302|RCV000037914|RCV001811232|RCV001813221|RCV002250499	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	RASopathy|Non-small cell lung carcinoma|not provided|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1	germline;somatic;unknown	germline/somatic	GRCh38	NC_000007.14	7	140781617.0	140781617.0	7q34	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA135076,UniProtKB:P15056#VAR_018616	2.0	40364.0	140781617.0	C	A	-	-	-	-	-	-	SCV000061576|SCV000288405|SCV001471782|SCV002060473|SCV002521451|SCV005086395	-	-	1391G>T 	Gly464Val	NM_004333.6	2.0	1_Pathogenic		40364.0	7	140781617.0	C	A	G	V	rs121913348	7	140481417.0	7	140127886.0	464.0	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1391G>T	p.Gly464Val	c.1391G>T	p.Gly464Val	principal4	Y	.	YES	Select	-	GGA	2.0	0.0	C	./.	./.	./.	./.	.	.	.	.	.	.	0.999	0.77914	D	0.989	0.78402	D	.	0.99291	.	.	.	.	3.33	0.90723	M	.	.	.	.	.	1.058	0.9829	D	0.9095	0.96994	D	10.0	0.9907639	0.99584	D	0.535553	0.95644	D	.	0.98743	0.987	0.99867	P15056	G464V	Loss of disorder (P = 0.0738)| Gain of MoRF binding (P = 0.081)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S465 (P = 0.1405)| Loss of loop (P = 0.2237)	.	0.98525	.	0.87595	.	0.96493	0.860752463341	0.91208	D	0.964298	0.99559	D	0.488804	0.93915	D	0.464356	0.93838	D	0.997959613800049	0.92787	D	0.835416	0.50397	T	0.99103737	0.99812	0.9789484	0.99787	0.98836577	0.99669	0.97783434	0.99754	-16.405	0.98310	D	0.9999	0.99795	P	0.999967477835789	0.99297	0.99925166	0.99245	1	0.99985	.	.	.	.	.	.	5.543189	0.91993	32.0	0.9983198102305745	0.91377	0.896613	0.83728	D	1.05336862643538	0.97152	15.69308	0.967625534540837	0.97885	16.98583	5.62	5.62	0.85695	.	.	7.886	0.85829	7.656000	0.64019	0.549	0.27038	1.0	0.71675	1.0	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	RASopathy|Neoplasm|Noonan_syndrome_and_Noonan-related_syndrome|not_provided|Non-small_cell_lung_carcinoma|Breast_neoplasm|Cardiofaciocutaneous_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781617C>A	ClinGen:CA135076|UniProtKB:P15056#VAR_018616	C5555857|C0027651|C5681679|C3661900|C0007131|C1458155|CN029449	115150	536391|98733|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Val	48834.0	single nucleotide variant	NM_004333.6(BRAF):c.1391G>T (p.Gly464Val)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 16, 2023	121913348.0	-	RCV000033302|RCV000037914|RCV001811232|RCV001813221|RCV002250499	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	RASopathy|Non-small cell lung carcinoma|not provided|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1	germline;somatic;unknown	germline/somatic	GRCh38	NC_000007.14	7	140781617.0	140781617.0	7q34	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA135076,UniProtKB:P15056#VAR_018616	2.0	40364.0	140781617.0	C	A	-	-	-	-	-	-	SCV000061576|SCV000288405|SCV001471782|SCV002060473|SCV002521451|SCV005086395	-	-	1391G>T 	Gly464Val	NM_004333.6	2.0	1_Pathogenic	76.48	0.2142857142857142	['115150']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	76.48	0.21428572	10-90	70-90						G	18			76.48	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	ATP	Serine/threonine-protein kinase B-raf							Protein kinase			-0.4								G464-V471; PAE: 1.0	66 interactions	G464-V471; PAE: 1.0	68 interactions							75									152.8				178.1				dbSNP: rs121913348; Variant type: LP/P; AA change: Gly464Glu; PTM type: Phosphorylation; PTM morphology: RIG*sGsFGtVY; Var class: II&rs121913348		B (undefined)	E (parallel sheets)	Beta strand																																																																			true	BRAFGly464Val																																																																																																																																																																																																																																		
CTCF	CTCF_Tyr226Cys	-2.0081090165748017	0.08460141469372065	9.898022384502617	0.00002288890486814957	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8000113975237665	0.703415442134992	0.6998887761277843	0.7382475220170412	0.7520422461314531	0.7492800853906024	0.7696342836386185	0.7179964404154167	0.6719436870404148	0.7975981630763701	0.7548044068723039	0.706860760395464	0.681781111840152	0.7348871972295691	0.8024246319711629	CTCF	-2.0081090165748017	0.08460141469372065	9.898022384502617	0.00002288890486814957	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8000113975237665	0.703415442134992	0.6998887761277843	0.7382475220170412	0.7520422461314531	0.7492800853906024	0.7696342836386185	0.7179964404154167	0.6719436870404148	0.7975981630763701	0.7548044068723039	0.706860760395464	0.681781111840152	0.7348871972295691	0.8024246319711629	CTCF		6173		CCSBVarC010845		NC_000016.10:67611509:A:G	677A>G	Tyr226Cys																												16.0	67611509.0	A	G	16						16-67611509-A-G	1244743.0	single nucleotide variant	NM_006565.4(CTCF):c.677A>G (p.Tyr226Cys)	10664.0	CTCF	HGNC:13723	Pathogenic	1.0	Sep 17, 2024	2142826609.0	-	RCV002471133|RCV001658992	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided	germline	germline	GRCh38	NC_000016.10	16	67611509.0	67611509.0	16q22.1	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA396307384	2.0	1254810.0	67611509.0	A	G	-	-	-	-	-	-	SCV001875117|SCV002767483	-	-	677A>G 	Tyr226Cys	NM_006565.4	2.0	1_Pathogenic		1254810.0	16	67611509.0	A	G	Y	C	rs2142826609	16	67645412.0	16	66202913.0	226.0	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.677A>G	p.Tyr226Cys	c.677A>G	p.Tyr226Cys	principal4	Y	.	.	.	+	TAC	2.0	0.0	A	A/A	A/A	A/A	A/A	.	0.41793	.	.	0.57928	.	0.999	0.77914	D	0.994	0.82066	D	.	0.93300	.	.	.	.	0	0.06502	N	.	0.63348	.	.	0.82100	-1.1031	0.03749	T	0.048	0.20364	T	10.0	0.539923	0.63354	D	0.02103	0.43507	T	.	0.68503	0.299	0.26397	P49711	Y226C	Loss of helix (P = 0.0123)| Loss of phosphorylation at Y226 (P = 0.0176)| Gain of loop (P = 0.0195)| Gain of sheet (P = 0.0507)| Loss of solvent accessibility (P = 0.1322)	.	0.57041	.	0.57532	.	0.84168	0.925917685032	0.98740	D	0.788068	0.94419	D	0.0396152	0.56698	T	-0.180872	0.56141	T	0.918294548988342	0.57406	D	.	0.94986	.	0.5466574	0.69471	0.56271493	0.74444	0.5466574	0.69472	0.56271493	0.74445	-4.564	0.31751	T	.	0.82640	.	0.983475363820255	0.86213	0.91155195	0.91636	0.692	0.82910	.	.	.	.	.	.	4.655767	0.74309	26.1	0.9979348162828725	0.87938	0.923554	0.89985	D	0.63659219199805	0.75371	6.317652	0.680657746933852	0.80807	7.405549	5.5	5.5	0.8136	6.5	0.99641	8.886	0.92093	11.212000	0.89448	0.756	0.943	1.0	0.71675	1.0	0.68239	0.991	0.66489	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614212	6.194970e-07	0	0	75060	0.000000e+00	0	0	75060	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29604	0.000000e+00	0	0	44890	0.000000e+00	0	0	64044	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180026	0.000000e+00	0	0	91084	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67611509A>G	.	C3809686|C3661900	615502	363611	.	Tyr	Cys	1244743.0	single nucleotide variant	NM_006565.4(CTCF):c.677A>G (p.Tyr226Cys)	10664.0	CTCF	HGNC:13723	Pathogenic	1.0	Sep 17, 2024	2142826609.0	-	RCV002471133|RCV001658992	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided	germline	germline	GRCh38	NC_000016.10	16	67611509.0	67611509.0	16q22.1	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA396307384	2.0	1254810.0	67611509.0	A	G	-	-	-	-	-	-	SCV001875117|SCV002767483	-	-	677A>G 	Tyr226Cys	NM_006565.4	2.0	1_Pathogenic	38.83	0.6261261261261262	['615502']	unknown		0	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	38.83	0.6261261	10-90	<=50						Y	139			38.83	Aromatic	Tyrosine		Transcriptional repressor CTCF										-1.3			2 interactions	2 interactions														181									-58.6	Morphology: KDVDVsVyDFEEEQQ			111.4						C (loop/coil)	C (loop/coil)	Helix																																																																			true	CTCFTyr226Cys																																																																																																																																																																																																																																		
RAF1	RAF1_Thr491Arg	-5.242335541861087	0.17352561940663738	2.486225049163244	0.12982347958537951	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7768325021684765	0.7389094948039057	0.7222199134850542	0.7343440951648996	0.756363971056786	0.8035216812448265	0.7758778365355458	0.7156887829290858	0.7773362432954989	0.848415594617929	0.7092062608687455	0.6928103537942536	0.7287510440410226	0.7004827463123123	0.7052494097190242	RAF1	-5.242335541861087	0.17352561940663738	2.486225049163244	0.12982347958537951	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7768325021684765	0.7389094948039057	0.7222199134850542	0.7343440951648996	0.756363971056786	0.8035216812448265	0.7758778365355458	0.7156887829290858	0.7773362432954989	0.848415594617929	0.7092062608687455	0.6928103537942536	0.7287510440410226	0.7004827463123123	0.7052494097190242	RAF1	ENSG00000132155	732	213823.0	CCSBVarC003427	ALE00003427	NC_000003.12:12585745:G:C	1472C>G	Thr491Arg	CEGS2	CegsMutGDEh1015	G06	GDEhDisVCh_40029	F08	1.0									1.0	1.0	0.0		0.0			0.0			0.0			3.0	12585745.0	G	C	3	Y	N	N	N	N	3-12585745-G-C	28998.0	single nucleotide variant	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Sep 11, 2024	80338799.0	-	RCV000014988|RCV000680803|RCV001229313	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 5|not provided|RASopathy	germline	germline	GRCh38	NC_000003.12	3	12585745.0	12585745.0	3p25.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	3.0	13959.0	12585745.0	G	C	-	-	-	-	-	-	SCV000808247|SCV001401755	-	-	1472C>G 	Thr491Arg	NM_002880.4	2.0	1_Pathogenic		13959.0	3	12585745.0	G	C	T	R	rs80338799	3	12627244.0	3	12602244.0	491.0	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1472C>G	p.Thr491Arg	c.1472C>G	p.Thr491Arg	principal3	Y	1	YES	Select	-	ACA	2.0	0.0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.122	0.40143	T	1.0	0.90580	D	0.999	0.92348	D	0.98	0.99291	A	simple_aae	2.0	98.0	0.02	0.07909	N	-5.37	0.84911	D	0.961	0.99191	0.1373	0.84771	D	0.4388	0.77686	T	10.0	0.899554	0.89196	D	0.235705	0.88439	D	0.786	0.92884	0.752	0.88177	P04049	T491R	Gain of MoRF binding (P = 0.0086)| Loss of ubiquitination at K493 (P = 0.0532)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K493 (P = 0.0976)| Gain of solvent accessibility (P = 0.1456)	0.974052792841	0.97352	.	0.85535	2.53490677304	0.97794	0.845280706882	0.88882	D	0.900422	0.98022	D	0.39866	0.89767	D	0.334871	0.89639	D	0.996480882167816	0.89353	D	.	0.92373	.	0.9571182	0.96940	0.9388268	0.97656	0.9463269	0.95828	0.90921533	0.95572	-12.126	0.85499	D	0.9852	0.92260	P	0.999988562000968	0.99579	0.99762386	0.98444	0.978	0.99209	.	.	.	.	.	.	5.424006	0.90747	31.0	0.994371183537825	0.64619	0.916990	0.88355	D	0.626065396186754	0.74692	6.199454	0.704879681503555	0.82653	7.84486	5.26	5.26	0.73443	.	.	9.996	0.99292	11.849000	0.98025	0.676	0.76753	1.0	0.71675	1.0	0.68239	0.994	0.71086	692.0	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	RASopathy|not_provided|Noonan_syndrome_5	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.12585745G>C	ClinGen:CA257064|OMIM:164760.0003|UniProtKB:P04049#VAR_037819	C5555857|C3661900|C1969057	611553	536391|648	Protein kinase domain|Protein kinase domain|Protein kinase domain	Thr	Arg	28998.0	single nucleotide variant	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Sep 11, 2024	80338799.0	-	RCV000014988|RCV000680803|RCV001229313	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 5|not provided|RASopathy	germline	germline	GRCh38	NC_000003.12	3	12585745.0	12585745.0	3p25.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	3.0	13959.0	12585745.0	G	C	-	-	-	-	-	-	SCV000808247|SCV001401755	-	-	1472C>G 	Thr491Arg	NM_002880.4	2.0	1_Pathogenic	53.92	0.2746478873239437	['611553']	autosomal dominant	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	NOONAN SYNDROME 5	53.92	0.2746479	10-90	50-70						T	39			53.92	Polar/Neutral	Threonine		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			-0.7								T491-R495; PAE: 5.0	4 interactions	T491-R495; PAE: 5.0	4 interactions						Phosphothreonine	119		Mutation: T -> D. Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494.							-65.0	Morphology: IGDFGLAtVksRWsG; Domain: PK_Tyr_Ser-Thr			-32.9		Regulatory site: T491-p; Morphology: IGDFGLAtVKSRWSG; Domain: PK_Tyr_Ser-Thr; On-Function: enzymatic activity, induced		dbSNP: rs80338799; Variant type: LP/P; AA change: Thr491Ile; PTM type: Ubiquitylation; PTM morphology: GLAt*VksRWsG; Var class: II&rs80338799		H (helix)	H (α-helix)																																																																				true	RAF1Thr491Arg																																																																																																																																																																																																																																		
FH	FH_Arg233Leu	1.6531294030768622	0.14939045875507265	-2.3788375489716853	0.04896572564958671	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7214334515404457	0.6085960717804378	0.7095397079688235	0.6399453036380933	0.6626860792837086	0.6513057530980928	0.623315681074625	0.7205268032862571	0.5721998696228244	0.7060392869124406	0.6740664054693245	0.6565749262015617	0.69855261265139	0.6449922739380513	0.7368276161684507	FH	1.6531294030768622	0.14939045875507265	-2.3788375489716853	0.04896572564958671	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7214334515404457	0.6085960717804378	0.7095397079688235	0.6399453036380933	0.6626860792837086	0.6513057530980928	0.623315681074625	0.7205268032862571	0.5721998696228244	0.7060392869124406	0.6740664054693245	0.6565749262015617	0.69855261265139	0.6449922739380513	0.7368276161684507	FH	ENSG00000091483	3408	214595.0	CCSBVarC004050	ALE00004050	NC_000001.11:241508643:C:A	698G>T	Arg233Leu	CEGS2	CegsMutGDEh1040	H07	GDEhDisVCh_40065	E08	1.0	CegsMutGDDh1040	H07							1.0	2.0	1.0	1.0	0.0			0.0			0.0			1.0	241508643.0	C	A	1	Y	Y	N	N	N	1-241508643-C-A	31276.0	single nucleotide variant	NM_000143.4(FH):c.698G>T (p.Arg233Leu)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Mar 04, 2025	121913123.0	-	RCV000017624|RCV001781272|RCV002362588	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241508643.0	241508643.0	1q43	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA257461,OMIM:136850.0008	3.0	16237.0	241508643.0	C	A	-	-	-	-	-	-	SCV000537240|SCV001430110|SCV002219616|SCV002665339|SCV004017822|SCV004025213	-	-	698G>T 	Arg233Leu	NM_000143.4	2.0	1_Pathogenic	3.42101e-6	16237.0	1	241508643.0	C	A	R	L	rs121913123	1	241671943.0	1	239738566.0	233.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.698G>T	p.Arg233Leu	c.698G>T	p.Arg233Leu	principal1	Y	1	YES	Select	-	CGT	2.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	5.07	0.99905	H	-6.84	0.93080	D	0.963	0.97332	0.9273	0.96051	D	0.9945	0.99874	D	10.0	0.989849	0.99460	D	0.745296	0.97960	D	0.945	0.98886	0.889	0.97257	P07954	R233L	Loss of phosphorylation at T236 (P = 0.0525)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of methylation at K230 (P = 0.0761)| Loss of MoRF binding (P = 0.0923)| Loss of glycosylation at K230 (P = 0.1752)	0.972808251769	0.97225	0.9751746669812705	0.97494	1.09694667183	0.77481	0.830429792404	0.86606	D	0.995902	0.99993	D	0.51557	0.94692	D	0.599658	0.96962	D	0.999926209449768	0.9973	D	0.988918	0.96274	D	0.99120563	0.99821	0.9549934	0.98673	0.99120563	0.99821	0.9549934	0.98673	-15.96	0.97705	D	0.9946	0.95323	P	0.999900398311514	0.98723	0.93478185	0.92608	1	0.99985	.	.	.	.	.	.	5.201626	0.87283	29.2	0.9986609805258406	0.94461	0.927182	0.90912	D	1.08057729138192	0.97745	16.70746	0.942227821079248	0.97147	15.68653	5.65	5.65	0.86862	6.32	0.99010	7.503	0.80522	7.704000	0.66498	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.948	0.49339	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109390	9.141600e-06	0	1	208074	4.805980e-06	0	1	236740	4.224040e-06	0	0	7164	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13392	0.000000e+00	0	0	42766	0.000000e+00	0	1	15688	6.374300e-05	0	1	15688	6.374300e-05	0	0	16216	0.000000e+00	0	0	30494	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	0	89538	0.000000e+00	0	1	30604	3.267550e-05	0	1	30604	3.267550e-05	0	0	14900	0.000000e+00	0	0	34228	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	0	102598	0.000000e+00	0	1	30522	3.276330e-05	0	1	30522	3.276330e-05	0	.	5	1613808	3.098260e-06	0	5	91072	5.490160e-05	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29598	0.000000e+00	0	0	44856	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179792	0.000000e+00	0	5	91072	5.490160e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241508643C>A	ClinGen:CA257461|OMIM:136850.0008	C3661900|C1708350|C0027672	150800	523|140162	Fumarate lyase, N-terminal	Arg	Leu	31276.0	single nucleotide variant	NM_000143.4(FH):c.698G>T (p.Arg233Leu)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Mar 04, 2025	121913123.0	-	RCV000017624|RCV001781272|RCV002362588	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241508643.0	241508643.0	1q43	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA257461,OMIM:136850.0008	3.0	16237.0	241508643.0	C	A	-	-	-	-	-	-	SCV000537240|SCV001430110|SCV002219616|SCV002665339|SCV004017822|SCV004025213	-	-	698G>T 	Arg233Leu	NM_000143.4	2.0	1_Pathogenic	98.76	0.2983870967741935	['150800']	autosomal dominant	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	98.76	0.2983871	10-90	>90						R	74			98.76	Positively-charged	Arginine		Fumarate hydratase, mitochondrial								0.0745		-4.5			4 interactions	4 interactions				R233-E355; PAE: 1.0	4 interactions			R233-E355; PAE: 1.0	4 interactions					175									-131.5		Pocket 2: Mean pLDDT: 99.39, Volume: 605.37 Å³, Druggability score: 0.07		124.2				dbSNP: rs121913123; Variant type: LP/P; AA change: Arg233His; PTM type: Ubiquitylation; PTM morphology: FAQIIkIGR*TH; Var class: II&rs121913123		B (undefined)	E (parallel sheets)	Beta strand																																																																			true	FHArg233Leu																																																																																																																																																																																																																																		
BRCA1	BRCA1_Arg71Lys	0.07187573777971566	0.9447113095236084	2.373169074983095	0.049375562988145466	2025_01_Batch_13-14	false	false	false	true	true	false	false	false	false	true	0.8961384748612593	0.8256555767918938	0.9384860819973107	0.9385579821550951	0.9563793607358764	0.9330729959912138	0.9452772116535713	0.9024167501696188	0.7431486177108632	0.8545819894997295	0.9796857254805389	0.9318387526566191	0.9745554138250025	0.9081625358729246	0.937694960222789	BRCA1	0.07187573777971566	0.9447113095236084	2.373169074983095	0.049375562988145466	2025_01_Batch_13-14	false	false	false	true	true	false	false	false	false	true	0.8961384748612593	0.8256555767918938	0.9384860819973107	0.9385579821550951	0.9563793607358764	0.9330729959912138	0.9452772116535713	0.9024167501696188	0.7431486177108632	0.8545819894997295	0.9796857254805389	0.9318387526566191	0.9745554138250025	0.9081625358729246	0.937694960222789	BRCA1	ENSG00000012048	14613	218389.0	CCSBVarC003297	ALE00003297	NC_000017.11:43106456:C:T	212G>A	Arg71Lys	CEGS2	CegsMutGDEh1010	A12	GDEhDisVCh_40059	E03	1.0									1.0	7.0	0.0		0.0			0.0			0.0			17.0	43106456.0	C	T	17	N	N	N	N	N	17-43106456-C-T	69138.0	single nucleotide variant	NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jul 30, 2024	80356913.0	-	RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106456.0	43106456.0	17q21.31	criteria provided, multiple submitters, no conflicts	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001420,UniProtKB:P38398#VAR_020681	2.0	54471.0	43106456.0	C	T	-	-	-	-	-	-	SCV000325249|SCV001345474|SCV001583916|SCV002046151|SCV002600545|SCV002726126|SCV003809169|SCV005416672	-	-	212G>A 	Arg71Lys	NM_007294.4	2.0	1_Pathogenic	0.0	54471.0	17	43106456.0	C	T	R	K	rs80356913	17	41258473.0	17	38511999.0	71.0	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.212G>A	p.Arg71Lys	c.212G>A	p.Arg71Lys	principal2	Y	1	.	.	-	AGG	2.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.016	0.68204	D	0.9	0.59057	P	0.275	0.68273	B	.	0.99291	.	.	.	.	2.455	0.71058	M	-0.66	0.59576	N	.	0.78462	0.7801	0.94146	D	0.843	0.94745	D	9.0	0.82008123	0.81025	D	0.514985	0.95351	D	0.737	0.90816	0.727	0.86044	E9PFC7	R71K	Gain of methylation at R71 (P = 0.0062)| Gain of relative solvent accessibility (P = 0.0522)| Gain of ubiquitination at R71 (P = 0.068)| Gain of disorder (P = 0.0771)| Gain of solvent accessibility (P = 0.1456)	0.968767862813	0.96814	.	0.47432	.	0.17790	0.610298812389	0.54292	T	0.29865	0.66937	T	0.411382	0.90492	D	0.353145	0.90373	D	0.960748553276062	0.65672	D	.	0.27626	.	0.80958927	0.84328	0.4717919	0.69118	0.759881	0.81221	0.3838624	0.63093	-8.907	0.67174	D	0.7791	0.80812	LP	0.996372846491178	0.92086	0.99942493	0.99371	0.917	0.95747	.	.	.	.	.	.	5.467383	0.91245	32.0	0.9950540223175232	0.68305	0.849361	0.76532	D	0.589132871463434	0.72350	5.814887	0.56907193894025	0.72585	5.856808	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.0	0.68239	0.995	0.73271	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43106456C>T	ClinGen:CA001420|UniProtKB:P38398#VAR_020681	C0677776|C0027672|C3661900|C2676676	604370	145|140162|145	.	Arg	Lys	69138.0	single nucleotide variant	NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jul 30, 2024	80356913.0	-	RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106456.0	43106456.0	17q21.31	criteria provided, multiple submitters, no conflicts	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001420,UniProtKB:P38398#VAR_020681	2.0	54471.0	43106456.0	C	T	-	-	-	-	-	-	SCV000325249|SCV001345474|SCV001583916|SCV002046151|SCV002600545|SCV002726126|SCV003809169|SCV005416672	-	-	212G>A 	Arg71Lys	NM_007294.4	2.0	1_Pathogenic	82.37	0.9758064516129032	['604370', '617883', '604370', '614320']	multiple	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	82.37	0.9758065	$\geqslant$90	70-90																																																																																																																																		true	BRCA1Arg71Lys																																																																																																																																																																																																																																		
RHO	RHO_Arg135Trp	-17.38033735531913	5.133434051767988e-7	-16.193593012622983	8.332379341880668e-7	2025_01_Batch_13-14	true	true	true	true	false	true	true	true	true	false	0.9996950640265384	0.9862363901267608	0.9976911028021254	0.98032175111109	0.8387034419466344	0.8484507787368682	0.9769099185317103	0.997114828657089	0.9830374641219721	0.9995777144441768	0.8289561051564006	0.9837335836904696	0.9982673769471616	0.9894353161315496	0.9998124136089	RHO	-17.38033735531913	5.133434051767988e-7	-16.193593012622983	8.332379341880668e-7	2025_01_Batch_13-14	true	true	true	true	false	true	true	true	true	false	0.9996950640265384	0.9862363901267608	0.9976911028021254	0.98032175111109	0.8387034419466344	0.8484507787368682	0.9769099185317103	0.997114828657089	0.9830374641219721	0.9995777144441768	0.8289561051564006	0.9837335836904696	0.9982673769471616	0.9894353161315496	0.9998124136089	RHO		40080645		CCSBVarC013570		NC_000003.12:129530917:C:T	403C>T	Arg135Trp																												3.0	129530917.0	C	T	3						3-129530917-C-T	28067.0	single nucleotide variant	NM_000539.3(RHO):c.403C>T (p.Arg135Trp)	6010.0	RHO	HGNC:10012	Pathogenic	1.0	Feb 12, 2025	104893775.0	-	RCV000013902|RCV000013903|RCV000413771|RCV000132597|RCV001074272|RCV004755734	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MONDO:MONDO:0018877,MedGen:C1405854,Orphanet:52427|MedGen:C3661900|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|	Retinitis pigmentosa 4|Retinitis punctata albescens|not provided|Retinitis pigmentosa|Retinal dystrophy|RHO-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000003.12	3	129530917.0	129530917.0	3q22.1	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA122819,UniProtKB:P08100#VAR_004797,OMIM:180380.0012	3.0	13028.0	129530917.0	C	T	-	-	-	-	-	-	SCV000490772|SCV001234184|SCV001239845|SCV001443216|SCV002521615|SCV004030293|SCV004705655|SCV005073429|SCV005690572	-	-	403C>T 	Arg135Trp	NM_000539.3	2.0	1_Pathogenic		13028.0	3	129530917.0	C	T	R	W	rs104893775	3	129249760.0	3	130732450.0	135.0	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.403C>T	p.Arg135Trp	c.403C>T	p.Arg135Trp	principal1	Y	1	YES	Select	+	CGG	1.0	2.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.9	0.92286	A	simple_aae	10.0	90.0	4.615	0.99277	H	-6.98	0.93600	D	0.975	0.98575	1.076	0.98756	D	0.9723	0.99129	D	9.0	0.99393994	0.99911	D	0.669966	0.97240	D	0.931	0.98376	0.97	0.99713	P08100	R135W	Loss of sheet (P = 0.3635)| Loss of stability (P = 0.3899)| Loss of helix (P = 0.3949)| Gain of catalytic residue at R135 (P = 0.455)| Loss of MoRF binding (P = 0.548)	0.989048607444	0.98880	0.9895061687762009	0.98942	0.882892313764	0.69650	0.786314368248	0.79846	T	0.923243	0.98626	D	0.558549	0.9603	D	0.56454	0.95966	D	0.99931013584137	0.96902	D	0.911709	0.68570	D	0.98723143	0.99601	0.9844158	0.99913	0.98945296	0.99731	0.9847179	0.99918	-13.703	0.92067	D	0.9939	0.95008	P	0.99932078557985	0.96263	0.99994576	0.99953	0.941	0.97199	.	.	.	.	.	.	5.094248	0.85113	28.5	0.9991547294763471	0.9838	0.715194	0.66623	D	0.650539432728276	0.76276	6.480144	0.469200349890802	0.65773	4.890175	5.26	2.05	0.2579	2.8	0.51230	1.284	0.32959	2.777000	0.34791	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.995	0.73271	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614258	1.238960e-06	0	2	1180052	1.694840e-06	0	0	75066	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29608	0.000000e+00	0	0	44886	0.000000e+00	0	0	64044	0.000000e+00	0	0	6062	0.000000e+00	0	2	1180052	1.694840e-06	0	0	91088	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Retinitis_punctata_albescens|Retinitis_pigmentosa_4|not_provided|Retinitis_pigmentosa|Retinal_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129530917C>T	ClinGen:CA122819|OMIM:180380.0012|UniProtKB:P08100#VAR_004797	C1405854|C3151001|C3661900|C0035334|C0854723	613731|268000|PS268000	52427|791|791|71862	GPCR, rhodopsin-like, 7TM	Arg	Trp	28067.0	single nucleotide variant	NM_000539.3(RHO):c.403C>T (p.Arg135Trp)	6010.0	RHO	HGNC:10012	Pathogenic	1.0	Feb 12, 2025	104893775.0	-	RCV000013902|RCV000013903|RCV000413771|RCV000132597|RCV001074272|RCV004755734	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MONDO:MONDO:0018877,MedGen:C1405854,Orphanet:52427|MedGen:C3661900|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|	Retinitis pigmentosa 4|Retinitis punctata albescens|not provided|Retinitis pigmentosa|Retinal dystrophy|RHO-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000003.12	3	129530917.0	129530917.0	3q22.1	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA122819,UniProtKB:P08100#VAR_004797,OMIM:180380.0012	3.0	13028.0	129530917.0	C	T	-	-	-	-	-	-	SCV000490772|SCV001234184|SCV001239845|SCV001443216|SCV002521615|SCV004030293|SCV004705655|SCV005073429|SCV005690572	-	-	403C>T 	Arg135Trp	NM_000539.3	2.0	1_Pathogenic	86.9	0.1048387096774193	['613731', '268000']	unknown		0	RETINITIS PIGMENTOSA 4; RETINITIS PIGMENTOSA	86.9	0.10483871	10-90	70-90						R	26			86.9	Positively-charged	Arginine		Rhodopsin										-4.5								R135-L131, R135-V139; PAE: 1.0, 1.0	3 interactions	R135-L131, R135-V139; PAE: 1.0, 1.0	2 interactions							175	'Ionic lock' involved in activated form stabilization								-62.9				-41.0				dbSNP: rs104893775; Variant type: LP/P; AA change: Arg135Gly; PTM type: Phosphorylation; PTM morphology: LAIER*yVVVCK; Var class: II&rs104893774		H (helix)	H (α-helix)	Helix						Cytoplasmic																																																													true	RHOArg135Trp																																																																																																																																																																																																																																		
F9	F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8373728260210328	0.6538648579987193	0.7988165422982787	0.7937370734497426	0.7087061576907538	0.8238798819066757	0.8054950025083605	0.7994653617496963	0.7906061765477359	0.801351506763675	0.593532433474832	0.7819791443911247	0.7981677228468611	0.5171235394497027	0.8733941452783907	F9	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8373728260210328	0.6538648579987193	0.7988165422982787	0.7937370734497426	0.7087061576907538	0.8238798819066757	0.8054950025083605	0.7994653617496963	0.7906061765477359	0.801351506763675	0.593532433474832	0.7819791443911247	0.7981677228468611	0.5171235394497027	0.8733941452783907	F9	ENSG00000101981	52861	24983.0	CCSBVarC002183	ALE00002183	NC_000023.11:139561904:T:C	1219T>C	Cys407Arg	RC4	RC4_Mut_GDEh1022	F11	GDEhDisVCh_40052	E12	2.0	RC4_Mut_GDDh1022	F11							1.0	6.0	1.0	1.0	0.0			0.0			0.0			23.0	139561904.0	T	C	X	N	Y	N	N	N	X-139561904-T-C																																														5_Others																																																																																																																																																																																																																																																																																																																																																																																																																																																	unknown	Rare genetic hematologic disease	1				10-90	>90						C	10			61.02	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa heavy chain						Disulfide bond 407-435	Peptidase S1			2.5						C407-C435; PAE: 10.0	1 interaction				3 interactions							121									-123.8				-179.1						C (loop/coil)	C (loop/coil)																														0.897		0.734		0.658		0.589		0.651																														true	F9Cys407Arg																																																																																																																																																																																																																																		
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5273919721098301	0.59070453412355	0.5925313724025432	0.555578334961777	0.6797031476051614	0.7411643768406764	0.5713085317690365	0.6850563500483203	0.6121885811580178	0.5122464098145436	0.6182419183696463	0.5398481381545175	0.5000063947567659	0.569220487089082	0.5425375344051167	F9	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.5273919721098301	0.59070453412355	0.5925313724025432	0.555578334961777	0.6797031476051614	0.7411643768406764	0.5713085317690365	0.6850563500483203	0.6121885811580178	0.5122464098145436	0.6182419183696463	0.5398481381545175	0.5000063947567659	0.569220487089082	0.5425375344051167	F9	ENSG00000101981	52861	204390.0	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2.0									1.0	1.0	0.0		0.0			0.0			0.0			23.0	139561925.0	C	A	X	Y	N	N	N	N	X-139561925-C-A	25659.0	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852265.0	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925.0	139561925.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1.0	10620.0	139561925.0	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic		10620.0	X	139561925.0	C	A	P	T	rs137852265	X	138644084.0	X	138471750.0	414.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1.0	0.0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10.0	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.9996	D	0.818304	0.9996	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.9974540563958588	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.0	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659.0	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852265.0	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925.0	139561925.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1.0	10620.0	139561925.0	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic	96.53	0.0	['306900']	x-linked recessive	Rare genetic hematologic disease	1	HEMOPHILIA B	96.53	0.0	<10	>90						P	0			96.53	Special, No backbone hydrogen	Proline		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			1.6											7 interactions							115									-77.7				147.6						B (undefined)	E (parallel sheets)	Beta strand																													1.0		0.825		0.798		0.808	3 mutation(s) (Pro414Gln: 1.104, Pro414Leu: 1.109, Pro414Ile: 1.118)	0.765																														true	F9Pro414Thr																																																																																																																																																																																																																																		
RAD51D	RAD51D_Ile251Val	0.7776406398453396	0.4622488886013073	4.73346535387811	0.0021239643067238714	2025_01_Batch_13-14	false	false	false	true	false	false	false	false	false	false	0.9589705639948699	0.8405335983766445	0.9518864369742187	0.9584403093903882	0.9014840098779016	0.9995217075101795	0.9534029604719589	0.942729026977195	0.9995249189219388	0.931935185443018	0.8034463122456237	0.9634776583088173	0.9610438469712425	0.6815422778313502	0.9860059425467218	RAD51D	0.7776406398453396	0.4622488886013073	4.73346535387811	0.0021239643067238714	2025_01_Batch_13-14	false	false	false	true	false	false	false	false	false	false	0.9589705639948699	0.8405335983766445	0.9518864369742187	0.9584403093903882	0.9014840098779016	0.9995217075101795	0.9534029604719589	0.942729026977195	0.9995249189219388	0.931935185443018	0.8034463122456237	0.9634776583088173	0.9610438469712425	0.6815422778313502	0.9860059425467218	RAD51D		7201		CCSBVarC024857		NC_000017.11:35101353:T:C	751A>G	Ile251Val																												17.0	35101353.0	T	C	17						17-35101353-T-C	151014.0	single nucleotide variant	NM_002878.4(RAD51D):c.751A>G (p.Ile251Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jun 23, 2024	540273429.0	-	RCV000236753|RCV000542443|RCV000129767	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35101353.0	35101353.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA165041	2.0	141300.0	35101353.0	T	C	-	-	-	-	-	-	SCV000184576|SCV000293833|SCV000651777|SCV000904087	-	-	751A>G 	Ile251Val	NM_002878.4	1.0	3_Conflicting		141300.0	17	35101353.0	T	C	I	V	rs540273429	17	33428372.0	17	30452485.0	251.0	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.751A>G	p.Ile251Val	c.751A>G	p.Ile251Val	principal1	Y	1	YES	Select	-	ATA	1.0	0.0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	1.0	0.03926	T	0.0	0.02950	B	0.001	0.04348	B	0.06	0.18971	N	simple_aae	94.0	6.0	-1.04	0.01100	N	0.1	0.05782	N	0.105	0.14965	-0.9577	0.39436	T	0.0599	0.24885	T	10.0	0.036506176	0.01956	T	0.010139	0.26052	T	0.070	0.20265	0.474	0.54885	O75771	I251V	Gain of phosphorylation at T248 (P = 0.0936)| Gain of disorder (P = 0.0983)| Gain of MoRF binding (P = 0.1184)| Gain of methylation at R255 (P = 0.2396)| Loss of stability (P = 0.2941)	0.388174495139	0.38033	.	0.16030	.	0.31871	.	.	.	0.075571	0.34949	T	-0.130246	0.31098	T	-0.424866	0.30159	T	0.0309130971524996	0.02119	T	.	0.39652	.	0.015923232	0.00166	0.02370252	0.00388	0.015923232	0.00166	0.02370252	0.00387	-0.859	0.00857	T	0.0667	0.04993	LB	1.1537049706086e-05	0.00991	0.23355223	0.74518	0.014	0.01428	.	.	.	.	.	.	-0.048466	0.03972	0.888	0.813108619791494	0.1384	0.042627	0.06525	N	-1.20699475414867	0.04841	0.2220042	-1.14727300713446	0.06706	0.3294306	4.86	-3.91	0.03894	-5.59	0.03621	0.337	0.19651	-2.070000	0.04280	0.665	0.62996	0.881	0.31099	0.0	0.08389	0.946	0.49004	911	0.21960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109058	0.000000e+00	0	1	207758	4.813290e-06	0	1	236598	4.226580e-06	0	0	7158	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13062	0.000000e+00	0	0	42762	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16206	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16402	0.000000e+00	0	1	89534	1.116890e-05	0	0	30606	0.000000e+00	0	1	89534	1.116890e-05	0	0	14896	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21300	0.000000e+00	0	1	102740	9.733310e-06	0	0	30524	0.000000e+00	0	1	102740	9.733310e-06	0	.	7	1613900	4.337320e-06	0	1	6060	1.650170e-04	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	63756	0.000000e+00	0	1	6060	1.650170e-04	0	4	1180012	3.389800e-06	0	1	91084	1.097890e-05	0	0	6062	0	0	8	0	0	26	0	0	586	0	0	0	0	0	0	0	0	30	0	0	0	0	1	2276	4.393673110720562E-4	0	594	0	0	56	0	1	8988	1.1125945705384957E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101353T>C	ClinGen:CA165041	C0027672|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Ile	Val	151014.0	single nucleotide variant	NM_002878.4(RAD51D):c.751A>G (p.Ile251Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jun 23, 2024	540273429.0	-	RCV000236753|RCV000542443|RCV000129767	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35101353.0	35101353.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA165041	2.0	141300.0	35101353.0	T	C	-	-	-	-	-	-	SCV000184576|SCV000293833|SCV000651777|SCV000904087	-	-	751A>G 	Ile251Val	NM_002878.4	1.0	3_Conflicting	93.94	0.2544378698224852	['614291']	unknown	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	93.94	0.25443786	10-90	>90						I	43			93.94	Aliphatic	Isoleucine		DNA repair protein RAD51 homolog 4								0.4068		4.5										I251-G107; PAE: 1.5	7 interactions							131									-95.2		Pocket 1: Mean pLDDT: 91.59, Volume: 402.91 Å³, Druggability score: 0.41		143.2						B (undefined)	E (parallel sheets)	Beta strand																																																																			true	RAD51DIle251Val																																																																																																																																																																																																																																		
KRAS	KRAS_Pro34Arg	-1.8765842108443014	0.10267990481406933	11.210462647469498	0.000010026137401729719	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8770738296669155	0.5739505316173716	0.8312156765753302	0.8052015105754018	0.7084694925277798	0.676061446084069	0.7812795635760178	0.7723692043021924	0.5994054833375623	0.8548183969376422	0.7408775389714906	0.8291234575747858	0.8900621488484681	0.548495579897181	0.8993292623961888	KRAS	-1.8765842108443014	0.10267990481406933	11.210462647469498	0.000010026137401729719	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.8770738296669155	0.5739505316173716	0.8312156765753302	0.8052015105754018	0.7084694925277798	0.676061446084069	0.7812795635760178	0.7723692043021924	0.5994054833375623	0.8548183969376422	0.7408775389714906	0.8291234575747858	0.8900621488484681	0.548495579897181	0.8993292623961888	KRAS	ENSG00000133703	3084	214476.0	CCSBVarC006094	ALE00006094	NC_000012.12:25245284:G:C	101C>G	Pro34Arg	CEGS2	CegsMutGDEh1040	C02	GDEhDisVCh_40061	F09	1.0	CegsMutGDDh1040	C02							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25245284.0	G	C	12	Y	Y	N	N	N	12-25245284-G-C	27629.0	single nucleotide variant	NM_004985.5(KRAS):c.101C>G (p.Pro34Arg)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Jun 14, 2022	104894366.0	-	RCV000043674|RCV000207495|RCV000211723|RCV000850569|RCV001851825	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519;MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648;MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114;MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardiofaciocutaneous syndrome 2|not provided|Cardio-facio-cutaneous syndrome;Noonan syndrome|Acute myeloid leukemia;Noonan syndrome 3;Autoimmune lymphoproliferative syndrome type 4;Cardiofaciocutaneous syndrome 2|RASopathy	germline;unknown	germline	GRCh38	NC_000012.12	12	25245284.0	25245284.0	12p12.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA280040,UniProtKB:P01116#VAR_026110,OMIM:190070.0013	3.0	12590.0	25245284.0	G	C	-	-	-	-	-	-	SCV000061924|SCV000263050|SCV000329384|SCV000992785|SCV002159858	-	-	101C>G 	Pro34Arg	NM_004985.5	2.0	1_Pathogenic		12590.0	12	25245284.0	G	C	P	R	rs104894366	12	25398218.0	12	25289485.0	34.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.101C>G	p.Pro34Arg	c.101C>G	p.Pro34Arg	alternative1	Y	1	.	Plus_Clinical	-	CCA	2.0	0.0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.445	0.92067	M	-7.6	0.97924	D	0.961	0.98079	0.8728	0.95298	D	0.8174	0.93837	D	9.0	0.94139737	0.93391	D	0.322268	0.91490	D	0.905	0.97394	0.79	0.91170	P01116	P34R	Gain of catalytic residue at I36 (P = 0.0042)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.0874)| Gain of solvent accessibility (P = 0.1708)| Loss of disorder (P = 0.1763)	0.993217693452	0.99306	0.9765456698593341	0.97632	2.76950302636	0.98787	0.913441181183	0.97783	D	0.919051	0.98519	D	0.468623	0.93232	D	0.435368	0.93147	D	0.999483346939087	0.97568	D	0.976402	0.92683	D	0.9888393	0.99697	0.96837485	0.99382	0.9863729	0.99547	0.978969	0.99788	-17.558	0.99602	D	0.9972	0.97478	P	0.999953297071636	0.99183	0.99935538	0.99325	0.97	0.98836	.	.	.	.	.	.	5.331179	0.89486	30.0	0.9985170252260999	0.93107	0.907375	0.86082	D	1.08644740414511	0.97862	16.94078	1.01441952461028	0.98880	19.75079	5.68	5.68	0.88004	.	.	9.985	0.99185	11.891000	0.99094	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|Noonan_syndrome|RASopathy|not_provided|Acute_myeloid_leukemia|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2|Autoimmune_lymphoproliferative_syndrome_type_4	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245284G>C	ClinGen:CA280040|OMIM:190070.0013|UniProtKB:P01116#VAR_026110	C1275081|C0028326|C5555857|C3661900|C0023467|C1860991|C3809005|C2674723	PS115150|PS163950|601626|609942|615278|614470	1340|648|536391|519|648|1340|268114	Small GTP-binding domain	Pro	Arg	27629.0	single nucleotide variant	NM_004985.5(KRAS):c.101C>G (p.Pro34Arg)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Jun 14, 2022	104894366.0	-	RCV000043674|RCV000207495|RCV000211723|RCV000850569|RCV001851825	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519;MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648;MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114;MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardiofaciocutaneous syndrome 2|not provided|Cardio-facio-cutaneous syndrome;Noonan syndrome|Acute myeloid leukemia;Noonan syndrome 3;Autoimmune lymphoproliferative syndrome type 4;Cardiofaciocutaneous syndrome 2|RASopathy	germline;unknown	germline	GRCh38	NC_000012.12	12	25245284.0	25245284.0	12p12.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA280040,UniProtKB:P01116#VAR_026110,OMIM:190070.0013	3.0	12590.0	25245284.0	G	C	-	-	-	-	-	-	SCV000061924|SCV000263050|SCV000329384|SCV000992785|SCV002159858	-	-	101C>G 	Pro34Arg	NM_004985.5	2.0	1_Pathogenic	86.47	0.4558823529411764	['615278', '601626', '609942', '614470', '615278']	autosomal dominant	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2; LEUKEMIA, ACUTE MYELOID; NOONAN SYNDROME 3; RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; CARDIOFACIOCUTANEOUS SYNDROME 2	86.47	0.45588234	10-90	70-90																																																																																																																																		true	KRASPro34Arg																																																																																																																																																																																																																																		
F9	F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.669060478007286	0.5112754352585243	0.7435592092766099	0.7071193405925851	0.6604163357563947	0.7827194086302407	0.7722172073904454	0.7985744700478877	0.5683757034214649	0.6948973070114324	0.5381132628825487	0.6420214737947247	0.688543948505332	0.45417516709558364	0.6432236490031396	F9	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.669060478007286	0.5112754352585243	0.7435592092766099	0.7071193405925851	0.6604163357563947	0.7827194086302407	0.7722172073904454	0.7985744700478877	0.5683757034214649	0.6948973070114324	0.5381132628825487	0.6420214737947247	0.688543948505332	0.45417516709558364	0.6432236490031396	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A	658T>A	Ser220Thr																												23.0	139551199.0	T	A	X						X-139551199-T-A	352093.0	single nucleotide variant	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2158.0	F9	HGNC:3551	Benign/Likely benign	0.0	Nov 26, 2024	777361659.0	-	RCV000279243|RCV000862176|RCV002502409|RCV003950311	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139551199.0	139551199.0	Xq27.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA10529817	2.0	368001.0	139551199.0	T	A	-	-	-	-	-	-	SCV000481884|SCV001002642|SCV002806336	-	-	658T>A 	Ser220Thr	NM_000133.4	2.0	2_Benign		368001.0	X	139551199.0	T	A	S	T	rs777361659	X	138633358.0	X	138461024.0	220.0	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.658T>A	p.Ser220Thr	c.658T>A	p.Ser220Thr	principal1	Y	1	YES	Select	+	TCA	1.0	0.0	T	T/T	T/T	T/T	T/T	0.323	0.13513	T	0.558	0.09916	T	0.0	0.02950	B	0.003	0.08696	B	0.02	0.08015	N	simple_aae	98.0	2.0	1.1	0.27864	L	-0.33	0.13346	N	0.092	0.14545	-0.3176	0.74375	T	0.6106	0.86163	D	10.0	0.011437386	0.00246	T	0.311014	0.91165	D	0.120	0.33155	0.293	0.25438	P00740	S220T	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.68087794957	0.67565	0.8672301792330431	0.86606	0.600742330255	0.54859	0.357546925545	0.19008	T	0.331657	0.69995	T	-0.470828	0.00791	T	-0.455873	0.26695	T	0.0342450906531738	0.0266	T	0.538146	0.20839	T	0.066854715	0.14292	0.059238464	0.11090	0.053613782	0.10077	0.06703769	0.13813	-3.522	0.18335	T	0.0749	0.05513	B	0.483090820042852	0.60269	0.99953437	0.99461	0.214	0.47926	.	.	.	.	.	.	-0.836136	0.0104	0.044	0.5333618171217865	0.04982	.	.	.	.	.	.	.	.	.	5.31	-7.5	0.01209	-4.88	0.04680	-0.667	0.05383	-2.955000	0.03212	0.665	0.62996	0.0	0.06393	0.0	0.08389	0.021	0.11764	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	75	264690	2.8335032E-4	.	23	80344	2.862690e-04	1	57	151861	3.753430e-04	2	65	172271	3.773120e-04	2	0	5702	0.000000e+00	0	22	13667	1.609720e-03	1	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	22	13667	1.609720e-03	1	0	13134	0.000000e+00	0	48	24393	1.967780e-03	1	0	4649	0.000000e+00	0	0	10125	0.000000e+00	0	0	12192	0.000000e+00	0	0	64670	0.000000e+00	0	0	19072	0.000000e+00	0	48	24393	1.967780e-03	1	0	12064	0.000000e+00	0	56	27171	2.061020e-03	1	0	7083	0.000000e+00	0	0	13316	0.000000e+00	0	0	15997	0.000000e+00	0	0	73484	0.000000e+00	0	0	19007	0.000000e+00	0	56	27171	2.061020e-03	1	.	74	1209534	6.118060e-05	1	71	45655	1.555140e-03	1	0	57031	0.000000e+00	0	0	686	0.000000e+00	0	71	45655	1.555140e-03	1	0	22028	0.000000e+00	0	0	33747	0.000000e+00	0	0	46522	0.000000e+00	0	0	4376	0.000000e+00	0	0	895139	0.000000e+00	0	0	56756	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Benign/Likely_benign	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551199T>A	ClinGen:CA10529817	C5393318|C0008533|C2749016	301052|306900|300807	98879	.	Ser	Thr	352093.0	single nucleotide variant	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2158.0	F9	HGNC:3551	Benign/Likely benign	0.0	Nov 26, 2024	777361659.0	-	RCV000279243|RCV000862176|RCV002502409|RCV003950311	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139551199.0	139551199.0	Xq27.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA10529817	2.0	368001.0	139551199.0	T	A	-	-	-	-	-	-	SCV000481884|SCV001002642|SCV002806336	-	-	658T>A 	Ser220Thr	NM_000133.4	2.0	2_Benign	27.51	0.8	['306900', '306900', '300807', '306900', '300807', '301052']	unknown	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; WARFARIN SENSITIVITY, X-LINKED	27.51	0.8	10-90	<=50						S	104			27.51	Polar/Neutral	Serine		Coagulation factor IX										-0.8																		105									-54.2			Activation peptide	92.6						C (loop/coil)	C (loop/coil)																														0.943		0.922		0.917		0.923		0.918																														true	F9Ser220Thr																																																																																																																																																																																																																																		
KRAS	KRAS_Gly13Asp	-1.6558698671862377	0.1417194965294439	2.6206139205304035	0.03437849113816	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7540548002340555	0.5681581141711468	0.8121931582548083	0.8559732047718378	0.7528446537976217	0.6073739488369176	0.8428727998723612	0.6966658948865165	0.47154727380685507	0.6736711985672156	0.8983153587583257	0.8690736096713144	0.9277204216231002	0.6647689545354385	0.8344384019008955	KRAS	-1.6558698671862377	0.1417194965294439	2.6206139205304035	0.03437849113816	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7540548002340555	0.5681581141711468	0.8121931582548083	0.8559732047718378	0.7528446537976217	0.6073739488369176	0.8428727998723612	0.6966658948865165	0.47154727380685507	0.6736711985672156	0.8983153587583257	0.8690736096713144	0.9277204216231002	0.6647689545354385	0.8344384019008955	KRAS	ENSG00000133703	3084	214486.0	CCSBVarC006091	ALE00006091	NC_000012.12:25245347:C:T	38G>A	Gly13Asp	CEGS2	CegsMutGDEh1039	E06	GDEhDisVCh_40061	E09	1.0	CegsMutGDDh1039	E06							1.0	1.0	1.0	1.0	0.0			0.0			0.0			12.0	25245347.0	C	T	12	Y	Y	N	N	N	12-25245347-C-T	27619.0	single nucleotide variant	NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Dec 18, 2024	112445441.0	-	RCV000013409|RCV000791297|RCV001526657|RCV004668723|RCV001857340|RCV004813034|RCV000038269|RCV000144967|RCV000144968|RCV004549358|RCV001092389|RCV001266168|RCV001813183|RCV001839444	MONDO:MONDO:0004988,MedGen:C0858252||Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015278,MedGen:C2931038,OMIM:260350,Orphanet:1333|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114||MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396	Breast adenocarcinoma|OCULOECTODERMAL SYNDROME, SOMATIC|Nevus sebaceous|Neoplasm|RASopathy|Familial pancreatic carcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|KRAS-related disorder|not provided|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245347.0	25245347.0	12p12.1	criteria provided, multiple submitters, no conflicts	15.0	-	N	ClinGen:CA122534,UniProtKB:P01116#VAR_016029,OMIM:190070.0003	3.0	12580.0	25245347.0	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000061938|SCV001248878|SCV001444340|SCV001737088|SCV002016398|SCV002060774|SCV002117438|SCV005438357	-	SCV005094256	38G>A 	Gly13Asp	NM_004985.5	2.0	1_Pathogenic	1.36928e-6	12580.0	12	25245347.0	C	T	G	D	rs112445441	12	25398281.0	12	25289548.0	13.0	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.38G>A	p.Gly13Asp	c.38G>A	p.Gly13Asp	alternative1	Y	1	.	Plus_Clinical	-	GGC	2.0	0.0	C	./.	./.	./.	./.	0.032	0.54841	D	0.023	0.60671	D	0.803	0.45147	P	0.506	0.47822	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.025	0.86187	M	-5.4	0.92581	D	0.977	0.98762	0.5692	0.91461	D	0.6901	0.8927	D	10.0	0.9007832	0.89322	D	0.225927	0.87991	D	0.832	0.94675	0.722	0.85604	P01116	G13D	Gain of catalytic residue at A11 (P = 0)| Gain of solvent accessibility (P = 0.0648)| Loss of ubiquitination at K16 (P = 0.1191)| Loss of methylation at K16 (P = 0.1236)| Gain of relative solvent accessibility (P = 0.1684)	0.974405323578	0.97388	0.9548591274127232	0.95442	2.43727951051	0.97301	0.92631560564	0.98765	D	0.897336	0.97939	D	0.43077	0.91511	D	0.380995	0.91406	D	0.993683218955994	0.84461	D	0.853715	0.56129	D	0.91416115	0.92578	0.8911059	0.94268	0.90101796	0.91352	0.8511729	0.91471	-9.831	0.73003	D	0.998	0.98262	P	0.999983137957112	0.99579	0.99862206	0.98875	0.995	0.99826	.	.	.	.	.	.	4.988767	0.82721	27.9	0.9983568526590726	0.9172	0.894850	0.83365	D	0.645709001054705	0.75963	6.423009	0.687742056596172	0.81343	7.528909	5.68	5.68	0.88004	.	.	7.892	0.85894	5.998000	0.52513	0.58	0.29757	1.0	0.71675	1.000000	0.68239	0.999	0.91597	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	1612796	3.100210e-06	0	5	1179366	4.239570e-06	0	0	74896	0.000000e+00	0	0	912	0.000000e+00	0	0	59938	0.000000e+00	0	0	29526	0.000000e+00	0	0	44868	0.000000e+00	0	0	63986	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179366	4.239570e-06	0	0	90796	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Conflicting_classifications_of_pathogenicity	Juvenile_myelomonocytic_leukemia|OCULOECTODERMAL_SYNDROME,_SOMATIC|Noonan_syndrome_and_Noonan-related_syndrome|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Inborn_genetic_diseases|Acute_myeloid_leukemia|not_provided|RASopathy|Breast_adenocarcinoma|Ovarian_neoplasm|Non-small_cell_lung_carcinoma|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|KRAS-related_disorder	criteria_provided,_conflicting_classifications	NC_000012.12:g.25245347C>T	ClinGen:CA122534|OMIM:190070.0003|UniProtKB:P01116#VAR_016029	C0349639|C5681679|C0406612|C0009404|C0040136|C0950123|C0023467|C3661900|C5555857|C0858252|C0919267|C0007131|C2674723|C3854181	607785|613001|601626|614470	86834|98733|2396|100087|519|536391|268114	Small GTP-binding domain	Gly	Asp	27619.0	single nucleotide variant	NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Dec 18, 2024	112445441.0	-	RCV000013409|RCV000791297|RCV001526657|RCV004668723|RCV001857340|RCV004813034|RCV000038269|RCV000144967|RCV000144968|RCV004549358|RCV001092389|RCV001266168|RCV001813183|RCV001839444	MONDO:MONDO:0004988,MedGen:C0858252||Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015278,MedGen:C2931038,OMIM:260350,Orphanet:1333|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114||MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396	Breast adenocarcinoma|OCULOECTODERMAL SYNDROME, SOMATIC|Nevus sebaceous|Neoplasm|RASopathy|Familial pancreatic carcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|KRAS-related disorder|not provided|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245347.0	25245347.0	12p12.1	criteria provided, multiple submitters, no conflicts	15.0	-	N	ClinGen:CA122534,UniProtKB:P01116#VAR_016029,OMIM:190070.0003	3.0	12580.0	25245347.0	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000061938|SCV001248878|SCV001444340|SCV001737088|SCV002016398|SCV002060774|SCV002117438|SCV005438357	-	SCV005094256	38G>A 	Gly13Asp	NM_004985.5	2.0	1_Pathogenic	94.74	0.2857142857142857	['260350', '607785', '614470', '613001']	multiple	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	PANCREATIC CANCER; JUVENILE MYELOMONOCYTIC LEUKEMIA; RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	94.74	0.2857143	10-90	>90																																																																																																																																		true	KRASGly13Asp																																																																																																																																																																																																																																		
FARS2	FARS2_Gly3Val	-2.1910901347520046	0.41370840506561246	-2.0289898882089776	0.1046229420390252	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7248292842114841	0.5482645366173237	0.7144890642119599	0.7417014384860704	0.6254015747492417	0.63007241908453	0.7579250535477255	0.6785107013649005	0.613947755326278	0.7324038549786723	0.6207307304139534	0.7254778234244152	0.7504674270590193	0.48258131790836933	0.7172547134442959	FARS2	-2.1910901347520046	0.41370840506561246	-2.0289898882089776	0.1046229420390252	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.7248292842114841	0.5482645366173237	0.7144890642119599	0.7417014384860704	0.6254015747492417	0.63007241908453	0.7579250535477255	0.6785107013649005	0.613947755326278	0.7324038549786723	0.6207307304139534	0.7254778234244152	0.7504674270590193	0.48258131790836933	0.7172547134442959	FARS2		12653		CCSBVarC011880		NC_000006.12:5368578:G:T	8G>T	Gly3Val																												6.0	5368578.0	G	T	6						6-5368578-G-T	963613.0	single nucleotide variant	NM_006567.5(FARS2):c.8G>T (p.Gly3Val)	10667.0	FARS2	HGNC:21062	Likely benign	0.0	Jan 01, 2019	200380429.0	-	RCV001252485	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability	inherited	germline	GRCh38	NC_000006.12	6	5368578.0	5368578.0	6p25.1	no assertion criteria provided	1.0	-	N	ClinGen:CA3623578	2.0	975692.0	5368578.0	G	T	-	-	-	-	-	-	SCV001428242	-	-	8G>T 	Gly3Val	NM_006567.5		2_Benign		975692.0	6	5368578.0	G	T	G	V	rs200380429	6	5368811.0	6	5313810.0	3.0	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.8G>T	p.Gly3Val	c.8G>T	p.Gly3Val	principal1	Y	1	YES	Select	+	GGC	2.0	0.0	G	G/G	G/G	G/G	G/G	0.108	0.29555	T	0.173	0.33996	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	0.69	0.16877	N	0.37	0.03617	N	0.201	0.22970	-1.0183	0.2421	T	0.049	0.20756	T	10.0	0.06419563	0.08450	T	0.011909	0.29732	T	0.063	0.18106	0.264	0.20839	O95363	G3V	Gain of stability (P = 0.0417)| Gain of helix (P = 0.0425)| Loss of disorder (P = 0.0976)| Loss of loop (P = 0.1242)| Loss of methylation at R7 (P = 0.1536)	0.533179623451	0.52623	.	0.50277	.	0.21965	0.352800011635	0.18315	T	0.028576	0.20467	T	-0.160298	0.26369	T	-0.468033	0.25378	T	0.0261529918185712	0.0142	T	0.706229	0.31439	T	0.04899978	0.08549	0.05854014	0.10844	0.04899978	0.08549	0.05854014	0.10843	-2.72	0.07480	T	0.0811	0.19666	B	0.0342656122538894	0.33942	0.14797659	0.70290	0.104	0.28905	.	.	.	.	.	.	0.478147	0.08506	5.236	0.7263689461775646	0.10205	0.048075	0.08031	N	-1.29901716008698	0.03647	0.1651864	-1.25431266583447	0.04988	0.2405891	5.01	1.67	0.23089	0.277	0.23484	0.253	0.18128	1.445000	0.26644	-0.779	0.0337	0.0	0.06393	0.002	0.18256	0.033	0.13527	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1608378	1.865230e-06	0	3	1176546	2.549840e-06	0	0	74836	0.000000e+00	0	0	912	0.000000e+00	0	0	59726	0.000000e+00	0	0	29148	0.000000e+00	0	0	44808	0.000000e+00	0	0	63832	0.000000e+00	0	0	6032	0.000000e+00	0	3	1176546	2.549840e-06	0	0	90348	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Likely_benign	Intellectual_disability	no_assertion_criteria_provided	NC_000006.12:g.5368578G>T	.	C3714756	.	.	.	Gly	Val	963613.0	single nucleotide variant	NM_006567.5(FARS2):c.8G>T (p.Gly3Val)	10667.0	FARS2	HGNC:21062	Likely benign	0.0	Jan 01, 2019	200380429.0	-	RCV001252485	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability	inherited	germline	GRCh38	NC_000006.12	6	5368578.0	5368578.0	6p25.1	no assertion criteria provided	1.0	-	N	ClinGen:CA3623578	2.0	975692.0	5368578.0	G	T	-	-	-	-	-	-	SCV001428242	-	-	8G>T 	Gly3Val	NM_006567.5		2_Benign	27.24	0.8333333333333334		unknown		0		27.24	0.8333333	10-90	<=50						G	70			27.24	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine												-0.4																		75									168.8				83.7						C (loop/coil)	C (loop/coil)																																																																				true	FARS2Gly3Val																																																																																																																																																																																																																																		
BRCA1	BRCA1_Gly602Ala	3.458879566726189	0.010563565807662701	0.5419560155120805	0.604663137301014	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.9335001818236008	0.8515877673158113	0.9560825583379694	0.9280970078246464	0.9402713519288463	0.8899492981161312	0.9204675782920699	0.9268155515133806	0.784515980472033	0.9160276724904372	0.9905934057415613	0.9357264373572229	0.9853495651625582	0.9186595541595897	0.9509726911567646	BRCA1	3.458879566726189	0.010563565807662701	0.5419560155120805	0.604663137301014	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	0.9335001818236008	0.8515877673158113	0.9560825583379694	0.9280970078246464	0.9402713519288463	0.8899492981161312	0.9204675782920699	0.9268155515133806	0.784515980472033	0.9160276724904372	0.9905934057415613	0.9357264373572229	0.9853495651625582	0.9186595541595897	0.9509726911567646	BRCA1		14613		CCSBVarC013096		NC_000017.11:43063909:C:G	1805G>C	Gly602Ala																												17.0	43063909.0	C	G	17						17-43063909-C-G	70073.0	single nucleotide variant	NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80356860.0	-	RCV000048801|RCV000077598|RCV000162991|RCV001086320|RCV001353853|RCV000586262	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063909.0	43063909.0	17q21.31	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502	2.0	55406.0	43063909.0	C	G	-	-	-	-	-	-	SCV000244384	-	-	5117G>C 	Gly1706Ala	NM_007294.4	3.0	2_Benign		55406.0	17	43063909.0	C	G	G	A	rs80356860	17	41215926.0	17	38469452.0	1706.0	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5117G>C	p.Gly1706Ala	principal2	Y	.	.	.	-	GGA	2.0	0.0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.858	0.90580	P	0.415	0.97365	B	.	0.97016	.	.	.	.	1.88	0.49806	L	.	0.77997	.	.	0.83220	-0.0839	0.80378	T	0.4691	0.79463	T	10.0	.	0.52478	.	0.376865	0.92864	D	.	0.79354	.	.	.	.	.	.	0.85197	.	0.86205	.	0.41014	0.788811266422	0.80226	T	0.144841	0.58712	T	0.220015	0.75596	D	0.234626	0.84783	D	0.174270822478175	0.18632	T	.	0.95417	.	0.7676474	0.81684	0.45108074	0.67803	0.816965	0.84823	0.6340818	0.78412	-8.619	0.65921	D	.	0.77716	.	0.953210802210829	0.80831	0.99961549	0.99542	0.738	0.85485	.	.	.	.	.	.	4.015836	0.59356	24.1	0.9983272752129662	0.91463	0.783255	0.71325	D	0.704029495450117	0.79789	7.175777	0.72533764037511	0.84214	8.254455	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.0	0.68239	0.995	0.73271	549	0.72286	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	25	264690	9.445011E-5	.	4	109376	3.657110e-05	0	11	208038	5.287500e-05	0	10	236838	4.222300e-05	0	0	7158	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	1	13394	7.466030e-05	0	1	42758	2.338740e-05	0	0	15682	0.000000e+00	0	1	42758	2.338740e-05	0	0	16206	0.000000e+00	0	1	30514	3.277180e-05	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	1	16734	5.975860e-05	0	5	89502	5.586470e-05	0	0	30596	0.000000e+00	0	5	89502	5.586470e-05	0	0	14892	0.000000e+00	0	0	34250	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	1	21628	4.623640e-05	0	5	102688	4.869120e-05	0	0	30514	0.000000e+00	0	5	102688	4.869120e-05	0	.	75	1614060	4.646670e-05	0	4	6062	6.598480e-04	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	4	59998	6.666890e-05	0	0	29604	0.000000e+00	0	0	44864	0.000000e+00	0	8	64028	1.249450e-04	0	4	6062	6.598480e-04	0	48	1179976	4.067880e-05	0	0	91072	0.000000e+00	0	2	31050	6.44122383252818E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4596	2.175805047867711E-4	0	2918	0	0	112	0	3	39902	7.518420129316827E-5	Benign	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Malignant_tumor_of_breast	reviewed_by_expert_panel	NC_000017.11:g.43063909C>G	BRCA1-HCI:BRCA1_00109|ClinGen:CA003250|UniProtKB:P38398#VAR_070502	C0027672|CN169374|C3661900|C0677776|C2676676|C0006142	604370	140162|145|145	BRCT domain|BRCT domain|BRCT domain	Gly	Ala	70073.0	single nucleotide variant	NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80356860.0	-	RCV000048801|RCV000077598|RCV000162991|RCV001086320|RCV001353853|RCV000586262	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063909.0	43063909.0	17q21.31	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502	2.0	55406.0	43063909.0	C	G	-	-	-	-	-	-	SCV000244384	-	-	5117G>C 	Gly1706Ala	NM_007294.4	3.0	2_Benign	95.97	0.0	['604370']	unknown	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	95.97	0.0	<10	>90																																																																																																																																		true	BRCA1Gly602Ala																																																																																																																																																																																																																																		
FH	FH_Gln376Pro	4.964945865150239	0.0025396516076362347	-7.121042736745749	0.00019011851741779218	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9549051546009037	0.8207792549503905	0.9377944606532265	0.8931372409154646	0.5882125537797547	0.4809332923956441	0.8970850884189809	0.9209322629506538	0.7859056690255877	0.9509859139522358	0.6954918151638652	0.8891893934119484	0.9546566583557993	0.8556528408751934	0.9588243952495716	FH	4.964945865150239	0.0025396516076362347	-7.121042736745749	0.00019011851741779218	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	0.9549051546009037	0.8207792549503905	0.9377944606532265	0.8931372409154646	0.5882125537797547	0.4809332923956441	0.8970850884189809	0.9209322629506538	0.7859056690255877	0.9509859139522358	0.6954918151638652	0.8891893934119484	0.9546566583557993	0.8556528408751934	0.9588243952495716	FH	ENSG00000091483	3408	214601.0	CCSBVarC004055	ALE00004055	NC_000001.11:241502552:T:G	1127A>C	Gln376Pro	CEGS2	CegsMutGDEh1042	C05	GDEhDisVCh_40065	B09	1.0	CegsMutGDDh1042	C05							1.0	1.0	1.0	1.0	0.0			0.0			0.0			1.0	241502552.0	T	G	1	Y	Y	N	N	N	1-241502552-T-G	51260.0	single nucleotide variant	NM_000143.4(FH):c.1127A>C (p.Gln376Pro)	2271.0	FH	HGNC:3700	Conflicting classifications of pathogenicity	1.0	Jan 29, 2025	200796606.0	-	RCV000163798|RCV000199873|RCV002280864|RCV000034920|RCV004595492	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MONDO:MONDO:0007256,MedGen:C2239176,OMIM:114550,Orphanet:88673|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary cancer-predisposing syndrome|not provided|Hepatocellular carcinoma|Fumarase deficiency|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241502552.0	241502552.0	1q43	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA189211	3.0	42094.0	241502552.0	T	G	-	-	-	-	-	-	SCV000214379|SCV000251429|SCV000632435|SCV001428576|SCV002022985|SCV003928116|SCV004197296|SCV005640073	-	-	1127A>C 	Gln376Pro	NM_000143.4	1.0	3_Conflicting	0.0000465174	42094.0	1	241502552.0	T	G	Q	P	rs200796606	1	241665852.0	1	239732475.0	376.0	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1127A>C	p.Gln376Pro	c.1127A>C	p.Gln376Pro	principal1	Y	1	YES	Select	-	CAG	2.0	0.0	T	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.55	0.99107	H	-5.97	0.89297	D	0.588	0.60631	0.9801	0.96852	D	0.9899	0.99722	D	10.0	0.89965594	0.89206	D	0.783004	0.98288	D	0.970	0.99647	.	.	.	.	.	0.988874007372	0.98862	0.9931077487324933	0.99305	1.08544749973	0.77132	0.73917901516	0.72804	T	0.978282	0.99806	D	0.409114	0.90364	D	0.565222	0.95975	D	0.996202170848846	0.8878	D	0.989101	0.96387	D	0.99478674	0.99956	0.97383636	0.99614	0.99478674	0.99956	0.97383636	0.99615	-15.301	0.96526	D	0.89	0.82051	P	0.999990050804425	0.99831	0.96386050	0.94214	0.995	0.99826	.	.	.	.	.	.	4.747101	0.76664	26.5	0.9969500950308227	0.80201	0.750574	0.69053	D	0.94256199435676	0.93648	12.20484	0.851050495351092	0.93038	11.80997	5.96	5.96	0.96689	.	.	2.556	0.45625	7.892000	0.73146	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	19	264690	7.178209E-5	segdup	7	109398	6.398650e-05	0	12	208098	5.766510e-05	0	15	236884	6.332210e-05	0	1	7164	1.395870e-04	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	1	13394	7.466030e-05	0	5	42768	1.169100e-04	0	0	15688	0.000000e+00	0	1	7164	1.395870e-04	0	1	16218	6.165990e-05	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	1	16734	5.975860e-05	0	10	89552	1.116670e-04	0	0	30606	0.000000e+00	0	10	89552	1.116670e-04	0	1	14902	6.710510e-05	0	0	34238	0.000000e+00	0	0	9570	0.000000e+00	0	0	17688	0.000000e+00	0	2	21632	9.245560e-05	0	12	102714	1.168290e-04	0	0	30524	0.000000e+00	0	12	102714	1.168290e-04	0	.	75	1614038	4.646730e-05	0	10	64034	1.561670e-04	0	2	74940	2.668800e-05	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44886	0.000000e+00	0	10	64034	1.561670e-04	0	0	6084	0.000000e+00	0	62	1180012	5.254180e-05	0	0	91086	0.000000e+00	0	18	178358	1.0092062032541293E-4	0	352	0	0	2686	0	1	8798	1.1366219595362583E-4	0	796	0	0	968	0	0	652	0	0	280	0	1	13144	7.608034083992696E-5	1	9150	1.092896174863388E-4	0	3338	0	20	206034	9.707135715464438E-5	Conflicting_classifications_of_pathogenicity	not_provided|Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|Hepatocellular_carcinoma|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_conflicting_classifications	NC_000001.11:g.241502552T>G	ClinGen:CA189211	C3661900|C0342770|C0027672|C2239176|C1708350	606812|114550|150800	24|140162|88673|523	Fumarate lyase, N-terminal	Gln	Pro	51260.0	single nucleotide variant	NM_000143.4(FH):c.1127A>C (p.Gln376Pro)	2271.0	FH	HGNC:3700	Conflicting classifications of pathogenicity	1.0	Jan 29, 2025	200796606.0	-	RCV000163798|RCV000199873|RCV002280864|RCV000034920|RCV004595492	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MONDO:MONDO:0007256,MedGen:C2239176,OMIM:114550,Orphanet:88673|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary cancer-predisposing syndrome|not provided|Hepatocellular carcinoma|Fumarase deficiency|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241502552.0	241502552.0	1q43	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA189211	3.0	42094.0	241502552.0	T	G	-	-	-	-	-	-	SCV000214379|SCV000251429|SCV000632435|SCV001428576|SCV002022985|SCV003928116|SCV004197296|SCV005640073	-	-	1127A>C 	Gln376Pro	NM_000143.4	1.0	3_Conflicting	98.7	0.1363636363636363	['114550', '606812', '606812', '150800']	multiple	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEPATOCELLULAR CARCINOMA; FUMARASE DEFICIENCY; FUMARASE DEFICIENCY; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	98.7	0.13636364	10-90	>90						Q	27			98.7	Polar/Neutral	Glutamine		Fumarate hydratase, mitochondrial										-3.5			4 interactions					Q376-M380, Q376-S429; PAE: 1.0, 1.0	6 interactions	Q376-M380, Q376-F430, Q376-S429; PAE: 1.0, 1.0, 1.0	10 interactions							146									-68.2				-33.3						H (helix)	H (α-helix)	Helix																																																																			true	FHGln376Pro																																																																																																																																																																																																																																		
